[
  {
    "id": "DEXA_Synt_45395",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41331332",
    "title": "Pentraxin 3 ameliorates glucocorticoid-induced osteonecrosis of the femoral head via TLR4/NF-κB/FGF21 signaling axis.",
    "authors": [
      "Li J",
      "Zhou Z",
      "Kong Y",
      "Li Y",
      "Wang Z",
      "Yang Y",
      "Wang J",
      "Liu T",
      "Wang X",
      "Luo D",
      "Zhang F",
      "Qiu C",
      "Liu J"
    ],
    "journal": "Commun Biol",
    "publicationDate": "2025-12-3",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "data_entry",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5c548c05-909c-4712-8fff-18d0ee10b795",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:18.977Z"
      },
      {
        "id": "b2b8fa33-2e3e-4086-9082-460b2ee17f4d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 83e34ee6-6524-4419-b6e7-e908f0d5c0c2 to DEXA_Synt_45395",
        "type": "system",
        "createdAt": "2025-12-14T10:11:56.364Z"
      },
      {
        "id": "8cd72975-8c8f-4949-ab36-9cc301b23ff0",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-15T19:34:32.829Z",
        "type": "system"
      },
      {
        "id": "2b6ac941-3dd5-41f5-9552-f61853359dd8",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to Data Entry.",
        "timestamp": "2025-12-15T19:34:37.544Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:36.929Z",
    "updatedAt": "2025-12-15T19:34:42.052Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41331332",
      "DOI": "https://doi.org10.1038/s42003-025-09282-3",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:54:44",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Li J, Zhou Z, Kong Y, Li Y, Wang Z, Yang Y, Wang J, Liu T, Wang X, Luo D, Zhang F, Qiu C, Liu J. Pentraxin 3 ameliorates glucocorticoid-induced osteonecrosis of the femoral head via TLR4/NF-κB/FGF21 signaling axis. Commun Biol. 2025;",
      "pubdate": "2025-12-3",
      "Lead_author": "Li J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s42003-025-09282-3",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Li J, Zhou Z, Kong Y, Li Y, Wang Z, Yang Y, Wang J, Liu T, Wang X, Luo D, Zhang F, Qiu C, Liu J. Pentraxin 3 ameliorates glucocorticoid-induced osteonecrosis of the femoral head via TLR4/NF-κB/FGF21 signaling axis. Commun Biol. 2025;",
    "leadAuthor": "Li J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "not_applicable",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjsBgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjsBgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6df9-dc10f00501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765827282
  },
  {
    "id": "DEXA_Synt_94020",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41330797",
    "title": "Duration of analgesia after supraclavicular brachial plexus block with intravenous dexamethasone with or without dexmedetomidine: a randomised, placebo-controlled, triple-blind trial.",
    "authors": [
      "Grape S",
      "Andany A",
      "Cibotto C",
      "Berri L",
      "Rossel JB",
      "Albrecht E"
    ],
    "journal": "Br J Anaesth",
    "publicationDate": "2025-12-3",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "d0984dd0-f8bc-443a-8772-11e38824bc85",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.030Z"
      },
      {
        "id": "a6d64600-98bc-49ae-b28b-0c715efff9cd",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from c26b82fa-2169-4b51-9520-6a4ae84594f6 to DEXA_Synt_94020",
        "type": "system",
        "createdAt": "2025-12-14T10:11:56.448Z"
      },
      {
        "id": "94711000-6e68-4a80-bbd5-b5a8eebbfe3d",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"AOI\". Moving to QC Triage.",
        "timestamp": "2025-12-15T19:34:50.026Z",
        "type": "system"
      },
      {
        "id": "d24d6cdf-132d-4908-b44d-6ecf4030737d",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"AOI\" approved by QC",
        "timestamp": "2025-12-15T19:38:25.929Z",
        "type": "QC_approval"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:37.005Z",
    "updatedAt": "2025-12-15T19:38:25.941Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41330797",
      "DOI": "https://doi.org10.1016/j.bja.2025.10.049",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:54:21",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Grape S, Andany A, Cibotto C, Berri L, Rossel JB, Albrecht E. Duration of analgesia after supraclavicular brachial plexus block with intravenous dexamethasone with or without dexmedetomidine: a randomised, placebo-controlled, triple-blind trial. Br J Anaesth. 2025;",
      "pubdate": "2025-12-3",
      "Lead_author": "Grape S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.bja.2025.10.049",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Grape S, Andany A, Cibotto C, Berri L, Rossel JB, Albrecht E. Duration of analgesia after supraclavicular brachial plexus block with intravenous dexamethasone with or without dexmedetomidine: a randomised, placebo-controlled, triple-blind trial. Br J Anaesth. 2025;",
    "leadAuthor": "Grape S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "AOI",
    "effectiveClassification": "AOI",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-15T19:38:25.929Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjtBgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjtBgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dfa-61830c0501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765827505
  },
  {
    "id": "DEXA_Synt_44523",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41330698",
    "title": "Effectiveness of Fascia Iliaca Compartment Blocks for Pain Relief After Hip Arthroplasty Using Ropivacaine and Dexamethasone.",
    "authors": [
      "Pham QM",
      "Pham HS",
      "Nguyen TH",
      "Nguyen HT"
    ],
    "journal": "Asian J Anesthesiol",
    "publicationDate": "2025-12-3",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_data_entry",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5dfb8131-3217-4ce3-84aa-33d1f8b83001",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.056Z"
      },
      {
        "id": "21883ce5-0d35-4109-855a-4ccd9dcf0976",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3aec1fdd-7bcc-44f7-8e85-467a41f3f723 to DEXA_Synt_44523",
        "type": "system",
        "createdAt": "2025-12-14T10:11:56.492Z"
      },
      {
        "id": "394bcc93-7f16-4c57-b62d-d398b6fd01f2",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"No Case\". Moving to QC Triage.",
        "timestamp": "2025-12-15T19:37:38.270Z",
        "type": "system"
      },
      {
        "id": "a12c1098-a3cf-4e7a-9e49-49f8eb86bb39",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to Data Entry.",
        "timestamp": "2025-12-15T19:37:41.804Z",
        "type": "system"
      },
      {
        "id": "a48ffd43-57d7-471b-ac83-971dd452e827",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"No Case\". Moving to QC Data Entry.",
        "timestamp": "2025-12-15T19:37:43.824Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:37.043Z",
    "updatedAt": "2025-12-15T19:38:09.378Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41330698",
      "DOI": "https://doi.org10.6859/aja.202511/PP.0001",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:55:00",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Pham QM, Pham HS, Nguyen TH, Nguyen HT. Effectiveness of Fascia Iliaca Compartment Blocks for Pain Relief After Hip Arthroplasty Using Ropivacaine and Dexamethasone. Asian J Anesthesiol. 2025;",
      "pubdate": "2025-12-3",
      "Lead_author": "Pham QM",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.6859/aja.202511/PP.0001",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Pham QM, Pham HS, Nguyen TH, Nguyen HT. Effectiveness of Fascia Iliaca Compartment Blocks for Pain Relief After Hip Arthroplasty Using Ropivacaine and Dexamethasone. Asian J Anesthesiol. 2025;",
    "leadAuthor": "Pham QM",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjuBgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjuBgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dfa-57a3d00501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765827489
  },
  {
    "id": "DEXA_Synt_17875",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41328200",
    "title": "Diagnostic Challenges of Adrenal Venous Sampling for Primary Hyperaldosteronism in a Patient With Subclinical Cushing's Syndrome: A Case Report.",
    "authors": [
      "Malekian M",
      "Sadra V",
      "Bahrami A",
      "Jalili J",
      "Ashayeri H"
    ],
    "journal": "Clin Case Rep",
    "publicationDate": "2025-12-2",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "fefa647d-fd8f-4aa1-83ae-2cc8c20d8f9b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.087Z"
      },
      {
        "id": "1fc52e27-19a3-490c-9d7c-58b3a9c194c2",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 54ca5c1a-c5bf-48b2-8689-9f13d9836396 to DEXA_Synt_17875",
        "type": "system",
        "createdAt": "2025-12-14T10:11:56.537Z"
      },
      {
        "id": "e3b986c8-1cb5-4146-82c0-c28625526daa",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"AOI\". Moving to QC Triage.",
        "timestamp": "2025-12-15T19:37:56.247Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:37.073Z",
    "updatedAt": "2025-12-15T19:38:09.448Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41328200",
      "DOI": "https://doi.org10.1002/ccr3.71578",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:55:09",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Malekian M, Sadra V, Bahrami A, Jalili J, Ashayeri H. Diagnostic Challenges of Adrenal Venous Sampling for Primary Hyperaldosteronism in a Patient With Subclinical Cushing's Syndrome: A Case Report. Clin Case Rep. 2025;13(12):e71578",
      "pubdate": "2025-12-2",
      "Lead_author": "Malekian M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/ccr3.71578",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Malekian M, Sadra V, Bahrami A, Jalili J, Ashayeri H. Diagnostic Challenges of Adrenal Venous Sampling for Primary Hyperaldosteronism in a Patient With Subclinical Cushing's Syndrome: A Case Report. Clin Case Rep. 2025;13(12):e71578",
    "leadAuthor": "Malekian M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "AOI",
    "effectiveClassification": "AOI",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjvBgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjvBgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dfa-57ae740501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765827489
  },
  {
    "id": "DEXA_Synt_13687",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41327520",
    "title": "Lycium Radicis Cortex and Its Kukoamine Constituents Attenuate Sarcopenia by Modulating Anabolic and Catabolic Pathways.",
    "authors": [
      "Kim JY",
      "Son RH",
      "Kim SY",
      "Kim JH",
      "Kim S",
      "Kim CY"
    ],
    "journal": "Biomol Ther (Seoul)",
    "publicationDate": "2025-12-2",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "data_entry",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a826100f-062a-4512-a523-1e371fb9e93b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.119Z"
      },
      {
        "id": "a668efab-ee14-4796-bbf5-485caab75317",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9f4b63eb-c1a1-420e-8131-7621b1d6169c to DEXA_Synt_13687",
        "type": "system",
        "createdAt": "2025-12-14T10:11:56.597Z"
      },
      {
        "id": "aa50533c-5375-482d-a11f-a672f206f1ce",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"AOI\". Moving to QC Triage.",
        "timestamp": "2025-12-15T19:48:33.937Z",
        "type": "system"
      },
      {
        "id": "ca356060-18ba-4267-bc07-05fe1298aeeb",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"AOI\". Moving to Data Entry.",
        "timestamp": "2025-12-15T19:50:10.421Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:37.106Z",
    "updatedAt": "2025-12-15T19:51:46.926Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41327520",
      "DOI": "https://doi.org10.4062/biomolther.2025.134",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:54:28",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Kim JY, Son RH, Kim SY, Kim JH, Kim S, Kim CY. Lycium Radicis Cortex and Its Kukoamine Constituents Attenuate Sarcopenia by Modulating Anabolic and Catabolic Pathways. Biomol Ther (Seoul). 2025;",
      "pubdate": "2025-12-2",
      "Lead_author": "Kim JY",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.4062/biomolther.2025.134",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Kim JY, Son RH, Kim SY, Kim JH, Kim S, Kim CY. Lycium Radicis Cortex and Its Kukoamine Constituents Attenuate Sarcopenia by Modulating Anabolic and Catabolic Pathways. Biomol Ther (Seoul). 2025;",
    "leadAuthor": "Kim JY",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Adverse Event",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "AOI",
    "effectiveClassification": "AOI",
    "qaApprovalStatus": "not_applicable",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjwBgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjwBgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dfc-3eef200501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765828306
  },
  {
    "id": "DEXA_Synt_98288",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41324227",
    "title": "Amorphous calcium phosphate tagged benzimidazole derivative MR10 nanoconjugate mitigates corticosteroid induced secondary osteoporosis .",
    "authors": [
      "Gopi S",
      "Prethiba S",
      "Madesh S",
      "Chitra V",
      "Muthu Kumaradoss K",
      "Nallasivan Palani K",
      "Rajagopal R",
      "Alfarhan A",
      "Choi KC",
      "Palaniappan S",
      "Arockiaraj J"
    ],
    "journal": "J Drug Target",
    "publicationDate": "2025-12-1",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "data_entry",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "29fcf672-f6d3-4b01-9aad-300d7a761056",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.148Z"
      },
      {
        "id": "adbe22a3-7720-4881-8e82-e67e3e35b606",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 5bd13a34-0dbf-4475-b01b-9c3489e3dc24 to DEXA_Synt_98288",
        "type": "system",
        "createdAt": "2025-12-14T10:11:56.814Z"
      },
      {
        "id": "afb15ea7-ac29-4e60-bbe1-dd450171daca",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-15T19:51:52.075Z",
        "type": "system"
      },
      {
        "id": "97246a27-ecd3-4af3-8b6c-ac710f22b821",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to Data Entry.",
        "timestamp": "2025-12-15T19:52:09.746Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:37.143Z",
    "updatedAt": "2025-12-15T19:53:19.661Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41324227",
      "DOI": "https://doi.org10.1080/1061186X.2025.2596084",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:54:53",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Gopi S, Prethiba S, Madesh S, Chitra V, Muthu Kumaradoss K, Nallasivan Palani K, Rajagopal R, Alfarhan A, Choi KC, Palaniappan S, Arockiaraj J. Amorphous calcium phosphate tagged benzimidazole derivative MR10 nanoconjugate mitigates corticosteroid induced secondary osteoporosis <i>in vivo</i>. J Drug Target. 2025;1-24",
      "pubdate": "2025-12-1",
      "Lead_author": "Gopi S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/1061186X.2025.2596084",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Gopi S, Prethiba S, Madesh S, Chitra V, Muthu Kumaradoss K, Nallasivan Palani K, Rajagopal R, Alfarhan A, Choi KC, Palaniappan S, Arockiaraj J. Amorphous calcium phosphate tagged benzimidazole derivative MR10 nanoconjugate mitigates corticosteroid induced secondary osteoporosis <i>in vivo</i>. J Drug Target. 2025;1-24",
    "leadAuthor": "Gopi S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "not_applicable",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjxBgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjxBgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dfc-7635880501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765828399
  },
  {
    "id": "DEXA_Synt_53846",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41323877",
    "title": "Outcomes of adults with community-acquired bacterial meningitis in the Netherlands: a prospective nationwide cohort study.",
    "authors": [
      "Drost EHGM",
      "Schepers EN",
      "Chekrouni N",
      "van Soest TM",
      "Koelman DLH",
      "Bijlsma MW",
      "Brouwer MC",
      "van de Beek D"
    ],
    "journal": "Lancet Reg Health Eur",
    "publicationDate": "2025-12-1",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "data_entry",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "87aca747-a47a-4485-a43e-8565e62128c4",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.179Z"
      },
      {
        "id": "fa941aac-7cf7-4fa3-ac2f-c418fd089e7f",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9f895ff0-4f8e-4178-b9e4-f04b7721dc2c to DEXA_Synt_53846",
        "type": "system",
        "createdAt": "2025-12-14T10:11:57.049Z"
      },
      {
        "id": "5edbb734-d9fa-401b-b92c-4deaec11c396",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-15T19:53:42.197Z",
        "type": "system"
      },
      {
        "id": "62ec7180-01c3-4111-a1f9-eb393b334f49",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to Data Entry.",
        "timestamp": "2025-12-15T19:54:14.815Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:37.185Z",
    "updatedAt": "2025-12-15T19:56:04.028Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41323877",
      "DOI": "https://doi.org10.1016/j.lanepe.2025.101529",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:55:23",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Drost EHGM, Schepers EN, Chekrouni N, van Soest TM, Koelman DLH, Bijlsma MW, Brouwer MC, van de Beek D. Outcomes of adults with community-acquired bacterial meningitis in the Netherlands: a prospective nationwide cohort study. Lancet Reg Health Eur. 2026;61101529",
      "pubdate": "2025-12-1",
      "Lead_author": "Drost EHGM",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.lanepe.2025.101529",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Drost EHGM, Schepers EN, Chekrouni N, van Soest TM, Koelman DLH, Bijlsma MW, Brouwer MC, van de Beek D. Outcomes of adults with community-acquired bacterial meningitis in the Netherlands: a prospective nationwide cohort study. Lancet Reg Health Eur. 2026;61101529",
    "leadAuthor": "Drost EHGM",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Potential Valid case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "not_applicable",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjyBgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjyBgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dfc-d82e8c0501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765828564
  },
  {
    "id": "DEXA_Synt_12959",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41323644",
    "title": "Single-cell RNA sequencing data analysis of the inner ear in gentamicin-treated mice via intraperitoneal injection.",
    "authors": [
      "Bao X",
      "Wang Y",
      "Liu W",
      "Tang H",
      "Guo Y"
    ],
    "journal": "Open Med (Wars)",
    "publicationDate": "2025-12-1",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "data_entry",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "2bbcc7f9-c815-4c61-88f3-412bef7d5634",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.211Z"
      },
      {
        "id": "f5a1ab41-73c1-43a1-a392-48e4ddc678f1",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from c4d7d5e8-1459-4136-8627-9d07db0f4389 to DEXA_Synt_12959",
        "type": "system",
        "createdAt": "2025-12-14T10:11:57.264Z"
      },
      {
        "id": "599c671b-e4f2-4e21-927f-2c97fb13382d",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-15T19:56:13.345Z",
        "type": "system"
      },
      {
        "id": "70d6d2f1-bdea-4f33-8eea-6b72d8b69a93",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to Data Entry.",
        "timestamp": "2025-12-15T19:58:47.231Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:37.211Z",
    "updatedAt": "2025-12-15T19:58:47.240Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41323644",
      "DOI": "https://doi.org10.1515/med-2025-1242",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:54:36",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Bao X, Wang Y, Liu W, Tang H, Guo Y. Single-cell RNA sequencing data analysis of the inner ear in gentamicin-treated mice via intraperitoneal injection. Open Med (Wars). 2025;20(1):20251242",
      "pubdate": "2025-12-1",
      "Lead_author": "Bao X",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1515/med-2025-1242",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Bao X, Wang Y, Liu W, Tang H, Guo Y. Single-cell RNA sequencing data analysis of the inner ear in gentamicin-treated mice via intraperitoneal injection. Open Med (Wars). 2025;20(1):20251242",
    "leadAuthor": "Bao X",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Potential Valid case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "not_applicable",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjzBgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjzBgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dfd-3976a00501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765828727
  },
  {
    "id": "DEXA_Synt_63102",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41322616",
    "title": "Integrative Transcriptome and Machine Learning Analysis Uncovers Critical STAT3/GREM2 Signaling Mechanisms in Dexamethasone Treatment of Hashimoto's Thyroiditis.",
    "authors": [
      "Zeng H",
      "Chen Y",
      "Hu T",
      "Zhou Y",
      "Su M",
      "Lin L",
      "Ke Z"
    ],
    "journal": "ACS Omega",
    "publicationDate": "2025-12-1",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ac9b603f-5da8-4efb-86fe-c42de40c60e6",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.243Z"
      },
      {
        "id": "8015b819-a70a-449a-85e0-ba37f7e02fb4",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3379f0cb-e5d8-415a-a8d9-2775e2c6f5ab to DEXA_Synt_63102",
        "type": "system",
        "createdAt": "2025-12-14T10:11:57.496Z"
      },
      {
        "id": "95b787d9-f46e-48ca-a6d4-935e78cb69c4",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-15T19:59:00.322Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:37.244Z",
    "updatedAt": "2025-12-15T20:12:32.927Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41322616",
      "DOI": "https://doi.org10.1021/acsomega.5c04845",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:55:16",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Zeng H, Chen Y, Hu T, Zhou Y, Su M, Lin L, Ke Z. Integrative Transcriptome and Machine Learning Analysis Uncovers Critical STAT3/GREM2 Signaling Mechanisms in Dexamethasone Treatment of Hashimoto's Thyroiditis. ACS Omega. 2025;10(46):55377-",
      "pubdate": "2025-12-1",
      "Lead_author": "Zeng H",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1021/acsomega.5c04845",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Zeng H, Chen Y, Hu T, Zhou Y, Su M, Lin L, Ke Z. Integrative Transcriptome and Machine Learning Analysis Uncovers Critical STAT3/GREM2 Signaling Mechanisms in Dexamethasone Treatment of Hashimoto's Thyroiditis. ACS Omega. 2025;10(46):55377-",
    "leadAuthor": "Zeng H",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj0BgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj0BgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dff-259c740501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765829552
  },
  {
    "id": "DEXA_Synt_75668",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41320217",
    "title": "INDEX study: intravenous dexamethasone palmitate for prophylaxis of postoperative nausea and vomiting: a study protocol for a randomised controlled study.",
    "authors": [
      "Ren H",
      "Zhao C",
      "Yuan L",
      "Meng L",
      "Shen Y",
      "Luo F"
    ],
    "journal": "BMJ Open",
    "publicationDate": "2025-12-1",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "7a6dd44b-1e63-4113-9c97-497b06a67d05",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.273Z"
      },
      {
        "id": "8c8da618-1fc2-425c-bdd0-d4fb8f0950d7",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 001e9063-c663-4f3c-8d47-5d80f2fc2b2c to DEXA_Synt_75668",
        "type": "system",
        "createdAt": "2025-12-14T10:11:57.728Z"
      },
      {
        "id": "67f94560-c270-45b2-bf15-f1518c58ad99",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-15T20:02:41.640Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:37.275Z",
    "updatedAt": "2025-12-15T20:12:32.824Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41320217",
      "DOI": "https://doi.org10.1136/bmjopen-2025-106979",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:54:13",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Ren H, Zhao C, Yuan L, Meng L, Shen Y, Luo F. INDEX study: intravenous dexamethasone palmitate for prophylaxis of postoperative nausea and vomiting: a study protocol for a randomised controlled study. BMJ Open. 2025;15(11):e106979",
      "pubdate": "2025-12-1",
      "Lead_author": "Ren H",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1136/bmjopen-2025-106979",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Ren H, Zhao C, Yuan L, Meng L, Shen Y, Luo F. INDEX study: intravenous dexamethasone palmitate for prophylaxis of postoperative nausea and vomiting: a study protocol for a randomised controlled study. BMJ Open. 2025;15(11):e106979",
    "leadAuthor": "Ren H",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj1BgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj1BgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dff-258ca40501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765829552
  },
  {
    "id": "DEXA_Synt_51086",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41320029",
    "title": "Impact of a Discharge Prescription for Dexamethasone on Outcomes of Children Treated in the Emergency Department for Acute Asthma Exacerbations.",
    "authors": [
      "Lawless C",
      "Abreo A"
    ],
    "journal": "Pediatrics",
    "publicationDate": "2025-12-1",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ed12d499-8c44-4840-b8a3-fe5058f80b44",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.304Z"
      },
      {
        "id": "9439ac57-ea38-4120-9098-0ac25eb7d278",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from b758717c-439a-47e8-ae55-0d515ac85b02 to DEXA_Synt_51086",
        "type": "system",
        "createdAt": "2025-12-14T10:11:57.948Z"
      },
      {
        "id": "200ced37-1274-4ff7-b53f-d161d5819e6a",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-15T20:02:57.643Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:37.310Z",
    "updatedAt": "2025-12-15T20:12:32.975Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41320029",
      "DOI": "https://doi.org10.1542/peds.2025-074246NC",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:55:53",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Lawless C, Abreo A. Impact of a Discharge Prescription for Dexamethasone on Outcomes of Children Treated in the Emergency Department for Acute Asthma Exacerbations. Pediatrics. 2025;156(Suppl 2):S56-7",
      "pubdate": "2025-12-1",
      "Lead_author": "Lawless C",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1542/peds.2025-074246NC",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Lawless C, Abreo A. Impact of a Discharge Prescription for Dexamethasone on Outcomes of Children Treated in the Emergency Department for Acute Asthma Exacerbations. Pediatrics. 2025;156(Suppl 2):S56-7",
    "leadAuthor": "Lawless C",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Potential Valid case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj2BgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj2BgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dff-25a3e80501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765829552
  },
  {
    "id": "DEXA_Synt_12767",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41319785",
    "title": "Survival analysis of drug effectiveness of remdesivir and dexamethasone for confirmed COVID-19 patients using Japanese medical claim data.",
    "authors": [
      "Mitsushima S",
      "Horiguchi H",
      "Taniguchi K"
    ],
    "journal": "Int J Infect Dis",
    "publicationDate": "2025-12-1",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "data_entry",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "7ca6d682-b26a-412c-808e-72bc54fe4e1a",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.338Z"
      },
      {
        "id": "1353e564-4cc3-4ec1-a08e-66aacd82dccc",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 093982d7-2fde-4d9e-9fc3-a5d2fa64e68b to DEXA_Synt_12767",
        "type": "system",
        "createdAt": "2025-12-14T10:11:58.159Z"
      },
      {
        "id": "d705dc65-1443-475c-929a-c48ba0157497",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-15T20:14:37.140Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:37.335Z",
    "updatedAt": "2025-12-15T20:15:05.333Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41319785",
      "DOI": "https://doi.org10.1016/j.ijid.2025.108268",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:55:46",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Mitsushima S, Horiguchi H, Taniguchi K. Survival analysis of drug effectiveness of remdesivir and dexamethasone for confirmed COVID-19 patients using Japanese medical claim data. Int J Infect Dis. 2025;108268",
      "pubdate": "2025-12-1",
      "Lead_author": "Mitsushima S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ijid.2025.108268",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Mitsushima S, Horiguchi H, Taniguchi K. Survival analysis of drug effectiveness of remdesivir and dexamethasone for confirmed COVID-19 patients using Japanese medical claim data. Int J Infect Dis. 2025;108268",
    "leadAuthor": "Mitsushima S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Potential Valid case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-15T20:15:05.325Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Auto approved QC",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj3BgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj3BgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dff-8073f40501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765829705
  },
  {
    "id": "DEXA_Synt_56179",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41319386",
    "title": "Functional polygenic risk score of glucocorticoid-dependent regulatory element activity and its relation to clinical and stress-related phenotypes.",
    "authors": [
      "Linsen F",
      "Habets PC",
      "Milaneschi Y",
      "Penner-Goeke S",
      "Mishuris B",
      "Czamara D",
      "Penninx BWJH",
      "Binder EB",
      "Meijer OC",
      "Vinkers CH"
    ],
    "journal": "Psychoneuroendocrinology",
    "publicationDate": "2025-12-1",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "8c1dc093-6668-4d8b-b8a4-baf54704c2ad",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.369Z"
      },
      {
        "id": "6036714e-2186-4bc0-aa9c-d5f856c3ca3d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6a1226ff-3ed4-480b-aba5-3a750202f91d to DEXA_Synt_56179",
        "type": "system",
        "createdAt": "2025-12-14T10:11:58.362Z"
      },
      {
        "id": "63fd1bc7-2a4e-43fa-b992-66b7af922367",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"AOI\". Moving to QC Triage.",
        "timestamp": "2025-12-15T20:14:39.659Z",
        "type": "system"
      },
      {
        "id": "8eb5668c-eecd-4672-a2a5-a5c05cb1cd7e",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"AOI\" approved by QC",
        "timestamp": "2025-12-17T17:53:10.721Z",
        "type": "QC_approval"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:37.537Z",
    "updatedAt": "2025-12-17T17:53:10.733Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41319386",
      "DOI": "https://doi.org10.1016/j.psyneuen.2025.107703",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:55:39",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Linsen F, Habets PC, Milaneschi Y, Penner-Goeke S, Mishuris B, Czamara D, Penninx BWJH, Binder EB, Meijer OC, Vinkers CH. Functional polygenic risk score of glucocorticoid-dependent regulatory element activity and its relation to clinical and stress-related phenotypes. Psychoneuroendocrinology. 2025;184107703",
      "pubdate": "2025-12-1",
      "Lead_author": "Linsen F",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.psyneuen.2025.107703",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Linsen F, Habets PC, Milaneschi Y, Penner-Goeke S, Mishuris B, Czamara D, Penninx BWJH, Binder EB, Meijer OC, Vinkers CH. Functional polygenic risk score of glucocorticoid-dependent regulatory element activity and its relation to clinical and stress-related phenotypes. Psychoneuroendocrinology. 2025;184107703",
    "leadAuthor": "Linsen F",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Special Situations",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "AOI",
    "effectiveClassification": "AOI",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-17T17:53:10.721Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj4BgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj4BgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f7e-022e5c0501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765993990
  },
  {
    "id": "DEXA_Synt_14316",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41319363",
    "title": "Comprehensive review on outcomes from Phase 3 clinical trials of drugs in multiple myeloma.",
    "authors": [
      "Singh S",
      "Uttam V",
      "Haque S",
      "Tuli HS",
      "Mishra P",
      "Jain A"
    ],
    "journal": "Cancer Treat Res Commun",
    "publicationDate": "2025-11-30",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "750178b8-4a9d-4a4f-b0f3-93ce2c9bce9b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.402Z"
      },
      {
        "id": "09cb0340-2e2c-479f-aa0e-44800aad2c13",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a23ecf67-0961-4520-83d7-00941733cecb to DEXA_Synt_14316",
        "type": "system",
        "createdAt": "2025-12-14T10:11:58.607Z"
      },
      {
        "id": "19781c9c-879a-4daa-b643-1bdd7bed09d0",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"No Case\". Moving to QC Triage.",
        "timestamp": "2025-12-15T20:14:42.073Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:37.611Z",
    "updatedAt": "2025-12-15T20:15:05.266Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41319363",
      "DOI": "https://doi.org10.1016/j.ctarc.2025.101041",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:55:31",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Singh S, Uttam V, Haque S, Tuli HS, Mishra P, Jain A. Comprehensive review on outcomes from Phase 3 clinical trials of drugs in multiple myeloma. Cancer Treat Res Commun. 2025;45101041",
      "pubdate": "2025-11-30",
      "Lead_author": "Singh S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ctarc.2025.101041",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Singh S, Uttam V, Haque S, Tuli HS, Mishra P, Jain A. Comprehensive review on outcomes from Phase 3 clinical trials of drugs in multiple myeloma. Cancer Treat Res Commun. 2025;45101041",
    "leadAuthor": "Singh S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Pre-Clinical study",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-15T20:15:05.249Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Auto approved QC",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj5BgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj5BgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dff-80698c0501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765829705
  },
  {
    "id": "DEXA_Synt_61730",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41316326",
    "title": "The N-butanol extract of modified Yanghe decoction alleviates ferroptosis in bone marrow mesenchymal stem cells in glucocorticoid-induced osteoporosis by activating the HIF-1α/GPX4 signaling pathway.",
    "authors": [
      "Yang F",
      "Wu F",
      "Liu J",
      "Cao D",
      "Yang W",
      "Xia H"
    ],
    "journal": "J Orthop Surg Res",
    "publicationDate": "2025-11-29",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "data_entry",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "914568b8-3274-4f54-a568-d11aaadd2366",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.429Z"
      },
      {
        "id": "b5dc3a38-202d-4acc-b1b9-32d615e63474",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6048ddf7-b408-4466-9c5d-db8c3ff09dd9 to DEXA_Synt_61730",
        "type": "system",
        "createdAt": "2025-12-14T10:11:58.845Z"
      },
      {
        "id": "90165a52-948b-425e-ae16-98fd81933b26",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-15T20:14:44.886Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:37.778Z",
    "updatedAt": "2025-12-15T20:15:05.214Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41316326",
      "DOI": "https://doi.org10.1186/s13018-025-06404-9",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:56:08",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Yang F, Wu F, Liu J, Cao D, Yang W, Xia H. The N-butanol extract of modified Yanghe decoction alleviates ferroptosis in bone marrow mesenchymal stem cells in glucocorticoid-induced osteoporosis by activating the HIF-1α/GPX4 signaling pathway. J Orthop Surg Res. 2025;20(1):1049",
      "pubdate": "2025-11-29",
      "Lead_author": "Yang F",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s13018-025-06404-9",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Yang F, Wu F, Liu J, Cao D, Yang W, Xia H. The N-butanol extract of modified Yanghe decoction alleviates ferroptosis in bone marrow mesenchymal stem cells in glucocorticoid-induced osteoporosis by activating the HIF-1α/GPX4 signaling pathway. J Orthop Surg Res. 2025;20(1):1049",
    "leadAuthor": "Yang F",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Potential Valid case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-15T20:15:05.201Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Auto approved QC",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj6BgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj6BgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dff-8061440501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765829705
  },
  {
    "id": "DEXA_Synt_96907",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41312892",
    "title": "A multicentre prospective phase II study of rituximab combined with bortezomib, lenalidomide and dexamethasone, followed by lenalidomide maintenance (R-VRD) in patients with Waldenström's macroglobulinaemia (KMM1803).",
    "authors": [
      "Jung SH",
      "Kim D",
      "Lee JJ",
      "Kim K",
      "Min CK",
      "Lee JH",
      "Lee WS",
      "Lee JH",
      "Lee GW",
      "Kim MK",
      "Shin HJ",
      "Kim HJ",
      "Yi JH",
      "Lee HS"
    ],
    "journal": "Br J Haematol",
    "publicationDate": "2025-11-28",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "454cbde1-ae04-42bb-80e0-2830613253c1",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.458Z"
      },
      {
        "id": "33a1bb60-cf0c-4e37-bd0b-8eaa6e7d7cf6",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from bcad61fd-a199-4705-8ba5-61ef0363d228 to DEXA_Synt_96907",
        "type": "system",
        "createdAt": "2025-12-14T10:11:59.053Z"
      },
      {
        "id": "9c4fb082-cf0c-47c9-b645-0d506b6b1721",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"AOI\". Moving to QC Triage.",
        "timestamp": "2025-12-15T20:14:47.539Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:37.891Z",
    "updatedAt": "2025-12-15T20:15:05.379Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41312892",
      "DOI": "https://doi.org10.1111/bjh.70261",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:56:00",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Jung SH, Kim D, Lee JJ, Kim K, Min CK, Lee JH, Lee WS, Lee JH, Lee GW, Kim MK, Shin HJ, Kim HJ, Yi JH, Lee HS. A multicentre prospective phase II study of rituximab combined with bortezomib, lenalidomide and dexamethasone, followed by lenalidomide maintenance (R-VRD) in patients with Waldenström's macroglobulinaemia (KMM1803). Br J Haematol. 2025;",
      "pubdate": "2025-11-28",
      "Lead_author": "Jung SH",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/bjh.70261",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Jung SH, Kim D, Lee JJ, Kim K, Min CK, Lee JH, Lee WS, Lee JH, Lee GW, Kim MK, Shin HJ, Kim HJ, Yi JH, Lee HS. A multicentre prospective phase II study of rituximab combined with bortezomib, lenalidomide and dexamethasone, followed by lenalidomide maintenance (R-VRD) in patients with Waldenström's macroglobulinaemia (KMM1803). Br J Haematol. 2025;",
    "leadAuthor": "Jung SH",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Special Situations",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "AOI",
    "effectiveClassification": "AOI",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj7BgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj7BgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dff-807ab40501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765829705
  },
  {
    "id": "DEXA_Synt_63724",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41310738",
    "title": "Progressive vestibular dysfunction in unilateral acute otitis media with serous labyrinthitis: a case report.",
    "authors": [
      "Chen L",
      "Wu Y",
      "Li Y",
      "Zhang X",
      "Du J",
      "Zhang N",
      "Tang Z",
      "Wu Q",
      "Yuan Q"
    ],
    "journal": "J Med Case Rep",
    "publicationDate": "2025-11-28",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "16a8d7fb-d7e3-4b5a-aa64-79f5f6c3d1f3",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.491Z"
      },
      {
        "id": "9926a5d3-a7b4-4fe4-8ab9-c6d4013fa9eb",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f9c04bc9-031a-4352-a53c-9ef7692084b6 to DEXA_Synt_63724",
        "type": "system",
        "createdAt": "2025-12-14T10:11:59.300Z"
      },
      {
        "id": "7243f7f0-bfb5-4f2c-a474-d9c4b0a8a8bb",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"No Case\". Moving to QC Triage.",
        "timestamp": "2025-12-15T20:14:49.849Z",
        "type": "system"
      },
      {
        "id": "65925a60-df4e-4221-b5fe-86f0125afdf1",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"No Case\" approved by QC",
        "timestamp": "2025-12-17T17:53:04.619Z",
        "type": "QC_approval"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:38.044Z",
    "updatedAt": "2025-12-17T17:53:04.631Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41310738",
      "DOI": "https://doi.org10.1186/s13256-025-05651-y",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:56:23",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Chen L, Wu Y, Li Y, Zhang X, Du J, Zhang N, Tang Z, Wu Q, Yuan Q. Progressive vestibular dysfunction in unilateral acute otitis media with serous labyrinthitis: a case report. J Med Case Rep. 2025;19(1):617",
      "pubdate": "2025-11-28",
      "Lead_author": "Chen L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s13256-025-05651-y",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Chen L, Wu Y, Li Y, Zhang X, Du J, Zhang N, Tang Z, Wu Q, Yuan Q. Progressive vestibular dysfunction in unilateral acute otitis media with serous labyrinthitis: a case report. J Med Case Rep. 2025;19(1):617",
    "leadAuthor": "Chen L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Pre-Clinical study",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-17T17:53:04.619Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj8BgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj8BgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f7d-fe8b200501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765993984
  },
  {
    "id": "DEXA_Synt_67508",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41310270",
    "title": "Amelanotic melanoma of the central nervous system with systemic spread - imaging pitfalls and clues in a rare paediatric case with congenital melanocytic naevi.",
    "authors": [
      "Tan XY",
      "Teh DJW",
      "Tan TSE"
    ],
    "journal": "Childs Nerv Syst",
    "publicationDate": "2025-11-28",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b2e467b3-c5fc-465b-a30e-639a1e9bdb4b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.521Z"
      },
      {
        "id": "0b767c44-7766-4166-af61-e189696d38b7",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a53bdf8e-4ea9-4990-a0d4-2b41376db9da to DEXA_Synt_67508",
        "type": "system",
        "createdAt": "2025-12-14T10:11:59.562Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:38.152Z",
    "updatedAt": "2025-12-15T20:33:47.337Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41310270",
      "DOI": "https://doi.org10.1007/s00381-025-07045-3",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:56:38",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Tan XY, Teh DJW, Tan TSE. Amelanotic melanoma of the central nervous system with systemic spread - imaging pitfalls and clues in a rare paediatric case with congenital melanocytic naevi. Childs Nerv Syst. 2025;41(1):386",
      "pubdate": "2025-11-28",
      "Lead_author": "Tan XY",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s00381-025-07045-3",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Tan XY, Teh DJW, Tan TSE. Amelanotic melanoma of the central nervous system with systemic spread - imaging pitfalls and clues in a rare paediatric case with congenital melanocytic naevi. Childs Nerv Syst. 2025;41(1):386",
    "leadAuthor": "Tan XY",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj9BgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj9BgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6e02-1d37700501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765830827
  },
  {
    "id": "DEXA_Synt_59711",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41309377",
    "title": "Gut Microbiota Modulation by  EFEL6501 Ameliorates Muscle Atrophy.",
    "authors": [
      "Pyeon GN",
      "Seong H",
      "Moon JS",
      "Han NS"
    ],
    "journal": "J Microbiol Biotechnol",
    "publicationDate": "2025-11-28",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5014dac8-7290-4785-8090-8b32f22154db",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.553Z"
      },
      {
        "id": "22c8263e-5f24-4136-acbe-c97fbf6b7600",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from cd43dc50-4bf8-4384-892a-bd865d23a16f to DEXA_Synt_59711",
        "type": "system",
        "createdAt": "2025-12-14T10:11:59.808Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:38.308Z",
    "updatedAt": "2025-12-14T08:54:19.561Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41309377",
      "DOI": "https://doi.org10.4014/jmb.2508.08024",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:56:16",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Pyeon GN, Seong H, Moon JS, Han NS. Gut Microbiota Modulation by <i>Lacticaseibacillus paracasei</i> EFEL6501 Ameliorates Muscle Atrophy. J Microbiol Biotechnol. 2025;35e2508024",
      "pubdate": "2025-11-28",
      "Lead_author": "Pyeon GN",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.4014/jmb.2508.08024",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Pyeon GN, Seong H, Moon JS, Han NS. Gut Microbiota Modulation by <i>Lacticaseibacillus paracasei</i> EFEL6501 Ameliorates Muscle Atrophy. J Microbiol Biotechnol. 2025;35e2508024",
    "leadAuthor": "Pyeon GN",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj+BgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj+BgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-15c9ac0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707119
  },
  {
    "id": "DEXA_Synt_37112",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41309099",
    "title": "Epidemiology and Risk Factors for Arthrofibrosis Following Total Knee Arthroplasty: Towards Effective Prevention.",
    "authors": [
      "Hoveidaei AH",
      "Smitterberg C",
      "Tavakoli Y",
      "Moein SA",
      "Katanbaf RM",
      "Misch M",
      "Nace J",
      "Delanois RE",
      "Mont MA"
    ],
    "journal": "J Knee Surg",
    "publicationDate": "2025-11-28",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "27258452-93dc-4efc-bb8c-01c14435f818",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.581Z"
      },
      {
        "id": "2143e100-69ab-4db9-ba70-5b0708028b68",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 78dfb20a-da01-4a09-be3a-9ccdb41953c1 to DEXA_Synt_37112",
        "type": "system",
        "createdAt": "2025-12-14T10:11:59.997Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:38.403Z",
    "updatedAt": "2025-12-14T08:54:19.590Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41309099",
      "DOI": "https://doi.org10.1055/a-2756-0644",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:56:30",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Hoveidaei AH, Smitterberg C, Tavakoli Y, Moein SA, Katanbaf RM, Misch M, Nace J, Delanois RE, Mont MA. Epidemiology and Risk Factors for Arthrofibrosis Following Total Knee Arthroplasty: Towards Effective Prevention. J Knee Surg. 2025;",
      "pubdate": "2025-11-28",
      "Lead_author": "Hoveidaei AH",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1055/a-2756-0644",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Hoveidaei AH, Smitterberg C, Tavakoli Y, Moein SA, Katanbaf RM, Misch M, Nace J, Delanois RE, Mont MA. Epidemiology and Risk Factors for Arthrofibrosis Following Total Knee Arthroplasty: Towards Effective Prevention. J Knee Surg. 2025;",
    "leadAuthor": "Hoveidaei AH",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj-BgAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj-BgAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-15ed500501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707120
  },
  {
    "id": "DEXA_Synt_57481",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41300538",
    "title": "Evaluation of Dexamethasone and Swimming Exercise as Complementary Interventions in a Rat Sciatic Nerve Injury Model.",
    "authors": [
      "Karakoç M",
      "Ayaz H",
      "Çelik F",
      "Aşır F"
    ],
    "journal": "Antioxidants (Basel)",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6d45df0a-1eee-4f19-9171-d513f612d67d",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.618Z"
      },
      {
        "id": "153206e3-f6cd-4134-870d-ff9dd757227f",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 2e228aaa-915a-4886-bd89-99dfb8eebbf8 to DEXA_Synt_57481",
        "type": "system",
        "createdAt": "2025-12-14T10:12:00.211Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:38.573Z",
    "updatedAt": "2025-12-14T08:54:19.624Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41300538",
      "DOI": "https://doi.org10.3390/antiox14111382",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:56:45",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Karakoç M, Ayaz H, Çelik F, Aşır F. Evaluation of Dexamethasone and Swimming Exercise as Complementary Interventions in a Rat Sciatic Nerve Injury Model. Antioxidants (Basel). 2025;14(11):",
      "pubdate": "2025-11-27",
      "Lead_author": "Karakoç M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3390/antiox14111382",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Karakoç M, Ayaz H, Çelik F, Aşır F. Evaluation of Dexamethasone and Swimming Exercise as Complementary Interventions in a Rat Sciatic Nerve Injury Model. Antioxidants (Basel). 2025;14(11):",
    "leadAuthor": "Karakoç M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgABwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgABwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-160f4c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707120
  },
  {
    "id": "DEXA_Synt_55917",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41300500",
    "title": "Protective Effects of Thyme Leaf Extract Against Particulate Matter-Induced Pulmonary Injury in Mice.",
    "authors": [
      "Lee JK",
      "Bashir KMI",
      "Park HR",
      "Kwon JG",
      "Choi BR",
      "Choi JS",
      "Ku SK"
    ],
    "journal": "Antioxidants (Basel)",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b270f728-5890-42e3-be03-e7cfe79df2ec",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.643Z"
      },
      {
        "id": "6eafccff-6188-4264-9512-85b03615a267",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from ecb75b8e-1f55-4b06-b905-749e3e77c0ad to DEXA_Synt_55917",
        "type": "system",
        "createdAt": "2025-12-14T10:12:00.428Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:38.647Z",
    "updatedAt": "2025-12-14T08:54:19.650Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41300500",
      "DOI": "https://doi.org10.3390/antiox14111343",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:56:54",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Lee JK, Bashir KMI, Park HR, Kwon JG, Choi BR, Choi JS, Ku SK. Protective Effects of Thyme Leaf Extract Against Particulate Matter-Induced Pulmonary Injury in Mice. Antioxidants (Basel). 2025;14(11):",
      "pubdate": "2025-11-27",
      "Lead_author": "Lee JK",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3390/antiox14111343",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Lee JK, Bashir KMI, Park HR, Kwon JG, Choi BR, Choi JS, Ku SK. Protective Effects of Thyme Leaf Extract Against Particulate Matter-Induced Pulmonary Injury in Mice. Antioxidants (Basel). 2025;14(11):",
    "leadAuthor": "Lee JK",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgBBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgBBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-16307c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707120
  },
  {
    "id": "DEXA_Synt_60559",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41298283",
    "title": "Value of the Serum Dexamethasone Determination for the Diagnosis of Mild Autonomous Cortisol Secretion.",
    "authors": [
      "Araujo-Castro M",
      "Cortés Gómez A",
      "Rosillo M",
      "Rodríguez A",
      "Madrid I",
      "Pascual-Corrales E",
      "García Cano AM"
    ],
    "journal": "Clin Endocrinol (Oxf)",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9e05144f-6604-4236-9c71-a130d804ed63",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.674Z"
      },
      {
        "id": "d03c76a2-8fe3-4933-a8c9-ffd6cc2d3731",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from dda8210c-ca8f-40c7-ab65-023d9bdb7a7d to DEXA_Synt_60559",
        "type": "system",
        "createdAt": "2025-12-14T10:12:00.661Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:38.832Z",
    "updatedAt": "2025-12-14T08:54:19.684Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41298283",
      "DOI": "https://doi.org10.1111/cen.70065",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:57:15",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Araujo-Castro M, Cortés Gómez A, Rosillo M, Rodríguez A, Madrid I, Pascual-Corrales E, García Cano AM. Value of the Serum Dexamethasone Determination for the Diagnosis of Mild Autonomous Cortisol Secretion. Clin Endocrinol (Oxf). 2025;",
      "pubdate": "2025-11-27",
      "Lead_author": "Araujo-Castro M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/cen.70065",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Araujo-Castro M, Cortés Gómez A, Rosillo M, Rodríguez A, Madrid I, Pascual-Corrales E, García Cano AM. Value of the Serum Dexamethasone Determination for the Diagnosis of Mild Autonomous Cortisol Secretion. Clin Endocrinol (Oxf). 2025;",
    "leadAuthor": "Araujo-Castro M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgCBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgCBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1656400501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707120
  },
  {
    "id": "DEXA_Synt_55921",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41297521",
    "title": "Association between early dexamethasone administration and mortality in SARS-CoV-2 infection: A cohort study.",
    "authors": [
      "Báez-Saldaña R",
      "Murillo-Trejo E",
      "Barranco-Garduño L",
      "Neri-Salvador JC",
      "Jacobo-Vargas T",
      "Bazany-Rivero AL",
      "Rumbo-Nava U"
    ],
    "journal": "J Infect Public Health",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "565dab92-b2bc-4676-93a7-6c0d4cd45e2a",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.705Z"
      },
      {
        "id": "21ed78a6-1fcb-4820-89f2-731db7e4a989",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 78df818f-9a81-45e9-b0ff-7978b9d3259e to DEXA_Synt_55921",
        "type": "system",
        "createdAt": "2025-12-14T10:12:00.869Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:38.908Z",
    "updatedAt": "2025-12-14T08:54:19.710Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41297521",
      "DOI": "https://doi.org10.1016/j.jiph.2025.103066",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:57:00",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Báez-Saldaña R, Murillo-Trejo E, Barranco-Garduño L, Neri-Salvador JC, Jacobo-Vargas T, Bazany-Rivero AL, Rumbo-Nava U. Association between early dexamethasone administration and mortality in SARS-CoV-2 infection: A cohort study. J Infect Public Health. 2025;19(2):103066",
      "pubdate": "2025-11-27",
      "Lead_author": "Báez-Saldaña R",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jiph.2025.103066",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Báez-Saldaña R, Murillo-Trejo E, Barranco-Garduño L, Neri-Salvador JC, Jacobo-Vargas T, Bazany-Rivero AL, Rumbo-Nava U. Association between early dexamethasone administration and mortality in SARS-CoV-2 infection: A cohort study. J Infect Public Health. 2025;19(2):103066",
    "leadAuthor": "Báez-Saldaña R",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgDBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgDBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1677740501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707120
  },
  {
    "id": "DEXA_Synt_23556",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41296055",
    "title": "Dexamethasone regulates gene expression in chondrocytes through MKP-1 and downregulates cholesterol hydroxylases CH25H and CYP7B1.",
    "authors": [
      "Lehtola T",
      "Pemmari A",
      "Nummenmaa E",
      "Valjus I",
      "Hämäläinen M",
      "Moilanen T",
      "Vuolteenaho K",
      "Moilanen E"
    ],
    "journal": "Inflamm Res",
    "publicationDate": "2025-11-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6532bb02-c229-4912-9854-111b57acadcb",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.737Z"
      },
      {
        "id": "336b7444-4d98-4bc1-b679-09a55bf34d58",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 5594bf00-686d-493d-9c99-ec3909e7631d to DEXA_Synt_23556",
        "type": "system",
        "createdAt": "2025-12-14T10:12:01.098Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:39.110Z",
    "updatedAt": "2025-12-14T08:54:19.744Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41296055",
      "DOI": "https://doi.org10.1007/s00011-025-02121-5",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:57:09",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Lehtola T, Pemmari A, Nummenmaa E, Valjus I, Hämäläinen M, Moilanen T, Vuolteenaho K, Moilanen E. Dexamethasone regulates gene expression in chondrocytes through MKP-1 and downregulates cholesterol hydroxylases CH25H and CYP7B1. Inflamm Res. 2025;74(1):176",
      "pubdate": "2025-11-26",
      "Lead_author": "Lehtola T",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s00011-025-02121-5",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Lehtola T, Pemmari A, Nummenmaa E, Valjus I, Hämäläinen M, Moilanen T, Vuolteenaho K, Moilanen E. Dexamethasone regulates gene expression in chondrocytes through MKP-1 and downregulates cholesterol hydroxylases CH25H and CYP7B1. Inflamm Res. 2025;74(1):176",
    "leadAuthor": "Lehtola T",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgEBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgEBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1698b80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707121
  },
  {
    "id": "DEXA_Synt_54718",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41292503",
    "title": "Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan.",
    "authors": [
      "Suzuki K",
      "Ito M",
      "Sakai C",
      "Tsuchiya H",
      "Wu DB",
      "Koroki Y"
    ],
    "journal": "Curr Med Res Opin",
    "publicationDate": "2025-11-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "55724d7a-606a-4f9c-a40e-ca1f0095bf91",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.768Z"
      },
      {
        "id": "fa613134-e0ac-4e8f-99f7-81efa5a35880",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 7e38cd8f-dcea-45d8-aff3-0ca8b2abc2bf to DEXA_Synt_54718",
        "type": "system",
        "createdAt": "2025-12-14T10:12:01.330Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:39.148Z",
    "updatedAt": "2025-12-14T08:54:19.775Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41292503",
      "DOI": "https://doi.org10.1080/03007995.2025.2590840",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:57:23",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Suzuki K, Ito M, Sakai C, Tsuchiya H, Wu DB, Koroki Y. Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan. Curr Med Res Opin. 2025;1-12",
      "pubdate": "2025-11-26",
      "Lead_author": "Suzuki K",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/03007995.2025.2590840",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Suzuki K, Ito M, Sakai C, Tsuchiya H, Wu DB, Koroki Y. Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan. Curr Med Res Opin. 2025;1-12",
    "leadAuthor": "Suzuki K",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgFBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgFBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-16ba200501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707121
  },
  {
    "id": "DEXA_Synt_85003",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41288549",
    "title": "Bibliometric Analysis of Perioperative Sleep Disturbance From 2000 to 2023: Current Status and Development Trends.",
    "authors": [
      "Chen P",
      "He X"
    ],
    "journal": "J Perianesth Nurs",
    "publicationDate": "2025-11-25",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "8572c3fc-2436-48eb-9100-d82aca6f3498",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.797Z"
      },
      {
        "id": "e2d02c8e-daba-4472-9712-91510439ef3c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 2d974ca1-69fc-4b03-90c1-94c96523c1aa to DEXA_Synt_85003",
        "type": "system",
        "createdAt": "2025-12-14T10:12:01.549Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:39.341Z",
    "updatedAt": "2025-12-14T08:54:19.808Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41288549",
      "DOI": "https://doi.org10.1016/j.jopan.2025.07.020",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:57:54",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Chen P, He X. Bibliometric Analysis of Perioperative Sleep Disturbance From 2000 to 2023: Current Status and Development Trends. J Perianesth Nurs. 2025;",
      "pubdate": "2025-11-25",
      "Lead_author": "Chen P",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jopan.2025.07.020",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Chen P, He X. Bibliometric Analysis of Perioperative Sleep Disturbance From 2000 to 2023: Current Status and Development Trends. J Perianesth Nurs. 2025;",
    "leadAuthor": "Chen P",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgGBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgGBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-16daa00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707121
  },
  {
    "id": "DEXA_Synt_67572",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41287975",
    "title": "Are Glucocorticoids Associated with Worse Survival among Rheumatoid Arthritis Patients with Lung Cancer Treated with Immune Checkpoint Inhibitors?",
    "authors": [
      "Jannat-Khah D",
      "Curtis JR",
      "Xie F",
      "Saxena A",
      "Bass AR"
    ],
    "journal": "Are Glucocorticoids Associated with Worse Survival among Rheumatoid Arthritis Patients with Lung Cancer Treated with Immune Checkpoint Inhibitors? Arthritis Rheumatol",
    "publicationDate": "2025-11-25",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "7659c2e6-fbe4-4a45-8e75-1cc6221d34a9",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.830Z"
      },
      {
        "id": "551ad77b-fd53-4f85-9207-960d296f4745",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9c0a7ac3-4c7b-43e0-b903-25217abdfde6 to DEXA_Synt_67572",
        "type": "system",
        "createdAt": "2025-12-14T10:12:01.792Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:39.449Z",
    "updatedAt": "2025-12-14T08:54:19.838Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41287975",
      "DOI": "https://doi.org10.1002/art.43445",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:57:33",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Jannat-Khah D, Curtis JR, Xie F, Saxena A, Bass AR. Are Glucocorticoids Associated with Worse Survival among Rheumatoid Arthritis Patients with Lung Cancer Treated with Immune Checkpoint Inhibitors? Arthritis Rheumatol. 2025;",
      "pubdate": "2025-11-25",
      "Lead_author": "Jannat-Khah D",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/art.43445",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Jannat-Khah D, Curtis JR, Xie F, Saxena A, Bass AR. Are Glucocorticoids Associated with Worse Survival among Rheumatoid Arthritis Patients with Lung Cancer Treated with Immune Checkpoint Inhibitors? Arthritis Rheumatol. 2025;",
    "leadAuthor": "Jannat-Khah D",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgHBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgHBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-16fde00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707121
  },
  {
    "id": "DEXA_Synt_31446",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41287753",
    "title": "Peripheral Blood Glucocorticoid Receptor α/β (GRα/GRβ) Ratio Predicts Response to Pemetrexed-Based Chemotherapy in Non-Squamous NSCLC: A Prospective Cohort Study.",
    "authors": [
      "Forouzani-Haghighi B",
      "Rezvani A",
      "Geramizadeh B",
      "Esfandiari E",
      "Ghasemian M",
      "Vazin A"
    ],
    "journal": "Cancer Manag Res",
    "publicationDate": "2025-11-25",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "694b944c-a1d3-4ebe-8821-8076cfc649d5",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.859Z"
      },
      {
        "id": "31a77111-fbbc-47d7-9832-7f54bc5a9dfa",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from eafc36dc-f395-4495-a89b-a13b8286eb5f to DEXA_Synt_31446",
        "type": "system",
        "createdAt": "2025-12-14T10:12:02.006Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:39.589Z",
    "updatedAt": "2025-12-14T08:54:19.868Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41287753",
      "DOI": "https://doi.org10.2147/CMAR.S560466",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:57:46",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Forouzani-Haghighi B, Rezvani A, Geramizadeh B, Esfandiari E, Ghasemian M, Vazin A. Peripheral Blood Glucocorticoid Receptor α/β (GRα/GRβ) Ratio Predicts Response to Pemetrexed-Based Chemotherapy in Non-Squamous NSCLC: A Prospective Cohort Study. Cancer Manag Res. 2025;172837-49",
      "pubdate": "2025-11-25",
      "Lead_author": "Forouzani-Haghighi B",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.2147/CMAR.S560466",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Forouzani-Haghighi B, Rezvani A, Geramizadeh B, Esfandiari E, Ghasemian M, Vazin A. Peripheral Blood Glucocorticoid Receptor α/β (GRα/GRβ) Ratio Predicts Response to Pemetrexed-Based Chemotherapy in Non-Squamous NSCLC: A Prospective Cohort Study. Cancer Manag Res. 2025;172837-49",
    "leadAuthor": "Forouzani-Haghighi B",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgIBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgIBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-171e8c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707122
  },
  {
    "id": "DEXA_Synt_20023",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41286427",
    "title": "Optimizing adipogenic cocktail composition to enhance beige adipogenesis and evaluate thermogenic potential in primary mouse subcutaneous fat cell cultures.",
    "authors": [
      "Ma Y",
      "Zhang Z",
      "Ramos ET",
      "Martin E",
      "Gunukula R",
      "Sprabary K",
      "Jun H"
    ],
    "journal": "Int J Obes (Lond)",
    "publicationDate": "2025-11-25",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ed02321c-80dc-44d4-83c8-49e83a3c7dd8",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.890Z"
      },
      {
        "id": "6e13009a-885d-4424-870d-5f8b80281ad7",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 401adf9e-a190-4ab2-96e8-12355043aa38 to DEXA_Synt_20023",
        "type": "system",
        "createdAt": "2025-12-14T10:12:02.225Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:39.712Z",
    "updatedAt": "2025-12-14T08:54:19.896Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41286427",
      "DOI": "https://doi.org10.1038/s41366-025-01946-8",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:57:39",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Ma Y, Zhang Z, Ramos ET, Martin E, Gunukula R, Sprabary K, Jun H. Optimizing adipogenic cocktail composition to enhance beige adipogenesis and evaluate thermogenic potential in primary mouse subcutaneous fat cell cultures. Int J Obes (Lond). 2025;",
      "pubdate": "2025-11-25",
      "Lead_author": "Ma Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41366-025-01946-8",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Ma Y, Zhang Z, Ramos ET, Martin E, Gunukula R, Sprabary K, Jun H. Optimizing adipogenic cocktail composition to enhance beige adipogenesis and evaluate thermogenic potential in primary mouse subcutaneous fat cell cultures. Int J Obes (Lond). 2025;",
    "leadAuthor": "Ma Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgJBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgJBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1742740501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707122
  },
  {
    "id": "DEXA_Synt_23875",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41278499",
    "title": "Dexamethasone-loaded lipid-polymeric nanoparticles to improve therapy for cisplatin-induced sensorineural hearing loss.",
    "authors": [
      "Qi W",
      "Qiling H",
      "Liling L",
      "Zhicheng L",
      "Peng L",
      "Xiangli Z"
    ],
    "journal": "Nanoscale Adv",
    "publicationDate": "2025-11-24",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "cc41a930-610d-4adc-af74-355b739f418a",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.920Z"
      },
      {
        "id": "15a9a81f-bc2f-4c90-b91c-fd3b19a410c3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 23442574-48b3-4c54-ab4d-fd33759f4565 to DEXA_Synt_23875",
        "type": "system",
        "createdAt": "2025-12-14T10:12:02.444Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:39.837Z",
    "updatedAt": "2025-12-14T08:54:19.928Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41278499",
      "DOI": "https://doi.org10.1039/d5na00419e",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:58:02",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Qi W, Qiling H, Liling L, Zhicheng L, Peng L, Xiangli Z. Dexamethasone-loaded lipid-polymeric nanoparticles to improve therapy for cisplatin-induced sensorineural hearing loss. Nanoscale Adv. 2025;",
      "pubdate": "2025-11-24",
      "Lead_author": "Qi W",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1039/d5na00419e",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Qi W, Qiling H, Liling L, Zhicheng L, Peng L, Xiangli Z. Dexamethasone-loaded lipid-polymeric nanoparticles to improve therapy for cisplatin-induced sensorineural hearing loss. Nanoscale Adv. 2025;",
    "leadAuthor": "Qi W",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgKBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgKBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-17659c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707122
  },
  {
    "id": "DEXA_Synt_46132",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41275825",
    "title": "Carnosic acid attenuates ventilator-induced diaphragmatic dysfunction via activation of the Nrf2/HO-1 pathway.",
    "authors": [
      "Liu Z",
      "Yu Q",
      "Zhou X",
      "Ma H",
      "Wei R",
      "Xia J"
    ],
    "journal": "Int Immunopharmacol",
    "publicationDate": "2025-11-24",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b7ade92f-3128-4862-a90a-19b9b22346f3",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.953Z"
      },
      {
        "id": "391b0b33-df32-4f4e-a854-04917261d77e",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 2c06a1cf-40e4-4632-bfb3-e5cc15a59cba to DEXA_Synt_46132",
        "type": "system",
        "createdAt": "2025-12-14T10:12:02.658Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:39.973Z",
    "updatedAt": "2025-12-14T08:54:19.960Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41275825",
      "DOI": "https://doi.org10.1016/j.intimp.2025.115926",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:58:17",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Liu Z, Yu Q, Zhou X, Ma H, Wei R, Xia J. Carnosic acid attenuates ventilator-induced diaphragmatic dysfunction via activation of the Nrf2/HO-1 pathway. Int Immunopharmacol. 2025;168(Pt 2):115926",
      "pubdate": "2025-11-24",
      "Lead_author": "Liu Z",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.intimp.2025.115926",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Liu Z, Yu Q, Zhou X, Ma H, Wei R, Xia J. Carnosic acid attenuates ventilator-induced diaphragmatic dysfunction via activation of the Nrf2/HO-1 pathway. Int Immunopharmacol. 2025;168(Pt 2):115926",
    "leadAuthor": "Liu Z",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgLBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgLBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-17874c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707122
  },
  {
    "id": "DEXA_Synt_38177",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41274129",
    "title": "Retraction notice to 'Statistical modeling and optimization of dexamethasone adsorption from aqueous solution by Fe3O4@NH2-MIL88B nanorods: Isotherm, Kinetics, and Thermodynamic' [Environ. Res. 236 (2023) 116773].",
    "authors": [
      "Mahmoudian MH",
      "Azari A",
      "Jahantigh A",
      "Sarkhosh M",
      "Yousefi M",
      "Razavinasab SA",
      "Afsharizadeh M",
      "Mohammadi Shahraji F",
      "Pour Pasandi A",
      "Zeidabadi A",
      "Ilaghinezhad Bardsiri T",
      "Ghasemian M"
    ],
    "journal": "Environ Res",
    "publicationDate": "2025-11-23",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "f630c12a-8192-42b7-b0fb-5a90dbbc8274",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:19.984Z"
      },
      {
        "id": "f1461616-1082-4d5e-8de5-83c1dc03fb8b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 311c1666-8330-413d-96e0-ef86aeb10c7c to DEXA_Synt_38177",
        "type": "system",
        "createdAt": "2025-12-14T10:12:02.890Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:40.097Z",
    "updatedAt": "2025-12-14T08:54:19.991Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41274129",
      "DOI": "https://doi.org10.1016/j.envres.2025.123311",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:58:31",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Mahmoudian MH, Azari A, Jahantigh A, Sarkhosh M, Yousefi M, Razavinasab SA, Afsharizadeh M, Mohammadi Shahraji F, Pour Pasandi A, Zeidabadi A, Ilaghinezhad Bardsiri T, Ghasemian M. Retraction notice to 'Statistical modeling and optimization of dexamethasone adsorption from aqueous solution by Fe3O4@NH2-MIL88B nanorods: Isotherm, Kinetics, and Thermodynamic' [Environ. Res. 236 (2023) 116773]. Environ Res. 2025;289123311",
      "pubdate": "2025-11-23",
      "Lead_author": "Mahmoudian MH",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.envres.2025.123311",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Mahmoudian MH, Azari A, Jahantigh A, Sarkhosh M, Yousefi M, Razavinasab SA, Afsharizadeh M, Mohammadi Shahraji F, Pour Pasandi A, Zeidabadi A, Ilaghinezhad Bardsiri T, Ghasemian M. Retraction notice to 'Statistical modeling and optimization of dexamethasone adsorption from aqueous solution by Fe3O4@NH2-MIL88B nanorods: Isotherm, Kinetics, and Thermodynamic' [Environ. Res. 236 (2023) 116773]. Environ Res. 2025;289123311",
    "leadAuthor": "Mahmoudian MH",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgMBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgMBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-17a7b00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707122
  },
  {
    "id": "DEXA_Synt_41063",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41273382",
    "title": "Luminespib protects against dexamethasone-induced hepatic, vascular, and metabolic abnormalities in rats.",
    "authors": [
      "Aloufi MF",
      "Hazem SH",
      "Abdelaziz RR",
      "Suddek GM"
    ],
    "journal": "Naunyn Schmiedebergs Arch Pharmacol",
    "publicationDate": "2025-11-22",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "d42af44e-6dd9-4196-b33f-d9afc1509779",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.014Z"
      },
      {
        "id": "f25cbf16-48c5-4325-9527-37c5d0578ca3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 0030f910-c587-4067-96ed-14432c3b5785 to DEXA_Synt_41063",
        "type": "system",
        "createdAt": "2025-12-14T10:12:03.151Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:40.264Z",
    "updatedAt": "2025-12-14T08:54:20.023Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41273382",
      "DOI": "https://doi.org10.1007/s00210-025-04773-w",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:58:24",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Aloufi MF, Hazem SH, Abdelaziz RR, Suddek GM. Luminespib protects against dexamethasone-induced hepatic, vascular, and metabolic abnormalities in rats. Naunyn Schmiedebergs Arch Pharmacol. 2025;",
      "pubdate": "2025-11-22",
      "Lead_author": "Aloufi MF",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s00210-025-04773-w",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Aloufi MF, Hazem SH, Abdelaziz RR, Suddek GM. Luminespib protects against dexamethasone-induced hepatic, vascular, and metabolic abnormalities in rats. Naunyn Schmiedebergs Arch Pharmacol. 2025;",
    "leadAuthor": "Aloufi MF",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgNBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgNBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-17c7540501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707123
  },
  {
    "id": "DEXA_Synt_79409",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41273171",
    "title": "Revolutionizing Rheumatoid Arthritis Management: Glucocorticoid-Loaded, Folic Acid-Conjugated -Based Zinc-Oxide Nanoparticles.",
    "authors": [
      "Dwivedi SD",
      "Singh D",
      "Singh MR"
    ],
    "journal": "Assay Drug Dev Technol",
    "publicationDate": "2025-11-22",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "37302ced-e1ad-4fa8-881d-3834170753ee",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.046Z"
      },
      {
        "id": "163e93f0-efb5-4b72-8c94-e3a55c504001",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 135b3655-95a7-4c51-bfc3-3f53a590cd38 to DEXA_Synt_79409",
        "type": "system",
        "createdAt": "2025-12-14T10:12:03.370Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:40.344Z",
    "updatedAt": "2025-12-14T08:54:20.056Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41273171",
      "DOI": "https://doi.org10.1177/1540658X251393093",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:58:10",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Dwivedi SD, Singh D, Singh MR. Revolutionizing Rheumatoid Arthritis Management: Glucocorticoid-Loaded, Folic Acid-Conjugated <i>Piper nigrum</i>-Based Zinc-Oxide Nanoparticles. Assay Drug Dev Technol. 2025;",
      "pubdate": "2025-11-22",
      "Lead_author": "Dwivedi SD",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1177/1540658X251393093",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Dwivedi SD, Singh D, Singh MR. Revolutionizing Rheumatoid Arthritis Management: Glucocorticoid-Loaded, Folic Acid-Conjugated <i>Piper nigrum</i>-Based Zinc-Oxide Nanoparticles. Assay Drug Dev Technol. 2025;",
    "leadAuthor": "Dwivedi SD",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgOBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgOBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-17e9340501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707123
  },
  {
    "id": "DEXA_Synt_88358",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41269676",
    "title": "Limonoids and protolimonoid from .",
    "authors": [
      "Sun YP",
      "Jin WF",
      "Xu ZR",
      "Liu YW",
      "Sun LJ",
      "Yu Y",
      "Liu JS",
      "Wang GK"
    ],
    "journal": "Nat Prod Res",
    "publicationDate": "2025-11-21",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "3e98328f-20df-4384-a164-6d95466e9614",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.077Z"
      },
      {
        "id": "585ccd86-3c04-40ff-bb7a-5eba7290a813",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 403f660b-2150-4ab9-8c1d-b7af770a273b to DEXA_Synt_88358",
        "type": "system",
        "createdAt": "2025-12-14T10:12:03.584Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:40.526Z",
    "updatedAt": "2025-12-14T08:54:20.085Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41269676",
      "DOI": "https://doi.org10.1080/14786419.2025.2588797",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:58:38",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Sun YP, Jin WF, Xu ZR, Liu YW, Sun LJ, Yu Y, Liu JS, Wang GK. Limonoids and protolimonoid from <i>Swietenia macrophylla</i>. Nat Prod Res. 2025;1-6",
      "pubdate": "2025-11-21",
      "Lead_author": "Sun YP",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/14786419.2025.2588797",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Sun YP, Jin WF, Xu ZR, Liu YW, Sun LJ, Yu Y, Liu JS, Wang GK. Limonoids and protolimonoid from <i>Swietenia macrophylla</i>. Nat Prod Res. 2025;1-6",
    "leadAuthor": "Sun YP",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgPBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgPBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1809f40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707123
  },
  {
    "id": "DEXA_Synt_31469",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41261350",
    "title": "Comprehensive assessment of DeVIC therapy for relapsed or refractory diffuse large B-cell lymphoma.",
    "authors": [
      "Nakaya Y",
      "Yoshimura T",
      "Hayashi T",
      "Yoshida M",
      "Hayashi Y",
      "Nakao T"
    ],
    "journal": "Int J Hematol",
    "publicationDate": "2025-11-20",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "25f8a3c0-906b-413a-ba55-8cfe2dbf9005",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.108Z"
      },
      {
        "id": "333d355d-cb1f-4a75-b122-5211e48fe01b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f9d39752-bbcb-4b87-b306-84ccd3256403 to DEXA_Synt_31469",
        "type": "system",
        "createdAt": "2025-12-14T10:12:03.803Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:40.588Z",
    "updatedAt": "2025-12-14T08:54:20.114Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41261350",
      "DOI": "https://doi.org10.1007/s12185-025-04104-y",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:58:47",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Nakaya Y, Yoshimura T, Hayashi T, Yoshida M, Hayashi Y, Nakao T. Comprehensive assessment of DeVIC therapy for relapsed or refractory diffuse large B-cell lymphoma. Int J Hematol. 2025;",
      "pubdate": "2025-11-20",
      "Lead_author": "Nakaya Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s12185-025-04104-y",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Nakaya Y, Yoshimura T, Hayashi T, Yoshida M, Hayashi Y, Nakao T. Comprehensive assessment of DeVIC therapy for relapsed or refractory diffuse large B-cell lymphoma. Int J Hematol. 2025;",
    "leadAuthor": "Nakaya Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgQBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgQBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-182b600501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707123
  },
  {
    "id": "DEXA_Synt_63217",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41261233",
    "title": "Activated glucocorticoid receptor is an estrogen receptor silencer in ER+ metastatic breast cancer.",
    "authors": [
      "Manivannan M",
      "Jehanno C",
      "Kloc M",
      "Gomez Miragaya J",
      "Diepenbruck M",
      "Volkmann K",
      "Coissieux MM",
      "Palafox M",
      "Rouchon A",
      "Kramer N",
      "Schmidt A",
      "Blum Y",
      "Hamelin B",
      "Schuster H",
      "Heidinger M",
      "Muenst S",
      "Vetter M",
      "Kurzeder C",
      "Weber WP",
      "Bentires-Alj M"
    ],
    "journal": "EMBO Mol Med",
    "publicationDate": "2025-11-20",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5ff831e7-cf7e-4d17-9ca7-2ec867cf1bf4",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.139Z"
      },
      {
        "id": "407b9c13-e7c8-4bc4-be56-6b65b8994fa5",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 2d567852-1b7f-4f99-b8e8-7524b2489bdb to DEXA_Synt_63217",
        "type": "system",
        "createdAt": "2025-12-14T10:12:04.034Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:40.792Z",
    "updatedAt": "2025-12-14T08:54:20.146Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41261233",
      "DOI": "https://doi.org10.1038/s44321-025-00342-z",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:59:02",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Manivannan M, Jehanno C, Kloc M, Gomez Miragaya J, Diepenbruck M, Volkmann K, Coissieux MM, Palafox M, Rouchon A, Kramer N, Schmidt A, Blum Y, Hamelin B, Schuster H, Heidinger M, Muenst S, Vetter M, Kurzeder C, Weber WP, Bentires-Alj M. Activated glucocorticoid receptor is an estrogen receptor silencer in ER+ metastatic breast cancer. EMBO Mol Med. 2025;",
      "pubdate": "2025-11-20",
      "Lead_author": "Manivannan M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s44321-025-00342-z",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Manivannan M, Jehanno C, Kloc M, Gomez Miragaya J, Diepenbruck M, Volkmann K, Coissieux MM, Palafox M, Rouchon A, Kramer N, Schmidt A, Blum Y, Hamelin B, Schuster H, Heidinger M, Muenst S, Vetter M, Kurzeder C, Weber WP, Bentires-Alj M. Activated glucocorticoid receptor is an estrogen receptor silencer in ER+ metastatic breast cancer. EMBO Mol Med. 2025;",
    "leadAuthor": "Manivannan M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgRBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgRBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-184e140501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707124
  },
  {
    "id": "DEXA_Synt_54143",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41260042",
    "title": "Lymphoma-associated hemophagocytic lymphohistiocytosis.",
    "authors": [
      "Marcondes TSP",
      "Chiattone CS",
      "Gaiolla RD"
    ],
    "journal": "Hematol Transfus Cell Ther",
    "publicationDate": "2025-11-20",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ff0c136c-c9b9-4cfb-9abe-fb56ed7a73cc",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.202Z"
      },
      {
        "id": "583d7d25-2ce2-4d21-a4d1-68bf9be552af",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 5993b79f-9636-4346-a60d-e007dc2be21b to DEXA_Synt_54143",
        "type": "system",
        "createdAt": "2025-12-14T10:12:04.274Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:40.852Z",
    "updatedAt": "2025-12-14T08:54:20.209Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41260042",
      "DOI": "https://doi.org10.1016/j.htct.2025.106087",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:59:09",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Marcondes TSP, Chiattone CS, Gaiolla RD. Lymphoma-associated hemophagocytic lymphohistiocytosis. Hematol Transfus Cell Ther. 2025;48(1):106087",
      "pubdate": "2025-11-20",
      "Lead_author": "Marcondes TSP",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.htct.2025.106087",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Marcondes TSP, Chiattone CS, Gaiolla RD. Lymphoma-associated hemophagocytic lymphohistiocytosis. Hematol Transfus Cell Ther. 2025;48(1):106087",
    "leadAuthor": "Marcondes TSP",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgSBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgSBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-18732c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707124
  },
  {
    "id": "DEXA_Synt_55107",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41258950",
    "title": "Dexamethasone modulates cytokine and chemokine secretion by CD4 + T cells from SSc patients and exerts antifibrotic effects in HOCl-induced SSc mice.",
    "authors": [
      "de Oliveira Gonçalves ME",
      "de Almeida AR",
      "Dantas AT",
      "Florencio KSS",
      "da Silva Ferreira JR",
      "Dos Santos Barbosa FH",
      "Silva RC",
      "da Silva AA",
      "da Matta DN",
      "Duarte ALBP",
      "de Melo Rêgo MJB",
      "Pereira MC",
      "da Rocha Pitta MG"
    ],
    "journal": "Inflammopharmacology",
    "publicationDate": "2025-11-19",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "cf267207-4b40-450f-bca3-01c9a307fec0",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.232Z"
      },
      {
        "id": "f7b37d99-feed-4fca-8b30-8fef5132edcf",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 8c90de84-d5fa-4c44-b902-484daa36eb49 to DEXA_Synt_55107",
        "type": "system",
        "createdAt": "2025-12-14T10:12:04.498Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:41.049Z",
    "updatedAt": "2025-12-14T08:54:20.241Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41258950",
      "DOI": "https://doi.org10.1007/s10787-025-02037-w",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:58:54",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "de Oliveira Gonçalves ME, de Almeida AR, Dantas AT, Florencio KSS, da Silva Ferreira JR, Dos Santos Barbosa FH, Silva RC, da Silva AA, da Matta DN, Duarte ALBP, de Melo Rêgo MJB, Pereira MC, da Rocha Pitta MG. Dexamethasone modulates cytokine and chemokine secretion by CD4 + T cells from SSc patients and exerts antifibrotic effects in HOCl-induced SSc mice. Inflammopharmacology. 2025;",
      "pubdate": "2025-11-19",
      "Lead_author": "de Oliveira Gonçalves ME",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s10787-025-02037-w",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "de Oliveira Gonçalves ME, de Almeida AR, Dantas AT, Florencio KSS, da Silva Ferreira JR, Dos Santos Barbosa FH, Silva RC, da Silva AA, da Matta DN, Duarte ALBP, de Melo Rêgo MJB, Pereira MC, da Rocha Pitta MG. Dexamethasone modulates cytokine and chemokine secretion by CD4 + T cells from SSc patients and exerts antifibrotic effects in HOCl-induced SSc mice. Inflammopharmacology. 2025;",
    "leadAuthor": "de Oliveira Gonçalves ME",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgTBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgTBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1895400501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707124
  },
  {
    "id": "DEXA_Synt_67671",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41255961",
    "title": "Herpes simplex virus type 2 implicated in a case of acute disseminated encephalomyelitis.",
    "authors": [
      "Booth S",
      "Starinskij I",
      "Gallacher S",
      "Garmany P"
    ],
    "journal": "Access Microbiol",
    "publicationDate": "2025-11-19",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "8cd311f8-4924-4b4c-855b-f5c394078ad5",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.262Z"
      },
      {
        "id": "e57eeb2c-75c8-40a4-9751-cb94ac801e57",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 322337c8-45b9-41cd-b1cf-c7533bb26c50 to DEXA_Synt_67671",
        "type": "system",
        "createdAt": "2025-12-14T10:12:04.703Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:41.133Z",
    "updatedAt": "2025-12-14T08:54:20.328Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41255961",
      "DOI": "https://doi.org10.1099/acmi.0.001018.v3",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:59:17",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Booth S, Starinskij I, Gallacher S, Garmany P. Herpes simplex virus type 2 implicated in a case of acute disseminated encephalomyelitis. Access Microbiol. 2025;7(11):",
      "pubdate": "2025-11-19",
      "Lead_author": "Booth S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1099/acmi.0.001018.v3",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Booth S, Starinskij I, Gallacher S, Garmany P. Herpes simplex virus type 2 implicated in a case of acute disseminated encephalomyelitis. Access Microbiol. 2025;7(11):",
    "leadAuthor": "Booth S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgUBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgUBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-18b9500501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707124
  },
  {
    "id": "DEXA_Synt_14245",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41253602",
    "title": "Selenium Attenuates Dexamethasone-Induced Osteoblast Dysfunction and Prevents Femoral Head Osteonecrosis via PI3K/AKT/GSK3β Pathway Activation.",
    "authors": [
      "Xuecheng S",
      "Changjun C",
      "Xiaojie M",
      "Shufeng L",
      "Lei Z",
      "Ma X"
    ],
    "journal": "Orthop Surg",
    "publicationDate": "2025-11-19",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "e5644162-3177-4da6-9166-f39c06c3a5c7",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.354Z"
      },
      {
        "id": "144b6262-0bfe-4995-afca-99a2ac80bcad",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 33f85972-55ee-4860-8dce-66888c23f2d6 to DEXA_Synt_14245",
        "type": "system",
        "createdAt": "2025-12-14T10:12:04.933Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:41.284Z",
    "updatedAt": "2025-12-14T08:54:20.364Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41253602",
      "DOI": "https://doi.org10.1111/os.70191",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:59:25",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Xuecheng S, Changjun C, Xiaojie M, Shufeng L, Lei Z, Ma X. Selenium Attenuates Dexamethasone-Induced Osteoblast Dysfunction and Prevents Femoral Head Osteonecrosis via PI3K/AKT/GSK3β Pathway Activation. Orthop Surg. 2025;",
      "pubdate": "2025-11-19",
      "Lead_author": "Xuecheng S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/os.70191",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Xuecheng S, Changjun C, Xiaojie M, Shufeng L, Lei Z, Ma X. Selenium Attenuates Dexamethasone-Induced Osteoblast Dysfunction and Prevents Femoral Head Osteonecrosis via PI3K/AKT/GSK3β Pathway Activation. Orthop Surg. 2025;",
    "leadAuthor": "Xuecheng S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgVBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgVBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-18d7780501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707124
  },
  {
    "id": "DEXA_Synt_58104",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41247273",
    "title": "Real-World Characteristics and Safety Outcomes of 10,000 Eyes Treated with Intracanalicular Dexamethasone Insert: An IRIS® Registry Analysis 2019-2021.",
    "authors": [
      "Vantipalli S",
      "Mbagwu M",
      "Chang RT",
      "Li S",
      "Akasheh D",
      "Cheung MW",
      "Gurses-Ozden R",
      "Goldstein MH"
    ],
    "journal": "J Cataract Refract Surg",
    "publicationDate": "2025-11-17",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "f19680d5-c751-457c-8b50-6c179405c028",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.385Z"
      },
      {
        "id": "683c1d87-f76c-4690-a988-7804a3580e71",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d8905d01-cac4-48f9-93d0-5f728dba5940 to DEXA_Synt_58104",
        "type": "system",
        "createdAt": "2025-12-14T10:12:05.152Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:41.410Z",
    "updatedAt": "2025-12-14T08:54:20.393Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41247273",
      "DOI": "https://doi.org10.1097/j.jcrs.0000000000001827",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:59:48",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Vantipalli S, Mbagwu M, Chang RT, Li S, Akasheh D, Cheung MW, Gurses-Ozden R, Goldstein MH. Real-World Characteristics and Safety Outcomes of 10,000 Eyes Treated with Intracanalicular Dexamethasone Insert: An IRIS® Registry Analysis 2019-2021. J Cataract Refract Surg. 2025;",
      "pubdate": "2025-11-17",
      "Lead_author": "Vantipalli S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/j.jcrs.0000000000001827",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Vantipalli S, Mbagwu M, Chang RT, Li S, Akasheh D, Cheung MW, Gurses-Ozden R, Goldstein MH. Real-World Characteristics and Safety Outcomes of 10,000 Eyes Treated with Intracanalicular Dexamethasone Insert: An IRIS® Registry Analysis 2019-2021. J Cataract Refract Surg. 2025;",
    "leadAuthor": "Vantipalli S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgWBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgWBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-18f8e40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707125
  },
  {
    "id": "DEXA_Synt_94643",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41245944",
    "title": "Recurrent Airway Swelling in a Patient With Lymphoproliferative Disorder: A Diagnostic Challenge Between Anaphylaxis and Acquired Angioedema.",
    "authors": [
      "Nahid MH",
      "Khan B",
      "Munshi R"
    ],
    "journal": "Cureus",
    "publicationDate": "2025-11-17",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "cb2d0177-a5d7-40dd-82a5-b65c9216192b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.418Z"
      },
      {
        "id": "0ecf37b2-a1ca-4c3f-81ea-54840e7cc7d1",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from e13ef636-432f-4938-9e75-6175927f4579 to DEXA_Synt_94643",
        "type": "system",
        "createdAt": "2025-12-14T10:12:05.369Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:41.550Z",
    "updatedAt": "2025-12-14T08:54:20.466Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41245944",
      "DOI": "https://doi.org10.7759/cureus.96070",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:59:41",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Nahid MH, Khan B, Munshi R. Recurrent Airway Swelling in a Patient With Lymphoproliferative Disorder: A Diagnostic Challenge Between Anaphylaxis and Acquired Angioedema. Cureus. 2025;17(11):e96070",
      "pubdate": "2025-11-17",
      "Lead_author": "Nahid MH",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.7759/cureus.96070",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Nahid MH, Khan B, Munshi R. Recurrent Airway Swelling in a Patient With Lymphoproliferative Disorder: A Diagnostic Challenge Between Anaphylaxis and Acquired Angioedema. Cureus. 2025;17(11):e96070",
    "leadAuthor": "Nahid MH",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgXBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgXBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-191a0c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707125
  },
  {
    "id": "DEXA_Synt_38636",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41245156",
    "title": "Evidence for Functional Ovarian Hyperandrogenism in Early Pubertal, but Not Late Pubertal, Girls With Excess Weight.",
    "authors": [
      "Houghton MA",
      "McCartney CR",
      "Kim SH",
      "Patrie JT",
      "Marshall JC",
      "Burt Solorzano CM"
    ],
    "journal": "J Endocr Soc",
    "publicationDate": "2025-11-17",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "3903026c-0da0-4c5f-8961-347256e587dd",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.478Z"
      },
      {
        "id": "8afa8d76-b688-40e9-89ae-d998a5c56e0c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3ff0171a-adf9-409d-82b3-8d1d8252cb01 to DEXA_Synt_38636",
        "type": "system",
        "createdAt": "2025-12-14T10:12:05.592Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:41.671Z",
    "updatedAt": "2025-12-14T08:54:20.485Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41245156",
      "DOI": "https://doi.org10.1210/jendso/bvaf154",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:59:33",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Houghton MA, McCartney CR, Kim SH, Patrie JT, Marshall JC, Burt Solorzano CM. Evidence for Functional Ovarian Hyperandrogenism in Early Pubertal, but Not Late Pubertal, Girls With Excess Weight. J Endocr Soc. 2025;9(12):bvaf154",
      "pubdate": "2025-11-17",
      "Lead_author": "Houghton MA",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1210/jendso/bvaf154",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Houghton MA, McCartney CR, Kim SH, Patrie JT, Marshall JC, Burt Solorzano CM. Evidence for Functional Ovarian Hyperandrogenism in Early Pubertal, but Not Late Pubertal, Girls With Excess Weight. J Endocr Soc. 2025;9(12):bvaf154",
    "leadAuthor": "Houghton MA",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgYBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgYBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-193bf80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707125
  },
  {
    "id": "DEXA_Synt_60433",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41243594",
    "title": "Risk-Stratified Phase II Clinical Trial for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Pediatric, Adolescent, and Young Adult Patients in Japan.",
    "authors": [
      "Sakamoto K",
      "Yanagisawa R",
      "Ono R",
      "Doi T",
      "Negishi T",
      "Kada A",
      "Saito AM",
      "Kanegane H",
      "Morimoto A",
      "Shioda Y",
      "Nakazawa Y"
    ],
    "journal": "Pediatr Blood Cancer",
    "publicationDate": "2025-11-17",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "7aba599d-3e69-48bb-b108-5b61c48dd668",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.540Z"
      },
      {
        "id": "640083d6-00bb-48f1-87da-c772b5fe9cf0",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from e4d3af28-c282-4702-aed2-7cd300066fa6 to DEXA_Synt_60433",
        "type": "system",
        "createdAt": "2025-12-14T10:12:05.827Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:41.795Z",
    "updatedAt": "2025-12-14T08:54:20.549Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41243594",
      "DOI": "https://doi.org10.1002/pbc.32166",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 12:59:56",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Sakamoto K, Yanagisawa R, Ono R, Doi T, Negishi T, Kada A, Saito AM, Kanegane H, Morimoto A, Shioda Y, Nakazawa Y. Risk-Stratified Phase II Clinical Trial for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Pediatric, Adolescent, and Young Adult Patients in Japan. Pediatr Blood Cancer. 2025;e32166",
      "pubdate": "2025-11-17",
      "Lead_author": "Sakamoto K",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/pbc.32166",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Sakamoto K, Yanagisawa R, Ono R, Doi T, Negishi T, Kada A, Saito AM, Kanegane H, Morimoto A, Shioda Y, Nakazawa Y. Risk-Stratified Phase II Clinical Trial for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Pediatric, Adolescent, and Young Adult Patients in Japan. Pediatr Blood Cancer. 2025;e32166",
    "leadAuthor": "Sakamoto K",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgZBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgZBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-195f900501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707125
  },
  {
    "id": "DEXA_Synt_88796",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41230333",
    "title": "Co-Occurrence of Endogenous and Exogenous Cushing's Syndromes: Does \"Double Cushing Syndrome\" Really Exist? A Case Report.",
    "authors": [
      "Amani-Beni R",
      "Shervedani AK",
      "Darouei B",
      "Noroozi M",
      "Heidarpour M"
    ],
    "journal": "Clin Case Rep",
    "publicationDate": "2025-11-13",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "13b318d2-92ae-4c6b-bc95-a72e7962996e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.568Z"
      },
      {
        "id": "37f8af60-09f9-4f69-8362-0bb3a2997142",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from ce09fbe1-356a-4a33-abdd-0d930f50a15d to DEXA_Synt_88796",
        "type": "system",
        "createdAt": "2025-12-14T10:12:06.047Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:41.934Z",
    "updatedAt": "2025-12-14T08:54:20.653Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41230333",
      "DOI": "https://doi.org10.1002/ccr3.71419",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:00:04",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Amani-Beni R, Shervedani AK, Darouei B, Noroozi M, Heidarpour M. Co-Occurrence of Endogenous and Exogenous Cushing's Syndromes: Does \"Double Cushing Syndrome\" Really Exist? A Case Report. Clin Case Rep. 2025;13(11):e71419",
      "pubdate": "2025-11-13",
      "Lead_author": "Amani-Beni R",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/ccr3.71419",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Amani-Beni R, Shervedani AK, Darouei B, Noroozi M, Heidarpour M. Co-Occurrence of Endogenous and Exogenous Cushing's Syndromes: Does \"Double Cushing Syndrome\" Really Exist? A Case Report. Clin Case Rep. 2025;13(11):e71419",
    "leadAuthor": "Amani-Beni R",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgaBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgaBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1981100501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707126
  },
  {
    "id": "DEXA_Synt_68154",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41226746",
    "title": "Immunomodulatory Effects of a High-CBD Cannabis Extract: A Comparative Analysis with Conventional Therapies for Oral Lichen Planus and Graft-Versus-Host Disease.",
    "authors": [
      "Blal K",
      "Rosenblum R",
      "Novak-Kotzer H",
      "Procaccia S",
      "Abu Tair J",
      "Casap N",
      "Meiri D",
      "Benny O"
    ],
    "journal": "Int J Mol Sci",
    "publicationDate": "2025-11-13",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ac53e34a-46a5-4172-a523-76fdec28e0a0",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.680Z"
      },
      {
        "id": "9557263e-914f-49da-80c1-3fa650fe26b6",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 282ab9a3-ba25-4b38-8e46-2b562014f4ed to DEXA_Synt_68154",
        "type": "system",
        "createdAt": "2025-12-14T10:12:06.262Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:42.043Z",
    "updatedAt": "2025-12-14T08:54:20.692Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41226746",
      "DOI": "https://doi.org10.3390/ijms262110711",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:00:12",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Blal K, Rosenblum R, Novak-Kotzer H, Procaccia S, Abu Tair J, Casap N, Meiri D, Benny O. Immunomodulatory Effects of a High-CBD Cannabis Extract: A Comparative Analysis with Conventional Therapies for Oral Lichen Planus and Graft-Versus-Host Disease. Int J Mol Sci. 2025;26(21):",
      "pubdate": "2025-11-13",
      "Lead_author": "Blal K",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3390/ijms262110711",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Blal K, Rosenblum R, Novak-Kotzer H, Procaccia S, Abu Tair J, Casap N, Meiri D, Benny O. Immunomodulatory Effects of a High-CBD Cannabis Extract: A Comparative Analysis with Conventional Therapies for Oral Lichen Planus and Graft-Versus-Host Disease. Int J Mol Sci. 2025;26(21):",
    "leadAuthor": "Blal K",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgbBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgbBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-19a1fc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707126
  },
  {
    "id": "DEXA_Synt_88932",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41226721",
    "title": "Decreased Glucocorticoid Receptor Expression and Function in Cord Blood Immune Cells from Preterm Neonates with Morbidity.",
    "authors": [
      "Anti NAO",
      "Deming DD",
      "Gheorghe CP",
      "Tugung A",
      "Gray-Hutto N",
      "Zhang L",
      "Mata-Greenwood E"
    ],
    "journal": "Int J Mol Sci",
    "publicationDate": "2025-11-13",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "0f2ba157-cc2f-433d-9b75-c71e95dc97bf",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.711Z"
      },
      {
        "id": "9b98b59b-da1d-4908-9c1c-cc387ca36719",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 710eaf30-0742-48ed-a23e-5ba17c7422f8 to DEXA_Synt_88932",
        "type": "system",
        "createdAt": "2025-12-14T10:12:06.462Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:42.196Z",
    "updatedAt": "2025-12-14T08:54:20.720Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41226721",
      "DOI": "https://doi.org10.3390/ijms262110686",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:00:35",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Anti NAO, Deming DD, Gheorghe CP, Tugung A, Gray-Hutto N, Zhang L, Mata-Greenwood E. Decreased Glucocorticoid Receptor Expression and Function in Cord Blood Immune Cells from Preterm Neonates with Morbidity. Int J Mol Sci. 2025;26(21):",
      "pubdate": "2025-11-13",
      "Lead_author": "Anti NAO",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3390/ijms262110686",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Anti NAO, Deming DD, Gheorghe CP, Tugung A, Gray-Hutto N, Zhang L, Mata-Greenwood E. Decreased Glucocorticoid Receptor Expression and Function in Cord Blood Immune Cells from Preterm Neonates with Morbidity. Int J Mol Sci. 2025;26(21):",
    "leadAuthor": "Anti NAO",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgcBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgcBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-19c68c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707126
  },
  {
    "id": "DEXA_Synt_82680",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41225644",
    "title": "Piperine suppresses M1 phenotype and induces indoleamine 2,3-dioxygenase gene in LPS-stimulated murine macrophage cell line.",
    "authors": [
      "Gholijani N",
      "Dehghan Z",
      "Abolmaali SS",
      "Talepoor AG",
      "Kalantar K",
      "Daryabor G"
    ],
    "journal": "BMC Res Notes",
    "publicationDate": "2025-11-13",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "55971c92-9e05-4f8b-bdab-bdd93c31b094",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.741Z"
      },
      {
        "id": "a249fedd-30b3-4425-b13b-aa8552f84bbd",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 61f64aba-9dad-494b-9d9a-ae341c5a7653 to DEXA_Synt_82680",
        "type": "system",
        "createdAt": "2025-12-14T10:12:06.695Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:42.302Z",
    "updatedAt": "2025-12-14T08:54:20.749Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41225644",
      "DOI": "https://doi.org10.1186/s13104-025-07559-8",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:00:20",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Gholijani N, Dehghan Z, Abolmaali SS, Talepoor AG, Kalantar K, Daryabor G. Piperine suppresses M1 phenotype and induces indoleamine 2,3-dioxygenase gene in LPS-stimulated murine macrophage cell line. BMC Res Notes. 2025;18(1):475",
      "pubdate": "2025-11-13",
      "Lead_author": "Gholijani N",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s13104-025-07559-8",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Gholijani N, Dehghan Z, Abolmaali SS, Talepoor AG, Kalantar K, Daryabor G. Piperine suppresses M1 phenotype and induces indoleamine 2,3-dioxygenase gene in LPS-stimulated murine macrophage cell line. BMC Res Notes. 2025;18(1):475",
    "leadAuthor": "Gholijani N",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgdBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgdBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-19e4a00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707126
  },
  {
    "id": "DEXA_Synt_80411",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41225556",
    "title": "A randomised controlled trial comparing epinephrine and dexamethasone to placebo in the treatment of infants with bronchiolitis (BIPED study): a statistical analysis plan.",
    "authors": [
      "Heath A",
      "Rios D",
      "Vogel KI",
      "Rowe T",
      "Wills-Ibarra N",
      "Oakley E",
      "Offringa M",
      "Pechlivanoglou P",
      "Klassen TP",
      "Dalziel SR",
      "Plint AC"
    ],
    "journal": "Trials",
    "publicationDate": "2025-11-13",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "c894d46a-045a-4e9b-b578-0b0fe6797b6e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.772Z"
      },
      {
        "id": "764da0e1-73ea-4cb9-bcdb-220524ba3325",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 750b15e5-c252-4df2-8c93-3163abfcffbb to DEXA_Synt_80411",
        "type": "system",
        "createdAt": "2025-12-14T10:12:06.930Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:42.442Z",
    "updatedAt": "2025-12-14T08:54:20.780Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41225556",
      "DOI": "https://doi.org10.1186/s13063-025-09125-w",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:00:27",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Heath A, Rios D, Vogel KI, Rowe T, Wills-Ibarra N, Oakley E, Offringa M, Pechlivanoglou P, Klassen TP, Dalziel SR, Plint AC, . A randomised controlled trial comparing epinephrine and dexamethasone to placebo in the treatment of infants with bronchiolitis (BIPED study): a statistical analysis plan. Trials. 2025;26(1):496",
      "pubdate": "2025-11-13",
      "Lead_author": "Heath A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s13063-025-09125-w",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Heath A, Rios D, Vogel KI, Rowe T, Wills-Ibarra N, Oakley E, Offringa M, Pechlivanoglou P, Klassen TP, Dalziel SR, Plint AC, . A randomised controlled trial comparing epinephrine and dexamethasone to placebo in the treatment of infants with bronchiolitis (BIPED study): a statistical analysis plan. Trials. 2025;26(1):496",
    "leadAuthor": "Heath A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgeBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgeBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1a08a40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707126
  },
  {
    "id": "DEXA_Synt_76116",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41225361",
    "title": "Early low-dose dexamethasone is associated with shorter acute symptom duration in Chikungunya virus infection: a retrospective cohort study.",
    "authors": [
      "Chancharoenthana W",
      "Bhunyakarnjanarat T",
      "Udompornpitak K",
      "Ariyanon W",
      "Leelahavanichkul A"
    ],
    "journal": "BMC Infect Dis",
    "publicationDate": "2025-11-13",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6cb5d09b-6d24-4f10-bec0-d075248b9f8d",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.837Z"
      },
      {
        "id": "0a1ac524-9685-42a6-9df5-caa5841a66c5",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3d76f0a5-191f-46f2-a28a-07747f4267b9 to DEXA_Synt_76116",
        "type": "system",
        "createdAt": "2025-12-14T10:12:07.144Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:42.598Z",
    "updatedAt": "2025-12-14T08:54:20.845Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41225361",
      "DOI": "https://doi.org10.1186/s12879-025-12006-x",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:02:01",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Chancharoenthana W, Bhunyakarnjanarat T, Udompornpitak K, Ariyanon W, Leelahavanichkul A. Early low-dose dexamethasone is associated with shorter acute symptom duration in Chikungunya virus infection: a retrospective cohort study. BMC Infect Dis. 2025;25(1):1559",
      "pubdate": "2025-11-13",
      "Lead_author": "Chancharoenthana W",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s12879-025-12006-x",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Chancharoenthana W, Bhunyakarnjanarat T, Udompornpitak K, Ariyanon W, Leelahavanichkul A. Early low-dose dexamethasone is associated with shorter acute symptom duration in Chikungunya virus infection: a retrospective cohort study. BMC Infect Dis. 2025;25(1):1559",
    "leadAuthor": "Chancharoenthana W",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgfBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgfBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1a295c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707127
  },
  {
    "id": "DEXA_Synt_88935",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41212257",
    "title": "Otoprotective measures for cisplatin-based chemoradiotherapy-induced toxicity in patients with head and neck cancer: a systematic review and meta-analysis.",
    "authors": [
      "Marchetti KR",
      "Guerra LD",
      "Gondim PAL",
      "de Castro Junior G"
    ],
    "journal": "Support Care Cancer",
    "publicationDate": "2025-11-10",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "4d669ffc-0b52-4e46-85c5-58e4d61795a8",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.867Z"
      },
      {
        "id": "69b4a816-6df6-452e-9a8a-653f1fd0622c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f29692e3-6ca1-438b-8ba5-2a3b88af926b to DEXA_Synt_88935",
        "type": "system",
        "createdAt": "2025-12-14T10:12:07.391Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:42.675Z",
    "updatedAt": "2025-12-14T08:54:20.901Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41212257",
      "DOI": "https://doi.org10.1007/s00520-025-10103-w",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:02:31",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Marchetti KR, Guerra LD, Gondim PAL, de Castro Junior G. Otoprotective measures for cisplatin-based chemoradiotherapy-induced toxicity in patients with head and neck cancer: a systematic review and meta-analysis. Support Care Cancer. 2025;33(12):1034",
      "pubdate": "2025-11-10",
      "Lead_author": "Marchetti KR",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s00520-025-10103-w",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Marchetti KR, Guerra LD, Gondim PAL, de Castro Junior G. Otoprotective measures for cisplatin-based chemoradiotherapy-induced toxicity in patients with head and neck cancer: a systematic review and meta-analysis. Support Care Cancer. 2025;33(12):1034",
    "leadAuthor": "Marchetti KR",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUggBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUggBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1a4eac0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707127
  },
  {
    "id": "DEXA_Synt_83300",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41209449",
    "title": "A Case of Corneal Melting Associated with Topical Diclofenac After Phacovitrectomy for Macular Pucker in a Patient with Rheumatoid Arthritis.",
    "authors": [
      "Tripodi S",
      "Maggio E",
      "Arena F",
      "Pertile G"
    ],
    "journal": "Int Med Case Rep J",
    "publicationDate": "2025-11-10",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "56f8c313-86de-40cb-a734-d1d338f25cd5",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.913Z"
      },
      {
        "id": "878b01d9-7bb6-49f0-b231-3584b9dca4c0",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from c72a5182-130d-463a-8306-5a5efbc2dd35 to DEXA_Synt_83300",
        "type": "system",
        "createdAt": "2025-12-14T10:12:07.582Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:42.874Z",
    "updatedAt": "2025-12-14T08:54:20.963Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41209449",
      "DOI": "https://doi.org10.2147/IMCRJ.S554111",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:02:17",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Tripodi S, Maggio E, Arena F, Pertile G. A Case of Corneal Melting Associated with Topical Diclofenac After Phacovitrectomy for Macular Pucker in a Patient with Rheumatoid Arthritis. Int Med Case Rep J. 2025;181399-406",
      "pubdate": "2025-11-10",
      "Lead_author": "Tripodi S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.2147/IMCRJ.S554111",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Tripodi S, Maggio E, Arena F, Pertile G. A Case of Corneal Melting Associated with Topical Diclofenac After Phacovitrectomy for Macular Pucker in a Patient with Rheumatoid Arthritis. Int Med Case Rep J. 2025;181399-406",
    "leadAuthor": "Tripodi S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUghBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUghBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1a6b680501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707127
  },
  {
    "id": "DEXA_Synt_49299",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41206651",
    "title": "Occurrence and Seasonal Variation of Pharmaceutical Residues of Emerging Concern in South African Surface Waters.",
    "authors": [
      "Belle G",
      "Omotola EO",
      "Moodley B",
      "Olatunji O",
      "Truter C",
      "Moodley R",
      "Oberholster P"
    ],
    "journal": "Integr Environ Assess Manag",
    "publicationDate": "2025-11-9",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a0d2be38-9b67-44c2-bec2-02b048ffd5b6",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:20.973Z"
      },
      {
        "id": "3c8b3921-f23b-4436-9769-830c9e786a58",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 7e3d0fd7-eec3-4619-a81c-73eee66d7ab4 to DEXA_Synt_49299",
        "type": "system",
        "createdAt": "2025-12-14T10:12:07.826Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:42.911Z",
    "updatedAt": "2025-12-14T08:54:21.039Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41206651",
      "DOI": "https://doi.org10.1093/inteam/vjaf156",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:02:24",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Belle G, Omotola EO, Moodley B, Olatunji O, Truter C, Moodley R, Oberholster P. Occurrence and Seasonal Variation of Pharmaceutical Residues of Emerging Concern in South African Surface Waters. Integr Environ Assess Manag. 2025;",
      "pubdate": "2025-11-9",
      "Lead_author": "Belle G",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1093/inteam/vjaf156",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Belle G, Omotola EO, Moodley B, Olatunji O, Truter C, Moodley R, Oberholster P. Occurrence and Seasonal Variation of Pharmaceutical Residues of Emerging Concern in South African Surface Waters. Integr Environ Assess Manag. 2025;",
    "leadAuthor": "Belle G",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgiBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgiBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1a91240501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707127
  },
  {
    "id": "DEXA_Synt_75059",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41206634",
    "title": "Oblongifolin B isolated from Brazilian red propolis exhibits anti-methicillin-resistant Staphylococcus aureus action and modulates macrophage activity.",
    "authors": [
      "Dos Santos Almeida JF",
      "da Silva Honorio M",
      "Lopes EC",
      "Ripari N",
      "Júnior AF",
      "Tanimoto MH",
      "Bastos JK",
      "Sforcin JM"
    ],
    "journal": "J Pharm Pharmacol",
    "publicationDate": "2025-11-9",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "afb45071-58f9-4dae-ace1-fcf0afc7dbaf",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.051Z"
      },
      {
        "id": "733bd1b9-fe41-4499-a20f-885ae5449143",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from b615d296-80ba-490b-93df-43c324d29bdf to DEXA_Synt_75059",
        "type": "system",
        "createdAt": "2025-12-14T10:12:08.014Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:43.135Z",
    "updatedAt": "2025-12-14T08:54:21.059Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41206634",
      "DOI": "https://doi.org10.1093/jpp/rgaf106",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:02:09",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Dos Santos Almeida JF, da Silva Honorio M, Lopes EC, Ripari N, Júnior AF, Tanimoto MH, Bastos JK, Sforcin JM. Oblongifolin B isolated from Brazilian red propolis exhibits anti-methicillin-resistant Staphylococcus aureus action and modulates macrophage activity. J Pharm Pharmacol. 2025;",
      "pubdate": "2025-11-9",
      "Lead_author": "Dos Santos Almeida JF",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1093/jpp/rgaf106",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Dos Santos Almeida JF, da Silva Honorio M, Lopes EC, Ripari N, Júnior AF, Tanimoto MH, Bastos JK, Sforcin JM. Oblongifolin B isolated from Brazilian red propolis exhibits anti-methicillin-resistant Staphylococcus aureus action and modulates macrophage activity. J Pharm Pharmacol. 2025;",
    "leadAuthor": "Dos Santos Almeida JF",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgjBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgjBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1ab5140501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707128
  },
  {
    "id": "DEXA_Synt_49055",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41204910",
    "title": "No benefit from daratumumab, bortezomib and dexamethasone (D-Vd) in real-world patients with functional high-risk multiple myeloma: A report from the Myeloma and Related Diseases Registry.",
    "authors": [
      "Lim SL",
      "Wellard C",
      "Rajagopal R",
      "Harrison SJ",
      "Khot A",
      "Quach H",
      "Ho PJ",
      "Moore E",
      "Wood E",
      "Spencer A"
    ],
    "journal": "Br J Haematol",
    "publicationDate": "2025-11-8",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "fa4a9709-41d8-4022-bfe2-0d0264013f5f",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.081Z"
      },
      {
        "id": "748b343d-8493-4d76-b083-ffae093e0301",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f6a981bf-2822-4659-be9d-487eaea945e2 to DEXA_Synt_49055",
        "type": "system",
        "createdAt": "2025-12-14T10:12:08.231Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:43.172Z",
    "updatedAt": "2025-12-14T08:54:21.129Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41204910",
      "DOI": "https://doi.org10.1111/bjh.70238",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:02:40",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Lim SL, Wellard C, Rajagopal R, Harrison SJ, Khot A, Quach H, Ho PJ, Moore E, Wood E, Spencer A. No benefit from daratumumab, bortezomib and dexamethasone (D-Vd) in real-world patients with functional high-risk multiple myeloma: A report from the Myeloma and Related Diseases Registry. Br J Haematol. 2025;",
      "pubdate": "2025-11-8",
      "Lead_author": "Lim SL",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/bjh.70238",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Lim SL, Wellard C, Rajagopal R, Harrison SJ, Khot A, Quach H, Ho PJ, Moore E, Wood E, Spencer A. No benefit from daratumumab, bortezomib and dexamethasone (D-Vd) in real-world patients with functional high-risk multiple myeloma: A report from the Myeloma and Related Diseases Registry. Br J Haematol. 2025;",
    "leadAuthor": "Lim SL",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgkBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgkBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1ad8c40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707128
  },
  {
    "id": "DEXA_Synt_39324",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41196738",
    "title": "Two cases of MACS due to PBMAH associated with an in vivo aberrant response to LHRH treated with leuprolide acetate.",
    "authors": [
      "Branchaud-Croisetière L",
      "Maillet M",
      "St-Jean M"
    ],
    "journal": "Endocrinol Diabetes Metab Case Rep",
    "publicationDate": "2025-11-6",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "c6629be3-63a6-43af-9e43-9ca5c9877af0",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.157Z"
      },
      {
        "id": "ddb31642-9352-4e82-b6ee-cfe0e604b157",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f9b35608-ed70-4d1b-89c8-1987d2643020 to DEXA_Synt_39324",
        "type": "system",
        "createdAt": "2025-12-14T10:12:08.444Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:43.381Z",
    "updatedAt": "2025-12-14T08:54:21.166Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41196738",
      "DOI": "https://doi.org10.1530/EDM-24-0074",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:02:49",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Branchaud-Croisetière L, Maillet M, St-Jean M. Two cases of MACS due to PBMAH associated with an in vivo aberrant response to LHRH treated with leuprolide acetate. Endocrinol Diabetes Metab Case Rep. 2025;2025(4):",
      "pubdate": "2025-11-6",
      "Lead_author": "Branchaud-Croisetière L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1530/EDM-24-0074",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Branchaud-Croisetière L, Maillet M, St-Jean M. Two cases of MACS due to PBMAH associated with an in vivo aberrant response to LHRH treated with leuprolide acetate. Endocrinol Diabetes Metab Case Rep. 2025;2025(4):",
    "leadAuthor": "Branchaud-Croisetière L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUglBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUglBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1afb780501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707128
  },
  {
    "id": "DEXA_Synt_14383",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41195628",
    "title": "Benign Adrenal Adenomas Are Associated With Reduced Prevalence of Hospitalised Patients With COVID-19.",
    "authors": [
      "Kelsall A",
      "Johns C",
      "Hills E",
      "Zhao J",
      "Newell-Price J"
    ],
    "journal": "Clin Endocrinol (Oxf)",
    "publicationDate": "2025-11-6",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "3511f6d2-8ec9-49a0-acea-afe75b72619e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.189Z"
      },
      {
        "id": "5a49d97c-b2cb-468f-b305-e8a355300042",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 658379d7-5bca-4a59-8fbd-b817e75af41e to DEXA_Synt_14383",
        "type": "system",
        "createdAt": "2025-12-14T10:12:08.690Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:43.440Z",
    "updatedAt": "2025-12-14T08:54:21.196Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41195628",
      "DOI": "https://doi.org10.1111/cen.70055",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:03:13",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Kelsall A, Johns C, Hills E, Zhao J, Newell-Price J. Benign Adrenal Adenomas Are Associated With Reduced Prevalence of Hospitalised Patients With COVID-19. Clin Endocrinol (Oxf). 2025;",
      "pubdate": "2025-11-6",
      "Lead_author": "Kelsall A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/cen.70055",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Kelsall A, Johns C, Hills E, Zhao J, Newell-Price J. Benign Adrenal Adenomas Are Associated With Reduced Prevalence of Hospitalised Patients With COVID-19. Clin Endocrinol (Oxf). 2025;",
    "leadAuthor": "Kelsall A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgmBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgmBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1b14a40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707128
  },
  {
    "id": "DEXA_Synt_72862",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41193983",
    "title": "Minimally invasive concretion-expulsion technique for primary canaliculitis: a prospective interventional study.",
    "authors": [
      "Wang C",
      "Liu C",
      "Wang L",
      "Wang H",
      "Pang Z"
    ],
    "journal": "BMC Ophthalmol",
    "publicationDate": "2025-11-6",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "f21a81e7-f774-408e-91d8-0e9b5ec28ed3",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.218Z"
      },
      {
        "id": "fd233de9-41be-409b-92bf-454da64839af",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 65a1b0c9-d1ed-4e7e-8dbf-20c289390374 to DEXA_Synt_72862",
        "type": "system",
        "createdAt": "2025-12-14T10:12:08.955Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:43.677Z",
    "updatedAt": "2025-12-14T08:54:21.286Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41193983",
      "DOI": "https://doi.org10.1186/s12886-025-04457-2",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:02:57",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Wang C, Liu C, Wang L, Wang H, Pang Z. Minimally invasive concretion-expulsion technique for primary canaliculitis: a prospective interventional study. BMC Ophthalmol. 2025;25(1):623",
      "pubdate": "2025-11-6",
      "Lead_author": "Wang C",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s12886-025-04457-2",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Wang C, Liu C, Wang L, Wang H, Pang Z. Minimally invasive concretion-expulsion technique for primary canaliculitis: a prospective interventional study. BMC Ophthalmol. 2025;25(1):623",
    "leadAuthor": "Wang C",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgnBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgnBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1b3d680501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707128
  },
  {
    "id": "DEXA_Synt_16741",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41193790",
    "title": "Beyond Impaired GABAergic Signaling: Inflammation and Metabolic Dysfunction in Genetic Epilepsy Induced by GABRG2 Mutation.",
    "authors": [
      "Shen D",
      "Wu W",
      "Zhou J",
      "Zhang X",
      "Zhan L",
      "Qian P",
      "Qian J",
      "Guo A",
      "Li A",
      "Zhang Q"
    ],
    "journal": "Mol Neurobiol",
    "publicationDate": "2025-11-6",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9d15c66a-7dc5-4a9a-81a8-752791098a03",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.312Z"
      },
      {
        "id": "c1cb80e0-0734-4706-a9ef-926b12aa96a4",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 225f3b16-e63e-447b-ae66-0419788e6439 to DEXA_Synt_16741",
        "type": "system",
        "createdAt": "2025-12-14T10:12:09.124Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:43.713Z",
    "updatedAt": "2025-12-14T08:54:21.321Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41193790",
      "DOI": "https://doi.org10.1007/s12035-025-05277-7",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:03:05",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Shen D, Wu W, Zhou J, Zhang X, Zhan L, Qian P, Qian J, Guo A, Li A, Zhang Q. Beyond Impaired GABAergic Signaling: Inflammation and Metabolic Dysfunction in Genetic Epilepsy Induced by GABRG2 Mutation. Mol Neurobiol. 2025;63(1):3",
      "pubdate": "2025-11-6",
      "Lead_author": "Shen D",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s12035-025-05277-7",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Shen D, Wu W, Zhou J, Zhang X, Zhan L, Qian P, Qian J, Guo A, Li A, Zhang Q. Beyond Impaired GABAergic Signaling: Inflammation and Metabolic Dysfunction in Genetic Epilepsy Induced by GABRG2 Mutation. Mol Neurobiol. 2025;63(1):3",
    "leadAuthor": "Shen D",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgoBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgoBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1b5f180501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707129
  },
  {
    "id": "DEXA_Synt_24888",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41184395",
    "title": "Dexamethasone enhances intestinal glucose absorption and TMPRSS2 expression with implications for hyperglycaemia and infection risk.",
    "authors": [
      "Visvanathan R",
      "Houghton MJ",
      "Barber E",
      "Day K",
      "Kellow NJ",
      "Williamson G"
    ],
    "journal": "Sci Rep",
    "publicationDate": "2025-11-4",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "efa77ef6-0097-4238-909e-47065081351d",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.341Z"
      },
      {
        "id": "15894f57-74f6-48ef-b97d-22f63d16a325",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a6fee456-9968-4cb0-b2f8-605542175622 to DEXA_Synt_24888",
        "type": "system",
        "createdAt": "2025-12-14T10:12:09.343Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:43.923Z",
    "updatedAt": "2025-12-14T08:54:21.350Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41184395",
      "DOI": "https://doi.org10.1038/s41598-025-22312-8",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:03:21",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Visvanathan R, Houghton MJ, Barber E, Day K, Kellow NJ, Williamson G. Dexamethasone enhances intestinal glucose absorption and TMPRSS2 expression with implications for hyperglycaemia and infection risk. Sci Rep. 2025;15(1):38329",
      "pubdate": "2025-11-4",
      "Lead_author": "Visvanathan R",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41598-025-22312-8",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Visvanathan R, Houghton MJ, Barber E, Day K, Kellow NJ, Williamson G. Dexamethasone enhances intestinal glucose absorption and TMPRSS2 expression with implications for hyperglycaemia and infection risk. Sci Rep. 2025;15(1):38329",
    "leadAuthor": "Visvanathan R",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgpBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgpBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1b82c00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707129
  },
  {
    "id": "DEXA_Synt_61167",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41148575",
    "title": "One Size Does Not Fit All: Novel Individualized Use of Dexamethasone in Infantile Epileptic Spasms Syndrome.",
    "authors": [
      "Kabak E",
      "Leitner IC",
      "Stark B",
      "Gröppel G"
    ],
    "journal": "Neurol Ther",
    "publicationDate": "2025-10-28",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "d2d3a393-fd0a-4c39-a3bc-9b85c3cec453",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.373Z"
      },
      {
        "id": "3a7c86c7-1176-4b67-b620-8276277d9ea1",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from e8b8a87b-fd7d-40aa-a4ef-be03b4117912 to DEXA_Synt_61167",
        "type": "system",
        "createdAt": "2025-12-14T10:12:09.575Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:43.962Z",
    "updatedAt": "2025-12-14T08:54:21.423Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41148575",
      "DOI": "https://doi.org10.1007/s40120-025-00829-4",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:03:30",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Kabak E, Leitner IC, Stark B, Gröppel G. One Size Does Not Fit All: Novel Individualized Use of Dexamethasone in Infantile Epileptic Spasms Syndrome. Neurol Ther. 2025;14(6):2683-93",
      "pubdate": "2025-10-28",
      "Lead_author": "Kabak E",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s40120-025-00829-4",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Kabak E, Leitner IC, Stark B, Gröppel G. One Size Does Not Fit All: Novel Individualized Use of Dexamethasone in Infantile Epileptic Spasms Syndrome. Neurol Ther. 2025;14(6):2683-93",
    "leadAuthor": "Kabak E",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgqBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgqBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1ba3ec0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707129
  },
  {
    "id": "DEXA_Synt_73914",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41140423",
    "title": "Optimizing Surgical Outcomes for Skull Base Epidermoid Cysts.",
    "authors": [
      "Waqar M",
      "Shoakazemi A",
      "Barber J",
      "Pathmanaban ON",
      "Rutherford SA",
      "King AT",
      "Hammerbeck-Ward C"
    ],
    "journal": "J Neurol Surg B Skull Base",
    "publicationDate": "2025-10-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9174b939-ce61-4be7-ae8f-1a326d3f5ff3",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.436Z"
      },
      {
        "id": "aeabb24f-6d2f-4e88-af88-80d0f08000c6",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from bd056dc2-5f6d-4acc-8a95-326398d909d8 to DEXA_Synt_73914",
        "type": "system",
        "createdAt": "2025-12-14T10:12:09.791Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:44.174Z",
    "updatedAt": "2025-12-14T08:54:21.443Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41140423",
      "DOI": "https://doi.org10.1055/a-2436-4097",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:03:54",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Waqar M, Shoakazemi A, Barber J, Pathmanaban ON, Rutherford SA, King AT, Hammerbeck-Ward C. Optimizing Surgical Outcomes for Skull Base Epidermoid Cysts. J Neurol Surg B Skull Base. 2025;86(6):667-72",
      "pubdate": "2025-10-27",
      "Lead_author": "Waqar M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1055/a-2436-4097",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Waqar M, Shoakazemi A, Barber J, Pathmanaban ON, Rutherford SA, King AT, Hammerbeck-Ward C. Optimizing Surgical Outcomes for Skull Base Epidermoid Cysts. J Neurol Surg B Skull Base. 2025;86(6):667-72",
    "leadAuthor": "Waqar M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgrBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgrBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1bc4d40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707129
  },
  {
    "id": "DEXA_Synt_32061",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41140347",
    "title": "Long-term follow-up and treatment of lamellar hole-associated epiretinal proliferation presenting with exudative perivascular anomalous complex.",
    "authors": [
      "Dósa G",
      "Fuller JM",
      "Zetterberg M",
      "Breimer M",
      "Kalaboukhova L"
    ],
    "journal": "Am J Ophthalmol Case Rep",
    "publicationDate": "2025-10-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ba0ce36c-9f66-4700-94cc-55110a1d6c87",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.499Z"
      },
      {
        "id": "b23dfc77-1680-4354-a6ba-700d1d8ec743",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 0bd5a681-a35d-43d8-b7ef-ed6afbc5bb3a to DEXA_Synt_32061",
        "type": "system",
        "createdAt": "2025-12-14T10:12:10.024Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:44.210Z",
    "updatedAt": "2025-12-14T08:54:21.507Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41140347",
      "DOI": "https://doi.org10.1016/j.ajoc.2025.102446",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:03:38",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Dósa G, Fuller JM, Zetterberg M, Breimer M, Kalaboukhova L. Long-term follow-up and treatment of lamellar hole-associated epiretinal proliferation presenting with exudative perivascular anomalous complex. Am J Ophthalmol Case Rep. 2025;40102446",
      "pubdate": "2025-10-27",
      "Lead_author": "Dósa G",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ajoc.2025.102446",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Dósa G, Fuller JM, Zetterberg M, Breimer M, Kalaboukhova L. Long-term follow-up and treatment of lamellar hole-associated epiretinal proliferation presenting with exudative perivascular anomalous complex. Am J Ophthalmol Case Rep. 2025;40102446",
    "leadAuthor": "Dósa G",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgsBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgsBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1be5bc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707130
  },
  {
    "id": "DEXA_Synt_78629",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41139882",
    "title": "Development of a reverse-phase HPLC method for the simultaneous determination of curcumin and dexamethasone in polymeric micelles.",
    "authors": [
      "Haj-Ali D",
      "Azzam H",
      "Aiedeh K",
      "Alshaer W"
    ],
    "journal": "Future Sci OA",
    "publicationDate": "2025-10-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "e55b5fde-8aa3-4d88-b48d-99aedc7899bc",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.531Z"
      },
      {
        "id": "04bb8b58-ea41-4127-bef1-bf7dfaa5dc6c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 949b1975-6f84-4dfc-aa18-33d89f9f12a0 to DEXA_Synt_78629",
        "type": "system",
        "createdAt": "2025-12-14T10:12:10.241Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:44.405Z",
    "updatedAt": "2025-12-14T08:54:21.566Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41139882",
      "DOI": "https://doi.org10.1080/20565623.2025.2577618",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:03:45",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Haj-Ali D, Azzam H, Aiedeh K, Alshaer W. Development of a reverse-phase HPLC method for the simultaneous determination of curcumin and dexamethasone in polymeric micelles. Future Sci OA. 2025;11(1):2577618",
      "pubdate": "2025-10-27",
      "Lead_author": "Haj-Ali D",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/20565623.2025.2577618",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Haj-Ali D, Azzam H, Aiedeh K, Alshaer W. Development of a reverse-phase HPLC method for the simultaneous determination of curcumin and dexamethasone in polymeric micelles. Future Sci OA. 2025;11(1):2577618",
    "leadAuthor": "Haj-Ali D",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgtBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgtBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1c09480501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707130
  },
  {
    "id": "DEXA_Synt_97247",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41115840",
    "title": "Space Charge Induced Dissociation Due to Extended Ion Accumulation Preceding Cyclic Ion Mobility Separation.",
    "authors": [
      "Mane SS",
      "Cox EK",
      "Lee KW"
    ],
    "journal": "J Am Soc Mass Spectrom",
    "publicationDate": "2025-10-21",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "4fc7f799-9a1c-4ee9-8880-e1b4e33b9db9",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.593Z"
      },
      {
        "id": "14609013-7c3a-43fe-a75e-8bdeed8ca727",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 042e5ed3-d7fb-4712-a6d0-689fe5eed352 to DEXA_Synt_97247",
        "type": "system",
        "createdAt": "2025-12-14T10:12:10.457Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:44.499Z",
    "updatedAt": "2025-12-14T08:54:21.601Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41115840",
      "DOI": "https://doi.org10.1021/jasms.5c00227",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:04:03",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Mane SS, Cox EK, Lee KW. Space Charge Induced Dissociation Due to Extended Ion Accumulation Preceding Cyclic Ion Mobility Separation. J Am Soc Mass Spectrom. 2025;36(11):2480-",
      "pubdate": "2025-10-21",
      "Lead_author": "Mane SS",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1021/jasms.5c00227",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Mane SS, Cox EK, Lee KW. Space Charge Induced Dissociation Due to Extended Ion Accumulation Preceding Cyclic Ion Mobility Separation. J Am Soc Mass Spectrom. 2025;36(11):2480-",
    "leadAuthor": "Mane SS",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUguBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUguBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1c2a6c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707130
  },
  {
    "id": "DEXA_Synt_63592",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41087000",
    "title": "Enhanced corneal permeation of diclofenac through an ophthalmic nanocrystal suspension.",
    "authors": [
      "Loi E",
      "Díaz-Tomé V",
      "Cuello-Rodríguez S",
      "Cardia MC",
      "Álvarez-González V",
      "Moreira J",
      "Lai F",
      "Otero-Espinar FJ"
    ],
    "journal": "Int J Pharm",
    "publicationDate": "2025-10-15",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ea581e75-969b-4f7c-a3f6-c48437fa9c35",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.622Z"
      },
      {
        "id": "1917f3ea-c870-4e8d-a60b-d9fd1920d8bb",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 32304b62-c040-4330-b711-b6438723622d to DEXA_Synt_63592",
        "type": "system",
        "createdAt": "2025-12-14T10:12:10.674Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:44.667Z",
    "updatedAt": "2025-12-14T08:54:21.672Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41087000",
      "DOI": "https://doi.org10.1016/j.ijpharm.2025.126272",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:04:34",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Loi E, Díaz-Tomé V, Cuello-Rodríguez S, Cardia MC, Álvarez-González V, Moreira J, Lai F, Otero-Espinar FJ. Enhanced corneal permeation of diclofenac through an ophthalmic nanocrystal suspension. Int J Pharm. 2025;685126272",
      "pubdate": "2025-10-15",
      "Lead_author": "Loi E",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ijpharm.2025.126272",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Loi E, Díaz-Tomé V, Cuello-Rodríguez S, Cardia MC, Álvarez-González V, Moreira J, Lai F, Otero-Espinar FJ. Enhanced corneal permeation of diclofenac through an ophthalmic nanocrystal suspension. Int J Pharm. 2025;685126272",
    "leadAuthor": "Loi E",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgvBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgvBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1c50480501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707130
  },
  {
    "id": "DEXA_Synt_10712",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41086495",
    "title": "Comparative in vitro assessment of bioactive chemicals in wastewater from South Australia and Oman using reporter gene assays and a fish cell line.",
    "authors": [
      "Alfarsi A",
      "Kumar A",
      "Nguyen TV",
      "Johnson M",
      "Mahdouri MA",
      "Nugegoda D"
    ],
    "journal": "J Hazard Mater",
    "publicationDate": "2025-10-15",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "06906950-e8af-4ff4-abe1-66ef7f734733",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.698Z"
      },
      {
        "id": "d21529a8-33e6-4eee-9171-9db4ffe8c2b2",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3d721705-317c-45dc-a9d6-0f3ef11bc444 to DEXA_Synt_10712",
        "type": "system",
        "createdAt": "2025-12-14T10:12:10.904Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:44.744Z",
    "updatedAt": "2025-12-14T08:54:21.708Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41086495",
      "DOI": "https://doi.org10.1016/j.jhazmat.2025.140003",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:04:12",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Alfarsi A, Kumar A, Nguyen TV, Johnson M, Mahdouri MA, Nugegoda D. Comparative in vitro assessment of bioactive chemicals in wastewater from South Australia and Oman using reporter gene assays and a fish cell line. J Hazard Mater. 2025;499140003",
      "pubdate": "2025-10-15",
      "Lead_author": "Alfarsi A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jhazmat.2025.140003",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Alfarsi A, Kumar A, Nguyen TV, Johnson M, Mahdouri MA, Nugegoda D. Comparative in vitro assessment of bioactive chemicals in wastewater from South Australia and Oman using reporter gene assays and a fish cell line. J Hazard Mater. 2025;499140003",
    "leadAuthor": "Alfarsi A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgwBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgwBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1c71200501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707130
  },
  {
    "id": "DEXA_Synt_30385",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41062381",
    "title": "Intraoperative high dose dexamethasone is associated with clinically relevant postoperative pancreatic fistula: a retrospective cohort study.",
    "authors": [
      "Fligor SC",
      "Polanco-Santana JC",
      "Lanys A",
      "Kasakewitch JPG",
      "Schaefer MS",
      "Sarpel U",
      "Kent TS"
    ],
    "journal": "HPB (Oxford)",
    "publicationDate": "2025-10-9",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "337a013f-a6cc-477a-8f07-5e0f76746d85",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.729Z"
      },
      {
        "id": "66c5705d-9fb8-4b5c-b00d-2a2ecceb9765",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a13e65d7-bacf-45d1-8a63-3f4ca654a2a4 to DEXA_Synt_30385",
        "type": "system",
        "createdAt": "2025-12-14T10:12:11.137Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:44.923Z",
    "updatedAt": "2025-12-14T08:54:21.762Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41062381",
      "DOI": "https://doi.org10.1016/j.hpb.2025.08.008",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:04:27",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Fligor SC, Polanco-Santana JC, Lanys A, Kasakewitch JPG, Schaefer MS, Sarpel U, Kent TS. Intraoperative high dose dexamethasone is associated with clinically relevant postoperative pancreatic fistula: a retrospective cohort study. HPB (Oxford). 2025;27(12):1517-26",
      "pubdate": "2025-10-9",
      "Lead_author": "Fligor SC",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.hpb.2025.08.008",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Fligor SC, Polanco-Santana JC, Lanys A, Kasakewitch JPG, Schaefer MS, Sarpel U, Kent TS. Intraoperative high dose dexamethasone is associated with clinically relevant postoperative pancreatic fistula: a retrospective cohort study. HPB (Oxford). 2025;27(12):1517-26",
    "leadAuthor": "Fligor SC",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgxBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgxBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1c926c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707131
  },
  {
    "id": "DEXA_Synt_72445",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41052694",
    "title": "Beta-Ecdysone protects osteocytes from excess glucocorticoids via Akt1-mediated regulation of Connexin43.",
    "authors": [
      "Xie A",
      "Wang L",
      "Zhang Y",
      "Zhang S",
      "Cao J",
      "Wang C",
      "Wu H",
      "Dai W"
    ],
    "journal": "Steroids",
    "publicationDate": "2025-10-7",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "f9618168-3f9c-4c81-a66e-25848987ace3",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.790Z"
      },
      {
        "id": "c4c4e243-3a28-45b6-9d54-48f802e9db18",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 19ecac1d-6440-4f4c-8675-fe1f6ef28295 to DEXA_Synt_72445",
        "type": "system",
        "createdAt": "2025-12-14T10:12:11.353Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:44.989Z",
    "updatedAt": "2025-12-14T08:54:21.798Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41052694",
      "DOI": "https://doi.org10.1016/j.steroids.2025.109693",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:04:20",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Xie A, Wang L, Zhang Y, Zhang S, Cao J, Wang C, Wu H, Dai W. Beta-Ecdysone protects osteocytes from excess glucocorticoids via Akt1-mediated regulation of Connexin43. Steroids. 2025;224109693",
      "pubdate": "2025-10-7",
      "Lead_author": "Xie A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.steroids.2025.109693",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Xie A, Wang L, Zhang Y, Zhang S, Cao J, Wang C, Wu H, Dai W. Beta-Ecdysone protects osteocytes from excess glucocorticoids via Akt1-mediated regulation of Connexin43. Steroids. 2025;224109693",
    "leadAuthor": "Xie A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgyBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgyBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1cb5d00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707131
  },
  {
    "id": "DEXA_Synt_65560",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41047944",
    "title": "Brutons tyrosine kinase inhibitor Zanubrutinib modulates Fc gamma receptors to inhibit platelet destruction for alleviation of refractory immune thrombocytopenia.",
    "authors": [
      "Yang XX",
      "Yao GL",
      "Yang YJ",
      "Han YH",
      "Yang L",
      "Zhang YF"
    ],
    "journal": "Hematology",
    "publicationDate": "2025-10-6",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "199722e9-5f98-4634-b9b3-421d182b4c7e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.834Z"
      },
      {
        "id": "8ca0a75b-2bb8-4868-b80a-9bab4a6a8827",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 24e007d0-9b25-4fed-93cb-527f76ddd164 to DEXA_Synt_65560",
        "type": "system",
        "createdAt": "2025-12-14T10:12:11.568Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:45.221Z",
    "updatedAt": "2025-12-14T08:54:21.843Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41047944",
      "DOI": "https://doi.org10.1080/16078454.2025.2545078",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:04:43",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Yang XX, Yao GL, Yang YJ, Han YH, Yang L, Zhang YF. Brutons tyrosine kinase inhibitor Zanubrutinib modulates Fc gamma receptors to inhibit platelet destruction for alleviation of refractory immune thrombocytopenia. Hematology. 2025;30(1):2545078",
      "pubdate": "2025-10-6",
      "Lead_author": "Yang XX",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/16078454.2025.2545078",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Yang XX, Yao GL, Yang YJ, Han YH, Yang L, Zhang YF. Brutons tyrosine kinase inhibitor Zanubrutinib modulates Fc gamma receptors to inhibit platelet destruction for alleviation of refractory immune thrombocytopenia. Hematology. 2025;30(1):2545078",
    "leadAuthor": "Yang XX",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgzBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgzBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1cd5e40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707131
  },
  {
    "id": "DEXA_Synt_11171",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40983426",
    "title": "A novel non-biological dual identification system based on SBE-β-CD@CdTe for the simultaneous detection of multiple steroids in environmental water.",
    "authors": [
      "Cui X",
      "Zhao Y",
      "Zhou N",
      "Hou Y",
      "Zhu Y",
      "Zhang P",
      "Guo P"
    ],
    "journal": "Anal Chim Acta",
    "publicationDate": "2025-09-23",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "84e0d7d0-0b0f-4c20-aaef-0a85f64b374e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.897Z"
      },
      {
        "id": "68f2614f-e185-4e04-9aba-e71939902d7a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 8dc0e378-0cc4-4e46-b40a-dab6999f018a to DEXA_Synt_11171",
        "type": "system",
        "createdAt": "2025-12-14T10:12:11.806Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:45.264Z",
    "updatedAt": "2025-12-14T08:54:21.930Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40983426",
      "DOI": "https://doi.org10.1016/j.aca.2025.344517",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:05:06",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Cui X, Zhao Y, Zhou N, Hou Y, Zhu Y, Zhang P, Guo P. A novel non-biological dual identification system based on SBE-β-CD@CdTe for the simultaneous detection of multiple steroids in environmental water. Anal Chim Acta. 2025;1374344517",
      "pubdate": "2025-09-23",
      "Lead_author": "Cui X",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.aca.2025.344517",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Cui X, Zhao Y, Zhou N, Hou Y, Zhu Y, Zhang P, Guo P. A novel non-biological dual identification system based on SBE-β-CD@CdTe for the simultaneous detection of multiple steroids in environmental water. Anal Chim Acta. 2025;1374344517",
    "leadAuthor": "Cui X",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg0BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg0BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1cfc3c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707131
  },
  {
    "id": "DEXA_Synt_78391",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40983292",
    "title": "Harnessing engineered adaptive nanoparticles to modulate macrophages for treating corneal alkali burns.",
    "authors": [
      "Qin X",
      "Zhang L",
      "Wang X",
      "Meng J",
      "Miao YB",
      "Wang Q",
      "Zou L",
      "Yang Q",
      "Jiang L",
      "Shi Y"
    ],
    "journal": "J Control Release",
    "publicationDate": "2025-09-23",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "8f1477ce-7afb-47cf-9d5c-1f32e9014401",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.941Z"
      },
      {
        "id": "9a375c66-cb7b-40ab-9579-71c9605a3d3c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 56da68cd-44ee-4876-baf5-72e3e18a7f2f to DEXA_Synt_78391",
        "type": "system",
        "createdAt": "2025-12-14T10:12:11.987Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:45.455Z",
    "updatedAt": "2025-12-14T08:54:21.975Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40983292",
      "DOI": "https://doi.org10.1016/j.jconrel.2025.114253",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:05:14",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Qin X, Zhang L, Wang X, Meng J, Miao YB, Wang Q, Zou L, Yang Q, Jiang L, Shi Y. Harnessing engineered adaptive nanoparticles to modulate macrophages for treating corneal alkali burns. J Control Release. 2025;387114253",
      "pubdate": "2025-09-23",
      "Lead_author": "Qin X",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jconrel.2025.114253",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Qin X, Zhang L, Wang X, Meng J, Miao YB, Wang Q, Zou L, Yang Q, Jiang L, Shi Y. Harnessing engineered adaptive nanoparticles to modulate macrophages for treating corneal alkali burns. J Control Release. 2025;387114253",
    "leadAuthor": "Qin X",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg1BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg1BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1dd4f40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707133
  },
  {
    "id": "DEXA_Synt_25695",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40962153",
    "title": "Endophytic fungus MH397503 mediates the structural modification of agarwood chromones and its anti-vascular endothelial injury activity.",
    "authors": [
      "Cao JM",
      "Zhu LP",
      "Lai YT",
      "Zeng W",
      "Liu X",
      "Yu XY",
      "Yu M",
      "Sun MJ",
      "Chen CX",
      "Mai DS",
      "Chen J",
      "Zhao ZX"
    ],
    "journal": "Fitoterapia",
    "publicationDate": "2025-09-18",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "49e3eb4b-6202-4514-9f81-71cecff46307",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:21.988Z"
      },
      {
        "id": "e0d34b74-250a-46d0-85cd-15f4fcbaee9e",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f2acd46d-f76a-47f1-a088-808f618fac92 to DEXA_Synt_25695",
        "type": "system",
        "createdAt": "2025-12-14T10:12:13.347Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:45.534Z",
    "updatedAt": "2025-12-14T08:54:22.037Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40962153",
      "DOI": "https://doi.org10.1016/j.fitote.2025.106872",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:04:59",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Cao JM, Zhu LP, Lai YT, Zeng W, Liu X, Yu XY, Yu M, Sun MJ, Chen CX, Mai DS, Chen J, Zhao ZX. Endophytic fungus MH397503 mediates the structural modification of agarwood chromones and its anti-vascular endothelial injury activity. Fitoterapia. 2025;187106872",
      "pubdate": "2025-09-18",
      "Lead_author": "Cao JM",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.fitote.2025.106872",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Cao JM, Zhu LP, Lai YT, Zeng W, Liu X, Yu XY, Yu M, Sun MJ, Chen CX, Mai DS, Chen J, Zhao ZX. Endophytic fungus MH397503 mediates the structural modification of agarwood chromones and its anti-vascular endothelial injury activity. Fitoterapia. 2025;187106872",
    "leadAuthor": "Cao JM",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg2BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg2BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1e3f400501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707134
  },
  {
    "id": "DEXA_Synt_23161",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40945533",
    "title": "Alkaline phosphatase-responsive hydrogel for efficient management of autoimmune intraocular inflammation.",
    "authors": [
      "Li Y",
      "Lin D",
      "Chen J",
      "Zhang W",
      "Jin H",
      "Feng S",
      "Mao H",
      "Hou J",
      "Li X",
      "Wang Y",
      "Zhou J"
    ],
    "journal": "J Control Release",
    "publicationDate": "2025-09-14",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ff1dcb08-4eb4-4cee-b6f3-b57c7cee0be0",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.049Z"
      },
      {
        "id": "e8b0aae0-fa9e-4018-965a-9eb093b25f2e",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 01988049-0186-4227-9a04-263b0a88982e to DEXA_Synt_23161",
        "type": "system",
        "createdAt": "2025-12-14T10:12:14.101Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:45.720Z",
    "updatedAt": "2025-12-14T08:54:22.057Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40945533",
      "DOI": "https://doi.org10.1016/j.jconrel.2025.114229",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:04:52",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Li Y, Lin D, Chen J, Zhang W, Jin H, Feng S, Mao H, Hou J, Li X, Wang Y, Zhou J. Alkaline phosphatase-responsive hydrogel for efficient management of autoimmune intraocular inflammation. J Control Release. 2025;387114229",
      "pubdate": "2025-09-14",
      "Lead_author": "Li Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jconrel.2025.114229",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Li Y, Lin D, Chen J, Zhang W, Jin H, Feng S, Mao H, Hou J, Li X, Wang Y, Zhou J. Alkaline phosphatase-responsive hydrogel for efficient management of autoimmune intraocular inflammation. J Control Release. 2025;387114229",
    "leadAuthor": "Li Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg3BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg3BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1e5f980501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707134
  },
  {
    "id": "DEXA_Synt_26884",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40925199",
    "title": "Myostatin knockout mice muscle derived exosome inhibited dexamethasone-induced muscle atrophy.",
    "authors": [
      "Liu MQ",
      "Li ZY",
      "Liu XY",
      "Lv ST",
      "Quan BH",
      "Yin XJ"
    ],
    "journal": "Int Immunopharmacol",
    "publicationDate": "2025-09-10",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "327c2078-544b-47de-ae28-516851b2c601",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.080Z"
      },
      {
        "id": "184940bc-3b1d-4d9a-9f80-e16f231915ef",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 89594f8e-83ae-4433-8965-da2342f60915 to DEXA_Synt_26884",
        "type": "system",
        "createdAt": "2025-12-14T10:12:14.985Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:45.776Z",
    "updatedAt": "2025-12-14T08:54:22.144Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40925199",
      "DOI": "https://doi.org10.1016/j.intimp.2025.115488",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:05:21",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Liu MQ, Li ZY, Liu XY, Lv ST, Quan BH, Yin XJ. Myostatin knockout mice muscle derived exosome inhibited dexamethasone-induced muscle atrophy. Int Immunopharmacol. 2025;165115488",
      "pubdate": "2025-09-10",
      "Lead_author": "Liu MQ",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.intimp.2025.115488",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Liu MQ, Li ZY, Liu XY, Lv ST, Quan BH, Yin XJ. Myostatin knockout mice muscle derived exosome inhibited dexamethasone-induced muscle atrophy. Int Immunopharmacol. 2025;165115488",
    "leadAuthor": "Liu MQ",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg4BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg4BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1ed4e40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707134
  },
  {
    "id": "DEXA_Synt_59245",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40848758",
    "title": "Round window membrane extracellular vesicles facilitate inner ear drug delivery.",
    "authors": [
      "Holdsclaw S",
      "Silkstone D",
      "Moazzam F",
      "Jeanneret H",
      "Tehsin N",
      "Norris E",
      "Talic E",
      "Popowski K",
      "Cruse G",
      "Cheng K",
      "Moatti A"
    ],
    "journal": "J Control Release",
    "publicationDate": "2025-08-24",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "87db8443-8b49-45d8-b8c2-b5e2b4e09565",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.156Z"
      },
      {
        "id": "20d2a6aa-cdc2-45bb-85a9-6e46b43d5e37",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from cebb49c6-223b-442d-9614-2ee7202a2c14 to DEXA_Synt_59245",
        "type": "system",
        "createdAt": "2025-12-14T10:12:15.127Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:45.981Z",
    "updatedAt": "2025-12-14T08:54:22.164Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40848758",
      "DOI": "https://doi.org10.1016/j.jconrel.2025.114153",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:05:30",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Holdsclaw S, Silkstone D, Moazzam F, Jeanneret H, Tehsin N, Norris E, Talic E, Popowski K, Cruse G, Cheng K, Moatti A. Round window membrane extracellular vesicles facilitate inner ear drug delivery. J Control Release. 2025;387114153",
      "pubdate": "2025-08-24",
      "Lead_author": "Holdsclaw S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jconrel.2025.114153",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Holdsclaw S, Silkstone D, Moazzam F, Jeanneret H, Tehsin N, Norris E, Talic E, Popowski K, Cruse G, Cheng K, Moatti A. Round window membrane extracellular vesicles facilitate inner ear drug delivery. J Control Release. 2025;387114153",
    "leadAuthor": "Holdsclaw S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg5BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg5BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1ef2ac0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707135
  },
  {
    "id": "DEXA_Synt_47962",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40845265",
    "title": "Frail subgroups determine heterogeneous outcomes in older patients with NDMM: long-term follow-up of the HOVON 143 trial.",
    "authors": [
      "Smits F",
      "Groen K",
      "Levin MD",
      "Stege CAM",
      "van Kampen R",
      "van der Spek E",
      "Nijhof I",
      "Bilgin YM",
      "Thielen N",
      "Ludwig I",
      "de Waal EGM",
      "Sandberg Y",
      "Kentos A",
      "Timmers GJ",
      "Regelink JC",
      "Westerman M",
      "de Heer K",
      "Vekemans MC",
      "Durdu-Rayman N",
      "de Graauw NCHP",
      "Seefat MR",
      "van de Donk NWCJ",
      "Ypma PF",
      "Nasserinejad K",
      "Zweegman S"
    ],
    "journal": "Blood Adv",
    "publicationDate": "2025-08-22",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ce16d142-3313-4047-8aa6-51ed17b96d92",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.186Z"
      },
      {
        "id": "398cd3c9-5b97-42e9-93ee-86ed2c553494",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 1c333414-1332-4073-92ad-112cb8e5f1bf to DEXA_Synt_47962",
        "type": "system",
        "createdAt": "2025-12-14T10:12:15.375Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:46.018Z",
    "updatedAt": "2025-12-14T08:54:22.238Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40845265",
      "DOI": "https://doi.org10.1182/bloodadvances.2025017394",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:05:45",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Smits F, Groen K, Levin MD, Stege CAM, van Kampen R, van der Spek E, Nijhof I, Bilgin YM, Thielen N, Ludwig I, de Waal EGM, Sandberg Y, Kentos A, Timmers GJ, Regelink JC, Westerman M, de Heer K, Vekemans MC, Durdu-Rayman N, de Graauw NCHP, Seefat MR, van de Donk NWCJ, Ypma PF, Nasserinejad K, Zweegman S. Frail subgroups determine heterogeneous outcomes in older patients with NDMM: long-term follow-up of the HOVON 143 trial. Blood Adv. 2025;9(22):5828-36",
      "pubdate": "2025-08-22",
      "Lead_author": "Smits F",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1182/bloodadvances.2025017394",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Smits F, Groen K, Levin MD, Stege CAM, van Kampen R, van der Spek E, Nijhof I, Bilgin YM, Thielen N, Ludwig I, de Waal EGM, Sandberg Y, Kentos A, Timmers GJ, Regelink JC, Westerman M, de Heer K, Vekemans MC, Durdu-Rayman N, de Graauw NCHP, Seefat MR, van de Donk NWCJ, Ypma PF, Nasserinejad K, Zweegman S. Frail subgroups determine heterogeneous outcomes in older patients with NDMM: long-term follow-up of the HOVON 143 trial. Blood Adv. 2025;9(22):5828-36",
    "leadAuthor": "Smits F",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg6BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg6BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1f16440501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707135
  },
  {
    "id": "DEXA_Synt_10845",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40841190",
    "title": "Survival analysis of infants with bronchopulmonary dysplasia-associated pulmonary hypertension: a single-center study in China.",
    "authors": [
      "Wang C",
      "Chen M",
      "Shi W",
      "Xu Y",
      "Chen Z",
      "Shi L",
      "Ma X"
    ],
    "journal": "J Matern Fetal Neonatal Med",
    "publicationDate": "2025-08-22",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "7df73c71-c93c-4511-9ff7-43cbd30ef3d5",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.264Z"
      },
      {
        "id": "3d4f54bc-8ef9-4f8b-9a4d-50717d07a354",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3ecce824-d934-4dd5-b259-1931a84b2033 to DEXA_Synt_10845",
        "type": "system",
        "createdAt": "2025-12-14T10:12:15.603Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:46.246Z",
    "updatedAt": "2025-12-14T08:54:22.275Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40841190",
      "DOI": "https://doi.org10.1080/14767058.2025.2546543",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:05:37",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Wang C, Chen M, Shi W, Xu Y, Chen Z, Shi L, Ma X. Survival analysis of infants with bronchopulmonary dysplasia-associated pulmonary hypertension: a single-center study in China. J Matern Fetal Neonatal Med. 2025;38(1):2546543",
      "pubdate": "2025-08-22",
      "Lead_author": "Wang C",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/14767058.2025.2546543",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Wang C, Chen M, Shi W, Xu Y, Chen Z, Shi L, Ma X. Survival analysis of infants with bronchopulmonary dysplasia-associated pulmonary hypertension: a single-center study in China. J Matern Fetal Neonatal Med. 2025;38(1):2546543",
    "leadAuthor": "Wang C",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg7BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg7BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1f39800501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707135
  },
  {
    "id": "DEXA_Synt_74779",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40831349",
    "title": "Update in new-onset refractory status epilepticus and febrile infection-related epilepsy syndrome.",
    "authors": [
      "Shah PD",
      "Voss-Hoynes HA",
      "Pauley RA"
    ],
    "journal": "Curr Opin Pediatr",
    "publicationDate": "2025-08-20",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "00a90131-d0ac-4fe4-9eb9-77cfc5316e9e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.307Z"
      },
      {
        "id": "1b2e7c95-743b-42e1-af03-65a071741693",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 89c3447a-0014-43f0-81ec-9043c21d7d68 to DEXA_Synt_74779",
        "type": "system",
        "createdAt": "2025-12-14T10:12:15.833Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:46.280Z",
    "updatedAt": "2025-12-14T08:54:22.315Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40831349",
      "DOI": "https://doi.org10.1097/MOP.0000000000001501",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:05:51",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Shah PD, Voss-Hoynes HA, Pauley RA. Update in new-onset refractory status epilepticus and febrile infection-related epilepsy syndrome. Curr Opin Pediatr. 2025;37(6):550-4",
      "pubdate": "2025-08-20",
      "Lead_author": "Shah PD",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/MOP.0000000000001501",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Shah PD, Voss-Hoynes HA, Pauley RA. Update in new-onset refractory status epilepticus and febrile infection-related epilepsy syndrome. Curr Opin Pediatr. 2025;37(6):550-4",
    "leadAuthor": "Shah PD",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg8BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg8BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1fb09c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707136
  },
  {
    "id": "DEXA_Synt_90961",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40829164",
    "title": "A T-cell-based metric of immune age predicts outcomes in older patients with myeloma receiving daratumumab-based therapy.",
    "authors": [
      "Bruins WSC",
      "Smits F",
      "Duetz C",
      "Groen K",
      "Korst CLBM",
      "de Jonge AV",
      "Verkleij CPM",
      "Rentenaar R",
      "Cosovic M",
      "Eken M",
      "Twickler I",
      "Homan-Weert PM",
      "Sonneveld P",
      "Moreau P",
      "Claesen J",
      "van de Donk NWCJ",
      "Zweegman S",
      "Mutis T"
    ],
    "journal": "Blood",
    "publicationDate": "2025-08-19",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "dd599d7e-8d1d-4af9-8caa-a3873ba46da5",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.341Z"
      },
      {
        "id": "118a72d2-a45b-4235-9847-d00246597df2",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a850bb9d-ead3-45e8-ae34-3e99b84fe262 to DEXA_Synt_90961",
        "type": "system",
        "createdAt": "2025-12-14T10:12:16.618Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:46.446Z",
    "updatedAt": "2025-12-14T08:54:22.373Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40829164",
      "DOI": "https://doi.org10.1182/blood.2025028587",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:05:59",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Bruins WSC, Smits F, Duetz C, Groen K, Korst CLBM, de Jonge AV, Verkleij CPM, Rentenaar R, Cosovic M, Eken M, Twickler I, Homan-Weert PM, Sonneveld P, Moreau P, Claesen J, van de Donk NWCJ, Zweegman S, Mutis T. A T-cell-based metric of immune age predicts outcomes in older patients with myeloma receiving daratumumab-based therapy. Blood. 2025;146(21):2517-30",
      "pubdate": "2025-08-19",
      "Lead_author": "Bruins WSC",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1182/blood.2025028587",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Bruins WSC, Smits F, Duetz C, Groen K, Korst CLBM, de Jonge AV, Verkleij CPM, Rentenaar R, Cosovic M, Eken M, Twickler I, Homan-Weert PM, Sonneveld P, Moreau P, Claesen J, van de Donk NWCJ, Zweegman S, Mutis T. A T-cell-based metric of immune age predicts outcomes in older patients with myeloma receiving daratumumab-based therapy. Blood. 2025;146(21):2517-30",
    "leadAuthor": "Bruins WSC",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg9BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg9BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1fd19c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707136
  },
  {
    "id": "DEXA_Synt_86643",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40763929",
    "title": "Toxicological Impacts of Arecoline and Tobacco in Oral Submucous Fibrosis: Mechanisms and Therapeutic Insights.",
    "authors": [
      "Ezhilarasan D",
      "Jayanth Kumar V"
    ],
    "journal": "J Appl Toxicol",
    "publicationDate": "2025-08-6",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a108a666-43dc-468c-8ae5-d72e55e29329",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.404Z"
      },
      {
        "id": "c3179f45-638c-450b-897e-ae5259bf5fb4",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 5b52c47d-e245-441b-bb6b-58d9c0ee888f to DEXA_Synt_86643",
        "type": "system",
        "createdAt": "2025-12-14T10:12:16.851Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:46.629Z",
    "updatedAt": "2025-12-14T08:54:22.414Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40763929",
      "DOI": "https://doi.org10.1002/jat.4877",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:06:06",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Ezhilarasan D, Jayanth Kumar V. Toxicological Impacts of Arecoline and Tobacco in Oral Submucous Fibrosis: Mechanisms and Therapeutic Insights. J Appl Toxicol. 2025;45(12):2498-511",
      "pubdate": "2025-08-6",
      "Lead_author": "Ezhilarasan D",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/jat.4877",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Ezhilarasan D, Jayanth Kumar V. Toxicological Impacts of Arecoline and Tobacco in Oral Submucous Fibrosis: Mechanisms and Therapeutic Insights. J Appl Toxicol. 2025;45(12):2498-511",
    "leadAuthor": "Ezhilarasan D",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg+BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg+BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-1ff7a80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707136
  },
  {
    "id": "DEXA_Synt_58550",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40712145",
    "title": "IMPACT OF THE DEXAMETHASONE IMPLANT ON SLOWING DIABETIC RETINOPATHY PROGRESSION: Post Hoc Analysis of the MEAD Study.",
    "authors": [
      "Blinder KJ",
      "Wykoff CC",
      "Ferencz JR",
      "Ehlers JP",
      "Fang Y",
      "Lai H",
      "Ogidigben M",
      "López FJ"
    ],
    "journal": "Retina",
    "publicationDate": "2025-07-25",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "304577cc-e5c9-49c6-b46e-c7a8332429fb",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.433Z"
      },
      {
        "id": "875504a1-992c-4a55-a0f3-1a98f70211a0",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from e41896b2-a183-40d6-a886-99c242fbf497 to DEXA_Synt_58550",
        "type": "system",
        "createdAt": "2025-12-14T10:12:17.068Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:46.666Z",
    "updatedAt": "2025-12-14T08:54:22.483Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40712145",
      "DOI": "https://doi.org10.1097/IAE.0000000000004623",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:06:22",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Blinder KJ, Wykoff CC, Ferencz JR, Ehlers JP, Fang Y, Lai H, Ogidigben M, López FJ. IMPACT OF THE DEXAMETHASONE IMPLANT ON SLOWING DIABETIC RETINOPATHY PROGRESSION: Post Hoc Analysis of the MEAD Study. Retina. 2025;45(12):2252-62",
      "pubdate": "2025-07-25",
      "Lead_author": "Blinder KJ",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/IAE.0000000000004623",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Blinder KJ, Wykoff CC, Ferencz JR, Ehlers JP, Fang Y, Lai H, Ogidigben M, López FJ. IMPACT OF THE DEXAMETHASONE IMPLANT ON SLOWING DIABETIC RETINOPATHY PROGRESSION: Post Hoc Analysis of the MEAD Study. Retina. 2025;45(12):2252-62",
    "leadAuthor": "Blinder KJ",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg-BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg-BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-206e5c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707137
  },
  {
    "id": "DEXA_Synt_83801",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40686190",
    "title": "Chemical Stability of Ceftazidime Compounded in Saline, Glycerin and Dexamethasone-SP Solutions Stored at -20°C, 4°C and 25°C Over a 60 Day Period.",
    "authors": [
      "Snidow M",
      "Bachtel J",
      "Hoppers S",
      "Banks K",
      "Gustafson D",
      "Daniels JB",
      "Tsai W"
    ],
    "journal": "Vet Dermatol",
    "publicationDate": "2025-07-21",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "af7e5a06-008e-4eca-b64b-95bbc648e661",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.495Z"
      },
      {
        "id": "bff964ff-b469-40c2-bcda-27a84c4c41c9",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 7d61d6c1-4915-4388-ac55-422ed9d4abf5 to DEXA_Synt_83801",
        "type": "system",
        "createdAt": "2025-12-14T10:12:17.876Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:46.847Z",
    "updatedAt": "2025-12-14T08:54:22.505Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40686190",
      "DOI": "https://doi.org10.1111/vde.70005",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:06:38",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Snidow M, Bachtel J, Hoppers S, Banks K, Gustafson D, Daniels JB, Tsai W. Chemical Stability of Ceftazidime Compounded in Saline, Glycerin and Dexamethasone-SP Solutions Stored at -20°C, 4°C and 25°C Over a 60 Day Period. Vet Dermatol. 2025;36(6):862-9",
      "pubdate": "2025-07-21",
      "Lead_author": "Snidow M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/vde.70005",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Snidow M, Bachtel J, Hoppers S, Banks K, Gustafson D, Daniels JB, Tsai W. Chemical Stability of Ceftazidime Compounded in Saline, Glycerin and Dexamethasone-SP Solutions Stored at -20°C, 4°C and 25°C Over a 60 Day Period. Vet Dermatol. 2025;36(6):862-9",
    "leadAuthor": "Snidow M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhABwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhABwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-208e6c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707137
  },
  {
    "id": "DEXA_Synt_35795",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40625153",
    "title": "Overcome Daratumumab' severe reaction with desensitization in relapsed multiple myeloma.",
    "authors": [
      "Nguyen TL",
      "Phan T",
      "Vu MT",
      "Huynh KV",
      "Gyu YH",
      "Nguyen TD",
      "Phan LQ",
      "Nguyen TD",
      "Nguyen DV"
    ],
    "journal": "J Oncol Pharm Pract",
    "publicationDate": "2025-07-8",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "bfaf7337-5b04-46f3-8623-29580b45619d",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.557Z"
      },
      {
        "id": "71b837f5-738b-4c5a-93c0-2d4dfd102cef",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 614c8ff2-4f9a-420a-8f77-f29e48b82d9f to DEXA_Synt_35795",
        "type": "system",
        "createdAt": "2025-12-14T10:12:18.108Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:47.014Z",
    "updatedAt": "2025-12-14T08:54:22.566Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40625153",
      "DOI": "https://doi.org10.1177/10781552251356918",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:06:14",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Nguyen TL, Phan T, Vu MT, Huynh KV, Gyu YH, Nguyen TD, Phan LQ, Nguyen TD, Nguyen DV. Overcome Daratumumab' severe reaction with desensitization in relapsed multiple myeloma. J Oncol Pharm Pract. 2025;31(8):1348-52",
      "pubdate": "2025-07-8",
      "Lead_author": "Nguyen TL",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1177/10781552251356918",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Nguyen TL, Phan T, Vu MT, Huynh KV, Gyu YH, Nguyen TD, Phan LQ, Nguyen TD, Nguyen DV. Overcome Daratumumab' severe reaction with desensitization in relapsed multiple myeloma. J Oncol Pharm Pract. 2025;31(8):1348-52",
    "leadAuthor": "Nguyen TL",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhBBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhBBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-20b1ac0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707138
  },
  {
    "id": "DEXA_Synt_10952",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40619303",
    "title": "Real-World Comparison of Carfilzomib, Lenalidomide, and Dexamethasone Versus Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma: KMM2004 Study.",
    "authors": [
      "Kim DY",
      "Min CK",
      "Eom HS",
      "Jung J",
      "Kim K",
      "Lee JH",
      "Yoo KH",
      "Lee JY",
      "Byun JM",
      "Kim SH",
      "Lee JH",
      "Cho HJ",
      "Lee SM",
      "Do YR",
      "Park S",
      "Lee J",
      "Lee SS",
      "Kang HJ",
      "Park YH",
      "Lim SN",
      "Shin HJ"
    ],
    "journal": "Clin Lymphoma Myeloma Leuk",
    "publicationDate": "2025-07-7",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "836cc348-d62e-4766-a0d7-6fd64436303e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.588Z"
      },
      {
        "id": "83a0f054-0109-4004-9a48-a8c0ce26ac29",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 138f81c6-4937-46d6-8a82-b30fd435eee7 to DEXA_Synt_10952",
        "type": "system",
        "createdAt": "2025-12-14T10:12:18.315Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:47.109Z",
    "updatedAt": "2025-12-14T08:54:22.622Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40619303",
      "DOI": "https://doi.org10.1016/j.clml.2025.06.006",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:06:30",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Kim DY, Min CK, Eom HS, Jung J, Kim K, Lee JH, Yoo KH, Lee JY, Byun JM, Kim SH, Lee JH, Cho HJ, Lee SM, Do YR, Park S, Lee J, Lee SS, Kang HJ, Park YH, Lim SN, Shin HJ, . Real-World Comparison of Carfilzomib, Lenalidomide, and Dexamethasone Versus Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma: KMM2004 Study. Clin Lymphoma Myeloma Leuk. 2025;25(12):873-84",
      "pubdate": "2025-07-7",
      "Lead_author": "Kim DY",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.clml.2025.06.006",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Kim DY, Min CK, Eom HS, Jung J, Kim K, Lee JH, Yoo KH, Lee JY, Byun JM, Kim SH, Lee JH, Cho HJ, Lee SM, Do YR, Park S, Lee J, Lee SS, Kang HJ, Park YH, Lim SN, Shin HJ, . Real-World Comparison of Carfilzomib, Lenalidomide, and Dexamethasone Versus Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma: KMM2004 Study. Clin Lymphoma Myeloma Leuk. 2025;25(12):873-84",
    "leadAuthor": "Kim DY",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhCBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhCBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-20d1e80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707138
  },
  {
    "id": "DEXA_Synt_99902",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40550011",
    "title": "Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment.",
    "authors": [
      "DeFronzo RA",
      "Fonseca V",
      "Aroda VR",
      "Auchus RJ",
      "Bailey T",
      "Bancos I",
      "Busch RS",
      "Buse JB",
      "Christofides EA",
      "Eilerman B",
      "Findling JW",
      "Handelsman Y",
      "Kahn SE",
      "Miller HJ",
      "Ownby JG",
      "Parker JC",
      "Philis-Tsimikas A",
      "Pratley R",
      "Rosenstock J",
      "Shanik MH",
      "Sloan LA",
      "Umpierrez G",
      "Shambharkar S",
      "Tudor IC",
      "Schlafly TK",
      "Einhorn D"
    ],
    "journal": "Diabetes Care",
    "publicationDate": "2025-06-24",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5c87a5a7-c972-4098-bd6f-44deb57e7135",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.649Z"
      },
      {
        "id": "2a051dd5-ddea-4954-af1c-36293e7d7c09",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f0b9037f-f71b-4680-b045-be2965e34868 to DEXA_Synt_99902",
        "type": "system",
        "createdAt": "2025-12-14T10:12:18.559Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:47.279Z",
    "updatedAt": "2025-12-14T08:54:22.659Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40550011",
      "DOI": "https://doi.org10.2337/dc25-1055",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:06:45",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "DeFronzo RA, Fonseca V, Aroda VR, Auchus RJ, Bailey T, Bancos I, Busch RS, Buse JB, Christofides EA, Eilerman B, Findling JW, Handelsman Y, Kahn SE, Miller HJ, Ownby JG, Parker JC, Philis-Tsimikas A, Pratley R, Rosenstock J, Shanik MH, Sloan LA, Umpierrez G, Shambharkar S, Tudor IC, Schlafly TK, Einhorn D, . Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment. Diabetes Care. 2025;48(12):2036-44",
      "pubdate": "2025-06-24",
      "Lead_author": "DeFronzo RA",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.2337/dc25-1055",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "DeFronzo RA, Fonseca V, Aroda VR, Auchus RJ, Bailey T, Bancos I, Busch RS, Buse JB, Christofides EA, Eilerman B, Findling JW, Handelsman Y, Kahn SE, Miller HJ, Ownby JG, Parker JC, Philis-Tsimikas A, Pratley R, Rosenstock J, Shanik MH, Sloan LA, Umpierrez G, Shambharkar S, Tudor IC, Schlafly TK, Einhorn D, . Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment. Diabetes Care. 2025;48(12):2036-44",
    "leadAuthor": "DeFronzo RA",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhDBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhDBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-20f6840501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707138
  },
  {
    "id": "DEXA_Synt_83615",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40302691",
    "title": "Period 1 (): A novel glucocorticoid-responsive gene involved in cortisol-induced proliferation of androgen-independent human prostate cancer DU145 cells.",
    "authors": [
      "Hata S",
      "Shimada H",
      "Yokoyama A",
      "Nakamura Y"
    ],
    "journal": "Histol Histopathol",
    "publicationDate": "2025-04-30",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "7209ecf8-54d5-426b-b9f0-c69ff139c713",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.714Z"
      },
      {
        "id": "018583d9-0800-433c-b54b-f11f2d6bd8f3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 53fa0913-93eb-494b-86d3-a532630baa9d to DEXA_Synt_83615",
        "type": "system",
        "createdAt": "2025-12-14T10:12:18.797Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:47.386Z",
    "updatedAt": "2025-12-14T08:54:22.725Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40302691",
      "DOI": "https://doi.org10.14670/HH-18-912",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:07:16",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Hata S, Shimada H, Yokoyama A, Nakamura Y. Period 1 (<i>PER1</i>): A novel glucocorticoid-responsive gene involved in cortisol-induced proliferation of androgen-independent human prostate cancer DU145 cells. Histol Histopathol. 2025;40(12):1941-",
      "pubdate": "2025-04-30",
      "Lead_author": "Hata S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.14670/HH-18-912",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Hata S, Shimada H, Yokoyama A, Nakamura Y. Period 1 (<i>PER1</i>): A novel glucocorticoid-responsive gene involved in cortisol-induced proliferation of androgen-independent human prostate cancer DU145 cells. Histol Histopathol. 2025;40(12):1941-",
    "leadAuthor": "Hata S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhEBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhEBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-211b440501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707138
  },
  {
    "id": "DEXA_Synt_22853",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40290045",
    "title": "Increased HSD11β1 Expression in Human Leiomyomatous Uteri: Implication for Enhanced Glucocorticoid Signaling.",
    "authors": [
      "Malcom C",
      "Guzeloglu-Kayisli O",
      "Un B",
      "New E",
      "Cetinkaya-Un B",
      "Guo X",
      "Mikhail E",
      "Imudia A",
      "Lockwood C",
      "Kayisli U"
    ],
    "journal": "J Clin Endocrinol Metab",
    "publicationDate": "2025-04-28",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "032b5cdc-81f0-4d79-8acc-29d775077257",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.742Z"
      },
      {
        "id": "6d4100c9-5d91-4735-8c16-6d4420d4107b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9bcb60a2-541b-4837-a64a-386e2eb5d695 to DEXA_Synt_22853",
        "type": "system",
        "createdAt": "2025-12-14T10:12:18.995Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:47.524Z",
    "updatedAt": "2025-12-14T08:54:22.750Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40290045",
      "DOI": "https://doi.org10.1210/clinem/dgaf255",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:07:01",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Malcom C, Guzeloglu-Kayisli O, Un B, New E, Cetinkaya-Un B, Guo X, Mikhail E, Imudia A, Lockwood C, Kayisli U. Increased HSD11β1 Expression in Human Leiomyomatous Uteri: Implication for Enhanced Glucocorticoid Signaling. J Clin Endocrinol Metab. 2025;110(12):3370-",
      "pubdate": "2025-04-28",
      "Lead_author": "Malcom C",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1210/clinem/dgaf255",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Malcom C, Guzeloglu-Kayisli O, Un B, New E, Cetinkaya-Un B, Guo X, Mikhail E, Imudia A, Lockwood C, Kayisli U. Increased HSD11β1 Expression in Human Leiomyomatous Uteri: Implication for Enhanced Glucocorticoid Signaling. J Clin Endocrinol Metab. 2025;110(12):3370-",
    "leadAuthor": "Malcom C",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhFBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhFBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-213c2c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707139
  },
  {
    "id": "DEXA_Synt_15425",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40249765",
    "title": "Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes.",
    "authors": [
      "Buse JB",
      "Kahn SE",
      "Aroda VR",
      "Auchus RJ",
      "Bailey T",
      "Bancos I",
      "Busch RS",
      "Christofides EA",
      "DeFronzo RA",
      "Eilerman B",
      "Findling JW",
      "Fonseca V",
      "Hamidi O",
      "Handelsman Y",
      "Miller HJ",
      "Ownby JG",
      "Parker JC",
      "Philis-Tsimikas A",
      "Pratley R",
      "Rosenstock J",
      "Shanik MH",
      "Sloan LL",
      "Umpierrez G",
      "Tudor IC",
      "Schlafly TK",
      "Einhorn D"
    ],
    "journal": "Diabetes Care",
    "publicationDate": "2025-04-18",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "d8cacff8-43a9-4a6b-a33c-14e15c179246",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.806Z"
      },
      {
        "id": "b1ef2c7b-8566-4a92-8646-82d5400a65e3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 076270be-7e50-497d-ac9b-2b23ff2edb06 to DEXA_Synt_15425",
        "type": "system",
        "createdAt": "2025-12-14T10:12:19.228Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:47.650Z",
    "updatedAt": "2025-12-14T08:54:22.816Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40249765",
      "DOI": "https://doi.org10.2337/dc24-2841",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:07:08",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Buse JB, Kahn SE, Aroda VR, Auchus RJ, Bailey T, Bancos I, Busch RS, Christofides EA, DeFronzo RA, Eilerman B, Findling JW, Fonseca V, Hamidi O, Handelsman Y, Miller HJ, Ownby JG, Parker JC, Philis-Tsimikas A, Pratley R, Rosenstock J, Shanik MH, Sloan LL, Umpierrez G, Tudor IC, Schlafly TK, Einhorn D, . Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes. Diabetes Care. 2025;48(12):2012-20",
      "pubdate": "2025-04-18",
      "Lead_author": "Buse JB",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.2337/dc24-2841",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Buse JB, Kahn SE, Aroda VR, Auchus RJ, Bailey T, Bancos I, Busch RS, Christofides EA, DeFronzo RA, Eilerman B, Findling JW, Fonseca V, Hamidi O, Handelsman Y, Miller HJ, Ownby JG, Parker JC, Philis-Tsimikas A, Pratley R, Rosenstock J, Shanik MH, Sloan LL, Umpierrez G, Tudor IC, Schlafly TK, Einhorn D, . Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes. Diabetes Care. 2025;48(12):2012-20",
    "leadAuthor": "Buse JB",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhGBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhGBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-215d280501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707139
  },
  {
    "id": "DEXA_Synt_97561",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40214048",
    "title": "Adrenalectomy Reduces the Risk of Vertebral Fractures in Patients With Mild Autonomous Cortisol Secretion.",
    "authors": [
      "Morelli V",
      "Favero V",
      "Frigerio S",
      "Aresta C",
      "Pugliese F",
      "Salcuni AS",
      "Risio A",
      "Eller-Vainicher C",
      "Palmieri S",
      "Cairoli E",
      "Corbetta S",
      "Mantovani G",
      "Scillitani A",
      "Chiodini I"
    ],
    "journal": "J Clin Endocrinol Metab",
    "publicationDate": "2025-04-11",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "44c2762a-1b1c-42b7-878b-bacc6172511a",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.836Z"
      },
      {
        "id": "43247fd7-443a-46f4-a1e1-32f799344124",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a7ccaa17-e25c-4de8-b1d7-48497a0ee349 to DEXA_Synt_97561",
        "type": "system",
        "createdAt": "2025-12-14T10:12:19.458Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:47.801Z",
    "updatedAt": "2025-12-14T08:54:22.870Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40214048",
      "DOI": "https://doi.org10.1210/clinem/dgaf227",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:06:53",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Morelli V, Favero V, Frigerio S, Aresta C, Pugliese F, Salcuni AS, Risio A, Eller-Vainicher C, Palmieri S, Cairoli E, Corbetta S, Mantovani G, Scillitani A, Chiodini I. Adrenalectomy Reduces the Risk of Vertebral Fractures in Patients With Mild Autonomous Cortisol Secretion. J Clin Endocrinol Metab. 2025;110(12):e4066-",
      "pubdate": "2025-04-11",
      "Lead_author": "Morelli V",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1210/clinem/dgaf227",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Morelli V, Favero V, Frigerio S, Aresta C, Pugliese F, Salcuni AS, Risio A, Eller-Vainicher C, Palmieri S, Cairoli E, Corbetta S, Mantovani G, Scillitani A, Chiodini I. Adrenalectomy Reduces the Risk of Vertebral Fractures in Patients With Mild Autonomous Cortisol Secretion. J Clin Endocrinol Metab. 2025;110(12):e4066-",
    "leadAuthor": "Morelli V",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhHBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhHBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-217ffc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707139
  },
  {
    "id": "DEXA_Synt_46509",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39957241",
    "title": "Ginsenoside compound K-based multifunctional liposomes for the treatment of rheumatoid arthritis.",
    "authors": [
      "Zhang M",
      "Zhang R",
      "Feng C",
      "Jiang X",
      "Xu X",
      "Wang J"
    ],
    "journal": "Drug Deliv",
    "publicationDate": "2025-02-17",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a0e3041c-9e95-40b4-97e7-da0d66139b93",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.898Z"
      },
      {
        "id": "6084d088-d1b0-4596-8abd-d767f7aac266",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 17d72ac0-0db9-4969-a15e-007b2ce9f8bf to DEXA_Synt_46509",
        "type": "system",
        "createdAt": "2025-12-14T10:12:19.688Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:47.910Z",
    "updatedAt": "2025-12-14T08:54:22.905Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39957241",
      "DOI": "https://doi.org10.1080/10717544.2025.2464190",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:07:23",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Zhang M, Zhang R, Feng C, Jiang X, Xu X, Wang J. Ginsenoside compound K-based multifunctional liposomes for the treatment of rheumatoid arthritis. Drug Deliv. 2025;32(1):2464190",
      "pubdate": "2025-02-17",
      "Lead_author": "Zhang M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/10717544.2025.2464190",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Zhang M, Zhang R, Feng C, Jiang X, Xu X, Wang J. Ginsenoside compound K-based multifunctional liposomes for the treatment of rheumatoid arthritis. Drug Deliv. 2025;32(1):2464190",
    "leadAuthor": "Zhang M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhIBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhIBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-21a85c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707139
  },
  {
    "id": "DEXA_Synt_48912",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39196659",
    "title": "Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy.",
    "authors": [
      "Araz M",
      "Beypinar I",
      "Inci F",
      "Koral L",
      "Kocak MZ",
      "Korkmaz M",
      "Demirkiran A",
      "Eryilmaz MK",
      "Artac M"
    ],
    "journal": "J Oncol Pharm Pract",
    "publicationDate": "2024-08-29",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "0882f4ba-254e-42d6-b05e-e41016bcc761",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:22.958Z"
      },
      {
        "id": "1f41ca4e-86af-41e4-8026-6374318f5e5b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f8ad729c-79f9-4573-9ea9-aabcecedc4a6 to DEXA_Synt_48912",
        "type": "system",
        "createdAt": "2025-12-14T10:12:19.903Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:37:48.097Z",
    "updatedAt": "2025-12-14T08:54:22.990Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39196659",
      "DOI": "https://doi.org10.1177/10781552241279537",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:07:31",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Araz M, Beypinar I, Inci F, Koral L, Kocak MZ, Korkmaz M, Demirkiran A, Eryilmaz MK, Artac M. Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy. J Oncol Pharm Pract. 2025;31(8):1241-",
      "pubdate": "2024-08-29",
      "Lead_author": "Araz M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1177/10781552241279537",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Araz M, Beypinar I, Inci F, Koral L, Kocak MZ, Korkmaz M, Demirkiran A, Eryilmaz MK, Artac M. Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy. J Oncol Pharm Pract. 2025;31(8):1241-",
    "leadAuthor": "Araz M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhJBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhJBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-21c92c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707139
  },
  {
    "id": "DEXA_Synt_18275",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41331127",
    "title": "Selection of isatuximab dosing regimen in pediatric patients with leukemia using population pharmacokinetics.",
    "authors": [
      "Brillac C",
      "Sémiond D",
      "Oprea C",
      "Baruchel A",
      "Zwaan CM",
      "Nguyen L"
    ],
    "journal": "Cancer Chemother Pharmacol",
    "publicationDate": "2025-12-3",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "7da0e0c3-b202-4844-a91f-76330f847893",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.021Z"
      },
      {
        "id": "5fe0381e-5f61-4ed5-9b81-f3930b81614b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 81c388ba-1036-4ee1-a718-2aa01f4781b4 to DEXA_Synt_18275",
        "type": "system",
        "createdAt": "2025-12-14T10:12:20.135Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:45.503Z",
    "updatedAt": "2025-12-14T08:54:23.041Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41331127",
      "DOI": "https://doi.org10.1007/s00280-025-04832-2",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:08:09",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Brillac C, Sémiond D, Oprea C, Baruchel A, Zwaan CM, Nguyen L. Selection of isatuximab dosing regimen in pediatric patients with leukemia using population pharmacokinetics. Cancer Chemother Pharmacol. 2025;95(1):116",
      "pubdate": "2025-12-3",
      "Lead_author": "Brillac C",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s00280-025-04832-2",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Brillac C, Sémiond D, Oprea C, Baruchel A, Zwaan CM, Nguyen L. Selection of isatuximab dosing regimen in pediatric patients with leukemia using population pharmacokinetics. Cancer Chemother Pharmacol. 2025;95(1):116",
    "leadAuthor": "Brillac C",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhKBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhKBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-21ea240501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707140
  },
  {
    "id": "DEXA_Synt_61848",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41328324",
    "title": "Negative Impact of p21-Activated Kinase 4-Mediated AMP-Activated Protein Kinase Inhibition on Sarcopenia in Mice and Humans.",
    "authors": [
      "Du J",
      "Yu HC",
      "Moon YJ",
      "Yoon SJ",
      "Seo SY",
      "Park BH",
      "Bae EJ"
    ],
    "journal": "MedComm (2020)",
    "publicationDate": "2025-12-2",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "402e617e-2519-4ed9-a4c3-1ac01e2db199",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.067Z"
      },
      {
        "id": "192fad06-3f71-4059-94f1-ff0ab58e643d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9cb144a6-06d4-49b9-aad8-912abaac47d5 to DEXA_Synt_61848",
        "type": "system",
        "createdAt": "2025-12-14T10:12:20.367Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:45.537Z",
    "updatedAt": "2025-12-14T08:54:23.076Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41328324",
      "DOI": "https://doi.org10.1002/mco2.70508",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:07:54",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Du J, Yu HC, Moon YJ, Yoon SJ, Seo SY, Park BH, Bae EJ. Negative Impact of p21-Activated Kinase 4-Mediated AMP-Activated Protein Kinase Inhibition on Sarcopenia in Mice and Humans. MedComm (2020). 2025;6(12):e70508",
      "pubdate": "2025-12-2",
      "Lead_author": "Du J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/mco2.70508",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Du J, Yu HC, Moon YJ, Yoon SJ, Seo SY, Park BH, Bae EJ. Negative Impact of p21-Activated Kinase 4-Mediated AMP-Activated Protein Kinase Inhibition on Sarcopenia in Mice and Humans. MedComm (2020). 2025;6(12):e70508",
    "leadAuthor": "Du J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhLBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhLBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2209d40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707140
  },
  {
    "id": "DEXA_Synt_20886",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41325986",
    "title": "Variation in Systemic Corticosteroid Prescribing for Asthma Exacerbations at Children's Hospitals.",
    "authors": [
      "Best S",
      "Hall M",
      "Bettenhausen JL",
      "Chesbro S",
      "Clark NA",
      "Collins ME",
      "DePorre A",
      "Ermer JD",
      "Jones BL",
      "Jones LN",
      "Markham JL",
      "McCoy E",
      "Newmaster M",
      "Plencner LM",
      "Puls HT",
      "Shah SK",
      "Kyler KE"
    ],
    "journal": "Hosp Pediatr",
    "publicationDate": "2025-12-2",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b36f0668-3b59-45a6-9918-e9ca97e034e4",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.105Z"
      },
      {
        "id": "e9e830c7-ea4d-4ca6-9fc9-688fe3a985bf",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6df6e699-6a60-4973-8d83-f077de8ba675 to DEXA_Synt_20886",
        "type": "system",
        "createdAt": "2025-12-14T10:12:20.626Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:45.570Z",
    "updatedAt": "2025-12-14T08:54:23.121Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41325986",
      "DOI": "https://doi.org10.1542/hpeds.2024-008228",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:08:17",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Best S, Hall M, Bettenhausen JL, Chesbro S, Clark NA, Collins ME, DePorre A, Ermer JD, Jones BL, Jones LN, Markham JL, McCoy E, Newmaster M, Plencner LM, Puls HT, Shah SK, Kyler KE. Variation in Systemic Corticosteroid Prescribing for Asthma Exacerbations at Children's Hospitals. Hosp Pediatr. 2025;",
      "pubdate": "2025-12-2",
      "Lead_author": "Best S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1542/hpeds.2024-008228",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Best S, Hall M, Bettenhausen JL, Chesbro S, Clark NA, Collins ME, DePorre A, Ermer JD, Jones BL, Jones LN, Markham JL, McCoy E, Newmaster M, Plencner LM, Puls HT, Shah SK, Kyler KE. Variation in Systemic Corticosteroid Prescribing for Asthma Exacerbations at Children's Hospitals. Hosp Pediatr. 2025;",
    "leadAuthor": "Best S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhMBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhMBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-22313c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707140
  },
  {
    "id": "DEXA_Synt_91454",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41318671",
    "title": "Extracellular condensates (ECs) are endogenous modulators of HIV transcription and latency reactivation.",
    "authors": [
      "Naushad W",
      "Premadasa LS",
      "Tallapaneni V",
      "Okeoma BC",
      "Chaudhary A",
      "Stapleton JT",
      "Mohan M",
      "Okeoma CM"
    ],
    "journal": "Mol Psychiatry",
    "publicationDate": "2025-11-30",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9e3c7241-9604-4050-92c3-f5e465ba347b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.139Z"
      },
      {
        "id": "603cb53c-d661-4bd9-8fd8-526f73acb9ef",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 93b7007a-966f-4b9c-918b-0e06793f71af to DEXA_Synt_91454",
        "type": "system",
        "createdAt": "2025-12-14T10:12:20.813Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:45.595Z",
    "updatedAt": "2025-12-14T08:54:23.156Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41318671",
      "DOI": "https://doi.org10.1038/s41380-025-03354-w",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:09:09",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Naushad W, Premadasa LS, Tallapaneni V, Okeoma BC, Chaudhary A, Stapleton JT, Mohan M, Okeoma CM. Extracellular condensates (ECs) are endogenous modulators of HIV transcription and latency reactivation. Mol Psychiatry. 2025;",
      "pubdate": "2025-11-30",
      "Lead_author": "Naushad W",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41380-025-03354-w",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Naushad W, Premadasa LS, Tallapaneni V, Okeoma BC, Chaudhary A, Stapleton JT, Mohan M, Okeoma CM. Extracellular condensates (ECs) are endogenous modulators of HIV transcription and latency reactivation. Mol Psychiatry. 2025;",
    "leadAuthor": "Naushad W",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhNBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhNBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2253c00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707140
  },
  {
    "id": "DEXA_Synt_28182",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41315016",
    "title": "Oral Corticosteroids Reduce Pain After Total Knee Arthroplasty: A Higher Dose of Dexamethasone Effectively Controlled Pain During Motion: A Dose-Response Randomized Placebo-Controlled Trial.",
    "authors": [
      "Kanitnate S",
      "Tanariyakul Y",
      "Charnwichai P",
      "Anthanont P",
      "Manuwong S",
      "Tammachote N"
    ],
    "journal": "J Bone Joint Surg Am",
    "publicationDate": "2025-11-29",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "cdf838e6-3dc8-41d6-a560-646d071b8ca4",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.215Z"
      },
      {
        "id": "f8887a61-e06f-4064-85ff-ce4ab1483bce",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 39b48695-33e8-4062-9d4a-161c2692f8c9 to DEXA_Synt_28182",
        "type": "system",
        "createdAt": "2025-12-14T10:12:21.026Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:45.627Z",
    "updatedAt": "2025-12-14T08:54:23.225Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41315016",
      "DOI": "https://doi.org10.2106/JBJS.25.00642",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:09:17",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Kanitnate S, Tanariyakul Y, Charnwichai P, Anthanont P, Manuwong S, Tammachote N. Oral Corticosteroids Reduce Pain After Total Knee Arthroplasty: A Higher Dose of Dexamethasone Effectively Controlled Pain During Motion: A Dose-Response Randomized Placebo-Controlled Trial. J Bone Joint Surg Am. 2025;",
      "pubdate": "2025-11-29",
      "Lead_author": "Kanitnate S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.2106/JBJS.25.00642",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Kanitnate S, Tanariyakul Y, Charnwichai P, Anthanont P, Manuwong S, Tammachote N. Oral Corticosteroids Reduce Pain After Total Knee Arthroplasty: A Higher Dose of Dexamethasone Effectively Controlled Pain During Motion: A Dose-Response Randomized Placebo-Controlled Trial. J Bone Joint Surg Am. 2025;",
    "leadAuthor": "Kanitnate S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhOBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhOBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2276d80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707141
  },
  {
    "id": "DEXA_Synt_27017",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41314363",
    "title": "Autonomic and Hormonal Biomarkers in individuals with Autism Spectrum Disorders and Developmental or Intellectual Delay: A Systematic PRISMA Review.",
    "authors": [
      "Vidal-Zaborski O",
      "Merino D",
      "Fernandez A",
      "Mercery M",
      "Herbreteau L",
      "Askenazy F",
      "Zuluaga MA",
      "Ismailova E",
      "Douet-Vannucci V",
      "Thümmler S"
    ],
    "journal": "Neurosci Biobehav Rev",
    "publicationDate": "2025-11-29",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a20d6bea-ef8e-4539-91d2-6db90d57504e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.247Z"
      },
      {
        "id": "800f0770-b829-4bf1-91f2-8b0c05a07817",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from baa26139-5a2e-448f-93d1-0eab3dcdf6e0 to DEXA_Synt_27017",
        "type": "system",
        "createdAt": "2025-12-14T10:12:21.240Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:45.657Z",
    "updatedAt": "2025-12-14T08:54:23.286Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41314363",
      "DOI": "https://doi.org10.1016/j.neubiorev.2025.106496",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:10:09",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Vidal-Zaborski O, Merino D, Fernandez A, Mercery M, Herbreteau L, Askenazy F, Zuluaga MA, Ismailova E, Douet-Vannucci V, Thümmler S. Autonomic and Hormonal Biomarkers in individuals with Autism Spectrum Disorders and Developmental or Intellectual Delay: A Systematic PRISMA Review. Neurosci Biobehav Rev. 2025;106496",
      "pubdate": "2025-11-29",
      "Lead_author": "Vidal-Zaborski O",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.neubiorev.2025.106496",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Vidal-Zaborski O, Merino D, Fernandez A, Mercery M, Herbreteau L, Askenazy F, Zuluaga MA, Ismailova E, Douet-Vannucci V, Thümmler S. Autonomic and Hormonal Biomarkers in individuals with Autism Spectrum Disorders and Developmental or Intellectual Delay: A Systematic PRISMA Review. Neurosci Biobehav Rev. 2025;106496",
    "leadAuthor": "Vidal-Zaborski O",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhPBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhPBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2297780501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707141
  },
  {
    "id": "DEXA_Synt_13959",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41313953",
    "title": "Granulocyte apheresis in donors: A comparative study of spectra optia and cobe spectra apheresis systems.",
    "authors": [
      "John L",
      "Vaheedu A A A",
      "Ramanadhan P",
      "Murugesan M",
      "Shenoy V"
    ],
    "journal": "Transfus Apher Sci",
    "publicationDate": "2025-11-29",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "1f918051-bb76-4dad-9a30-70539a7d5e90",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.309Z"
      },
      {
        "id": "6945a108-c903-49b3-8678-f6f2b0fdcf70",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from b05421e3-9f61-4769-9489-fa9f5a1f6e34 to DEXA_Synt_13959",
        "type": "system",
        "createdAt": "2025-12-14T10:12:21.523Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:45.693Z",
    "updatedAt": "2025-12-14T08:54:23.323Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41313953",
      "DOI": "https://doi.org10.1016/j.transci.2025.104284",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:09:55",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "John L, Vaheedu A A A, Ramanadhan P, Murugesan M, Shenoy V. Granulocyte apheresis in donors: A comparative study of spectra optia and cobe spectra apheresis systems. Transfus Apher Sci. 2025;65(1):104284",
      "pubdate": "2025-11-29",
      "Lead_author": "John L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.transci.2025.104284",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "John L, Vaheedu A A A, Ramanadhan P, Murugesan M, Shenoy V. Granulocyte apheresis in donors: A comparative study of spectra optia and cobe spectra apheresis systems. Transfus Apher Sci. 2025;65(1):104284",
    "leadAuthor": "John L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhQBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhQBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-22ba880501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707141
  },
  {
    "id": "DEXA_Synt_99564",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41313745",
    "title": "Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer.",
    "authors": [
      "Martin JD",
      "Nagaoka K",
      "Panagi M",
      "Hosoi A",
      "Mpkeris F",
      "Chen P",
      "Khan TT",
      "Martin MR",
      "Sun C",
      "Voutouri C",
      "Louca M",
      "Papageorgis P",
      "Sumiyoshi A",
      "Nitta N",
      "Takeda K",
      "Aoki I",
      "Kataoka K",
      "Stylianopoulos T",
      "Kakimi K",
      "Cabral H"
    ],
    "journal": "Adv Sci (Weinh)",
    "publicationDate": "2025-11-28",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "d2317679-bbf6-4f3a-88a2-235b102c7dc9",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.338Z"
      },
      {
        "id": "e9564cfa-4506-4b08-b110-9a3e5cb830a5",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6d594bc0-59d3-4ee0-a8e6-1165be6d7e0d to DEXA_Synt_99564",
        "type": "system",
        "createdAt": "2025-12-14T10:12:21.705Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:45.718Z",
    "updatedAt": "2025-12-14T08:54:23.389Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41313745",
      "DOI": "https://doi.org10.1002/advs.202514261",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:10:01",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Martin JD, Nagaoka K, Panagi M, Hosoi A, Mpkeris F, Chen P, Khan TT, Martin MR, Sun C, Voutouri C, Louca M, Papageorgis P, Sumiyoshi A, Nitta N, Takeda K, Aoki I, Kataoka K, Stylianopoulos T, Kakimi K, Cabral H. Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer. Adv Sci (Weinh). 2025;e14261",
      "pubdate": "2025-11-28",
      "Lead_author": "Martin JD",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/advs.202514261",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Martin JD, Nagaoka K, Panagi M, Hosoi A, Mpkeris F, Chen P, Khan TT, Martin MR, Sun C, Voutouri C, Louca M, Papageorgis P, Sumiyoshi A, Nitta N, Takeda K, Aoki I, Kataoka K, Stylianopoulos T, Kakimi K, Cabral H. Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer. Adv Sci (Weinh). 2025;e14261",
    "leadAuthor": "Martin JD",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhRBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhRBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-22de940501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707141
  },
  {
    "id": "DEXA_Synt_34825",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41305942",
    "title": "Optimizing Postoperative Analgesia in Total Knee Arthroplasty: A Randomized Controlled Trial on the Efficacy of Perineural Dexamethasone with iPACK and Adductor Canal Block.",
    "authors": [
      "Reysner T",
      "Kowalski G",
      "Mularski A",
      "Perek A",
      "Daroszewski P",
      "Reysner M"
    ],
    "journal": "Clin J Pain",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "68eff004-4cc7-45a0-8d47-7d10d99cc2d1",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.416Z"
      },
      {
        "id": "49737155-292b-4885-9583-e92a392dfac3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 868957bc-a828-4a86-a86f-df0a27d5aca7 to DEXA_Synt_34825",
        "type": "system",
        "createdAt": "2025-12-14T10:12:21.937Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:45.750Z",
    "updatedAt": "2025-12-14T08:54:23.429Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41305942",
      "DOI": "https://doi.org10.1097/AJP.0000000000001344",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:10:19",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Reysner T, Kowalski G, Mularski A, Perek A, Daroszewski P, Reysner M. Optimizing Postoperative Analgesia in Total Knee Arthroplasty: A Randomized Controlled Trial on the Efficacy of Perineural Dexamethasone with iPACK and Adductor Canal Block. Clin J Pain. 2025;",
      "pubdate": "2025-11-27",
      "Lead_author": "Reysner T",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/AJP.0000000000001344",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Reysner T, Kowalski G, Mularski A, Perek A, Daroszewski P, Reysner M. Optimizing Postoperative Analgesia in Total Knee Arthroplasty: A Randomized Controlled Trial on the Efficacy of Perineural Dexamethasone with iPACK and Adductor Canal Block. Clin J Pain. 2025;",
    "leadAuthor": "Reysner T",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhSBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhSBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2302400501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707142
  },
  {
    "id": "DEXA_Synt_50175",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41304788",
    "title": "Effective Oral Delivery of Teriparatide Using Organoclay-Polymethacrylate Nanocomposites for Osteoporosis Therapy.",
    "authors": [
      "Kim GL",
      "Kang YJ",
      "Seo SH",
      "Jeon J",
      "Han HK"
    ],
    "journal": "Pharmaceutics",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b196f4ae-c4e0-4bf9-be46-ecca36786ba1",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.447Z"
      },
      {
        "id": "bce8bd3e-aac7-4dd1-92d8-f6a63afa71e0",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 56b36f74-9b11-496e-bf31-ba5648c6fbeb to DEXA_Synt_50175",
        "type": "system",
        "createdAt": "2025-12-14T10:12:22.155Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:45.781Z",
    "updatedAt": "2025-12-14T08:54:23.460Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41304788",
      "DOI": "https://doi.org10.3390/pharmaceutics17111450",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:10:33",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Kim GL, Kang YJ, Seo SH, Jeon J, Han HK. Effective Oral Delivery of Teriparatide Using Organoclay-Polymethacrylate Nanocomposites for Osteoporosis Therapy. Pharmaceutics. 2025;17(11):",
      "pubdate": "2025-11-27",
      "Lead_author": "Kim GL",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3390/pharmaceutics17111450",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Kim GL, Kang YJ, Seo SH, Jeon J, Han HK. Effective Oral Delivery of Teriparatide Using Organoclay-Polymethacrylate Nanocomposites for Osteoporosis Therapy. Pharmaceutics. 2025;17(11):",
    "leadAuthor": "Kim GL",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhTBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhTBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2323440501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707142
  },
  {
    "id": "DEXA_Synt_34963",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41303576",
    "title": "Benefits of Steroid Injections into Paraspinous Muscles After Spinal Surgery in a Rat Paraspinal Muscle Retraction Model.",
    "authors": [
      "Sheu ML",
      "Pan LY",
      "Sheehan J",
      "Lai DW",
      "Chou YC",
      "Pan LY",
      "Wang CC",
      "Chen YJ",
      "Su HL",
      "Tsou HK",
      "Pan HC"
    ],
    "journal": "Int J Mol Sci",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "3b3a0f96-887b-4723-87c9-68b8774c93b5",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.478Z"
      },
      {
        "id": "98a913fb-4f10-402a-b4b7-4643c4e85c01",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 316972f8-1cdf-4cc0-8519-0c1f947e965e to DEXA_Synt_34963",
        "type": "system",
        "createdAt": "2025-12-14T10:12:22.387Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:45.812Z",
    "updatedAt": "2025-12-14T08:54:23.545Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41303576",
      "DOI": "https://doi.org10.3390/ijms262211093",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:10:26",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Sheu ML, Pan LY, Sheehan J, Lai DW, Chou YC, Pan LY, Wang CC, Chen YJ, Su HL, Tsou HK, Pan HC. Benefits of Steroid Injections into Paraspinous Muscles After Spinal Surgery in a Rat Paraspinal Muscle Retraction Model. Int J Mol Sci. 2025;26(22):",
      "pubdate": "2025-11-27",
      "Lead_author": "Sheu ML",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3390/ijms262211093",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Sheu ML, Pan LY, Sheehan J, Lai DW, Chou YC, Pan LY, Wang CC, Chen YJ, Su HL, Tsou HK, Pan HC. Benefits of Steroid Injections into Paraspinous Muscles After Spinal Surgery in a Rat Paraspinal Muscle Retraction Model. Int J Mol Sci. 2025;26(22):",
    "leadAuthor": "Sheu ML",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhUBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhUBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2344100501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707142
  },
  {
    "id": "DEXA_Synt_26723",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41303134",
    "title": "Efficacy of NSAID Transdermal Patch for Postoperative Management in Total Knee Arthroplasty.",
    "authors": [
      "Tubsrinuan K",
      "Sa-Ngasoongsong P",
      "Jarungvittayakon C",
      "Chulsomlee K",
      "Wongsak S"
    ],
    "journal": "J Clin Med",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ee4d3737-afb6-4685-8b3c-1c9c63bb9795",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.571Z"
      },
      {
        "id": "adfa17a6-7946-4655-82f5-9d459928bddc",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 42992915-90d4-4b80-a4a9-45a9d8812c17 to DEXA_Synt_26723",
        "type": "system",
        "createdAt": "2025-12-14T10:12:22.605Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:46.022Z",
    "updatedAt": "2025-12-14T08:54:23.582Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41303134",
      "DOI": "https://doi.org10.3390/jcm14228098",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:10:40",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Tubsrinuan K, Sa-Ngasoongsong P, Jarungvittayakon C, Chulsomlee K, Wongsak S. Efficacy of NSAID Transdermal Patch for Postoperative Management in Total Knee Arthroplasty. J Clin Med. 2025;14(22):",
      "pubdate": "2025-11-27",
      "Lead_author": "Tubsrinuan K",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3390/jcm14228098",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Tubsrinuan K, Sa-Ngasoongsong P, Jarungvittayakon C, Chulsomlee K, Wongsak S. Efficacy of NSAID Transdermal Patch for Postoperative Management in Total Knee Arthroplasty. J Clin Med. 2025;14(22):",
    "leadAuthor": "Tubsrinuan K",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhVBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhVBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2368280501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707142
  },
  {
    "id": "DEXA_Synt_14964",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41292771",
    "title": "Protectin DX resolves fracture-induced postoperative pain in mice via neuronal signaling and GPR37-activated macrophage efferocytosis.",
    "authors": [
      "Li Y",
      "Bang S",
      "Ji J",
      "Xu J",
      "Lee M",
      "Chandra S",
      "Serhan CN",
      "Ji RR"
    ],
    "journal": "bioRxiv",
    "publicationDate": "2025-11-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "c737f632-561c-44d3-925a-fa41bd85265f",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.600Z"
      },
      {
        "id": "31c52076-7466-44fb-9c7c-023eb9cab6ce",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6a35d18b-d43b-4520-8a48-9abce232d623 to DEXA_Synt_14964",
        "type": "system",
        "createdAt": "2025-12-14T10:12:22.840Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:46.120Z",
    "updatedAt": "2025-12-14T08:54:23.618Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41292771",
      "DOI": "https://doi.org10.1101/2025.11.10.687700",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:10:48",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Li Y, Bang S, Ji J, Xu J, Lee M, Chandra S, Serhan CN, Ji RR. Protectin DX resolves fracture-induced postoperative pain in mice via neuronal signaling and GPR37-activated macrophage efferocytosis. bioRxiv. 2025;",
      "pubdate": "2025-11-26",
      "Lead_author": "Li Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1101/2025.11.10.687700",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Li Y, Bang S, Ji J, Xu J, Lee M, Chandra S, Serhan CN, Ji RR. Protectin DX resolves fracture-induced postoperative pain in mice via neuronal signaling and GPR37-activated macrophage efferocytosis. bioRxiv. 2025;",
    "leadAuthor": "Li Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhWBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhWBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2389440501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707142
  },
  {
    "id": "DEXA_Synt_40391",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41292624",
    "title": "Obesity-Related Aldosteronism is Associated with Adverse Cardiac Structure, Function, and Adiposity.",
    "authors": [
      "Tsai CH",
      "Chan JM",
      "Milks J",
      "Ferrebus A",
      "Hanna I",
      "Mahrokhian S",
      "Newman AJ",
      "Stéfanie PS",
      "Reis Marques I",
      "Foote K",
      "Adler GK",
      "Kwong RY",
      "Jerosch-Herold M",
      "Pitt B",
      "Vaidya A",
      "Brown JM"
    ],
    "journal": "medRxiv",
    "publicationDate": "2025-11-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "3de5ac38-e45f-4232-9b01-6a9fc337441e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.648Z"
      },
      {
        "id": "b9fc54b0-3fb8-44d7-ab5b-bf25c8663ec3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 38d2b5f9-473b-49a8-89f7-84266a93c1d9 to DEXA_Synt_40391",
        "type": "system",
        "createdAt": "2025-12-14T10:12:23.057Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:46.259Z",
    "updatedAt": "2025-12-14T08:54:23.661Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41292624",
      "DOI": "https://doi.org10.1101/2025.11.12.25340075",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:10:57",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Tsai CH, Chan JM, Milks J, Ferrebus A, Hanna I, Mahrokhian S, Newman AJ, Stéfanie PS, Reis Marques I, Foote K, Adler GK, Kwong RY, Jerosch-Herold M, Pitt B, Vaidya A, Brown JM. Obesity-Related Aldosteronism is Associated with Adverse Cardiac Structure, Function, and Adiposity. medRxiv. 2025;",
      "pubdate": "2025-11-26",
      "Lead_author": "Tsai CH",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1101/2025.11.12.25340075",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Tsai CH, Chan JM, Milks J, Ferrebus A, Hanna I, Mahrokhian S, Newman AJ, Stéfanie PS, Reis Marques I, Foote K, Adler GK, Kwong RY, Jerosch-Herold M, Pitt B, Vaidya A, Brown JM. Obesity-Related Aldosteronism is Associated with Adverse Cardiac Structure, Function, and Adiposity. medRxiv. 2025;",
    "leadAuthor": "Tsai CH",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhXBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhXBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-23aa840501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707143
  },
  {
    "id": "DEXA_Synt_63042",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41292263",
    "title": "Hemophagocytic Lymphohistiocytosis in a Pediatric Lung Transplant Recipient.",
    "authors": [
      "Chickmagalur S",
      "Schrader A",
      "Parrish D",
      "McNeill DM",
      "Gazzaneo MC",
      "Melicoff-Portillo E",
      "Cortes-Santiago N"
    ],
    "journal": "Pediatr Transplant",
    "publicationDate": "2025-11-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "4329d6e4-a5ae-4141-b577-71006ed39741",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.695Z"
      },
      {
        "id": "748998b4-d4e0-4889-8092-1cfd069b4031",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 5cb66765-559e-4408-aafc-fa5f5b763d70 to DEXA_Synt_63042",
        "type": "system",
        "createdAt": "2025-12-14T10:12:23.305Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:46.401Z",
    "updatedAt": "2025-12-14T08:54:23.707Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41292263",
      "DOI": "https://doi.org10.1111/petr.70232",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:11:17",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Chickmagalur S, Schrader A, Parrish D, McNeill DM, Gazzaneo MC, Melicoff-Portillo E, Cortes-Santiago N. Hemophagocytic Lymphohistiocytosis in a Pediatric Lung Transplant Recipient. Pediatr Transplant. 2025;29(8):e70232",
      "pubdate": "2025-11-26",
      "Lead_author": "Chickmagalur S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/petr.70232",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Chickmagalur S, Schrader A, Parrish D, McNeill DM, Gazzaneo MC, Melicoff-Portillo E, Cortes-Santiago N. Hemophagocytic Lymphohistiocytosis in a Pediatric Lung Transplant Recipient. Pediatr Transplant. 2025;29(8):e70232",
    "leadAuthor": "Chickmagalur S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhYBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhYBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-23ca980501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707143
  },
  {
    "id": "DEXA_Synt_15699",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41291460",
    "title": "Initial management and outcome of community-acquired bacterial meningitis in two French ICUs over a period of fifteen years.",
    "authors": [
      "Baron F",
      "Houard M",
      "Degrendel M",
      "Devos P",
      "Delannoy PY",
      "Nseir S",
      "Leroy O",
      "Georges H"
    ],
    "journal": "BMC Infect Dis",
    "publicationDate": "2025-11-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5dd2bb6a-060b-4d94-91c5-75a89ee0c9be",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.771Z"
      },
      {
        "id": "37e51966-a6b5-4e42-840d-c513b97d414c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from e52357f4-fe71-4c39-b886-7c288183d91a to DEXA_Synt_15699",
        "type": "system",
        "createdAt": "2025-12-14T10:12:23.552Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:46.504Z",
    "updatedAt": "2025-12-14T08:54:23.783Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41291460",
      "DOI": "https://doi.org10.1186/s12879-025-12058-z",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:11:11",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Baron F, Houard M, Degrendel M, Devos P, Delannoy PY, Nseir S, Leroy O, Georges H. Initial management and outcome of community-acquired bacterial meningitis in two French ICUs over a period of fifteen years. BMC Infect Dis. 2025;25(1):1653",
      "pubdate": "2025-11-26",
      "Lead_author": "Baron F",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s12879-025-12058-z",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Baron F, Houard M, Degrendel M, Devos P, Delannoy PY, Nseir S, Leroy O, Georges H. Initial management and outcome of community-acquired bacterial meningitis in two French ICUs over a period of fifteen years. BMC Infect Dis. 2025;25(1):1653",
    "leadAuthor": "Baron F",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhZBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhZBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-23f07c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707143
  },
  {
    "id": "DEXA_Synt_35629",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41290519",
    "title": "Gymnemantoside A Ameliorates Steroid-Induced Skeletal Muscle Atrophy via Bridging Glucocorticoid and Insulin Receptor Signalling.",
    "authors": [
      "Park EJ",
      "Kim HJ",
      "Lee SH",
      "Choi S",
      "Doan TP",
      "Joo KH",
      "An JP",
      "Jung DW",
      "Williams DR",
      "Oh WK"
    ],
    "journal": "J Cachexia Sarcopenia Muscle",
    "publicationDate": "2025-11-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "776d1731-25ee-4bc6-8c75-3980e1ceda08",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.799Z"
      },
      {
        "id": "b327ffaa-2503-4a7d-830f-20674716832d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 5fb436c6-efd1-4965-8e3a-bf4ee52c36dc to DEXA_Synt_35629",
        "type": "system",
        "createdAt": "2025-12-14T10:12:23.735Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:46.660Z",
    "updatedAt": "2025-12-14T08:54:23.837Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41290519",
      "DOI": "https://doi.org10.1002/jcsm.70118",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:11:03",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Park EJ, Kim HJ, Lee SH, Choi S, Doan TP, Joo KH, An JP, Jung DW, Williams DR, Oh WK. Gymnemantoside A Ameliorates Steroid-Induced Skeletal Muscle Atrophy via Bridging Glucocorticoid and Insulin Receptor Signalling. J Cachexia Sarcopenia Muscle. 2025;16(6):e70118",
      "pubdate": "2025-11-26",
      "Lead_author": "Park EJ",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/jcsm.70118",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Park EJ, Kim HJ, Lee SH, Choi S, Doan TP, Joo KH, An JP, Jung DW, Williams DR, Oh WK. Gymnemantoside A Ameliorates Steroid-Induced Skeletal Muscle Atrophy via Bridging Glucocorticoid and Insulin Receptor Signalling. J Cachexia Sarcopenia Muscle. 2025;16(6):e70118",
    "leadAuthor": "Park EJ",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhaBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhaBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2414880501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707143
  },
  {
    "id": "DEXA_Synt_18551",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41289703",
    "title": "Early exposure of NOD/ShiLtJ mice to Freund's adjuvant prompts delayed, spontaneous progressive encephalomyelitis.",
    "authors": [
      "Ranieri G",
      "Chiarugi A",
      "Buonvicino D"
    ],
    "journal": "J Neuroimmunol",
    "publicationDate": "2025-11-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "bd9ee5c9-ac73-4fae-ab28-6d8abb1ea97b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.864Z"
      },
      {
        "id": "9c410f4a-5ef9-41fb-9cd8-f92f311cff0c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 7e944371-60c1-4f9f-995f-4724db3f01ee to DEXA_Synt_18551",
        "type": "system",
        "createdAt": "2025-12-14T10:12:23.969Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:46.784Z",
    "updatedAt": "2025-12-14T08:54:23.876Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41289703",
      "DOI": "https://doi.org10.1016/j.jneuroim.2025.578809",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:11:25",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Ranieri G, Chiarugi A, Buonvicino D. Early exposure of NOD/ShiLtJ mice to Freund's adjuvant prompts delayed, spontaneous progressive encephalomyelitis. J Neuroimmunol. 2025;410578809",
      "pubdate": "2025-11-26",
      "Lead_author": "Ranieri G",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jneuroim.2025.578809",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Ranieri G, Chiarugi A, Buonvicino D. Early exposure of NOD/ShiLtJ mice to Freund's adjuvant prompts delayed, spontaneous progressive encephalomyelitis. J Neuroimmunol. 2025;410578809",
    "leadAuthor": "Ranieri G",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhbBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhbBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2435200501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707144
  },
  {
    "id": "DEXA_Synt_35728",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41284407",
    "title": "Preoperative Aprepitant Decreases Postoperative Nausea After Laparoscopic Sleeve Gastrectomy.",
    "authors": [
      "Thorne W",
      "Snegovskikh D",
      "Giorgi M",
      "Luhrs AR",
      "Stafford TS",
      "Armstrong K",
      "Ryder BA"
    ],
    "journal": "R I Med J (2013)",
    "publicationDate": "2025-11-24",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "12f4fc0b-a5d9-4a85-a128-edcb422723a1",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.894Z"
      },
      {
        "id": "8307d71e-33a9-47dc-9436-bbac09cf7168",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 0dbdef8f-c734-4076-baac-b582a91b343d to DEXA_Synt_35728",
        "type": "system",
        "createdAt": "2025-12-14T10:12:24.200Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:46.925Z",
    "updatedAt": "2025-12-14T08:54:23.907Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41284407",
      "DOI": "Could not get DOI",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:11:56",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Thorne W, Snegovskikh D, Giorgi M, Luhrs AR, Stafford TS, Armstrong K, Ryder BA. Preoperative Aprepitant Decreases Postoperative Nausea After Laparoscopic Sleeve Gastrectomy. R I Med J (2013). 2025;108(12):41-4",
      "pubdate": "2025-11-24",
      "Lead_author": "Thorne W",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "Could not get DOI",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Thorne W, Snegovskikh D, Giorgi M, Luhrs AR, Stafford TS, Armstrong K, Ryder BA. Preoperative Aprepitant Decreases Postoperative Nausea After Laparoscopic Sleeve Gastrectomy. R I Med J (2013). 2025;108(12):41-4",
    "leadAuthor": "Thorne W",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhcBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhcBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-24533c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707144
  },
  {
    "id": "DEXA_Synt_84404",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41282597",
    "title": "Rifampicin-induced challenges in managing endocrine hypertension and primary aldosteronism: a case report and literature review.",
    "authors": [
      "Song X",
      "Jia M",
      "Yu H",
      "Dong Z",
      "Cheok K",
      "Pan X"
    ],
    "journal": "Front Pharmacol",
    "publicationDate": "2025-11-24",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "11b03542-34fd-4c98-9ee7-66f1f5d79fb4",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.957Z"
      },
      {
        "id": "0729fa46-5c6a-489a-9be6-138ef5725c15",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from fbe95047-8c74-4f63-95e5-660af1ebcdd0 to DEXA_Synt_84404",
        "type": "system",
        "createdAt": "2025-12-14T10:12:24.416Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:47.016Z",
    "updatedAt": "2025-12-14T08:54:23.968Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41282597",
      "DOI": "https://doi.org10.3389/fphar.2025.1678430",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:11:33",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Song X, Jia M, Yu H, Dong Z, Cheok K, Pan X. Rifampicin-induced challenges in managing endocrine hypertension and primary aldosteronism: a case report and literature review. Front Pharmacol. 2025;161678430",
      "pubdate": "2025-11-24",
      "Lead_author": "Song X",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3389/fphar.2025.1678430",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Song X, Jia M, Yu H, Dong Z, Cheok K, Pan X. Rifampicin-induced challenges in managing endocrine hypertension and primary aldosteronism: a case report and literature review. Front Pharmacol. 2025;161678430",
    "leadAuthor": "Song X",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhdBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhdBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2474380501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707144
  },
  {
    "id": "DEXA_Synt_65797",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41282293",
    "title": "Clinical management of ectopic Cushing Syndrome in neuroendocrine neoplasms: a national survey.",
    "authors": [
      "Laffi A",
      "Prinzi A",
      "Di Dato C",
      "Feola T",
      "Medici M",
      "Colao A",
      "Faggiano A",
      "Lania AGA"
    ],
    "journal": "Front Endocrinol (Lausanne)",
    "publicationDate": "2025-11-24",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "59d37fa9-2e0b-4e3f-bb6e-0423cfc7fac3",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:23.988Z"
      },
      {
        "id": "b46eefc0-3477-4192-8593-81ebe314a1c6",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 7cf32b22-57cc-4623-921a-40c092ee852b to DEXA_Synt_65797",
        "type": "system",
        "createdAt": "2025-12-14T10:12:24.644Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:47.202Z",
    "updatedAt": "2025-12-14T08:54:24.022Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41282293",
      "DOI": "https://doi.org10.3389/fendo.2025.1690837",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:11:48",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Laffi A, Prinzi A, Di Dato C, Feola T, Medici M, Colao A, Faggiano A, Lania AGA. Clinical management of ectopic Cushing Syndrome in neuroendocrine neoplasms: a national survey. Front Endocrinol (Lausanne). 2025;161690837",
      "pubdate": "2025-11-24",
      "Lead_author": "Laffi A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3389/fendo.2025.1690837",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Laffi A, Prinzi A, Di Dato C, Feola T, Medici M, Colao A, Faggiano A, Lania AGA. Clinical management of ectopic Cushing Syndrome in neuroendocrine neoplasms: a national survey. Front Endocrinol (Lausanne). 2025;161690837",
    "leadAuthor": "Laffi A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUheBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUheBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2496d00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707144
  },
  {
    "id": "DEXA_Synt_76634",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41282010",
    "title": "Efficacy of ultrasound-guided intra-articular injection in the treatment of knee osteoarthritis in early and middle stages: a network meta-analysis.",
    "authors": [
      "Zhang J",
      "Guo Y",
      "Lu B",
      "Li G",
      "Li J"
    ],
    "journal": "Front Med (Lausanne)",
    "publicationDate": "2025-11-24",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a6f8e926-9a7d-4049-9131-83b0ada38b1e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.051Z"
      },
      {
        "id": "a7af8478-a146-4447-80a8-30fc5f3fb8e2",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from bf2ed6ef-0bf4-4226-ba30-4b709dfc9474 to DEXA_Synt_76634",
        "type": "system",
        "createdAt": "2025-12-14T10:12:24.874Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:47.282Z",
    "updatedAt": "2025-12-14T08:54:24.064Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41282010",
      "DOI": "https://doi.org10.3389/fmed.2025.1700950",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:11:40",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Zhang J, Guo Y, Lu B, Li G, Li J. Efficacy of ultrasound-guided intra-articular injection in the treatment of knee osteoarthritis in early and middle stages: a network meta-analysis. Front Med (Lausanne). 2025;121700950",
      "pubdate": "2025-11-24",
      "Lead_author": "Zhang J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3389/fmed.2025.1700950",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Zhang J, Guo Y, Lu B, Li G, Li J. Efficacy of ultrasound-guided intra-articular injection in the treatment of knee osteoarthritis in early and middle stages: a network meta-analysis. Front Med (Lausanne). 2025;121700950",
    "leadAuthor": "Zhang J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhfBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhfBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-24ba000501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707144
  },
  {
    "id": "DEXA_Synt_37890",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41281654",
    "title": "Lactoferrin-cyanidin-3-glucoside nanoparticles alleviate inflammation and oxidative stress via  activation in mastitis.",
    "authors": [
      "Amona FM",
      "Pang Y",
      "Chen X",
      "Liu Z",
      "Su C",
      "Yang J",
      "Liu K",
      "Wu Q",
      "Liu B",
      "Chen X",
      "Zhang C"
    ],
    "journal": "Mater Today Bio",
    "publicationDate": "2025-11-24",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5ef40b2b-d631-437a-aaaa-a379d943ff43",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.100Z"
      },
      {
        "id": "860238c4-56ce-4c3b-b56d-7129f8fafbd2",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 37f665b5-ed45-4484-853a-f20dbd59537f to DEXA_Synt_37890",
        "type": "system",
        "createdAt": "2025-12-14T10:12:25.076Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:47.452Z",
    "updatedAt": "2025-12-14T08:54:24.112Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41281654",
      "DOI": "https://doi.org10.1016/j.mtbio.2025.102491",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:12:04",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Amona FM, Pang Y, Chen X, Liu Z, Su C, Yang J, Liu K, Wu Q, Liu B, Chen X, Zhang C. Lactoferrin-cyanidin-3-glucoside nanoparticles alleviate inflammation and oxidative stress via <i>Sesn2/Nrf2</i> activation in mastitis. Mater Today Bio. 2025;35102491",
      "pubdate": "2025-11-24",
      "Lead_author": "Amona FM",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.mtbio.2025.102491",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Amona FM, Pang Y, Chen X, Liu Z, Su C, Yang J, Liu K, Wu Q, Liu B, Chen X, Zhang C. Lactoferrin-cyanidin-3-glucoside nanoparticles alleviate inflammation and oxidative stress via <i>Sesn2/Nrf2</i> activation in mastitis. Mater Today Bio. 2025;35102491",
    "leadAuthor": "Amona FM",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhgBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhgBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-24ddf40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707145
  },
  {
    "id": "DEXA_Synt_74091",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41273037",
    "title": "A Randomized Controlled Trial to Evaluate the Effects of Topical Intraoperative Corticosteroid Application on Voice Quality in Thyroid Surgery With Preserved Recurrent Laryngeal Nerves.",
    "authors": [
      "Zhang D",
      "Brucchi F",
      "Barbieri D",
      "Indelicato P",
      "Colombo C",
      "Dionigi G",
      "Sun H"
    ],
    "journal": "World J Surg",
    "publicationDate": "2025-11-22",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "d8c792de-ed21-4f65-ab6a-445302c1e19f",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.142Z"
      },
      {
        "id": "6737f0db-a246-4ea5-b85b-5ee5b875af3a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 7fc2fc3e-cb96-483f-adf9-fb416bca3e3a to DEXA_Synt_74091",
        "type": "system",
        "createdAt": "2025-12-14T10:12:25.292Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:47.546Z",
    "updatedAt": "2025-12-14T08:54:24.188Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41273037",
      "DOI": "https://doi.org10.1002/wjs.70157",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:12:12",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Zhang D, Brucchi F, Barbieri D, Indelicato P, Colombo C, Dionigi G, Sun H. A Randomized Controlled Trial to Evaluate the Effects of Topical Intraoperative Corticosteroid Application on Voice Quality in Thyroid Surgery With Preserved Recurrent Laryngeal Nerves. World J Surg. 2025;",
      "pubdate": "2025-11-22",
      "Lead_author": "Zhang D",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/wjs.70157",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Zhang D, Brucchi F, Barbieri D, Indelicato P, Colombo C, Dionigi G, Sun H. A Randomized Controlled Trial to Evaluate the Effects of Topical Intraoperative Corticosteroid Application on Voice Quality in Thyroid Surgery With Preserved Recurrent Laryngeal Nerves. World J Surg. 2025;",
    "leadAuthor": "Zhang D",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhhBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhhBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2502100501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707145
  },
  {
    "id": "DEXA_Synt_57924",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41270911",
    "title": "Microsorum membranaceum (D. Don) Ching protected dexamethasone-induced sarcopenia by targeting protein degradation and synthesis pathway in C2C12 cells and C57BL/6 mice.",
    "authors": [
      "Park ES",
      "Kim JE",
      "Song HJ",
      "Seol A",
      "Kim TR",
      "Park KH",
      "Lim SJ",
      "Wang SH",
      "Park SH",
      "Win TTM",
      "Hlaing SS",
      "Hwang DY"
    ],
    "journal": "J Ethnopharmacol",
    "publicationDate": "2025-11-22",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6ea031f3-5627-4723-9487-ff82601ce820",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.201Z"
      },
      {
        "id": "1ba2970d-2cd8-431e-92d9-810c81cf5a1c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 38939e43-2eb5-4582-8bd6-c9ff01d9c717 to DEXA_Synt_57924",
        "type": "system",
        "createdAt": "2025-12-14T10:12:25.510Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:47.719Z",
    "updatedAt": "2025-12-14T08:54:24.207Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41270911",
      "DOI": "https://doi.org10.1016/j.jep.2025.120921",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:12:36",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Park ES, Kim JE, Song HJ, Seol A, Kim TR, Park KH, Lim SJ, Wang SH, Park SH, Win TTM, Hlaing SS, Hwang DY. Microsorum membranaceum (D. Don) Ching protected dexamethasone-induced sarcopenia by targeting protein degradation and synthesis pathway in C2C12 cells and C57BL/6 mice. J Ethnopharmacol. 2025;357120921",
      "pubdate": "2025-11-22",
      "Lead_author": "Park ES",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jep.2025.120921",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Park ES, Kim JE, Song HJ, Seol A, Kim TR, Park KH, Lim SJ, Wang SH, Park SH, Win TTM, Hlaing SS, Hwang DY. Microsorum membranaceum (D. Don) Ching protected dexamethasone-induced sarcopenia by targeting protein degradation and synthesis pathway in C2C12 cells and C57BL/6 mice. J Ethnopharmacol. 2025;357120921",
    "leadAuthor": "Park ES",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhiBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhiBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2525cc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707145
  },
  {
    "id": "DEXA_Synt_24559",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41269423",
    "title": "Brentuximab vedotin combined with cisplatin, cytarabine, and dexamethasone treatment in transplant-eligible Korean patients with relapsed or refractory Hodgkin's lymphoma.",
    "authors": [
      "Yi JH",
      "Park YH",
      "Lee MW",
      "Yoo KH",
      "Hong J",
      "Eom HS"
    ],
    "journal": "Blood Res",
    "publicationDate": "2025-11-21",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "856eb51e-fd98-4738-901e-c455fb8ce342",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.264Z"
      },
      {
        "id": "cfce40e8-97b0-4771-a864-dc9f0722537e",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 20182b82-d109-4d1c-9ac9-9fc7bc69cbde to DEXA_Synt_24559",
        "type": "system",
        "createdAt": "2025-12-14T10:12:25.729Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:47.798Z",
    "updatedAt": "2025-12-14T08:54:24.272Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41269423",
      "DOI": "https://doi.org10.1007/s44313-025-00097-z",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:12:20",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Yi JH, Park YH, Lee MW, Yoo KH, Hong J, Eom HS. Brentuximab vedotin combined with cisplatin, cytarabine, and dexamethasone treatment in transplant-eligible Korean patients with relapsed or refractory Hodgkin's lymphoma. Blood Res. 2025;60(1):62",
      "pubdate": "2025-11-21",
      "Lead_author": "Yi JH",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s44313-025-00097-z",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Yi JH, Park YH, Lee MW, Yoo KH, Hong J, Eom HS. Brentuximab vedotin combined with cisplatin, cytarabine, and dexamethasone treatment in transplant-eligible Korean patients with relapsed or refractory Hodgkin's lymphoma. Blood Res. 2025;60(1):62",
    "leadAuthor": "Yi JH",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhjBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhjBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2549840501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707145
  },
  {
    "id": "DEXA_Synt_46688",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41269241",
    "title": "Discovery of a novel dual-functional peptide from oyster protein hydrolysates with antioxidant and osteogenic properties: , , and zebrafish model evaluation.",
    "authors": [
      "Zhong S",
      "Quan Z",
      "Hou M",
      "Liang Y",
      "Li J",
      "Zhao L",
      "Zhu B",
      "Hu Y"
    ],
    "journal": "Food Funct",
    "publicationDate": "2025-11-21",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "e432e221-6a1f-4dee-99bf-4237f4889248",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.293Z"
      },
      {
        "id": "dcb95318-93f7-4c21-93a2-7f0bf05d752f",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from cb8ecbf8-7ce9-4565-95ae-11c1a4204199 to DEXA_Synt_46688",
        "type": "system",
        "createdAt": "2025-12-14T10:12:25.945Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:47.982Z",
    "updatedAt": "2025-12-14T08:54:24.329Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41269241",
      "DOI": "https://doi.org10.1039/d5fo02928g",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:12:28",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Zhong S, Quan Z, Hou M, Liang Y, Li J, Zhao L, Zhu B, Hu Y. Discovery of a novel dual-functional peptide from oyster protein hydrolysates with antioxidant and osteogenic properties: <i>in vitro</i>, <i>in silico</i>, and zebrafish model evaluation. Food Funct. 2025;",
      "pubdate": "2025-11-21",
      "Lead_author": "Zhong S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1039/d5fo02928g",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Zhong S, Quan Z, Hou M, Liang Y, Li J, Zhao L, Zhu B, Hu Y. Discovery of a novel dual-functional peptide from oyster protein hydrolysates with antioxidant and osteogenic properties: <i>in vitro</i>, <i>in silico</i>, and zebrafish model evaluation. Food Funct. 2025;",
    "leadAuthor": "Zhong S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhkBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhkBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-256cc40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707146
  },
  {
    "id": "DEXA_Synt_24175",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41267072",
    "title": "Impact of Dexamethasone-Enriched Tumescent Anesthesia for Radiofrequency Ablation of GSV insufficiency: A Double-Blind Randomized Clinical Trial.",
    "authors": [
      "Xiang Y",
      "Wang X",
      "Huang J",
      "Xu J",
      "Wang L",
      "Wu Z",
      "Hu H",
      "Xiong F",
      "Hu H",
      "Ma Y"
    ],
    "journal": "Ann Surg",
    "publicationDate": "2025-11-21",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "78ba81fe-86bf-4360-af97-b3db9a248518",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.356Z"
      },
      {
        "id": "8d61a18b-78b0-4167-90ef-2fd10731e8f4",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d3b2a9b9-bfc6-46b4-9216-d537d203749a to DEXA_Synt_24175",
        "type": "system",
        "createdAt": "2025-12-14T10:12:26.161Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:48.059Z",
    "updatedAt": "2025-12-14T08:54:24.368Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41267072",
      "DOI": "https://doi.org10.1097/SLA.0000000000006987",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:13:14",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Xiang Y, Wang X, Huang J, Xu J, Wang L, Wu Z, Hu H, Xiong F, Hu H, Ma Y. Impact of Dexamethasone-Enriched Tumescent Anesthesia for Radiofrequency Ablation of GSV insufficiency: A Double-Blind Randomized Clinical Trial. Ann Surg. 2025;",
      "pubdate": "2025-11-21",
      "Lead_author": "Xiang Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/SLA.0000000000006987",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Xiang Y, Wang X, Huang J, Xu J, Wang L, Wu Z, Hu H, Xiong F, Hu H, Ma Y. Impact of Dexamethasone-Enriched Tumescent Anesthesia for Radiofrequency Ablation of GSV insufficiency: A Double-Blind Randomized Clinical Trial. Ann Surg. 2025;",
    "leadAuthor": "Xiang Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhlBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhlBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-258da40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707146
  },
  {
    "id": "DEXA_Synt_90526",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41257092",
    "title": "Unusual presentation of fungal keratitis and endogenous endophthalmitis in Sézary syndrome: a case report.",
    "authors": [
      "Fernández-Gurría M",
      "Kwan J",
      "Dimitropoulou N",
      "Dhillon N"
    ],
    "journal": "Am J Ophthalmol Case Rep",
    "publicationDate": "2025-11-19",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "522744e4-2cdc-432d-8b13-a5b31e03e822",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.386Z"
      },
      {
        "id": "daa9f097-eaf3-496d-88eb-ab7571e75f41",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from de7376ce-bcf0-4dbb-886e-5ffc7ef327cc to DEXA_Synt_90526",
        "type": "system",
        "createdAt": "2025-12-14T10:12:26.429Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:48.242Z",
    "updatedAt": "2025-12-14T08:54:24.439Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41257092",
      "DOI": "https://doi.org10.1016/j.ajoc.2025.102464",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:13:39",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Fernández-Gurría M, Kwan J, Dimitropoulou N, Dhillon N. Unusual presentation of fungal keratitis and endogenous endophthalmitis in Sézary syndrome: a case report. Am J Ophthalmol Case Rep. 2025;40102464",
      "pubdate": "2025-11-19",
      "Lead_author": "Fernández-Gurría M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ajoc.2025.102464",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Fernández-Gurría M, Kwan J, Dimitropoulou N, Dhillon N. Unusual presentation of fungal keratitis and endogenous endophthalmitis in Sézary syndrome: a case report. Am J Ophthalmol Case Rep. 2025;40102464",
    "leadAuthor": "Fernández-Gurría M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhmBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhmBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-25ac740501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707146
  },
  {
    "id": "DEXA_Synt_46056",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41255610",
    "title": "POEMS syndrome complicated by portal hypertension resembling decompensated cirrhosis: a case report and diagnostic insights.",
    "authors": [
      "Zhou H",
      "Zhou Y",
      "Wu L",
      "Yan L",
      "Wei J",
      "Chen W",
      "Huang X",
      "Zhang S"
    ],
    "journal": "Front Med (Lausanne)",
    "publicationDate": "2025-11-19",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "e2e30f17-ea9d-41be-9bfc-ab32be142073",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.465Z"
      },
      {
        "id": "2a3773e7-ae06-4319-b60d-927b73faf733",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 65e00e9c-fa89-4ee2-8c41-c0009fb61509 to DEXA_Synt_46056",
        "type": "system",
        "createdAt": "2025-12-14T10:12:26.673Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:48.306Z",
    "updatedAt": "2025-12-14T08:54:24.475Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41255610",
      "DOI": "https://doi.org10.3389/fmed.2025.1654338",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:13:24",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Zhou H, Zhou Y, Wu L, Yan L, Wei J, Chen W, Huang X, Zhang S. POEMS syndrome complicated by portal hypertension resembling decompensated cirrhosis: a case report and diagnostic insights. Front Med (Lausanne). 2025;121654338",
      "pubdate": "2025-11-19",
      "Lead_author": "Zhou H",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3389/fmed.2025.1654338",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Zhou H, Zhou Y, Wu L, Yan L, Wei J, Chen W, Huang X, Zhang S. POEMS syndrome complicated by portal hypertension resembling decompensated cirrhosis: a case report and diagnostic insights. Front Med (Lausanne). 2025;121654338",
    "leadAuthor": "Zhou H",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhnBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhnBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-25cc880501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707146
  },
  {
    "id": "DEXA_Synt_38544",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41255452",
    "title": "Recognition of Diffuse Pustules and Hemorrhagic Crusts as Early Warning Signs of Invasive Candidiasis in a Patient With Toxic Epidermal Necrolysis.",
    "authors": [
      "Al-Zahawi S",
      "Saberi F",
      "Soori T",
      "Yousefi E",
      "Balighi K"
    ],
    "journal": "Clin Case Rep",
    "publicationDate": "2025-11-19",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "521bed01-b3c4-4955-a8a4-57a3ae6f2905",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.494Z"
      },
      {
        "id": "a4caca3b-1fc0-44b0-a1e3-67e23d456d47",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 97f6b286-a40f-470a-ab24-82622262686a to DEXA_Synt_38544",
        "type": "system",
        "createdAt": "2025-12-14T10:12:26.888Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:48.508Z",
    "updatedAt": "2025-12-14T08:54:24.535Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41255452",
      "DOI": "https://doi.org10.1002/ccr3.71451",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:13:31",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Al-Zahawi S, Saberi F, Soori T, Yousefi E, Balighi K. Recognition of Diffuse Pustules and Hemorrhagic Crusts as Early Warning Signs of Invasive Candidiasis in a Patient With Toxic Epidermal Necrolysis. Clin Case Rep. 2025;13(11):e71451",
      "pubdate": "2025-11-19",
      "Lead_author": "Al-Zahawi S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/ccr3.71451",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Al-Zahawi S, Saberi F, Soori T, Yousefi E, Balighi K. Recognition of Diffuse Pustules and Hemorrhagic Crusts as Early Warning Signs of Invasive Candidiasis in a Patient With Toxic Epidermal Necrolysis. Clin Case Rep. 2025;13(11):e71451",
    "leadAuthor": "Al-Zahawi S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhoBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhoBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-25ed6c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707146
  },
  {
    "id": "DEXA_Synt_38242",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41254786",
    "title": "Perineural versus intravenous dexamethasone for single-shot interscalene block in arthroscopic shoulder surgery: a systematic review and meta-analysis of studies published through May 2021.",
    "authors": [
      "Wu R",
      "Chen Z",
      "Chen G",
      "Sun J",
      "Liu W"
    ],
    "journal": "Perioper Med (Lond)",
    "publicationDate": "2025-11-19",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "68129ead-eab3-4021-910d-dc99680273aa",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.557Z"
      },
      {
        "id": "1dc7a867-3f98-469f-89dd-1045d8aa250d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from fef1a64c-2705-46d4-8759-ad8363a60f13 to DEXA_Synt_38242",
        "type": "system",
        "createdAt": "2025-12-14T10:12:27.106Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:48.546Z",
    "updatedAt": "2025-12-14T08:54:24.568Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41254786",
      "DOI": "https://doi.org10.1186/s13741-025-00617-6",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:13:47",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Wu R, Chen Z, Chen G, Sun J, Liu W. Perineural versus intravenous dexamethasone for single-shot interscalene block in arthroscopic shoulder surgery: a systematic review and meta-analysis of studies published through May 2021. Perioper Med (Lond). 2025;14(1):129",
      "pubdate": "2025-11-19",
      "Lead_author": "Wu R",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s13741-025-00617-6",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Wu R, Chen Z, Chen G, Sun J, Liu W. Perineural versus intravenous dexamethasone for single-shot interscalene block in arthroscopic shoulder surgery: a systematic review and meta-analysis of studies published through May 2021. Perioper Med (Lond). 2025;14(1):129",
    "leadAuthor": "Wu R",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhpBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhpBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-260ea80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707147
  },
  {
    "id": "DEXA_Synt_64324",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41247321",
    "title": "Human primary mesenchymal stem cells fail to recover full osteogenic differentiation potential following washout of electronic cigarette aerosol extracts.",
    "authors": [
      "Shaito A",
      "Daher MA",
      "El Hajj N",
      "Hijazi R",
      "Al Feghali F",
      "Husari A",
      "El-Sabban M",
      "Saliba J"
    ],
    "journal": "Nicotine Tob Res",
    "publicationDate": "2025-11-17",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "04ad7e92-4714-48e0-871c-d6439e8fd58d",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.589Z"
      },
      {
        "id": "51e57a9e-3cd0-4f72-ba31-dba8e967256e",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 7eb0184a-758c-47d3-ae9a-02accb6ec679 to DEXA_Synt_64324",
        "type": "system",
        "createdAt": "2025-12-14T10:12:27.321Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:48.721Z",
    "updatedAt": "2025-12-14T08:54:24.638Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41247321",
      "DOI": "https://doi.org10.1093/ntr/ntaf239",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:13:55",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Shaito A, Daher MA, El Hajj N, Hijazi R, Al Feghali F, Husari A, El-Sabban M, Saliba J. Human primary mesenchymal stem cells fail to recover full osteogenic differentiation potential following washout of electronic cigarette aerosol extracts. Nicotine Tob Res. 2025;",
      "pubdate": "2025-11-17",
      "Lead_author": "Shaito A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1093/ntr/ntaf239",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Shaito A, Daher MA, El Hajj N, Hijazi R, Al Feghali F, Husari A, El-Sabban M, Saliba J. Human primary mesenchymal stem cells fail to recover full osteogenic differentiation potential following washout of electronic cigarette aerosol extracts. Nicotine Tob Res. 2025;",
    "leadAuthor": "Shaito A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhqBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhqBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-262f3c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707147
  },
  {
    "id": "DEXA_Synt_31915",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41243342",
    "title": "When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review.",
    "authors": [
      "Shanshal M"
    ],
    "journal": "J Dermatolog Treat",
    "publicationDate": "2025-11-17",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "f7f507dc-7121-4b5c-9746-1aa14e1d8a84",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.663Z"
      },
      {
        "id": "9be821f5-35d8-4fe8-9834-d72a06332547",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 7566f35e-87e6-4991-af86-e3ea66fdd630 to DEXA_Synt_31915",
        "type": "system",
        "createdAt": "2025-12-14T10:12:27.571Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:48.878Z",
    "updatedAt": "2025-12-14T08:54:24.674Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41243342",
      "DOI": "https://doi.org10.1080/09546634.2025.2589031",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:14:27",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Shanshal M. When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review. J Dermatolog Treat. 2025;36(1):2589031",
      "pubdate": "2025-11-17",
      "Lead_author": "Shanshal M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/09546634.2025.2589031",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Shanshal M. When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review. J Dermatolog Treat. 2025;36(1):2589031",
    "leadAuthor": "Shanshal M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhrBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhrBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2655140501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707147
  },
  {
    "id": "DEXA_Synt_45792",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41243281",
    "title": "The Pivotal Role of GR-CAR Pathway in Fetal Programming of Hepatic Cytochrome P450 3A Alteration in Adulthood.",
    "authors": [
      "Sun X",
      "Liu J",
      "Xiang E",
      "Li X",
      "Yan X",
      "Wang Y",
      "Li F",
      "Kou H",
      "Wang H",
      "Guo Y"
    ],
    "journal": "Adv Sci (Weinh)",
    "publicationDate": "2025-11-17",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "076c5e6e-dbf2-466f-8b4c-cf51eb8e2ca2",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.695Z"
      },
      {
        "id": "dc82912c-29dc-4a1e-8056-36a72c303b57",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 00ff10b9-d172-4259-9205-5afd70db2bc1 to DEXA_Synt_45792",
        "type": "system",
        "createdAt": "2025-12-14T10:12:27.741Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:48.989Z",
    "updatedAt": "2025-12-14T08:54:24.731Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41243281",
      "DOI": "https://doi.org10.1002/advs.202515583",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:14:04",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Sun X, Liu J, Xiang E, Li X, Yan X, Wang Y, Li F, Kou H, Wang H, Guo Y. The Pivotal Role of GR-CAR Pathway in Fetal Programming of Hepatic Cytochrome P450 3A Alteration in Adulthood. Adv Sci (Weinh). 2025;e15583",
      "pubdate": "2025-11-17",
      "Lead_author": "Sun X",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/advs.202515583",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Sun X, Liu J, Xiang E, Li X, Yan X, Wang Y, Li F, Kou H, Wang H, Guo Y. The Pivotal Role of GR-CAR Pathway in Fetal Programming of Hepatic Cytochrome P450 3A Alteration in Adulthood. Adv Sci (Weinh). 2025;e15583",
    "leadAuthor": "Sun X",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhsBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhsBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2677a40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707147
  },
  {
    "id": "DEXA_Synt_56175",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41241712",
    "title": "Intratympanic corticosteroid injection for Ménière's disease: systematic review of randomized controlled trials.",
    "authors": [
      "Martínez HG",
      "Larrosa F",
      "Sandoval M",
      "Remacha J",
      "Bernal-Sprekelsen M"
    ],
    "journal": "Eur Arch Otorhinolaryngol",
    "publicationDate": "2025-11-16",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "601aa85d-6e1f-4a33-84cd-91ddadbb80ab",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.758Z"
      },
      {
        "id": "d364e614-a26c-4b25-b804-0df5b8f0d006",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 1dbe3a9b-5570-46af-8efa-238ca0d0a20a to DEXA_Synt_56175",
        "type": "system",
        "createdAt": "2025-12-14T10:12:27.989Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:49.113Z",
    "updatedAt": "2025-12-14T08:54:24.766Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41241712",
      "DOI": "https://doi.org10.1007/s00405-025-09764-4",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:14:20",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Martínez HG, Larrosa F, Sandoval M, Remacha J, Bernal-Sprekelsen M. Intratympanic corticosteroid injection for Ménière's disease: systematic review of randomized controlled trials. Eur Arch Otorhinolaryngol. 2025;",
      "pubdate": "2025-11-16",
      "Lead_author": "Martínez HG",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s00405-025-09764-4",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Martínez HG, Larrosa F, Sandoval M, Remacha J, Bernal-Sprekelsen M. Intratympanic corticosteroid injection for Ménière's disease: systematic review of randomized controlled trials. Eur Arch Otorhinolaryngol. 2025;",
    "leadAuthor": "Martínez HG",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhtBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhtBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-26957c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707148
  },
  {
    "id": "DEXA_Synt_36139",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41241333",
    "title": "Crosstalk between M1 muscarinic acetylcholine receptor and endocannabinoid system promotes attenuation of inflammation in ulcerative colitis.",
    "authors": [
      "de Aguiar Magalhães D",
      "Guimarães Sousa S",
      "da Silva Monteiro CE",
      "Arruda Batista J",
      "de Sousa AK",
      "Dos Santos Ferreira J",
      "Carvalho Pereira CM",
      "do Nascimento Lima JV",
      "da Silva Sousa JJ",
      "da Silva Prudêncio R",
      "Lino da Silva TM",
      "Oliveira Silva FG",
      "Franco AX",
      "Di Lenardo D",
      "Pereira Vasconcelos DF",
      "Almeida Rocha J",
      "Alves Figueiredo K",
      "Gomes Soares PM",
      "Dos Reis Barbosa AL"
    ],
    "journal": "Eur J Pharmacol",
    "publicationDate": "2025-11-16",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a2ce3745-381f-411c-ba24-bcb126b2716a",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.787Z"
      },
      {
        "id": "17d94633-8e7f-40c2-adf7-4b290d461ee4",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from ad81f516-85ad-4fdf-bff2-50ece6bf4247 to DEXA_Synt_36139",
        "type": "system",
        "createdAt": "2025-12-14T10:12:28.233Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:49.266Z",
    "updatedAt": "2025-12-14T08:54:24.838Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41241333",
      "DOI": "https://doi.org10.1016/j.ejphar.2025.178368",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:14:12",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "de Aguiar Magalhães D, Guimarães Sousa S, da Silva Monteiro CE, Arruda Batista J, de Sousa AK, Dos Santos Ferreira J, Carvalho Pereira CM, do Nascimento Lima JV, da Silva Sousa JJ, da Silva Prudêncio R, Lino da Silva TM, Oliveira Silva FG, Franco AX, Di Lenardo D, Pereira Vasconcelos DF, Almeida Rocha J, Alves Figueiredo K, Gomes Soares PM, Dos Reis Barbosa AL. Crosstalk between M1 muscarinic acetylcholine receptor and endocannabinoid system promotes attenuation of inflammation in ulcerative colitis. Eur J Pharmacol. 2025;1008178368",
      "pubdate": "2025-11-16",
      "Lead_author": "de Aguiar Magalhães D",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ejphar.2025.178368",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "de Aguiar Magalhães D, Guimarães Sousa S, da Silva Monteiro CE, Arruda Batista J, de Sousa AK, Dos Santos Ferreira J, Carvalho Pereira CM, do Nascimento Lima JV, da Silva Sousa JJ, da Silva Prudêncio R, Lino da Silva TM, Oliveira Silva FG, Franco AX, Di Lenardo D, Pereira Vasconcelos DF, Almeida Rocha J, Alves Figueiredo K, Gomes Soares PM, Dos Reis Barbosa AL. Crosstalk between M1 muscarinic acetylcholine receptor and endocannabinoid system promotes attenuation of inflammation in ulcerative colitis. Eur J Pharmacol. 2025;1008178368",
    "leadAuthor": "de Aguiar Magalhães D",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhuBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhuBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-26ba3c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707148
  },
  {
    "id": "DEXA_Synt_88174",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41236654",
    "title": "The crucial role of circadian synchronization in bone marrow adipose tissue mesenchymal stem cells: insights into pathogenesis in Fanconi anemia and acute myeloid leukemia.",
    "authors": [
      "Muratoğlu B",
      "Özdemir C",
      "Eylem CC",
      "Reçber T",
      "Nemutlu E",
      "Uçkan-Çetinkaya D"
    ],
    "journal": "Mol Biol Rep",
    "publicationDate": "2025-11-14",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "d5d92325-83c6-4e64-8761-480c8d2f96bf",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.864Z"
      },
      {
        "id": "9395cbc7-7dfe-4ab9-9f73-4bf17bb526c0",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 58a77608-da1f-484e-8533-0e961f7d76f0 to DEXA_Synt_88174",
        "type": "system",
        "createdAt": "2025-12-14T10:12:28.435Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:49.376Z",
    "updatedAt": "2025-12-14T08:54:24.876Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41236654",
      "DOI": "https://doi.org10.1007/s11033-025-11229-0",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:14:35",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Muratoğlu B, Özdemir C, Eylem CC, Reçber T, Nemutlu E, Uçkan-Çetinkaya D. The crucial role of circadian synchronization in bone marrow adipose tissue mesenchymal stem cells: insights into pathogenesis in Fanconi anemia and acute myeloid leukemia. Mol Biol Rep. 2025;53(1):80",
      "pubdate": "2025-11-14",
      "Lead_author": "Muratoğlu B",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s11033-025-11229-0",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Muratoğlu B, Özdemir C, Eylem CC, Reçber T, Nemutlu E, Uçkan-Çetinkaya D. The crucial role of circadian synchronization in bone marrow adipose tissue mesenchymal stem cells: insights into pathogenesis in Fanconi anemia and acute myeloid leukemia. Mol Biol Rep. 2025;53(1):80",
    "leadAuthor": "Muratoğlu B",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhvBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhvBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-26dc840501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707148
  },
  {
    "id": "DEXA_Synt_68046",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41227555",
    "title": "Effects of  on Dexameth-Asone-Induced Immune Injury in Goslings.",
    "authors": [
      "Wang H",
      "Li G",
      "Wang X",
      "Gong S",
      "He D"
    ],
    "journal": "Animals (Basel)",
    "publicationDate": "2025-11-13",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "1f1c7ba5-f68e-46b7-8cac-86327fedd991",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.893Z"
      },
      {
        "id": "4a3e7c96-87ab-47e6-b8db-3dd3c9fc5b5b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from fc0dc9b0-2991-4492-baa4-2f9d6b52ecff to DEXA_Synt_68046",
        "type": "system",
        "createdAt": "2025-12-14T10:12:28.669Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:49.531Z",
    "updatedAt": "2025-12-14T08:54:24.960Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41227555",
      "DOI": "https://doi.org10.3390/ani15213226",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:14:58",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Wang H, Li G, Wang X, Gong S, He D. Effects of <i>Ganoderma lucidum Polysaccharides</i> on Dexameth-Asone-Induced Immune Injury in Goslings. Animals (Basel). 2025;15(21):",
      "pubdate": "2025-11-13",
      "Lead_author": "Wang H",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3390/ani15213226",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Wang H, Li G, Wang X, Gong S, He D. Effects of <i>Ganoderma lucidum Polysaccharides</i> on Dexameth-Asone-Induced Immune Injury in Goslings. Animals (Basel). 2025;15(21):",
    "leadAuthor": "Wang H",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhwBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhwBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-26fd300501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707148
  },
  {
    "id": "DEXA_Synt_50584",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41225082",
    "title": "The Effect of Prenatal Dexamethasone Exposure on Placental Morphology and Function at Different Stages, Doses, and Courses In Mice.",
    "authors": [
      "Feng H",
      "Lin Y",
      "Zhao X",
      "Ge C",
      "Zhong W",
      "Zha X",
      "Fang M",
      "Wang H",
      "Zhang M"
    ],
    "journal": "Reprod Sci",
    "publicationDate": "2025-11-13",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "2ecb7322-d209-4a9a-9d5e-fa8fc2afe239",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:24.987Z"
      },
      {
        "id": "91a72eae-480a-47fa-941a-f0893f96df58",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 14534cb9-0281-43be-a459-da5d6c18178d to DEXA_Synt_50584",
        "type": "system",
        "createdAt": "2025-12-14T10:12:28.886Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:49.639Z",
    "updatedAt": "2025-12-14T08:54:24.997Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41225082",
      "DOI": "https://doi.org10.1007/s43032-025-02006-2",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:14:44",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Feng H, Lin Y, Zhao X, Ge C, Zhong W, Zha X, Fang M, Wang H, Zhang M. The Effect of Prenatal Dexamethasone Exposure on Placental Morphology and Function at Different Stages, Doses, and Courses In Mice. Reprod Sci. 2025;",
      "pubdate": "2025-11-13",
      "Lead_author": "Feng H",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s43032-025-02006-2",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Feng H, Lin Y, Zhao X, Ge C, Zhong W, Zha X, Fang M, Wang H, Zhang M. The Effect of Prenatal Dexamethasone Exposure on Placental Morphology and Function at Different Stages, Doses, and Courses In Mice. Reprod Sci. 2025;",
    "leadAuthor": "Feng H",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhxBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhxBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-271e600501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707148
  },
  {
    "id": "DEXA_Synt_55261",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41225025",
    "title": "Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy : Correction to: annals of hematology.",
    "authors": [
      "Conticello C",
      "Del Fabro V",
      "Romano A",
      "Mele A",
      "Mina R",
      "Bringhen S",
      "Orofino A",
      "Antonioli E",
      "Pulini S",
      "De Paoli L",
      "Za T",
      "Cotzia E",
      "Elia F",
      "Casson A",
      "Prete E",
      "Citiso S",
      "Liberatore C",
      "Margiotta-Casaluci G",
      "Fazio F",
      "Morè S",
      "Attucci I",
      "Accardi F",
      "Bongarzoni V",
      "Mangiacavalli S",
      "Rossi E",
      "Mannina D",
      "Garibaldi B",
      "Rizzi R",
      "Di Cecca M",
      "Rossini B",
      "Uccello G",
      "Botta C",
      "Leotta D",
      "Vincelli D",
      "Gentile M",
      "Piciocchi A",
      "Marsili G",
      "Patriarca F",
      "Zambello R",
      "Musto P",
      "Boccadoro M",
      "Offidani M",
      "Petrucci MT",
      "Di Raimondo F"
    ],
    "journal": "Ann Hematol",
    "publicationDate": "2025-11-13",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "aeeddba0-6408-4717-9ea4-4c1c495eec3c",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.015Z"
      },
      {
        "id": "41d97a42-8f65-4c11-b9b3-7e74c19fa8d0",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 73a8bf2e-7dbc-4ca4-8d9c-60c5e239a672 to DEXA_Synt_55261",
        "type": "system",
        "createdAt": "2025-12-14T10:12:29.102Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:49.780Z",
    "updatedAt": "2025-12-14T08:54:25.024Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41225025",
      "DOI": "https://doi.org10.1007/s00277-025-06713-3",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:15:20",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Conticello C, Del Fabro V, Romano A, Mele A, Mina R, Bringhen S, Orofino A, Antonioli E, Pulini S, De Paoli L, Za T, Cotzia E, Elia F, Casson A, Prete E, Citiso S, Liberatore C, Margiotta-Casaluci G, Fazio F, Morè S, Attucci I, Accardi F, Bongarzoni V, Mangiacavalli S, Rossi E, Mannina D, Garibaldi B, Rizzi R, Di Cecca M, Rossini B, Uccello G, Botta C, Leotta D, Vincelli D, Gentile M, Piciocchi A, Marsili G, Patriarca F, Zambello R, Musto P, Boccadoro M, Offidani M, Petrucci MT, Di Raimondo F. Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy : Correction to: annals of hematology. Ann Hematol. 2025;",
      "pubdate": "2025-11-13",
      "Lead_author": "Conticello C",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s00277-025-06713-3",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Conticello C, Del Fabro V, Romano A, Mele A, Mina R, Bringhen S, Orofino A, Antonioli E, Pulini S, De Paoli L, Za T, Cotzia E, Elia F, Casson A, Prete E, Citiso S, Liberatore C, Margiotta-Casaluci G, Fazio F, Morè S, Attucci I, Accardi F, Bongarzoni V, Mangiacavalli S, Rossi E, Mannina D, Garibaldi B, Rizzi R, Di Cecca M, Rossini B, Uccello G, Botta C, Leotta D, Vincelli D, Gentile M, Piciocchi A, Marsili G, Patriarca F, Zambello R, Musto P, Boccadoro M, Offidani M, Petrucci MT, Di Raimondo F. Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy : Correction to: annals of hematology. Ann Hematol. 2025;",
    "leadAuthor": "Conticello C",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhyBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhyBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-273f340501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707149
  },
  {
    "id": "DEXA_Synt_34763",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41224696",
    "title": "Synthesis of novel pyrazole derivatives and neuroprotective effect investigation.",
    "authors": [
      "Feng A",
      "Zeng Q",
      "Wang J",
      "Li H",
      "Fang X",
      "Geng Y",
      "Pan W",
      "Li G",
      "Dong J"
    ],
    "journal": "J Enzyme Inhib Med Chem",
    "publicationDate": "2025-11-13",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "69a653c5-430d-47ee-ba85-1bf37d3da94e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.046Z"
      },
      {
        "id": "a372f0e8-5451-4c00-9cd8-27b3edb236a9",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3ab5cdef-cbdc-43f9-bf5d-cce5db981866 to DEXA_Synt_34763",
        "type": "system",
        "createdAt": "2025-12-14T10:12:29.367Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:49.934Z",
    "updatedAt": "2025-12-14T08:54:25.097Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41224696",
      "DOI": "https://doi.org10.1080/14756366.2025.2583820",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:14:51",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Feng A, Zeng Q, Wang J, Li H, Fang X, Geng Y, Pan W, Li G, Dong J. Synthesis of novel pyrazole derivatives and neuroprotective effect investigation. J Enzyme Inhib Med Chem. 2025;40(1):2583820",
      "pubdate": "2025-11-13",
      "Lead_author": "Feng A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/14756366.2025.2583820",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Feng A, Zeng Q, Wang J, Li H, Fang X, Geng Y, Pan W, Li G, Dong J. Synthesis of novel pyrazole derivatives and neuroprotective effect investigation. J Enzyme Inhib Med Chem. 2025;40(1):2583820",
    "leadAuthor": "Feng A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhzBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhzBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-27674c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707149
  },
  {
    "id": "DEXA_Synt_85703",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41224359",
    "title": "Monoclonal gammopathy of renal significance presenting as cryoglobulinaemic vasculitis in a frail elderly patient.",
    "authors": [
      "Mantry V",
      "Das S",
      "Rao A",
      "Chakrawarty A"
    ],
    "journal": "BMJ Case Rep",
    "publicationDate": "2025-11-13",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b36f32cf-1d4b-419c-b03e-f942c9a3464b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.124Z"
      },
      {
        "id": "5e94ecb6-eed4-4cbf-81dc-0d904949d426",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a87876b5-2867-4c53-9324-4dcccc875bb2 to DEXA_Synt_85703",
        "type": "system",
        "createdAt": "2025-12-14T10:12:29.567Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:50.040Z",
    "updatedAt": "2025-12-14T08:54:25.135Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41224359",
      "DOI": "https://doi.org10.1136/bcr-2025-268524",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:15:43",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Mantry V, Das S, Rao A, Chakrawarty A. Monoclonal gammopathy of renal significance presenting as cryoglobulinaemic vasculitis in a frail elderly patient. BMJ Case Rep. 2025;18(11):",
      "pubdate": "2025-11-13",
      "Lead_author": "Mantry V",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1136/bcr-2025-268524",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Mantry V, Das S, Rao A, Chakrawarty A. Monoclonal gammopathy of renal significance presenting as cryoglobulinaemic vasculitis in a frail elderly patient. BMJ Case Rep. 2025;18(11):",
    "leadAuthor": "Mantry V",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh0BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh0BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2790440501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707149
  },
  {
    "id": "DEXA_Synt_59723",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41218635",
    "title": "Corticosteroids for Acute Respiratory Distress Syndrome.",
    "authors": [
      "Guglielmi R",
      "Campanella A",
      "Villar J",
      "Torres A",
      "Ferrando C"
    ],
    "journal": "Semin Respir Crit Care Med",
    "publicationDate": "2025-11-12",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "675b5622-edda-46ae-ad92-19f5a6d74ecd",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.154Z"
      },
      {
        "id": "b89f5067-d2ce-4819-b8e4-78e0b75b009c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from bfd0b43f-3c02-4391-ab20-9d4b7c248292 to DEXA_Synt_59723",
        "type": "system",
        "createdAt": "2025-12-14T10:12:29.784Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:50.176Z",
    "updatedAt": "2025-12-14T08:54:25.189Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41218635",
      "DOI": "https://doi.org10.1055/a-2721-6094",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:16:50",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Guglielmi R, Campanella A, Villar J, Torres A, Ferrando C. Corticosteroids for Acute Respiratory Distress Syndrome. Semin Respir Crit Care Med. 2025;",
      "pubdate": "2025-11-12",
      "Lead_author": "Guglielmi R",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1055/a-2721-6094",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Guglielmi R, Campanella A, Villar J, Torres A, Ferrando C. Corticosteroids for Acute Respiratory Distress Syndrome. Semin Respir Crit Care Med. 2025;",
    "leadAuthor": "Guglielmi R",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh1BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh1BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-27b20c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707149
  },
  {
    "id": "DEXA_Synt_94969",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41218481",
    "title": "Adjuvants in transversus abdominis plane blocks to prolong analgesia duration following cesarean delivery: A systematic review and network meta-analysis.",
    "authors": [
      "Wang LZ",
      "Huang JY",
      "Chang XY",
      "Xia F"
    ],
    "journal": "J Clin Anesth",
    "publicationDate": "2025-11-12",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "34f10598-410a-4688-95ca-38cf81e66328",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.215Z"
      },
      {
        "id": "d7f489bd-3c40-40a1-b641-02feb66a3631",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f383671d-ba79-4a76-bf44-c51dbc4b48cc to DEXA_Synt_94969",
        "type": "system",
        "createdAt": "2025-12-14T10:12:29.986Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:50.285Z",
    "updatedAt": "2025-12-14T08:54:25.224Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41218481",
      "DOI": "https://doi.org10.1016/j.jclinane.2025.112067",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:16:57",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Wang LZ, Huang JY, Chang XY, Xia F. Adjuvants in transversus abdominis plane blocks to prolong analgesia duration following cesarean delivery: A systematic review and network meta-analysis. J Clin Anesth. 2025;108112067",
      "pubdate": "2025-11-12",
      "Lead_author": "Wang LZ",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jclinane.2025.112067",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Wang LZ, Huang JY, Chang XY, Xia F. Adjuvants in transversus abdominis plane blocks to prolong analgesia duration following cesarean delivery: A systematic review and network meta-analysis. J Clin Anesth. 2025;108112067",
    "leadAuthor": "Wang LZ",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh2BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh2BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-27d7a00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707150
  },
  {
    "id": "DEXA_Synt_15207",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41205944",
    "title": "Injectable glycol chitosan hydrogel system for sustained drug delivery to treat neuropathic pain.",
    "authors": [
      "Lee D",
      "Han GH",
      "Kim SJ",
      "Ko WK",
      "Kim MJ",
      "Ju GB",
      "Sheen SH",
      "Hong JB",
      "Cho MJ",
      "Sohn S"
    ],
    "journal": "Int J Biol Macromol",
    "publicationDate": "2025-11-9",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6e6d82d5-4fa5-43b0-a6d3-99b42a11488b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.246Z"
      },
      {
        "id": "13863b44-30f3-4d9c-abd9-1ea8fe5995fb",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 959b5060-d5d3-4f3c-84e5-687d3427dee6 to DEXA_Synt_15207",
        "type": "system",
        "createdAt": "2025-12-14T10:12:30.203Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:50.439Z",
    "updatedAt": "2025-12-14T08:54:25.298Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41205944",
      "DOI": "https://doi.org10.1016/j.ijbiomac.2025.148757",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:16:44",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Lee D, Han GH, Kim SJ, Ko WK, Kim MJ, Ju GB, Sheen SH, Hong JB, Cho MJ, Sohn S. Injectable glycol chitosan hydrogel system for sustained drug delivery to treat neuropathic pain. Int J Biol Macromol. 2025;333(Pt 1):148757",
      "pubdate": "2025-11-9",
      "Lead_author": "Lee D",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ijbiomac.2025.148757",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Lee D, Han GH, Kim SJ, Ko WK, Kim MJ, Ju GB, Sheen SH, Hong JB, Cho MJ, Sohn S. Injectable glycol chitosan hydrogel system for sustained drug delivery to treat neuropathic pain. Int J Biol Macromol. 2025;333(Pt 1):148757",
    "leadAuthor": "Lee D",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh3BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh3BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-27f9180501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707150
  },
  {
    "id": "DEXA_Synt_18985",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41205576",
    "title": "Dexamethasone-induced immunosuppression in Pneumocystis pneumonia reprograms neutrophil metabolism and impairs antimicrobial function.",
    "authors": [
      "Zhou XX",
      "Chen YX",
      "Wang D",
      "Li T",
      "Rong HM",
      "Zhang C",
      "Yang HQ",
      "Sun H",
      "Zhai K",
      "Tong ZH"
    ],
    "journal": "Biochem Biophys Res Commun",
    "publicationDate": "2025-11-9",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "865865aa-48bd-4bc3-9c80-fc5f3af556d7",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.324Z"
      },
      {
        "id": "77e6df21-c160-4a19-9dc7-9fd891004931",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from cadfdf3f-d7cd-4bd1-bfeb-e385768a33ca to DEXA_Synt_18985",
        "type": "system",
        "createdAt": "2025-12-14T10:12:30.436Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:50.578Z",
    "updatedAt": "2025-12-14T08:54:25.336Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41205576",
      "DOI": "https://doi.org10.1016/j.bbrc.2025.152889",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:16:22",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Zhou XX, Chen YX, Wang D, Li T, Rong HM, Zhang C, Yang HQ, Sun H, Zhai K, Tong ZH. Dexamethasone-induced immunosuppression in Pneumocystis pneumonia reprograms neutrophil metabolism and impairs antimicrobial function. Biochem Biophys Res Commun. 2025;791152889",
      "pubdate": "2025-11-9",
      "Lead_author": "Zhou XX",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.bbrc.2025.152889",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Zhou XX, Chen YX, Wang D, Li T, Rong HM, Zhang C, Yang HQ, Sun H, Zhai K, Tong ZH. Dexamethasone-induced immunosuppression in Pneumocystis pneumonia reprograms neutrophil metabolism and impairs antimicrobial function. Biochem Biophys Res Commun. 2025;791152889",
    "leadAuthor": "Zhou XX",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh4BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh4BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-281a1c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707150
  },
  {
    "id": "DEXA_Synt_21793",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41198843",
    "title": "The role of thrombospondin-1 in trehalose-induced autophagy and ocular hypertension in mice.",
    "authors": [
      "Ling CY",
      "Choy KY",
      "Li HL",
      "Tse CY",
      "Yang WY",
      "Wong NW",
      "Stamer WD",
      "Do CW",
      "Tse DY",
      "Shan SS"
    ],
    "journal": "Sci Rep",
    "publicationDate": "2025-11-7",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "19f8de64-7ca2-4689-9a9b-06bd1fa8c2d5",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.354Z"
      },
      {
        "id": "d3eced43-47d4-4d5f-81a2-2e0cb14ff293",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from bccef659-d9dc-4884-804b-db57256667dd to DEXA_Synt_21793",
        "type": "system",
        "createdAt": "2025-12-14T10:12:30.670Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:50.701Z",
    "updatedAt": "2025-12-14T08:54:25.365Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41198843",
      "DOI": "https://doi.org10.1038/s41598-025-22873-8",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:17:13",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Ling CY, Choy KY, Li HL, Tse CY, Yang WY, Wong NW, Stamer WD, Do CW, Tse DY, Shan SS. The role of thrombospondin-1 in trehalose-induced autophagy and ocular hypertension in mice. Sci Rep. 2025;15(1):38930",
      "pubdate": "2025-11-7",
      "Lead_author": "Ling CY",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41598-025-22873-8",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Ling CY, Choy KY, Li HL, Tse CY, Yang WY, Wong NW, Stamer WD, Do CW, Tse DY, Shan SS. The role of thrombospondin-1 in trehalose-induced autophagy and ocular hypertension in mice. Sci Rep. 2025;15(1):38930",
    "leadAuthor": "Ling CY",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh5BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh5BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-283b040501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707150
  },
  {
    "id": "DEXA_Synt_39139",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41198609",
    "title": "Efficacy and Tolerability of Metyrapone in Mild Autonomous Cortisol Secretion: Real-World Findings From Clinical Practice.",
    "authors": [
      "Berry S",
      "Iqbal A",
      "Newell-Price J",
      "Debono M"
    ],
    "journal": "Clin Endocrinol (Oxf)",
    "publicationDate": "2025-11-7",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "3f31b034-8c9c-44ed-943e-ab8a1153602b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.385Z"
      },
      {
        "id": "b6dfd3f9-0035-4365-8e41-24a91a329be1",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from ecc75e4f-e582-40c1-9c4c-ef50570908e3 to DEXA_Synt_39139",
        "type": "system",
        "createdAt": "2025-12-14T10:12:30.900Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:50.838Z",
    "updatedAt": "2025-12-14T08:54:25.452Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41198609",
      "DOI": "https://doi.org10.1111/cen.70056",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:17:20",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Berry S, Iqbal A, Newell-Price J, Debono M. Efficacy and Tolerability of Metyrapone in Mild Autonomous Cortisol Secretion: Real-World Findings From Clinical Practice. Clin Endocrinol (Oxf). 2025;",
      "pubdate": "2025-11-7",
      "Lead_author": "Berry S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/cen.70056",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Berry S, Iqbal A, Newell-Price J, Debono M. Efficacy and Tolerability of Metyrapone in Mild Autonomous Cortisol Secretion: Real-World Findings From Clinical Practice. Clin Endocrinol (Oxf). 2025;",
    "leadAuthor": "Berry S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh6BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh6BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-285df80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707150
  },
  {
    "id": "DEXA_Synt_41374",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41197576",
    "title": "Comparison of the efficacy of dexmedetomidine and dexamethasone as adjuvants to ropivacaine for scalp nerve block in patients undergoing awake craniotomy: A randomized controlled trial.",
    "authors": [
      "Sharma L",
      "Reddy A",
      "Chauhan R",
      "Panda N",
      "Luthra A",
      "Meena SC",
      "Sarna R",
      "Sahoo SK"
    ],
    "journal": "Clin Neurol Neurosurg",
    "publicationDate": "2025-11-7",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a3d89bd3-bd21-4955-8f6f-65eb25f5ad0a",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.477Z"
      },
      {
        "id": "eef2b1dc-1ae7-483c-a684-87f940314a4b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3a171312-4446-4926-899f-6ff9f39ab936 to DEXA_Synt_41374",
        "type": "system",
        "createdAt": "2025-12-14T10:12:31.150Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:50.950Z",
    "updatedAt": "2025-12-14T08:54:25.490Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41197576",
      "DOI": "https://doi.org10.1016/j.clineuro.2025.109223",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:17:06",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Sharma L, Reddy A, Chauhan R, Panda N, Luthra A, Meena SC, Sarna R, Sahoo SK. Comparison of the efficacy of dexmedetomidine and dexamethasone as adjuvants to ropivacaine for scalp nerve block in patients undergoing awake craniotomy: A randomized controlled trial. Clin Neurol Neurosurg. 2025;259109223",
      "pubdate": "2025-11-7",
      "Lead_author": "Sharma L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.clineuro.2025.109223",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Sharma L, Reddy A, Chauhan R, Panda N, Luthra A, Meena SC, Sarna R, Sahoo SK. Comparison of the efficacy of dexmedetomidine and dexamethasone as adjuvants to ropivacaine for scalp nerve block in patients undergoing awake craniotomy: A randomized controlled trial. Clin Neurol Neurosurg. 2025;259109223",
    "leadAuthor": "Sharma L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh7BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh7BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2877740501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707151
  },
  {
    "id": "DEXA_Synt_55031",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41192015",
    "title": "Plasma secretory protein genes in hepatocellular carcinoma and heart failure: Comorbidity and biological function exploration.",
    "authors": [
      "Cao L",
      "Wang X",
      "Ning Z",
      "Xie F",
      "Li X",
      "Chen Y",
      "Geng Q",
      "Liu J",
      "Zhu Q",
      "Ma L",
      "Li Y"
    ],
    "journal": "Mol Immunol",
    "publicationDate": "2025-11-6",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5751d6e3-3ec2-48ee-a512-84acd3f0a435",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.523Z"
      },
      {
        "id": "813f91c5-c5eb-4955-84c6-fc4275f6a480",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from ffd361e1-3c80-439c-be0c-2305a255fdc8 to DEXA_Synt_55031",
        "type": "system",
        "createdAt": "2025-12-14T10:12:31.383Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:51.090Z",
    "updatedAt": "2025-12-14T08:54:25.536Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41192015",
      "DOI": "https://doi.org10.1016/j.molimm.2025.10.009",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:17:27",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Cao L, Wang X, Ning Z, Xie F, Li X, Chen Y, Geng Q, Liu J, Zhu Q, Ma L, Li Y. Plasma secretory protein genes in hepatocellular carcinoma and heart failure: Comorbidity and biological function exploration. Mol Immunol. 2025;18845-61",
      "pubdate": "2025-11-6",
      "Lead_author": "Cao L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.molimm.2025.10.009",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Cao L, Wang X, Ning Z, Xie F, Li X, Chen Y, Geng Q, Liu J, Zhu Q, Ma L, Li Y. Plasma secretory protein genes in hepatocellular carcinoma and heart failure: Comorbidity and biological function exploration. Mol Immunol. 2025;18845-61",
    "leadAuthor": "Cao L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh8BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh8BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-289b0c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707151
  },
  {
    "id": "DEXA_Synt_75115",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41191129",
    "title": "Real-life short-term experience of switching from other anti-VEGF therapy to faricimab in patients with refractory macular edema secondary to retinal vein occlusion in China.",
    "authors": [
      "Sun Y",
      "Zhao M",
      "Miao H",
      "Qi H"
    ],
    "journal": "Int Ophthalmol",
    "publicationDate": "2025-11-5",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "d318f066-7f37-4bb1-b45c-f2a16e03e43d",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.551Z"
      },
      {
        "id": "b724f976-a1bb-48db-89f0-94e62aa65e2e",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 533b7b40-0d90-4e06-be1b-7122b7549ba2 to DEXA_Synt_75115",
        "type": "system",
        "createdAt": "2025-12-14T10:12:31.617Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:51.226Z",
    "updatedAt": "2025-12-14T08:54:25.603Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41191129",
      "DOI": "https://doi.org10.1007/s10792-025-03836-4",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:17:35",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Sun Y, Zhao M, Miao H, Qi H. Real-life short-term experience of switching from other anti-VEGF therapy to faricimab in patients with refractory macular edema secondary to retinal vein occlusion in China. Int Ophthalmol. 2025;45(1):463",
      "pubdate": "2025-11-5",
      "Lead_author": "Sun Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s10792-025-03836-4",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Sun Y, Zhao M, Miao H, Qi H. Real-life short-term experience of switching from other anti-VEGF therapy to faricimab in patients with refractory macular edema secondary to retinal vein occlusion in China. Int Ophthalmol. 2025;45(1):463",
    "leadAuthor": "Sun Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh9BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh9BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-28becc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707151
  },
  {
    "id": "DEXA_Synt_96625",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41180851",
    "title": "Clarifying the postsurgical persistent pain after laparoscopic cholecystectomy and the role of intravenous lidocaine.",
    "authors": [
      "Abreu-Pires M",
      "Cavaleiro C",
      "Machado H",
      "Moreira da Silva Á"
    ],
    "journal": "Pain Rep",
    "publicationDate": "2025-11-3",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "09dc07d3-0f42-4b95-9884-15d02adf1e40",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.631Z"
      },
      {
        "id": "bda3cfb5-2513-4579-9367-632d38e24260",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 38d451b4-c91a-42f3-932a-8e9038661b36 to DEXA_Synt_96625",
        "type": "system",
        "createdAt": "2025-12-14T10:12:31.832Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:51.333Z",
    "updatedAt": "2025-12-14T08:54:25.644Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41180851",
      "DOI": "https://doi.org10.1097/PR9.0000000000001347",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:18:44",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Abreu-Pires M, Cavaleiro C, Machado H, Moreira da Silva Á. Clarifying the postsurgical persistent pain after laparoscopic cholecystectomy and the role of intravenous lidocaine. Pain Rep. 2025;10(6):e1347",
      "pubdate": "2025-11-3",
      "Lead_author": "Abreu-Pires M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/PR9.0000000000001347",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Abreu-Pires M, Cavaleiro C, Machado H, Moreira da Silva Á. Clarifying the postsurgical persistent pain after laparoscopic cholecystectomy and the role of intravenous lidocaine. Pain Rep. 2025;10(6):e1347",
    "leadAuthor": "Abreu-Pires M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh+BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh+BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-28df7c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707151
  },
  {
    "id": "DEXA_Synt_35413",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41172598",
    "title": "The miR-29a/c-3p/HMCCR pathway is a potential mechanism by which chicken bursa of Fabricius responds to stress affecting immune response.",
    "authors": [
      "Xia M",
      "Jiang Y",
      "Li J",
      "Zhang Y",
      "Ren L",
      "Lin J",
      "Wang X",
      "Man C"
    ],
    "journal": "Vet Microbiol",
    "publicationDate": "2025-11-1",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "92e8e531-60e2-4071-b90c-b45fbb721556",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.678Z"
      },
      {
        "id": "625ae0fd-507c-4d66-be7a-736bb42b5c48",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from efc55a80-762d-447d-822c-6c09b6aec379 to DEXA_Synt_35413",
        "type": "system",
        "createdAt": "2025-12-14T10:12:32.048Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:51.473Z",
    "updatedAt": "2025-12-14T08:54:25.690Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41172598",
      "DOI": "https://doi.org10.1016/j.vetmic.2025.110778",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:19:06",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Xia M, Jiang Y, Li J, Zhang Y, Ren L, Lin J, Wang X, Man C. The miR-29a/c-3p/HMCCR pathway is a potential mechanism by which chicken bursa of Fabricius responds to stress affecting immune response. Vet Microbiol. 2025;311110778",
      "pubdate": "2025-11-1",
      "Lead_author": "Xia M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.vetmic.2025.110778",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Xia M, Jiang Y, Li J, Zhang Y, Ren L, Lin J, Wang X, Man C. The miR-29a/c-3p/HMCCR pathway is a potential mechanism by which chicken bursa of Fabricius responds to stress affecting immune response. Vet Microbiol. 2025;311110778",
    "leadAuthor": "Xia M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh-BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh-BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2900780501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707152
  },
  {
    "id": "DEXA_Synt_89573",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41160904",
    "title": "Comparison of In-Vitro and In-Vivo Drug Release of Dexamethasone/PLGA Intravitreal Implants Using Two In-Vitro Release Methods and a Rabbit Model.",
    "authors": [
      "Johnson C",
      "Maier E",
      "Bhalla A",
      "Crowell E",
      "Wang Y",
      "Qin B",
      "Zhang F"
    ],
    "journal": "Mol Pharm",
    "publicationDate": "2025-10-30",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "e0b542ab-5dc9-4409-b755-509971da1128",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.707Z"
      },
      {
        "id": "b85acd5c-cd0c-46b7-b541-fddd90a13991",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 4e4b4a94-05a0-4102-b382-549690c7924c to DEXA_Synt_89573",
        "type": "system",
        "createdAt": "2025-12-14T10:12:32.264Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:51.630Z",
    "updatedAt": "2025-12-14T08:54:25.718Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41160904",
      "DOI": "https://doi.org10.1021/acs.molpharmaceut.5c01076",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:19:13",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Johnson C, Maier E, Bhalla A, Crowell E, Wang Y, Qin B, Zhang F. Comparison of In-Vitro and In-Vivo Drug Release of Dexamethasone/PLGA Intravitreal Implants Using Two In-Vitro Release Methods and a Rabbit Model. Mol Pharm. 2025;22(12):7534-49",
      "pubdate": "2025-10-30",
      "Lead_author": "Johnson C",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1021/acs.molpharmaceut.5c01076",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Johnson C, Maier E, Bhalla A, Crowell E, Wang Y, Qin B, Zhang F. Comparison of In-Vitro and In-Vivo Drug Release of Dexamethasone/PLGA Intravitreal Implants Using Two In-Vitro Release Methods and a Rabbit Model. Mol Pharm. 2025;22(12):7534-49",
    "leadAuthor": "Johnson C",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiABwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiABwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2921980501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707152
  },
  {
    "id": "DEXA_Synt_83712",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41151657",
    "title": "Mucus-penetrating archaeolipid nanocarriers delivering Thymus vulgaris essential oil and tobramycin: A multifunctional approach against Pseudomonas aeruginosa biofilms and inflammation.",
    "authors": [
      "Perez N",
      "Velurtas M",
      "Rivas Rojas PC",
      "Morilla MJ",
      "Romero EL",
      "Perez AP"
    ],
    "journal": "Eur J Pharm Biopharm",
    "publicationDate": "2025-10-29",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "e2364324-d468-47cd-a046-ccb22d584770",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.737Z"
      },
      {
        "id": "202c100c-740a-441b-9f99-e6b44f6c3dc3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 8e653404-7fbb-4f2f-94be-117835406f16 to DEXA_Synt_83712",
        "type": "system",
        "createdAt": "2025-12-14T10:12:32.516Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:51.735Z",
    "updatedAt": "2025-12-14T08:54:25.807Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41151657",
      "DOI": "https://doi.org10.1016/j.ejpb.2025.114906",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:19:50",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Perez N, Velurtas M, Rivas Rojas PC, Morilla MJ, Romero EL, Perez AP. Mucus-penetrating archaeolipid nanocarriers delivering Thymus vulgaris essential oil and tobramycin: A multifunctional approach against Pseudomonas aeruginosa biofilms and inflammation. Eur J Pharm Biopharm. 2025;217114906",
      "pubdate": "2025-10-29",
      "Lead_author": "Perez N",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ejpb.2025.114906",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Perez N, Velurtas M, Rivas Rojas PC, Morilla MJ, Romero EL, Perez AP. Mucus-penetrating archaeolipid nanocarriers delivering Thymus vulgaris essential oil and tobramycin: A multifunctional approach against Pseudomonas aeruginosa biofilms and inflammation. Eur J Pharm Biopharm. 2025;217114906",
    "leadAuthor": "Perez N",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiBBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiBBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2947ec0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707152
  },
  {
    "id": "DEXA_Synt_93279",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41107149",
    "title": "Association of peripheral nerve blocks with increased postoperative pain and opioid use in orthopaedic surgery. Comment on Br J Anaesth 2025; 135: 1286-96.",
    "authors": [
      "Edward R"
    ],
    "journal": "Br J Anaesth",
    "publicationDate": "2025-10-18",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "4c946a5d-a2f2-43e3-bc79-50b8faab3c1a",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.833Z"
      },
      {
        "id": "81c69c76-d49c-4b7a-a42a-a68e75e80b18",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a1b04733-3302-422f-a9cf-ec0c78a9ed3f to DEXA_Synt_93279",
        "type": "system",
        "createdAt": "2025-12-14T10:12:32.684Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:51.875Z",
    "updatedAt": "2025-12-14T08:54:25.846Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41107149",
      "DOI": "https://doi.org10.1016/j.bja.2025.09.010",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:20:05",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Edward R. Association of peripheral nerve blocks with increased postoperative pain and opioid use in orthopaedic surgery. Comment on Br J Anaesth 2025; 135: 1286-96. Br J Anaesth. 2025;135(6):1860-",
      "pubdate": "2025-10-18",
      "Lead_author": "Edward R",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.bja.2025.09.010",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Edward R. Association of peripheral nerve blocks with increased postoperative pain and opioid use in orthopaedic surgery. Comment on Br J Anaesth 2025; 135: 1286-96. Br J Anaesth. 2025;135(6):1860-",
    "leadAuthor": "Edward R",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiCBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiCBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2969cc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707152
  },
  {
    "id": "DEXA_Synt_16913",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41106096",
    "title": "Cistanche deserticola extract and its active components, echinacoside, ameliorate sarcopenia by activating the IGF-1/PI3K-AKT pathway to modulate ferroptosis.",
    "authors": [
      "Wang X",
      "Zhu L",
      "Du R",
      "Li A",
      "Li N",
      "Liu X",
      "Zhang Y",
      "Liu X",
      "Wang Q",
      "Han C",
      "Qu C",
      "Zou W",
      "Liu J",
      "Wang Y"
    ],
    "journal": "Phytomedicine",
    "publicationDate": "2025-10-18",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "45bcb468-5ffb-4ff6-af43-6b19509fbb45",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.879Z"
      },
      {
        "id": "ce319c03-47d4-451b-bf6a-a120101e3eed",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3cc18892-17c5-418d-8b58-ad4c7e79b425 to DEXA_Synt_16913",
        "type": "system",
        "createdAt": "2025-12-14T10:12:32.899Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:51.984Z",
    "updatedAt": "2025-12-14T08:54:25.890Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41106096",
      "DOI": "https://doi.org10.1016/j.phymed.2025.157378",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:20:13",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Wang X, Zhu L, Du R, Li A, Li N, Liu X, Zhang Y, Liu X, Wang Q, Han C, Qu C, Zou W, Liu J, Wang Y. Cistanche deserticola extract and its active components, echinacoside, ameliorate sarcopenia by activating the IGF-1/PI3K-AKT pathway to modulate ferroptosis. Phytomedicine. 2025;148157378",
      "pubdate": "2025-10-18",
      "Lead_author": "Wang X",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.phymed.2025.157378",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Wang X, Zhu L, Du R, Li A, Li N, Liu X, Zhang Y, Liu X, Wang Q, Han C, Qu C, Zou W, Liu J, Wang Y. Cistanche deserticola extract and its active components, echinacoside, ameliorate sarcopenia by activating the IGF-1/PI3K-AKT pathway to modulate ferroptosis. Phytomedicine. 2025;148157378",
    "leadAuthor": "Wang X",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiDBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiDBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-298cc00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707152
  },
  {
    "id": "DEXA_Synt_70084",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41093003",
    "title": "Simple hyperinflammation scores predict mortality in hospitalized patients with COVID-19 and offer a personalized medicine approach to dexamethasone intervention.",
    "authors": [
      "Oppong AE",
      "Coelewij L",
      "Hutchinson M",
      "Carpenter B",
      "Robinson GA",
      "Liddle T",
      "Hawkins E",
      "Cox MF",
      "Ciurtin C",
      "Venkatachalam S",
      "Collin M",
      "Tattersall RS",
      "Ardern-Jones M",
      "Duncombe AS",
      "Jury EC",
      "Manson JJ"
    ],
    "journal": "Int J Infect Dis",
    "publicationDate": "2025-10-16",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "1aea96cd-c66c-4aeb-8c6a-1e5a05696464",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.908Z"
      },
      {
        "id": "fdd27d3a-d46c-4be2-85bc-d1f7670cead3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from e6de11f7-2a30-411e-b3c6-84b5014ff54e to DEXA_Synt_70084",
        "type": "system",
        "createdAt": "2025-12-14T10:12:33.117Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:52.158Z",
    "updatedAt": "2025-12-14T08:54:25.918Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41093003",
      "DOI": "https://doi.org10.1016/j.ijid.2025.108119",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:20:19",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Oppong AE, Coelewij L, Hutchinson M, Carpenter B, Robinson GA, Liddle T, Hawkins E, Cox MF, Ciurtin C, Venkatachalam S, Collin M, Tattersall RS, Ardern-Jones M, Duncombe AS, Jury EC, Manson JJ. Simple hyperinflammation scores predict mortality in hospitalized patients with COVID-19 and offer a personalized medicine approach to dexamethasone intervention. Int J Infect Dis. 2025;161108119",
      "pubdate": "2025-10-16",
      "Lead_author": "Oppong AE",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ijid.2025.108119",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Oppong AE, Coelewij L, Hutchinson M, Carpenter B, Robinson GA, Liddle T, Hawkins E, Cox MF, Ciurtin C, Venkatachalam S, Collin M, Tattersall RS, Ardern-Jones M, Duncombe AS, Jury EC, Manson JJ. Simple hyperinflammation scores predict mortality in hospitalized patients with COVID-19 and offer a personalized medicine approach to dexamethasone intervention. Int J Infect Dis. 2025;161108119",
    "leadAuthor": "Oppong AE",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiEBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiEBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-29b05c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707153
  },
  {
    "id": "DEXA_Synt_22815",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41092734",
    "title": "Corrigendum to \"Impact of polymer source variations on hydrogel structure and product performance in dexamethasone-loaded ophthalmic inserts\" [Int. J. Pharm. 682 (2025) 125959].",
    "authors": [
      "VandenBerg MA",
      "Zaman RU",
      "Plavchak CL",
      "Smith WC",
      "Nejad HB",
      "Beringhs AO",
      "Wang Y",
      "Xu X"
    ],
    "journal": "Int J Pharm",
    "publicationDate": "2025-10-16",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "db4f80df-e073-438a-a7e2-b81730f17bf6",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:25.939Z"
      },
      {
        "id": "23b8295a-9510-4941-ac5b-723b54cdc598",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 7bcade18-a214-40d6-b330-6603574b5312 to DEXA_Synt_22815",
        "type": "system",
        "createdAt": "2025-12-14T10:12:33.349Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:52.250Z",
    "updatedAt": "2025-12-14T08:54:25.989Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41092734",
      "DOI": "https://doi.org10.1016/j.ijpharm.2025.126268",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:19:58",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "VandenBerg MA, Zaman RU, Plavchak CL, Smith WC, Nejad HB, Beringhs AO, Wang Y, Xu X. Corrigendum to \"Impact of polymer source variations on hydrogel structure and product performance in dexamethasone-loaded ophthalmic inserts\" [Int. J. Pharm. 682 (2025) 125959]. Int J Pharm. 2025;685126268",
      "pubdate": "2025-10-16",
      "Lead_author": "VandenBerg MA",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ijpharm.2025.126268",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "VandenBerg MA, Zaman RU, Plavchak CL, Smith WC, Nejad HB, Beringhs AO, Wang Y, Xu X. Corrigendum to \"Impact of polymer source variations on hydrogel structure and product performance in dexamethasone-loaded ophthalmic inserts\" [Int. J. Pharm. 682 (2025) 125959]. Int J Pharm. 2025;685126268",
    "leadAuthor": "VandenBerg MA",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiFBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiFBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-29d3dc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707153
  },
  {
    "id": "DEXA_Synt_29902",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41027155",
    "title": "Mangiferin reverses high glucose-induced osteoblast damage and ameliorates osteoporosis by targeting SOX9.",
    "authors": [
      "Chen Z",
      "Chao S",
      "Fu Y",
      "Zhao R",
      "Shi X",
      "Li S",
      "Li Y",
      "Huang L",
      "Shao M",
      "Shi M",
      "Xia X",
      "Liu B"
    ],
    "journal": "Phytomedicine",
    "publicationDate": "2025-10-1",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6772d764-3dd5-44f9-b288-97401db0a719",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.016Z"
      },
      {
        "id": "9f53201c-ba08-4ce0-af76-51afd19b38cb",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9f07b323-996f-45bb-a480-fed8f8182906 to DEXA_Synt_29902",
        "type": "system",
        "createdAt": "2025-12-14T10:12:33.595Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:52.403Z",
    "updatedAt": "2025-12-14T08:54:26.024Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41027155",
      "DOI": "https://doi.org10.1016/j.phymed.2025.157295",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:20:27",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Chen Z, Chao S, Fu Y, Zhao R, Shi X, Li S, Li Y, Huang L, Shao M, Shi M, Xia X, Liu B. Mangiferin reverses high glucose-induced osteoblast damage and ameliorates osteoporosis by targeting SOX9. Phytomedicine. 2025;148157295",
      "pubdate": "2025-10-1",
      "Lead_author": "Chen Z",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.phymed.2025.157295",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Chen Z, Chao S, Fu Y, Zhao R, Shi X, Li S, Li Y, Huang L, Shao M, Shi M, Xia X, Liu B. Mangiferin reverses high glucose-induced osteoblast damage and ameliorates osteoporosis by targeting SOX9. Phytomedicine. 2025;148157295",
    "leadAuthor": "Chen Z",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiGBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiGBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-29f4ec0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707153
  },
  {
    "id": "DEXA_Synt_69524",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41025912",
    "title": "Intravitreal Sustained Release of Dexamethasone from a Self-Healing Injectable Hydrogel: An In Vivo Safety and Release Study.",
    "authors": [
      "Annala A",
      "Sadeghi A",
      "Toropainen E",
      "Valtari A",
      "Puranen J",
      "Paterno JJ",
      "Pirskanen L",
      "Vellonen KS",
      "Hennink WE",
      "Ruponen M",
      "Vermonden T",
      "Urtti A"
    ],
    "journal": "Mol Pharm",
    "publicationDate": "2025-09-30",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "3074f3e3-142b-4f85-b45e-83e5b5fd1ba1",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.048Z"
      },
      {
        "id": "4e4bbd44-0205-42ed-a0d8-3b94f4e24cb1",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 585337fb-560d-4d51-816f-fc39674d902e to DEXA_Synt_69524",
        "type": "system",
        "createdAt": "2025-12-14T10:12:33.828Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:52.511Z",
    "updatedAt": "2025-12-14T08:54:26.084Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41025912",
      "DOI": "https://doi.org10.1021/acs.molpharmaceut.5c00872",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:20:36",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Annala A, Sadeghi A, Toropainen E, Valtari A, Puranen J, Paterno JJ, Pirskanen L, Vellonen KS, Hennink WE, Ruponen M, Vermonden T, Urtti A. Intravitreal Sustained Release of Dexamethasone from a Self-Healing Injectable Hydrogel: An In Vivo Safety and Release Study. Mol Pharm. 2025;22(11):6920-31",
      "pubdate": "2025-09-30",
      "Lead_author": "Annala A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1021/acs.molpharmaceut.5c00872",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Annala A, Sadeghi A, Toropainen E, Valtari A, Puranen J, Paterno JJ, Pirskanen L, Vellonen KS, Hennink WE, Ruponen M, Vermonden T, Urtti A. Intravitreal Sustained Release of Dexamethasone from a Self-Healing Injectable Hydrogel: An In Vivo Safety and Release Study. Mol Pharm. 2025;22(11):6920-31",
    "leadAuthor": "Annala A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiHBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiHBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2a18300501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707153
  },
  {
    "id": "DEXA_Synt_21184",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41019490",
    "title": "Ceria nanoparticles guard against glucocorticoid induced bone homeostasis imbalance through the promotion of osteogenesis and inhibition of osteoclastogenesis.",
    "authors": [
      "Zhang A",
      "Liu Z",
      "Zou L",
      "Yang L",
      "Wu Y",
      "Wang X",
      "Cao D",
      "Liu J",
      "Yang X",
      "Zhang S"
    ],
    "journal": "Mater Today Bio",
    "publicationDate": "2025-09-29",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "c1a91f93-4a9c-4952-9b81-13363271a408",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.109Z"
      },
      {
        "id": "82519b85-2619-47f1-b483-74f26dfee385",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9f51f1a7-7d28-475b-a436-708848d3ba41 to DEXA_Synt_21184",
        "type": "system",
        "createdAt": "2025-12-14T10:12:34.046Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:52.666Z",
    "updatedAt": "2025-12-14T08:54:26.121Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41019490",
      "DOI": "https://doi.org10.1016/j.mtbio.2025.102308",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:20:56",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Zhang A, Liu Z, Zou L, Yang L, Wu Y, Wang X, Cao D, Liu J, Yang X, Zhang S. Ceria nanoparticles guard against glucocorticoid induced bone homeostasis imbalance through the promotion of osteogenesis and inhibition of osteoclastogenesis. Mater Today Bio. 2025;35102308",
      "pubdate": "2025-09-29",
      "Lead_author": "Zhang A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.mtbio.2025.102308",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Zhang A, Liu Z, Zou L, Yang L, Wu Y, Wang X, Cao D, Liu J, Yang X, Zhang S. Ceria nanoparticles guard against glucocorticoid induced bone homeostasis imbalance through the promotion of osteogenesis and inhibition of osteoclastogenesis. Mater Today Bio. 2025;35102308",
    "leadAuthor": "Zhang A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiIBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiIBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2a3bbc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707154
  },
  {
    "id": "DEXA_Synt_80102",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41005496",
    "title": "Artemisia annua L. extract alleviates glucocorticoid-induced osteoporosis by stimulating bone formation via PGC-1α/Nrf2/HO-1/SOD2 pathway.",
    "authors": [
      "Lai L",
      "Li K",
      "Ding L",
      "Zhu R",
      "Jiang Y",
      "Xia T",
      "Yue X",
      "Xin H"
    ],
    "journal": "Fitoterapia",
    "publicationDate": "2025-09-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b2149fa5-dc7b-4cf8-9c73-af645cb8acd1",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.137Z"
      },
      {
        "id": "2473f829-8890-413c-8aff-5e65a152198d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from b58f76af-38f7-4f0d-add2-9820ce9c1822 to DEXA_Synt_80102",
        "type": "system",
        "createdAt": "2025-12-14T10:12:34.276Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:52.774Z",
    "updatedAt": "2025-12-14T08:54:26.189Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41005496",
      "DOI": "https://doi.org10.1016/j.fitote.2025.106892",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:20:42",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Lai L, Li K, Ding L, Zhu R, Jiang Y, Xia T, Yue X, Xin H. Artemisia annua L. extract alleviates glucocorticoid-induced osteoporosis by stimulating bone formation via PGC-1α/Nrf2/HO-1/SOD2 pathway. Fitoterapia. 2025;187106892",
      "pubdate": "2025-09-27",
      "Lead_author": "Lai L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.fitote.2025.106892",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Lai L, Li K, Ding L, Zhu R, Jiang Y, Xia T, Yue X, Xin H. Artemisia annua L. extract alleviates glucocorticoid-induced osteoporosis by stimulating bone formation via PGC-1α/Nrf2/HO-1/SOD2 pathway. Fitoterapia. 2025;187106892",
    "leadAuthor": "Lai L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiJBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiJBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2a5ca40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707154
  },
  {
    "id": "DEXA_Synt_70467",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40995111",
    "title": "Core-shell engineered Col/Cs@ECM microspheres for macrophage-targeted intracellular drug release in RA therapy.",
    "authors": [
      "Duan X",
      "Hu K",
      "Wang J",
      "Wang X",
      "Long X",
      "Lin W",
      "Wu C",
      "Weng W",
      "Song Z",
      "Cheng K"
    ],
    "journal": "Bioact Mater",
    "publicationDate": "2025-09-25",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "4785268d-438e-4fce-9196-9a06a6ac0e99",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.214Z"
      },
      {
        "id": "7c26a5b3-d0c7-44cf-a6ff-9c0477c0f69b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 4f01fb3b-c68e-4986-b321-70e8cdd6b73d to DEXA_Synt_70467",
        "type": "system",
        "createdAt": "2025-12-14T10:12:34.507Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:52.915Z",
    "updatedAt": "2025-12-14T08:54:26.228Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40995111",
      "DOI": "https://doi.org10.1016/j.bioactmat.2025.08.043",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:20:49",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Duan X, Hu K, Wang J, Wang X, Long X, Lin W, Wu C, Weng W, Song Z, Cheng K. Core-shell engineered Col/Cs@ECM microspheres for macrophage-targeted intracellular drug release in RA therapy. Bioact Mater. 2025;54715-29",
      "pubdate": "2025-09-25",
      "Lead_author": "Duan X",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.bioactmat.2025.08.043",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Duan X, Hu K, Wang J, Wang X, Long X, Lin W, Wu C, Weng W, Song Z, Cheng K. Core-shell engineered Col/Cs@ECM microspheres for macrophage-targeted intracellular drug release in RA therapy. Bioact Mater. 2025;54715-29",
    "leadAuthor": "Duan X",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiKBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiKBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2a7d0c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707154
  },
  {
    "id": "DEXA_Synt_24801",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40992487",
    "title": "Constitutive expression of cardiomyocyte Klf9 precipitates metabolic dysfunction and spontaneous cardiomyopathy.",
    "authors": [
      "Thakkar C",
      "Alikunju S",
      "Venkatasubramanian A",
      "D'Mello D",
      "Abbas H",
      "Yang Z",
      "Andreas I",
      "Sayed N",
      "Abdellatif M",
      "Sayed D"
    ],
    "journal": "Cell Signal",
    "publicationDate": "2025-09-25",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "c7907da1-25a7-4740-a3e6-f8138dc52029",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.244Z"
      },
      {
        "id": "78feddd8-5b23-477c-a50f-d348cd22892a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 8cf7e30f-6add-4540-ab6e-322ddabdc1aa to DEXA_Synt_24801",
        "type": "system",
        "createdAt": "2025-12-14T10:12:34.768Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:53.057Z",
    "updatedAt": "2025-12-14T08:54:26.279Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40992487",
      "DOI": "https://doi.org10.1016/j.cellsig.2025.112146",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:21:04",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Thakkar C, Alikunju S, Venkatasubramanian A, D'Mello D, Abbas H, Yang Z, Andreas I, Sayed N, Abdellatif M, Sayed D. Constitutive expression of cardiomyocyte Klf9 precipitates metabolic dysfunction and spontaneous cardiomyopathy. Cell Signal. 2025;136112146",
      "pubdate": "2025-09-25",
      "Lead_author": "Thakkar C",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.cellsig.2025.112146",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Thakkar C, Alikunju S, Venkatasubramanian A, D'Mello D, Abbas H, Yang Z, Andreas I, Sayed N, Abdellatif M, Sayed D. Constitutive expression of cardiomyocyte Klf9 precipitates metabolic dysfunction and spontaneous cardiomyopathy. Cell Signal. 2025;136112146",
    "leadAuthor": "Thakkar C",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiLBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiLBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2a9fc80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707154
  },
  {
    "id": "DEXA_Synt_78415",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40905264",
    "title": "Opioid Management in the Setting of Enhanced Recovery After Surgery (ERAS) Protocols.",
    "authors": [
      "Seitz V",
      "Tighe K",
      "Davidson ERW"
    ],
    "journal": "Clin Obstet Gynecol",
    "publicationDate": "2025-09-4",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5a3acbaa-03a0-4205-9c13-6abeda765d3d",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.306Z"
      },
      {
        "id": "ad4c117e-1d27-47e8-9253-7208f2ae1878",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 298bd8c8-2141-4c0c-9df0-4ab3a157d226 to DEXA_Synt_78415",
        "type": "system",
        "createdAt": "2025-12-14T10:12:34.967Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:53.161Z",
    "updatedAt": "2025-12-14T08:54:26.317Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40905264",
      "DOI": "https://doi.org10.1097/GRF.0000000000000965",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:21:33",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Seitz V, Tighe K, Davidson ERW. Opioid Management in the Setting of Enhanced Recovery After Surgery (ERAS) Protocols. Clin Obstet Gynecol. 2025;68(4):508-15",
      "pubdate": "2025-09-4",
      "Lead_author": "Seitz V",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/GRF.0000000000000965",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Seitz V, Tighe K, Davidson ERW. Opioid Management in the Setting of Enhanced Recovery After Surgery (ERAS) Protocols. Clin Obstet Gynecol. 2025;68(4):508-15",
    "leadAuthor": "Seitz V",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiMBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiMBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2ac3ec0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707155
  },
  {
    "id": "DEXA_Synt_37880",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40900396",
    "title": "Human Mesenchymal Stem Cell-Derived Skeletal Muscle Cell Spheroids for Treating Dexamethasone-Induced Sarcopenia.",
    "authors": [
      "Yum Y",
      "Yoon J",
      "Nam YH",
      "Kang DH",
      "Jung SC",
      "Park S"
    ],
    "journal": "Tissue Eng Regen Med",
    "publicationDate": "2025-09-3",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "011b0780-79b3-4658-a935-d623ac9d3ddd",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.335Z"
      },
      {
        "id": "d2a6b89d-9455-431b-b789-3c97fd23eab7",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from c28e49e2-400d-4d27-bf93-3e1f10dca3e5 to DEXA_Synt_37880",
        "type": "system",
        "createdAt": "2025-12-14T10:12:35.184Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:53.348Z",
    "updatedAt": "2025-12-14T08:54:26.387Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40900396",
      "DOI": "https://doi.org10.1007/s13770-025-00753-6",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:21:26",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Yum Y, Yoon J, Nam YH, Kang DH, Jung SC, Park S. Human Mesenchymal Stem Cell-Derived Skeletal Muscle Cell Spheroids for Treating Dexamethasone-Induced Sarcopenia. Tissue Eng Regen Med. 2025;22(8):1159-72",
      "pubdate": "2025-09-3",
      "Lead_author": "Yum Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s13770-025-00753-6",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Yum Y, Yoon J, Nam YH, Kang DH, Jung SC, Park S. Human Mesenchymal Stem Cell-Derived Skeletal Muscle Cell Spheroids for Treating Dexamethasone-Induced Sarcopenia. Tissue Eng Regen Med. 2025;22(8):1159-72",
    "leadAuthor": "Yum Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiNBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiNBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2ae4e00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707155
  },
  {
    "id": "DEXA_Synt_30364",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40895369",
    "title": "Perineural dexamethasone enhances analgesic duration of erector spinae plane block in total hip arthroplasty: A randomized quadruple-blind controlled trial.",
    "authors": [
      "Reysner T",
      "Pietraszek P",
      "Purat T",
      "Kowalski G",
      "Mularski A",
      "Daroszewski P",
      "Reysner M"
    ],
    "journal": "J Orthop",
    "publicationDate": "2025-09-2",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "47387977-8395-436f-89f8-41fb673b4112",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.416Z"
      },
      {
        "id": "2c22236a-a45a-4216-8f9b-1128ea42baa7",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 8d967a2f-848b-42d9-8bb0-a4e5623a46fa to DEXA_Synt_30364",
        "type": "system",
        "createdAt": "2025-12-14T10:12:35.407Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:53.411Z",
    "updatedAt": "2025-12-14T08:54:26.428Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40895369",
      "DOI": "https://doi.org10.1016/j.jor.2025.08.033",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:21:12",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Reysner T, Pietraszek P, Purat T, Kowalski G, Mularski A, Daroszewski P, Reysner M. Perineural dexamethasone enhances analgesic duration of erector spinae plane block in total hip arthroplasty: A randomized quadruple-blind controlled trial. J Orthop. 2025;70263-9",
      "pubdate": "2025-09-2",
      "Lead_author": "Reysner T",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jor.2025.08.033",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Reysner T, Pietraszek P, Purat T, Kowalski G, Mularski A, Daroszewski P, Reysner M. Perineural dexamethasone enhances analgesic duration of erector spinae plane block in total hip arthroplasty: A randomized quadruple-blind controlled trial. J Orthop. 2025;70263-9",
    "leadAuthor": "Reysner T",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiOBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiOBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2b08c80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707155
  },
  {
    "id": "DEXA_Synt_81433",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40895345",
    "title": "Development of 3D printed dexamethasone chewable tablets for prophylaxis of chemotherapy-induced nausea and vomiting in children.",
    "authors": [
      "Dadkhah A",
      "Gutowski T",
      "Wansing EM",
      "von Hugo A",
      "Woessmann W",
      "Winkler B",
      "Franke G",
      "Baehr M",
      "Langebrake C"
    ],
    "journal": "Int J Pharm X",
    "publicationDate": "2025-09-2",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "c17e089e-35b4-4911-bb6c-72958946b694",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.459Z"
      },
      {
        "id": "bc244b49-0eb9-4cf0-986e-a29d8602c780",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6614dddf-ee0d-4295-8f62-2398dd02f226 to DEXA_Synt_81433",
        "type": "system",
        "createdAt": "2025-12-14T10:12:35.622Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:53.613Z",
    "updatedAt": "2025-12-14T08:54:26.470Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40895345",
      "DOI": "https://doi.org10.1016/j.ijpx.2025.100380",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:21:19",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Dadkhah A, Gutowski T, Wansing EM, von Hugo A, Woessmann W, Winkler B, Franke G, Baehr M, Langebrake C. Development of 3D printed dexamethasone chewable tablets for prophylaxis of chemotherapy-induced nausea and vomiting in children. Int J Pharm X. 2025;10100380",
      "pubdate": "2025-09-2",
      "Lead_author": "Dadkhah A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ijpx.2025.100380",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Dadkhah A, Gutowski T, Wansing EM, von Hugo A, Woessmann W, Winkler B, Franke G, Baehr M, Langebrake C. Development of 3D printed dexamethasone chewable tablets for prophylaxis of chemotherapy-induced nausea and vomiting in children. Int J Pharm X. 2025;10100380",
    "leadAuthor": "Dadkhah A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiPBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiPBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2b29ec0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707155
  },
  {
    "id": "DEXA_Synt_54988",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40816648",
    "title": "Ferulic acid attenuates Sarcopenia progression by inhibiting peroxisomal ACOX1.",
    "authors": [
      "He Y",
      "Tan Y",
      "Song Z",
      "Chen Y"
    ],
    "journal": "Free Radic Biol Med",
    "publicationDate": "2025-08-16",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "13bcb4da-9c77-4b76-913d-4cc12c8f2c9e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.491Z"
      },
      {
        "id": "d1e36ca7-fdaf-4211-baff-09b8ffc933e2",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 481009ce-8b98-41de-aaff-3d8f68731ebc to DEXA_Synt_54988",
        "type": "system",
        "createdAt": "2025-12-14T10:12:35.854Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:53.649Z",
    "updatedAt": "2025-12-14T08:54:26.527Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40816648",
      "DOI": "https://doi.org10.1016/j.freeradbiomed.2025.08.025",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:21:41",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "He Y, Tan Y, Song Z, Chen Y. Ferulic acid attenuates Sarcopenia progression by inhibiting peroxisomal ACOX1. Free Radic Biol Med. 2025;240183-96",
      "pubdate": "2025-08-16",
      "Lead_author": "He Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.freeradbiomed.2025.08.025",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "He Y, Tan Y, Song Z, Chen Y. Ferulic acid attenuates Sarcopenia progression by inhibiting peroxisomal ACOX1. Free Radic Biol Med. 2025;240183-96",
    "leadAuthor": "He Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiQBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiQBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2b4d680501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707155
  },
  {
    "id": "DEXA_Synt_44875",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40772317",
    "title": "Treatment-free survival to bortezomib combined with dexamethasone in patients with refractory/relapsed pure red cell aplasia: a prospective clinical study.",
    "authors": [
      "Zhang L",
      "Shen Y",
      "Li R",
      "Pan H",
      "Gao Z",
      "Li W",
      "Zhao J",
      "Liang Q",
      "Fang L",
      "Shi J"
    ],
    "journal": "Ann Med",
    "publicationDate": "2025-08-7",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "d96543db-40c0-4710-b4a1-d23ccf7f453a",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.553Z"
      },
      {
        "id": "99651a17-f2e5-423f-a831-0c7c9f7382a2",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 013b2a4e-0b22-4e35-9768-131fca6f7df6 to DEXA_Synt_44875",
        "type": "system",
        "createdAt": "2025-12-14T10:12:36.073Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:53.858Z",
    "updatedAt": "2025-12-14T08:54:26.564Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40772317",
      "DOI": "https://doi.org10.1080/07853890.2025.2540016",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:21:57",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Zhang L, Shen Y, Li R, Pan H, Gao Z, Li W, Zhao J, Liang Q, Fang L, Shi J. Treatment-free survival to bortezomib combined with dexamethasone in patients with refractory/relapsed pure red cell aplasia: a prospective clinical study. Ann Med. 2025;57(1):2540016",
      "pubdate": "2025-08-7",
      "Lead_author": "Zhang L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/07853890.2025.2540016",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Zhang L, Shen Y, Li R, Pan H, Gao Z, Li W, Zhao J, Liang Q, Fang L, Shi J. Treatment-free survival to bortezomib combined with dexamethasone in patients with refractory/relapsed pure red cell aplasia: a prospective clinical study. Ann Med. 2025;57(1):2540016",
    "leadAuthor": "Zhang L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiRBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiRBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2b6eec0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707156
  },
  {
    "id": "DEXA_Synt_28501",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40760333",
    "title": "[Positron emission tomography-negative hemophagocytic lymphohistiocytosis in two patients with aggressive B-cell lymphoma].",
    "authors": [
      "Migaud P",
      "Hosmann K",
      "Müller M",
      "Ingold-Heppner B",
      "Stocker H"
    ],
    "journal": "Inn Med (Heidelb)",
    "publicationDate": "2025-08-5",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "74bba979-86b5-444d-be02-a6e499e7ffcb",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.582Z"
      },
      {
        "id": "a8b76697-329a-4445-a35b-ef613f4d7503",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 07e71678-bf93-4466-9262-60e95c1ff74c to DEXA_Synt_28501",
        "type": "system",
        "createdAt": "2025-12-14T10:12:36.306Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:53.940Z",
    "updatedAt": "2025-12-14T08:54:26.633Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40760333",
      "DOI": "https://doi.org10.1007/s00108-025-01957-7",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:22:04",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Migaud P, Hosmann K, Müller M, Ingold-Heppner B, Stocker H. [Positron emission tomography-negative hemophagocytic lymphohistiocytosis in two patients with aggressive B-cell lymphoma]. Inn Med (Heidelb). 2025;66(12):1311-",
      "pubdate": "2025-08-5",
      "Lead_author": "Migaud P",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s00108-025-01957-7",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Migaud P, Hosmann K, Müller M, Ingold-Heppner B, Stocker H. [Positron emission tomography-negative hemophagocytic lymphohistiocytosis in two patients with aggressive B-cell lymphoma]. Inn Med (Heidelb). 2025;66(12):1311-",
    "leadAuthor": "Migaud P",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiSBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiSBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2b8fe80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707156
  },
  {
    "id": "DEXA_Synt_37069",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40759602",
    "title": "Corticosteroid insensitivity in asthma associated with obstructive sleep apnoea: Role of oxidative stress and histone acetylation.",
    "authors": [
      "Lo CY",
      "Wang CH",
      "Lin CY",
      "Lin TY",
      "Chang PJ",
      "Lo YL",
      "Wang TY",
      "Huang TT",
      "He JR",
      "Heh CC",
      "Luo HR",
      "Chuang LP",
      "Lin SW",
      "Chen NH",
      "Lin SM",
      "Lin HC",
      "Chung KF"
    ],
    "journal": "Br J Pharmacol",
    "publicationDate": "2025-08-5",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "3c6427bf-3b64-4294-b2d0-fb4381fc1894",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.661Z"
      },
      {
        "id": "3dad35c1-1a7d-4103-ae89-e1acfc15d04b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 142bcc96-2d60-468b-9daa-318e544a532a to DEXA_Synt_37069",
        "type": "system",
        "createdAt": "2025-12-14T10:12:36.521Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:54.106Z",
    "updatedAt": "2025-12-14T08:54:26.674Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40759602",
      "DOI": "https://doi.org10.1111/bph.70157",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:21:50",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Lo CY, Wang CH, Lin CY, Lin TY, Chang PJ, Lo YL, Wang TY, Huang TT, He JR, Heh CC, Luo HR, Chuang LP, Lin SW, Chen NH, Lin SM, Lin HC, Chung KF. Corticosteroid insensitivity in asthma associated with obstructive sleep apnoea: Role of oxidative stress and histone acetylation. Br J Pharmacol. 2025;182(23):5790-802",
      "pubdate": "2025-08-5",
      "Lead_author": "Lo CY",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/bph.70157",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Lo CY, Wang CH, Lin CY, Lin TY, Chang PJ, Lo YL, Wang TY, Huang TT, He JR, Heh CC, Luo HR, Chuang LP, Lin SW, Chen NH, Lin SM, Lin HC, Chung KF. Corticosteroid insensitivity in asthma associated with obstructive sleep apnoea: Role of oxidative stress and histone acetylation. Br J Pharmacol. 2025;182(23):5790-802",
    "leadAuthor": "Lo CY",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiTBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiTBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2bb5800501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707156
  },
  {
    "id": "DEXA_Synt_89241",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40745864",
    "title": "A Hybrid Design Incorporating External Data to Evaluate Dexamethasone Intracameral Drug Delivery Suspension for Post-Cataract Surgery Inflammation.",
    "authors": [
      "Zhao Y",
      "Chen K",
      "Zhou J",
      "Zhao J",
      "Zhang D",
      "Wan J",
      "Yuan W",
      "Chen X",
      "Tan M",
      "Cui F",
      "Chow SC",
      "Wu Y"
    ],
    "journal": "Clin Pharmacol Ther",
    "publicationDate": "2025-08-1",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "965786a0-1f89-47b2-acd7-0f7322ec453f",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.705Z"
      },
      {
        "id": "e2cb4f69-92a4-4c3b-8ccf-f139439e22b2",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from ddd2159d-5cc9-499e-adab-2e5b530fffb4 to DEXA_Synt_89241",
        "type": "system",
        "createdAt": "2025-12-14T10:12:36.752Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:54.204Z",
    "updatedAt": "2025-12-14T08:54:26.718Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40745864",
      "DOI": "https://doi.org10.1002/cpt.70010",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:22:11",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Zhao Y, Chen K, Zhou J, Zhao J, Zhang D, Wan J, Yuan W, Chen X, Tan M, Cui F, Chow SC, Wu Y. A Hybrid Design Incorporating External Data to Evaluate Dexamethasone Intracameral Drug Delivery Suspension for Post-Cataract Surgery Inflammation. Clin Pharmacol Ther. 2025;118(6):1523-31",
      "pubdate": "2025-08-1",
      "Lead_author": "Zhao Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/cpt.70010",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Zhao Y, Chen K, Zhou J, Zhao J, Zhang D, Wan J, Yuan W, Chen X, Tan M, Cui F, Chow SC, Wu Y. A Hybrid Design Incorporating External Data to Evaluate Dexamethasone Intracameral Drug Delivery Suspension for Post-Cataract Surgery Inflammation. Clin Pharmacol Ther. 2025;118(6):1523-31",
    "leadAuthor": "Zhao Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiUBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiUBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2bd8cc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707156
  },
  {
    "id": "DEXA_Synt_74241",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40727959",
    "title": "Comparing the pericapsular nerve group block and fascia iliaca block for acute pain management in patients with hip fracture: a randomised clinical trial.",
    "authors": [
      "Di Pietro S",
      "Maffeis R",
      "Jannelli E",
      "Mascia B",
      "Resta F",
      "De Silvestri A",
      "Musella V",
      "Centurioni CE",
      "Regeni E",
      "Grassi FA",
      "Locatelli A",
      "Perlini S"
    ],
    "journal": "Anaesthesia",
    "publicationDate": "2025-07-29",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6b0f116a-37e0-4b5a-8033-8e585f896cd5",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.735Z"
      },
      {
        "id": "b64b5353-06f3-4aa1-a4eb-cb9f8152ce20",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 75cb6154-49cb-4cc8-aa49-a0f5e6b1a2de to DEXA_Synt_74241",
        "type": "system",
        "createdAt": "2025-12-14T10:12:36.984Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:54.373Z",
    "updatedAt": "2025-12-14T08:54:26.802Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40727959",
      "DOI": "https://doi.org10.1111/anae.16695",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:22:25",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Di Pietro S, Maffeis R, Jannelli E, Mascia B, Resta F, De Silvestri A, Musella V, Centurioni CE, Regeni E, Grassi FA, Locatelli A, Perlini S, . Comparing the pericapsular nerve group block and fascia iliaca block for acute pain management in patients with hip fracture: a randomised clinical trial. Anaesthesia. 2025;80(12):1484-92",
      "pubdate": "2025-07-29",
      "Lead_author": "Di Pietro S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/anae.16695",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Di Pietro S, Maffeis R, Jannelli E, Mascia B, Resta F, De Silvestri A, Musella V, Centurioni CE, Regeni E, Grassi FA, Locatelli A, Perlini S, . Comparing the pericapsular nerve group block and fascia iliaca block for acute pain management in patients with hip fracture: a randomised clinical trial. Anaesthesia. 2025;80(12):1484-92",
    "leadAuthor": "Di Pietro S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiVBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiVBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2bfc300501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707157
  },
  {
    "id": "DEXA_Synt_57016",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40609543",
    "title": "Therapeutic radiation drives leptomeningeal dissemination of medulloblastoma through an innate immune process.",
    "authors": [
      "Nör C",
      "Kharas K",
      "Rasnitsyn A",
      "Vladoiu MC",
      "Cho NW",
      "Young JS",
      "Nör F",
      "Mankahla N",
      "Haapasalo J",
      "Nordfors K",
      "Rapic S",
      "Skowron P",
      "Suárez RA",
      "Bahcheli AT",
      "Ocsenas O",
      "Chen X",
      "Bahrampour S",
      "Momin A",
      "Sundaresan L",
      "Ong W",
      "Hendrikse LD",
      "Abeysundara N",
      "Juraschka K",
      "Ly M",
      "Pallota JG",
      "Douglas T",
      "Huang N",
      "Wang H",
      "Mak E",
      "Qin L",
      "Liu J",
      "Shen L",
      "Luu B",
      "Manno A",
      "Kumar SA",
      "Donovan LK",
      "Fong V",
      "Richman C",
      "Daniels C",
      "Garzia L",
      "Rich JN",
      "Hawkins C",
      "Wu X",
      "DaCosta R",
      "Reimand J",
      "Huang X",
      "Ramaswamy V",
      "Raleigh DR",
      "Taylor MD"
    ],
    "journal": "2025;60(21):2880-2896",
    "publicationDate": "2025-07-4",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "800af7ac-31e6-4b05-9aa4-0166a0d09892",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.827Z"
      },
      {
        "id": "a1118cc2-1635-4a51-adb6-a1cafa54df52",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d0bff988-91ba-4562-926b-a6acabac66e4 to DEXA_Synt_57016",
        "type": "system",
        "createdAt": "2025-12-14T10:12:37.213Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:54.468Z",
    "updatedAt": "2025-12-14T08:54:26.840Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40609543",
      "DOI": "https://doi.org10.1016/j.devcel.2025.06.016",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:22:18",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Nör C, Kharas K, Rasnitsyn A, Vladoiu MC, Cho NW, Young JS, Nör F, Mankahla N, Haapasalo J, Nordfors K, Rapic S, Skowron P, Suárez RA, Bahcheli AT, Ocsenas O, Chen X, Bahrampour S, Momin A, Sundaresan L, Ong W, Hendrikse LD, Abeysundara N, Juraschka K, Ly M, Pallota JG, Douglas T, Huang N, Wang H, Mak E, Qin L, Liu J, Shen L, Luu B, Manno A, Kumar SA, Donovan LK, Fong V, Richman C, Daniels C, Garzia L, Rich JN, Hawkins C, Wu X, DaCosta R, Reimand J, Huang X, Ramaswamy V, Raleigh DR, Taylor MD. Therapeutic radiation drives leptomeningeal dissemination of medulloblastoma through an innate immune process. Dev Cell. 2025;60(21):2880-2896.e7",
      "pubdate": "2025-07-4",
      "Lead_author": "Nör C",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.devcel.2025.06.016",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Nör C, Kharas K, Rasnitsyn A, Vladoiu MC, Cho NW, Young JS, Nör F, Mankahla N, Haapasalo J, Nordfors K, Rapic S, Skowron P, Suárez RA, Bahcheli AT, Ocsenas O, Chen X, Bahrampour S, Momin A, Sundaresan L, Ong W, Hendrikse LD, Abeysundara N, Juraschka K, Ly M, Pallota JG, Douglas T, Huang N, Wang H, Mak E, Qin L, Liu J, Shen L, Luu B, Manno A, Kumar SA, Donovan LK, Fong V, Richman C, Daniels C, Garzia L, Rich JN, Hawkins C, Wu X, DaCosta R, Reimand J, Huang X, Ramaswamy V, Raleigh DR, Taylor MD. Therapeutic radiation drives leptomeningeal dissemination of medulloblastoma through an innate immune process. Dev Cell. 2025;60(21):2880-2896.e7",
    "leadAuthor": "Nör C",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiWBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiWBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2c1cec0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707157
  },
  {
    "id": "DEXA_Synt_48735",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40476595",
    "title": "Repurposing Acebutolol for Osteoporosis Treatment: Insights From Multi-Omics and Multi-Modal Data Analysis.",
    "authors": [
      "Liu DY",
      "Shen H",
      "Greenbaum J",
      "Yi QR",
      "Liang S",
      "Zhang Y",
      "Liu JC",
      "Qiu C",
      "Zhao LJ",
      "Tian Q",
      "Su KJ",
      "Luo Z",
      "Wu L",
      "Meng XH",
      "Xiao HM",
      "Deng Y",
      "Li Y",
      "Lovre D",
      "Fonseca V",
      "Sanchez FL",
      "Tan LJ",
      "Deng HW"
    ],
    "journal": "Clin Pharmacol Ther",
    "publicationDate": "2025-06-6",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "030dc0fe-1173-4769-beb9-05d50cfd00fd",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.873Z"
      },
      {
        "id": "6245895c-3081-4a73-a973-4c39c34c725d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a6167cec-ffd4-4a68-9aa2-ff9d7a6abd32 to DEXA_Synt_48735",
        "type": "system",
        "createdAt": "2025-12-14T10:12:37.476Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:54.686Z",
    "updatedAt": "2025-12-14T08:54:26.885Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40476595",
      "DOI": "https://doi.org10.1002/cpt.3738",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:22:40",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Liu DY, Shen H, Greenbaum J, Yi QR, Liang S, Zhang Y, Liu JC, Qiu C, Zhao LJ, Tian Q, Su KJ, Luo Z, Wu L, Meng XH, Xiao HM, Deng Y, Li Y, Lovre D, Fonseca V, Sanchez FL, Tan LJ, Deng HW. Repurposing Acebutolol for Osteoporosis Treatment: Insights From Multi-Omics and Multi-Modal Data Analysis. Clin Pharmacol Ther. 2025;118(6):1463-76",
      "pubdate": "2025-06-6",
      "Lead_author": "Liu DY",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/cpt.3738",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Liu DY, Shen H, Greenbaum J, Yi QR, Liang S, Zhang Y, Liu JC, Qiu C, Zhao LJ, Tian Q, Su KJ, Luo Z, Wu L, Meng XH, Xiao HM, Deng Y, Li Y, Lovre D, Fonseca V, Sanchez FL, Tan LJ, Deng HW. Repurposing Acebutolol for Osteoporosis Treatment: Insights From Multi-Omics and Multi-Modal Data Analysis. Clin Pharmacol Ther. 2025;118(6):1463-76",
    "leadAuthor": "Liu DY",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiXBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiXBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2c42780501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707157
  },
  {
    "id": "DEXA_Synt_38579",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40454579",
    "title": "Antenatal dexamethasone for late preterm delivery: Rate of complete course and neonatal outcomes.",
    "authors": [
      "Srisakulpanich P",
      "Talungchit P",
      "Panchalee T",
      "Yaiyiam C"
    ],
    "journal": "Int J Gynaecol Obstet",
    "publicationDate": "2025-06-2",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "227227d1-f321-4e08-b192-b3e7c5722ff9",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.902Z"
      },
      {
        "id": "a32b6e02-23a2-48a1-aa8b-ad1d1db04485",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 8cf67bd0-e9c5-4d2f-a6be-80acf62b8bcd to DEXA_Synt_38579",
        "type": "system",
        "createdAt": "2025-12-14T10:12:37.723Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:54.722Z",
    "updatedAt": "2025-12-14T08:54:26.912Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40454579",
      "DOI": "https://doi.org10.1002/ijgo.70266",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:22:33",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Srisakulpanich P, Talungchit P, Panchalee T, Yaiyiam C. Antenatal dexamethasone for late preterm delivery: Rate of complete course and neonatal outcomes. Int J Gynaecol Obstet. 2025;171(3):1180-",
      "pubdate": "2025-06-2",
      "Lead_author": "Srisakulpanich P",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/ijgo.70266",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Srisakulpanich P, Talungchit P, Panchalee T, Yaiyiam C. Antenatal dexamethasone for late preterm delivery: Rate of complete course and neonatal outcomes. Int J Gynaecol Obstet. 2025;171(3):1180-",
    "leadAuthor": "Srisakulpanich P",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiYBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiYBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2c62700501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707157
  },
  {
    "id": "DEXA_Synt_88432",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40420232",
    "title": "The Double-Blind Placebo-Controlled Study Comparing Upfront and Subsequent Netupitant in Addition to Olanzapine-Containing Regimen for Prevention of High-Dose Cisplatin-Induced Nausea/Vomiting.",
    "authors": [
      "Vinayanuwattikun C",
      "Lertanansit C",
      "Mahaparn W",
      "Chotirut A",
      "Zungsontiporn N",
      "Uttamapinan S",
      "Sintawichai N",
      "Sitthideatphaiboon P",
      "Sriuranpong V",
      "Tanasanvimon S"
    ],
    "journal": "Asia Pac J Clin Oncol",
    "publicationDate": "2025-05-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5980fd37-212b-461b-862b-9ed16f80c8c6",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:26.934Z"
      },
      {
        "id": "afcc026e-91e2-4281-a074-9817f01bfd33",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from fb5fd5d8-f656-40df-af9f-946f35fc5227 to DEXA_Synt_88432",
        "type": "system",
        "createdAt": "2025-12-14T10:12:37.970Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:54.933Z",
    "updatedAt": "2025-12-14T08:54:26.983Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40420232",
      "DOI": "https://doi.org10.1111/ajco.14192",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:22:54",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Vinayanuwattikun C, Lertanansit C, Mahaparn W, Chotirut A, Zungsontiporn N, Uttamapinan S, Sintawichai N, Sitthideatphaiboon P, Sriuranpong V, Tanasanvimon S. The Double-Blind Placebo-Controlled Study Comparing Upfront and Subsequent Netupitant in Addition to Olanzapine-Containing Regimen for Prevention of High-Dose Cisplatin-Induced Nausea/Vomiting. Asia Pac J Clin Oncol. 2025;21(6):631-8",
      "pubdate": "2025-05-27",
      "Lead_author": "Vinayanuwattikun C",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/ajco.14192",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Vinayanuwattikun C, Lertanansit C, Mahaparn W, Chotirut A, Zungsontiporn N, Uttamapinan S, Sintawichai N, Sitthideatphaiboon P, Sriuranpong V, Tanasanvimon S. The Double-Blind Placebo-Controlled Study Comparing Upfront and Subsequent Netupitant in Addition to Olanzapine-Containing Regimen for Prevention of High-Dose Cisplatin-Induced Nausea/Vomiting. Asia Pac J Clin Oncol. 2025;21(6):631-8",
    "leadAuthor": "Vinayanuwattikun C",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiZBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiZBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2c885c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707157
  },
  {
    "id": "DEXA_Synt_79534",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40414820",
    "title": "Evaluation of fetal outcomes in dichorionic diamniotic twins with hypertensive disorders during pregnancy by the fetal middle cerebral artery and umbilical artery doppler.",
    "authors": [
      "Liu LL",
      "Xu HH",
      "Lin X"
    ],
    "journal": "J Matern Fetal Neonatal Med",
    "publicationDate": "2025-05-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "03e1de49-152b-4d66-bf65-f888be730663",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.010Z"
      },
      {
        "id": "6a2ce1a8-a76b-41ba-a627-3f1c6e0a53d7",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 0a387d85-e0c1-4ff9-8902-c6d78efca644 to DEXA_Synt_79534",
        "type": "system",
        "createdAt": "2025-12-14T10:12:38.169Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:54.975Z",
    "updatedAt": "2025-12-14T08:54:27.021Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40414820",
      "DOI": "https://doi.org10.1080/14767058.2025.2508273",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:22:47",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Liu LL, Xu HH, Lin X. Evaluation of fetal outcomes in dichorionic diamniotic twins with hypertensive disorders during pregnancy by the fetal middle cerebral artery and umbilical artery doppler. J Matern Fetal Neonatal Med. 2025;38(1):2508273",
      "pubdate": "2025-05-26",
      "Lead_author": "Liu LL",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/14767058.2025.2508273",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Liu LL, Xu HH, Lin X. Evaluation of fetal outcomes in dichorionic diamniotic twins with hypertensive disorders during pregnancy by the fetal middle cerebral artery and umbilical artery doppler. J Matern Fetal Neonatal Med. 2025;38(1):2508273",
    "leadAuthor": "Liu LL",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiaBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiaBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2ca9a00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707158
  },
  {
    "id": "DEXA_Synt_67933",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40369957",
    "title": "Unveiling the role of oxidative stress in ANCA-associated glomerulonephritis through integrated machine learning and bioinformatics analyses.",
    "authors": [
      "Xie L",
      "Qiu X",
      "Jia J",
      "Yan T",
      "Xu P"
    ],
    "journal": "Ren Fail",
    "publicationDate": "2025-05-15",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "fef77e0e-f1d8-452f-a79e-29bfcf8e1131",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.040Z"
      },
      {
        "id": "e43e90fb-8d58-440c-b588-30849dcff747",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from b1f673ad-fbc1-4ac6-9739-08986b3be79b to DEXA_Synt_67933",
        "type": "system",
        "createdAt": "2025-12-14T10:12:38.400Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:55.169Z",
    "updatedAt": "2025-12-14T08:54:27.074Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40369957",
      "DOI": "https://doi.org10.1080/0886022X.2025.2499905",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:23:02",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Xie L, Qiu X, Jia J, Yan T, Xu P. Unveiling the role of oxidative stress in ANCA-associated glomerulonephritis through integrated machine learning and bioinformatics analyses. Ren Fail. 2025;47(1):2499905",
      "pubdate": "2025-05-15",
      "Lead_author": "Xie L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/0886022X.2025.2499905",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Xie L, Qiu X, Jia J, Yan T, Xu P. Unveiling the role of oxidative stress in ANCA-associated glomerulonephritis through integrated machine learning and bioinformatics analyses. Ren Fail. 2025;47(1):2499905",
    "leadAuthor": "Xie L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUibBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUibBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2cc9d80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707158
  },
  {
    "id": "DEXA_Synt_16183",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40008452",
    "title": "Gut microbial dysbiosis exacerbates long-term cognitive impairments by promoting intestinal dysfunction and neuroinflammation following neonatal hypoxia-ischemia.",
    "authors": [
      "Chen A",
      "Teng C",
      "Wei J",
      "Wu X",
      "Zhang H",
      "Chen P",
      "Cai D",
      "Qian H",
      "Zhu H",
      "Zheng X",
      "Chen X"
    ],
    "journal": "Gut Microbes",
    "publicationDate": "2025-02-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "179fbbd1-d2ae-4f23-9020-0eaf144ca4f6",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.101Z"
      },
      {
        "id": "22fe8b8c-3b44-4c0d-8e98-e3a81d2bd74f",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from c12d47a9-37de-4abf-9e0a-f632be15536d to DEXA_Synt_16183",
        "type": "system",
        "createdAt": "2025-12-14T10:12:38.613Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:55.257Z",
    "updatedAt": "2025-12-14T08:54:27.112Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40008452",
      "DOI": "https://doi.org10.1080/19490976.2025.2471015",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:23:32",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Chen A, Teng C, Wei J, Wu X, Zhang H, Chen P, Cai D, Qian H, Zhu H, Zheng X, Chen X. Gut microbial dysbiosis exacerbates long-term cognitive impairments by promoting intestinal dysfunction and neuroinflammation following neonatal hypoxia-ischemia. Gut Microbes. 2025;17(1):2471015",
      "pubdate": "2025-02-26",
      "Lead_author": "Chen A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/19490976.2025.2471015",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Chen A, Teng C, Wei J, Wu X, Zhang H, Chen P, Cai D, Qian H, Zhu H, Zheng X, Chen X. Gut microbial dysbiosis exacerbates long-term cognitive impairments by promoting intestinal dysfunction and neuroinflammation following neonatal hypoxia-ischemia. Gut Microbes. 2025;17(1):2471015",
    "leadAuthor": "Chen A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUicBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUicBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2cf0380501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707158
  },
  {
    "id": "DEXA_Synt_49874",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40007075",
    "title": "A polyepigenetic glucocorticoid exposure score and HPA axis-related DNA methylation are associated with gestational epigenetic aging.",
    "authors": [
      "Appleton AA"
    ],
    "journal": "Epigenetics",
    "publicationDate": "2025-02-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "104d7cd0-2689-440d-9bcc-b74e2439c94b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.164Z"
      },
      {
        "id": "3b5bf734-9db8-4e83-b051-ca82c7a0ab7a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 794ad6a5-f184-402d-9174-fdda21652ac7 to DEXA_Synt_49874",
        "type": "system",
        "createdAt": "2025-12-14T10:12:38.844Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:55.426Z",
    "updatedAt": "2025-12-14T08:54:27.175Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40007075",
      "DOI": "https://doi.org10.1080/15592294.2025.2471129",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:23:10",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Appleton AA. A polyepigenetic glucocorticoid exposure score and HPA axis-related DNA methylation are associated with gestational epigenetic aging. Epigenetics. 2025;20(1):2471129",
      "pubdate": "2025-02-26",
      "Lead_author": "Appleton AA",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/15592294.2025.2471129",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Appleton AA. A polyepigenetic glucocorticoid exposure score and HPA axis-related DNA methylation are associated with gestational epigenetic aging. Epigenetics. 2025;20(1):2471129",
    "leadAuthor": "Appleton AA",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUidBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUidBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2d0d600501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707158
  },
  {
    "id": "DEXA_Synt_57397",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39995107",
    "title": "Outcomes of BTD vs. BCD as initial treatment of renal amyloid light-chain amyloidosis: a retrospective cohort study in China.",
    "authors": [
      "Li S",
      "He W",
      "Yau HH",
      "Xie J",
      "Zhu Y",
      "Chen X",
      "Zhang S",
      "Zhang Y",
      "Liao P",
      "Liu H",
      "Li L",
      "Zhong L",
      "Wang W"
    ],
    "journal": "Ren Fail",
    "publicationDate": "2025-02-25",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "623841a5-0214-4653-923c-f11750eed6a1",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.195Z"
      },
      {
        "id": "7cfabbb7-4428-4bb0-b5c9-2a59b6de2405",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from cec2cdec-c5da-478e-b291-350d31ad8b02 to DEXA_Synt_57397",
        "type": "system",
        "createdAt": "2025-12-14T10:12:39.094Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:55.548Z",
    "updatedAt": "2025-12-14T08:54:27.208Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39995107",
      "DOI": "https://doi.org10.1080/0886022X.2025.2453006",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:23:17",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Li S, He W, Yau HH, Xie J, Zhu Y, Chen X, Zhang S, Zhang Y, Liao P, Liu H, Li L, Zhong L, Wang W. Outcomes of BTD vs. BCD as initial treatment of renal amyloid light-chain amyloidosis: a retrospective cohort study in China. Ren Fail. 2025;47(1):2453006",
      "pubdate": "2025-02-25",
      "Lead_author": "Li S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/0886022X.2025.2453006",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Li S, He W, Yau HH, Xie J, Zhu Y, Chen X, Zhang S, Zhang Y, Liao P, Liu H, Li L, Zhong L, Wang W. Outcomes of BTD vs. BCD as initial treatment of renal amyloid light-chain amyloidosis: a retrospective cohort study in China. Ren Fail. 2025;47(1):2453006",
    "leadAuthor": "Li S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUieBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUieBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2d33740501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707159
  },
  {
    "id": "DEXA_Synt_67526",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39988815",
    "title": "Acute kidney injury in hospitalized children with diphtheria in northwestern Nigeria: incidence and hospitalization outcomes.",
    "authors": [
      "Ibrahim OR",
      "Alege A",
      "Alao MA",
      "Adedoyin OT"
    ],
    "journal": "Ren Fail",
    "publicationDate": "2025-02-24",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b030c68b-c801-402c-a65b-95b53ea49360",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.242Z"
      },
      {
        "id": "b6c26895-e694-4116-b62f-bd6c24513baf",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f0a1c1c3-135a-4295-afa3-4cd18a5d0fc4 to DEXA_Synt_67526",
        "type": "system",
        "createdAt": "2025-12-14T10:12:39.275Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:55.689Z",
    "updatedAt": "2025-12-14T08:54:27.254Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39988815",
      "DOI": "https://doi.org10.1080/0886022X.2025.2465817",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:23:24",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Ibrahim OR, Alege A, Alao MA, Adedoyin OT. Acute kidney injury in hospitalized children with diphtheria in northwestern Nigeria: incidence and hospitalization outcomes. Ren Fail. 2025;47(1):2465817",
      "pubdate": "2025-02-24",
      "Lead_author": "Ibrahim OR",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/0886022X.2025.2465817",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Ibrahim OR, Alege A, Alao MA, Adedoyin OT. Acute kidney injury in hospitalized children with diphtheria in northwestern Nigeria: incidence and hospitalization outcomes. Ren Fail. 2025;47(1):2465817",
    "leadAuthor": "Ibrahim OR",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUifBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUifBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2d54f00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707159
  },
  {
    "id": "DEXA_Synt_50648",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39902793",
    "title": "Modified Xiao-Qing-Long-decoction prevents inflammation and promotes Nur77 expression in mice with acute respiratory distress syndrome by inhibiting HDAC7 expression.",
    "authors": [
      "Zhang Q",
      "Liu Y",
      "Jiang L",
      "Yang D"
    ],
    "journal": "Pharm Biol",
    "publicationDate": "2025-02-4",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "cd4507e6-28ee-4c00-b113-b60efcf03b84",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.273Z"
      },
      {
        "id": "7e471aad-249d-4ae2-8792-9b6b6cf3464e",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from b2fbb39b-a4e5-416c-b84e-355c1cbf59d8 to DEXA_Synt_50648",
        "type": "system",
        "createdAt": "2025-12-14T10:12:39.492Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T07:53:55.798Z",
    "updatedAt": "2025-12-14T08:54:27.337Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39902793",
      "DOI": "https://doi.org10.1080/13880209.2025.2459247",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:23:40",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Zhang Q, Liu Y, Jiang L, Yang D. Modified Xiao-Qing-Long-decoction prevents inflammation and promotes Nur77 expression in mice with acute respiratory distress syndrome by inhibiting HDAC7 expression. Pharm Biol. 2025;63(1):110-7",
      "pubdate": "2025-02-4",
      "Lead_author": "Zhang Q",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/13880209.2025.2459247",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Zhang Q, Liu Y, Jiang L, Yang D. Modified Xiao-Qing-Long-decoction prevents inflammation and promotes Nur77 expression in mice with acute respiratory distress syndrome by inhibiting HDAC7 expression. Pharm Biol. 2025;63(1):110-7",
    "leadAuthor": "Zhang Q",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUigBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUigBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2d766c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707159
  },
  {
    "id": "DEXA_Synt_71901",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41321588",
    "title": "Lipopolysaccharide Sensitizes Steroid-Induced Brain Injury in Neonatal Rat Pups.",
    "authors": [
      "Chang YS",
      "Yang TM",
      "Hsu YL",
      "Kuo YM",
      "Lin CH"
    ],
    "journal": "Mediators Inflamm",
    "publicationDate": "2025-12-1",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "7f5b25af-d56a-46f1-9e78-b3615b7df5cb",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.364Z"
      },
      {
        "id": "9c27d264-ec1f-4971-a56a-a03d4752710c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6b38cea0-758c-4233-80c1-664208dcd9b2 to DEXA_Synt_71901",
        "type": "system",
        "createdAt": "2025-12-14T10:12:39.708Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:39.554Z",
    "updatedAt": "2025-12-14T08:54:27.373Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41321588",
      "DOI": "https://doi.org10.1155/mi/8285898",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:25:17",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Chang YS, Yang TM, Hsu YL, Kuo YM, Lin CH. Lipopolysaccharide Sensitizes Steroid-Induced Brain Injury in Neonatal Rat Pups. Mediators Inflamm. 2025;20258285898",
      "pubdate": "2025-12-1",
      "Lead_author": "Chang YS",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1155/mi/8285898",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Chang YS, Yang TM, Hsu YL, Kuo YM, Lin CH. Lipopolysaccharide Sensitizes Steroid-Induced Brain Injury in Neonatal Rat Pups. Mediators Inflamm. 2025;20258285898",
    "leadAuthor": "Chang YS",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUihBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUihBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2d9c3c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707159
  },
  {
    "id": "DEXA_Synt_76032",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41321235",
    "title": "2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies.",
    "authors": [
      "Robblee J",
      "Minen MT",
      "Friedman BW",
      "Cortel-LeBlanc MA",
      "Cortel-LeBlanc A",
      "Orr SL"
    ],
    "journal": "Headache",
    "publicationDate": "2025-12-1",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "868d4478-f6a7-4879-abfc-30d72be437d8",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.395Z"
      },
      {
        "id": "53e4c4e7-bf55-49ed-a3f5-0446c2c09f53",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from adc06303-827a-491a-bc75-840d1d96d014 to DEXA_Synt_76032",
        "type": "system",
        "createdAt": "2025-12-14T10:12:39.943Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:39.589Z",
    "updatedAt": "2025-12-14T08:54:27.446Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41321235",
      "DOI": "https://doi.org10.1111/head.70016",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:25:25",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Robblee J, Minen MT, Friedman BW, Cortel-LeBlanc MA, Cortel-LeBlanc A, Orr SL. 2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies. Headache. 2025;",
      "pubdate": "2025-12-1",
      "Lead_author": "Robblee J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/head.70016",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Robblee J, Minen MT, Friedman BW, Cortel-LeBlanc MA, Cortel-LeBlanc A, Orr SL. 2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies. Headache. 2025;",
    "leadAuthor": "Robblee J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiiBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiiBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2db85c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707159
  },
  {
    "id": "DEXA_Synt_44528",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41318255",
    "title": "Evaluating the Real-World Value of Daratumumab Addition to Multiple Myeloma Induction Therapy by Real-World Minimal Residual Disease Assessment and Extended Genetic Profiling.",
    "authors": [
      "Bertuglia G",
      "Seneca E",
      "Corbett T",
      "Croft J",
      "Kaczmarek P",
      "Ellis L",
      "Neoh C",
      "Renaudon-Smith E",
      "Vanhinsbergh L",
      "Lindsay J",
      "Bonetto S",
      "Kristinsson SY",
      "Spence D",
      "Pratt G",
      "Jackson G",
      "Ethell M",
      "Nicholson E",
      "Messiou C",
      "Brown T",
      "Conneely L",
      "Thornton T",
      "Fuller L",
      "Petrizan MV",
      "Dunlop A",
      "Smith K",
      "Gay F",
      "Pawlyn C",
      "Boyd KD",
      "Kaiser MF"
    ],
    "journal": "Clin Lymphoma Myeloma Leuk",
    "publicationDate": "2025-11-30",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "d20099fc-6077-45ff-b708-49a1bd6fcebf",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.471Z"
      },
      {
        "id": "47343dbb-bf95-49e7-a695-bc17aaeffe45",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 7a02dc47-9d14-402d-b1d9-6738ce268f2f to DEXA_Synt_44528",
        "type": "system",
        "createdAt": "2025-12-14T10:12:40.194Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:39.616Z",
    "updatedAt": "2025-12-14T08:54:27.481Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41318255",
      "DOI": "https://doi.org10.1016/j.clml.2025.11.003",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:24:09",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Bertuglia G, Seneca E, Corbett T, Croft J, Kaczmarek P, Ellis L, Neoh C, Renaudon-Smith E, Vanhinsbergh L, Lindsay J, Bonetto S, Kristinsson SY, Spence D, Pratt G, Jackson G, Ethell M, Nicholson E, Messiou C, Brown T, Conneely L, Thornton T, Fuller L, Petrizan MV, Dunlop A, Smith K, Gay F, Pawlyn C, Boyd KD, Kaiser MF. Evaluating the Real-World Value of Daratumumab Addition to Multiple Myeloma Induction Therapy by Real-World Minimal Residual Disease Assessment and Extended Genetic Profiling. Clin Lymphoma Myeloma Leuk. 2025;",
      "pubdate": "2025-11-30",
      "Lead_author": "Bertuglia G",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.clml.2025.11.003",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Bertuglia G, Seneca E, Corbett T, Croft J, Kaczmarek P, Ellis L, Neoh C, Renaudon-Smith E, Vanhinsbergh L, Lindsay J, Bonetto S, Kristinsson SY, Spence D, Pratt G, Jackson G, Ethell M, Nicholson E, Messiou C, Brown T, Conneely L, Thornton T, Fuller L, Petrizan MV, Dunlop A, Smith K, Gay F, Pawlyn C, Boyd KD, Kaiser MF. Evaluating the Real-World Value of Daratumumab Addition to Multiple Myeloma Induction Therapy by Real-World Minimal Residual Disease Assessment and Extended Genetic Profiling. Clin Lymphoma Myeloma Leuk. 2025;",
    "leadAuthor": "Bertuglia G",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUijBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUijBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2ddbb80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707160
  },
  {
    "id": "DEXA_Synt_74235",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41317575",
    "title": "Computer assisted discovery of novel nicotinamide phosphoribosyltransferase agonists to combat muscle atrophy.",
    "authors": [
      "Li L",
      "Wang R",
      "Zhu J",
      "Cao F",
      "Min J",
      "Ouyang D",
      "Lin L"
    ],
    "journal": "Bioorg Chem",
    "publicationDate": "2025-11-30",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "eebf1b53-09ec-4a9e-8ae6-2e6a9fdd3e3c",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.502Z"
      },
      {
        "id": "0a854ae8-0977-4d12-a4c8-a5bfa375b4f7",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a63871c8-be0d-4573-b240-e25a2965017c to DEXA_Synt_74235",
        "type": "system",
        "createdAt": "2025-12-14T10:12:40.425Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:39.653Z",
    "updatedAt": "2025-12-14T08:54:27.512Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41317575",
      "DOI": "https://doi.org10.1016/j.bioorg.2025.109296",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:24:03",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Li L, Wang R, Zhu J, Cao F, Min J, Ouyang D, Lin L. Computer assisted discovery of novel nicotinamide phosphoribosyltransferase agonists to combat muscle atrophy. Bioorg Chem. 2025;168109296",
      "pubdate": "2025-11-30",
      "Lead_author": "Li L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.bioorg.2025.109296",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Li L, Wang R, Zhu J, Cao F, Min J, Ouyang D, Lin L. Computer assisted discovery of novel nicotinamide phosphoribosyltransferase agonists to combat muscle atrophy. Bioorg Chem. 2025;168109296",
    "leadAuthor": "Li L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUikBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUikBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2dfed00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707160
  },
  {
    "id": "DEXA_Synt_38651",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41307154",
    "title": "Macular Toxicity Following Intravitreal Clindamycin: A Case Report and Literature Review.",
    "authors": [
      "Fekri S",
      "Shafa S",
      "Zand A",
      "Nouri H",
      "Danesh Talab A",
      "Farhadi H",
      "Lohrasbi G"
    ],
    "journal": "Ocul Immunol Inflamm",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5a29517c-643c-4960-aa5c-7ec84ae38cef",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.532Z"
      },
      {
        "id": "dd6bce76-ac67-4d7d-ba51-aa88739e466b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from b1212b3a-4064-4464-b5ef-e8923b0cb445 to DEXA_Synt_38651",
        "type": "system",
        "createdAt": "2025-12-14T10:12:40.655Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:39.684Z",
    "updatedAt": "2025-12-14T08:54:27.604Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41307154",
      "DOI": "https://doi.org10.1080/09273948.2025.2594659",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:25:32",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Fekri S, Shafa S, Zand A, Nouri H, Danesh Talab A, Farhadi H, Lohrasbi G. Macular Toxicity Following Intravitreal Clindamycin: A Case Report and Literature Review. Ocul Immunol Inflamm. 2025;1-5",
      "pubdate": "2025-11-27",
      "Lead_author": "Fekri S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/09273948.2025.2594659",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Fekri S, Shafa S, Zand A, Nouri H, Danesh Talab A, Farhadi H, Lohrasbi G. Macular Toxicity Following Intravitreal Clindamycin: A Case Report and Literature Review. Ocul Immunol Inflamm. 2025;1-5",
    "leadAuthor": "Fekri S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUilBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUilBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2e22000501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707160
  },
  {
    "id": "DEXA_Synt_76580",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41306234",
    "title": "Efficacy of Oral and Intralesional Pentoxifylline in Grade II and Grade III Oral Submucous Fibrosis: a Systematic Review.",
    "authors": [
      "Dengra S",
      "Bhola N",
      "Nikunj A",
      "Elangovan B"
    ],
    "journal": "J Maxillofac Oral Surg",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "61daa48b-e69b-46d4-a701-13eeb5e02a04",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.627Z"
      },
      {
        "id": "3dd2013e-b77c-452a-9790-0af1b00e3680",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 1c2a0bad-349d-4d0c-8fd5-f4324f9e8b55 to DEXA_Synt_76580",
        "type": "system",
        "createdAt": "2025-12-14T10:12:40.857Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:39.709Z",
    "updatedAt": "2025-12-14T08:54:27.639Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41306234",
      "DOI": "https://doi.org10.1007/s12663-025-02728-5",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:25:47",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Dengra S, Bhola N, Nikunj A, Elangovan B. Efficacy of Oral and Intralesional Pentoxifylline in Grade II and Grade III Oral Submucous Fibrosis: a Systematic Review. J Maxillofac Oral Surg. 2025;24(6):1881-900",
      "pubdate": "2025-11-27",
      "Lead_author": "Dengra S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s12663-025-02728-5",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Dengra S, Bhola N, Nikunj A, Elangovan B. Efficacy of Oral and Intralesional Pentoxifylline in Grade II and Grade III Oral Submucous Fibrosis: a Systematic Review. J Maxillofac Oral Surg. 2025;24(6):1881-900",
    "leadAuthor": "Dengra S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUimBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUimBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2e43800501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707160
  },
  {
    "id": "DEXA_Synt_16338",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41303076",
    "title": "Use of Dexamethasone via Two Methods in PENG Block for Patients Undergoing Femoral Fracture Surgery: A Prospective Observational Study.",
    "authors": [
      "Ozdemir E",
      "Kelsaka E",
      "Cebeci H"
    ],
    "journal": "J Clin Med",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "33459c6c-98d4-4851-8d5f-12349b50ae59",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.655Z"
      },
      {
        "id": "9c8e4a74-f9ea-4068-9d49-bc5af2800a0d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 71de41bd-5351-40fb-885f-b52823708d57 to DEXA_Synt_16338",
        "type": "system",
        "createdAt": "2025-12-14T10:12:41.088Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:39.744Z",
    "updatedAt": "2025-12-14T08:54:27.664Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41303076",
      "DOI": "https://doi.org10.3390/jcm14228040",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:25:40",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Ozdemir E, Kelsaka E, Cebeci H. Use of Dexamethasone via Two Methods in PENG Block for Patients Undergoing Femoral Fracture Surgery: A Prospective Observational Study. J Clin Med. 2025;14(22):",
      "pubdate": "2025-11-27",
      "Lead_author": "Ozdemir E",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3390/jcm14228040",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Ozdemir E, Kelsaka E, Cebeci H. Use of Dexamethasone via Two Methods in PENG Block for Patients Undergoing Femoral Fracture Surgery: A Prospective Observational Study. J Clin Med. 2025;14(22):",
    "leadAuthor": "Ozdemir E",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUinBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUinBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2e644c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707161
  },
  {
    "id": "DEXA_Synt_18693",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41302395",
    "title": " L. (Cucurbitaceae) Leaf Extract from Phytochemical Characterization and Toxicity Evaluation to Modulation of Pro-Inflammatory Cytokines and MAPK/NFκB Pathways.",
    "authors": [
      "Oliveira MLA",
      "Sousa RM",
      "Barbosa EA",
      "Galdino OA",
      "Dantas DLA",
      "Alves IR",
      "Sousa Borges R",
      "Castelo Branco NCM",
      "Nascimento Rodrigues ASD",
      "de Souza GC",
      "Silva SVE",
      "Araujo-Silva G",
      "Luz JRDD",
      "Almeida MDG"
    ],
    "journal": "Molecules",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "efd05d19-be19-4026-b491-de7a76b637b6",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.686Z"
      },
      {
        "id": "25b38241-717e-493b-9645-47e22f62290e",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 4601d75e-9621-4eab-82ec-b1c3926cec98 to DEXA_Synt_18693",
        "type": "system",
        "createdAt": "2025-12-14T10:12:41.305Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:39.773Z",
    "updatedAt": "2025-12-14T08:54:27.737Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41302395",
      "DOI": "https://doi.org10.3390/molecules30224335",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:26:01",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Oliveira MLA, Sousa RM, Barbosa EA, Galdino OA, Dantas DLA, Alves IR, Sousa Borges R, Castelo Branco NCM, Nascimento Rodrigues ASD, de Souza GC, Silva SVE, Araujo-Silva G, Luz JRDD, Almeida MDG. <i>Momordica charantia</i> L. (Cucurbitaceae) Leaf Extract from Phytochemical Characterization and Toxicity Evaluation to Modulation of Pro-Inflammatory Cytokines and MAPK/NFκB Pathways. Molecules. 2025;30(22):",
      "pubdate": "2025-11-27",
      "Lead_author": "Oliveira MLA",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3390/molecules30224335",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Oliveira MLA, Sousa RM, Barbosa EA, Galdino OA, Dantas DLA, Alves IR, Sousa Borges R, Castelo Branco NCM, Nascimento Rodrigues ASD, de Souza GC, Silva SVE, Araujo-Silva G, Luz JRDD, Almeida MDG. <i>Momordica charantia</i> L. (Cucurbitaceae) Leaf Extract from Phytochemical Characterization and Toxicity Evaluation to Modulation of Pro-Inflammatory Cytokines and MAPK/NFκB Pathways. Molecules. 2025;30(22):",
    "leadAuthor": "Oliveira MLA",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUioBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUioBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2e85400501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707161
  },
  {
    "id": "DEXA_Synt_82143",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41301469",
    "title": "Stigmasterol Protects Against Dexamethasone-Induced Muscle Atrophy by Modulating the FoxO3-MuRF1/MAFbx Signaling Pathway in C2C12 Myotubes and Mouse Skeletal Muscle.",
    "authors": [
      "Hah YS",
      "Lee SJ",
      "Ji YH",
      "Hwang J",
      "Kim HG",
      "Ju YT",
      "Yoo JI",
      "Kwag SJ"
    ],
    "journal": "Biomolecules",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a8216121-54e0-41df-8030-67d505fb298c",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.764Z"
      },
      {
        "id": "e3d99f81-b754-42e1-bff9-a47acd694f4c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 91d1ab33-f809-4c90-81e7-50617e27a93b to DEXA_Synt_82143",
        "type": "system",
        "createdAt": "2025-12-14T10:12:41.523Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:39.809Z",
    "updatedAt": "2025-12-14T08:54:27.775Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41301469",
      "DOI": "https://doi.org10.3390/biom15111551",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:25:54",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Hah YS, Lee SJ, Ji YH, Hwang J, Kim HG, Ju YT, Yoo JI, Kwag SJ. Stigmasterol Protects Against Dexamethasone-Induced Muscle Atrophy by Modulating the FoxO3-MuRF1/MAFbx Signaling Pathway in C2C12 Myotubes and Mouse Skeletal Muscle. Biomolecules. 2025;15(11):",
      "pubdate": "2025-11-27",
      "Lead_author": "Hah YS",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3390/biom15111551",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Hah YS, Lee SJ, Ji YH, Hwang J, Kim HG, Ju YT, Yoo JI, Kwag SJ. Stigmasterol Protects Against Dexamethasone-Induced Muscle Atrophy by Modulating the FoxO3-MuRF1/MAFbx Signaling Pathway in C2C12 Myotubes and Mouse Skeletal Muscle. Biomolecules. 2025;15(11):",
    "leadAuthor": "Hah YS",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUipBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUipBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2ea6540501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707161
  },
  {
    "id": "DEXA_Synt_59720",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41289184",
    "title": "Physicochemical and microbiological evaluation of dexamethasone-based mouthwash formulations.",
    "authors": [
      "Jegham N",
      "Rassas R",
      "Mahfoudhi S",
      "Trabelsi A",
      "Kalboussi N",
      "Kacem B"
    ],
    "journal": "J Oncol Pharm Pract",
    "publicationDate": "2025-11-25",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "d06223fc-0f81-4901-9462-7afad4a52e26",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.792Z"
      },
      {
        "id": "b6f787d6-b4d6-4dcf-b664-f300dc2e539a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 5a730be8-b525-4a19-a019-9cfe8812c147 to DEXA_Synt_59720",
        "type": "system",
        "createdAt": "2025-12-14T10:12:41.780Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:39.836Z",
    "updatedAt": "2025-12-14T08:54:27.800Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41289184",
      "DOI": "https://doi.org10.1177/10781552251399107",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:26:10",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Jegham N, Rassas R, Mahfoudhi S, Trabelsi A, Kalboussi N, Kacem B. Physicochemical and microbiological evaluation of dexamethasone-based mouthwash formulations. J Oncol Pharm Pract. 2025;10781552251399107",
      "pubdate": "2025-11-25",
      "Lead_author": "Jegham N",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1177/10781552251399107",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Jegham N, Rassas R, Mahfoudhi S, Trabelsi A, Kalboussi N, Kacem B. Physicochemical and microbiological evaluation of dexamethasone-based mouthwash formulations. J Oncol Pharm Pract. 2025;10781552251399107",
    "leadAuthor": "Jegham N",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiqBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiqBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2ecda80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707161
  },
  {
    "id": "DEXA_Synt_84130",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41286036",
    "title": "Optimization of primary culture, inflammatory induction, and molecular analysis of fibroblast-like synoviocytes in a rat model of osteoarthritis pain.",
    "authors": [
      "Xiong A",
      "Ma Z",
      "Xiong R",
      "Luo F"
    ],
    "journal": "Sci Rep",
    "publicationDate": "2025-11-25",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "340633f3-40c8-4b46-b863-efd409b82086",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.868Z"
      },
      {
        "id": "a83c343e-361e-4383-80e9-4acdf7c1dcd0",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from bbc4b945-bdb6-4499-bbf9-5d336325c5f6 to DEXA_Synt_84130",
        "type": "system",
        "createdAt": "2025-12-14T10:12:41.954Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:39.868Z",
    "updatedAt": "2025-12-14T08:54:27.879Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41286036",
      "DOI": "https://doi.org10.1038/s41598-025-25494-3",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:26:38",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Xiong A, Ma Z, Xiong R, Luo F. Optimization of primary culture, inflammatory induction, and molecular analysis of fibroblast-like synoviocytes in a rat model of osteoarthritis pain. Sci Rep. 2025;15(1):41557",
      "pubdate": "2025-11-25",
      "Lead_author": "Xiong A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41598-025-25494-3",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Xiong A, Ma Z, Xiong R, Luo F. Optimization of primary culture, inflammatory induction, and molecular analysis of fibroblast-like synoviocytes in a rat model of osteoarthritis pain. Sci Rep. 2025;15(1):41557",
    "leadAuthor": "Xiong A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUirBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUirBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2ef2280501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707162
  },
  {
    "id": "DEXA_Synt_13099",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41281260",
    "title": "High-Dose Corticosteroids in Critically Ill COVID-19 Patients: A Retrospective Cohort Study from Suriname.",
    "authors": [
      "Daenen K",
      "Neus A",
      "Woittiez L",
      "Bansie R",
      "Nierich A",
      "Huijben JA",
      "Endeman H",
      "van Gorp ECM",
      "Bihariesingh-Sanchit R"
    ],
    "journal": "J Inflamm Res",
    "publicationDate": "2025-11-24",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ad7a3d02-345d-4f48-b31a-b52886f1241b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.900Z"
      },
      {
        "id": "db70c7fa-807f-4ba6-af2b-882d83e2ccf2",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from b0d6560d-309d-445f-b355-988c7e41cf8e to DEXA_Synt_13099",
        "type": "system",
        "createdAt": "2025-12-14T10:12:42.168Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:40.029Z",
    "updatedAt": "2025-12-14T08:54:27.911Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41281260",
      "DOI": "https://doi.org10.2147/JIR.S546976",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:26:17",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Daenen K, Neus A, Woittiez L, Bansie R, Nierich A, Huijben JA, Endeman H, van Gorp ECM, Bihariesingh-Sanchit R. High-Dose Corticosteroids in Critically Ill COVID-19 Patients: A Retrospective Cohort Study from Suriname. J Inflamm Res. 2025;1815995-6008",
      "pubdate": "2025-11-24",
      "Lead_author": "Daenen K",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.2147/JIR.S546976",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Daenen K, Neus A, Woittiez L, Bansie R, Nierich A, Huijben JA, Endeman H, van Gorp ECM, Bihariesingh-Sanchit R. High-Dose Corticosteroids in Critically Ill COVID-19 Patients: A Retrospective Cohort Study from Suriname. J Inflamm Res. 2025;1815995-6008",
    "leadAuthor": "Daenen K",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUisBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUisBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2f13440501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707162
  },
  {
    "id": "DEXA_Synt_38079",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41280937",
    "title": "Case Report: Severe autoimmune hemolytic anemia in an elderly patient caused by warm-reactive IgG and IgA autoantibodies.",
    "authors": [
      "Xia W",
      "Lu J",
      "Hou J",
      "Zhou J",
      "Lin H",
      "Lai X",
      "Zhang X",
      "Zhang R",
      "Ke P"
    ],
    "journal": "Front Immunol",
    "publicationDate": "2025-11-24",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "3a71cc92-16a3-455f-8890-242ee23118fd",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:27.930Z"
      },
      {
        "id": "0a94fe1f-baeb-420b-ba82-a1b6656f7793",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from b8d67bb9-1028-4010-92e4-37bfc43ae5f9 to DEXA_Synt_38079",
        "type": "system",
        "createdAt": "2025-12-14T10:12:42.386Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:40.122Z",
    "updatedAt": "2025-12-14T08:54:27.984Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41280937",
      "DOI": "https://doi.org10.3389/fimmu.2025.1664498",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:26:31",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Xia W, Lu J, Hou J, Zhou J, Lin H, Lai X, Zhang X, Zhang R, Ke P. Case Report: Severe autoimmune hemolytic anemia in an elderly patient caused by warm-reactive IgG and IgA autoantibodies. Front Immunol. 2025;161664498",
      "pubdate": "2025-11-24",
      "Lead_author": "Xia W",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3389/fimmu.2025.1664498",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Xia W, Lu J, Hou J, Zhou J, Lin H, Lai X, Zhang X, Zhang R, Ke P. Case Report: Severe autoimmune hemolytic anemia in an elderly patient caused by warm-reactive IgG and IgA autoantibodies. Front Immunol. 2025;161664498",
    "leadAuthor": "Xia W",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUitBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUitBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2f36bc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707162
  },
  {
    "id": "DEXA_Synt_32078",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41278073",
    "title": "Soft Palate and Uvula Thermal Burn Injury in an Adolescent Following Recreational Inhalation of Nitrous Oxide.",
    "authors": [
      "Yeung T"
    ],
    "journal": "Cureus",
    "publicationDate": "2025-11-24",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6e387b13-92e5-47a0-8ed1-1151d3992bc7",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.006Z"
      },
      {
        "id": "a27a5ac7-5f90-4472-a9d3-632e02dc5da2",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from c8b9dc18-a3c7-4a9a-95c6-d469bb6d7102 to DEXA_Synt_32078",
        "type": "system",
        "createdAt": "2025-12-14T10:12:42.635Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:40.295Z",
    "updatedAt": "2025-12-14T08:54:28.018Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41278073",
      "DOI": "https://doi.org10.7759/cureus.97445",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:26:24",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Yeung T. Soft Palate and Uvula Thermal Burn Injury in an Adolescent Following Recreational Inhalation of Nitrous Oxide. Cureus. 2025;17(11):e97445",
      "pubdate": "2025-11-24",
      "Lead_author": "Yeung T",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.7759/cureus.97445",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Yeung T. Soft Palate and Uvula Thermal Burn Injury in an Adolescent Following Recreational Inhalation of Nitrous Oxide. Cureus. 2025;17(11):e97445",
    "leadAuthor": "Yeung T",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiuBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiuBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2f557c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707162
  },
  {
    "id": "DEXA_Synt_90561",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41265642",
    "title": "Integrin/CD44-targeted liposomes remodel the pulmonary microenvironment to alleviate acute exacerbation of pulmonary fibrosis.",
    "authors": [
      "Huang X",
      "Zhang Y",
      "Yan X",
      "Huang Q",
      "Chen M",
      "Jiang C",
      "Wang Z",
      "Sun D",
      "Li Y",
      "Ding J",
      "Qiu X",
      "Cao M",
      "Xiao Y"
    ],
    "journal": "J Control Release",
    "publicationDate": "2025-11-21",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "224be0c0-a9e5-4cfb-af43-dfac96c4e592",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.038Z"
      },
      {
        "id": "660a17b1-db61-4c27-8390-80ab22172687",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 20346434-e305-4373-b9b4-b8a97c94a5dd to DEXA_Synt_90561",
        "type": "system",
        "createdAt": "2025-12-14T10:12:42.852Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:40.374Z",
    "updatedAt": "2025-12-14T08:54:28.048Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41265642",
      "DOI": "https://doi.org10.1016/j.jconrel.2025.114427",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:26:45",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Huang X, Zhang Y, Yan X, Huang Q, Chen M, Jiang C, Wang Z, Sun D, Li Y, Ding J, Qiu X, Cao M, Xiao Y. Integrin/CD44-targeted liposomes remodel the pulmonary microenvironment to alleviate acute exacerbation of pulmonary fibrosis. J Control Release. 2025;389114427",
      "pubdate": "2025-11-21",
      "Lead_author": "Huang X",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jconrel.2025.114427",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Huang X, Zhang Y, Yan X, Huang Q, Chen M, Jiang C, Wang Z, Sun D, Li Y, Ding J, Qiu X, Cao M, Xiao Y. Integrin/CD44-targeted liposomes remodel the pulmonary microenvironment to alleviate acute exacerbation of pulmonary fibrosis. J Control Release. 2025;389114427",
    "leadAuthor": "Huang X",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUivBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUivBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2f76f00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707162
  },
  {
    "id": "DEXA_Synt_50572",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41261435",
    "title": "Chinese leek-derived extracellular vesicles ameliorate sarcopenia by regulating mitochondrial biogenesis and autophagy via AMPK and maintaining myosin homeostasis.",
    "authors": [
      "Qi W",
      "Yang L",
      "Pan Y",
      "Lv K",
      "Zhao L",
      "Zhang Y",
      "Kai G",
      "Sun Y",
      "Pan H",
      "Wang D"
    ],
    "journal": "J Nanobiotechnology",
    "publicationDate": "2025-11-20",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "df183a25-eee5-452c-aa3a-d0dd30b12e59",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.114Z"
      },
      {
        "id": "81c54314-9800-4561-9fde-4f16bb1ff902",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from bb786857-bc69-4d00-84a5-ee4bec56163b to DEXA_Synt_50572",
        "type": "system",
        "createdAt": "2025-12-14T10:12:43.086Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:40.557Z",
    "updatedAt": "2025-12-14T08:54:28.126Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41261435",
      "DOI": "https://doi.org10.1186/s12951-025-03764-6",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:27:00",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Qi W, Yang L, Pan Y, Lv K, Zhao L, Zhang Y, Kai G, Sun Y, Pan H, Wang D. Chinese leek-derived extracellular vesicles ameliorate sarcopenia by regulating mitochondrial biogenesis and autophagy via AMPK and maintaining myosin homeostasis. J Nanobiotechnology. 2025;23(1):721",
      "pubdate": "2025-11-20",
      "Lead_author": "Qi W",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s12951-025-03764-6",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Qi W, Yang L, Pan Y, Lv K, Zhao L, Zhang Y, Kai G, Sun Y, Pan H, Wang D. Chinese leek-derived extracellular vesicles ameliorate sarcopenia by regulating mitochondrial biogenesis and autophagy via AMPK and maintaining myosin homeostasis. J Nanobiotechnology. 2025;23(1):721",
    "leadAuthor": "Qi W",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiwBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiwBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2f99e40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707163
  },
  {
    "id": "DEXA_Synt_95713",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41254702",
    "title": "Methylprednisolone versus dexamethasone in hospitalized patients with severe COVID-19: a systematic review and meta-analysis of randomized controlled trials.",
    "authors": [
      "Qin J",
      "Wang G",
      "Han D"
    ],
    "journal": "Syst Rev",
    "publicationDate": "2025-11-19",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "79d9334d-681b-4fbb-8570-c49103fa4bdf",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.161Z"
      },
      {
        "id": "45323df1-7d09-422d-85dc-8b8a45149890",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d059047b-05cd-431c-be1a-1092066c160f to DEXA_Synt_95713",
        "type": "system",
        "createdAt": "2025-12-14T10:12:43.328Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:40.638Z",
    "updatedAt": "2025-12-14T08:54:28.174Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41254702",
      "DOI": "https://doi.org10.1186/s13643-025-02976-z",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:26:53",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Qin J, Wang G, Han D. Methylprednisolone versus dexamethasone in hospitalized patients with severe COVID-19: a systematic review and meta-analysis of randomized controlled trials. Syst Rev. 2025;14(1):228",
      "pubdate": "2025-11-19",
      "Lead_author": "Qin J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s13643-025-02976-z",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Qin J, Wang G, Han D. Methylprednisolone versus dexamethasone in hospitalized patients with severe COVID-19: a systematic review and meta-analysis of randomized controlled trials. Syst Rev. 2025;14(1):228",
    "leadAuthor": "Qin J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUixBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUixBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2fb9d80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707163
  },
  {
    "id": "DEXA_Synt_57590",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41252862",
    "title": "Duck-egg white hydrolysate supplementation enhances muscle endurance and fatigue resistance during high-intensity exercise.",
    "authors": [
      "Shang KL",
      "Lin YL",
      "Sutopo CCY",
      "Chen JW",
      "Chen YC"
    ],
    "journal": "Poult Sci",
    "publicationDate": "2025-11-19",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "dd037727-374a-42d1-a47a-c4475c5640bc",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.190Z"
      },
      {
        "id": "aa628d0d-f42e-46f6-be3b-4a0348046f65",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 4712e18e-ff4c-4572-8e84-d59797a96fa5 to DEXA_Synt_57590",
        "type": "system",
        "createdAt": "2025-12-14T10:12:43.546Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:40.809Z",
    "updatedAt": "2025-12-14T08:54:28.238Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41252862",
      "DOI": "https://doi.org10.1016/j.psj.2025.106088",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:27:09",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Shang KL, Lin YL, Sutopo CCY, Chen JW, Chen YC. Duck-egg white hydrolysate supplementation enhances muscle endurance and fatigue resistance during high-intensity exercise. Poult Sci. 2025;105(1):106088",
      "pubdate": "2025-11-19",
      "Lead_author": "Shang KL",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.psj.2025.106088",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Shang KL, Lin YL, Sutopo CCY, Chen JW, Chen YC. Duck-egg white hydrolysate supplementation enhances muscle endurance and fatigue resistance during high-intensity exercise. Poult Sci. 2025;105(1):106088",
    "leadAuthor": "Shang KL",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiyBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiyBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2fdb040501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707163
  },
  {
    "id": "DEXA_Synt_50628",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41250038",
    "title": "Estimation of cortisol exposure in patients with adrenal incidentalomas.",
    "authors": [
      "Yener S",
      "Tuna G",
      "Sahin H",
      "Adiyaman SC",
      "Saydam BO",
      "Baris M",
      "Islekel GH"
    ],
    "journal": "BMC Endocr Disord",
    "publicationDate": "2025-11-18",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a5b7220a-fb94-4403-9bd4-0e7cd055c279",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.251Z"
      },
      {
        "id": "9fbef3cc-70a8-4621-8399-4aad1568dae3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 06671db3-4239-4f33-930a-d125711876f6 to DEXA_Synt_50628",
        "type": "system",
        "createdAt": "2025-12-14T10:12:43.761Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:40.899Z",
    "updatedAt": "2025-12-14T08:54:28.261Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41250038",
      "DOI": "https://doi.org10.1186/s12902-025-02090-0",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:27:16",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Yener S, Tuna G, Sahin H, Adiyaman SC, Saydam BO, Baris M, Islekel GH. Estimation of cortisol exposure in patients with adrenal incidentalomas. BMC Endocr Disord. 2025;25(1):266",
      "pubdate": "2025-11-18",
      "Lead_author": "Yener S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s12902-025-02090-0",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Yener S, Tuna G, Sahin H, Adiyaman SC, Saydam BO, Baris M, Islekel GH. Estimation of cortisol exposure in patients with adrenal incidentalomas. BMC Endocr Disord. 2025;25(1):266",
    "leadAuthor": "Yener S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUizBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUizBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-2ffbb00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707163
  },
  {
    "id": "DEXA_Synt_13308",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41248447",
    "title": "Immune Effector Cell-Associated Neurotoxicity Delayed Relapse After Chimeric Antigen Receptor T-Cell Therapy: A Case Report.",
    "authors": [
      "Favero A",
      "Mohamed S",
      "Battista ML",
      "Cenacchi V",
      "Sartori A",
      "Mazzon G",
      "Bratina A",
      "Tomaselli M",
      "Patriarca F",
      "Zaja F",
      "Manganotti P",
      "Benussi A"
    ],
    "journal": "Neurol Neuroimmunol Neuroinflamm",
    "publicationDate": "2025-11-17",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "7fc83315-5db0-464c-bd54-b1de609f7cb9",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.280Z"
      },
      {
        "id": "f5e7d542-0a4f-4025-bf39-8d1374e9ebd6",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 522b546b-19cc-4b9b-941b-478cc83b5b84 to DEXA_Synt_13308",
        "type": "system",
        "createdAt": "2025-12-14T10:12:44.013Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:41.069Z",
    "updatedAt": "2025-12-14T08:54:28.345Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41248447",
      "DOI": "https://doi.org10.1212/NXI.0000000000200515",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:27:24",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Favero A, Mohamed S, Battista ML, Cenacchi V, Sartori A, Mazzon G, Bratina A, Tomaselli M, Patriarca F, Zaja F, Manganotti P, Benussi A. Immune Effector Cell-Associated Neurotoxicity Delayed Relapse After Chimeric Antigen Receptor T-Cell Therapy: A Case Report. Neurol Neuroimmunol Neuroinflamm. 2026;13(1):e200515",
      "pubdate": "2025-11-17",
      "Lead_author": "Favero A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1212/NXI.0000000000200515",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Favero A, Mohamed S, Battista ML, Cenacchi V, Sartori A, Mazzon G, Bratina A, Tomaselli M, Patriarca F, Zaja F, Manganotti P, Benussi A. Immune Effector Cell-Associated Neurotoxicity Delayed Relapse After Chimeric Antigen Receptor T-Cell Therapy: A Case Report. Neurol Neuroimmunol Neuroinflamm. 2026;13(1):e200515",
    "leadAuthor": "Favero A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi0BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi0BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3022300501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707164
  },
  {
    "id": "DEXA_Synt_13899",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41237067",
    "title": "Daratumumab-Based Regimen Significantly Induced Remission of Crystalline Light Chain Proximal Tubulopathy: A Case Report.",
    "authors": [
      "Zou X",
      "Wang K",
      "Zeng R"
    ],
    "journal": "Am J Case Rep",
    "publicationDate": "2025-11-14",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "d5b12a60-6076-4223-b8ce-7071284e6b65",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.371Z"
      },
      {
        "id": "f96a26cb-fc6c-410b-80da-607ae2d0e153",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9b1b7fe1-40c9-4d30-82cd-c04f06949572 to DEXA_Synt_13899",
        "type": "system",
        "createdAt": "2025-12-14T10:12:44.179Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:41.179Z",
    "updatedAt": "2025-12-14T08:54:28.380Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41237067",
      "DOI": "https://doi.org10.12659/AJCR.948890",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:27:46",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Zou X, Wang K, Zeng R. Daratumumab-Based Regimen Significantly Induced Remission of Crystalline Light Chain Proximal Tubulopathy: A Case Report. Am J Case Rep. 2025;26e948890",
      "pubdate": "2025-11-14",
      "Lead_author": "Zou X",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.12659/AJCR.948890",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Zou X, Wang K, Zeng R. Daratumumab-Based Regimen Significantly Induced Remission of Crystalline Light Chain Proximal Tubulopathy: A Case Report. Am J Case Rep. 2025;26e948890",
    "leadAuthor": "Zou X",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi1BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi1BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3046700501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707164
  },
  {
    "id": "DEXA_Synt_81322",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41224428",
    "title": "Extending the Duration of Your Peripheral Nerve Block: From Perineural Additives and Continuous Catheters, to Liposomal Preparations and Beyond.",
    "authors": [
      "Aldwinckle RJ",
      "Saldanha U",
      "Penta DL",
      "Macres S",
      "Jung M",
      "Bishop R"
    ],
    "journal": "Adv Anesth",
    "publicationDate": "2025-11-13",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "256d4903-bd28-483a-8c02-ed1154bd0d94",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.401Z"
      },
      {
        "id": "2de48346-6521-44e2-a35c-f6de87f0f777",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d48789ba-21d8-4ece-bd2b-7010a2496c51 to DEXA_Synt_81322",
        "type": "system",
        "createdAt": "2025-12-14T10:12:44.397Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:41.302Z",
    "updatedAt": "2025-12-14T08:54:28.408Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41224428",
      "DOI": "https://doi.org10.1016/j.aan.2025.07.003",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:27:32",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Aldwinckle RJ, Saldanha U, Penta DL, Macres S, Jung M, Bishop R. Extending the Duration of Your Peripheral Nerve Block: From Perineural Additives and Continuous Catheters, to Liposomal Preparations and Beyond. Adv Anesth. 2025;43(1):33-50",
      "pubdate": "2025-11-13",
      "Lead_author": "Aldwinckle RJ",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.aan.2025.07.003",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Aldwinckle RJ, Saldanha U, Penta DL, Macres S, Jung M, Bishop R. Extending the Duration of Your Peripheral Nerve Block: From Perineural Additives and Continuous Catheters, to Liposomal Preparations and Beyond. Adv Anesth. 2025;43(1):33-50",
    "leadAuthor": "Aldwinckle RJ",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi2BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi2BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3067640501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707164
  },
  {
    "id": "DEXA_Synt_71737",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41224234",
    "title": "Management of Arthrofibrosis After Total Knee Arthroplasty: Insights and Future Directions.",
    "authors": [
      "Hoveidaei AH",
      "Smitterberg CW",
      "Misch M",
      "Katanbaf R",
      "Nace J",
      "Delanois RE",
      "Mont MA"
    ],
    "journal": "J Knee Surg",
    "publicationDate": "2025-11-13",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a24b806d-112e-4622-b586-d225a014d086",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.442Z"
      },
      {
        "id": "0f1b4d31-f6fd-4e33-8aee-89a5e37e3c78",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 383b3c54-403a-41ca-8bc5-a2b30ca75fb5 to DEXA_Synt_71737",
        "type": "system",
        "createdAt": "2025-12-14T10:12:44.660Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:41.426Z",
    "updatedAt": "2025-12-14T08:54:28.483Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41224234",
      "DOI": "https://doi.org10.1055/a-2741-1796",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:27:39",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Hoveidaei AH, Smitterberg CW, Misch M, Katanbaf R, Nace J, Delanois RE, Mont MA. Management of Arthrofibrosis After Total Knee Arthroplasty: Insights and Future Directions. J Knee Surg. 2025;",
      "pubdate": "2025-11-13",
      "Lead_author": "Hoveidaei AH",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1055/a-2741-1796",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Hoveidaei AH, Smitterberg CW, Misch M, Katanbaf R, Nace J, Delanois RE, Mont MA. Management of Arthrofibrosis After Total Knee Arthroplasty: Insights and Future Directions. J Knee Surg. 2025;",
    "leadAuthor": "Hoveidaei AH",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi3BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi3BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-30852c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707164
  },
  {
    "id": "DEXA_Synt_88252",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41224102",
    "title": "Redox-dependent suppression of ATF3 impairs steroid sensitivity in asthma through MKP-1/p38 MAPK signaling.",
    "authors": [
      "Li J",
      "Zhao L",
      "Qiu Y",
      "Liao J",
      "Tian X",
      "Gao J",
      "Zhang M",
      "Bao A"
    ],
    "journal": "Free Radic Biol Med",
    "publicationDate": "2025-11-13",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a1c60bd3-21c4-4086-857a-3aec000adbcd",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.510Z"
      },
      {
        "id": "dadd9f6d-c112-4546-a8e5-9216c5fb32ad",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d840bc4e-e873-4e37-bad0-0e772d89cdfc to DEXA_Synt_88252",
        "type": "system",
        "createdAt": "2025-12-14T10:12:44.889Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:41.593Z",
    "updatedAt": "2025-12-14T08:54:28.519Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41224102",
      "DOI": "https://doi.org10.1016/j.freeradbiomed.2025.11.011",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:27:52",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Li J, Zhao L, Qiu Y, Liao J, Tian X, Gao J, Zhang M, Bao A. Redox-dependent suppression of ATF3 impairs steroid sensitivity in asthma through MKP-1/p38 MAPK signaling. Free Radic Biol Med. 2025;2431-15",
      "pubdate": "2025-11-13",
      "Lead_author": "Li J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.freeradbiomed.2025.11.011",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Li J, Zhao L, Qiu Y, Liao J, Tian X, Gao J, Zhang M, Bao A. Redox-dependent suppression of ATF3 impairs steroid sensitivity in asthma through MKP-1/p38 MAPK signaling. Free Radic Biol Med. 2025;2431-15",
    "leadAuthor": "Li J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi4BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi4BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-30a8080501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707164
  },
  {
    "id": "DEXA_Synt_23143",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41218671",
    "title": "Liposome-chondroitin sulfate/chitosan hybrid system for combinational drug delivery of curcumin and dexamethasone: In vitro anti-cancer activities.",
    "authors": [
      "Eldurini S",
      "Tolba E",
      "Abd El-Hady BM",
      "Ibrahim AM",
      "Shafaa MW"
    ],
    "journal": "Int J Biol Macromol",
    "publicationDate": "2025-11-12",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "eee22da8-4898-4621-a4de-56ed85952529",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.539Z"
      },
      {
        "id": "2edfb5c9-052d-4a12-9916-40885aba60f8",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 4dc5a7ac-b88e-49a7-826e-714fd7949cd9 to DEXA_Synt_23143",
        "type": "system",
        "createdAt": "2025-12-14T10:12:45.092Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:41.673Z",
    "updatedAt": "2025-12-14T08:54:28.549Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41218671",
      "DOI": "https://doi.org10.1016/j.ijbiomac.2025.148941",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:27:59",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Eldurini S, Tolba E, Abd El-Hady BM, Ibrahim AM, Shafaa MW. Liposome-chondroitin sulfate/chitosan hybrid system for combinational drug delivery of curcumin and dexamethasone: In vitro anti-cancer activities. Int J Biol Macromol. 2025;335(Pt 2):148941",
      "pubdate": "2025-11-12",
      "Lead_author": "Eldurini S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ijbiomac.2025.148941",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Eldurini S, Tolba E, Abd El-Hady BM, Ibrahim AM, Shafaa MW. Liposome-chondroitin sulfate/chitosan hybrid system for combinational drug delivery of curcumin and dexamethasone: In vitro anti-cancer activities. Int J Biol Macromol. 2025;335(Pt 2):148941",
    "leadAuthor": "Eldurini S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi5BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi5BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-30ca040501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707165
  },
  {
    "id": "DEXA_Synt_83270",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41199603",
    "title": "Rare and rapidly progressive crescentic proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a case series study.",
    "authors": [
      "Zhou H",
      "Tu Y",
      "Liang S",
      "Zeng C",
      "Cheng Z"
    ],
    "journal": "Ren Fail",
    "publicationDate": "2025-11-7",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "11ab065e-69e2-4ec7-ad6c-2ed7cb0a38fc",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.601Z"
      },
      {
        "id": "4d121dc2-046c-4bbb-949d-543c56f56bde",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from b6bd7140-7d50-4d19-91d6-9d3b89853771 to DEXA_Synt_83270",
        "type": "system",
        "createdAt": "2025-12-14T10:12:45.321Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:41.858Z",
    "updatedAt": "2025-12-14T08:54:28.636Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41199603",
      "DOI": "https://doi.org10.1080/0886022X.2025.2578414",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:28:29",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Zhou H, Tu Y, Liang S, Zeng C, Cheng Z. Rare and rapidly progressive crescentic proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a case series study. Ren Fail. 2025;47(1):2578414",
      "pubdate": "2025-11-7",
      "Lead_author": "Zhou H",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/0886022X.2025.2578414",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Zhou H, Tu Y, Liang S, Zeng C, Cheng Z. Rare and rapidly progressive crescentic proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a case series study. Ren Fail. 2025;47(1):2578414",
    "leadAuthor": "Zhou H",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi6BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi6BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-30e9d80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707165
  },
  {
    "id": "DEXA_Synt_87653",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41199309",
    "title": "Next-generation microneedle platforms for site-specific management of diabetic neuropathy.",
    "authors": [
      "Kondaveeti SB",
      "Kaur K",
      "Gupta V",
      "Tanwar R",
      "Choudhary N",
      "Kumar D",
      "Gupta S",
      "Rani P",
      "Vk A"
    ],
    "journal": "Diabetol Metab Syndr",
    "publicationDate": "2025-11-7",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "47131eac-9d10-4ac5-9443-637855a90c78",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.664Z"
      },
      {
        "id": "5fb1072e-0459-4825-922e-79fcf6c06467",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 132d26bf-3f00-4fca-81a0-1b8d2cdfa250 to DEXA_Synt_87653",
        "type": "system",
        "createdAt": "2025-12-14T10:12:45.537Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:41.918Z",
    "updatedAt": "2025-12-14T08:54:28.675Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41199309",
      "DOI": "https://doi.org10.1186/s13098-025-01966-4",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:28:07",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Kondaveeti SB, Kaur K, Gupta V, Tanwar R, Choudhary N, Kumar D, Gupta S, Rani P, Vk A. Next-generation microneedle platforms for site-specific management of diabetic neuropathy. Diabetol Metab Syndr. 2025;17(1):418",
      "pubdate": "2025-11-7",
      "Lead_author": "Kondaveeti SB",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s13098-025-01966-4",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Kondaveeti SB, Kaur K, Gupta V, Tanwar R, Choudhary N, Kumar D, Gupta S, Rani P, Vk A. Next-generation microneedle platforms for site-specific management of diabetic neuropathy. Diabetol Metab Syndr. 2025;17(1):418",
    "leadAuthor": "Kondaveeti SB",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi7BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi7BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-310ac80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707165
  },
  {
    "id": "DEXA_Synt_16125",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41191234",
    "title": "Evaluation of factors associated with clinically problematic hiccups in cisplatin-containing treatment with dexamethasone and neurokinin 1 receptor antagonists.",
    "authors": [
      "Saito Y",
      "Takekuma Y",
      "Sakakibara-Konishi J",
      "Shimizu Y",
      "Kinoshita I",
      "Sugawara M"
    ],
    "journal": "Int J Clin Oncol",
    "publicationDate": "2025-11-5",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ec6e1556-0c01-4bdc-a445-50a71cbf0bc2",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.693Z"
      },
      {
        "id": "26d785a6-0289-4a66-a9f5-1bd6213396a5",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from e5f2f5b9-902e-447f-a5b5-7dc90a1c090d to DEXA_Synt_16125",
        "type": "system",
        "createdAt": "2025-12-14T10:12:45.781Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:42.117Z",
    "updatedAt": "2025-12-14T08:54:28.705Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41191234",
      "DOI": "https://doi.org10.1007/s10147-025-02912-0",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:28:22",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Saito Y, Takekuma Y, Sakakibara-Konishi J, Shimizu Y, Kinoshita I, Sugawara M. Evaluation of factors associated with clinically problematic hiccups in cisplatin-containing treatment with dexamethasone and neurokinin 1 receptor antagonists. Int J Clin Oncol. 2025;30(12):2504-11",
      "pubdate": "2025-11-5",
      "Lead_author": "Saito Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s10147-025-02912-0",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Saito Y, Takekuma Y, Sakakibara-Konishi J, Shimizu Y, Kinoshita I, Sugawara M. Evaluation of factors associated with clinically problematic hiccups in cisplatin-containing treatment with dexamethasone and neurokinin 1 receptor antagonists. Int J Clin Oncol. 2025;30(12):2504-11",
    "leadAuthor": "Saito Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi8BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi8BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-312fbc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707165
  },
  {
    "id": "DEXA_Synt_55213",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41189811",
    "title": "Synthesis, characterization and biological studies of pyrazole-linked Schiff bases and their copper(ii) complexes as potential therapeutics.",
    "authors": [
      "Kumari P",
      "Kumar A",
      "Kataria R",
      "Kaushik NK",
      "Ahmed M",
      "Ansari A",
      "Ekta",
      "Brahma M",
      "Maruthi M",
      "Babu YS",
      "Singh B",
      "Kumar V"
    ],
    "journal": "RSC Adv",
    "publicationDate": "2025-11-5",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ebdaad05-bc30-471f-8060-770a4acc1d41",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.755Z"
      },
      {
        "id": "46db4fb1-c03b-4031-b8ca-d8389dfc7d06",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 01ca5181-cf59-4fe8-a307-7d63acb0db32 to DEXA_Synt_55213",
        "type": "system",
        "createdAt": "2025-12-14T10:12:45.983Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:42.177Z",
    "updatedAt": "2025-12-14T08:54:28.764Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41189811",
      "DOI": "https://doi.org10.1039/d5ra06008g",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:28:14",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Kumari P, Kumar A, Kataria R, Kaushik NK, Ahmed M, Ansari A, Ekta, Brahma M, Maruthi M, Babu YS, Singh B, Kumar V. Synthesis, characterization and biological studies of pyrazole-linked Schiff bases and their copper(ii) complexes as potential therapeutics. RSC Adv. 2025;15(50):42299-314",
      "pubdate": "2025-11-5",
      "Lead_author": "Kumari P",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1039/d5ra06008g",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Kumari P, Kumar A, Kataria R, Kaushik NK, Ahmed M, Ansari A, Ekta, Brahma M, Maruthi M, Babu YS, Singh B, Kumar V. Synthesis, characterization and biological studies of pyrazole-linked Schiff bases and their copper(ii) complexes as potential therapeutics. RSC Adv. 2025;15(50):42299-314",
    "leadAuthor": "Kumari P",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi9BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi9BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3151b40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707166
  },
  {
    "id": "DEXA_Synt_28377",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41188793",
    "title": "The potential role of IgG subclass in NF155-associated nodopathy for targeting therapy: a pediatric case report highlighting the efficacy of pulsed oral corticosteroids.",
    "authors": [
      "Turčanová Koprušáková M",
      "Kurča E",
      "Trusiková E",
      "Mgbachi V",
      "Rinaldi S"
    ],
    "journal": "BMC Neurol",
    "publicationDate": "2025-11-5",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "463dc899-9fa1-40a0-a0c2-740f620a6516",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.786Z"
      },
      {
        "id": "8e796a66-23e7-45ad-8f43-ab1536508a64",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a7ce38e4-833a-4103-a53a-80e628327983 to DEXA_Synt_28377",
        "type": "system",
        "createdAt": "2025-12-14T10:12:46.211Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:42.382Z",
    "updatedAt": "2025-12-14T08:54:28.850Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41188793",
      "DOI": "https://doi.org10.1186/s12883-025-04467-z",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:28:37",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Turčanová Koprušáková M, Kurča E, Trusiková E, Mgbachi V, Rinaldi S. The potential role of IgG subclass in NF155-associated nodopathy for targeting therapy: a pediatric case report highlighting the efficacy of pulsed oral corticosteroids. BMC Neurol. 2025;25(1):451",
      "pubdate": "2025-11-5",
      "Lead_author": "Turčanová Koprušáková M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s12883-025-04467-z",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Turčanová Koprušáková M, Kurča E, Trusiková E, Mgbachi V, Rinaldi S. The potential role of IgG subclass in NF155-associated nodopathy for targeting therapy: a pediatric case report highlighting the efficacy of pulsed oral corticosteroids. BMC Neurol. 2025;25(1):451",
    "leadAuthor": "Turčanová Koprušáková M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi+BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi+BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3171fc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707166
  },
  {
    "id": "DEXA_Synt_84180",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41114831",
    "title": "β-Sheet-Assisted Fabrication of Drug-Loaded Gelatin/Silk Fibroin Nanoparticles for Spinal Cord Injury Treatment.",
    "authors": [
      "Guo J",
      "Liu J",
      "Wang M",
      "Zhang Y",
      "Zhang Z",
      "Cohen Stuart M",
      "Chen J",
      "Tang W",
      "Guo X",
      "Qi D",
      "Liu T"
    ],
    "journal": "Biomacromolecules",
    "publicationDate": "2025-10-20",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "06aa0d35-e7d8-46d3-bc5b-d9e02cedb090",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.880Z"
      },
      {
        "id": "bfb8bba9-7284-4827-873b-863a2c2ab04b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from dc14a816-3067-4a4b-85f6-df0c94a7299e to DEXA_Synt_84180",
        "type": "system",
        "createdAt": "2025-12-14T10:12:46.428Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:42.422Z",
    "updatedAt": "2025-12-14T08:54:28.888Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41114831",
      "DOI": "https://doi.org10.1021/acs.biomac.5c01478",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:28:58",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Guo J, Liu J, Wang M, Zhang Y, Zhang Z, Cohen Stuart M, Chen J, Tang W, Guo X, Qi D, Liu T. β-Sheet-Assisted Fabrication of Drug-Loaded Gelatin/Silk Fibroin Nanoparticles for Spinal Cord Injury Treatment. Biomacromolecules. 2025;26(11):8064-73",
      "pubdate": "2025-10-20",
      "Lead_author": "Guo J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1021/acs.biomac.5c01478",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Guo J, Liu J, Wang M, Zhang Y, Zhang Z, Cohen Stuart M, Chen J, Tang W, Guo X, Qi D, Liu T. β-Sheet-Assisted Fabrication of Drug-Loaded Gelatin/Silk Fibroin Nanoparticles for Spinal Cord Injury Treatment. Biomacromolecules. 2025;26(11):8064-73",
    "leadAuthor": "Guo J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi-BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi-BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3193180501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707166
  },
  {
    "id": "DEXA_Synt_98259",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41114432",
    "title": "Treating rheumatoid arthritis using fibroblast-activated protein-α-responsive micelles through a cascade control program.",
    "authors": [
      "Li Y",
      "Xie P",
      "Gong R",
      "Chen J",
      "Liu Y",
      "Yin Z"
    ],
    "journal": "J Mater Chem B",
    "publicationDate": "2025-10-20",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "093f3eb3-b159-476e-84bf-2ae386f7776f",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.911Z"
      },
      {
        "id": "d2f5ed70-a4b9-4813-b3d1-deacf8585f1c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 769f917e-f5ea-4a1f-941d-12511d02ed58 to DEXA_Synt_98259",
        "type": "system",
        "createdAt": "2025-12-14T10:12:46.691Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:42.626Z",
    "updatedAt": "2025-12-14T08:54:28.921Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41114432",
      "DOI": "https://doi.org10.1039/d5tb01441g",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:29:05",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Li Y, Xie P, Gong R, Chen J, Liu Y, Yin Z. Treating rheumatoid arthritis using fibroblast-activated protein-α-responsive micelles through a cascade control program. J Mater Chem B. 2025;13(43):14131-",
      "pubdate": "2025-10-20",
      "Lead_author": "Li Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1039/d5tb01441g",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Li Y, Xie P, Gong R, Chen J, Liu Y, Yin Z. Treating rheumatoid arthritis using fibroblast-activated protein-α-responsive micelles through a cascade control program. J Mater Chem B. 2025;13(43):14131-",
    "leadAuthor": "Li Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjABwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjABwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-31bb0c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707166
  },
  {
    "id": "DEXA_Synt_96629",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41107632",
    "title": "Etanercept-induced sarcoidosis presenting with bilateral panuveitis: diagnostic value of ocular signs and therapeutic response to IL-17A inhibition-a case-based review.",
    "authors": [
      "Bonifazi T",
      "Cerquaglia A",
      "Iaccheri B"
    ],
    "journal": "Clin Rheumatol",
    "publicationDate": "2025-10-18",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "31e97e25-4cf1-4f3a-a353-81ac529954d2",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.954Z"
      },
      {
        "id": "a56bee59-0453-483e-a264-e83a0ff7429b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a466dcc7-b3ff-4116-9634-89e3c87fdf1d to DEXA_Synt_96629",
        "type": "system",
        "createdAt": "2025-12-14T10:12:46.860Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:42.705Z",
    "updatedAt": "2025-12-14T08:54:28.966Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41107632",
      "DOI": "https://doi.org10.1007/s10067-025-07759-4",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:28:44",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Bonifazi T, Cerquaglia A, Iaccheri B. Etanercept-induced sarcoidosis presenting with bilateral panuveitis: diagnostic value of ocular signs and therapeutic response to IL-17A inhibition-a case-based review. Clin Rheumatol. 2025;44(12):5123-",
      "pubdate": "2025-10-18",
      "Lead_author": "Bonifazi T",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s10067-025-07759-4",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Bonifazi T, Cerquaglia A, Iaccheri B. Etanercept-induced sarcoidosis presenting with bilateral panuveitis: diagnostic value of ocular signs and therapeutic response to IL-17A inhibition-a case-based review. Clin Rheumatol. 2025;44(12):5123-",
    "leadAuthor": "Bonifazi T",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjBBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjBBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-31df980501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707166
  },
  {
    "id": "DEXA_Synt_17035",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41091406",
    "title": "Real-world adherence to antiemetic guidelines in Japanese patients receiving high or carboplatin-based moderate emetic risk chemotherapy.",
    "authors": [
      "Okuyama A",
      "Higashi T",
      "Abe M",
      "Hayashi T",
      "Iihara H",
      "Iino K",
      "Ishii C",
      "Okita K",
      "Wada M",
      "Yamamoto N",
      "Zenda S",
      "Aogi K",
      "Satomi E"
    ],
    "journal": "Int J Clin Oncol",
    "publicationDate": "2025-10-15",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "dcd066c9-dff8-4ac5-b373-c2021b2a59d8",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:28.985Z"
      },
      {
        "id": "ce6a4f46-b620-44c8-b40e-38e4da338082",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 07383921-e72c-43d8-9718-233a4e16f4ea to DEXA_Synt_17035",
        "type": "system",
        "createdAt": "2025-12-14T10:12:47.078Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:42.908Z",
    "updatedAt": "2025-12-14T08:54:29.034Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41091406",
      "DOI": "https://doi.org10.1007/s10147-025-02894-z",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:28:51",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Okuyama A, Higashi T, Abe M, Hayashi T, Iihara H, Iino K, Ishii C, Okita K, Wada M, Yamamoto N, Zenda S, Aogi K, Satomi E. Real-world adherence to antiemetic guidelines in Japanese patients receiving high or carboplatin-based moderate emetic risk chemotherapy. Int J Clin Oncol. 2025;30(12):2464-73",
      "pubdate": "2025-10-15",
      "Lead_author": "Okuyama A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s10147-025-02894-z",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Okuyama A, Higashi T, Abe M, Hayashi T, Iihara H, Iino K, Ishii C, Okita K, Wada M, Yamamoto N, Zenda S, Aogi K, Satomi E. Real-world adherence to antiemetic guidelines in Japanese patients receiving high or carboplatin-based moderate emetic risk chemotherapy. Int J Clin Oncol. 2025;30(12):2464-73",
    "leadAuthor": "Okuyama A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjCBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjCBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-32009c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707167
  },
  {
    "id": "DEXA_Synt_58274",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41048199",
    "title": "Integration of Metabolic Profiling and Functional Genomics Suggests IGJ as a Driver of Chemoresistance in B-ALL.",
    "authors": [
      "Pachón-Meza KL",
      "Moreno-Cristancho CE",
      "Padilla-Agudelo JL",
      "Ramos-Murillo AI",
      "Londoño-Barbosa D",
      "Salguero G",
      "Sanabria-Barrera SM",
      "Chica C",
      "Cruz-Rodriguez N",
      "Godoy-Silva RD",
      "Gutiérrez-Triana JA"
    ],
    "journal": "Pediatr Blood Cancer",
    "publicationDate": "2025-10-6",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ca00a4d4-0154-4e9f-94d7-ab95df72b1be",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.046Z"
      },
      {
        "id": "1801cf75-1b2b-41dd-a7ee-d4d775d90fdd",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6f53344f-8619-4f7b-b5f9-1f959eb0af3e to DEXA_Synt_58274",
        "type": "system",
        "createdAt": "2025-12-14T10:12:47.308Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:42.984Z",
    "updatedAt": "2025-12-14T08:54:29.064Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41048199",
      "DOI": "https://doi.org10.1002/pbc.32068",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:29:12",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Pachón-Meza KL, Moreno-Cristancho CE, Padilla-Agudelo JL, Ramos-Murillo AI, Londoño-Barbosa D, Salguero G, Sanabria-Barrera SM, Chica C, Cruz-Rodriguez N, Godoy-Silva RD, Gutiérrez-Triana JA. Integration of Metabolic Profiling and Functional Genomics Suggests IGJ as a Driver of Chemoresistance in B-ALL. Pediatr Blood Cancer. 2025;72(12):e32068",
      "pubdate": "2025-10-6",
      "Lead_author": "Pachón-Meza KL",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/pbc.32068",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Pachón-Meza KL, Moreno-Cristancho CE, Padilla-Agudelo JL, Ramos-Murillo AI, Londoño-Barbosa D, Salguero G, Sanabria-Barrera SM, Chica C, Cruz-Rodriguez N, Godoy-Silva RD, Gutiérrez-Triana JA. Integration of Metabolic Profiling and Functional Genomics Suggests IGJ as a Driver of Chemoresistance in B-ALL. Pediatr Blood Cancer. 2025;72(12):e32068",
    "leadAuthor": "Pachón-Meza KL",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjDBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjDBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3221300501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707167
  },
  {
    "id": "DEXA_Synt_99575",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40935291",
    "title": "Maternal glycaemic responses to antenatal glucocorticoids: a scoping review.",
    "authors": [
      "Jones AS",
      "Lee IL",
      "Kevat D",
      "Said JM",
      "Atallah K",
      "Fletcher T",
      "Yates CJ"
    ],
    "journal": "J Gynecol Obstet Hum Reprod",
    "publicationDate": "2025-09-12",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "3877ff9b-02c2-4d3f-a7b8-3405527f9a4d",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.076Z"
      },
      {
        "id": "8d619fa3-04ee-4307-ab26-6fbd20b27711",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from cbf0621c-77c0-4d1f-9cd4-be0700b75280 to DEXA_Synt_99575",
        "type": "system",
        "createdAt": "2025-12-14T10:12:47.541Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:43.155Z",
    "updatedAt": "2025-12-14T08:54:29.143Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40935291",
      "DOI": "https://doi.org10.1016/j.jogoh.2025.103029",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:29:34",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Jones AS, Lee IL, Kevat D, Said JM, Atallah K, Fletcher T, Yates CJ. Maternal glycaemic responses to antenatal glucocorticoids: a scoping review. J Gynecol Obstet Hum Reprod. 2025;54(10):103029",
      "pubdate": "2025-09-12",
      "Lead_author": "Jones AS",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jogoh.2025.103029",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Jones AS, Lee IL, Kevat D, Said JM, Atallah K, Fletcher T, Yates CJ. Maternal glycaemic responses to antenatal glucocorticoids: a scoping review. J Gynecol Obstet Hum Reprod. 2025;54(10):103029",
    "leadAuthor": "Jones AS",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjEBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjEBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3242980501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707167
  },
  {
    "id": "DEXA_Synt_52451",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40929958",
    "title": "Integrative multi-omics identifies S100A8/IGFBP5/CTSK/S100P as dual diagnostic biomarkers and therapeutic targets in Crohn's disease: from computational discovery to preclinical validation.",
    "authors": [
      "Wu J",
      "Nie H",
      "Wang H",
      "Li F",
      "Ma Y",
      "Yang X",
      "Wang D",
      "Xu H",
      "Zhan Q",
      "Huang Y",
      "Yang Y"
    ],
    "journal": "Int Immunopharmacol",
    "publicationDate": "2025-09-11",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a174dcde-ff39-4739-96fa-1ddc5f5c583e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.170Z"
      },
      {
        "id": "982fdc7e-0b7b-487c-875a-3d14c38f66e6",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 5d96d8c6-5b88-48ad-9b9b-d5204b31a18e to DEXA_Synt_52451",
        "type": "system",
        "createdAt": "2025-12-14T10:12:47.774Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:43.248Z",
    "updatedAt": "2025-12-14T08:54:29.181Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40929958",
      "DOI": "https://doi.org10.1016/j.intimp.2025.115500",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:29:20",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Wu J, Nie H, Wang H, Li F, Ma Y, Yang X, Wang D, Xu H, Zhan Q, Huang Y, Yang Y. Integrative multi-omics identifies S100A8/IGFBP5/CTSK/S100P as dual diagnostic biomarkers and therapeutic targets in Crohn's disease: from computational discovery to preclinical validation. Int Immunopharmacol. 2025;165115500",
      "pubdate": "2025-09-11",
      "Lead_author": "Wu J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.intimp.2025.115500",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Wu J, Nie H, Wang H, Li F, Ma Y, Yang X, Wang D, Xu H, Zhan Q, Huang Y, Yang Y. Integrative multi-omics identifies S100A8/IGFBP5/CTSK/S100P as dual diagnostic biomarkers and therapeutic targets in Crohn's disease: from computational discovery to preclinical validation. Int Immunopharmacol. 2025;165115500",
    "leadAuthor": "Wu J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjFBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjFBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-32633c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707167
  },
  {
    "id": "DEXA_Synt_16232",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40926506",
    "title": "Intraoperative dexamethasone after pancreatoduodenectomy in pancreatic ductal adenocarcinoma: A retrospective cohort study.",
    "authors": [
      "Peltoniemi P",
      "Mustonen H",
      "Johansson K",
      "Lehto I",
      "Seppänen H",
      "Pere P"
    ],
    "journal": "Scand J Surg",
    "publicationDate": "2025-09-10",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "08e0cf58-d820-429d-8679-a9d308946283",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.201Z"
      },
      {
        "id": "ba16cd63-52e5-4a3d-9cec-f92e2ce071cc",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from cbe83a7b-d140-4a9a-9ef9-b83bc1024be5 to DEXA_Synt_16232",
        "type": "system",
        "createdAt": "2025-12-14T10:12:48.037Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:43.416Z",
    "updatedAt": "2025-12-14T08:54:29.206Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40926506",
      "DOI": "https://doi.org10.1177/14574969251371868",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:29:28",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Peltoniemi P, Mustonen H, Johansson K, Lehto I, Seppänen H, Pere P. Intraoperative dexamethasone after pancreatoduodenectomy in pancreatic ductal adenocarcinoma: A retrospective cohort study. Scand J Surg. 2025;114(4):436-45",
      "pubdate": "2025-09-10",
      "Lead_author": "Peltoniemi P",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1177/14574969251371868",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Peltoniemi P, Mustonen H, Johansson K, Lehto I, Seppänen H, Pere P. Intraoperative dexamethasone after pancreatoduodenectomy in pancreatic ductal adenocarcinoma: A retrospective cohort study. Scand J Surg. 2025;114(4):436-45",
    "leadAuthor": "Peltoniemi P",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjGBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjGBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3288400501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707168
  },
  {
    "id": "DEXA_Synt_57724",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40883152",
    "title": "Pomalidomide, Cyclophosphamide, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Experience.",
    "authors": [
      "Ntanasis-Stathopoulos I",
      "Malandrakis P",
      "Filippatos C",
      "Maganas S",
      "Fotiou D",
      "Theodorakakou F",
      "Spiliopoulou V",
      "Kanellias N",
      "Migkou M",
      "Eleutherakis-Papaiakovou E",
      "Terpos E",
      "Kastritis E",
      "Dimopoulos MA",
      "Gavriatopoulou M"
    ],
    "journal": "Clin Lymphoma Myeloma Leuk",
    "publicationDate": "2025-08-30",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6d2f2336-ce13-4963-971c-08440b5a64a6",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.234Z"
      },
      {
        "id": "2a515a85-535e-4b0e-a2b7-b208bf64d7a8",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6f091f7b-437a-4339-a34f-0dba4fb177c4 to DEXA_Synt_57724",
        "type": "system",
        "createdAt": "2025-12-14T10:12:48.226Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:43.494Z",
    "updatedAt": "2025-12-14T08:54:29.298Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40883152",
      "DOI": "https://doi.org10.1016/j.clml.2025.08.003",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:29:41",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Ntanasis-Stathopoulos I, Malandrakis P, Filippatos C, Maganas S, Fotiou D, Theodorakakou F, Spiliopoulou V, Kanellias N, Migkou M, Eleutherakis-Papaiakovou E, Terpos E, Kastritis E, Dimopoulos MA, Gavriatopoulou M. Pomalidomide, Cyclophosphamide, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Experience. Clin Lymphoma Myeloma Leuk. 2025;25(12):e1077-",
      "pubdate": "2025-08-30",
      "Lead_author": "Ntanasis-Stathopoulos I",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.clml.2025.08.003",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Ntanasis-Stathopoulos I, Malandrakis P, Filippatos C, Maganas S, Fotiou D, Theodorakakou F, Spiliopoulou V, Kanellias N, Migkou M, Eleutherakis-Papaiakovou E, Terpos E, Kastritis E, Dimopoulos MA, Gavriatopoulou M. Pomalidomide, Cyclophosphamide, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Experience. Clin Lymphoma Myeloma Leuk. 2025;25(12):e1077-",
    "leadAuthor": "Ntanasis-Stathopoulos I",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjHBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjHBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-32a55c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707168
  },
  {
    "id": "DEXA_Synt_12413",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40811892",
    "title": "Peripheral blood T regulatory cell profiles in repeat-breeder Cattle: Differential responses to seminal components.",
    "authors": [
      "Pandit A",
      "Umar SIU",
      "Shah SM",
      "Ganai N",
      "Darzi S",
      "Shah R",
      "Bhat F",
      "Malik A",
      "Yaqoob H",
      "Saleem M"
    ],
    "journal": "Theriogenology",
    "publicationDate": "2025-08-14",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "e4a914b8-993b-4989-a8c3-6876d0dd832b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.321Z"
      },
      {
        "id": "9b37e97b-28a1-4f55-b829-6b86d6e775b2",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 2ed6a980-2a6a-459d-87ff-ccf82a8033fa to DEXA_Synt_12413",
        "type": "system",
        "createdAt": "2025-12-14T10:12:48.481Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:43.692Z",
    "updatedAt": "2025-12-14T08:54:29.333Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40811892",
      "DOI": "https://doi.org10.1016/j.theriogenology.2025.117625",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:29:49",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Pandit A, Umar SIU, Shah SM, Ganai N, Darzi S, Shah R, Bhat F, Malik A, Yaqoob H, Saleem M. Peripheral blood T regulatory cell profiles in repeat-breeder Cattle: Differential responses to seminal components. Theriogenology. 2025;248117625",
      "pubdate": "2025-08-14",
      "Lead_author": "Pandit A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.theriogenology.2025.117625",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Pandit A, Umar SIU, Shah SM, Ganai N, Darzi S, Shah R, Bhat F, Malik A, Yaqoob H, Saleem M. Peripheral blood T regulatory cell profiles in repeat-breeder Cattle: Differential responses to seminal components. Theriogenology. 2025;248117625",
    "leadAuthor": "Pandit A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjIBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjIBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-32cc380501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707168
  },
  {
    "id": "DEXA_Synt_50789",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40613758",
    "title": "Beneficial effects of aerobic exercises on multiple myeloma: Mechanisms and clinical observations.",
    "authors": [
      "He S",
      "Wen J",
      "Zou Z",
      "Li L",
      "Zhao X",
      "Liu X",
      "Luo H",
      "Huang J",
      "Mi Z",
      "Zhang Y",
      "Gao Q",
      "Yang H",
      "Feng Y",
      "Zhai X",
      "Wang F",
      "Niu T",
      "Zhang L",
      "Zheng Y"
    ],
    "journal": "Int J Cancer",
    "publicationDate": "2025-07-4",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "73835a6a-1bc2-46da-832c-bb875ab53b2f",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.353Z"
      },
      {
        "id": "36f0f08e-ff82-4882-a4a6-8b62315a07d1",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 054998cc-eff7-4e75-bf95-5d500bf34dc6 to DEXA_Synt_50789",
        "type": "system",
        "createdAt": "2025-12-14T10:12:48.669Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:43.731Z",
    "updatedAt": "2025-12-14T08:54:29.362Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40613758",
      "DOI": "https://doi.org10.1002/ijc.70032",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:30:11",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "He S, Wen J, Zou Z, Li L, Zhao X, Liu X, Luo H, Huang J, Mi Z, Zhang Y, Gao Q, Yang H, Feng Y, Zhai X, Wang F, Niu T, Zhang L, Zheng Y. Beneficial effects of aerobic exercises on multiple myeloma: Mechanisms and clinical observations. Int J Cancer. 2025;157(11):2343-53",
      "pubdate": "2025-07-4",
      "Lead_author": "He S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/ijc.70032",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "He S, Wen J, Zou Z, Li L, Zhao X, Liu X, Luo H, Huang J, Mi Z, Zhang Y, Gao Q, Yang H, Feng Y, Zhai X, Wang F, Niu T, Zhang L, Zheng Y. Beneficial effects of aerobic exercises on multiple myeloma: Mechanisms and clinical observations. Int J Cancer. 2025;157(11):2343-53",
    "leadAuthor": "He S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjJBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjJBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-32ee980501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707168
  },
  {
    "id": "DEXA_Synt_16431",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40530755",
    "title": "Pharmacoeconomic evaluation of carfilzomib  ixazomib for the treatment of relapsed and refractory multiple myeloma.",
    "authors": [
      "Wang L",
      "Chen F",
      "Ma Y",
      "Lin X",
      "Liu J",
      "Zhang Y",
      "You R"
    ],
    "journal": "Future Sci OA",
    "publicationDate": "2025-06-18",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5a3b93bd-ae15-4f1d-832a-6af33f752605",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.384Z"
      },
      {
        "id": "5ea87a0b-b610-48a8-9405-738cbdcc63c9",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 99c93233-0e7f-425a-bbb9-4ab55d4ac253 to DEXA_Synt_16431",
        "type": "system",
        "createdAt": "2025-12-14T10:12:48.914Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:43.956Z",
    "updatedAt": "2025-12-14T08:54:29.437Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40530755",
      "DOI": "https://doi.org10.1080/20565623.2025.2514969",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:29:57",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Wang L, Chen F, Ma Y, Lin X, Liu J, Zhang Y, You R. Pharmacoeconomic evaluation of carfilzomib <i>versus</i> ixazomib for the treatment of relapsed and refractory multiple myeloma. Future Sci OA. 2025;11(1):2514969",
      "pubdate": "2025-06-18",
      "Lead_author": "Wang L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/20565623.2025.2514969",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Wang L, Chen F, Ma Y, Lin X, Liu J, Zhang Y, You R. Pharmacoeconomic evaluation of carfilzomib <i>versus</i> ixazomib for the treatment of relapsed and refractory multiple myeloma. Future Sci OA. 2025;11(1):2514969",
    "leadAuthor": "Wang L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjKBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjKBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-330e000501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707168
  },
  {
    "id": "DEXA_Synt_89178",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40414368",
    "title": "Implication of Preoperative Intravenous Dexamethasone on Pain and Nausea in Late-Stage Elderly Total Knee Arthroplasty Patients: A Randomized Double-Blind Trial.",
    "authors": [
      "Xu C",
      "Wang X",
      "Wang M",
      "Wang D",
      "Kong S",
      "Zhou Q",
      "Lu J",
      "Wang A"
    ],
    "journal": "J Arthroplasty",
    "publicationDate": "2025-05-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "aa739ca7-6237-42ef-ab7b-306478367d40",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.461Z"
      },
      {
        "id": "b2906f07-ebd6-4316-884a-b461ac44bbdd",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d335d900-0f25-4168-976c-cba5b8ab01de to DEXA_Synt_89178",
        "type": "system",
        "createdAt": "2025-12-14T10:12:49.181Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:44.030Z",
    "updatedAt": "2025-12-14T08:54:29.472Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40414368",
      "DOI": "https://doi.org10.1016/j.arth.2025.05.065",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:30:19",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Xu C, Wang X, Wang M, Wang D, Kong S, Zhou Q, Lu J, Wang A. Implication of Preoperative Intravenous Dexamethasone on Pain and Nausea in Late-Stage Elderly Total Knee Arthroplasty Patients: A Randomized Double-Blind Trial. J Arthroplasty. 2025;40(12):3176-85",
      "pubdate": "2025-05-26",
      "Lead_author": "Xu C",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.arth.2025.05.065",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Xu C, Wang X, Wang M, Wang D, Kong S, Zhou Q, Lu J, Wang A. Implication of Preoperative Intravenous Dexamethasone on Pain and Nausea in Late-Stage Elderly Total Knee Arthroplasty Patients: A Randomized Double-Blind Trial. J Arthroplasty. 2025;40(12):3176-85",
    "leadAuthor": "Xu C",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjLBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjLBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3337040501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707169
  },
  {
    "id": "DEXA_Synt_87479",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40368793",
    "title": "Methylprednisolone-induced Anaphylaxis in Acute Hepatitis B: A Case Report and Literature Review.",
    "authors": [
      "Tamura Y",
      "Takizawa D",
      "Honda K",
      "Maruyama Y",
      "Ito K",
      "Inoue M",
      "Abe T",
      "Shibasaki M",
      "Sekiguchi M",
      "Sogabe Y",
      "Arai H",
      "Uraoka T"
    ],
    "journal": "Intern Med",
    "publicationDate": "2025-05-15",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "0ebcc6cc-ad6a-44af-a2a6-5e8bf9dc7e84",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.493Z"
      },
      {
        "id": "ae8efded-f839-428a-8801-be104c85afc8",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d6b7eaf4-8cc2-4962-a1de-386b9038d7e4 to DEXA_Synt_87479",
        "type": "system",
        "createdAt": "2025-12-14T10:12:49.332Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:44.217Z",
    "updatedAt": "2025-12-14T08:54:29.502Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40368793",
      "DOI": "https://doi.org10.2169/internalmedicine.5405-25",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:30:04",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Tamura Y, Takizawa D, Honda K, Maruyama Y, Ito K, Inoue M, Abe T, Shibasaki M, Sekiguchi M, Sogabe Y, Arai H, Uraoka T. Methylprednisolone-induced Anaphylaxis in Acute Hepatitis B: A Case Report and Literature Review. Intern Med. 2025;64(22):3232-",
      "pubdate": "2025-05-15",
      "Lead_author": "Tamura Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.2169/internalmedicine.5405-25",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Tamura Y, Takizawa D, Honda K, Maruyama Y, Ito K, Inoue M, Abe T, Shibasaki M, Sekiguchi M, Sogabe Y, Arai H, Uraoka T. Methylprednisolone-induced Anaphylaxis in Acute Hepatitis B: A Case Report and Literature Review. Intern Med. 2025;64(22):3232-",
    "leadAuthor": "Tamura Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjMBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjMBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3355f00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707169
  },
  {
    "id": "DEXA_Synt_89682",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40360445",
    "title": "Epstein-Barr virus infection plays a crucial role in triggering hemophagocytic lymphohistiocytosis in patients with X-linked inhibitor of apoptosis protein deficiency.",
    "authors": [
      "Shi L",
      "Dou L",
      "Wang J",
      "Wang Z"
    ],
    "journal": "Hematology",
    "publicationDate": "2025-05-14",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6440aa53-269d-4101-9bb6-8e6cf910bda4",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.553Z"
      },
      {
        "id": "1d4e19d9-e134-4b6a-bf4a-337a71ea9790",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 5748bb58-287d-48fe-8d55-08958ac12343 to DEXA_Synt_89682",
        "type": "system",
        "createdAt": "2025-12-14T10:12:49.594Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:44.296Z",
    "updatedAt": "2025-12-14T08:54:29.563Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40360445",
      "DOI": "https://doi.org10.1080/16078454.2025.2503745",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:30:26",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Shi L, Dou L, Wang J, Wang Z. Epstein-Barr virus infection plays a crucial role in triggering hemophagocytic lymphohistiocytosis in patients with X-linked inhibitor of apoptosis protein deficiency. Hematology. 2025;30(1):2503745",
      "pubdate": "2025-05-14",
      "Lead_author": "Shi L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/16078454.2025.2503745",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Shi L, Dou L, Wang J, Wang Z. Epstein-Barr virus infection plays a crucial role in triggering hemophagocytic lymphohistiocytosis in patients with X-linked inhibitor of apoptosis protein deficiency. Hematology. 2025;30(1):2503745",
    "leadAuthor": "Shi L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjNBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjNBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3376400501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707169
  },
  {
    "id": "DEXA_Synt_18902",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39800474",
    "title": "Spontaneous conversion of fetal heart block to sinus rhythm post externalized pacemaker placement in an undiagnosed mother with lupus antibodies.",
    "authors": [
      "Repicky J",
      "Gur J",
      "Fishberger S",
      "Byrum C",
      "Tague L"
    ],
    "journal": "J Matern Fetal Neonatal Med",
    "publicationDate": "2025-01-13",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "d84f0fbd-346a-4dcc-8fd7-ed0b82c3af79",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.586Z"
      },
      {
        "id": "0c8a8564-1259-421c-8296-061ece0d8194",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 94039c8e-4be3-4142-9f12-cf8a36faea31 to DEXA_Synt_18902",
        "type": "system",
        "createdAt": "2025-12-14T10:12:49.809Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:00:44.468Z",
    "updatedAt": "2025-12-14T08:54:29.637Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39800474",
      "DOI": "https://doi.org10.1080/14767058.2024.2428390",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:30:34",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Repicky J, Gur J, Fishberger S, Byrum C, Tague L. Spontaneous conversion of fetal heart block to sinus rhythm post externalized pacemaker placement in an undiagnosed mother with lupus antibodies. J Matern Fetal Neonatal Med. 2025;38(1):2428390",
      "pubdate": "2025-01-13",
      "Lead_author": "Repicky J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/14767058.2024.2428390",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Repicky J, Gur J, Fishberger S, Byrum C, Tague L. Spontaneous conversion of fetal heart block to sinus rhythm post externalized pacemaker placement in an undiagnosed mother with lupus antibodies. J Matern Fetal Neonatal Med. 2025;38(1):2428390",
    "leadAuthor": "Repicky J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjOBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjOBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3396c80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707169
  },
  {
    "id": "DEXA_Synt_26907",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41316801",
    "title": "Dexamethasone-Induced Nightmares in a Patient With Follicular Lymphoma.",
    "authors": [
      "Marinella MA"
    ],
    "journal": "Ann Pharmacother",
    "publicationDate": "2025-11-29",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "8c4d2873-8414-4768-a2d4-e211269c071e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.660Z"
      },
      {
        "id": "1caf1ee2-d2a7-45b1-875b-09e8573d14be",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6aa5b549-c0c4-4117-9dd6-71ed1893d159 to DEXA_Synt_26907",
        "type": "system",
        "createdAt": "2025-12-14T10:12:50.029Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:57.142Z",
    "updatedAt": "2025-12-14T08:54:29.671Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41316801",
      "DOI": "https://doi.org10.1177/10600280251400312",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:31:15",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Marinella MA. Dexamethasone-Induced Nightmares in a Patient With Follicular Lymphoma. Ann Pharmacother. 2025;10600280251400312",
      "pubdate": "2025-11-29",
      "Lead_author": "Marinella MA",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1177/10600280251400312",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Marinella MA. Dexamethasone-Induced Nightmares in a Patient With Follicular Lymphoma. Ann Pharmacother. 2025;10600280251400312",
    "leadAuthor": "Marinella MA",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjPBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjPBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-33b8380501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707170
  },
  {
    "id": "DEXA_Synt_51019",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41313710",
    "title": "Modeling the Impact of Hollow Microneedle Geometry on Iontophoretic Drug Transport Through Age-Variant Skin Surfaces.",
    "authors": [
      "Bhattacharjee A",
      "Alam MA",
      "Baruah RK"
    ],
    "journal": "IEEE Trans Nanobioscience",
    "publicationDate": "2025-11-28",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a8abdc5a-e3dd-4459-bf4c-69a7dbf99ee7",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.711Z"
      },
      {
        "id": "f26fc99a-30de-4884-9980-b7eada94967c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6ae9a5e1-9322-4d43-b500-c46b0e3a8a81 to DEXA_Synt_51019",
        "type": "system",
        "createdAt": "2025-12-14T10:12:50.245Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:57.240Z",
    "updatedAt": "2025-12-14T08:54:29.723Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41313710",
      "DOI": "https://doi.org10.1109/TNB.2025.3638648",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:31:07",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Bhattacharjee A, Alam MA, Baruah RK. Modeling the Impact of Hollow Microneedle Geometry on Iontophoretic Drug Transport Through Age-Variant Skin Surfaces. IEEE Trans Nanobioscience. 2025;PP",
      "pubdate": "2025-11-28",
      "Lead_author": "Bhattacharjee A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1109/TNB.2025.3638648",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Bhattacharjee A, Alam MA, Baruah RK. Modeling the Impact of Hollow Microneedle Geometry on Iontophoretic Drug Transport Through Age-Variant Skin Surfaces. IEEE Trans Nanobioscience. 2025;PP",
    "leadAuthor": "Bhattacharjee A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjQBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjQBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-33d97c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707170
  },
  {
    "id": "DEXA_Synt_30062",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41311657",
    "title": "Efficacy of faricimab for recalcitrant multifactorial cystoid macular edema.",
    "authors": [
      "Hanson J",
      "Yamamoto M",
      "Tsui E",
      "Tsui I"
    ],
    "journal": "Am J Ophthalmol Case Rep",
    "publicationDate": "2025-11-28",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "51ff3cea-42ad-4dd7-9d1a-d16b28700764",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.756Z"
      },
      {
        "id": "2c348774-77d0-408f-9fde-ce2648a0ed34",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 230f4365-b3c7-4b2c-a42d-6b5a60022a61 to DEXA_Synt_30062",
        "type": "system",
        "createdAt": "2025-12-14T10:12:50.460Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:57.271Z",
    "updatedAt": "2025-12-14T08:54:29.768Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41311657",
      "DOI": "https://doi.org10.1016/j.ajoc.2025.102475",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:31:00",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Hanson J, Yamamoto M, Tsui E, Tsui I. Efficacy of faricimab for recalcitrant multifactorial cystoid macular edema. Am J Ophthalmol Case Rep. 2025;40102475",
      "pubdate": "2025-11-28",
      "Lead_author": "Hanson J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ajoc.2025.102475",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Hanson J, Yamamoto M, Tsui E, Tsui I. Efficacy of faricimab for recalcitrant multifactorial cystoid macular edema. Am J Ophthalmol Case Rep. 2025;40102475",
    "leadAuthor": "Hanson J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjRBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjRBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-33fa580501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707170
  },
  {
    "id": "DEXA_Synt_46217",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41309039",
    "title": "Does Injection of Dexamethasone Into the Pterygopalatine Fossa Reduce the Side Effects of Third Molar Surgery?",
    "authors": [
      "Kumchai T",
      "Yongvikul A",
      "Khanijou M",
      "Wongsirichat N"
    ],
    "journal": "Does Injection of Dexamethasone Into the Pterygopalatine Fossa Reduce the Side Effects of Third Molar Surgery? J Oral Maxillofac Surg",
    "publicationDate": "2025-11-28",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "0d60c74a-4c41-4dad-9560-2299efd5f55d",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.788Z"
      },
      {
        "id": "0ba2b9f9-7029-4ba9-b526-59d20f4ae9cf",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 81f87cfa-16f9-46f5-af83-6030db0c8810 to DEXA_Synt_46217",
        "type": "system",
        "createdAt": "2025-12-14T10:12:50.711Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:57.302Z",
    "updatedAt": "2025-12-14T08:54:29.797Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41309039",
      "DOI": "https://doi.org10.1016/j.joms.2025.11.003",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:30:53",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Kumchai T, Yongvikul A, Khanijou M, Wongsirichat N. Does Injection of Dexamethasone Into the Pterygopalatine Fossa Reduce the Side Effects of Third Molar Surgery? J Oral Maxillofac Surg. 2025;",
      "pubdate": "2025-11-28",
      "Lead_author": "Kumchai T",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.joms.2025.11.003",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Kumchai T, Yongvikul A, Khanijou M, Wongsirichat N. Does Injection of Dexamethasone Into the Pterygopalatine Fossa Reduce the Side Effects of Third Molar Surgery? J Oral Maxillofac Surg. 2025;",
    "leadAuthor": "Kumchai T",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjSBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjSBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-341fcc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707170
  },
  {
    "id": "DEXA_Synt_18184",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41289704",
    "title": "Prior dexamethasone exposure attenuates the therapeutic efficacy of mouse bone marrow-derived mesenchymal stem cells in experimental autoimmune encephalomyelitis by fostering a hostile immunological microenvironment.",
    "authors": [
      "Zhang Y",
      "Lv X",
      "Wang Q",
      "Ma X",
      "Wu R",
      "Cui T",
      "Ding X",
      "Zhang Q",
      "Yang L",
      "Ma C",
      "Yan Y"
    ],
    "journal": "J Neuroimmunol",
    "publicationDate": "2025-11-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b337d6df-04d1-425e-ad7b-ff2a73535026",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.851Z"
      },
      {
        "id": "b101ea74-eeb8-41a9-a3f4-8f8551f28d38",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d8763b4f-5685-4377-b167-78cc9e802a59 to DEXA_Synt_18184",
        "type": "system",
        "createdAt": "2025-12-14T10:12:50.912Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:57.336Z",
    "updatedAt": "2025-12-14T08:54:29.865Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41289704",
      "DOI": "https://doi.org10.1016/j.jneuroim.2025.578814",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:31:22",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Zhang Y, Lv X, Wang Q, Ma X, Wu R, Cui T, Ding X, Zhang Q, Yang L, Ma C, Yan Y. Prior dexamethasone exposure attenuates the therapeutic efficacy of mouse bone marrow-derived mesenchymal stem cells in experimental autoimmune encephalomyelitis by fostering a hostile immunological microenvironment. J Neuroimmunol. 2025;410578814",
      "pubdate": "2025-11-26",
      "Lead_author": "Zhang Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jneuroim.2025.578814",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Zhang Y, Lv X, Wang Q, Ma X, Wu R, Cui T, Ding X, Zhang Q, Yang L, Ma C, Yan Y. Prior dexamethasone exposure attenuates the therapeutic efficacy of mouse bone marrow-derived mesenchymal stem cells in experimental autoimmune encephalomyelitis by fostering a hostile immunological microenvironment. J Neuroimmunol. 2025;410578814",
    "leadAuthor": "Zhang Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjTBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjTBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-343f240501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707170
  },
  {
    "id": "DEXA_Synt_97139",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41276104",
    "title": "Spinal microglial membrane glucocorticoid receptors regulate anti-hypersensitivity by stimulating dynorphin A expression.",
    "authors": [
      "Ma L",
      "Wei J",
      "Deng MY",
      "Ahmad KA",
      "Huang J",
      "Zhao MJ",
      "Li X",
      "Mao Y",
      "Wang YX",
      "Chen J"
    ],
    "journal": "Eur J Pharmacol",
    "publicationDate": "2025-11-24",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "56d656fa-2b95-4106-b454-bb1fa9158602",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.899Z"
      },
      {
        "id": "37cffd58-7d50-427e-b9f7-f58a5826f1a5",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 2e4359b6-8253-4c99-be8d-2d9552d8031a to DEXA_Synt_97139",
        "type": "system",
        "createdAt": "2025-12-14T10:12:51.128Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:57.362Z",
    "updatedAt": "2025-12-14T08:54:29.913Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41276104",
      "DOI": "https://doi.org10.1016/j.ejphar.2025.178362",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:31:37",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Ma L, Wei J, Deng MY, Ahmad KA, Huang J, Zhao MJ, Li X, Mao Y, Wang YX, Chen J. Spinal microglial membrane glucocorticoid receptors regulate anti-hypersensitivity by stimulating dynorphin A expression. Eur J Pharmacol. 2025;1010178362",
      "pubdate": "2025-11-24",
      "Lead_author": "Ma L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ejphar.2025.178362",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Ma L, Wei J, Deng MY, Ahmad KA, Huang J, Zhao MJ, Li X, Mao Y, Wang YX, Chen J. Spinal microglial membrane glucocorticoid receptors regulate anti-hypersensitivity by stimulating dynorphin A expression. Eur J Pharmacol. 2025;1010178362",
    "leadAuthor": "Ma L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjUBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjUBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3460280501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707171
  },
  {
    "id": "DEXA_Synt_54747",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41273107",
    "title": "Convalescent plasma in hospitalised patients with COVID-19.",
    "authors": [
      "McQuilten Z",
      "O'Sullivan MVN",
      "Purcell D",
      "Edler P",
      "Meagher N",
      "Alcorn K",
      "Bowen A",
      "Daly J",
      "Foo H",
      "Goulding S",
      "Gosbell I",
      "Hammond N",
      "Hills T",
      "Hoad V",
      "Jha V",
      "Lim LL",
      "McPhee G",
      "Molton J",
      "Morpeth S",
      "Nguyen V",
      "Paterson D",
      "Rees M",
      "Roberts J",
      "Rogers BA",
      "Stewart A",
      "Sasadeusz J",
      "Snelling T",
      "Venkatesh B",
      "Wood E",
      "Davis JS",
      "Tong SYC",
      "Price DJ",
      "Denholm JT"
    ],
    "journal": "Intern Med J",
    "publicationDate": "2025-11-22",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "2c0437e3-535a-492f-a2b1-b82e2d1f41e5",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.940Z"
      },
      {
        "id": "bada562b-8a99-4d2d-bb7a-b399c6a2abba",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 14e5f123-2af4-478a-89f8-e89105b77537 to DEXA_Synt_54747",
        "type": "system",
        "createdAt": "2025-12-14T10:12:51.374Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:57.394Z",
    "updatedAt": "2025-12-14T08:54:29.956Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41273107",
      "DOI": "https://doi.org10.1111/imj.70253",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:31:51",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "McQuilten Z, O'Sullivan MVN, Purcell D, Edler P, Meagher N, Alcorn K, Bowen A, Daly J, Foo H, Goulding S, Gosbell I, Hammond N, Hills T, Hoad V, Jha V, Lim LL, McPhee G, Molton J, Morpeth S, Nguyen V, Paterson D, Rees M, Roberts J, Rogers BA, Stewart A, Sasadeusz J, Snelling T, Venkatesh B, Wood E, Davis JS, Tong SYC, Price DJ, Denholm JT. Convalescent plasma in hospitalised patients with COVID-19. Intern Med J. 2025;",
      "pubdate": "2025-11-22",
      "Lead_author": "McQuilten Z",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/imj.70253",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "McQuilten Z, O'Sullivan MVN, Purcell D, Edler P, Meagher N, Alcorn K, Bowen A, Daly J, Foo H, Goulding S, Gosbell I, Hammond N, Hills T, Hoad V, Jha V, Lim LL, McPhee G, Molton J, Morpeth S, Nguyen V, Paterson D, Rees M, Roberts J, Rogers BA, Stewart A, Sasadeusz J, Snelling T, Venkatesh B, Wood E, Davis JS, Tong SYC, Price DJ, Denholm JT. Convalescent plasma in hospitalised patients with COVID-19. Intern Med J. 2025;",
    "leadAuthor": "McQuilten Z",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjVBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjVBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3486a80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707171
  },
  {
    "id": "DEXA_Synt_92808",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41268978",
    "title": "Mechano- and Glucocorticoid-Sensitive TREK-1 Channels Regulate Conventional Outflow and Intraocular Pressure.",
    "authors": [
      "Redmon SN",
      "Yarishkin O",
      "Rudzitis CN",
      "Lakk M",
      "Bertrand J",
      "van Batenburg-Sherwood J",
      "Nicou CM",
      "Passaglia CL",
      "Overby DR",
      "Križaj D"
    ],
    "journal": "Invest Ophthalmol Vis Sci",
    "publicationDate": "2025-11-21",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "745cb22f-b9d5-4819-8ca2-d6af25e2c62b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:29.989Z"
      },
      {
        "id": "8b36f2dd-0a52-4409-b264-cc2efd3022e2",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 62c0376c-4e24-43b2-aa98-f0e8f11e3932 to DEXA_Synt_92808",
        "type": "system",
        "createdAt": "2025-12-14T10:12:51.576Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:57.426Z",
    "updatedAt": "2025-12-14T08:54:30.001Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41268978",
      "DOI": "https://doi.org10.1167/iovs.66.14.57",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:31:31",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Redmon SN, Yarishkin O, Rudzitis CN, Lakk M, Bertrand J, van Batenburg-Sherwood J, Nicou CM, Passaglia CL, Overby DR, Križaj D. Mechano- and Glucocorticoid-Sensitive TREK-1 Channels Regulate Conventional Outflow and Intraocular Pressure. Invest Ophthalmol Vis Sci. 2025;66(14):57",
      "pubdate": "2025-11-21",
      "Lead_author": "Redmon SN",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1167/iovs.66.14.57",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Redmon SN, Yarishkin O, Rudzitis CN, Lakk M, Bertrand J, van Batenburg-Sherwood J, Nicou CM, Passaglia CL, Overby DR, Križaj D. Mechano- and Glucocorticoid-Sensitive TREK-1 Channels Regulate Conventional Outflow and Intraocular Pressure. Invest Ophthalmol Vis Sci. 2025;66(14):57",
    "leadAuthor": "Redmon SN",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjWBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjWBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-34ac000501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707171
  },
  {
    "id": "DEXA_Synt_81438",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41263118",
    "title": "Lung Microphysiological System Validates Novel Cell Therapy for Acute Respiratory Distress Syndrome.",
    "authors": [
      "Kim B",
      "Kim SH",
      "Kim J",
      "Eo EY",
      "Kim HJ",
      "Lee JH",
      "Lee CT",
      "Kong T",
      "Seo SK",
      "Lee S",
      "Park J",
      "Cho YJ"
    ],
    "journal": "Adv Biol (Weinh)",
    "publicationDate": "2025-11-20",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "542c5c3f-a720-4db9-a85b-821ba6fe598f",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.050Z"
      },
      {
        "id": "82c69914-28d1-4327-bcda-c3b627da02d5",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6469c4f4-d39d-4a20-b1b3-4c5c3d115f95 to DEXA_Synt_81438",
        "type": "system",
        "createdAt": "2025-12-14T10:12:51.793Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:57.455Z",
    "updatedAt": "2025-12-14T08:54:30.060Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41263118",
      "DOI": "https://doi.org10.1002/adbi.202500225",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:31:45",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Kim B, Kim SH, Kim J, Eo EY, Kim HJ, Lee JH, Lee CT, Kong T, Seo SK, Lee S, Park J, Cho YJ. Lung Microphysiological System Validates Novel Cell Therapy for Acute Respiratory Distress Syndrome. Adv Biol (Weinh). 2025;e00225",
      "pubdate": "2025-11-20",
      "Lead_author": "Kim B",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/adbi.202500225",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Kim B, Kim SH, Kim J, Eo EY, Kim HJ, Lee JH, Lee CT, Kong T, Seo SK, Lee S, Park J, Cho YJ. Lung Microphysiological System Validates Novel Cell Therapy for Acute Respiratory Distress Syndrome. Adv Biol (Weinh). 2025;e00225",
    "leadAuthor": "Kim B",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjXBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjXBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-34d01c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707171
  },
  {
    "id": "DEXA_Synt_85782",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41247845",
    "title": "Engineering Mixed Micelle-Loaded Contact Lenses for Sustained Ocular Delivery of Dexamethasone:  and  Studies.",
    "authors": [
      "Maulvi FA",
      "Mahala SM",
      "Shetty KH",
      "Sahu A",
      "Patel AR",
      "Desai DT",
      "Shah DO",
      "Willcox MDP"
    ],
    "journal": "ACS Appl Bio Mater",
    "publicationDate": "2025-11-17",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5ce382a7-5ee0-462f-a4a6-aa56980f195e",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T14:12:40.202Z",
        "type": "system"
      },
      {
        "id": "83042c72-dbed-42e9-81f0-e71819e1c244",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-13T07:37:53.995Z",
        "type": "QC_approval"
      },
      {
        "id": "fa8818c2-d12d-4ee6-a801-d9d1d631d2c1",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from e53aad7d-5aa1-4018-aa11-6f764ff9280c to DEXA_Synt_85782",
        "type": "system",
        "createdAt": "2025-12-14T10:12:52.025Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:57.487Z",
    "updatedAt": "2025-12-13T07:37:54.006Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41247845",
      "DOI": "https://doi.org10.1021/acsabm.5c01145",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:31:59",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Maulvi FA, Mahala SM, Shetty KH, Sahu A, Patel AR, Desai DT, Shah DO, Willcox MDP. Engineering Mixed Micelle-Loaded Contact Lenses for Sustained Ocular Delivery of Dexamethasone: <i>In Vitro</i> and <i>In Vivo</i> Studies. ACS Appl Bio Mater. 2025;",
      "pubdate": "2025-11-17",
      "Lead_author": "Maulvi FA",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1021/acsabm.5c01145",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Maulvi FA, Mahala SM, Shetty KH, Sahu A, Patel AR, Desai DT, Shah DO, Willcox MDP. Engineering Mixed Micelle-Loaded Contact Lenses for Sustained Ocular Delivery of Dexamethasone: <i>In Vitro</i> and <i>In Vivo</i> Studies. ACS Appl Bio Mater. 2025;",
    "leadAuthor": "Maulvi FA",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-13T07:37:53.995Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjYBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjYBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-34f1040501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707172
  },
  {
    "id": "DEXA_Synt_63074",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41221412",
    "title": "Cystoid Macular Edema Secondary to Acute Retinal Necrosis: The Role of Fundus Fluorescein Angiography in Guiding Treatment.",
    "authors": [
      "Rana V",
      "Markan A",
      "Arora A",
      "Tripathi M",
      "Mahendradas P",
      "Sharma V",
      "Roodkee U",
      "Kumar S",
      "Goenka R"
    ],
    "journal": "Cureus",
    "publicationDate": "2025-11-12",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "0c385724-8750-4d0a-8c0f-71b9b89f6f2b",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"No Case\". Moving to QC Triage.",
        "timestamp": "2025-12-12T14:05:47.855Z",
        "type": "system"
      },
      {
        "id": "89b071d5-813b-43a0-a780-8efde3087ee3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 08f8a853-32b4-4934-b714-3694561ad169 to DEXA_Synt_63074",
        "type": "system",
        "createdAt": "2025-12-14T10:12:52.259Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:57.517Z",
    "updatedAt": "2025-12-12T14:05:56.127Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41221412",
      "DOI": "https://doi.org10.7759/cureus.96108",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:32:29",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Rana V, Markan A, Arora A, Tripathi M, Mahendradas P, Sharma V, Roodkee U, Kumar S, Goenka R. Cystoid Macular Edema Secondary to Acute Retinal Necrosis: The Role of Fundus Fluorescein Angiography in Guiding Treatment. Cureus. 2025;17(11):e96108",
      "pubdate": "2025-11-12",
      "Lead_author": "Rana V",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.7759/cureus.96108",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Rana V, Markan A, Arora A, Tripathi M, Mahendradas P, Sharma V, Roodkee U, Kumar S, Goenka R. Cystoid Macular Edema Secondary to Acute Retinal Necrosis: The Role of Fundus Fluorescein Angiography in Guiding Treatment. Cureus. 2025;17(11):e96108",
    "leadAuthor": "Rana V",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "In Vitro Study",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T14:05:56.113Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Auto approved QC",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjZBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjZBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3514a40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707172
  },
  {
    "id": "DEXA_Synt_18839",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41204712",
    "title": "Biomarker-driven mechanisms and therapeutic targets for prostate diseases through mendelian randomization and molecular docking.",
    "authors": [
      "Lu L",
      "Shen J",
      "Chen Z",
      "Zhang J",
      "Gong X",
      "Pan H",
      "Luo X",
      "Meng S",
      "Zheng Y"
    ],
    "journal": "Aging Male",
    "publicationDate": "2025-11-8",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "0a5390cb-e35a-4984-9c40-88c7a93f1a0d",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"No Case\". Moving to QC Triage.",
        "timestamp": "2025-12-12T12:12:55.212Z",
        "type": "system"
      },
      {
        "id": "2b20a173-4020-4979-8b7a-098b806aa201",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from c426971c-a509-4aaa-96dc-235fb5917542 to DEXA_Synt_18839",
        "type": "system",
        "createdAt": "2025-12-14T10:12:52.494Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:57.550Z",
    "updatedAt": "2025-12-12T13:53:55.345Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41204712",
      "DOI": "https://doi.org10.1080/13685538.2025.2578633",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:32:07",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Lu L, Shen J, Chen Z, Zhang J, Gong X, Pan H, Luo X, Meng S, Zheng Y. Biomarker-driven mechanisms and therapeutic targets for prostate diseases through mendelian randomization and molecular docking. Aging Male. 2025;28(1):2578633",
      "pubdate": "2025-11-8",
      "Lead_author": "Lu L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/13685538.2025.2578633",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Lu L, Shen J, Chen Z, Zhang J, Gong X, Pan H, Luo X, Meng S, Zheng Y. Biomarker-driven mechanisms and therapeutic targets for prostate diseases through mendelian randomization and molecular docking. Aging Male. 2025;28(1):2578633",
    "leadAuthor": "Lu L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "In Vitro Study",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T13:53:55.333Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Auto approved QC",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjaBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjaBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3538180501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707172
  },
  {
    "id": "DEXA_Synt_81975",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41204582",
    "title": "Listeria monocytogenes infection in multiple myeloma: A case report about a rare but lethal complication requiring heightened clinical vigilance.",
    "authors": [
      "Wu Q",
      "Liu W",
      "Wu T",
      "Liu Y"
    ],
    "journal": "Medicine (Baltimore)",
    "publicationDate": "2025-11-8",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "74805a0e-b63e-4f6f-a33a-b53aaafe1581",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"No Case\". Moving to QC Triage.",
        "timestamp": "2025-12-12T13:54:50.821Z",
        "type": "system"
      },
      {
        "id": "29eeccc7-fef6-4b10-ab33-7891822e9fc7",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"No Case\" approved by QC",
        "timestamp": "2025-12-12T14:04:14.425Z",
        "type": "QC_approval"
      },
      {
        "id": "9f72abb0-60a8-41f6-9a01-bcba9be36529",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3694f024-fe78-4575-aaae-77c192daf38f to DEXA_Synt_81975",
        "type": "system",
        "createdAt": "2025-12-14T10:12:52.717Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:57.764Z",
    "updatedAt": "2025-12-12T14:04:14.436Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41204582",
      "DOI": "https://doi.org10.1097/MD.0000000000045685",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:32:15",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Wu Q, Liu W, Wu T, Liu Y. Listeria monocytogenes infection in multiple myeloma: A case report about a rare but lethal complication requiring heightened clinical vigilance. Medicine (Baltimore). 2025;104(45):e45685",
      "pubdate": "2025-11-8",
      "Lead_author": "Wu Q",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/MD.0000000000045685",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Wu Q, Liu W, Wu T, Liu Y. Listeria monocytogenes infection in multiple myeloma: A case report about a rare but lethal complication requiring heightened clinical vigilance. Medicine (Baltimore). 2025;104(45):e45685",
    "leadAuthor": "Wu Q",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Pre-Clinical study",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T14:04:14.425Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjbBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjbBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-355d300501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707172
  },
  {
    "id": "DEXA_Synt_86582",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41203636",
    "title": "Nanoparticle delivery of combined plant extracts enhances immune response in immunocompromised rats.",
    "authors": [
      "Milad SS",
      "Elshoky HA",
      "Ali SE",
      "Khattab MS",
      "Attia MZ",
      "Azouz AM"
    ],
    "journal": "Sci Rep",
    "publicationDate": "2025-11-8",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "212f8be5-ed53-449c-8cd4-43ce6f98271c",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T13:54:29.063Z",
        "type": "system"
      },
      {
        "id": "827ef44d-999c-4c18-92ad-d3a317c1aefc",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" rejected by QC. Reason: This is test. Study returned to Triage for re-classification.",
        "timestamp": "2025-12-12T13:59:50.806Z",
        "type": "QC_rejection"
      },
      {
        "id": "c530a56a-0c62-4d16-8f6a-4b038713bdcc",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 12d774b1-a5c9-49cc-b37f-27413d717572 to DEXA_Synt_86582",
        "type": "system",
        "createdAt": "2025-12-14T10:12:52.950Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:57.839Z",
    "updatedAt": "2025-12-12T13:59:50.817Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41203636",
      "DOI": "https://doi.org10.1038/s41598-025-21329-3",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:32:22",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Milad SS, Elshoky HA, Ali SE, Khattab MS, Attia MZ, Azouz AM. Nanoparticle delivery of combined plant extracts enhances immune response in immunocompromised rats. Sci Rep. 2025;15(1):39015",
      "pubdate": "2025-11-8",
      "Lead_author": "Milad SS",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41598-025-21329-3",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Milad SS, Elshoky HA, Ali SE, Khattab MS, Attia MZ, Azouz AM. Nanoparticle delivery of combined plant extracts enhances immune response in immunocompromised rats. Sci Rep. 2025;15(1):39015",
    "leadAuthor": "Milad SS",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "rejected",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaRejectedAt": "2025-12-12T13:59:50.806Z",
    "qaComments": "This is test",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjcBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjcBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-357db40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707173
  },
  {
    "id": "DEXA_Synt_89938",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41138693",
    "title": "Uncovering the Molecular Networks of Extracellular Vesicles in the Pathogenesis of Periodontitis.",
    "authors": [
      "Yu W",
      "Huoshen W",
      "Zhong W",
      "Gao X",
      "Song J"
    ],
    "journal": "Int Dent J",
    "publicationDate": "2025-10-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "2ffd6950-b2d9-4439-8e5d-ef2b9f0437b2",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"No Case\". Moving to QC Triage.",
        "timestamp": "2025-12-12T11:47:47.516Z",
        "type": "system"
      },
      {
        "id": "2151dfd9-8a22-425f-a055-a35e1f8dc751",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 5eae9df0-09d4-4d82-a568-eeb0ce9abd06 to DEXA_Synt_89938",
        "type": "system",
        "createdAt": "2025-12-14T10:12:53.179Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:58.021Z",
    "updatedAt": "2025-12-12T12:13:22.819Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41138693",
      "DOI": "https://doi.org10.1016/j.identj.2025.103936",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:32:37",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Yu W, Huoshen W, Zhong W, Gao X, Song J. Uncovering the Molecular Networks of Extracellular Vesicles in the Pathogenesis of Periodontitis. Int Dent J. 2025;75(6):103936",
      "pubdate": "2025-10-26",
      "Lead_author": "Yu W",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.identj.2025.103936",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Yu W, Huoshen W, Zhong W, Gao X, Song J. Uncovering the Molecular Networks of Extracellular Vesicles in the Pathogenesis of Periodontitis. Int Dent J. 2025;75(6):103936",
    "leadAuthor": "Yu W",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "In Vitro Study",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T12:13:22.812Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjdBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjdBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-35a13c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707173
  },
  {
    "id": "DEXA_Synt_54350",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41038751",
    "title": "Treatment Accessibility, Availability, and Healthcare Costs for Multiple Myeloma in South Asian Countries.",
    "authors": [
      "Yanamandra U",
      "Raphael C",
      "Peela R",
      "Saleh AJM",
      "Dorji T",
      "Juneh H",
      "Gyi AA",
      "Jha A",
      "Mir MA",
      "Somawardana B",
      "Kabir AL",
      "Poudyal B",
      "Wimalachandra M",
      "Aziz Z",
      "Williams S",
      "Usmani S",
      "Kumar S",
      "Malhotra P"
    ],
    "journal": "Clin Lymphoma Myeloma Leuk",
    "publicationDate": "2025-10-3",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "aoi_assessment",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "059a0365-8653-4880-9e84-433009d6a316",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"AOI\". Moving to QC Triage.",
        "timestamp": "2025-12-12T11:47:52.189Z",
        "type": "system"
      },
      {
        "id": "618900c1-3de9-4c45-801c-5d09a4308499",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from fa5b6f47-4710-45d7-87b7-ae29ed2c735b to DEXA_Synt_54350",
        "type": "system",
        "createdAt": "2025-12-14T10:12:53.425Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:58.085Z",
    "updatedAt": "2025-12-12T11:48:38.544Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41038751",
      "DOI": "https://doi.org10.1016/j.clml.2025.09.002",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:32:45",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Yanamandra U, Raphael C, Peela R, Saleh AJM, Dorji T, Juneh H, Gyi AA, Jha A, Mir MA, Somawardana B, Kabir AL, Poudyal B, Wimalachandra M, Aziz Z, Williams S, Usmani S, Kumar S, Malhotra P. Treatment Accessibility, Availability, and Healthcare Costs for Multiple Myeloma in South Asian Countries. Clin Lymphoma Myeloma Leuk. 2025;25(12):e1134-",
      "pubdate": "2025-10-3",
      "Lead_author": "Yanamandra U",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.clml.2025.09.002",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Yanamandra U, Raphael C, Peela R, Saleh AJM, Dorji T, Juneh H, Gyi AA, Jha A, Mir MA, Somawardana B, Kabir AL, Poudyal B, Wimalachandra M, Aziz Z, Williams S, Usmani S, Kumar S, Malhotra P. Treatment Accessibility, Availability, and Healthcare Costs for Multiple Myeloma in South Asian Countries. Clin Lymphoma Myeloma Leuk. 2025;25(12):e1134-",
    "leadAuthor": "Yanamandra U",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Adverse Event",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "AOI",
    "effectiveClassification": "AOI",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:48:38.532Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjeBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjeBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-35c2080501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707173
  },
  {
    "id": "DEXA_Synt_65398",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41038141",
    "title": "Euchrenone A10 attenuates septic lung injury though S100A8/A9-dependent TLR4/MyD88/NF-κB signaling.",
    "authors": [
      "Zhou L",
      "Xiao Y",
      "He J",
      "Ren H",
      "Zhao C",
      "Zhang C",
      "Shu X",
      "Chen Y",
      "Chen D",
      "Chen Y",
      "He X",
      "Lian L",
      "Shao J",
      "Wang J",
      "Wang Y",
      "Li C",
      "OuYang J",
      "Li R",
      "Zhang Z",
      "Liu L",
      "Pan H"
    ],
    "journal": "Phytomedicine",
    "publicationDate": "2025-10-3",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "data_entry",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5e2a97f9-386d-4f83-b797-e5d7afd640b6",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T13:45:32.186Z",
        "type": "system"
      },
      {
        "id": "06d3221c-f59d-42af-8844-a9d32ab7e528",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9cb20676-cf4e-4a45-a635-6c57916bd2d3 to DEXA_Synt_65398",
        "type": "system",
        "createdAt": "2025-12-14T10:12:53.677Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:58.292Z",
    "updatedAt": "2025-12-12T13:53:55.206Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41038141",
      "DOI": "https://doi.org10.1016/j.phymed.2025.157336",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:32:52",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Zhou L, Xiao Y, He J, Ren H, Zhao C, Zhang C, Shu X, Chen Y, Chen D, Chen Y, He X, Lian L, Shao J, Wang J, Wang Y, Li C, OuYang J, Li R, Zhang Z, Liu L, Pan H. Euchrenone A10 attenuates septic lung injury though S100A8/A9-dependent TLR4/MyD88/NF-κB signaling. Phytomedicine. 2025;148157336",
      "pubdate": "2025-10-3",
      "Lead_author": "Zhou L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.phymed.2025.157336",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Zhou L, Xiao Y, He J, Ren H, Zhao C, Zhang C, Shu X, Chen Y, Chen D, Chen Y, He X, Lian L, Shao J, Wang J, Wang Y, Li C, OuYang J, Li R, Zhang Z, Liu L, Pan H. Euchrenone A10 attenuates septic lung injury though S100A8/A9-dependent TLR4/MyD88/NF-κB signaling. Phytomedicine. 2025;148157336",
    "leadAuthor": "Zhou L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T13:53:55.190Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Auto approved QC",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjfBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjfBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-35e4f40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707173
  },
  {
    "id": "DEXA_Synt_28855",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41033840",
    "title": "Initial management and disposition of metastatic spinal cord compression in the emergency department: a review of the literature.",
    "authors": [
      "Singer E",
      "Elsayem A",
      "Nassif T",
      "Rodriguez C",
      "Zoghbi M",
      "Dagher J",
      "Yammine N",
      "Kamal M",
      "Cruz Carreras MT",
      "Vu T",
      "Qdaisat A",
      "Yeung SJ",
      "Chaftari P"
    ],
    "journal": "Ann Med",
    "publicationDate": "2025-10-2",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "fd3124ab-b1f9-40b3-bc22-63df0e45f377",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T12:17:19.133Z",
        "type": "system"
      },
      {
        "id": "f4e05dd1-2cc0-4fad-8506-d31f514deecd",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-12T14:01:49.645Z",
        "type": "QC_approval"
      },
      {
        "id": "96d19d71-68bc-413f-97c8-6ee517f70279",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Study revoked by Medical Reviewer. Reason: Test. Returned to triage for corrections.",
        "timestamp": "2025-12-12T14:02:47.086Z",
        "type": "revocation"
      },
      {
        "id": "819f88c1-36df-4d69-ab5c-603bd970333c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from c19b73df-6fd2-4613-81d0-e67661c9dcac to DEXA_Synt_28855",
        "type": "system",
        "createdAt": "2025-12-14T10:12:53.910Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:58.363Z",
    "updatedAt": "2025-12-12T14:02:47.093Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41033840",
      "DOI": "https://doi.org10.1080/07853890.2025.2568117",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:33:06",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Singer E, Elsayem A, Nassif T, Rodriguez C, Zoghbi M, Dagher J, Yammine N, Kamal M, Cruz Carreras MT, Vu T, Qdaisat A, Yeung SJ, Chaftari P. Initial management and disposition of metastatic spinal cord compression in the emergency department: a review of the literature. Ann Med. 2025;57(1):2568117",
      "pubdate": "2025-10-2",
      "Lead_author": "Singer E",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/07853890.2025.2568117",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Singer E, Elsayem A, Nassif T, Rodriguez C, Zoghbi M, Dagher J, Yammine N, Kamal M, Cruz Carreras MT, Vu T, Qdaisat A, Yeung SJ, Chaftari P. Initial management and disposition of metastatic spinal cord compression in the emergency department: a review of the literature. Ann Med. 2025;57(1):2568117",
    "leadAuthor": "Singer E",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": null,
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "revokedAt": "2025-12-12T14:02:47.086Z",
    "revocationReason": "Test",
    "_rid": "Vf9WAOX6zUjgBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjgBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3609200501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707173
  },
  {
    "id": "DEXA_Synt_12914",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40985293",
    "title": "Statement of Retraction: Does implementing a regime of dexamethasone before planned cesarean section at term reduce admission with respiratory morbidity to neonatal intensive care unit? A randomized controlled trial.",
    "authors": [
      "Author error: 'AuthorList'"
    ],
    "journal": "J Matern Fetal Neonatal Med",
    "publicationDate": "2025-09-23",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "aoi_assessment",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "36d6675f-c033-4d5b-841c-ce2242a1d14d",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"AOI\". Moving to QC Triage.",
        "timestamp": "2025-12-12T11:44:52.036Z",
        "type": "system"
      },
      {
        "id": "bb256d77-0583-4a19-a98b-4dcd7f643165",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from b37e490d-17bb-4a81-a55d-4b503b5e511b to DEXA_Synt_12914",
        "type": "system",
        "createdAt": "2025-12-14T10:12:54.140Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:58.551Z",
    "updatedAt": "2025-12-12T11:48:15.065Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40985293",
      "DOI": "https://doi.org10.1080/14767058.2025.2564749",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:32:59",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Author error: 'AuthorList'. Statement of Retraction: Does implementing a regime of dexamethasone before planned cesarean section at term reduce admission with respiratory morbidity to neonatal intensive care unit? A randomized controlled trial. J Matern Fetal Neonatal Med. 2025;38(1):2564749",
      "pubdate": "2025-09-23",
      "Lead_author": "Author error: 'AuthorList'",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/14767058.2025.2564749",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Author error: 'AuthorList'. Statement of Retraction: Does implementing a regime of dexamethasone before planned cesarean section at term reduce admission with respiratory morbidity to neonatal intensive care unit? A randomized controlled trial. J Matern Fetal Neonatal Med. 2025;38(1):2564749",
    "leadAuthor": "Author error: 'AuthorList'",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Adverse Event",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "AOI",
    "effectiveClassification": "AOI",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:48:15.052Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjhBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjhBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-362bcc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707174
  },
  {
    "id": "DEXA_Synt_60449",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40856981",
    "title": "Lowering the dexamethasone suppression test cut-off: is it time yet?",
    "authors": [
      "Favero V",
      "Eller-Vainicher C",
      "Morelli V",
      "Scillitani A",
      "Chiodini I"
    ],
    "journal": "Lowering the dexamethasone suppression test cut-off: is it time yet? J Endocrinol Invest",
    "publicationDate": "2025-08-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9a3c5d2a-e63e-4c37-bc9e-d40582dfcdab",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"No Case\". Moving to Reporting.",
        "timestamp": "2025-12-12T11:44:40.041Z",
        "type": "system"
      },
      {
        "id": "db6cf3f3-6566-4515-a713-05cc1286b3cb",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 30b8df64-0be3-42be-9480-a57fc35076fb to DEXA_Synt_60449",
        "type": "system",
        "createdAt": "2025-12-14T10:12:54.373Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:58.642Z",
    "updatedAt": "2025-12-12T11:44:40.053Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40856981",
      "DOI": "https://doi.org10.1007/s40618-025-02679-1",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:33:14",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Favero V, Eller-Vainicher C, Morelli V, Scillitani A, Chiodini I. Lowering the dexamethasone suppression test cut-off: is it time yet? J Endocrinol Invest. 2025;48(12):2831-43",
      "pubdate": "2025-08-26",
      "Lead_author": "Favero V",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s40618-025-02679-1",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Favero V, Eller-Vainicher C, Morelli V, Scillitani A, Chiodini I. Lowering the dexamethasone suppression test cut-off: is it time yet? J Endocrinol Invest. 2025;48(12):2831-43",
    "leadAuthor": "Favero V",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "In Vitro Study",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "not_applicable",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": null,
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjiBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjiBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-364fa40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707174
  },
  {
    "id": "DEXA_Synt_34668",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40100484",
    "title": "Drug repositioning as a promising approach for the eradication of emerging and re-emerging viral agents.",
    "authors": [
      "Almulhim M",
      "Ghasemian A",
      "Memariani M",
      "Karami F",
      "Yassen ASA",
      "Alexiou A",
      "Papadakis M",
      "Batiha GE"
    ],
    "journal": "Mol Divers",
    "publicationDate": "2025-03-18",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "data_entry",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ae7d721f-98ae-4084-9fd2-5193593e38be",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to Data Entry.",
        "timestamp": "2025-12-12T11:44:45.376Z",
        "type": "system"
      },
      {
        "id": "d7fd0ddc-2680-4b95-b063-65a65c0cca4e",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 70fb9414-d983-4c8e-ba13-a758799dbe89 to DEXA_Synt_34668",
        "type": "system",
        "createdAt": "2025-12-14T10:12:54.568Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:58.797Z",
    "updatedAt": "2025-12-12T11:44:45.388Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40100484",
      "DOI": "https://doi.org10.1007/s11030-025-11131-8",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:33:23",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Almulhim M, Ghasemian A, Memariani M, Karami F, Yassen ASA, Alexiou A, Papadakis M, Batiha GE. Drug repositioning as a promising approach for the eradication of emerging and re-emerging viral agents. Mol Divers. 2025;29(6):5465-85",
      "pubdate": "2025-03-18",
      "Lead_author": "Almulhim M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s11030-025-11131-8",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Almulhim M, Ghasemian A, Memariani M, Karami F, Yassen ASA, Alexiou A, Papadakis M, Batiha GE. Drug repositioning as a promising approach for the eradication of emerging and re-emerging viral agents. Mol Divers. 2025;29(6):5465-85",
    "leadAuthor": "Almulhim M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "not_applicable",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": null,
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjjBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjjBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-366d840501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707174
  },
  {
    "id": "DEXA_Synt_50468",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40028723",
    "title": "Extracellular vesicles of  SLAM216 ameliorate skin symptoms of atopic dermatitis by regulating gut microbiome on serotonin metabolism.",
    "authors": [
      "Choi H",
      "Kwak MJ",
      "Choi Y",
      "Kang AN",
      "Mun D",
      "Eor JY",
      "Park MR",
      "Oh S",
      "Kim Y"
    ],
    "journal": "Gut Microbes",
    "publicationDate": "2025-03-3",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "aoi_assessment",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "809418cb-6845-4e30-ad80-d4891c993ff9",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"AOI\". Moving to QC Triage.",
        "timestamp": "2025-12-12T11:48:28.961Z",
        "type": "system"
      },
      {
        "id": "8f460c48-0172-4cee-8f95-744e5fc42ef1",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 70b907a3-6dcd-4610-a52d-90c761fb3c3b to DEXA_Synt_50468",
        "type": "system",
        "createdAt": "2025-12-14T10:12:54.804Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:58.905Z",
    "updatedAt": "2025-12-12T13:53:55.405Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40028723",
      "DOI": "https://doi.org10.1080/19490976.2025.2474256",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:33:29",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Choi H, Kwak MJ, Choi Y, Kang AN, Mun D, Eor JY, Park MR, Oh S, Kim Y. Extracellular vesicles of <i>Limosilactobacillus fermentum</i> SLAM216 ameliorate skin symptoms of atopic dermatitis by regulating gut microbiome on serotonin metabolism. Gut Microbes. 2025;17(1):2474256",
      "pubdate": "2025-03-3",
      "Lead_author": "Choi H",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/19490976.2025.2474256",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Choi H, Kwak MJ, Choi Y, Kang AN, Mun D, Eor JY, Park MR, Oh S, Kim Y. Extracellular vesicles of <i>Limosilactobacillus fermentum</i> SLAM216 ameliorate skin symptoms of atopic dermatitis by regulating gut microbiome on serotonin metabolism. Gut Microbes. 2025;17(1):2474256",
    "leadAuthor": "Choi H",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Adverse Event",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "AOI",
    "effectiveClassification": "AOI",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T13:53:55.395Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Auto approved QC",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjkBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjkBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3691300501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707174
  },
  {
    "id": "DEXA_Synt_35062",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39973324",
    "title": "Polymeric nanoparticles-based targeted delivery of drugs and bioactive compounds for arthritis management.",
    "authors": [
      "Dixit T",
      "Vaidya A",
      "Ravindran S"
    ],
    "journal": "Future Sci OA",
    "publicationDate": "2025-02-20",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "data_entry",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b954dbed-f59d-489a-aaeb-cb5ce8ab03b6",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T12:12:50.686Z",
        "type": "system"
      },
      {
        "id": "f6f03e03-38c2-4fd0-9ee3-93a6c5fc2c4f",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 47f797ee-0165-4040-8447-07c4b0d1a736 to DEXA_Synt_35062",
        "type": "system",
        "createdAt": "2025-12-14T10:12:55.017Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:59.061Z",
    "updatedAt": "2025-12-12T12:22:47.551Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39973324",
      "DOI": "https://doi.org10.1080/20565623.2025.2467591",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:33:36",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Dixit T, Vaidya A, Ravindran S. Polymeric nanoparticles-based targeted delivery of drugs and bioactive compounds for arthritis management. Future Sci OA. 2025;11(1):2467591",
      "pubdate": "2025-02-20",
      "Lead_author": "Dixit T",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/20565623.2025.2467591",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Dixit T, Vaidya A, Ravindran S. Polymeric nanoparticles-based targeted delivery of drugs and bioactive compounds for arthritis management. Future Sci OA. 2025;11(1):2467591",
    "leadAuthor": "Dixit T",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T12:22:47.534Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjlBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjlBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-36b73c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707175
  },
  {
    "id": "DEXA_Synt_33079",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39913258",
    "title": "Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis.",
    "authors": [
      "Wang YC",
      "Lin CH",
      "Su YC",
      "Teng CJ"
    ],
    "journal": "Hematology",
    "publicationDate": "2025-02-6",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "320c620a-874f-4994-a93f-f11678addd74",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T11:47:43.309Z",
        "type": "system"
      },
      {
        "id": "f78db1ac-035b-4597-b93e-bbb73be0eb30",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-12T12:10:37.585Z",
        "type": "QC_approval"
      },
      {
        "id": "05322060-35ce-49ac-af7f-58ce94c96b42",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9d99fd34-3bba-4f6c-85de-792b3d132057 to DEXA_Synt_33079",
        "type": "system",
        "createdAt": "2025-12-14T10:12:55.252Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:59.166Z",
    "updatedAt": "2025-12-12T12:10:37.595Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39913258",
      "DOI": "https://doi.org10.1080/16078454.2025.2462249",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:33:43",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Wang YC, Lin CH, Su YC, Teng CJ. Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis. Hematology. 2025;30(1):2462249",
      "pubdate": "2025-02-6",
      "Lead_author": "Wang YC",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/16078454.2025.2462249",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Wang YC, Lin CH, Su YC, Teng CJ. Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis. Hematology. 2025;30(1):2462249",
    "leadAuthor": "Wang YC",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T12:10:37.585Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjmBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjmBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-36d5a40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707175
  },
  {
    "id": "DEXA_Synt_55543",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39894785",
    "title": "Sustained response off treatment after fostamatinib in refractory immune thrombocytopenia: A series of four case reports.",
    "authors": [
      "Ghanima W",
      "Lucas Boronat FJ",
      "Carrai V",
      "Rackwitz S"
    ],
    "journal": "Hematology",
    "publicationDate": "2025-02-3",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "81107a2a-fdd6-42e7-b91c-af2e915ae79e",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"No Case\". Moving to Reporting.",
        "timestamp": "2025-12-12T11:45:34.978Z",
        "type": "system"
      },
      {
        "id": "758b91ad-28b5-4746-b4b8-b6fbda740a36",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from c8dd01bd-be75-4220-978b-182ca37e03dd to DEXA_Synt_55543",
        "type": "system",
        "createdAt": "2025-12-14T10:12:55.455Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:03:59.307Z",
    "updatedAt": "2025-12-12T11:45:35.001Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39894785",
      "DOI": "https://doi.org10.1080/16078454.2025.2456687",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:33:51",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Ghanima W, Lucas Boronat FJ, Carrai V, Rackwitz S. Sustained response off treatment after fostamatinib in refractory immune thrombocytopenia: A series of four case reports. Hematology. 2025;30(1):2456687",
      "pubdate": "2025-02-3",
      "Lead_author": "Ghanima W",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/16078454.2025.2456687",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Ghanima W, Lucas Boronat FJ, Carrai V, Rackwitz S. Sustained response off treatment after fostamatinib in refractory immune thrombocytopenia: A series of four case reports. Hematology. 2025;30(1):2456687",
    "leadAuthor": "Ghanima W",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "In Vitro Study",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "not_applicable",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": null,
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjnBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjnBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-36f9b00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707175
  },
  {
    "id": "DEXA_Synt_45314",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41306613",
    "title": "Identification and validation of potential shared diagnostic markers for sepsis-induced ARDS and cardiomyopathy via WGCNA and machine learning.",
    "authors": [
      "Wei J",
      "Huang B",
      "Hu K",
      "Xiong B",
      "Xiang S"
    ],
    "journal": "Front Mol Biosci",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "data_entry",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "20a5d567-694e-485b-abe6-c785c9d327e3",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to Data Entry.",
        "timestamp": "2025-12-12T11:44:34.281Z",
        "type": "system"
      },
      {
        "id": "a3a37f16-5c0c-44c6-9d86-80790564397b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 70700606-5b01-4a99-a18d-22ac4603e277 to DEXA_Synt_45314",
        "type": "system",
        "createdAt": "2025-12-14T10:12:55.702Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:05:25.338Z",
    "updatedAt": "2025-12-12T11:44:34.292Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41306613",
      "DOI": "https://doi.org10.3389/fmolb.2025.1665387",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:34:27",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Wei J, Huang B, Hu K, Xiong B, Xiang S. Identification and validation of potential shared diagnostic markers for sepsis-induced ARDS and cardiomyopathy via WGCNA and machine learning. Front Mol Biosci. 2025;121665387",
      "pubdate": "2025-11-27",
      "Lead_author": "Wei J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3389/fmolb.2025.1665387",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Wei J, Huang B, Hu K, Xiong B, Xiang S. Identification and validation of potential shared diagnostic markers for sepsis-induced ARDS and cardiomyopathy via WGCNA and machine learning. Front Mol Biosci. 2025;121665387",
    "leadAuthor": "Wei J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "not_applicable",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": null,
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjoBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjoBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3719e00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707175
  },
  {
    "id": "DEXA_Synt_19290",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41294172",
    "title": "Different formulations of corticosteroid eye drops at different treatment times in the control of inflammation and prevention of cystoid macular edema after cataract surgery: randomized clinical trial.",
    "authors": [
      "Feitosa AM",
      "Albano MCF",
      "Lopes SP",
      "Miranda JEO",
      "Oliveira TCB",
      "Rodriguez PJY",
      "Machado AJ",
      "Feitosa MM",
      "Ribeiro JCML"
    ],
    "journal": "Arq Bras Oftalmol",
    "publicationDate": "2025-11-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "data_entry",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "7d98a460-356e-40e0-abd0-6d24bf5b4555",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T10:59:33.184Z",
        "type": "system"
      },
      {
        "id": "671d30a1-7305-4a61-8fb5-17cf80cb10be",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-12T10:59:48.091Z",
        "type": "QC_approval"
      },
      {
        "id": "357c7c3e-6a50-4408-b429-ace63cc4f4a0",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Study revoked by Medical Reviewer. Reason: Test Revoke. Returned to triage for corrections.",
        "timestamp": "2025-12-12T11:00:11.655Z",
        "type": "revocation"
      },
      {
        "id": "10850f98-142e-42fe-8064-0050727d58fd",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T11:00:27.306Z",
        "type": "system"
      },
      {
        "id": "84cf0fb5-bece-48fa-8f7c-2698de65dab5",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-12T11:00:49.259Z",
        "type": "QC_approval"
      },
      {
        "id": "816c1199-0213-42b2-af14-058ccc282813",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-12T11:01:44.697Z",
        "type": "system"
      },
      {
        "id": "e8526658-627b-4d7d-9184-6b79a9eab37b",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed and resubmitted after Medical Reviewer revocation. Awaiting QC approval before medical re-review.",
        "timestamp": "2025-12-12T11:01:44.798Z",
        "type": "resubmission"
      },
      {
        "id": "adfd8bcc-29eb-481a-9a22-118a9f680024",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 XML form approved by QC. Ready for Medical Reviewer",
        "timestamp": "2025-12-12T11:01:55.811Z",
        "type": "qc_r3_approval"
      },
      {
        "id": "613ddb5d-5449-4293-b04b-ec0c9a86db82",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Medical review completed. Study approved for final processing.",
        "timestamp": "2025-12-12T11:02:13.638Z",
        "type": "medical_approval"
      },
      {
        "id": "863cf924-129e-4578-8ba7-9a9fe6362b4f",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 7d3ca8ac-a76c-4f82-bb64-0bc118a4bb01 to DEXA_Synt_19290",
        "type": "system",
        "createdAt": "2025-12-14T10:12:55.921Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:05:25.374Z",
    "updatedAt": "2025-12-12T11:28:07.566Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41294172",
      "DOI": "https://doi.org10.5935/0004-2749.2025-0097",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:34:34",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Feitosa AM, Albano MCF, Lopes SP, Miranda JEO, Oliveira TCB, Rodriguez PJY, Machado AJ, Feitosa MM, Ribeiro JCML. Different formulations of corticosteroid eye drops at different treatment times in the control of inflammation and prevention of cystoid macular edema after cataract surgery: randomized clinical trial. Arq Bras Oftalmol. 2025;89(1):e20250097",
      "pubdate": "2025-11-26",
      "Lead_author": "Feitosa AM",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.5935/0004-2749.2025-0097",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Feitosa AM, Albano MCF, Lopes SP, Miranda JEO, Oliveira TCB, Rodriguez PJY, Machado AJ, Feitosa MM, Ribeiro JCML. Different formulations of corticosteroid eye drops at different treatment times in the control of inflammation and prevention of cystoid macular edema after cataract surgery: randomized clinical trial. Arq Bras Oftalmol. 2025;89(1):e20250097",
    "leadAuthor": "Feitosa AM",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:28:07.555Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": {
      "C.2.r.1": "Feitosa AM",
      "C.2.r.1.2": "Feitosa",
      "C.2.r.1.4": "AM",
      "C.4.r.1": "Feitosa AM, Albano MCF, Lopes SP, Miranda JEO, Oliveira TCB, Rodriguez PJY, Machado AJ, Feitosa MM, Ribeiro JCML. Different formulations of corticosteroid eye drops at different treatment times in the control of inflammation and prevention of cystoid macular edema after cataract surgery: randomized clinical trial. Arq Bras Oftalmol. 2025;89(1):e20250097",
      "D.7.1.r": "Article requires manual review",
      "D.7": "Article requires manual review",
      "D.7.1.r.2": "Article requires manual review",
      "E.i.1.1a": "Article requires manual review",
      "C.2.r.2.1": "Institution in Article requires manual review"
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-12T11:01:44.798Z",
    "qcR3Status": "approved",
    "qcR3ApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qcR3ApprovedAt": "2025-12-12T11:01:55.811Z",
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "completed",
    "medicalReviewedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "medicalReviewedAt": "2025-12-12T11:02:13.638Z",
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjpBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjpBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-373b740501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707175
  },
  {
    "id": "DEXA_Synt_23408",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41292984",
    "title": "SMARCA2 is an essential and potent cofactor for a specific subset of the glucocorticoid response in A549 cells.",
    "authors": [
      "Melore SM",
      "Koçak DD",
      "Siklenkla K",
      "Johnson GD",
      "Williams C",
      "Bartelt LC",
      "Jones AG",
      "Barrera A",
      "Venukuttan R",
      "Gersbach CA",
      "Reddy TE"
    ],
    "journal": "bioRxiv",
    "publicationDate": "2025-11-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "aoi_assessment",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a786fa54-fa2d-4f4b-92eb-81bc796d8f03",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T09:59:26.379Z",
        "type": "system"
      },
      {
        "id": "5eb35466-4cf9-4b8c-b98c-3f7c72ca0074",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-12T10:02:36.475Z",
        "type": "QC_approval"
      },
      {
        "id": "c6b5f8b7-b928-4460-b313-2c68a45fc84e",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Study revoked by Medical Reviewer. Reason: This is a test. Returned to triage for corrections.",
        "timestamp": "2025-12-12T10:16:22.726Z",
        "type": "revocation"
      },
      {
        "id": "bd8de8b5-5003-4d60-9939-83f298a21989",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"AOI\". Moving to QC Triage.",
        "timestamp": "2025-12-12T10:35:19.078Z",
        "type": "system"
      },
      {
        "id": "cd04da72-6c5c-459b-9a20-bcc691fe30ce",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"AOI\" approved by QC",
        "timestamp": "2025-12-12T10:35:40.684Z",
        "type": "QC_approval"
      },
      {
        "id": "9ed67146-ce04-4253-aefc-e18a392aad07",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d5bfd17a-6292-4220-8bc5-db563a91b60a to DEXA_Synt_23408",
        "type": "system",
        "createdAt": "2025-12-14T10:12:56.217Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:05:25.403Z",
    "updatedAt": "2025-12-12T11:28:07.637Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41292984",
      "DOI": "https://doi.org10.1101/2025.11.13.688306",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:34:20",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Melore SM, Koçak DD, Siklenkla K, Johnson GD, Williams C, Bartelt LC, Jones AG, Barrera A, Venukuttan R, Gersbach CA, Reddy TE. SMARCA2 is an essential and potent cofactor for a specific subset of the glucocorticoid response in A549 cells. bioRxiv. 2025;",
      "pubdate": "2025-11-26",
      "Lead_author": "Melore SM",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1101/2025.11.13.688306",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Melore SM, Koçak DD, Siklenkla K, Johnson GD, Williams C, Bartelt LC, Jones AG, Barrera A, Venukuttan R, Gersbach CA, Reddy TE. SMARCA2 is an essential and potent cofactor for a specific subset of the glucocorticoid response in A549 cells. bioRxiv. 2025;",
    "leadAuthor": "Melore SM",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Adverse Event",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "AOI",
    "effectiveClassification": "AOI",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:28:07.621Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "revokedAt": "2025-12-12T10:16:22.726Z",
    "revocationReason": "This is a test",
    "_rid": "Vf9WAOX6zUjqBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjqBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3768b80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707176
  },
  {
    "id": "DEXA_Synt_44831",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41290229",
    "title": "Immune-Mediated Macular Edema After Intravitreal Methotrexate in Primary Vitreoretinal Lymphoma.",
    "authors": [
      "Brissos J",
      "Pinto R",
      "Correia R",
      "Frazão S",
      "Nogueira V"
    ],
    "journal": "Ocul Immunol Inflamm",
    "publicationDate": "2025-11-26",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "data_entry",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "d71d2e5a-266c-484a-9e66-e7a1009d2098",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T09:48:46.149Z",
        "type": "system"
      },
      {
        "id": "d91fa3ab-ca98-4304-9bd4-31475e294f10",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-12T10:36:22.825Z",
        "type": "QC_approval"
      },
      {
        "id": "27662ede-3d23-4f11-aaf9-e8735548f0c2",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Study revoked by Medical Reviewer. Reason: Test Revoke. Returned to triage for corrections.",
        "timestamp": "2025-12-12T10:37:11.641Z",
        "type": "revocation"
      },
      {
        "id": "5e2188d6-fbee-4d89-9955-2abf17ad983f",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T10:58:51.051Z",
        "type": "system"
      },
      {
        "id": "2b992694-6506-4fde-a881-465fa4090643",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 8068b5cc-e9d6-4f02-868e-f03b888e521c to DEXA_Synt_44831",
        "type": "system",
        "createdAt": "2025-12-14T10:12:56.429Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:05:25.431Z",
    "updatedAt": "2025-12-12T11:28:07.699Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41290229",
      "DOI": "https://doi.org10.1080/09273948.2025.2593458",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:34:12",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Brissos J, Pinto R, Correia R, Frazão S, Nogueira V. Immune-Mediated Macular Edema After Intravitreal Methotrexate in Primary Vitreoretinal Lymphoma. Ocul Immunol Inflamm. 2025;1-4",
      "pubdate": "2025-11-26",
      "Lead_author": "Brissos J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/09273948.2025.2593458",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Brissos J, Pinto R, Correia R, Frazão S, Nogueira V. Immune-Mediated Macular Edema After Intravitreal Methotrexate in Primary Vitreoretinal Lymphoma. Ocul Immunol Inflamm. 2025;1-4",
    "leadAuthor": "Brissos J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Potential Valid case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:28:07.686Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "revokedAt": "2025-12-12T10:37:11.641Z",
    "revocationReason": "Test Revoke",
    "_rid": "Vf9WAOX6zUjrBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjrBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-378edc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707176
  },
  {
    "id": "DEXA_Synt_19509",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41262029",
    "title": "Early Toxicity in Childhood Acute Lymphoblastic Leukemia: A Comparison of NOPHO ALL2008 and ALLTogether Protocols in Sweden.",
    "authors": [
      "Fermér J",
      "van Bunningen H",
      "Zhou O",
      "Abrahamsson J",
      "Borssen M",
      "Donnér I",
      "Heyman M",
      "Holmqvist AS",
      "Valind A",
      "Vogt H",
      "Ranta S",
      "Harila A"
    ],
    "journal": "Pediatr Blood Cancer",
    "publicationDate": "2025-11-20",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "aoi_assessment",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "61711375-80b0-4e77-bf20-b8da4b5111ef",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T09:46:50.534Z",
        "type": "system"
      },
      {
        "id": "181dc35e-3c7a-40e3-89be-d4f663b683fa",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-12T10:53:45.567Z",
        "type": "QC_approval"
      },
      {
        "id": "7207fdf7-66ca-47f1-8047-ccec7ba5e4e2",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Study revoked by Medical Reviewer. Reason: This is a test. Returned to triage for corrections.",
        "timestamp": "2025-12-12T10:56:57.546Z",
        "type": "revocation"
      },
      {
        "id": "b4edd07c-452f-40d2-a948-8f418bbeb473",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"AOI\". Moving to QC Triage.",
        "timestamp": "2025-12-12T10:57:56.615Z",
        "type": "system"
      },
      {
        "id": "50bc15b7-c112-43be-adfe-1f7e9cab7530",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"AOI\" approved by QC",
        "timestamp": "2025-12-12T10:58:16.069Z",
        "type": "QC_approval"
      },
      {
        "id": "55f4bf8b-18e3-4baa-b329-41d213e26289",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from eaead6e2-eaf2-43c7-a4f4-26538e1349ea to DEXA_Synt_19509",
        "type": "system",
        "createdAt": "2025-12-14T10:12:56.677Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:05:25.464Z",
    "updatedAt": "2025-12-12T11:28:07.759Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41262029",
      "DOI": "https://doi.org10.1002/pbc.32168",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:34:42",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Fermér J, van Bunningen H, Zhou O, Abrahamsson J, Borssen M, Donnér I, Heyman M, Holmqvist AS, Valind A, Vogt H, Ranta S, Harila A. Early Toxicity in Childhood Acute Lymphoblastic Leukemia: A Comparison of NOPHO ALL2008 and ALLTogether Protocols in Sweden. Pediatr Blood Cancer. 2025;e32168",
      "pubdate": "2025-11-20",
      "Lead_author": "Fermér J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/pbc.32168",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Fermér J, van Bunningen H, Zhou O, Abrahamsson J, Borssen M, Donnér I, Heyman M, Holmqvist AS, Valind A, Vogt H, Ranta S, Harila A. Early Toxicity in Childhood Acute Lymphoblastic Leukemia: A Comparison of NOPHO ALL2008 and ALLTogether Protocols in Sweden. Pediatr Blood Cancer. 2025;e32168",
    "leadAuthor": "Fermér J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Adverse Event",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "AOI",
    "effectiveClassification": "AOI",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:28:07.747Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "revokedAt": "2025-12-12T10:56:57.546Z",
    "revocationReason": "This is a test",
    "_rid": "Vf9WAOX6zUjsBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjsBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-37aeb80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707176
  },
  {
    "id": "DEXA_Synt_58902",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41201304",
    "title": "Dysfunctional T cells due to the abnormal glucose metabolism in patients with primary immune thrombocytopenia.",
    "authors": [
      "Tang M",
      "Li B",
      "Zhuang J",
      "Zhan Y",
      "Xie F",
      "Ye H",
      "Li Z",
      "Pang W",
      "Cheng Y",
      "Ji L"
    ],
    "journal": "Br J Haematol",
    "publicationDate": "2025-11-7",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "de70e4de-258c-4d37-a647-766a3d6d2f0f",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to Data Entry.",
        "timestamp": "2025-12-12T09:42:25.108Z",
        "type": "system"
      },
      {
        "id": "f936b75c-824c-4373-95f2-163ef2571848",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Study revoked by Medical Reviewer. Reason: It is a test from data entry to triage . Returned to Data Entry for corrections.",
        "timestamp": "2025-12-12T10:09:38.206Z",
        "type": "revocation"
      },
      {
        "id": "8a213e8d-afcf-4372-b1a9-bf679e15aa62",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Study revoked by Medical Reviewer. Reason: This is another test. Returned to triage for corrections.",
        "timestamp": "2025-12-12T10:12:40.226Z",
        "type": "revocation"
      },
      {
        "id": "041929ce-0401-492b-a501-6405951ba47f",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Study revoked by Medical Reviewer. Reason: Test 3. Returned to triage for corrections.",
        "timestamp": "2025-12-12T10:13:29.649Z",
        "type": "revocation"
      },
      {
        "id": "826ec487-d131-4082-b15b-2134095e84b3",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Study revoked by Medical Reviewer. Reason: This is a test 4. Returned to triage for corrections.",
        "timestamp": "2025-12-12T10:15:41.217Z",
        "type": "revocation"
      },
      {
        "id": "b2187a80-20c1-41f8-ba1a-85cf091a0c2e",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"No Case\". Moving to QC Triage.",
        "timestamp": "2025-12-12T10:34:03.229Z",
        "type": "system"
      },
      {
        "id": "b11f522c-5ad7-4541-8677-0b02d3bb3232",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"No Case\" approved by QC",
        "timestamp": "2025-12-12T10:34:27.224Z",
        "type": "QC_approval"
      },
      {
        "id": "e5954669-83e3-4cf7-a73d-d5ca2b6a5b87",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 39f56054-35fb-4b26-8b02-95bf71bdb840 to DEXA_Synt_58902",
        "type": "system",
        "createdAt": "2025-12-14T10:12:56.940Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:05:25.491Z",
    "updatedAt": "2025-12-12T11:28:07.823Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41201304",
      "DOI": "https://doi.org10.1111/bjh.70229",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:35:05",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Tang M, Li B, Zhuang J, Zhan Y, Xie F, Ye H, Li Z, Pang W, Cheng Y, Ji L. Dysfunctional T cells due to the abnormal glucose metabolism in patients with primary immune thrombocytopenia. Br J Haematol. 2025;",
      "pubdate": "2025-11-7",
      "Lead_author": "Tang M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/bjh.70229",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Tang M, Li B, Zhuang J, Zhan Y, Xie F, Ye H, Li Z, Pang W, Cheng Y, Ji L. Dysfunctional T cells due to the abnormal glucose metabolism in patients with primary immune thrombocytopenia. Br J Haematol. 2025;",
    "leadAuthor": "Tang M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "In Vitro Study",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:28:07.811Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "revokedAt": "2025-12-12T10:15:41.217Z",
    "revocationReason": "This is a test 4",
    "_rid": "Vf9WAOX6zUjtBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjtBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-37d7040501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707176
  },
  {
    "id": "DEXA_Synt_50408",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41187422",
    "title": "β-Aminoisobutyric acid targets AMPK to suppress macrophage pro-inflammatory phenotype and alleviate lipopolysaccharide-induced sepsis in mice.",
    "authors": [
      "Hu X",
      "Wang C",
      "Zou P",
      "Wu T",
      "Shi H",
      "Gao B",
      "Zhu L",
      "Duan R"
    ],
    "journal": "Int Immunopharmacol",
    "publicationDate": "2025-11-5",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "data_entry",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "2e536ca6-6641-4825-aa85-f3d177519234",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-12T09:21:40.758Z",
        "type": "system"
      },
      {
        "id": "122fc799-d5ab-4f12-95ce-28c85bca611a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from b197e19c-95e8-4dd5-8ee8-eb2f7ffb6339 to DEXA_Synt_50408",
        "type": "system",
        "createdAt": "2025-12-14T10:12:57.181Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:05:25.525Z",
    "updatedAt": "2025-12-12T11:42:13.621Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41187422",
      "DOI": "https://doi.org10.1016/j.intimp.2025.115781",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:35:12",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Hu X, Wang C, Zou P, Wu T, Shi H, Gao B, Zhu L, Duan R. β-Aminoisobutyric acid targets AMPK to suppress macrophage pro-inflammatory phenotype and alleviate lipopolysaccharide-induced sepsis in mice. Int Immunopharmacol. 2025;168(Pt 1):115781",
      "pubdate": "2025-11-5",
      "Lead_author": "Hu X",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.intimp.2025.115781",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Hu X, Wang C, Zou P, Wu T, Shi H, Gao B, Zhu L, Duan R. β-Aminoisobutyric acid targets AMPK to suppress macrophage pro-inflammatory phenotype and alleviate lipopolysaccharide-induced sepsis in mice. Int Immunopharmacol. 2025;168(Pt 1):115781",
    "leadAuthor": "Hu X",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:42:13.610Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjuBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjuBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-37fc100501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707177
  },
  {
    "id": "DEXA_Synt_59672",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41182516",
    "title": "Network pharmacology analysis and in vitro verification of the anti-sarcopenia effects of formononetin.",
    "authors": [
      "Fang Y",
      "Wei Z",
      "Lei Z"
    ],
    "journal": "Bioresour Bioprocess",
    "publicationDate": "2025-11-3",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "82db5b2d-8581-4090-a459-2bec25c65adf",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-12T09:34:18.917Z",
        "type": "system"
      },
      {
        "id": "3de54450-84cc-42a0-9a65-6f80dbceee72",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Study revoked by Medical Reviewer. Reason: Test. Returned to triage for corrections.",
        "timestamp": "2025-12-12T16:16:15.678Z",
        "type": "revocation"
      },
      {
        "id": "a67b678f-8744-4366-8d08-90bc38f2c3e9",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 5686cb28-c499-4b08-8649-cc4b710eec7d to DEXA_Synt_59672",
        "type": "system",
        "createdAt": "2025-12-14T10:12:57.416Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:05:25.559Z",
    "updatedAt": "2025-12-12T16:16:15.691Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41182516",
      "DOI": "https://doi.org10.1186/s40643-025-00965-7",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:34:57",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Fang Y, Wei Z, Lei Z. Network pharmacology analysis and in vitro verification of the anti-sarcopenia effects of formononetin. Bioresour Bioprocess. 2025;12(1):122",
      "pubdate": "2025-11-3",
      "Lead_author": "Fang Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s40643-025-00965-7",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Fang Y, Wei Z, Lei Z. Network pharmacology analysis and in vitro verification of the anti-sarcopenia effects of formononetin. Bioresour Bioprocess. 2025;12(1):122",
    "leadAuthor": "Fang Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": null,
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "revokedAt": "2025-12-12T16:16:15.678Z",
    "revocationReason": "Test",
    "_rid": "Vf9WAOX6zUjvBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjvBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-381ffc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707177
  },
  {
    "id": "DEXA_Synt_81444",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41132053",
    "title": "Adipose tissue explant culture using PDMS flow chambers: an alternative to static explant culture.",
    "authors": [
      "Cohen M",
      "Bandaru P",
      "Szylo K",
      "Nguyen N",
      "Nadeak B",
      "Paszkiewicz R",
      "Ashby JW",
      "Mack JJ",
      "Tanaka L",
      "Tan J",
      "Khademhosseini A",
      "Mittelman SD"
    ],
    "journal": "Adipocyte",
    "publicationDate": "2025-10-24",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "69f49331-9929-4e74-befc-3944b5c71d11",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-12T09:32:18.803Z",
        "type": "system"
      },
      {
        "id": "038782fb-21b3-42e2-ac52-c3db48e08592",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Study revoked by Medical Reviewer. Reason: Test. Returned to triage for corrections.",
        "timestamp": "2025-12-12T16:14:29.649Z",
        "type": "revocation"
      },
      {
        "id": "85476d80-2c7c-4b93-9ee7-f56234e37baf",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 8b517519-46e4-4efe-b094-a98ad51b2ac8 to DEXA_Synt_81444",
        "type": "system",
        "createdAt": "2025-12-14T10:12:57.615Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:05:25.590Z",
    "updatedAt": "2025-12-12T16:14:29.663Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41132053",
      "DOI": "https://doi.org10.1080/21623945.2025.2578286",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:34:50",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Cohen M, Bandaru P, Szylo K, Nguyen N, Nadeak B, Paszkiewicz R, Ashby JW, Mack JJ, Tanaka L, Tan J, Khademhosseini A, Mittelman SD. Adipose tissue explant culture using PDMS flow chambers: an alternative to static explant culture. Adipocyte. 2025;14(1):2578286",
      "pubdate": "2025-10-24",
      "Lead_author": "Cohen M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/21623945.2025.2578286",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Cohen M, Bandaru P, Szylo K, Nguyen N, Nadeak B, Paszkiewicz R, Ashby JW, Mack JJ, Tanaka L, Tan J, Khademhosseini A, Mittelman SD. Adipose tissue explant culture using PDMS flow chambers: an alternative to static explant culture. Adipocyte. 2025;14(1):2578286",
    "leadAuthor": "Cohen M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": null,
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "revokedAt": "2025-12-12T16:14:29.649Z",
    "revocationReason": "Test",
    "_rid": "Vf9WAOX6zUjwBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjwBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3843a80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707177
  },
  {
    "id": "DEXA_Synt_19520",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40819324",
    "title": "Dexamethasone conjugation to an Avidin-Nucleic-Acid-NanoASsembly eliminates the steroid plasma absorption, enhancing selective lung tropism in a murine model of pulmonary fibrosis.",
    "authors": [
      "Morelli A",
      "Schiavon E",
      "Violatto MB",
      "Moscatiello GY",
      "Salmaso A",
      "Passoni A",
      "Lanno A",
      "Bernardotto S",
      "Stocco M",
      "Mattarei A",
      "Bagnati R",
      "Meloni F",
      "Bigini P",
      "Morpurgo M"
    ],
    "journal": "Drug Deliv",
    "publicationDate": "2025-08-17",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "d90e39ae-7171-46bd-8f00-5034d2a3ed08",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-12T09:22:17.459Z",
        "type": "system"
      },
      {
        "id": "f8272481-db0f-4849-9fa6-c352cf7a7318",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Study revoked by Medical Reviewer. Reason: Test. Returned to triage for corrections.",
        "timestamp": "2025-12-12T16:13:00.016Z",
        "type": "revocation"
      },
      {
        "id": "342f1457-8b9c-4fe9-b532-2f99ed0b0546",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f55395a0-bfe2-45e0-b8e4-b91a7bfbd951 to DEXA_Synt_19520",
        "type": "system",
        "createdAt": "2025-12-14T10:12:57.848Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:05:25.617Z",
    "updatedAt": "2025-12-12T16:13:00.044Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40819324",
      "DOI": "https://doi.org10.1080/10717544.2025.2531063",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:35:20",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Morelli A, Schiavon E, Violatto MB, Moscatiello GY, Salmaso A, Passoni A, Lanno A, Bernardotto S, Stocco M, Mattarei A, Bagnati R, Meloni F, Bigini P, Morpurgo M. Dexamethasone conjugation to an Avidin-Nucleic-Acid-NanoASsembly eliminates the steroid plasma absorption, enhancing selective lung tropism in a murine model of pulmonary fibrosis. Drug Deliv. 2025;32(1):2531063",
      "pubdate": "2025-08-17",
      "Lead_author": "Morelli A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/10717544.2025.2531063",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Morelli A, Schiavon E, Violatto MB, Moscatiello GY, Salmaso A, Passoni A, Lanno A, Bernardotto S, Stocco M, Mattarei A, Bagnati R, Meloni F, Bigini P, Morpurgo M. Dexamethasone conjugation to an Avidin-Nucleic-Acid-NanoASsembly eliminates the steroid plasma absorption, enhancing selective lung tropism in a murine model of pulmonary fibrosis. Drug Deliv. 2025;32(1):2531063",
    "leadAuthor": "Morelli A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": null,
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "revokedAt": "2025-12-12T16:13:00.016Z",
    "revocationReason": "Test",
    "_rid": "Vf9WAOX6zUjxBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjxBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-38672c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707177
  },
  {
    "id": "DEXA_Synt_22084",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41286382",
    "title": "A multicenter observational retrospective study of second-line treatment with daratumumab-bortezomib-dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide.",
    "authors": [
      "Rizzello I",
      "Sacchetti I",
      "Barbato S",
      "Solli V",
      "Stefanoni P",
      "Cani L",
      "Quaresima M",
      "Belotti A",
      "Sgherza N",
      "Gentile M",
      "Zambello R",
      "Barilà G",
      "Celli M",
      "Mele G",
      "Mancuso K",
      "Pantani L",
      "Tacchetti P",
      "Talarico M",
      "Puppi M",
      "Manzato E",
      "Restuccia R",
      "Masci S",
      "Ghibellini S",
      "Bigi F",
      "Cavo M",
      "Zamagni E"
    ],
    "journal": "Clin Exp Med",
    "publicationDate": "2025-11-25",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "437c3c1f-1587-47cb-adbd-7b9742739f95",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-12T09:19:07.377Z",
        "type": "system"
      },
      {
        "id": "69e4c186-1082-41e1-ac19-c73c96bc7089",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Study revoked by Medical Reviewer. Reason: Test. Returned to triage for corrections.",
        "timestamp": "2025-12-12T15:58:54.188Z",
        "type": "revocation"
      },
      {
        "id": "d1db8421-126e-4c0b-9802-03af514758f6",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 24315f73-6a1b-43c8-ae5f-ce3c27081e14 to DEXA_Synt_22084",
        "type": "system",
        "createdAt": "2025-12-14T10:12:58.093Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:06:20.868Z",
    "updatedAt": "2025-12-12T15:58:54.200Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41286382",
      "DOI": "https://doi.org10.1007/s10238-025-01956-w",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:35:59",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Rizzello I, Sacchetti I, Barbato S, Solli V, Stefanoni P, Cani L, Quaresima M, Belotti A, Sgherza N, Gentile M, Zambello R, Barilà G, Celli M, Mele G, Mancuso K, Pantani L, Tacchetti P, Talarico M, Puppi M, Manzato E, Restuccia R, Masci S, Ghibellini S, Bigi F, Cavo M, Zamagni E. A multicenter observational retrospective study of second-line treatment with daratumumab-bortezomib-dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide. Clin Exp Med. 2025;26(1):43",
      "pubdate": "2025-11-25",
      "Lead_author": "Rizzello I",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s10238-025-01956-w",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Rizzello I, Sacchetti I, Barbato S, Solli V, Stefanoni P, Cani L, Quaresima M, Belotti A, Sgherza N, Gentile M, Zambello R, Barilà G, Celli M, Mele G, Mancuso K, Pantani L, Tacchetti P, Talarico M, Puppi M, Manzato E, Restuccia R, Masci S, Ghibellini S, Bigi F, Cavo M, Zamagni E. A multicenter observational retrospective study of second-line treatment with daratumumab-bortezomib-dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide. Clin Exp Med. 2025;26(1):43",
    "leadAuthor": "Rizzello I",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": null,
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "revokedAt": "2025-12-12T15:58:54.187Z",
    "revocationReason": "Test",
    "_rid": "Vf9WAOX6zUjyBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjyBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-388c600501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707178
  },
  {
    "id": "DEXA_Synt_88054",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41240971",
    "title": "Liposomal Bupivacaine versus Ropivacaine with Perineural Dexamethasone in Adductor Canal Block for Total Knee Arthroplasty: A Randomized Clinical Trial.",
    "authors": [
      "Liao C",
      "Li J",
      "Hu X",
      "Sun Y",
      "Zheng K",
      "Pan X",
      "Wang L"
    ],
    "journal": "J Arthroplasty",
    "publicationDate": "2025-11-16",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "bc44131c-2055-4d95-a309-87dfc4dde98f",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-12T09:11:53.454Z",
        "type": "system"
      },
      {
        "id": "40e8c9c4-6997-4e41-856c-91a6adb1ee48",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" rejected by QC. Reason: Test. Study returned to Triage for re-classification.",
        "timestamp": "2025-12-12T09:12:39.570Z",
        "type": "QC_rejection"
      },
      {
        "id": "56a33190-f7bf-4a95-b425-00276c32ef17",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-12T09:16:36.398Z",
        "type": "system"
      },
      {
        "id": "9b16811b-b63c-48e9-958e-16b3d093d2a1",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Study revoked by Medical Reviewer. Reason: Test. Returned to triage for corrections.",
        "timestamp": "2025-12-12T15:57:22.073Z",
        "type": "revocation"
      },
      {
        "id": "8ac6d83c-ac8f-4c4c-a72a-e2aa362139fa",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 43135206-2d54-4988-a157-b58006592c63 to DEXA_Synt_88054",
        "type": "system",
        "createdAt": "2025-12-14T10:12:58.352Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:06:20.906Z",
    "updatedAt": "2025-12-12T15:57:22.081Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41240971",
      "DOI": "https://doi.org10.1016/j.arth.2025.11.015",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:35:43",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Liao C, Li J, Hu X, Sun Y, Zheng K, Pan X, Wang L. Liposomal Bupivacaine versus Ropivacaine with Perineural Dexamethasone in Adductor Canal Block for Total Knee Arthroplasty: A Randomized Clinical Trial. J Arthroplasty. 2025;",
      "pubdate": "2025-11-16",
      "Lead_author": "Liao C",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.arth.2025.11.015",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Liao C, Li J, Hu X, Sun Y, Zheng K, Pan X, Wang L. Liposomal Bupivacaine versus Ropivacaine with Perineural Dexamethasone in Adductor Canal Block for Total Knee Arthroplasty: A Randomized Clinical Trial. J Arthroplasty. 2025;",
    "leadAuthor": "Liao C",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": null,
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaRejectedAt": "2025-12-12T09:12:39.570Z",
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "revokedAt": "2025-12-12T15:57:22.073Z",
    "revocationReason": "Test",
    "_rid": "Vf9WAOX6zUjzBwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjzBwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-38aee00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707178
  },
  {
    "id": "DEXA_Synt_10873",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41240201",
    "title": "S100A4 Induces Neutrophilic Inflammation in Chronic Rhinosinusitis with Nasal Polyps via TLR4 Pathway.",
    "authors": [
      "Tu Y",
      "Li C",
      "Li T",
      "Liu J",
      "Meng L",
      "Liu S",
      "Li P",
      "Wan Y",
      "Chen A",
      "Shi L",
      "Wang DY"
    ],
    "journal": "J Clin Immunol",
    "publicationDate": "2025-11-15",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "192b81c3-08cb-4083-9483-0f5d04ef71b2",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-12T09:11:30.597Z",
        "type": "system"
      },
      {
        "id": "4f4bbcf7-7c65-47ec-b049-f2957e4db72e",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Study revoked by Medical Reviewer. Reason: Test. Returned to triage for corrections.",
        "timestamp": "2025-12-12T15:56:00.677Z",
        "type": "revocation"
      },
      {
        "id": "107a8e5a-8174-460b-8e8e-7a9a4d3120d3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 66f6401f-693d-4a6d-a89b-ec331b80b216 to DEXA_Synt_10873",
        "type": "system",
        "createdAt": "2025-12-14T10:12:58.583Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:06:20.931Z",
    "updatedAt": "2025-12-12T15:56:00.688Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41240201",
      "DOI": "https://doi.org10.1007/s10875-025-01953-4",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:35:51",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Tu Y, Li C, Li T, Liu J, Meng L, Liu S, Li P, Wan Y, Chen A, Shi L, Wang DY. S100A4 Induces Neutrophilic Inflammation in Chronic Rhinosinusitis with Nasal Polyps via TLR4 Pathway. J Clin Immunol. 2025;45(1):160",
      "pubdate": "2025-11-15",
      "Lead_author": "Tu Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s10875-025-01953-4",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Tu Y, Li C, Li T, Liu J, Meng L, Liu S, Li P, Wan Y, Chen A, Shi L, Wang DY. S100A4 Induces Neutrophilic Inflammation in Chronic Rhinosinusitis with Nasal Polyps via TLR4 Pathway. J Clin Immunol. 2025;45(1):160",
    "leadAuthor": "Tu Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": null,
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "revokedAt": "2025-12-12T15:56:00.677Z",
    "revocationReason": "Test",
    "_rid": "Vf9WAOX6zUj0BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj0BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-38d8080501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707178
  },
  {
    "id": "DEXA_Synt_89155",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41237865",
    "title": "Effect of different doses of dexamethasone on the penetration of acyclovir across the blood-brain barrier.",
    "authors": [
      "Zhao J",
      "Shan Y",
      "Cen Y",
      "Wang M",
      "Zhuang T",
      "Li Y",
      "Liu Y",
      "Nie Z",
      "Xie J",
      "Zhang J"
    ],
    "journal": "Eur J Pharm Sci",
    "publicationDate": "2025-11-15",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "78a30bc1-b246-4ba4-b312-543be91beacd",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-12T09:10:14.941Z",
        "type": "system"
      },
      {
        "id": "85fb2db8-8961-481b-92e1-a26ee91198d3",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-12T15:52:33.580Z",
        "type": "system"
      },
      {
        "id": "8afdb835-2331-470f-ba98-86ac1fa86fa3",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. Awaiting QC approval before Medical Reviewer review.",
        "timestamp": "2025-12-12T15:52:33.727Z",
        "type": "system"
      },
      {
        "id": "b48d03dc-67ff-4017-b304-16087cf2aa1b",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 XML form approved by QC. Medical Review skipped (disabled). Ready for Reports.",
        "timestamp": "2025-12-12T15:52:51.227Z",
        "type": "qc_r3_approval"
      },
      {
        "id": "56cb8305-b0f3-4cee-b34b-0526238db876",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 5c1eb744-f075-4451-b21d-43469f3e0a55 to DEXA_Synt_89155",
        "type": "system",
        "createdAt": "2025-12-14T10:12:58.800Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:06:20.963Z",
    "updatedAt": "2025-12-12T15:52:51.236Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41237865",
      "DOI": "https://doi.org10.1016/j.ejps.2025.107378",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:36:07",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Zhao J, Shan Y, Cen Y, Wang M, Zhuang T, Li Y, Liu Y, Nie Z, Xie J, Zhang J. Effect of different doses of dexamethasone on the penetration of acyclovir across the blood-brain barrier. Eur J Pharm Sci. 2025;216107378",
      "pubdate": "2025-11-15",
      "Lead_author": "Zhao J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ejps.2025.107378",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Zhao J, Shan Y, Cen Y, Wang M, Zhuang T, Li Y, Liu Y, Nie Z, Xie J, Zhang J. Effect of different doses of dexamethasone on the penetration of acyclovir across the blood-brain barrier. Eur J Pharm Sci. 2025;216107378",
    "leadAuthor": "Zhao J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:42:14.033Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": {
      "C.2.r.1": "Zhao J",
      "C.2.r.1.2": "Zhao",
      "C.2.r.1.4": "J",
      "C.4.r.1": "Zhao J, Shan Y, Cen Y, Wang M, Zhuang T, Li Y, Liu Y, Nie Z, Xie J, Zhang J. Effect of different doses of dexamethasone on the penetration of acyclovir across the blood-brain barrier. Eur J Pharm Sci. 2025;216107378",
      "D.7.1.r": "Article requires manual review",
      "D.7": "Article requires manual review",
      "D.7.1.r.2": "Article requires manual review",
      "E.i.1.1a": "Article requires manual review",
      "C.2.r.2.1": "Institution in Article requires manual review"
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-12T15:52:33.727Z",
    "qcR3Status": "approved",
    "qcR3ApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qcR3ApprovedAt": "2025-12-12T15:52:51.227Z",
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "completed",
    "medicalReviewedBy": "system",
    "medicalReviewedAt": "2025-12-12T15:52:51.227Z",
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj1BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj1BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-38fd500501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707178
  },
  {
    "id": "DEXA_Synt_74255",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41127973",
    "title": "Dexamethasone-Appended Activatable Prodrug Overcoming Multidrug Resistance.",
    "authors": [
      "Kim J",
      "Hu C",
      "Jangili P",
      "Tang C",
      "Wang F",
      "Kim JS"
    ],
    "journal": "J Med Chem",
    "publicationDate": "2025-10-23",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "7c96ffdd-7fc2-46c6-9130-2acabcc1c42f",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-12T09:05:52.776Z",
        "type": "system"
      },
      {
        "id": "97f98b83-6723-4b3d-8ce0-509524493fc1",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-12T15:51:27.366Z",
        "type": "system"
      },
      {
        "id": "ca4a3001-d708-40fa-be11-451d40b1a107",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. Awaiting QC approval before Medical Reviewer review.",
        "timestamp": "2025-12-12T15:51:27.537Z",
        "type": "system"
      },
      {
        "id": "eee32dc4-f889-4900-a793-e598c5424dd5",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 XML form approved by QC. Medical Review skipped (disabled). Ready for Reports.",
        "timestamp": "2025-12-12T15:51:42.636Z",
        "type": "qc_r3_approval"
      },
      {
        "id": "5a9e3eca-25ee-41de-836f-fc1c4bcf7dfb",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Medical review completed. Study approved for final processing.",
        "timestamp": "2025-12-12T15:52:03.841Z",
        "type": "medical_approval"
      },
      {
        "id": "e2364fbd-a9e1-4a12-aee6-649dea2cacbf",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 603ee8c4-fe19-45e6-b1f5-a6d2b1eeda6f to DEXA_Synt_74255",
        "type": "system",
        "createdAt": "2025-12-14T10:12:59.034Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:06:20.993Z",
    "updatedAt": "2025-12-12T15:52:03.848Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41127973",
      "DOI": "https://doi.org10.1021/acs.jmedchem.5c02565",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:36:15",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Kim J, Hu C, Jangili P, Tang C, Wang F, Kim JS. Dexamethasone-Appended Activatable Prodrug Overcoming Multidrug Resistance. J Med Chem. 2025;68(21):23589-",
      "pubdate": "2025-10-23",
      "Lead_author": "Kim J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1021/acs.jmedchem.5c02565",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Kim J, Hu C, Jangili P, Tang C, Wang F, Kim JS. Dexamethasone-Appended Activatable Prodrug Overcoming Multidrug Resistance. J Med Chem. 2025;68(21):23589-",
    "leadAuthor": "Kim J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:42:14.103Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": {
      "C.2.r.1": "Kim J",
      "C.2.r.1.2": "Kim",
      "C.2.r.1.4": "J",
      "C.4.r.1": "Kim J, Hu C, Jangili P, Tang C, Wang F, Kim JS. Dexamethasone-Appended Activatable Prodrug Overcoming Multidrug Resistance. J Med Chem. 2025;68(21):23589-",
      "D.7.1.r": "Article requires manual review",
      "D.7": "Article requires manual review",
      "D.7.1.r.2": "Article requires manual review",
      "E.i.1.1a": "Article requires manual review",
      "C.2.r.2.1": "Institution in Article requires manual review"
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-12T15:51:27.537Z",
    "qcR3Status": "approved",
    "qcR3ApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qcR3ApprovedAt": "2025-12-12T15:51:42.636Z",
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "completed",
    "medicalReviewedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "medicalReviewedAt": "2025-12-12T15:52:03.841Z",
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj2BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj2BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-392a040501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707179
  },
  {
    "id": "DEXA_Synt_50392",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41237701",
    "title": "Anti-oxidative and anti-inflammatory effects of the phosphodiesterase 3/4 inhibitor ensifentrine.",
    "authors": [
      "Lea S",
      "Li J",
      "Littolff K",
      "Vijayacumaran K",
      "Singh D"
    ],
    "journal": "Int Immunopharmacol",
    "publicationDate": "2025-11-15",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "medical_review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "f709949e-ac56-4ba8-b06b-986f4db093b6",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-11T11:40:16.632Z",
        "type": "system"
      },
      {
        "id": "23cf6155-5496-4acd-9d40-fb31ca558b94",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-12T15:50:12.175Z",
        "type": "system"
      },
      {
        "id": "b699d601-664c-4eca-913d-3aa517bb20c7",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. Awaiting QC approval before Medical Reviewer review.",
        "timestamp": "2025-12-12T15:50:12.357Z",
        "type": "system"
      },
      {
        "id": "83233a22-261b-4fd2-a48b-91a909f89110",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 XML form approved by QC. Ready for Medical Reviewer",
        "timestamp": "2025-12-12T15:50:28.660Z",
        "type": "qc_r3_approval"
      },
      {
        "id": "4811ff06-120d-4fbf-aebc-ef03f8b672db",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 91c804b1-92c4-4781-aa87-b21a652d1279 to DEXA_Synt_50392",
        "type": "system",
        "createdAt": "2025-12-14T10:12:59.294Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:07:27.505Z",
    "updatedAt": "2025-12-12T15:50:28.668Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41237701",
      "DOI": "https://doi.org10.1016/j.intimp.2025.115814",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:37:01",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Lea S, Li J, Littolff K, Vijayacumaran K, Singh D. Anti-oxidative and anti-inflammatory effects of the phosphodiesterase 3/4 inhibitor ensifentrine. Int Immunopharmacol. 2025;168(Pt 1):115814",
      "pubdate": "2025-11-15",
      "Lead_author": "Lea S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.intimp.2025.115814",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Lea S, Li J, Littolff K, Vijayacumaran K, Singh D. Anti-oxidative and anti-inflammatory effects of the phosphodiesterase 3/4 inhibitor ensifentrine. Int Immunopharmacol. 2025;168(Pt 1):115814",
    "leadAuthor": "Lea S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:42:14.171Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": {
      "C.2.r.1": "Lea S",
      "C.2.r.1.2": "Lea",
      "C.2.r.1.4": "S",
      "C.4.r.1": "Lea S, Li J, Littolff K, Vijayacumaran K, Singh D. Anti-oxidative and anti-inflammatory effects of the phosphodiesterase 3/4 inhibitor ensifentrine. Int Immunopharmacol. 2025;168(Pt 1):115814",
      "D.7.1.r": "Article requires manual review",
      "D.7": "Article requires manual review",
      "D.7.1.r.2": "Article requires manual review",
      "E.i.1.1a": "Article requires manual review",
      "C.2.r.2.1": "Institution in Article requires manual review"
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-12T15:50:12.357Z",
    "qcR3Status": "approved",
    "qcR3ApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qcR3ApprovedAt": "2025-12-12T15:50:28.660Z",
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj3BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj3BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-394f900501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707179
  },
  {
    "id": "DEXA_Synt_24823",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40938661",
    "title": "Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival.",
    "authors": [
      "Bota DA",
      "Piccioni DE",
      "Duma CM",
      "Kesari S",
      "Carrillo JA",
      "LaRocca RV",
      "Aiken RD",
      "Taylor TH",
      "Abedi M",
      "Robles RM",
      "Godding K",
      "Keirstead HS",
      "Nistor GI",
      "Dillman RO"
    ],
    "journal": "Hum Vaccin Immunother",
    "publicationDate": "2025-09-12",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "aoi_assessment",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "c7dfadd1-c68e-4d49-9d67-24e162621031",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"AOI\". Awaiting QC approval.",
        "timestamp": "2025-12-11T07:28:17.830Z",
        "type": "system"
      },
      {
        "id": "5ed86293-a717-40c9-b6b7-8f29a47eceb1",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 822fa715-87be-446b-8c9b-4381c6c7ea58 to DEXA_Synt_24823",
        "type": "system",
        "createdAt": "2025-12-14T10:12:59.555Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:07:27.534Z",
    "updatedAt": "2025-12-12T11:42:14.259Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40938661",
      "DOI": "https://doi.org10.1080/21645515.2025.2556591",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:37:07",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Bota DA, Piccioni DE, Duma CM, Kesari S, Carrillo JA, LaRocca RV, Aiken RD, Taylor TH, Abedi M, Robles RM, Godding K, Keirstead HS, Nistor GI, Dillman RO. Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival. Hum Vaccin Immunother. 2025;21(1):2556591",
      "pubdate": "2025-09-12",
      "Lead_author": "Bota DA",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/21645515.2025.2556591",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Bota DA, Piccioni DE, Duma CM, Kesari S, Carrillo JA, LaRocca RV, Aiken RD, Taylor TH, Abedi M, Robles RM, Godding K, Keirstead HS, Nistor GI, Dillman RO. Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival. Hum Vaccin Immunother. 2025;21(1):2556591",
    "leadAuthor": "Bota DA",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "AOI",
    "effectiveClassification": "AOI",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:42:14.248Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj4BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj4BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3975500501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707179
  },
  {
    "id": "DEXA_Synt_22369",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40876663",
    "title": "Palonosetron Plus Megestrol Acetate Versus Palonosetron Plus Dexamethasone in Preventing Moderately Emetogenic Chemotherapy-induced Nausea and Vomiting: A Randomized, Multicenter, Crossover Trial.",
    "authors": [
      "Li Q",
      "Luo Y",
      "Zhao Y",
      "Gou H",
      "Min S",
      "Yang B",
      "Yi C"
    ],
    "journal": "2025;70(6):557-568",
    "publicationDate": "2025-08-29",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9ce6f48b-68e9-4dcc-968d-3f22d9052b20",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"No Case\". Awaiting QC approval.",
        "timestamp": "2025-12-03T12:35:28.557Z",
        "type": "system"
      },
      {
        "id": "648b22ce-e8ea-425d-beb5-733fe85daa5c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from ebc64090-de32-454a-94d6-abf2c193f52d to DEXA_Synt_22369",
        "type": "system",
        "createdAt": "2025-12-14T10:12:59.788Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-03T08:07:27.564Z",
    "updatedAt": "2025-12-12T11:42:14.322Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40876663",
      "DOI": "https://doi.org10.1016/j.jpainsymman.2025.07.034",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Synthon",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-03 13:36:54",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Li Q, Luo Y, Zhao Y, Gou H, Min S, Yang B, Yi C. Palonosetron Plus Megestrol Acetate Versus Palonosetron Plus Dexamethasone in Preventing Moderately Emetogenic Chemotherapy-induced Nausea and Vomiting: A Randomized, Multicenter, Crossover Trial. J Pain Symptom Manage. 2025;70(6):557-568.e1",
      "pubdate": "2025-08-29",
      "Lead_author": "Li Q",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jpainsymman.2025.07.034",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Li Q, Luo Y, Zhao Y, Gou H, Min S, Yang B, Yi C. Palonosetron Plus Megestrol Acetate Versus Palonosetron Plus Dexamethasone in Preventing Moderately Emetogenic Chemotherapy-induced Nausea and Vomiting: A Randomized, Multicenter, Crossover Trial. J Pain Symptom Manage. 2025;70(6):557-568.e1",
    "leadAuthor": "Li Q",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Synthon",
    "sponsor": "Synthon",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:42:14.310Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj5BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj5BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-39988c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707179
  },
  {
    "id": "DEXA_Unkn_89960",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41370738",
    "title": "Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study.",
    "authors": [
      "Popat R",
      "Beksac M",
      "Dimopoulos MA",
      "Gatt ME",
      "Gay F",
      "Jo JC",
      "Kapoor P",
      "Katodritou E",
      "Kortüm KM",
      "Ling S",
      "Nagarajan C",
      "Suzuki K",
      "Qiu L",
      "Onishi M",
      "Ku G",
      "Dail M",
      "Mukherjee N",
      "Ross JA",
      "Badawi MA",
      "Fusco MJ",
      "Dobkowska E",
      "Arriola E",
      "Bueno OF",
      "Bahlis NJ",
      "Iida S",
      "Moreau P",
      "Valent J",
      "Mateos MV"
    ],
    "journal": "J Clin Oncol",
    "publicationDate": "2025-12-10",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "4bada60a-e89b-49d6-97c7-7f76ac942364",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-12T09:05:01.045Z",
        "type": "system"
      },
      {
        "id": "2c8cfc1c-c14a-4378-90cf-7d033a2acf33",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-12T15:48:51.469Z",
        "type": "system"
      },
      {
        "id": "36e4d6b2-06fa-4ab1-aaa2-395238bf18c3",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. QC Data Entry and Medical Review skipped (disabled). Ready for Reports.",
        "timestamp": "2025-12-12T15:48:51.553Z",
        "type": "system"
      },
      {
        "id": "830088f0-503e-4141-8bb5-ff1dc85ff95a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from e9ef6b16-be24-4863-b902-324e06f6c238 to DEXA_Unkn_89960",
        "type": "system",
        "createdAt": "2025-12-14T10:13:00.050Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-11T12:02:55.791Z",
    "updatedAt": "2025-12-12T15:48:51.560Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41370738",
      "DOI": "https://doi.org10.1200/JCO-25-00924",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Unknown",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-11 17:30:56",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Popat R, Beksac M, Dimopoulos MA, Gatt ME, Gay F, Jo JC, Kapoor P, Katodritou E, Kortüm KM, Ling S, Nagarajan C, Suzuki K, Qiu L, Onishi M, Ku G, Dail M, Mukherjee N, Ross JA, Badawi MA, Fusco MJ, Dobkowska E, Arriola E, Bueno OF, Bahlis NJ, Iida S, Moreau P, Valent J, Mateos MV. Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study. J Clin Oncol. 2025;JCO2500924",
      "pubdate": "2025-12-10",
      "Lead_author": "Popat R",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1200/JCO-25-00924",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Popat R, Beksac M, Dimopoulos MA, Gatt ME, Gay F, Jo JC, Kapoor P, Katodritou E, Kortüm KM, Ling S, Nagarajan C, Suzuki K, Qiu L, Onishi M, Ku G, Dail M, Mukherjee N, Ross JA, Badawi MA, Fusco MJ, Dobkowska E, Arriola E, Bueno OF, Bahlis NJ, Iida S, Moreau P, Valent J, Mateos MV. Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study. J Clin Oncol. 2025;JCO2500924",
    "leadAuthor": "Popat R",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Unknown",
    "sponsor": "Unknown",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:42:14.355Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": {
      "C.2.r.1": "Popat R",
      "C.2.r.1.2": "Popat",
      "C.2.r.1.4": "R",
      "C.4.r.1": "Popat R, Beksac M, Dimopoulos MA, Gatt ME, Gay F, Jo JC, Kapoor P, Katodritou E, Kortüm KM, Ling S, Nagarajan C, Suzuki K, Qiu L, Onishi M, Ku G, Dail M, Mukherjee N, Ross JA, Badawi MA, Fusco MJ, Dobkowska E, Arriola E, Bueno OF, Bahlis NJ, Iida S, Moreau P, Valent J, Mateos MV. Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study. J Clin Oncol. 2025;JCO2500924",
      "D.7.1.r": "Article requires manual review",
      "D.7": "Article requires manual review",
      "D.7.1.r.2": "Article requires manual review",
      "E.i.1.1a": "Article requires manual review",
      "C.2.r.2.1": "Institution in Article requires manual review"
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-12T15:48:51.553Z",
    "qcR3Status": "approved",
    "qcR3ApprovedBy": "system",
    "qcR3ApprovedAt": "2025-12-12T15:48:51.553Z",
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": "Auto-approved (QC Data Entry disabled)",
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "completed",
    "medicalReviewedBy": "system",
    "medicalReviewedAt": "2025-12-12T15:48:51.553Z",
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj6BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj6BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-39b19c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707180
  },
  {
    "id": "DEXA_Unkn_44490",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41369195",
    "title": "Volumetric Analysis of Contrast Enhancement in Patients With Newly Diagnosed Glioblastomas.",
    "authors": [
      "Saint-Germain MA",
      "Sherief M",
      "Sair HI",
      "Schreck KC",
      "Mukherjee D",
      "Kamson DO",
      "Grossman SA"
    ],
    "journal": "Neurosurgery",
    "publicationDate": "2025-12-10",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "85829deb-8403-42bf-b678-f3ba3b98fd55",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"No Case\". Awaiting QC approval.",
        "timestamp": "2025-12-12T07:35:27.702Z",
        "type": "system"
      },
      {
        "id": "ea18e68c-4260-4eda-8ac7-61ac109e3bef",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3f97a3cc-5725-43d8-9529-d12fc9f82139 to DEXA_Unkn_44490",
        "type": "system",
        "createdAt": "2025-12-14T10:13:00.347Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-11T12:02:55.830Z",
    "updatedAt": "2025-12-12T11:42:14.424Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41369195",
      "DOI": "https://doi.org10.1227/neu.0000000000003876",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Unknown",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-11 17:31:50",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Saint-Germain MA, Sherief M, Sair HI, Schreck KC, Mukherjee D, Kamson DO, Grossman SA. Volumetric Analysis of Contrast Enhancement in Patients With Newly Diagnosed Glioblastomas. Neurosurgery. 2025;",
      "pubdate": "2025-12-10",
      "Lead_author": "Saint-Germain MA",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1227/neu.0000000000003876",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Saint-Germain MA, Sherief M, Sair HI, Schreck KC, Mukherjee D, Kamson DO, Grossman SA. Volumetric Analysis of Contrast Enhancement in Patients With Newly Diagnosed Glioblastomas. Neurosurgery. 2025;",
    "leadAuthor": "Saint-Germain MA",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Secondary analysis",
    "clientName": "Unknown",
    "sponsor": "Unknown",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:42:14.415Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj7BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj7BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-39deec0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707180
  },
  {
    "id": "DEXA_Unkn_18437",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41366832",
    "title": "Metagenomic Next-generation Sequencing Aids Diagnosis of Leishmania donovani-associated Hemophagocytic Lymphohistiocytosis in Infants: Case Report and Systematic Review.",
    "authors": [
      "Wu X",
      "Yang C",
      "Qing L",
      "Yang W",
      "Zhou K",
      "Lu G"
    ],
    "journal": "Pediatr Infect Dis J",
    "publicationDate": "2025-12-10",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "61250c5a-3590-4146-87ca-0588426f2697",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"No Case\". Awaiting QC approval.",
        "timestamp": "2025-12-12T07:29:47.813Z",
        "type": "system"
      },
      {
        "id": "1cf67fa3-0aea-4c3e-bd2b-66a8e212a14c",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"No Case\" rejected by QC. Reason: Coming as pre clinical. Study returned to Triage for re-classification.",
        "timestamp": "2025-12-12T07:33:04.897Z",
        "type": "QC_rejection"
      },
      {
        "id": "c5be2a4e-2cf3-4157-b97a-930c36de3268",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"No Case\". Awaiting QC approval.",
        "timestamp": "2025-12-12T07:33:14.201Z",
        "type": "system"
      },
      {
        "id": "8ed04228-96af-4278-9c1e-e9e86d42b8a4",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from babd28b7-e6df-4dce-85db-919a676ee953 to DEXA_Unkn_18437",
        "type": "system",
        "createdAt": "2025-12-14T10:13:00.558Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-11T12:02:55.865Z",
    "updatedAt": "2025-12-12T11:42:14.488Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41366832",
      "DOI": "https://doi.org10.1097/INF.0000000000005078",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Unknown",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-11 17:32:44",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Wu X, Yang C, Qing L, Yang W, Zhou K, Lu G. Metagenomic Next-generation Sequencing Aids Diagnosis of Leishmania donovani-associated Hemophagocytic Lymphohistiocytosis in Infants: Case Report and Systematic Review. Pediatr Infect Dis J. 2025;",
      "pubdate": "2025-12-10",
      "Lead_author": "Wu X",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/INF.0000000000005078",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Wu X, Yang C, Qing L, Yang W, Zhou K, Lu G. Metagenomic Next-generation Sequencing Aids Diagnosis of Leishmania donovani-associated Hemophagocytic Lymphohistiocytosis in Infants: Case Report and Systematic Review. Pediatr Infect Dis J. 2025;",
    "leadAuthor": "Wu X",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Secondary analysis",
    "clientName": "Unknown",
    "sponsor": "Unknown",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:42:14.478Z",
    "qaRejectedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaRejectedAt": "2025-12-12T07:33:04.897Z",
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj8BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj8BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-39fee40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707180
  },
  {
    "id": "DEXA_Unkn_43478",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41101227",
    "title": "Deficiency of the innate immune protein IFITM3 impairs phagocytosis and promotes autism-like behaviors in mice.",
    "authors": [
      "Lin G",
      "Xinying G",
      "Jingwen Q",
      "Ziwen S",
      "Xingrong S",
      "Lei P"
    ],
    "journal": "Int Immunopharmacol",
    "publicationDate": "2025-10-17",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "aoi_assessment",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a39028e3-fb44-4392-bae7-d348c43a896e",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"AOI\". Awaiting QC approval.",
        "timestamp": "2025-12-12T07:20:29.960Z",
        "type": "system"
      },
      {
        "id": "89f0a684-cfcc-4050-8345-1fea381284bd",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a49877fc-5813-48b6-80eb-df2d12659ca7 to DEXA_Unkn_43478",
        "type": "system",
        "createdAt": "2025-12-14T10:13:00.786Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-11T12:02:55.887Z",
    "updatedAt": "2025-12-12T19:09:00.108Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41101227",
      "DOI": "https://doi.org10.1016/j.intimp.2025.115599",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Unknown",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-11 17:32:54",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Lin G, Xinying G, Jingwen Q, Ziwen S, Xingrong S, Lei P. Deficiency of the innate immune protein IFITM3 impairs phagocytosis and promotes autism-like behaviors in mice. Int Immunopharmacol. 2025;167115599",
      "pubdate": "2025-10-17",
      "Lead_author": "Lin G",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.intimp.2025.115599",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Lin G, Xinying G, Jingwen Q, Ziwen S, Xingrong S, Lei P. Deficiency of the innate immune protein IFITM3 impairs phagocytosis and promotes autism-like behaviors in mice. Int Immunopharmacol. 2025;167115599",
    "leadAuthor": "Lin G",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Adverse Event",
    "clientName": "Unknown",
    "sponsor": "Unknown",
    "userTag": "AOI",
    "effectiveClassification": "AOI",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:42:14.540Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": "No",
    "seriousness": "Yes",
    "aoiAssessedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "aoiAssessedAt": "2025-12-12T19:09:00.099Z",
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj9BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj9BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3a219c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707180
  },
  {
    "id": "DEXA_Demo_95011",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41373094",
    "title": "Hydroxychloroquine After Complete Heart Block Diagnosis and Relationship to Patient Outcomes: A Descriptive Cohort Study.",
    "authors": [
      "Carter EL",
      "Gebb J",
      "Janson C",
      "Szwast A"
    ],
    "journal": "Prenat Diagn",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "medical_review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "21bc2eb7-0077-4726-a814-65214e341ad1",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-12T07:18:17.789Z",
        "type": "system"
      },
      {
        "id": "7ec22960-95ff-46ba-9bcd-4893534680c6",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" rejected by QC. Reason: Test 2. Study returned to Triage for re-classification.",
        "timestamp": "2025-12-12T07:19:19.637Z",
        "type": "QC_rejection"
      },
      {
        "id": "602ef9fc-ed16-4da5-8967-0e07b8345c0b",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-12T07:19:32.137Z",
        "type": "system"
      },
      {
        "id": "fba10133-2ea9-4a55-94fc-89858ac1d541",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-12T15:48:11.094Z",
        "type": "system"
      },
      {
        "id": "bce402c8-b33a-4f3d-90bc-cd559bb41c5b",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. QC Data Entry skipped (disabled). Ready for Medical Reviewer.",
        "timestamp": "2025-12-12T15:48:11.253Z",
        "type": "system"
      },
      {
        "id": "ddf2dd09-73df-4458-9e0d-152c1b684b20",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 0e34e423-cd19-4b4c-ab72-f4519eea37f6 to DEXA_Demo_95011",
        "type": "system",
        "createdAt": "2025-12-14T10:13:01.032Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-11T15:32:20.593Z",
    "updatedAt": "2025-12-12T15:48:11.262Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41373094",
      "DOI": "https://doi.org10.1002/pd.70036",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-11 21:01:36",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Carter EL, Gebb J, Janson C, Szwast A. Hydroxychloroquine After Complete Heart Block Diagnosis and Relationship to Patient Outcomes: A Descriptive Cohort Study. Prenat Diagn. 2025;",
      "pubdate": "2025-12-11",
      "Lead_author": "Carter EL",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/pd.70036",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Carter EL, Gebb J, Janson C, Szwast A. Hydroxychloroquine After Complete Heart Block Diagnosis and Relationship to Patient Outcomes: A Descriptive Cohort Study. Prenat Diagn. 2025;",
    "leadAuthor": "Carter EL",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:42:14.624Z",
    "qaRejectedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaRejectedAt": "2025-12-12T07:19:19.637Z",
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": {
      "C.2.r.1": "Carter EL",
      "C.2.r.1.2": "Carter",
      "C.2.r.1.4": "EL",
      "C.4.r.1": "Carter EL, Gebb J, Janson C, Szwast A. Hydroxychloroquine After Complete Heart Block Diagnosis and Relationship to Patient Outcomes: A Descriptive Cohort Study. Prenat Diagn. 2025;",
      "D.7.1.r": "Article requires manual review",
      "D.7": "Article requires manual review",
      "D.7.1.r.2": "Article requires manual review",
      "E.i.1.1a": "Article requires manual review",
      "C.2.r.2.1": "Institution in Article requires manual review"
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-12T15:48:11.253Z",
    "qcR3Status": "approved",
    "qcR3ApprovedBy": "system",
    "qcR3ApprovedAt": "2025-12-12T15:48:11.253Z",
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": "Auto-approved (QC Data Entry disabled)",
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj+BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj+BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3a46fc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707181
  },
  {
    "id": "DEXA_Demo_40456",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41376593",
    "title": "Gestational Glucocorticoids' Exposure Impairs Vascular Contractility in Male Offspring Mice With Transgenerational Effects.",
    "authors": [
      "Lei J",
      "Zhao M",
      "Yao S",
      "Lu M",
      "Deng F",
      "Xu T",
      "Zhang M",
      "Sun M",
      "Gao Q"
    ],
    "journal": "Arterioscler Thromb Vasc Biol",
    "publicationDate": "2025-12-11",
    "abstract": "This study investigates the transgenerational effects of gestational exposure to dexamethasone, a synthetic glucocorticoid, using a mouse model. Pregnant mice were administered dexamethasone intraperitoneally on specific gestational days (12, 14, 16, and 18), and the vascular function of male offspring across three generations (F1, F2, and F3) was analyzed. The study found that exposure to dexamethasone during gestation led to a modest but consistent increase in systolic blood pressure and enhanced vascular contractility mediated by angiotensin II (Ang II) in male offspring. Mechanistically, the exposure reduced DNA methylation in the Agtr1a gene promoter, resulting in upregulated Agtr1a expression and increased oxidative stress through the AT1R/NOX2/reactive oxygen species axis. These vascular abnormalities were stably inherited across generations due to alterations in DNA methylation patterns in sperm. The findings highlight the epigenetic transmission of acquired vascular dysfunction caused by gestational glucocorticoid exposure, offering insights into intergenerational disease mechanisms and potential clinical strategies to mitigate adverse effects of glucocorticoid therapy during pregnancy.",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "No AE",
    "status": "medical_review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "4dda2038-ed6d-427f-8d9a-c6c3207c4fe7",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-11T16:54:42.695Z",
        "type": "system"
      },
      {
        "id": "287ddb91-7dbc-4832-afdd-491187c9df7c",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-12T15:47:33.764Z",
        "type": "system"
      },
      {
        "id": "fe8cd842-e614-4aea-ba4d-9c3800fe80af",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. QC Data Entry skipped (disabled). Ready for Medical Reviewer.",
        "timestamp": "2025-12-12T15:47:33.896Z",
        "type": "system"
      },
      {
        "id": "882480e9-4ecd-422e-8c7a-ece367ab90bf",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 38eac684-0a4b-4bac-ade8-4fb415c14462 to DEXA_Demo_40456",
        "type": "system",
        "createdAt": "2025-12-14T10:13:01.261Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-11T15:33:38.831Z",
    "updatedAt": "2025-12-12T15:47:33.905Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41376593",
      "DOI": "https://doi.org/10.1161/ATVBAHA.125.323061",
      "special_case": "No",
      "Country_of_first_author": "China",
      "Country_of_occurrence": "China",
      "Patient_details": "No human subject",
      "Key_events": "Key events: not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Dexamethasone",
      "Attributability": "Attributability: not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "This study investigates the transgenerational effects of gestational exposure to dexamethasone, a synthetic glucocorticoid, using a mouse model. Pregnant mice were administered dexamethasone intraperitoneally on specific gestational days (12, 14, 16, and 18), and the vascular function of male offspring across three generations (F1, F2, and F3) was analyzed. The study found that exposure to dexamethasone during gestation led to a modest but consistent increase in systolic blood pressure and enhanced vascular contractility mediated by angiotensin II (Ang II) in male offspring. Mechanistically, the exposure reduced DNA methylation in the Agtr1a gene promoter, resulting in upregulated Agtr1a expression and increased oxidative stress through the AT1R/NOX2/reactive oxygen species axis. These vascular abnormalities were stably inherited across generations due to alterations in DNA methylation patterns in sperm. The findings highlight the epigenetic transmission of acquired vascular dysfunction caused by gestational glucocorticoid exposure, offering insights into intergenerational disease mechanisms and potential clinical strategies to mitigate adverse effects of glucocorticoid therapy during pregnancy.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article comments on the adverse effects of gestational dexamethasone exposure, particularly its role in inducing transgenerational vascular dysfunction through epigenetic mechanisms. It highlights the importance of understanding these effects for developing clinical strategies to mitigate risks associated with glucocorticoid therapy during pregnancy.",
      "Adverse_event": "No AE",
      "Abstract": "The application or excessive exposure to glucocorticoids constitutes a common adverse factor endured by intrauterine fetuses. Gestational glucocorticoids' exposure is intimately associated with the risk of postnatal vascular problems; however, whether the vascular problem can be transgenerationally inherited remains indistinct. In this study, a mouse model of gestational glucocorticoids' exposure was established, aiming to discover the abnormal phenotype of acquired vascular function of the offspring and clarify the epigenetic mechanism of the transgenerational transmission of the relevant abnormal phenotypes.\n\nTo model gestational glucocorticoid exposure, pregnant mice received intraperitoneal injections of dexamethasone (a synthetic glucocorticoid) on gestational days 12, 14, 16, and 18. Male offspring (F1) derived from dexamethasone group-exposed pregnancies were bred with wild-type females to generate F2 progeny, and this breeding strategy was repeated to produce F3 offspring. Adult male offspring from all 3 generations were subsequently analyzed.\n\nWe observed that gestational dexamethasone group exposure induced a modest but consistent elevation in systolic blood pressure across F1 to F3 male offspring, accompanied by enhanced Ang II (angiotensin II)-mediated vascular contractility. Mechanistically, dexamethasone group exposure significantly reduced DNA methylation in the Agtr1a (Ang II receptor subtype A) gene promoter within F1 offspring vasculature, leading to upregulated Agtr1a expression and heightened oxidative stress via the AT1R (Ang II receptor 1)/NOX (nicotinamide adenine dinucleotide phosphate oxidase) 2/reactive oxygen species axis. This cascade potentiated Ang II-induced vascular contractility. Moreover, these acquired abnormal vascular problems can be stably inherited and transgenerationally transmitted through the alteration of the DNA methylation pattern of the Agtr1a gene in sperm.\n\nThis study demonstrates that gestational glucocorticoids' exposure triggers transgenerational inheritance of vascular dysfunction in male offspring via DNA methylation reprogramming, providing direct evidence for the epigenetic transmission of acquired traits. These findings advance our understanding of intergenerational disease mechanisms and offer novel insights for clinical strategies aimed at mitigating the adverse effects of gestational glucocorticoid therapy.",
      "Title": "Gestational Glucocorticoids' Exposure Impairs Vascular Contractility in Male Offspring Mice With Transgenerational Effects.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-11 21:03:06",
      "Vancouver_citation": "Lei J, Zhao M, Yao S, Lu M, Deng F, Xu T, Zhang M, Sun M, Gao Q. Gestational Glucocorticoids' Exposure Impairs Vascular Contractility in Male Offspring Mice With Transgenerational Effects. Arterioscler Thromb Vasc Biol. 2025;",
      "pubdate": "2025-12-11",
      "Lead_author": "Lei J",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study are pregnant mice exposed to the drug of study, dexamethasone, via intraperitoneal injections during specific gestational days (12, 14, 16, and 18). The male offspring (F1 generation) of these mice were analyzed, and subsequent generations (F2 and F3) were produced through breeding with wild-type females to study transgenerational effects.",
      "AOI_drug_effect": "  \n2. The drug of study, dexamethasone, had a significant effect on the test subjects. It induced vascular dysfunction in male offspring across three generations (F1, F2, and F3). Specifically, it caused elevated systolic blood pressure and enhanced Ang II-mediated vascular contractility. Mechanistically, dexamethasone exposure reduced DNA methylation in the Agtr1a gene promoter, leading to upregulated gene expression, increased oxidative stress, and heightened vascular contractility. These effects were stably inherited across generations.",
      "Approved_indication": "  \n3. The drug of study, dexamethasone, is conventionally used as a synthetic glucocorticoid for its anti-inflammatory and immunosuppressive properties. It is typically administered to patients with conditions such as autoimmune diseases, allergies, and certain cancers, and is sometimes used in pregnant women to promote fetal lung development in cases of preterm labor risk. In this study, dexamethasone was administered to pregnant mice via intraperitoneal injections to model gestational glucocorticoid exposure. The intention was to investigate its impact on vascular function and transgenerational inheritance of vascular dysfunction in offspring.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "  \n5. The study links dexamethasone exposure to adverse effects, including elevated systolic blood pressure, enhanced vascular contractility, and epigenetic changes leading to transgenerational vascular dysfunction.",
      "Client_name": "Demo",
      "Drugname": "DEXAMETHASONE"
    },
    "doi": "https://doi.org/10.1161/ATVBAHA.125.323061",
    "specialCase": "No",
    "countryOfFirstAuthor": "China",
    "countryOfOccurrence": "China",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Dexamethasone"
    ],
    "attributability": "Attributability: not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "This study investigates the transgenerational effects of gestational exposure to dexamethasone, a synthetic glucocorticoid, using a mouse model. Pregnant mice were administered dexamethasone intraperitoneally on specific gestational days (12, 14, 16, and 18), and the vascular function of male offspring across three generations (F1, F2, and F3) was analyzed. The study found that exposure to dexamethasone during gestation led to a modest but consistent increase in systolic blood pressure and enhanced vascular contractility mediated by angiotensin II (Ang II) in male offspring. Mechanistically, the exposure reduced DNA methylation in the Agtr1a gene promoter, resulting in upregulated Agtr1a expression and increased oxidative stress through the AT1R/NOX2/reactive oxygen species axis. These vascular abnormalities were stably inherited across generations due to alterations in DNA methylation patterns in sperm. The findings highlight the epigenetic transmission of acquired vascular dysfunction caused by gestational glucocorticoid exposure, offering insights into intergenerational disease mechanisms and potential clinical strategies to mitigate adverse effects of glucocorticoid therapy during pregnancy.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article comments on the adverse effects of gestational dexamethasone exposure, particularly its role in inducing transgenerational vascular dysfunction through epigenetic mechanisms. It highlights the importance of understanding these effects for developing clinical strategies to mitigate risks associated with glucocorticoid therapy during pregnancy.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Lei J, Zhao M, Yao S, Lu M, Deng F, Xu T, Zhang M, Sun M, Gao Q. Gestational Glucocorticoids' Exposure Impairs Vascular Contractility in Male Offspring Mice With Transgenerational Effects. Arterioscler Thromb Vasc Biol. 2025;",
    "leadAuthor": "Lei J",
    "serious": "No",
    "testSubject": "The test subjects involved in this study are pregnant mice exposed to the drug of study, dexamethasone, via intraperitoneal injections during specific gestational days (12, 14, 16, and 18). The male offspring (F1 generation) of these mice were analyzed, and subsequent generations (F2 and F3) were produced through breeding with wild-type females to study transgenerational effects.",
    "aoiDrugEffect": "  \n2. The drug of study, dexamethasone, had a significant effect on the test subjects. It induced vascular dysfunction in male offspring across three generations (F1, F2, and F3). Specifically, it caused elevated systolic blood pressure and enhanced Ang II-mediated vascular contractility. Mechanistically, dexamethasone exposure reduced DNA methylation in the Agtr1a gene promoter, leading to upregulated gene expression, increased oxidative stress, and heightened vascular contractility. These effects were stably inherited across generations.",
    "approvedIndication": "  \n3. The drug of study, dexamethasone, is conventionally used as a synthetic glucocorticoid for its anti-inflammatory and immunosuppressive properties. It is typically administered to patients with conditions such as autoimmune diseases, allergies, and certain cancers, and is sometimes used in pregnant women to promote fetal lung development in cases of preterm labor risk. In this study, dexamethasone was administered to pregnant mice via intraperitoneal injections to model gestational glucocorticoid exposure. The intention was to investigate its impact on vascular function and transgenerational inheritance of vascular dysfunction in offspring.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:42:14.663Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": {
      "C.2.r.1": "Lei J",
      "C.2.r.1.2": "Lei",
      "C.2.r.1.4": "J",
      "C.4.r.1": "Lei J, Zhao M, Yao S, Lu M, Deng F, Xu T, Zhang M, Sun M, Gao Q. Gestational Glucocorticoids' Exposure Impairs Vascular Contractility in Male Offspring Mice With Transgenerational Effects. Arterioscler Thromb Vasc Biol. 2025;",
      "D.7.1.r": "No human subject",
      "D.7": "This study investigates the transgenerational effects of gestational exposure to dexamethasone, a synthetic glucocorticoid, using a mouse model. Pregnant mice were administered dexamethasone intraperitoneally on specific gestational days (12, 14, 16, and 18), and the vascular function of male offspring across three generations (F1, F2, and F3) was analyzed. The study found that exposure to dexamethasone during gestation led to a modest but consistent increase in systolic blood pressure and enhanced vascular contractility mediated by angiotensin II (Ang II) in male offspring. Mechanistically, the exposure reduced DNA methylation in the Agtr1a gene promoter, resulting in upregulated Agtr1a expression and increased oxidative stress through the AT1R/NOX2/reactive oxygen species axis. These vascular abnormalities were stably inherited across generations due to alterations in DNA methylation patterns in sperm. The findings highlight the epigenetic transmission of acquired vascular dysfunction caused by gestational glucocorticoid exposure, offering insights into intergenerational disease mechanisms and potential clinical strategies to mitigate adverse effects of glucocorticoid therapy during pregnancy.",
      "D.7.1.r.2": "Relevant dates: not mentioned",
      "E.i.1.1a": "No AE",
      "C.2.r.2.1": "Institution in China"
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-12T15:47:33.896Z",
    "qcR3Status": "approved",
    "qcR3ApprovedBy": "system",
    "qcR3ApprovedAt": "2025-12-12T15:47:33.896Z",
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": "Auto-approved (QC Data Entry disabled)",
    "listedness": "Unlisted",
    "seriousness": "Serious",
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUj-BwAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj-BwAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3a6fc00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707181
  },
  {
    "id": "DEXA_Demo_65976",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41376557",
    "title": "Rituximab, Dexamethasone, Etoposide, Ifosfamide and Carboplatin (R-DeVIC) in relapsed or refractory central nervous system lymphoma - a retrospective multicentre clinical study.",
    "authors": [
      "Kama K",
      "Treiber H",
      "Kutilina A",
      "Trefz S",
      "Wollnitza S",
      "Shumilov E",
      "Finke J",
      "Lenz G",
      "Wulf G",
      "Isbell LK",
      "Aksoy A",
      "Jensch A",
      "Illerhaus G",
      "Wendler J",
      "Schorb E"
    ],
    "journal": "Haematologica",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "medical_review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a3e324fe-f5c2-43b0-8604-2b02fbece80e",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-11T16:21:45.900Z",
        "type": "system"
      },
      {
        "id": "fa73281f-fc2a-47e6-928a-8de321296b8e",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-12T12:44:04.128Z",
        "type": "system"
      },
      {
        "id": "44fb6123-6c45-4c9f-9254-9be923ad04eb",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. Awaiting QC approval before Medical Reviewer review.",
        "timestamp": "2025-12-12T12:44:04.248Z",
        "type": "system"
      },
      {
        "id": "d6629b46-f959-4c0c-9013-b33e017521e6",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-12T12:45:00.277Z",
        "type": "system"
      },
      {
        "id": "739dbacc-162f-471d-9968-39d54c6996a6",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. Awaiting QC approval before Medical Reviewer review.",
        "timestamp": "2025-12-12T12:45:00.363Z",
        "type": "system"
      },
      {
        "id": "9dca234e-3013-4490-ac50-95cec39b0134",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 XML form approved by QC. Ready for Medical Reviewer",
        "timestamp": "2025-12-12T12:52:12.485Z",
        "type": "qc_r3_approval"
      },
      {
        "id": "2fb153ab-9052-43c2-935a-09b2f6736ded",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Medical review completed. Study approved for final processing.",
        "timestamp": "2025-12-12T13:02:50.443Z",
        "type": "medical_approval"
      },
      {
        "id": "e1643980-f06c-4df5-abfc-94d9cab7c022",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-12T15:38:09.881Z",
        "type": "system"
      },
      {
        "id": "17d36f69-7b2d-4d1e-bc47-e644c9aeb170",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. QC Data Entry skipped (disabled). Ready for Medical Reviewer.",
        "timestamp": "2025-12-12T15:38:10.082Z",
        "type": "system"
      },
      {
        "id": "b4dfb75f-7847-4b3e-b89a-df1cef90e04f",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-12T15:39:21.271Z",
        "type": "system"
      },
      {
        "id": "145d7231-8fba-4c21-9955-7de45f00f25a",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. QC Data Entry skipped (disabled). Ready for Medical Reviewer.",
        "timestamp": "2025-12-12T15:39:21.443Z",
        "type": "system"
      },
      {
        "id": "0b7ba5fb-59d9-42cd-979d-807d1aefa9c6",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-12T15:40:14.420Z",
        "type": "system"
      },
      {
        "id": "92e5f4d1-8d11-451c-bd96-5efa86f30095",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. QC Data Entry skipped (disabled). Ready for Medical Reviewer.",
        "timestamp": "2025-12-12T15:40:14.609Z",
        "type": "system"
      },
      {
        "id": "5829e2a7-cff9-4fd2-9dfd-d133bb95293c",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-12T15:45:57.546Z",
        "type": "system"
      },
      {
        "id": "03ee4467-125c-463b-baeb-812ecbfc7ade",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. QC Data Entry skipped (disabled). Ready for Medical Reviewer.",
        "timestamp": "2025-12-12T15:45:57.732Z",
        "type": "system"
      },
      {
        "id": "a62f440a-a3f3-4563-97cd-246f99a04b14",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f50663f1-f15d-42fc-86b9-7b6d5c2e557a to DEXA_Demo_65976",
        "type": "system",
        "createdAt": "2025-12-14T10:13:01.540Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-11T15:33:38.972Z",
    "updatedAt": "2025-12-12T15:45:57.744Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41376557",
      "DOI": "https://doi.org10.3324/haematol.2025.287982",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-11 21:03:37",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Kama K, Treiber H, Kutilina A, Trefz S, Wollnitza S, Shumilov E, Finke J, Lenz G, Wulf G, Isbell LK, Aksoy A, Jensch A, Illerhaus G, Wendler J, Schorb E. Rituximab, Dexamethasone, Etoposide, Ifosfamide and Carboplatin (R-DeVIC) in relapsed or refractory central nervous system lymphoma - a retrospective multicentre clinical study. Haematologica. 2025;",
      "pubdate": "2025-12-11",
      "Lead_author": "Kama K",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3324/haematol.2025.287982",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Kama K, Treiber H, Kutilina A, Trefz S, Wollnitza S, Shumilov E, Finke J, Lenz G, Wulf G, Isbell LK, Aksoy A, Jensch A, Illerhaus G, Wendler J, Schorb E. Rituximab, Dexamethasone, Etoposide, Ifosfamide and Carboplatin (R-DeVIC) in relapsed or refractory central nervous system lymphoma - a retrospective multicentre clinical study. Haematologica. 2025;",
    "leadAuthor": "Kama K",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T11:42:14.710Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Bulk processed from QC Triage",
    "r3FormData": {
      "C.2.r.1": "Kama K",
      "C.2.r.1.2": "Kama",
      "C.2.r.1.4": "K",
      "C.4.r.1": "Kama K, Treiber H, Kutilina A, Trefz S, Wollnitza S, Shumilov E, Finke J, Lenz G, Wulf G, Isbell LK, Aksoy A, Jensch A, Illerhaus G, Wendler J, Schorb E. Rituximab, Dexamethasone, Etoposide, Ifosfamide and Carboplatin (R-DeVIC) in relapsed or refractory central nervous system lymphoma - a retrospective multicentre clinical study. Haematologica. 2025;",
      "D.7.1.r": "Article requires manual review",
      "D.7": "Article requires manual review",
      "D.7.1.r.2": "Article requires manual review",
      "E.i.1.1a": "Article requires manual review",
      "C.2.r.2.1": "Institution in Article requires manual review"
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-12T15:45:57.732Z",
    "qcR3Status": "approved",
    "qcR3ApprovedBy": "system",
    "qcR3ApprovedAt": "2025-12-12T15:45:57.732Z",
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": "Auto-approved (QC Data Entry disabled)",
    "listedness": "Listed",
    "seriousness": "Non-Serious",
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "completed",
    "medicalReviewedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "medicalReviewedAt": "2025-12-12T13:02:50.443Z",
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgACAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgACAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3a9a040501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707181
  },
  {
    "id": "DEXA_Demo_74372",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41378492",
    "title": "Inhalable Food-Grade MOFs Loaded Gas Messenger for Acute Lung Injury Treatment by Pulmonary Delivery.",
    "authors": [
      "Hu ZE",
      "Zhang FZ",
      "Zeng M",
      "Zhang YT",
      "Li J",
      "Che YT",
      "Feng JF",
      "Li BJ",
      "Zhang S"
    ],
    "journal": "ACS Appl Mater Interfaces",
    "publicationDate": "2025-12-11",
    "abstract": "The article discusses a novel therapeutic strategy for treating acute lung injury (ALI) using a dry powder inhaler (DPI) platform loaded with sulfur dioxide (SO₂) within a food-grade γ-cyclodextrin-based metal-organic framework (γCD-MOF) modified with cholesterol (CHS). The study highlights the superior lung-targeting capability of CHS-CD-MOF@SO₂, which releases SO₂ rapidly and demonstrates high permeability in simulated lung fluid. In an ALI mouse model, the treatment significantly reduces pro-inflammatory factors such as TNF-α, IL-1β, and IL-6 by regulating the P38 and NF-κB pathways. It also improves lung tissue dry/wet ratio and reduces neutrophil infiltration. Importantly, the therapeutic outcomes of CHS-CD-MOF@SO₂ were comparable to or better than those of dexamethasone (DXMS), a frontline drug for ALI. The study underscores the potential of this DPI-based gas messenger platform as an effective treatment for ALI. However, the article does not provide specific details about human subjects, adverse events, or direct administration of dexamethasone to human patients.",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "No AE",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b1154ab9-9742-41e3-a7b7-47821976c3b6",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-12T07:15:08.703Z",
        "type": "system"
      },
      {
        "id": "1fbab78b-951d-44cc-9bf5-bab6baebbcd8",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" rejected by QC. Reason: Test Rejection. Study returned to Triage for re-classification.",
        "timestamp": "2025-12-12T07:17:00.243Z",
        "type": "QC_rejection"
      },
      {
        "id": "bc2c1086-834a-442e-9101-2d08dd1afe7b",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated from \"None\" to \"ICSR\". Awaiting QC approval.",
        "timestamp": "2025-12-12T07:17:31.420Z",
        "type": "system"
      },
      {
        "id": "666512c2-c92f-4b65-9d4a-f4f6f582f361",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Study revoked by Medical Reviewer. Reason: Test for Triage. Returned to triage for corrections.",
        "timestamp": "2025-12-12T12:11:57.218Z",
        "type": "revocation"
      },
      {
        "id": "8cd6eec9-1099-4087-a3bd-435d1d2b0516",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"AOI\". Moving to QC Triage.",
        "timestamp": "2025-12-12T13:54:40.271Z",
        "type": "system"
      },
      {
        "id": "ce197223-7f88-458e-b466-6aa24d75ecea",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"AOI\" approved by QC",
        "timestamp": "2025-12-12T14:03:40.917Z",
        "type": "QC_approval"
      },
      {
        "id": "474e9f12-e029-4788-bef1-70a405ca81f7",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 92752b4d-d5e9-4060-af0b-327bb0166737 to DEXA_Demo_74372",
        "type": "system",
        "createdAt": "2025-12-14T10:13:01.865Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T05:06:07.040Z",
    "updatedAt": "2025-12-12T18:58:26.396Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41378492",
      "DOI": "https://doi.org/10.1021/acsami.5c20962",
      "special_case": "No",
      "Country_of_first_author": "China",
      "Country_of_occurrence": "China",
      "Patient_details": "No human subject",
      "Key_events": "Key events: not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The article discusses a novel therapeutic strategy for treating acute lung injury (ALI) using a dry powder inhaler (DPI) platform loaded with sulfur dioxide (SO₂) within a food-grade γ-cyclodextrin-based metal-organic framework (γCD-MOF) modified with cholesterol (CHS). The study highlights the superior lung-targeting capability of CHS-CD-MOF@SO₂, which releases SO₂ rapidly and demonstrates high permeability in simulated lung fluid. In an ALI mouse model, the treatment significantly reduces pro-inflammatory factors such as TNF-α, IL-1β, and IL-6 by regulating the P38 and NF-κB pathways. It also improves lung tissue dry/wet ratio and reduces neutrophil infiltration. Importantly, the therapeutic outcomes of CHS-CD-MOF@SO₂ were comparable to or better than those of dexamethasone (DXMS), a frontline drug for ALI. The study underscores the potential of this DPI-based gas messenger platform as an effective treatment for ALI. However, the article does not provide specific details about human subjects, adverse events, or direct administration of dexamethasone to human patients.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article comments positively on the therapeutic potential of CHS-CD-MOF@SO₂, stating that its efficacy in treating ALI in a mouse model was comparable to or better than dexamethasone, a frontline drug for ALI.",
      "Adverse_event": "No AE",
      "Abstract": "Acute lung injury (ALI) is a serious clinical disease the severe stage of which develops into acute respiratory distress syndrome (ARDS), with a high mortality rate of 35 to 40%. Despite decades of research and development of drugs such as corticosteroids and β-2 adrenergic agonists, treatment efficacy has been limited due to an insufficient drug concentration reaching the lungs. Here, a food-grade γ-cyclodextrin-based metal-organic framework (γCD-MOF) modified with cholesterol (CHS) is developed to load sulfur dioxide (SO<sub>2</sub>) as a dry powder inhaler (DPI) platform (CHS-CD-MOF@SO<sub>2</sub>) for ALI treatment. CHS-CD-MOF@SO<sub>2</sub> has suitable storage stability and excellent aerodynamic characteristics, with a fine particle fraction (FPF) of 40%, a geometric standard deviation (GSD) value of 1.61, and a mass median aerodynamic diameter (MMAD) of 4.8 μm, which can effectively target the lungs. By employing rhodamine B (RhB) as a fluorescence indicator, in vivo fluorescence imaging confirms the superior lung-targeting capability of CHS-CD-MOFs. CHS-CD-MOF@SO<sub>2</sub> can release 92.3 ± 4.4% of SO<sub>2</sub> in PBS solution within 5 min. What's more, the permeability of simulated lung fluid within 30 min is as high as 85%, which has the potential for rapid treatment of ALI. In an ALI mouse model, CHS-CD-MOF@SO<sub>2</sub> reduces the expression of pro-inflammatory factors tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and IL-6 by regulating the P38 and nuclear factor kappa B (NF-κB) pathways. It also significantly improves the lung tissue dry/wet ratio and reduces neutrophil infiltration. Importantly, this treatment achieves therapeutic outcomes in key efficacy parameters that was comparable to or better than those of dexamethasone (DXMS), a frontline drug for ALI, underscoring its significant therapeutic potential. This study presents a novel strategy for treating ALI using a DPI-based gas messenger platform. This study provides a novel therapeutic strategy to treat ALI using DPI-loaded gas messengers.",
      "Title": "Inhalable Food-Grade MOFs Loaded Gas Messenger for Acute Lung Injury Treatment by Pulmonary Delivery.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-12 10:33:48",
      "Vancouver_citation": "Hu ZE, Zhang FZ, Zeng M, Zhang YT, Li J, Che YT, Feng JF, Li BJ, Zhang S. Inhalable Food-Grade MOFs Loaded Gas Messenger for Acute Lung Injury Treatment by Pulmonary Delivery. ACS Appl Mater Interfaces. 2025;",
      "pubdate": "2025-12-11",
      "Lead_author": "Hu ZE",
      "Serious": "No",
      "Test_subject": "The test subject involved in this study is an ALI (acute lung injury) mouse model. The study utilized mice to evaluate the therapeutic effects of the novel DPI platform (CHS-CD-MOF@SO₂) and compared its efficacy to dexamethasone (DXMS), the drug of study.",
      "AOI_drug_effect": "  \n2. The drug of study, dexamethasone (DXMS), was used as a comparative treatment in the study. The study demonstrated that the novel DPI platform achieved therapeutic outcomes comparable to or better than dexamethasone in reducing pro-inflammatory factors, improving lung tissue dry/wet ratio, and reducing neutrophil infiltration in the ALI mouse model. However, the study does not specify any adverse events or direct effects caused by dexamethasone. Therefore, \"No Drug Effect.\"",
      "Approved_indication": "  \n3. Dexamethasone is conventionally used as a corticosteroid to treat inflammatory and autoimmune conditions, including acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). It is typically administered orally, intravenously, or via inhalation, depending on the condition being treated. In this study, dexamethasone was used as a frontline drug for ALI treatment in the mouse model, serving as a benchmark for comparison with the novel DPI platform.",
      "AOI_classification": "No",
      "Justification": "  \n5. The study does not link dexamethasone to any negative or adverse effects within the test subjects. It only mentions its therapeutic efficacy as a comparison to the novel treatment platform.",
      "Client_name": "Demo",
      "Drugname": "DEXAMETHASONE"
    },
    "doi": "https://doi.org/10.1021/acsami.5c20962",
    "specialCase": "No",
    "countryOfFirstAuthor": "China",
    "countryOfOccurrence": "China",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "The article discusses a novel therapeutic strategy for treating acute lung injury (ALI) using a dry powder inhaler (DPI) platform loaded with sulfur dioxide (SO₂) within a food-grade γ-cyclodextrin-based metal-organic framework (γCD-MOF) modified with cholesterol (CHS). The study highlights the superior lung-targeting capability of CHS-CD-MOF@SO₂, which releases SO₂ rapidly and demonstrates high permeability in simulated lung fluid. In an ALI mouse model, the treatment significantly reduces pro-inflammatory factors such as TNF-α, IL-1β, and IL-6 by regulating the P38 and NF-κB pathways. It also improves lung tissue dry/wet ratio and reduces neutrophil infiltration. Importantly, the therapeutic outcomes of CHS-CD-MOF@SO₂ were comparable to or better than those of dexamethasone (DXMS), a frontline drug for ALI. The study underscores the potential of this DPI-based gas messenger platform as an effective treatment for ALI. However, the article does not provide specific details about human subjects, adverse events, or direct administration of dexamethasone to human patients.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article comments positively on the therapeutic potential of CHS-CD-MOF@SO₂, stating that its efficacy in treating ALI in a mouse model was comparable to or better than dexamethasone, a frontline drug for ALI.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Hu ZE, Zhang FZ, Zeng M, Zhang YT, Li J, Che YT, Feng JF, Li BJ, Zhang S. Inhalable Food-Grade MOFs Loaded Gas Messenger for Acute Lung Injury Treatment by Pulmonary Delivery. ACS Appl Mater Interfaces. 2025;",
    "leadAuthor": "Hu ZE",
    "serious": "No",
    "testSubject": "The test subject involved in this study is an ALI (acute lung injury) mouse model. The study utilized mice to evaluate the therapeutic effects of the novel DPI platform (CHS-CD-MOF@SO₂) and compared its efficacy to dexamethasone (DXMS), the drug of study.",
    "aoiDrugEffect": "  \n2. The drug of study, dexamethasone (DXMS), was used as a comparative treatment in the study. The study demonstrated that the novel DPI platform achieved therapeutic outcomes comparable to or better than dexamethasone in reducing pro-inflammatory factors, improving lung tissue dry/wet ratio, and reducing neutrophil infiltration in the ALI mouse model. However, the study does not specify any adverse events or direct effects caused by dexamethasone. Therefore, \"No Drug Effect.\"",
    "approvedIndication": "  \n3. Dexamethasone is conventionally used as a corticosteroid to treat inflammatory and autoimmune conditions, including acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). It is typically administered orally, intravenously, or via inhalation, depending on the condition being treated. In this study, dexamethasone was used as a frontline drug for ALI treatment in the mouse model, serving as a benchmark for comparison with the novel DPI platform.",
    "aoiClassification": "No",
    "justification": "Adverse Event",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "AOI",
    "effectiveClassification": "AOI",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T14:03:40.917Z",
    "qaRejectedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaRejectedAt": "2025-12-12T07:17:00.243Z",
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": "Yes",
    "seriousness": "Yes",
    "aoiAssessedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "aoiAssessedAt": "2025-12-12T18:58:26.386Z",
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "revokedAt": "2025-12-12T12:11:57.218Z",
    "revocationReason": "Test for Triage",
    "_rid": "Vf9WAOX6zUgBCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgBCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3ac6600501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707181
  },
  {
    "id": "DEXA_Demo_30438",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41384226",
    "title": "Multiple Myeloma in Young Adults-Insights From a Tertiary Care Cancer Centre in India.",
    "authors": [
      "John G",
      "Mirgh S",
      "Punatar S",
      "Jindal N",
      "Nayak L",
      "Chichra A",
      "Shetty A",
      "Gokarn A",
      "Rajpal S",
      "Patkar N",
      "Chatterjee G",
      "Shetty D",
      "Jain H",
      "Ghosh K",
      "Tembhare P",
      "Jain H",
      "Pawar A",
      "Gujral S",
      "Subramaniam P",
      "Sengar M",
      "Khattry N",
      "Bagal B"
    ],
    "journal": "EJHaem",
    "publicationDate": "2025-12-12",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "2c1ea468-dc13-4745-a54c-e887d49ca0e9",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.078Z"
      },
      {
        "id": "c45851ec-5398-4d0f-aa04-721571092cdb",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 2d428210-72e1-4b9d-b740-97506c29f5c8 to DEXA_Demo_30438",
        "type": "system",
        "createdAt": "2025-12-14T10:13:02.130Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:32:53.433Z",
    "updatedAt": "2025-12-14T08:54:30.146Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41384226",
      "DOI": "https://doi.org10.1002/jha2.70187",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:02:14",
      "Drugname": "DEXAMETHASONE*",
      "Vancouver_citation": "John G, Mirgh S, Punatar S, Jindal N, Nayak L, Chichra A, Shetty A, Gokarn A, Rajpal S, Patkar N, Chatterjee G, Shetty D, Jain H, Ghosh K, Tembhare P, Jain H, Pawar A, Gujral S, Subramaniam P, Sengar M, Khattry N, Bagal B. Multiple Myeloma in Young Adults-Insights From a Tertiary Care Cancer Centre in India. EJHaem. 2025;6(6):e70187",
      "pubdate": "2025-12-12",
      "Lead_author": "John G",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/jha2.70187",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE*",
    "vancouverCitation": "John G, Mirgh S, Punatar S, Jindal N, Nayak L, Chichra A, Shetty A, Gokarn A, Rajpal S, Patkar N, Chatterjee G, Shetty D, Jain H, Ghosh K, Tembhare P, Jain H, Pawar A, Gujral S, Subramaniam P, Sengar M, Khattry N, Bagal B. Multiple Myeloma in Young Adults-Insights From a Tertiary Care Cancer Centre in India. EJHaem. 2025;6(6):e70187",
    "leadAuthor": "John G",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgCCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgCCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3aeec40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707182
  },
  {
    "id": "DEXA_Demo_13080",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41383530",
    "title": "Needle and Nodule: A Case of Intra-Lesional Success in Oral Mucocele Treatment.",
    "authors": [
      "Kar SR",
      "N C S",
      "Nahar N",
      "Sharan J",
      "Basnyat SK"
    ],
    "journal": "Clin Case Rep",
    "publicationDate": "2025-12-12",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "117564e1-7562-4af4-bef7-bc8e8895639a",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.171Z"
      },
      {
        "id": "acebc89e-c292-4561-8e2c-c4d7e418c958",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 079cedb6-08f9-4338-b189-3380d929604d to DEXA_Demo_13080",
        "type": "system",
        "createdAt": "2025-12-14T10:13:02.363Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:32:53.530Z",
    "updatedAt": "2025-12-14T08:54:30.184Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41383530",
      "DOI": "https://doi.org10.1002/ccr3.71668",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:01:59",
      "Drugname": "DEXAMETHASONE*",
      "Vancouver_citation": "Kar SR, N C S, Nahar N, Sharan J, Basnyat SK. Needle and Nodule: A Case of Intra-Lesional Success in Oral Mucocele Treatment. Clin Case Rep. 2025;13(12):e71668",
      "pubdate": "2025-12-12",
      "Lead_author": "Kar SR",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/ccr3.71668",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE*",
    "vancouverCitation": "Kar SR, N C S, Nahar N, Sharan J, Basnyat SK. Needle and Nodule: A Case of Intra-Lesional Success in Oral Mucocele Treatment. Clin Case Rep. 2025;13(12):e71668",
    "leadAuthor": "Kar SR",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgDCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgDCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3b12940501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707182
  },
  {
    "id": "DEXA_Demo_43195",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41372020",
    "title": "Prostaglandins prevent long-lasting pain in a mouse model of chronic postsurgical pain.",
    "authors": [
      "Karaky M",
      "Lima LV",
      "Oveisi A",
      "Montagna F",
      "Mogil JS",
      "Diatchenko L"
    ],
    "journal": "Br J Anaesth",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "f734c19f-abf3-491f-8e3e-1425befd60b4",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.200Z"
      },
      {
        "id": "c0662993-a3cd-4694-8c3d-fddf40a631a1",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 2a86af80-74ae-493e-b427-2ec462d9f7b8 to DEXA_Demo_43195",
        "type": "system",
        "createdAt": "2025-12-14T10:13:02.577Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:32:53.614Z",
    "updatedAt": "2025-12-14T08:54:30.213Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41372020",
      "DOI": "https://doi.org10.1016/j.bja.2025.10.020",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:01:17",
      "Drugname": "DEXAMETHASONE*",
      "Vancouver_citation": "Karaky M, Lima LV, Oveisi A, Montagna F, Mogil JS, Diatchenko L. Prostaglandins prevent long-lasting pain in a mouse model of chronic postsurgical pain. Br J Anaesth. 2025;",
      "pubdate": "2025-12-11",
      "Lead_author": "Karaky M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.bja.2025.10.020",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE*",
    "vancouverCitation": "Karaky M, Lima LV, Oveisi A, Montagna F, Mogil JS, Diatchenko L. Prostaglandins prevent long-lasting pain in a mouse model of chronic postsurgical pain. Br J Anaesth. 2025;",
    "leadAuthor": "Karaky M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgECAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgECAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3b32c40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707182
  },
  {
    "id": "DEXA_Demo_81177",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41364328",
    "title": "Who and how to screen for Cushing's syndrome: the position statement of the Italian Society of Endocrinology.",
    "authors": [
      "Ceccato F",
      "Terzolo M",
      "Gatto F",
      "Cannavò S",
      "Bianchi A",
      "Isidori AM",
      "Colao A",
      "Ferone D",
      "Aimaretti G",
      "Pecori Giraldi F",
      "Arnaldi G",
      "Scaroni C"
    ],
    "journal": "J Endocrinol Invest",
    "publicationDate": "2025-12-9",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "16b2c52e-0255-4cd9-9834-aa793fb3b609",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.233Z"
      },
      {
        "id": "d40f45d7-e75b-4825-b9df-c41a07f058fb",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a73c4097-012e-4e44-ae48-8c0b831b69e4 to DEXA_Demo_81177",
        "type": "system",
        "createdAt": "2025-12-14T10:13:02.809Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:32:53.688Z",
    "updatedAt": "2025-12-14T08:54:30.288Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41364328",
      "DOI": "https://doi.org10.1007/s40618-025-02758-3",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:01:45",
      "Drugname": "DEXAMETHASONE*",
      "Vancouver_citation": "Ceccato F, Terzolo M, Gatto F, Cannavò S, Bianchi A, Isidori AM, Colao A, Ferone D, Aimaretti G, Pecori Giraldi F, Arnaldi G, Scaroni C. Who and how to screen for Cushing's syndrome: the position statement of the Italian Society of Endocrinology. J Endocrinol Invest. 2025;",
      "pubdate": "2025-12-9",
      "Lead_author": "Ceccato F",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s40618-025-02758-3",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE*",
    "vancouverCitation": "Ceccato F, Terzolo M, Gatto F, Cannavò S, Bianchi A, Isidori AM, Colao A, Ferone D, Aimaretti G, Pecori Giraldi F, Arnaldi G, Scaroni C. Who and how to screen for Cushing's syndrome: the position statement of the Italian Society of Endocrinology. J Endocrinol Invest. 2025;",
    "leadAuthor": "Ceccato F",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgFCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgFCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3b56640501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707182
  },
  {
    "id": "DEXA_Demo_97201",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41363801",
    "title": "Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma.",
    "authors": [
      "Costa LJ",
      "Bahlis NJ",
      "Perrot A",
      "Nooka AK",
      "Lu J",
      "Pawlyn C",
      "Mina R",
      "Caeiro G",
      "Kentos A",
      "Hungria V",
      "Reece D",
      "Niu T",
      "Mylin AK",
      "Hansen CT",
      "Teipel R",
      "Besemer B",
      "Dimopoulos MA",
      "Zamagni E",
      "Yoshihara S",
      "Kim K",
      "Min CK",
      "Geerts P",
      "Van Leeuwen-Segarceanu E",
      "Tyczynska A",
      "Reguera JL",
      "Johansson M",
      "Hansson M",
      "Turgut M",
      "Grey M",
      "Sidana S",
      "Rodriguez-Otero P",
      "Martinez-Lopez J",
      "Hashmi H",
      "Carson R",
      "Kobos R",
      "Sun W",
      "Lantz K",
      "Seifert A",
      "Briseno-Toomey D",
      "O'Rourke L",
      "Rubin M",
      "Vieyra D",
      "Kang L",
      "Mateos MV"
    ],
    "journal": "N Engl J Med",
    "publicationDate": "2025-12-9",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "1c71e79e-e1e1-409c-b276-22574199ba99",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.311Z"
      },
      {
        "id": "b4d9e39e-91e4-4ecd-a7f4-6e62305f0cdf",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from fd7c89fc-337e-4b8d-beb0-6f4617494939 to DEXA_Demo_97201",
        "type": "system",
        "createdAt": "2025-12-14T10:13:03.009Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:32:53.739Z",
    "updatedAt": "2025-12-14T08:54:30.323Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41363801",
      "DOI": "https://doi.org10.1056/NEJMoa2514663",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:01:31",
      "Drugname": "DEXAMETHASONE*",
      "Vancouver_citation": "Costa LJ, Bahlis NJ, Perrot A, Nooka AK, Lu J, Pawlyn C, Mina R, Caeiro G, Kentos A, Hungria V, Reece D, Niu T, Mylin AK, Hansen CT, Teipel R, Besemer B, Dimopoulos MA, Zamagni E, Yoshihara S, Kim K, Min CK, Geerts P, Van Leeuwen-Segarceanu E, Tyczynska A, Reguera JL, Johansson M, Hansson M, Turgut M, Grey M, Sidana S, Rodriguez-Otero P, Martinez-Lopez J, Hashmi H, Carson R, Kobos R, Sun W, Lantz K, Seifert A, Briseno-Toomey D, O'Rourke L, Rubin M, Vieyra D, Kang L, Mateos MV, . Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma. N Engl J Med. 2025;",
      "pubdate": "2025-12-9",
      "Lead_author": "Costa LJ",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1056/NEJMoa2514663",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE*",
    "vancouverCitation": "Costa LJ, Bahlis NJ, Perrot A, Nooka AK, Lu J, Pawlyn C, Mina R, Caeiro G, Kentos A, Hungria V, Reece D, Niu T, Mylin AK, Hansen CT, Teipel R, Besemer B, Dimopoulos MA, Zamagni E, Yoshihara S, Kim K, Min CK, Geerts P, Van Leeuwen-Segarceanu E, Tyczynska A, Reguera JL, Johansson M, Hansson M, Turgut M, Grey M, Sidana S, Rodriguez-Otero P, Martinez-Lopez J, Hashmi H, Carson R, Kobos R, Sun W, Lantz K, Seifert A, Briseno-Toomey D, O'Rourke L, Rubin M, Vieyra D, Kang L, Mateos MV, . Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma. N Engl J Med. 2025;",
    "leadAuthor": "Costa LJ",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgGCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgGCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3b7a940501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707183
  },
  {
    "id": "DEXA_Demo_63430",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41361598",
    "title": "Drug Dissolution Enhancement Using 3D-Printed Silica-Based Oral Films.",
    "authors": [
      "Blaháčková D",
      "Elbl J",
      "Lammerding LC",
      "Mašková E",
      "Muselík J",
      "Kašlík J",
      "Gajdziok J"
    ],
    "journal": "AAPS J",
    "publicationDate": "2025-12-9",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "d48a458c-1c0d-44fa-8b1b-6f6d21f011aa",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.342Z"
      },
      {
        "id": "312476f2-2722-4b7c-ad1a-a39d2aa8e13d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from c17c4aec-be5b-4f79-90f9-e2ae08c8f41c to DEXA_Demo_63430",
        "type": "system",
        "createdAt": "2025-12-14T10:13:03.259Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:32:53.785Z",
    "updatedAt": "2025-12-14T08:54:30.354Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41361598",
      "DOI": "https://doi.org10.1208/s12248-025-01185-9",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:02:30",
      "Drugname": "DEXAMETHASONE*",
      "Vancouver_citation": "Blaháčková D, Elbl J, Lammerding LC, Mašková E, Muselík J, Kašlík J, Gajdziok J. Drug Dissolution Enhancement Using 3D-Printed Silica-Based Oral Films. AAPS J. 2025;28(1):30",
      "pubdate": "2025-12-9",
      "Lead_author": "Blaháčková D",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1208/s12248-025-01185-9",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE*",
    "vancouverCitation": "Blaháčková D, Elbl J, Lammerding LC, Mašková E, Muselík J, Kašlík J, Gajdziok J. Drug Dissolution Enhancement Using 3D-Printed Silica-Based Oral Films. AAPS J. 2025;28(1):30",
    "leadAuthor": "Blaháčková D",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgHCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgHCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3ba2ec0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707183
  },
  {
    "id": "DEXA_Demo_98720",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41360896",
    "title": "Glucocorticoid inhibits lung cancer cells proliferation and migration by suppressing smad2/3 activation.",
    "authors": [
      "Xu L",
      "Li Q",
      "Xu C",
      "Tan D",
      "Tan Y"
    ],
    "journal": "Sci Rep",
    "publicationDate": "2025-12-9",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9f82d912-6913-4a34-82e3-0fc44b9be1b9",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.373Z"
      },
      {
        "id": "152cd96b-79ae-4f3e-b1bc-f8051c75448a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 08b48e4b-68ae-4644-92bf-58f20c1a286b to DEXA_Demo_98720",
        "type": "system",
        "createdAt": "2025-12-14T10:13:03.473Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:32:53.827Z",
    "updatedAt": "2025-12-14T08:54:30.441Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41360896",
      "DOI": "https://doi.org10.1038/s41598-025-29163-3",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:02:36",
      "Drugname": "DEXAMETHASONE*",
      "Vancouver_citation": "Xu L, Li Q, Xu C, Tan D, Tan Y. Glucocorticoid inhibits lung cancer cells proliferation and migration by suppressing smad2/3 activation. Sci Rep. 2025;",
      "pubdate": "2025-12-9",
      "Lead_author": "Xu L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41598-025-29163-3",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE*",
    "vancouverCitation": "Xu L, Li Q, Xu C, Tan D, Tan Y. Glucocorticoid inhibits lung cancer cells proliferation and migration by suppressing smad2/3 activation. Sci Rep. 2025;",
    "leadAuthor": "Xu L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgICAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgICAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3bc4000501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707183
  },
  {
    "id": "DEXA_Demo_34891",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41360105",
    "title": "Does Propofol-based or Remimazolam-based Anesthesia Impact the Incidence of Postoperative Nausea and Vomiting When Used In Combination With Prophylactic Dexamethasone and Ondansetron?",
    "authors": [
      "Nakakuki A",
      "Koshika K",
      "Nakazawa M",
      "Nishino M",
      "Nomura R",
      "Iimura M",
      "Saito N",
      "Yoshida K",
      "Handa T",
      "Ichinohe T"
    ],
    "journal": "Does Propofol-based or Remimazolam-based Anesthesia Impact the Incidence of Postoperative Nausea and Vomiting When Used In Combination With Prophylactic Dexamethasone and Ondansetron? Anesth Prog",
    "publicationDate": "2025-12-9",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ba064b84-1c7f-4461-9376-eb65c0c3c7a6",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.466Z"
      },
      {
        "id": "f59d3985-84fa-4eea-8eb6-80947afd6b59",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 273cef69-81db-4c71-9eb7-202ae101c263 to DEXA_Demo_34891",
        "type": "system",
        "createdAt": "2025-12-14T10:13:03.706Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:32:53.881Z",
    "updatedAt": "2025-12-14T08:54:30.480Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41360105",
      "DOI": "https://doi.org10.2344/24-0029",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:02:44",
      "Drugname": "DEXAMETHASONE*",
      "Vancouver_citation": "Nakakuki A, Koshika K, Nakazawa M, Nishino M, Nomura R, Iimura M, Saito N, Yoshida K, Handa T, Ichinohe T. Does Propofol-based or Remimazolam-based Anesthesia Impact the Incidence of Postoperative Nausea and Vomiting When Used In Combination With Prophylactic Dexamethasone and Ondansetron? Anesth Prog. 2025;72(4):218-23",
      "pubdate": "2025-12-9",
      "Lead_author": "Nakakuki A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.2344/24-0029",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE*",
    "vancouverCitation": "Nakakuki A, Koshika K, Nakazawa M, Nishino M, Nomura R, Iimura M, Saito N, Yoshida K, Handa T, Ichinohe T. Does Propofol-based or Remimazolam-based Anesthesia Impact the Incidence of Postoperative Nausea and Vomiting When Used In Combination With Prophylactic Dexamethasone and Ondansetron? Anesth Prog. 2025;72(4):218-23",
    "leadAuthor": "Nakakuki A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgJCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgJCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3be47c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707183
  },
  {
    "id": "DEXA_Demo_57444",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41359096",
    "title": "Long-term outcomes of intravitreal 0.19 mg fluocinolone acetonide implant in uveitic macular edema after prior local corticosteroid treatments.",
    "authors": [
      "Ferreira AM",
      "Silva MI",
      "Torres-Costa S",
      "Oliveira-Ferreira C",
      "Pedrosa AC",
      "Figueira L",
      "Araújo JR"
    ],
    "journal": "J Ophthalmic Inflamm Infect",
    "publicationDate": "2025-12-8",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b611fe06-ed83-4c1d-8c9d-0718637bedf2",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.499Z"
      },
      {
        "id": "af1d6af2-621f-4f8d-ad72-23d3effa5505",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 94f853c4-3223-4431-8fa3-ca157bc857e5 to DEXA_Demo_57444",
        "type": "system",
        "createdAt": "2025-12-14T10:13:03.952Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:32:53.935Z",
    "updatedAt": "2025-12-14T08:54:30.513Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41359096",
      "DOI": "https://doi.org10.1186/s12348-025-00558-7",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:02:22",
      "Drugname": "DEXAMETHASONE*",
      "Vancouver_citation": "Ferreira AM, Silva MI, Torres-Costa S, Oliveira-Ferreira C, Pedrosa AC, Figueira L, Araújo JR. Long-term outcomes of intravitreal 0.19 mg fluocinolone acetonide implant in uveitic macular edema after prior local corticosteroid treatments. J Ophthalmic Inflamm Infect. 2025;15(1):92",
      "pubdate": "2025-12-8",
      "Lead_author": "Ferreira AM",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s12348-025-00558-7",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE*",
    "vancouverCitation": "Ferreira AM, Silva MI, Torres-Costa S, Oliveira-Ferreira C, Pedrosa AC, Figueira L, Araújo JR. Long-term outcomes of intravitreal 0.19 mg fluocinolone acetonide implant in uveitic macular edema after prior local corticosteroid treatments. J Ophthalmic Inflamm Infect. 2025;15(1):92",
    "leadAuthor": "Ferreira AM",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgKCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgKCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3c04d00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707183
  },
  {
    "id": "DEXA_Demo_38640",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41380922",
    "title": "Encapsulation-based enhancements in modern drug delivery systems.",
    "authors": [
      "Bakrim S",
      "Khalid A",
      "Abdalla AN",
      "Ibrahim SE",
      "Hamza SMA",
      "Omari NE",
      "Wen GK",
      "Lee LH",
      "Bouyahya A"
    ],
    "journal": "Int J Pharm",
    "publicationDate": "2025-12-12",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "c90edc1f-4314-4d40-8767-ec2d9ade677e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.543Z"
      },
      {
        "id": "ae6e9392-db95-45bf-ad2b-42194b8dd618",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a4d58db2-3e98-44f7-8da4-c7032076a29d to DEXA_Demo_38640",
        "type": "system",
        "createdAt": "2025-12-14T10:13:04.185Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:33:42.384Z",
    "updatedAt": "2025-12-14T08:54:30.559Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41380922",
      "DOI": "https://doi.org10.1016/j.ijpharm.2025.126470",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:03:10",
      "Drugname": "DEXAMETHASONE*",
      "Vancouver_citation": "Bakrim S, Khalid A, Abdalla AN, Ibrahim SE, Hamza SMA, Omari NE, Wen GK, Lee LH, Bouyahya A. Encapsulation-based enhancements in modern drug delivery systems. Int J Pharm. 2025;126470",
      "pubdate": "2025-12-12",
      "Lead_author": "Bakrim S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ijpharm.2025.126470",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE*",
    "vancouverCitation": "Bakrim S, Khalid A, Abdalla AN, Ibrahim SE, Hamza SMA, Omari NE, Wen GK, Lee LH, Bouyahya A. Encapsulation-based enhancements in modern drug delivery systems. Int J Pharm. 2025;126470",
    "leadAuthor": "Bakrim S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgLCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgLCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3c285c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707184
  },
  {
    "id": "DEXA_Demo_19189",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41371564",
    "title": "ED-71 prevents glucocorticoid-induced bone loss by inhibiting type H vascular endothelial cell senescence through maintaining mitochondria-associated membrane-mediated calcium homeostasis.",
    "authors": [
      "Wang X",
      "Zhang W",
      "Liu T",
      "Rong X",
      "Ren Q",
      "Guan S",
      "Li M"
    ],
    "journal": "Cell Signal",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "0629d933-4b41-44b0-a349-7ac9eb2b4d64",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.590Z"
      },
      {
        "id": "3b3ed40d-0fd4-4f24-8201-ec14e3f17932",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 0749ab7e-d567-4906-8e7c-f8684f6cf66c to DEXA_Demo_19189",
        "type": "system",
        "createdAt": "2025-12-14T10:13:04.385Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:33:42.498Z",
    "updatedAt": "2025-12-14T08:54:30.606Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41371564",
      "DOI": "https://doi.org10.1016/j.cellsig.2025.112298",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:03:25",
      "Drugname": "DEXAMETHASONE*",
      "Vancouver_citation": "Wang X, Zhang W, Liu T, Rong X, Ren Q, Guan S, Li M. ED-71 prevents glucocorticoid-induced bone loss by inhibiting type H vascular endothelial cell senescence through maintaining mitochondria-associated membrane-mediated calcium homeostasis. Cell Signal. 2025;112298",
      "pubdate": "2025-12-11",
      "Lead_author": "Wang X",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.cellsig.2025.112298",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE*",
    "vancouverCitation": "Wang X, Zhang W, Liu T, Rong X, Ren Q, Guan S, Li M. ED-71 prevents glucocorticoid-induced bone loss by inhibiting type H vascular endothelial cell senescence through maintaining mitochondria-associated membrane-mediated calcium homeostasis. Cell Signal. 2025;112298",
    "leadAuthor": "Wang X",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgMCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgMCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3c4c880501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707184
  },
  {
    "id": "DEXA_Demo_25405",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41371375",
    "title": "Pharmacokinetic profile of dexamethasone in urine and plasma after single and multiple oral administration: Relevance to doping controls.",
    "authors": [
      "Coll S",
      "Bressan C",
      "Monfort N",
      "Aldea-Perona A",
      "Carbó ML",
      "Ventura R"
    ],
    "journal": "Eur J Pharm Sci",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "8308dc2e-3d8e-4190-b26a-b1928e3a06d7",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.637Z"
      },
      {
        "id": "6a9709cd-999e-4a64-83e1-129c8452d4cf",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 20a0969f-9c5c-47fd-83c3-e9cf8bff7902 to DEXA_Demo_25405",
        "type": "system",
        "createdAt": "2025-12-14T10:13:04.604Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:33:42.543Z",
    "updatedAt": "2025-12-14T08:54:30.652Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41371375",
      "DOI": "https://doi.org10.1016/j.ejps.2025.107405",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:03:18",
      "Drugname": "DEXAMETHASONE*",
      "Vancouver_citation": "Coll S, Bressan C, Monfort N, Aldea-Perona A, Carbó ML, Ventura R. Pharmacokinetic profile of dexamethasone in urine and plasma after single and multiple oral administration: Relevance to doping controls. Eur J Pharm Sci. 2025;107405",
      "pubdate": "2025-12-11",
      "Lead_author": "Coll S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ejps.2025.107405",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE*",
    "vancouverCitation": "Coll S, Bressan C, Monfort N, Aldea-Perona A, Carbó ML, Ventura R. Pharmacokinetic profile of dexamethasone in urine and plasma after single and multiple oral administration: Relevance to doping controls. Eur J Pharm Sci. 2025;107405",
    "leadAuthor": "Coll S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgNCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgNCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3c6fd80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707184
  },
  {
    "id": "DEXA_Demo_97239",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41366512",
    "title": "Efficacy of aflibercept in vitrectomized vs. non-vitrectomized eyes with diabetic macular edema: a prospective study.",
    "authors": [
      "Thury G",
      "Baranyi N",
      "Rárosi F",
      "Héjja R",
      "Kovács A"
    ],
    "journal": "Int J Retina Vitreous",
    "publicationDate": "2025-12-10",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "3f5f244e-664b-4f07-aec0-f4a17a9dfeee",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.684Z"
      },
      {
        "id": "7e6b0e28-fd02-4461-8517-739bf41d25cf",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 995cb74c-64af-4f72-9bbd-2e592e729324 to DEXA_Demo_97239",
        "type": "system",
        "createdAt": "2025-12-14T10:13:04.817Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:35:07.680Z",
    "updatedAt": "2025-12-14T08:54:30.694Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41366512",
      "DOI": "https://doi.org10.1186/s40942-025-00778-y",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:04:26",
      "Drugname": "DEXAMETHASONE*",
      "Vancouver_citation": "Thury G, Baranyi N, Rárosi F, Héjja R, Kovács A. Efficacy of aflibercept in vitrectomized vs. non-vitrectomized eyes with diabetic macular edema: a prospective study. Int J Retina Vitreous. 2025;",
      "pubdate": "2025-12-10",
      "Lead_author": "Thury G",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s40942-025-00778-y",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE*",
    "vancouverCitation": "Thury G, Baranyi N, Rárosi F, Héjja R, Kovács A. Efficacy of aflibercept in vitrectomized vs. non-vitrectomized eyes with diabetic macular edema: a prospective study. Int J Retina Vitreous. 2025;",
    "leadAuthor": "Thury G",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgOCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgOCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3c909c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707184
  },
  {
    "id": "ENZA_Demo_66195",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41379401",
    "title": "Glutathione-responsive folic acid modified fluorescent SBA-15 nanocarrier for simultaneous imaging and drug delivery in prostate cancer treatment.",
    "authors": [
      "Mahani M",
      "Fallahi Nezhad F",
      "Khakbaz F",
      "Divsar F"
    ],
    "journal": "J Mater Sci Mater Med",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6c7d3fe1-ea4e-4d54-9ed6-0e7a191d541e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.712Z"
      },
      {
        "id": "f34cc2e5-df5e-419c-9033-90d497d2e7e8",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from e52275f4-1a4d-4b70-b2b8-bf3df8fff71c to ENZA_Demo_66195",
        "type": "system",
        "createdAt": "2025-12-14T10:13:05.064Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:48:55.797Z",
    "updatedAt": "2025-12-14T08:54:30.781Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41379401",
      "DOI": "https://doi.org10.1007/s10856-025-06984-2",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:18:47",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Mahani M, Fallahi Nezhad F, Khakbaz F, Divsar F. Glutathione-responsive folic acid modified fluorescent SBA-15 nanocarrier for simultaneous imaging and drug delivery in prostate cancer treatment. J Mater Sci Mater Med. 2025;",
      "pubdate": "2025-12-11",
      "Lead_author": "Mahani M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s10856-025-06984-2",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Mahani M, Fallahi Nezhad F, Khakbaz F, Divsar F. Glutathione-responsive folic acid modified fluorescent SBA-15 nanocarrier for simultaneous imaging and drug delivery in prostate cancer treatment. J Mater Sci Mater Med. 2025;",
    "leadAuthor": "Mahani M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgPCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgPCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3cb3ac0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707185
  },
  {
    "id": "ENZA_Demo_63986",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41372579",
    "title": "Casticin inhibits AKR1C3 and enhances abiraterone efficacy in castration-resistant prostate cancer.",
    "authors": [
      "Piska K",
      "Zubek M",
      "Bucki A",
      "Świtalska M",
      "Koczurkiewicz-Adamczyk P",
      "Władyka B",
      "Kołaczkowski M",
      "Pękala E"
    ],
    "journal": "J Nat Med",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "704714d5-d081-4029-9a65-7a87d1aee31e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.807Z"
      },
      {
        "id": "eee8f0f1-37d9-490d-8dca-65d8a1f81891",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6ac1b3de-5fe3-414b-a873-7879660f1d44 to ENZA_Demo_63986",
        "type": "system",
        "createdAt": "2025-12-14T10:13:05.274Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:48:55.893Z",
    "updatedAt": "2025-12-14T08:54:30.818Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41372579",
      "DOI": "https://doi.org10.1007/s11418-025-01974-8",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:18:34",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Piska K, Zubek M, Bucki A, Świtalska M, Koczurkiewicz-Adamczyk P, Władyka B, Kołaczkowski M, Pękala E. Casticin inhibits AKR1C3 and enhances abiraterone efficacy in castration-resistant prostate cancer. J Nat Med. 2025;",
      "pubdate": "2025-12-11",
      "Lead_author": "Piska K",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s11418-025-01974-8",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Piska K, Zubek M, Bucki A, Świtalska M, Koczurkiewicz-Adamczyk P, Władyka B, Kołaczkowski M, Pękala E. Casticin inhibits AKR1C3 and enhances abiraterone efficacy in castration-resistant prostate cancer. J Nat Med. 2025;",
    "leadAuthor": "Piska K",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgQCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgQCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3cd4ac0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707185
  },
  {
    "id": "ENZA_Demo_40763",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41366824",
    "title": "Prostate Cancer Cells With the AR-Low and EMT-High Phenotype Are Vulnerable to NAD+ Synthesis Inhibitors.",
    "authors": [
      "Ko HK",
      "Foertsch RL",
      "Shi K",
      "Pittsenbarger J",
      "Xue C",
      "Shi K",
      "Geng H",
      "Gao L",
      "Qian DZ"
    ],
    "journal": "Prostate",
    "publicationDate": "2025-12-10",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "26fb7abd-7d2b-455d-9416-c5454fb78d05",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.836Z"
      },
      {
        "id": "b45b59a9-a8b4-4ceb-a99a-9d93c2e3aa45",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f3faa36c-b569-490c-a7d6-0e7a584937de to ENZA_Demo_40763",
        "type": "system",
        "createdAt": "2025-12-14T10:13:05.507Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:48:55.942Z",
    "updatedAt": "2025-12-14T08:54:30.851Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41366824",
      "DOI": "https://doi.org10.1002/pros.70100",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:18:23",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Ko HK, Foertsch RL, Shi K, Pittsenbarger J, Xue C, Shi K, Geng H, Gao L, Qian DZ. Prostate Cancer Cells With the AR-Low and EMT-High Phenotype Are Vulnerable to NAD+ Synthesis Inhibitors. Prostate. 2025;",
      "pubdate": "2025-12-10",
      "Lead_author": "Ko HK",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/pros.70100",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Ko HK, Foertsch RL, Shi K, Pittsenbarger J, Xue C, Shi K, Geng H, Gao L, Qian DZ. Prostate Cancer Cells With the AR-Low and EMT-High Phenotype Are Vulnerable to NAD+ Synthesis Inhibitors. Prostate. 2025;",
    "leadAuthor": "Ko HK",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgRCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgRCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3cf5500501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707185
  },
  {
    "id": "ENZA_Demo_98000",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41364813",
    "title": "Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary Endpoints From the EMBARK Trial.",
    "authors": [
      "Shore ND",
      "Gleave M",
      "De Giorgi U",
      "Rannikko A",
      "Pieczonka CM",
      "Sridharan S",
      "Brasso K",
      "Woo HH",
      "Gómez Caamaño A",
      "Saranchuk JW",
      "Nordquist LT",
      "Ferreira U",
      "Tang Y",
      "Rosbrook B",
      "Haas GP",
      "Rosales M",
      "Zohren F",
      "Tarazi J",
      "Freedland SJ"
    ],
    "journal": "J Urol",
    "publicationDate": "2025-12-9",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "f48ea02d-6264-4797-b3a5-da747e0f97b9",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.881Z"
      },
      {
        "id": "dccc8a88-f454-464c-a584-637109209d04",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from ec4bd874-d959-4871-85ee-47b610f84cc4 to ENZA_Demo_98000",
        "type": "system",
        "createdAt": "2025-12-14T10:13:05.753Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:48:55.984Z",
    "updatedAt": "2025-12-14T08:54:30.889Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41364813",
      "DOI": "https://doi.org10.1097/JU.0000000000004890",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:18:12",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Shore ND, Gleave M, De Giorgi U, Rannikko A, Pieczonka CM, Sridharan S, Brasso K, Woo HH, Gómez Caamaño A, Saranchuk JW, Nordquist LT, Ferreira U, Tang Y, Rosbrook B, Haas GP, Rosales M, Zohren F, Tarazi J, Freedland SJ. Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary Endpoints From the EMBARK Trial. J Urol. 2025;101097JU0000000000004890",
      "pubdate": "2025-12-9",
      "Lead_author": "Shore ND",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/JU.0000000000004890",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Shore ND, Gleave M, De Giorgi U, Rannikko A, Pieczonka CM, Sridharan S, Brasso K, Woo HH, Gómez Caamaño A, Saranchuk JW, Nordquist LT, Ferreira U, Tang Y, Rosbrook B, Haas GP, Rosales M, Zohren F, Tarazi J, Freedland SJ. Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary Endpoints From the EMBARK Trial. J Urol. 2025;101097JU0000000000004890",
    "leadAuthor": "Shore ND",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgSCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgSCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3d17540501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707185
  },
  {
    "id": "ENZA_Demo_14214",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41362128",
    "title": "Preclinical Efficacy of TSL2109 in Prostate Cancer Treatment and Overcoming Enzalutamide Resistance.",
    "authors": [
      "Yuan K",
      "Wang W",
      "Tong C",
      "Yang H",
      "Chen W",
      "Zhang XY",
      "Wang G",
      "Li G",
      "Chen Y",
      "Zhuang X",
      "Min W",
      "Hao H",
      "Xiao Y",
      "Ma X",
      "Yang P"
    ],
    "journal": "J Med Chem",
    "publicationDate": "2025-12-9",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6e9f894e-f530-40a2-a30a-68524e69f3e7",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.943Z"
      },
      {
        "id": "330f1491-8f9c-4599-a07c-884741d1ca6f",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 18c675a0-7247-4b83-8f9d-bc35bc290f05 to ENZA_Demo_14214",
        "type": "system",
        "createdAt": "2025-12-14T10:13:06.002Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:48:56.036Z",
    "updatedAt": "2025-12-14T08:54:30.956Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41362128",
      "DOI": "https://doi.org10.1021/acs.jmedchem.5c03245",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:18:54",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Yuan K, Wang W, Tong C, Yang H, Chen W, Zhang XY, Wang G, Li G, Chen Y, Zhuang X, Min W, Hao H, Xiao Y, Ma X, Yang P. Preclinical Efficacy of TSL2109 in Prostate Cancer Treatment and Overcoming Enzalutamide Resistance. J Med Chem. 2025;",
      "pubdate": "2025-12-9",
      "Lead_author": "Yuan K",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1021/acs.jmedchem.5c03245",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Yuan K, Wang W, Tong C, Yang H, Chen W, Zhang XY, Wang G, Li G, Chen Y, Zhuang X, Min W, Hao H, Xiao Y, Ma X, Yang P. Preclinical Efficacy of TSL2109 in Prostate Cancer Treatment and Overcoming Enzalutamide Resistance. J Med Chem. 2025;",
    "leadAuthor": "Yuan K",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgTCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgTCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3d3d440501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707186
  },
  {
    "id": "ENZA_Demo_27945",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41360764",
    "title": "CircPPFIA2 drives prostate cancer progression and enzalutamide resistance by sponging miR-646 and miR-1200 to upregulate ETS1.",
    "authors": [
      "Mao Y",
      "Leng Q",
      "Wu J",
      "Chen W",
      "Lin C",
      "Deng Z",
      "Shen Q",
      "Zou J",
      "Long Z",
      "Zhan Y",
      "Cheng S",
      "Chen Z",
      "Zhou R",
      "Wang J",
      "Peng H",
      "Lu Y",
      "Huang Y",
      "Li C",
      "Cai A",
      "Xu J",
      "Huang H",
      "Jiang D",
      "Mao X",
      "Lv D"
    ],
    "journal": "Cell Death Discov",
    "publicationDate": "2025-12-9",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "34c2f7a0-0207-47df-9b80-d29618101823",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:30.974Z"
      },
      {
        "id": "7e6f725e-8edb-4952-aca0-0ef396022fc9",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 8f5d4334-1f0a-4b32-8871-6bb16b83f280 to ENZA_Demo_27945",
        "type": "system",
        "createdAt": "2025-12-14T10:13:06.185Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:48:56.082Z",
    "updatedAt": "2025-12-14T08:54:31.009Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41360764",
      "DOI": "https://doi.org10.1038/s41420-025-02904-z",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:18:40",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Mao Y, Leng Q, Wu J, Chen W, Lin C, Deng Z, Shen Q, Zou J, Long Z, Zhan Y, Cheng S, Chen Z, Zhou R, Wang J, Peng H, Lu Y, Huang Y, Li C, Cai A, Xu J, Huang H, Jiang D, Mao X, Lv D. CircPPFIA2 drives prostate cancer progression and enzalutamide resistance by sponging miR-646 and miR-1200 to upregulate ETS1. Cell Death Discov. 2025;",
      "pubdate": "2025-12-9",
      "Lead_author": "Mao Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41420-025-02904-z",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Mao Y, Leng Q, Wu J, Chen W, Lin C, Deng Z, Shen Q, Zou J, Long Z, Zhan Y, Cheng S, Chen Z, Zhou R, Wang J, Peng H, Lu Y, Huang Y, Li C, Cai A, Xu J, Huang H, Jiang D, Mao X, Lv D. CircPPFIA2 drives prostate cancer progression and enzalutamide resistance by sponging miR-646 and miR-1200 to upregulate ETS1. Cell Death Discov. 2025;",
    "leadAuthor": "Mao Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgUCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgUCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3d61280501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707186
  },
  {
    "id": "ENZA_Demo_72439",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41373813",
    "title": "Therapeutic Advances in Metastatic Prostate Cancer: A Journey from Standard of Care to New Emerging Treatment.",
    "authors": [
      "Cicchetti R",
      "Basconi M",
      "Litterio G",
      "Orsini A",
      "Mascitti M",
      "Digiacomo A",
      "Salzano G",
      "Tătaru OS",
      "Ferro M",
      "Giulioni C",
      "Cafarelli A",
      "Schips L",
      "Marchioni M"
    ],
    "journal": "Int J Mol Sci",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "42e7e8b4-cf0d-4062-86e3-f464c78c0c85",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.036Z"
      },
      {
        "id": "62bf2230-2f76-46af-916d-07bc70be2ffe",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 98af71c4-c197-4548-99cc-453e76a7986a to ENZA_Demo_72439",
        "type": "system",
        "createdAt": "2025-12-14T10:13:06.417Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:17.745Z",
    "updatedAt": "2025-12-14T08:54:31.046Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41373813",
      "DOI": "https://doi.org10.3390/ijms262311665",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:20:49",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Cicchetti R, Basconi M, Litterio G, Orsini A, Mascitti M, Digiacomo A, Salzano G, Tătaru OS, Ferro M, Giulioni C, Cafarelli A, Schips L, Marchioni M. Therapeutic Advances in Metastatic Prostate Cancer: A Journey from Standard of Care to New Emerging Treatment. Int J Mol Sci. 2025;26(23):",
      "pubdate": "2025-12-11",
      "Lead_author": "Cicchetti R",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3390/ijms262311665",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Cicchetti R, Basconi M, Litterio G, Orsini A, Mascitti M, Digiacomo A, Salzano G, Tătaru OS, Ferro M, Giulioni C, Cafarelli A, Schips L, Marchioni M. Therapeutic Advances in Metastatic Prostate Cancer: A Journey from Standard of Care to New Emerging Treatment. Int J Mol Sci. 2025;26(23):",
    "leadAuthor": "Cicchetti R",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgVCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgVCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3d87300501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707186
  },
  {
    "id": "ENZA_Demo_45050",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41372093",
    "title": "Real World Hospitalizations in US Veterans Treated for Metastatic Prostate Cancer with Combination Therapy.",
    "authors": [
      "Ingram K",
      "Wilson R",
      "Doherty JM",
      "Eaton DB",
      "Khan S",
      "Schoen MW"
    ],
    "journal": "Clin Genitourin Cancer",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b0f9822c-7bae-4f09-b06c-5b89f33f18cd",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.066Z"
      },
      {
        "id": "030bc358-6aa0-4b4f-bc5e-bdf43ba6a7f4",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 23d9d908-10c2-4e5c-9464-271e93f94358 to ENZA_Demo_45050",
        "type": "system",
        "createdAt": "2025-12-14T10:13:06.630Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:17.835Z",
    "updatedAt": "2025-12-14T08:54:31.118Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41372093",
      "DOI": "https://doi.org10.1016/j.clgc.2025.102469",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:20:20",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Ingram K, Wilson R, Doherty JM, Eaton DB, Khan S, Schoen MW. Real World Hospitalizations in US Veterans Treated for Metastatic Prostate Cancer with Combination Therapy. Clin Genitourin Cancer. 2025;102469",
      "pubdate": "2025-12-11",
      "Lead_author": "Ingram K",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.clgc.2025.102469",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Ingram K, Wilson R, Doherty JM, Eaton DB, Khan S, Schoen MW. Real World Hospitalizations in US Veterans Treated for Metastatic Prostate Cancer with Combination Therapy. Clin Genitourin Cancer. 2025;102469",
    "leadAuthor": "Ingram K",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgWCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgWCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3daee40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707186
  },
  {
    "id": "ENZA_Demo_44795",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41368253",
    "title": "Efficacy at a cost?-quality of life implications of PARP inhibition in the homologus recombination repair (HRR) cohort of TALAPRO-2.",
    "authors": [
      "Esteban-Villarrubia J",
      "Castro E"
    ],
    "journal": "Transl Androl Urol",
    "publicationDate": "2025-12-10",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6afd0da4-cdf7-4dd4-af41-9d3a32c386de",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.148Z"
      },
      {
        "id": "1d23b89b-6c78-481b-a52a-9ae84af98668",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 4c331f38-dd9f-424e-8ee5-3f54eb952d98 to ENZA_Demo_44795",
        "type": "system",
        "createdAt": "2025-12-14T10:13:06.846Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:17.882Z",
    "updatedAt": "2025-12-14T08:54:31.160Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41368253",
      "DOI": "https://doi.org10.21037/tau-2025-645",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:21:03",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Esteban-Villarrubia J, Castro E. Efficacy at a cost?-quality of life implications of PARP inhibition in the homologus recombination repair (HRR) cohort of TALAPRO-2. Transl Androl Urol. 2025;14(11):3453-",
      "pubdate": "2025-12-10",
      "Lead_author": "Esteban-Villarrubia J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.21037/tau-2025-645",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Esteban-Villarrubia J, Castro E. Efficacy at a cost?-quality of life implications of PARP inhibition in the homologus recombination repair (HRR) cohort of TALAPRO-2. Transl Androl Urol. 2025;14(11):3453-",
    "leadAuthor": "Esteban-Villarrubia J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgXCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgXCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3dcf640501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707186
  },
  {
    "id": "ENZA_Demo_38045",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41362045",
    "title": "An Eco-Friendly and Quality-by-Design Optimized Synchronous Spectrofluorescence Method for the Simultaneous Determination of Cleaning Residues of Anticancer Drugs Darolutamide and Enzalutamide From Manufacturing Surfaces.",
    "authors": [
      "Jain JK",
      "Sujatha K",
      "Sheelarani T",
      "Trivedi H",
      "Khemchandani R",
      "Gananadhamu S"
    ],
    "journal": "Luminescence",
    "publicationDate": "2025-12-9",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "aa24bc6b-bd91-41f9-b860-ecb7a4fb3c6b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.191Z"
      },
      {
        "id": "8f74e12c-c097-431e-8e82-42bae4338a97",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 0d817c03-9053-4da5-851e-e0f780252ecb to ENZA_Demo_38045",
        "type": "system",
        "createdAt": "2025-12-14T10:13:07.080Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:17.952Z",
    "updatedAt": "2025-12-14T08:54:31.203Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41362045",
      "DOI": "https://doi.org10.1002/bio.70376",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:21:10",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Jain JK, Sujatha K, Sheelarani T, Trivedi H, Khemchandani R, Gananadhamu S. An Eco-Friendly and Quality-by-Design Optimized Synchronous Spectrofluorescence Method for the Simultaneous Determination of Cleaning Residues of Anticancer Drugs Darolutamide and Enzalutamide From Manufacturing Surfaces. Luminescence. 2025;40(12):e70376",
      "pubdate": "2025-12-9",
      "Lead_author": "Jain JK",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/bio.70376",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Jain JK, Sujatha K, Sheelarani T, Trivedi H, Khemchandani R, Gananadhamu S. An Eco-Friendly and Quality-by-Design Optimized Synchronous Spectrofluorescence Method for the Simultaneous Determination of Cleaning Residues of Anticancer Drugs Darolutamide and Enzalutamide From Manufacturing Surfaces. Luminescence. 2025;40(12):e70376",
    "leadAuthor": "Jain JK",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgYCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgYCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3def0c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707187
  },
  {
    "id": "ENZA_Demo_44404",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41349040",
    "title": "Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary Endpoints.",
    "authors": [
      "Shore ND",
      "De Giorgi U",
      "Tutrone RF",
      "Bailen JL",
      "Roos EP",
      "Kliment J",
      "Marx G",
      "Karsh LI",
      "Ramirez-Backhaus M",
      "Uchio EM",
      "Supiot S",
      "Tang Y",
      "Rosbrook B",
      "Haas GP",
      "Rosales M",
      "Zohren F",
      "Tarazi J",
      "Freedland SJ"
    ],
    "journal": "J Urol",
    "publicationDate": "2025-12-5",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "7ed5308b-7809-4479-bfb3-69b55255026c",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.223Z"
      },
      {
        "id": "16cd5356-1b76-4caa-85cc-f05514a36b14",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 5e923fe2-680e-4d9e-8dba-393a8b35c8af to ENZA_Demo_44404",
        "type": "system",
        "createdAt": "2025-12-14T10:13:07.310Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:17.997Z",
    "updatedAt": "2025-12-14T08:54:31.289Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41349040",
      "DOI": "https://doi.org10.1097/JU.0000000000004879",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:20:56",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Shore ND, De Giorgi U, Tutrone RF, Bailen JL, Roos EP, Kliment J, Marx G, Karsh LI, Ramirez-Backhaus M, Uchio EM, Supiot S, Tang Y, Rosbrook B, Haas GP, Rosales M, Zohren F, Tarazi J, Freedland SJ. Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary Endpoints. J Urol. 2025;101097JU0000000000004879",
      "pubdate": "2025-12-5",
      "Lead_author": "Shore ND",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/JU.0000000000004879",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Shore ND, De Giorgi U, Tutrone RF, Bailen JL, Roos EP, Kliment J, Marx G, Karsh LI, Ramirez-Backhaus M, Uchio EM, Supiot S, Tang Y, Rosbrook B, Haas GP, Rosales M, Zohren F, Tarazi J, Freedland SJ. Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary Endpoints. J Urol. 2025;101097JU0000000000004879",
    "leadAuthor": "Shore ND",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgZCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgZCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3e10180501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707187
  },
  {
    "id": "ENZA_Demo_62871",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41347288",
    "title": "IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate Cancer.",
    "authors": [
      "Leslie AR",
      "Ning S",
      "Sharifi M",
      "Schaaf ZA",
      "Maine JP",
      "Lou W",
      "Leslie KD",
      "Liu C",
      "Xu H",
      "Lombard AP",
      "Chen HW",
      "Parikh M",
      "Dall'Era M",
      "Gao AC"
    ],
    "journal": "Mol Cancer Ther",
    "publicationDate": "2025-12-5",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "92d9d524-1a8e-48e6-bc6b-836b63348461",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.316Z"
      },
      {
        "id": "50af2af1-ddba-4a85-b817-53da7a243a7d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 5fb1e860-250a-492f-ab34-14e7c77cd13e to ENZA_Demo_62871",
        "type": "system",
        "createdAt": "2025-12-14T10:13:07.558Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:18.043Z",
    "updatedAt": "2025-12-14T08:54:31.329Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41347288",
      "DOI": "https://doi.org10.1158/1535-7163.MCT-25-0644",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:20:41",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Leslie AR, Ning S, Sharifi M, Schaaf ZA, Maine JP, Lou W, Leslie KD, Liu C, Xu H, Lombard AP, Chen HW, Parikh M, Dall'Era M, Gao AC. IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate Cancer. Mol Cancer Ther. 2025;",
      "pubdate": "2025-12-5",
      "Lead_author": "Leslie AR",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1158/1535-7163.MCT-25-0644",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Leslie AR, Ning S, Sharifi M, Schaaf ZA, Maine JP, Lou W, Leslie KD, Liu C, Xu H, Lombard AP, Chen HW, Parikh M, Dall'Era M, Gao AC. IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate Cancer. Mol Cancer Ther. 2025;",
    "leadAuthor": "Leslie AR",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgaCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgaCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3e30a00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707187
  },
  {
    "id": "ENZA_Demo_21532",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41317235",
    "title": "Real-World Treatment Patterns in Patients with Metastatic Castration-Sensitive Prostate Cancer in Japan: A Retrospective Health Administrative Data Analysis.",
    "authors": [
      "Kawai T",
      "Kiyonaga F",
      "Shibata H",
      "Tanaka Y",
      "Saito A"
    ],
    "journal": "Adv Ther",
    "publicationDate": "2025-11-29",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "8a570658-32c9-45c0-90f0-409c379ff427",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.349Z"
      },
      {
        "id": "d1d1574f-0864-4087-b4a3-83ac0347ec89",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a2d69976-6e1b-4051-91da-ada15e3eee33 to ENZA_Demo_21532",
        "type": "system",
        "createdAt": "2025-12-14T10:13:07.789Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:18.092Z",
    "updatedAt": "2025-12-14T08:54:31.364Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41317235",
      "DOI": "https://doi.org10.1007/s12325-025-03437-8",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:20:34",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Kawai T, Kiyonaga F, Shibata H, Tanaka Y, Saito A. Real-World Treatment Patterns in Patients with Metastatic Castration-Sensitive Prostate Cancer in Japan: A Retrospective Health Administrative Data Analysis. Adv Ther. 2025;",
      "pubdate": "2025-11-29",
      "Lead_author": "Kawai T",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s12325-025-03437-8",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Kawai T, Kiyonaga F, Shibata H, Tanaka Y, Saito A. Real-World Treatment Patterns in Patients with Metastatic Castration-Sensitive Prostate Cancer in Japan: A Retrospective Health Administrative Data Analysis. Adv Ther. 2025;",
    "leadAuthor": "Kawai T",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgbCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgbCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3e51b80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707187
  },
  {
    "id": "ENZA_Demo_11883",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41315084",
    "title": "Proteome-Based Plasma Biomarkers for Cognitive Dysfunction in an Androgen Deprivation Model.",
    "authors": [
      "Singh V",
      "Verma S",
      "Shankar E",
      "Swain D",
      "Willard BB",
      "Chao HH",
      "Li CR",
      "Lee Z",
      "MacLennan GT",
      "Ponsky LE",
      "Gupta S"
    ],
    "journal": "Mol Neurobiol",
    "publicationDate": "2025-11-29",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ee6c0768-140b-4047-8814-3c2f53594581",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.399Z"
      },
      {
        "id": "d62a143b-c78b-4103-acbf-07aebed00e19",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from da9b1a6d-3bdc-45dd-850d-832123c5eecf to ENZA_Demo_11883",
        "type": "system",
        "createdAt": "2025-12-14T10:13:08.022Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:18.136Z",
    "updatedAt": "2025-12-14T08:54:31.414Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41315084",
      "DOI": "https://doi.org10.1007/s12035-025-05548-3",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:21:41",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Singh V, Verma S, Shankar E, Swain D, Willard BB, Chao HH, Li CR, Lee Z, MacLennan GT, Ponsky LE, Gupta S. Proteome-Based Plasma Biomarkers for Cognitive Dysfunction in an Androgen Deprivation Model. Mol Neurobiol. 2025;63(1):201",
      "pubdate": "2025-11-29",
      "Lead_author": "Singh V",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s12035-025-05548-3",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Singh V, Verma S, Shankar E, Swain D, Willard BB, Chao HH, Li CR, Lee Z, MacLennan GT, Ponsky LE, Gupta S. Proteome-Based Plasma Biomarkers for Cognitive Dysfunction in an Androgen Deprivation Model. Mol Neurobiol. 2025;63(1):201",
    "leadAuthor": "Singh V",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgcCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgcCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3e71540501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707188
  },
  {
    "id": "ENZA_Demo_96614",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41315064",
    "title": "Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer.",
    "authors": [
      "Perimbeti S",
      "Jamroze A",
      "Gopalakrishnan D",
      "Jain R",
      "Jiang C",
      "Holleran JL",
      "Parise RA",
      "Bies R",
      "Quinn D",
      "Attwood K",
      "Liu X",
      "Green K",
      "Kirk JS",
      "Beumer JH",
      "Tang DG",
      "Chatta G"
    ],
    "journal": "Cancer Chemother Pharmacol",
    "publicationDate": "2025-11-29",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "8ba9d554-d75f-4738-ad5d-f106fb3b6d52",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.444Z"
      },
      {
        "id": "afc33489-7620-4932-b566-11a605100711",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 907d566c-8028-45dd-80a1-fe519f1d12bc to ENZA_Demo_96614",
        "type": "system",
        "createdAt": "2025-12-14T10:13:08.289Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:18.181Z",
    "updatedAt": "2025-12-14T08:54:31.461Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41315064",
      "DOI": "https://doi.org10.1007/s00280-025-04840-2",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:21:48",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Perimbeti S, Jamroze A, Gopalakrishnan D, Jain R, Jiang C, Holleran JL, Parise RA, Bies R, Quinn D, Attwood K, Liu X, Green K, Kirk JS, Beumer JH, Tang DG, Chatta G. Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer. Cancer Chemother Pharmacol. 2025;95(1):115",
      "pubdate": "2025-11-29",
      "Lead_author": "Perimbeti S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s00280-025-04840-2",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Perimbeti S, Jamroze A, Gopalakrishnan D, Jain R, Jiang C, Holleran JL, Parise RA, Bies R, Quinn D, Attwood K, Liu X, Green K, Kirk JS, Beumer JH, Tang DG, Chatta G. Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer. Cancer Chemother Pharmacol. 2025;95(1):115",
    "leadAuthor": "Perimbeti S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgdCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgdCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3e9a0c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707188
  },
  {
    "id": "ENZA_Demo_75159",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41313547",
    "title": "Response to Letter to the Editor Regarding: 'Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'.",
    "authors": [
      "Bilen MA",
      "Lowentritt B",
      "Khilfeh I",
      "Rossi C",
      "Du S",
      "Kinkead F",
      "Diaz L",
      "Pilon D",
      "Ellis L",
      "Shore ND"
    ],
    "journal": "Adv Ther",
    "publicationDate": "2025-11-28",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "199cbc0d-f824-4034-a3e4-f531d0290ca5",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.489Z"
      },
      {
        "id": "88f0b22b-655d-42d3-9504-a4fa70f8c906",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 4612a7a9-3f92-4979-b8da-8daacadf9f95 to ENZA_Demo_75159",
        "type": "system",
        "createdAt": "2025-12-14T10:13:08.473Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:18.229Z",
    "updatedAt": "2025-12-14T08:54:31.498Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41313547",
      "DOI": "https://doi.org10.1007/s12325-025-03436-9",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:21:33",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Bilen MA, Lowentritt B, Khilfeh I, Rossi C, Du S, Kinkead F, Diaz L, Pilon D, Ellis L, Shore ND. Response to Letter to the Editor Regarding: 'Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'. Adv Ther. 2025;",
      "pubdate": "2025-11-28",
      "Lead_author": "Bilen MA",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s12325-025-03436-9",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Bilen MA, Lowentritt B, Khilfeh I, Rossi C, Du S, Kinkead F, Diaz L, Pilon D, Ellis L, Shore ND. Response to Letter to the Editor Regarding: 'Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'. Adv Ther. 2025;",
    "leadAuthor": "Bilen MA",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgeCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgeCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3eb6900501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707188
  },
  {
    "id": "ENZA_Demo_72027",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41313546",
    "title": "Letter to the Editor Regarding 'Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'.",
    "authors": [
      "Schoen MW",
      "Fojo T"
    ],
    "journal": "Adv Ther",
    "publicationDate": "2025-11-28",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "04b87277-6691-4da7-94f6-3f140bfa6a93",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.518Z"
      },
      {
        "id": "a4f3532b-c136-49e3-9c3b-5ec8c59c883e",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 2a8342bd-5b1f-4465-bb3d-ab90c1138e34 to ENZA_Demo_72027",
        "type": "system",
        "createdAt": "2025-12-14T10:13:08.725Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:18.278Z",
    "updatedAt": "2025-12-14T08:54:31.568Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41313546",
      "DOI": "https://doi.org10.1007/s12325-025-03434-x",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:21:27",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Schoen MW, Fojo T. Letter to the Editor Regarding 'Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'. Adv Ther. 2025;",
      "pubdate": "2025-11-28",
      "Lead_author": "Schoen MW",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s12325-025-03434-x",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Schoen MW, Fojo T. Letter to the Editor Regarding 'Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'. Adv Ther. 2025;",
    "leadAuthor": "Schoen MW",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgfCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgfCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3edd100501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707188
  },
  {
    "id": "ENZA_Demo_12798",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41259940",
    "title": "Corrigendum to \"Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study\" [Eur J Cancer 213 (December) (2024) 115078].",
    "authors": [
      "Azad AA",
      "Fizazi K",
      "Matsubara N",
      "Saad F",
      "De Giorgi U",
      "Joung JY",
      "Fong PCC",
      "Jones RJ",
      "Zschäbitz S",
      "Oldenburg J",
      "Shore ND",
      "Dunshee C",
      "Carles J",
      "Fay AP",
      "Lin X",
      "DeAnnuntis L",
      "Di Santo N",
      "Zielinski MA",
      "Agarwal N"
    ],
    "journal": "Eur J Cancer",
    "publicationDate": "2025-11-20",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "3e0e1f4b-35d1-46cc-b229-e35596c405d9",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.595Z"
      },
      {
        "id": "a6a718a3-5475-4f30-b57b-02daa705f6d0",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a4d6ce95-9113-4979-b5f3-070b3151764c to ENZA_Demo_12798",
        "type": "system",
        "createdAt": "2025-12-14T10:13:08.921Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:18.321Z",
    "updatedAt": "2025-12-14T08:54:31.605Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41259940",
      "DOI": "https://doi.org10.1016/j.ejca.2025.116106",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:21:57",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Azad AA, Fizazi K, Matsubara N, Saad F, De Giorgi U, Joung JY, Fong PCC, Jones RJ, Zschäbitz S, Oldenburg J, Shore ND, Dunshee C, Carles J, Fay AP, Lin X, DeAnnuntis L, Di Santo N, Zielinski MA, Agarwal N. Corrigendum to \"Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study\" [Eur J Cancer 213 (December) (2024) 115078]. Eur J Cancer. 2025;232116106",
      "pubdate": "2025-11-20",
      "Lead_author": "Azad AA",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ejca.2025.116106",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Azad AA, Fizazi K, Matsubara N, Saad F, De Giorgi U, Joung JY, Fong PCC, Jones RJ, Zschäbitz S, Oldenburg J, Shore ND, Dunshee C, Carles J, Fay AP, Lin X, DeAnnuntis L, Di Santo N, Zielinski MA, Agarwal N. Corrigendum to \"Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study\" [Eur J Cancer 213 (December) (2024) 115078]. Eur J Cancer. 2025;232116106",
    "leadAuthor": "Azad AA",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUggCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUggCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3efb0c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707188
  },
  {
    "id": "ENZA_Demo_73081",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41257618",
    "title": "Androgenic effects of 11-oxyandrogens in castration-resistant prostate cancer.",
    "authors": [
      "Lapointe-Belleau A",
      "Rouleau M",
      "Villeneuve L",
      "Descarreaux J",
      "Caron P",
      "Beaudoin C",
      "Uchil A",
      "Simonyan D",
      "Dahmani C",
      "Joly-Beauparlant C",
      "Gélinas V",
      "Droit A",
      "Marcoux N",
      "Castonguay V",
      "Lacombe L",
      "Lévesque É",
      "Guillemette C"
    ],
    "journal": "BMC Cancer",
    "publicationDate": "2025-11-19",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "0c80f350-79ef-4703-9e67-1105c702239a",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.635Z"
      },
      {
        "id": "c3d78748-fe19-48a4-86f8-8241e983500d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 58f610a3-6ddb-4772-8d94-bb10bf9cedb0 to ENZA_Demo_73081",
        "type": "system",
        "createdAt": "2025-12-14T10:13:09.169Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:18.364Z",
    "updatedAt": "2025-12-14T08:54:31.646Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41257618",
      "DOI": "https://doi.org10.1186/s12885-025-15193-7",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:22:26",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Lapointe-Belleau A, Rouleau M, Villeneuve L, Descarreaux J, Caron P, Beaudoin C, Uchil A, Simonyan D, Dahmani C, Joly-Beauparlant C, Gélinas V, Droit A, Marcoux N, Castonguay V, Lacombe L, Lévesque É, Guillemette C. Androgenic effects of 11-oxyandrogens in castration-resistant prostate cancer. BMC Cancer. 2025;25(1):1786",
      "pubdate": "2025-11-19",
      "Lead_author": "Lapointe-Belleau A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s12885-025-15193-7",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Lapointe-Belleau A, Rouleau M, Villeneuve L, Descarreaux J, Caron P, Beaudoin C, Uchil A, Simonyan D, Dahmani C, Joly-Beauparlant C, Gélinas V, Droit A, Marcoux N, Castonguay V, Lacombe L, Lévesque É, Guillemette C. Androgenic effects of 11-oxyandrogens in castration-resistant prostate cancer. BMC Cancer. 2025;25(1):1786",
    "leadAuthor": "Lapointe-Belleau A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUghCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUghCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3f20e00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707189
  },
  {
    "id": "ENZA_Demo_28819",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41257454",
    "title": "GLP1 receptor agonism alters growth and therapeutic response in prostate cancer.",
    "authors": [
      "Bera S",
      "Gutgesell LC",
      "Darden B",
      "Sargis RM",
      "Maienschein-Cline M",
      "Gaber CE",
      "Reizine NM",
      "Vander Griend DJ",
      "Vellky JE"
    ],
    "journal": "Endocr Relat Cancer",
    "publicationDate": "2025-11-19",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "2b8b71c7-6faa-498b-a51d-b07a2be85112",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.659Z"
      },
      {
        "id": "a4f934fc-8f3f-47f6-9a56-aefd6b8af681",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d72b2e9d-2388-4315-8b3d-366eaec0b4a8 to ENZA_Demo_28819",
        "type": "system",
        "createdAt": "2025-12-14T10:13:09.372Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:18.576Z",
    "updatedAt": "2025-12-14T08:54:31.738Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41257454",
      "DOI": "https://doi.org10.1530/ERC-25-0185",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:22:05",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Bera S, Gutgesell LC, Darden B, Sargis RM, Maienschein-Cline M, Gaber CE, Reizine NM, Vander Griend DJ, Vellky JE. GLP1 receptor agonism alters growth and therapeutic response in prostate cancer. Endocr Relat Cancer. 2025;32(12):",
      "pubdate": "2025-11-19",
      "Lead_author": "Bera S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1530/ERC-25-0185",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Bera S, Gutgesell LC, Darden B, Sargis RM, Maienschein-Cline M, Gaber CE, Reizine NM, Vander Griend DJ, Vellky JE. GLP1 receptor agonism alters growth and therapeutic response in prostate cancer. Endocr Relat Cancer. 2025;32(12):",
    "leadAuthor": "Bera S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgiCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgiCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3f44ec0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707189
  },
  {
    "id": "ENZA_Demo_26154",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41253772",
    "title": "Correction: SLC7A11 upregulation via AR and NEDD4L ubiquitination contributes to ferroptosis inhibition and enzalutamide resistance in castration-resistant prostate cancer.",
    "authors": [
      "Tang M",
      "Xue L",
      "Wang B",
      "Jiang Z",
      "Li P",
      "Bu H",
      "Zhao C",
      "Zhang Y",
      "Liu S",
      "Chen X",
      "Liu B",
      "Meng X",
      "Li J"
    ],
    "journal": "Cell Death Dis",
    "publicationDate": "2025-11-19",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "2870402b-667f-409a-a724-7cd0cd1ddf89",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.765Z"
      },
      {
        "id": "ea7fa75e-b081-4f29-a273-8927033b5c8b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from aac09d94-edc5-4893-996f-e0cb9ab8c45f to ENZA_Demo_26154",
        "type": "system",
        "createdAt": "2025-12-14T10:13:09.603Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:18.669Z",
    "updatedAt": "2025-12-14T08:54:31.774Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41253772",
      "DOI": "https://doi.org10.1038/s41419-025-08123-9",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:22:12",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Tang M, Xue L, Wang B, Jiang Z, Li P, Bu H, Zhao C, Zhang Y, Liu S, Chen X, Liu B, Meng X, Li J. Correction: SLC7A11 upregulation via AR and NEDD4L ubiquitination contributes to ferroptosis inhibition and enzalutamide resistance in castration-resistant prostate cancer. Cell Death Dis. 2025;16(1):844",
      "pubdate": "2025-11-19",
      "Lead_author": "Tang M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41419-025-08123-9",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Tang M, Xue L, Wang B, Jiang Z, Li P, Bu H, Zhao C, Zhang Y, Liu S, Chen X, Liu B, Meng X, Li J. Correction: SLC7A11 upregulation via AR and NEDD4L ubiquitination contributes to ferroptosis inhibition and enzalutamide resistance in castration-resistant prostate cancer. Cell Death Dis. 2025;16(1):844",
    "leadAuthor": "Tang M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgjCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgjCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3f631c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707189
  },
  {
    "id": "ENZA_Demo_72087",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41251917",
    "title": "Recurrent vertebrobasilar stroke in giant cell arteritis associated with progressive prostate carcinoma: a case report and literature review.",
    "authors": [
      "Bertens JPF",
      "Oskam LC",
      "van Bon L",
      "van der Heijden CDCC"
    ],
    "journal": "Clin Rheumatol",
    "publicationDate": "2025-11-18",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "15ae1400-234e-4680-b28c-f2403486c85f",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.796Z"
      },
      {
        "id": "b3934a5c-0d89-40b4-b388-a02e909b525c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 06a41271-339f-4b55-802d-4c9dae0a1348 to ENZA_Demo_72087",
        "type": "system",
        "createdAt": "2025-12-14T10:13:09.834Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:18.779Z",
    "updatedAt": "2025-12-14T08:54:31.806Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41251917",
      "DOI": "https://doi.org10.1007/s10067-025-07810-4",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:22:18",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Bertens JPF, Oskam LC, van Bon L, van der Heijden CDCC. Recurrent vertebrobasilar stroke in giant cell arteritis associated with progressive prostate carcinoma: a case report and literature review. Clin Rheumatol. 2025;",
      "pubdate": "2025-11-18",
      "Lead_author": "Bertens JPF",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s10067-025-07810-4",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Bertens JPF, Oskam LC, van Bon L, van der Heijden CDCC. Recurrent vertebrobasilar stroke in giant cell arteritis associated with progressive prostate carcinoma: a case report and literature review. Clin Rheumatol. 2025;",
    "leadAuthor": "Bertens JPF",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgkCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgkCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3f86640501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707189
  },
  {
    "id": "ENZA_Demo_80415",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41110727",
    "title": "Phosphorylation of UDP-glucose dehydrogenase increases glycosaminoglycan biosynthesis and promotes tumor cell motility, spheroid growth, and therapeutic resistance.",
    "authors": [
      "Utz AR",
      "Ma L",
      "Hilovsky D",
      "Zimmer BM",
      "Allego E",
      "Fluharty J",
      "Narasimhan P",
      "Enders JR",
      "Grady G",
      "Milici M",
      "Liu P",
      "Liu X",
      "Barycki JJ",
      "Simpson MA"
    ],
    "journal": "Matrix Biol",
    "publicationDate": "2025-10-20",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a2bb8455-8b19-41ae-adef-1fffa031ac5b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.827Z"
      },
      {
        "id": "6b09b15b-8c51-4544-9d20-ad3b6735ba54",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a694a7bc-32ec-4cdc-8dae-a54ba831fd6d to ENZA_Demo_80415",
        "type": "system",
        "createdAt": "2025-12-14T10:13:10.081Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:18.879Z",
    "updatedAt": "2025-12-14T08:54:31.839Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41110727",
      "DOI": "https://doi.org10.1016/j.matbio.2025.10.004",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:22:33",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Utz AR, Ma L, Hilovsky D, Zimmer BM, Allego E, Fluharty J, Narasimhan P, Enders JR, Grady G, Milici M, Liu P, Liu X, Barycki JJ, Simpson MA. Phosphorylation of UDP-glucose dehydrogenase increases glycosaminoglycan biosynthesis and promotes tumor cell motility, spheroid growth, and therapeutic resistance. Matrix Biol. 2025;14233-45",
      "pubdate": "2025-10-20",
      "Lead_author": "Utz AR",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.matbio.2025.10.004",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Utz AR, Ma L, Hilovsky D, Zimmer BM, Allego E, Fluharty J, Narasimhan P, Enders JR, Grady G, Milici M, Liu P, Liu X, Barycki JJ, Simpson MA. Phosphorylation of UDP-glucose dehydrogenase increases glycosaminoglycan biosynthesis and promotes tumor cell motility, spheroid growth, and therapeutic resistance. Matrix Biol. 2025;14233-45",
    "leadAuthor": "Utz AR",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUglCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUglCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3fab600501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707190
  },
  {
    "id": "ENZA_Demo_27711",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41090322",
    "title": "UK real-world data of radium-223 dichloride in metastatic prostate cancer.",
    "authors": [
      "Randhawa M",
      "Buchanan G",
      "Stratton IM",
      "Race G",
      "Challapalli A",
      "Bottomley D",
      "Logue J",
      "Sundar S",
      "Robinson A",
      "Mclaren DB",
      "Stevenson R",
      "O'Sullivan JM",
      "Sweeney L",
      "McGrane J",
      "Jiang X",
      "Mazhar D",
      "Khoo V",
      "McPhail N",
      "Jones RJ"
    ],
    "journal": "Nucl Med Commun",
    "publicationDate": "2025-10-15",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "80b4292c-93d9-4d51-92b3-c0f55b68c951",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.861Z"
      },
      {
        "id": "c1fb159a-93ed-4e02-910c-bad94dbc474e",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d251caa6-0927-4f39-badb-f31326ec0b55 to ENZA_Demo_27711",
        "type": "system",
        "createdAt": "2025-12-14T10:13:10.285Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:19.084Z",
    "updatedAt": "2025-12-14T08:54:31.923Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41090322",
      "DOI": "https://doi.org10.1097/MNM.0000000000002050",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:22:49",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Randhawa M, Buchanan G, Stratton IM, Race G, Challapalli A, Bottomley D, Logue J, Sundar S, Robinson A, Mclaren DB, Stevenson R, O'Sullivan JM, Sweeney L, McGrane J, Jiang X, Mazhar D, Khoo V, McPhail N, Jones RJ, . UK real-world data of radium-223 dichloride in metastatic prostate cancer. Nucl Med Commun. 2025;46(12):1155-62",
      "pubdate": "2025-10-15",
      "Lead_author": "Randhawa M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/MNM.0000000000002050",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Randhawa M, Buchanan G, Stratton IM, Race G, Challapalli A, Bottomley D, Logue J, Sundar S, Robinson A, Mclaren DB, Stevenson R, O'Sullivan JM, Sweeney L, McGrane J, Jiang X, Mazhar D, Khoo V, McPhail N, Jones RJ, . UK real-world data of radium-223 dichloride in metastatic prostate cancer. Nucl Med Commun. 2025;46(12):1155-62",
    "leadAuthor": "Randhawa M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgmCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgmCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3fcaf80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707190
  },
  {
    "id": "ENZA_Demo_27569",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41076395",
    "title": "Comprehensive Evaluation of Androgen Receptor Pathway Inhibitors in Metastatic Castration-Sensitive Prostate Cancer: A Multicenter Inverse Probability of Treatment Weighting-Based Study.",
    "authors": [
      "Kobayashi K",
      "Tokunaga T",
      "Nagao K",
      "Fujikawa K",
      "Oba K",
      "Takai K",
      "Matsumoto H",
      "Sakano S",
      "Shirataki S",
      "Tei Y",
      "Tabara M",
      "Yoshihiro S",
      "Yano S",
      "Ito H",
      "Kitahara S",
      "Ohmi C",
      "Akao J",
      "Shiraishi K"
    ],
    "journal": "Clin Genitourin Cancer",
    "publicationDate": "2025-10-12",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "817cb878-32b1-48ff-91bd-544ee1a36e3c",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.952Z"
      },
      {
        "id": "8da07888-beeb-4e74-9e17-321aeae17a53",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from b67bdfbf-b8ef-4ec2-ac17-433ecb2b7d7e to ENZA_Demo_27569",
        "type": "system",
        "createdAt": "2025-12-14T10:13:10.516Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:19.175Z",
    "updatedAt": "2025-12-14T08:54:31.963Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41076395",
      "DOI": "https://doi.org10.1016/j.clgc.2025.102437",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:22:56",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Kobayashi K, Tokunaga T, Nagao K, Fujikawa K, Oba K, Takai K, Matsumoto H, Sakano S, Shirataki S, Tei Y, Tabara M, Yoshihiro S, Yano S, Ito H, Kitahara S, Ohmi C, Akao J, Shiraishi K. Comprehensive Evaluation of Androgen Receptor Pathway Inhibitors in Metastatic Castration-Sensitive Prostate Cancer: A Multicenter Inverse Probability of Treatment Weighting-Based Study. Clin Genitourin Cancer. 2025;23(6):102437",
      "pubdate": "2025-10-12",
      "Lead_author": "Kobayashi K",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.clgc.2025.102437",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Kobayashi K, Tokunaga T, Nagao K, Fujikawa K, Oba K, Takai K, Matsumoto H, Sakano S, Shirataki S, Tei Y, Tabara M, Yoshihiro S, Yano S, Ito H, Kitahara S, Ohmi C, Akao J, Shiraishi K. Comprehensive Evaluation of Androgen Receptor Pathway Inhibitors in Metastatic Castration-Sensitive Prostate Cancer: A Multicenter Inverse Probability of Treatment Weighting-Based Study. Clin Genitourin Cancer. 2025;23(6):102437",
    "leadAuthor": "Kobayashi K",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgnCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgnCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-3fee240501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707190
  },
  {
    "id": "ENZA_Demo_54128",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41067365",
    "title": "PPP1R14B promotes the progression of prostate cancer by regulating the JAK2/STAT3/AR pathway and alters the sensitivity and resistance to enzalutamide.",
    "authors": [
      "Cheng L",
      "You C",
      "Ma L",
      "Liu S",
      "Lao Y",
      "Guan X",
      "Wang W",
      "Xiao X",
      "Tao Y",
      "Dong Z"
    ],
    "journal": "Cell Signal",
    "publicationDate": "2025-10-10",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9370efb5-e97e-401d-ad39-0ea1438327e8",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:31.981Z"
      },
      {
        "id": "e44e6fd1-8763-47d4-bca2-f00d6497b38f",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f3ca2d06-f82f-4913-b545-9d76a968bc0a to ENZA_Demo_54128",
        "type": "system",
        "createdAt": "2025-12-14T10:13:10.746Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:19.320Z",
    "updatedAt": "2025-12-14T08:54:31.993Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41067365",
      "DOI": "https://doi.org10.1016/j.cellsig.2025.112163",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:22:42",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Cheng L, You C, Ma L, Liu S, Lao Y, Guan X, Wang W, Xiao X, Tao Y, Dong Z. PPP1R14B promotes the progression of prostate cancer by regulating the JAK2/STAT3/AR pathway and alters the sensitivity and resistance to enzalutamide. Cell Signal. 2025;136112163",
      "pubdate": "2025-10-10",
      "Lead_author": "Cheng L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.cellsig.2025.112163",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Cheng L, You C, Ma L, Liu S, Lao Y, Guan X, Wang W, Xiao X, Tao Y, Dong Z. PPP1R14B promotes the progression of prostate cancer by regulating the JAK2/STAT3/AR pathway and alters the sensitivity and resistance to enzalutamide. Cell Signal. 2025;136112163",
    "leadAuthor": "Cheng L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgoCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgoCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4011440501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707190
  },
  {
    "id": "ENZA_Demo_72612",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41045691",
    "title": "Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial.",
    "authors": [
      "Rousseau A",
      "Karimi M",
      "Michiels S",
      "Roubaud G",
      "Maldonado X",
      "Supiot S",
      "McDermott R",
      "Flechon A",
      "Tombal B",
      "Ronchin P",
      "Berthold D",
      "Berdah JF",
      "Kacso G",
      "Gravis G",
      "Calabro F",
      "Tartas S",
      "Muracciole X",
      "Ribault H",
      "Fizazi K",
      "Foulon S"
    ],
    "journal": "Eur J Cancer",
    "publicationDate": "2025-10-5",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "fd3d0d4c-7355-45be-896e-143815b7c086",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.012Z"
      },
      {
        "id": "5c5974df-4552-4690-8ede-81291d9f363a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 2dc850bb-b5c5-4f50-a2b6-143d5e8779b4 to ENZA_Demo_72612",
        "type": "system",
        "createdAt": "2025-12-14T10:13:10.979Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:19.409Z",
    "updatedAt": "2025-12-14T08:54:32.063Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41045691",
      "DOI": "https://doi.org10.1016/j.ejca.2025.116024",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:23:02",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Rousseau A, Karimi M, Michiels S, Roubaud G, Maldonado X, Supiot S, McDermott R, Flechon A, Tombal B, Ronchin P, Berthold D, Berdah JF, Kacso G, Gravis G, Calabro F, Tartas S, Muracciole X, Ribault H, Fizazi K, Foulon S. Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial. Eur J Cancer. 2025;230116024",
      "pubdate": "2025-10-5",
      "Lead_author": "Rousseau A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ejca.2025.116024",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Rousseau A, Karimi M, Michiels S, Roubaud G, Maldonado X, Supiot S, McDermott R, Flechon A, Tombal B, Ronchin P, Berthold D, Berdah JF, Kacso G, Gravis G, Calabro F, Tartas S, Muracciole X, Ribault H, Fizazi K, Foulon S. Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial. Eur J Cancer. 2025;230116024",
    "leadAuthor": "Rousseau A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgpCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgpCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4035300501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707190
  },
  {
    "id": "ENZA_Demo_95254",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40395149",
    "title": "Cost-effectiveness of enzalutamide with androgen-deprivation therapy (ADT) versus ADT alone for the treatment of high-risk biochemically recurrent non-metastatic castration-sensitive prostate cancer in Canada.",
    "authors": [
      "Aprikian A",
      "Saad F",
      "Wywial E",
      "McLean T",
      "Johnston K",
      "Li Y",
      "Chilelli A"
    ],
    "journal": "J Med Econ",
    "publicationDate": "2025-05-21",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "e4dc48f5-176c-4331-964c-67845a3226e7",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.088Z"
      },
      {
        "id": "0d9ec295-31fc-4857-9e6e-5cbffa41b764",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 0909aec6-a0eb-4842-8b4d-615d50429e18 to ENZA_Demo_95254",
        "type": "system",
        "createdAt": "2025-12-14T10:13:11.182Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:19.596Z",
    "updatedAt": "2025-12-14T08:54:32.097Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40395149",
      "DOI": "https://doi.org10.1080/13696998.2025.2503660",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:23:16",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Aprikian A, Saad F, Wywial E, McLean T, Johnston K, Li Y, Chilelli A. Cost-effectiveness of enzalutamide with androgen-deprivation therapy (ADT) versus ADT alone for the treatment of high-risk biochemically recurrent non-metastatic castration-sensitive prostate cancer in Canada. J Med Econ. 2025;28(1):766-77",
      "pubdate": "2025-05-21",
      "Lead_author": "Aprikian A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/13696998.2025.2503660",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Aprikian A, Saad F, Wywial E, McLean T, Johnston K, Li Y, Chilelli A. Cost-effectiveness of enzalutamide with androgen-deprivation therapy (ADT) versus ADT alone for the treatment of high-risk biochemically recurrent non-metastatic castration-sensitive prostate cancer in Canada. J Med Econ. 2025;28(1):766-77",
    "leadAuthor": "Aprikian A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgqCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgqCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4059c40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707191
  },
  {
    "id": "ENZA_Demo_22740",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40185917",
    "title": "Real-world utilization patterns and survival in men with metastatic prostate cancer treated with Radium-223 in the United States.",
    "authors": [
      "Raval AD",
      "Zhang Y",
      "Korn M",
      "Constantinovici N",
      "McKay RR"
    ],
    "journal": "Prostate Cancer Prostatic Dis",
    "publicationDate": "2025-04-5",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5fd89f53-d1c0-42e7-9966-51ef4abb9943",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.119Z"
      },
      {
        "id": "8119c666-11a5-425a-a9e5-51a842c7b569",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 389dbd44-af3f-4839-b453-80147e7dae43 to ENZA_Demo_22740",
        "type": "system",
        "createdAt": "2025-12-14T10:13:11.438Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:53:19.690Z",
    "updatedAt": "2025-12-14T08:54:32.129Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40185917",
      "DOI": "https://doi.org10.1038/s41391-025-00969-6",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:23:09",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Raval AD, Zhang Y, Korn M, Constantinovici N, McKay RR. Real-world utilization patterns and survival in men with metastatic prostate cancer treated with Radium-223 in the United States. Prostate Cancer Prostatic Dis. 2025;28(4):960-7",
      "pubdate": "2025-04-5",
      "Lead_author": "Raval AD",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41391-025-00969-6",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Raval AD, Zhang Y, Korn M, Constantinovici N, McKay RR. Real-world utilization patterns and survival in men with metastatic prostate cancer treated with Radium-223 in the United States. Prostate Cancer Prostatic Dis. 2025;28(4):960-7",
    "leadAuthor": "Raval AD",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgrCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgrCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-407a840501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707191
  },
  {
    "id": "ENZA_Demo_69655",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41313045",
    "title": "A plain language summary of the EORTC 1333/PEACE-3 study of enzalutamide alone vs enzalutamide plus radium-223 in patients with metastatic castrationresistant prostate cancer (mCRPC) and bone metastases.",
    "authors": [
      "Tombal B",
      "Saad F",
      "Gallardo E",
      "Soares A",
      "Loriot Y",
      "McDermott R",
      "Briers E",
      "Lagström M",
      "Coens C",
      "Poncet C",
      "Fournier B",
      "Gillessen S"
    ],
    "journal": "Future Oncol",
    "publicationDate": "2025-11-28",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "89bbfadc-9220-452a-9328-f51dd606ffc1",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.184Z"
      },
      {
        "id": "b8d7fd64-37b5-49ef-89ab-b443228a1fe4",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 8617bd28-a1b4-4bb1-ba6c-7edbd8659744 to ENZA_Demo_69655",
        "type": "system",
        "createdAt": "2025-12-14T10:13:11.657Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:05.373Z",
    "updatedAt": "2025-12-14T08:54:32.194Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41313045",
      "DOI": "https://doi.org10.1080/14796694.2025.2592722",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:23:57",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Tombal B, Saad F, Gallardo E, Soares A, Loriot Y, McDermott R, Briers E, Lagström M, Coens C, Poncet C, Fournier B, Gillessen S. A plain language summary of the EORTC 1333/PEACE-3 study of enzalutamide alone vs enzalutamide plus radium-223 in patients with metastatic castrationresistant prostate cancer (mCRPC) and bone metastases. Future Oncol. 2025;1-14",
      "pubdate": "2025-11-28",
      "Lead_author": "Tombal B",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/14796694.2025.2592722",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Tombal B, Saad F, Gallardo E, Soares A, Loriot Y, McDermott R, Briers E, Lagström M, Coens C, Poncet C, Fournier B, Gillessen S. A plain language summary of the EORTC 1333/PEACE-3 study of enzalutamide alone vs enzalutamide plus radium-223 in patients with metastatic castrationresistant prostate cancer (mCRPC) and bone metastases. Future Oncol. 2025;1-14",
    "leadAuthor": "Tombal B",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgsCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgsCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-409c500501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707191
  },
  {
    "id": "ENZA_Demo_94875",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41307573",
    "title": "Reply to Parth Aphale, Shashank Dokania, Himanshu Shekhar's Letter to the Editor re: Bahl A, Chilelli A, Faria R, et al. Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study. World J Urol 43:465. https://doi.org/10.1007/s00345-025-05841-9.",
    "authors": [
      "Bahl A",
      "Chilelli A",
      "Faria R",
      "Rozario N",
      "Snijder R",
      "Stark S",
      "Merseburger AS"
    ],
    "journal": "World J Urol",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "fde71f8d-77ea-4c64-b6e2-bce1256fac20",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.215Z"
      },
      {
        "id": "fc0a6c13-fd46-4f77-9e3a-0c8b0ecc0505",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from ad6497db-a478-4a2b-81e7-69d02d08a3a9 to ENZA_Demo_94875",
        "type": "system",
        "createdAt": "2025-12-14T10:13:11.870Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:05.464Z",
    "updatedAt": "2025-12-14T08:54:32.267Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41307573",
      "DOI": "https://doi.org10.1007/s00345-025-06100-7",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:24:04",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Bahl A, Chilelli A, Faria R, Rozario N, Snijder R, Stark S, Merseburger AS. Reply to Parth Aphale, Shashank Dokania, Himanshu Shekhar's Letter to the Editor re: Bahl A, Chilelli A, Faria R, et al. Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study. World J Urol 43:465. https://doi.org/10.1007/s00345-025-05841-9. World J Urol. 2025;44(1):5",
      "pubdate": "2025-11-27",
      "Lead_author": "Bahl A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s00345-025-06100-7",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Bahl A, Chilelli A, Faria R, Rozario N, Snijder R, Stark S, Merseburger AS. Reply to Parth Aphale, Shashank Dokania, Himanshu Shekhar's Letter to the Editor re: Bahl A, Chilelli A, Faria R, et al. Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study. World J Urol 43:465. https://doi.org/10.1007/s00345-025-05841-9. World J Urol. 2025;44(1):5",
    "leadAuthor": "Bahl A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgtCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgtCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-40bc380501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707191
  },
  {
    "id": "ENZA_Demo_63247",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41303903",
    "title": "Elderly Men with De Novo Metastatic Castration-Sensitive Prostate Cancer: Therapy and Does Comorbidity Matter.",
    "authors": [
      "Ozberk U",
      "Esen SA",
      "Uguz A",
      "Algın E",
      "Bal O",
      "Akıncı B",
      "Uncu D"
    ],
    "journal": "Medicina (Kaunas)",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "81d09d62-964e-4f5a-8934-d75a7b62f771",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.291Z"
      },
      {
        "id": "a1ba463d-95e5-4228-b4f2-f895af57085a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d6862725-1272-4854-854c-79c8ac9b0bd1 to ENZA_Demo_63247",
        "type": "system",
        "createdAt": "2025-12-14T10:13:12.093Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:05.506Z",
    "updatedAt": "2025-12-14T08:54:32.300Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41303903",
      "DOI": "https://doi.org10.3390/medicina61112068",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:24:27",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Ozberk U, Esen SA, Uguz A, Algın E, Bal O, Akıncı B, Uncu D. Elderly Men with De Novo Metastatic Castration-Sensitive Prostate Cancer: Therapy and Does Comorbidity Matter. Medicina (Kaunas). 2025;61(11):",
      "pubdate": "2025-11-27",
      "Lead_author": "Ozberk U",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3390/medicina61112068",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Ozberk U, Esen SA, Uguz A, Algın E, Bal O, Akıncı B, Uncu D. Elderly Men with De Novo Metastatic Castration-Sensitive Prostate Cancer: Therapy and Does Comorbidity Matter. Medicina (Kaunas). 2025;61(11):",
    "leadAuthor": "Ozberk U",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUguCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUguCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-40de900501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707192
  },
  {
    "id": "ENZA_Demo_32200",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41303148",
    "title": "KELIM PSA as a Prognostic Biomarker in Castration-Resistant Prostate Cancer Treated with ARPI.",
    "authors": [
      "Atalah F",
      "Kuş F",
      "Acarbay A",
      "Karakök A",
      "Alkan O",
      "Nazlı İ",
      "Özilice U",
      "Beşiroğlu M",
      "Gümüş M"
    ],
    "journal": "J Clin Med",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "fb26f26a-f30a-4cb5-93ad-a6c2c156cb71",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.320Z"
      },
      {
        "id": "674d8efe-bd64-433f-8607-8898aef8e274",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 8a737df5-6cae-4779-a905-baff818b48fa to ENZA_Demo_32200",
        "type": "system",
        "createdAt": "2025-12-14T10:13:12.325Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:05.539Z",
    "updatedAt": "2025-12-14T08:54:32.332Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41303148",
      "DOI": "https://doi.org10.3390/jcm14228114",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:24:20",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Atalah F, Kuş F, Acarbay A, Karakök A, Alkan O, Nazlı İ, Özilice U, Beşiroğlu M, Gümüş M. KELIM PSA as a Prognostic Biomarker in Castration-Resistant Prostate Cancer Treated with ARPI. J Clin Med. 2025;14(22):",
      "pubdate": "2025-11-27",
      "Lead_author": "Atalah F",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3390/jcm14228114",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Atalah F, Kuş F, Acarbay A, Karakök A, Alkan O, Nazlı İ, Özilice U, Beşiroğlu M, Gümüş M. KELIM PSA as a Prognostic Biomarker in Castration-Resistant Prostate Cancer Treated with ARPI. J Clin Med. 2025;14(22):",
    "leadAuthor": "Atalah F",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgvCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgvCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4102340501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707192
  },
  {
    "id": "ENZA_Demo_27023",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41299174",
    "title": "NSD2 targeting reverses plasticity and drug resistance in prostate cancer.",
    "authors": [
      "Li JJ",
      "Vasciaveo A",
      "Karagiannis D",
      "Sun Z",
      "Gretarsson KH",
      "Chen X",
      "Ouerfelli O",
      "Socciarelli F",
      "Frankenstein Z",
      "Dong H",
      "Zou M",
      "Yuan W",
      "Yang G",
      "Aizenman GM",
      "Pannellini T",
      "Xu X",
      "Beltran H",
      "Chen Y",
      "Gardner K",
      "Robinson BD",
      "de Bono J",
      "Gozani O",
      "Abate-Shen C",
      "Rubin MA",
      "Loda M",
      "Sawyers CL",
      "Califano A",
      "Lu C",
      "Shen MM"
    ],
    "journal": "Nature",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "c6dddf33-98bf-4d29-abc0-0d407d8dad7d",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.383Z"
      },
      {
        "id": "95d069bb-a958-4238-b10e-a59553116655",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from ca467815-bf56-469e-aa19-882d209ecc16 to ENZA_Demo_27023",
        "type": "system",
        "createdAt": "2025-12-14T10:13:12.526Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:05.578Z",
    "updatedAt": "2025-12-14T08:54:32.398Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41299174",
      "DOI": "https://doi.org10.1038/s41586-025-09727-z",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:24:13",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Li JJ, Vasciaveo A, Karagiannis D, Sun Z, Gretarsson KH, Chen X, Ouerfelli O, Socciarelli F, Frankenstein Z, Dong H, Zou M, Yuan W, Yang G, Aizenman GM, Pannellini T, Xu X, Beltran H, Chen Y, Gardner K, Robinson BD, de Bono J, Gozani O, Abate-Shen C, Rubin MA, Loda M, Sawyers CL, Califano A, Lu C, Shen MM. NSD2 targeting reverses plasticity and drug resistance in prostate cancer. Nature. 2025;",
      "pubdate": "2025-11-27",
      "Lead_author": "Li JJ",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41586-025-09727-z",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Li JJ, Vasciaveo A, Karagiannis D, Sun Z, Gretarsson KH, Chen X, Ouerfelli O, Socciarelli F, Frankenstein Z, Dong H, Zou M, Yuan W, Yang G, Aizenman GM, Pannellini T, Xu X, Beltran H, Chen Y, Gardner K, Robinson BD, de Bono J, Gozani O, Abate-Shen C, Rubin MA, Loda M, Sawyers CL, Califano A, Lu C, Shen MM. NSD2 targeting reverses plasticity and drug resistance in prostate cancer. Nature. 2025;",
    "leadAuthor": "Li JJ",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgwCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgwCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4125f80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707192
  },
  {
    "id": "ENZA_Demo_80609",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41287346",
    "title": "Population Pharmacokinetics Analysis of Talazoparib and Enzalutamide Combination Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer.",
    "authors": [
      "Hadigol M",
      "Williams JH",
      "Shi H",
      "Yang DZ",
      "Hoffman J",
      "Wang DD"
    ],
    "journal": "J Clin Pharmacol",
    "publicationDate": "2025-11-25",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "598d663f-5cfa-4622-98fc-8596b4c2dc53",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.450Z"
      },
      {
        "id": "f28e9f50-06a6-481f-a0b1-90f0b22df7ee",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 348309a7-988c-4f1e-b7c0-7159d4b08c27 to ENZA_Demo_80609",
        "type": "system",
        "createdAt": "2025-12-14T10:13:12.754Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:05.613Z",
    "updatedAt": "2025-12-14T08:54:32.464Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41287346",
      "DOI": "https://doi.org10.1002/jcph.70125",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:24:34",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Hadigol M, Williams JH, Shi H, Yang DZ, Hoffman J, Wang DD. Population Pharmacokinetics Analysis of Talazoparib and Enzalutamide Combination Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer. J Clin Pharmacol. 2025;",
      "pubdate": "2025-11-25",
      "Lead_author": "Hadigol M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/jcph.70125",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Hadigol M, Williams JH, Shi H, Yang DZ, Hoffman J, Wang DD. Population Pharmacokinetics Analysis of Talazoparib and Enzalutamide Combination Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer. J Clin Pharmacol. 2025;",
    "leadAuthor": "Hadigol M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgxCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgxCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-414eb00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707192
  },
  {
    "id": "ENZA_Demo_97242",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41277135",
    "title": "Prognostic Effect of KELIM Score of Prostate-Specific Antigen in Hormone-Sensitive Prostate Cancer Patients Treated With Novel Androgen Receptor Inhibitors: Pioneering New Ways.",
    "authors": [
      "Ilhan Y",
      "Araz M",
      "Gurbuz AF",
      "Urvay S",
      "Urun M",
      "Mermit Ercek B",
      "Ozilice O",
      "Balcik OY",
      "Yildiz C",
      "Demir H",
      "Beypinar I"
    ],
    "journal": "Prostate",
    "publicationDate": "2025-11-24",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "c8c8e935-1909-408c-94a6-8f40f5225193",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.494Z"
      },
      {
        "id": "1a1c4e86-dfc1-49a3-96f2-c3cf10fbf666",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from fcc74a1b-6904-4452-bb49-98e153b4ce6f to ENZA_Demo_97242",
        "type": "system",
        "createdAt": "2025-12-14T10:13:12.987Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:05.663Z",
    "updatedAt": "2025-12-14T08:54:32.501Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41277135",
      "DOI": "https://doi.org10.1002/pros.70098",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:24:49",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Ilhan Y, Araz M, Gurbuz AF, Urvay S, Urun M, Mermit Ercek B, Ozilice O, Balcik OY, Yildiz C, Demir H, Beypinar I. Prognostic Effect of KELIM Score of Prostate-Specific Antigen in Hormone-Sensitive Prostate Cancer Patients Treated With Novel Androgen Receptor Inhibitors: Pioneering New Ways. Prostate. 2025;",
      "pubdate": "2025-11-24",
      "Lead_author": "Ilhan Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/pros.70098",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Ilhan Y, Araz M, Gurbuz AF, Urvay S, Urun M, Mermit Ercek B, Ozilice O, Balcik OY, Yildiz C, Demir H, Beypinar I. Prognostic Effect of KELIM Score of Prostate-Specific Antigen in Hormone-Sensitive Prostate Cancer Patients Treated With Novel Androgen Receptor Inhibitors: Pioneering New Ways. Prostate. 2025;",
    "leadAuthor": "Ilhan Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgyCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgyCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-416f140501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707193
  },
  {
    "id": "ENZA_Demo_89500",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41258335",
    "title": "Targeting prostate adenocarcinoma tumor microenvironment via cancer nanotheranostics: a comprehensive update on improved roadmap for disease diagnosis, therapy and management.",
    "authors": [
      "Wasai A",
      "Roy A",
      "Pandita D"
    ],
    "journal": "Clin Transl Oncol",
    "publicationDate": "2025-11-19",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "f84bfc12-d162-47a9-9b3f-b4a437bbb223",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.520Z"
      },
      {
        "id": "6bd53294-9c58-485d-99b5-7a7a4871b316",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from c898a698-5771-4943-8c07-5f18ff89b72a to ENZA_Demo_89500",
        "type": "system",
        "createdAt": "2025-12-14T10:13:13.217Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:05.702Z",
    "updatedAt": "2025-12-14T08:54:32.532Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41258335",
      "DOI": "https://doi.org10.1007/s12094-025-04121-7",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:24:42",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Wasai A, Roy A, Pandita D. Targeting prostate adenocarcinoma tumor microenvironment via cancer nanotheranostics: a comprehensive update on improved roadmap for disease diagnosis, therapy and management. Clin Transl Oncol. 2025;",
      "pubdate": "2025-11-19",
      "Lead_author": "Wasai A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s12094-025-04121-7",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Wasai A, Roy A, Pandita D. Targeting prostate adenocarcinoma tumor microenvironment via cancer nanotheranostics: a comprehensive update on improved roadmap for disease diagnosis, therapy and management. Clin Transl Oncol. 2025;",
    "leadAuthor": "Wasai A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUgzCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUgzCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4192400501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707193
  },
  {
    "id": "ENZA_Demo_49621",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41245095",
    "title": "Risk of seizure in patients with prostate cancer treated with enzalutamide in China: a noninterventional study.",
    "authors": [
      "Wang Y",
      "Cui Y",
      "Li Y",
      "Hu B",
      "Long X",
      "Xie Q",
      "Robinson NJ",
      "Zu Y",
      "Sun N",
      "Qian X",
      "Yang M",
      "He S",
      "Wei S",
      "Niu Y"
    ],
    "journal": "Ther Adv Drug Saf",
    "publicationDate": "2025-11-17",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "14754335-26f1-446d-9150-942465334886",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.581Z"
      },
      {
        "id": "7e9ecbd1-4f32-40c9-b006-aadd2d36b7e8",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 7040dbea-8794-4ffb-b490-084be4ec6f6e to ENZA_Demo_49621",
        "type": "system",
        "createdAt": "2025-12-14T10:13:13.432Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:05.738Z",
    "updatedAt": "2025-12-14T08:54:32.585Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41245095",
      "DOI": "https://doi.org10.1177/20420986251391078",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:25:18",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Wang Y, Cui Y, Li Y, Hu B, Long X, Xie Q, Robinson NJ, Zu Y, Sun N, Qian X, Yang M, He S, Wei S, Niu Y. Risk of seizure in patients with prostate cancer treated with enzalutamide in China: a noninterventional study. Ther Adv Drug Saf. 2025;1620420986251391078",
      "pubdate": "2025-11-17",
      "Lead_author": "Wang Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1177/20420986251391078",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Wang Y, Cui Y, Li Y, Hu B, Long X, Xie Q, Robinson NJ, Zu Y, Sun N, Qian X, Yang M, He S, Wei S, Niu Y. Risk of seizure in patients with prostate cancer treated with enzalutamide in China: a noninterventional study. Ther Adv Drug Saf. 2025;1620420986251391078",
    "leadAuthor": "Wang Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg0CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg0CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-41b2c00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707193
  },
  {
    "id": "ENZA_Demo_74421",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41241930",
    "title": "Long-Term Follow-Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility Trial.",
    "authors": [
      "Millan B",
      "Pramod N",
      "Blachman-Braun R",
      "Saini J",
      "Loebach L",
      "Patel M",
      "Gurram S",
      "Turkbey B",
      "Karzai F",
      "Pinto PA"
    ],
    "journal": "Prostate",
    "publicationDate": "2025-11-16",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "0fc11cdf-9cae-4c1e-9549-3726f81437b6",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.643Z"
      },
      {
        "id": "5f056152-ae69-4d89-a87c-31df2e67d25b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 75ce9206-7d0a-4c80-a372-4b061cdba762 to ENZA_Demo_74421",
        "type": "system",
        "createdAt": "2025-12-14T10:13:13.665Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:05.762Z",
    "updatedAt": "2025-12-14T08:54:32.648Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41241930",
      "DOI": "https://doi.org10.1002/pros.70093",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:25:11",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Millan B, Pramod N, Blachman-Braun R, Saini J, Loebach L, Patel M, Gurram S, Turkbey B, Karzai F, Pinto PA. Long-Term Follow-Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility Trial. Prostate. 2025;",
      "pubdate": "2025-11-16",
      "Lead_author": "Millan B",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/pros.70093",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Millan B, Pramod N, Blachman-Braun R, Saini J, Loebach L, Patel M, Gurram S, Turkbey B, Karzai F, Pinto PA. Long-Term Follow-Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility Trial. Prostate. 2025;",
    "leadAuthor": "Millan B",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg1CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg1CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-41d4700501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707193
  },
  {
    "id": "ENZA_Demo_21319",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41241169",
    "title": "Synergistic inhibitory effects of enzalutamide and its phase I metabolite on UDP-glucuronosyltransferase 1A1 (UGT1A1) and risk prediction of drug-drug interactions.",
    "authors": [
      "Zheng T",
      "Yin H",
      "Shan H",
      "Sun L",
      "Jiang L",
      "Liu Y"
    ],
    "journal": "Chem Biol Interact",
    "publicationDate": "2025-11-16",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "7b0ab9bb-de3c-46cd-a292-e95a843f6f41",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.658Z"
      },
      {
        "id": "50208edd-5637-4a44-819a-517ad1497e85",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6de8243c-dc1a-4516-9f4c-a1ad7d2319ab to ENZA_Demo_21319",
        "type": "system",
        "createdAt": "2025-12-14T10:13:13.894Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:05.793Z",
    "updatedAt": "2025-12-14T08:54:32.721Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41241169",
      "DOI": "https://doi.org10.1016/j.cbi.2025.111829",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:24:57",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Zheng T, Yin H, Shan H, Sun L, Jiang L, Liu Y. Synergistic inhibitory effects of enzalutamide and its phase I metabolite on UDP-glucuronosyltransferase 1A1 (UGT1A1) and risk prediction of drug-drug interactions. Chem Biol Interact. 2026;423111829",
      "pubdate": "2025-11-16",
      "Lead_author": "Zheng T",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.cbi.2025.111829",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Zheng T, Yin H, Shan H, Sun L, Jiang L, Liu Y. Synergistic inhibitory effects of enzalutamide and its phase I metabolite on UDP-glucuronosyltransferase 1A1 (UGT1A1) and risk prediction of drug-drug interactions. Chem Biol Interact. 2026;423111829",
    "leadAuthor": "Zheng T",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg2CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg2CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-41f6ec0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707193
  },
  {
    "id": "ENZA_Demo_69314",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41237749",
    "title": "Oral bioavailable ITRI-148 degrades androgen receptor variants and overcomes antiandrogen resistance in advanced prostate cancer.",
    "authors": [
      "Hung CL",
      "Hsu WN",
      "Wang TC",
      "Chen WR",
      "Chen YT",
      "Kuo ZK",
      "Hu TL",
      "Lin YC",
      "Yeh HH",
      "Lin HC",
      "Yu CJ",
      "Fu CW",
      "Liu HH",
      "Hsu HC",
      "Lin PH",
      "Pang ST",
      "Lai CH",
      "Wang LY"
    ],
    "journal": "Neoplasia",
    "publicationDate": "2025-11-15",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "58baaee0-6be1-4a13-9767-e1e1ea38e3e8",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.733Z"
      },
      {
        "id": "b4891534-bc9f-4fdc-9fb6-c0c9950ef20e",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 23dccb8c-947e-46ab-a4a9-9df0da2f849e to ENZA_Demo_69314",
        "type": "system",
        "createdAt": "2025-12-14T10:13:14.126Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:05.826Z",
    "updatedAt": "2025-12-14T08:54:32.739Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41237749",
      "DOI": "https://doi.org10.1016/j.neo.2025.101253",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:25:04",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Hung CL, Hsu WN, Wang TC, Chen WR, Chen YT, Kuo ZK, Hu TL, Lin YC, Yeh HH, Lin HC, Yu CJ, Fu CW, Liu HH, Hsu HC, Lin PH, Pang ST, Lai CH, Wang LY. Oral bioavailable ITRI-148 degrades androgen receptor variants and overcomes antiandrogen resistance in advanced prostate cancer. Neoplasia. 2025;71101253",
      "pubdate": "2025-11-15",
      "Lead_author": "Hung CL",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.neo.2025.101253",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Hung CL, Hsu WN, Wang TC, Chen WR, Chen YT, Kuo ZK, Hu TL, Lin YC, Yeh HH, Lin HC, Yu CJ, Fu CW, Liu HH, Hsu HC, Lin PH, Pang ST, Lai CH, Wang LY. Oral bioavailable ITRI-148 degrades androgen receptor variants and overcomes antiandrogen resistance in advanced prostate cancer. Neoplasia. 2025;71101253",
    "leadAuthor": "Hung CL",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg3CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg3CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-421a940501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707194
  },
  {
    "id": "ENZA_Demo_72514",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41109640",
    "title": "A multidisciplinary approach to managing non-metastatic castration resistant prostate cancer: Insights from a national practice survey.",
    "authors": [
      "Sargos P",
      "Merlin C",
      "Rozet F",
      "Chebbah M",
      "Le Clanche S",
      "Supiot S",
      "Pignot G",
      "Neuzillet Y"
    ],
    "journal": "Fr J Urol",
    "publicationDate": "2025-10-19",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9d7c5a0d-215f-467f-89ce-0a379edc3706",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.779Z"
      },
      {
        "id": "c2ba7b26-7850-446e-bec7-1528ef91ae68",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6cc17e78-ac5c-48a2-a156-85c0af6c8ac8 to ENZA_Demo_72514",
        "type": "system",
        "createdAt": "2025-12-14T10:13:14.360Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:06.024Z",
    "updatedAt": "2025-12-14T08:54:32.785Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41109640",
      "DOI": "https://doi.org10.1016/j.fjurol.2025.103009",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:25:26",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Sargos P, Merlin C, Rozet F, Chebbah M, Le Clanche S, Supiot S, Pignot G, Neuzillet Y. A multidisciplinary approach to managing non-metastatic castration resistant prostate cancer: Insights from a national practice survey. Fr J Urol. 2025;35(12):103009",
      "pubdate": "2025-10-19",
      "Lead_author": "Sargos P",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.fjurol.2025.103009",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Sargos P, Merlin C, Rozet F, Chebbah M, Le Clanche S, Supiot S, Pignot G, Neuzillet Y. A multidisciplinary approach to managing non-metastatic castration resistant prostate cancer: Insights from a national practice survey. Fr J Urol. 2025;35(12):103009",
    "leadAuthor": "Sargos P",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg4CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg4CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-423e0c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707194
  },
  {
    "id": "ENZA_Demo_45181",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40954422",
    "title": "The Role of Oncology Nurses and Advanced Practice Providers in the Treatment of Patients With HRR-Deficient mCRPC Receiving Talazoparib Plus Enzalutamide: A Podcast.",
    "authors": [
      "Lloyd JLE",
      "Batten J"
    ],
    "journal": "Oncol Ther",
    "publicationDate": "2025-09-16",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a5ef9a34-e426-47a6-94ba-6fcc35672352",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.840Z"
      },
      {
        "id": "87f81dbc-4603-4295-b1df-1f373e00af77",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from b81785fb-bb73-4033-8626-7ab0a808a3c6 to ENZA_Demo_45181",
        "type": "system",
        "createdAt": "2025-12-14T10:13:14.577Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:06.125Z",
    "updatedAt": "2025-12-14T08:54:32.848Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40954422",
      "DOI": "https://doi.org10.1007/s40487-025-00376-w",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:25:35",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Lloyd JLE, Batten J. The Role of Oncology Nurses and Advanced Practice Providers in the Treatment of Patients With HRR-Deficient mCRPC Receiving Talazoparib Plus Enzalutamide: A Podcast. Oncol Ther. 2025;13(4):861-70",
      "pubdate": "2025-09-16",
      "Lead_author": "Lloyd JLE",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s40487-025-00376-w",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Lloyd JLE, Batten J. The Role of Oncology Nurses and Advanced Practice Providers in the Treatment of Patients With HRR-Deficient mCRPC Receiving Talazoparib Plus Enzalutamide: A Podcast. Oncol Ther. 2025;13(4):861-70",
    "leadAuthor": "Lloyd JLE",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg5CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg5CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4261a40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707194
  },
  {
    "id": "ENZA_Demo_63445",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40906535",
    "title": "Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibition.",
    "authors": [
      "Wilkinson S",
      "Ku AT",
      "Lis RT",
      "King IM",
      "Low D",
      "Trostel SY",
      "Bright JR",
      "Terrigino NT",
      "Baj A",
      "Summerbell ER",
      "Heyward KE",
      "Kartal S",
      "Fenimore JM",
      "Li C",
      "Singler C",
      "Vo B",
      "Jansen CS",
      "Ye H",
      "Whitlock NC",
      "Harmon SA",
      "Carrabba NV",
      "Atway R",
      "Lake R",
      "Takeda DY",
      "Kissick HT",
      "Pinto PA",
      "Choyke PL",
      "Turkbey B",
      "Dahut WL",
      "Karzai F",
      "Sowalsky AG"
    ],
    "journal": "J Clin Invest",
    "publicationDate": "2025-09-4",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "362eb3a7-8aaa-4cd2-8d69-fb90c9fe19d3",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.870Z"
      },
      {
        "id": "1c861d46-ce2b-4770-aac6-3c8eb29cbd0b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from ca978b45-5418-4724-8aab-e76bbffe11b9 to ENZA_Demo_63445",
        "type": "system",
        "createdAt": "2025-12-14T10:13:14.793Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:06.271Z",
    "updatedAt": "2025-12-14T08:54:32.915Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40906535",
      "DOI": "https://doi.org10.1172/JCI189900",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:25:56",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Wilkinson S, Ku AT, Lis RT, King IM, Low D, Trostel SY, Bright JR, Terrigino NT, Baj A, Summerbell ER, Heyward KE, Kartal S, Fenimore JM, Li C, Singler C, Vo B, Jansen CS, Ye H, Whitlock NC, Harmon SA, Carrabba NV, Atway R, Lake R, Takeda DY, Kissick HT, Pinto PA, Choyke PL, Turkbey B, Dahut WL, Karzai F, Sowalsky AG. Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibition. J Clin Invest. 2025;135(22):",
      "pubdate": "2025-09-4",
      "Lead_author": "Wilkinson S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1172/JCI189900",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Wilkinson S, Ku AT, Lis RT, King IM, Low D, Trostel SY, Bright JR, Terrigino NT, Baj A, Summerbell ER, Heyward KE, Kartal S, Fenimore JM, Li C, Singler C, Vo B, Jansen CS, Ye H, Whitlock NC, Harmon SA, Carrabba NV, Atway R, Lake R, Takeda DY, Kissick HT, Pinto PA, Choyke PL, Turkbey B, Dahut WL, Karzai F, Sowalsky AG. Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibition. J Clin Invest. 2025;135(22):",
    "leadAuthor": "Wilkinson S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg6CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg6CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4282fc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707194
  },
  {
    "id": "ENZA_Demo_48990",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40899980",
    "title": "LHX2 Rewires the Metabolic and Epigenetic Landscape to Drive Tumor Progression in Prostate Cancer.",
    "authors": [
      "Jiang J",
      "Liu S",
      "Xu C",
      "He L",
      "Li H",
      "Zhou Y",
      "Li Z",
      "Li Y",
      "Yang F",
      "Wei Y",
      "Lu T",
      "Zhang K",
      "Zhang J",
      "Wang P",
      "Guo L",
      "Shi C",
      "Wen W",
      "Zhang R",
      "Han D",
      "Qin W"
    ],
    "journal": "Cancer Res",
    "publicationDate": "2025-09-3",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "91ab7170-8bfd-4a3e-96de-2aee1542bdac",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.934Z"
      },
      {
        "id": "f2b07b8a-9526-4fda-870a-f82b81344754",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from c98d8fb6-1029-47f9-a461-c4f7df6d1f21 to ENZA_Demo_48990",
        "type": "system",
        "createdAt": "2025-12-14T10:13:15.043Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:06.368Z",
    "updatedAt": "2025-12-14T08:54:32.942Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40899980",
      "DOI": "https://doi.org10.1158/0008-5472.CAN-25-0587",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:25:41",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Jiang J, Liu S, Xu C, He L, Li H, Zhou Y, Li Z, Li Y, Yang F, Wei Y, Lu T, Zhang K, Zhang J, Wang P, Guo L, Shi C, Wen W, Zhang R, Han D, Qin W. LHX2 Rewires the Metabolic and Epigenetic Landscape to Drive Tumor Progression in Prostate Cancer. Cancer Res. 2025;85(23):4751-68",
      "pubdate": "2025-09-3",
      "Lead_author": "Jiang J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1158/0008-5472.CAN-25-0587",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Jiang J, Liu S, Xu C, He L, Li H, Zhou Y, Li Z, Li Y, Yang F, Wei Y, Lu T, Zhang K, Zhang J, Wang P, Guo L, Shi C, Wen W, Zhang R, Han D, Qin W. LHX2 Rewires the Metabolic and Epigenetic Landscape to Drive Tumor Progression in Prostate Cancer. Cancer Res. 2025;85(23):4751-68",
    "leadAuthor": "Jiang J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg7CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg7CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-42a8880501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707195
  },
  {
    "id": "ENZA_Demo_35155",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40660892",
    "title": "Healthcare resource utilization and costs among patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or enzalutamide in the United States (2019-2023).",
    "authors": [
      "Bilen MA",
      "Lowentritt B",
      "Burbage S",
      "Kinkead F",
      "Khilfeh I",
      "Rossi C",
      "Du S",
      "Wong G",
      "Pilon D",
      "Joshi K",
      "Shore ND"
    ],
    "journal": "J Med Econ",
    "publicationDate": "2025-07-15",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "f451132e-f982-4b56-9ac0-27ee3c7defb6",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:32.982Z"
      },
      {
        "id": "281e9164-37e9-4728-a7f3-20014d642e5c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 16af190b-2723-4dc6-b114-c065b9ded620 to ENZA_Demo_35155",
        "type": "system",
        "createdAt": "2025-12-14T10:13:15.269Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:06.580Z",
    "updatedAt": "2025-12-14T08:54:32.993Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40660892",
      "DOI": "https://doi.org10.1080/13696998.2025.2530865",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:25:48",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Bilen MA, Lowentritt B, Burbage S, Kinkead F, Khilfeh I, Rossi C, Du S, Wong G, Pilon D, Joshi K, Shore ND. Healthcare resource utilization and costs among patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or enzalutamide in the United States (2019-2023). J Med Econ. 2025;28(1):1096-109",
      "pubdate": "2025-07-15",
      "Lead_author": "Bilen MA",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/13696998.2025.2530865",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Bilen MA, Lowentritt B, Burbage S, Kinkead F, Khilfeh I, Rossi C, Du S, Wong G, Pilon D, Joshi K, Shore ND. Healthcare resource utilization and costs among patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or enzalutamide in the United States (2019-2023). J Med Econ. 2025;28(1):1096-109",
    "leadAuthor": "Bilen MA",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg8CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg8CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-42cbb80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707195
  },
  {
    "id": "ENZA_Demo_68593",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39702472",
    "title": "Survival outcomes of apalutamide as a starting treatment: impact in real-world patients with metastatic hormone sensitive prostate cancer (OASIS).",
    "authors": [
      "Maughan BL",
      "Liu Y",
      "Mundle S",
      "Wang X",
      "Nematian-Samani M",
      "Karsh LI"
    ],
    "journal": "Prostate Cancer Prostatic Dis",
    "publicationDate": "2024-12-20",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "627bbc7e-6885-45b7-af6d-18ca10e004b6",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.012Z"
      },
      {
        "id": "71b4dea6-af35-4aed-aa8e-b43602122a1b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 116d10fa-f28f-49f8-b6e8-a776bde7d15e to ENZA_Demo_68593",
        "type": "system",
        "createdAt": "2025-12-14T10:13:15.514Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:56:06.671Z",
    "updatedAt": "2025-12-14T08:54:33.078Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39702472",
      "DOI": "https://doi.org10.1038/s41391-024-00929-6",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:26:03",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Maughan BL, Liu Y, Mundle S, Wang X, Nematian-Samani M, Karsh LI. Survival outcomes of apalutamide as a starting treatment: impact in real-world patients with metastatic hormone sensitive prostate cancer (OASIS). Prostate Cancer Prostatic Dis. 2025;28(4):865-73",
      "pubdate": "2024-12-20",
      "Lead_author": "Maughan BL",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41391-024-00929-6",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Maughan BL, Liu Y, Mundle S, Wang X, Nematian-Samani M, Karsh LI. Survival outcomes of apalutamide as a starting treatment: impact in real-world patients with metastatic hormone sensitive prostate cancer (OASIS). Prostate Cancer Prostatic Dis. 2025;28(4):865-73",
    "leadAuthor": "Maughan BL",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg9CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg9CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-42eea00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707195
  },
  {
    "id": "ENZA_Demo_87085",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41346252",
    "title": "Association of SULT2A1 Locus With Abiraterone Clearance in the Alliance A031201: Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer.",
    "authors": [
      "Norton N",
      "Larson NB",
      "Jenkins GD",
      "Beumer JH",
      "Langevin B",
      "Gobbaru J",
      "Morris MJ",
      "Nakamura Y",
      "Kroetz DL",
      "Zhu HJ",
      "O'Donnell PH",
      "Lewis LD",
      "Hertz DL"
    ],
    "journal": "Clin Transl Sci",
    "publicationDate": "2025-12-5",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "4fd1e16e-ae08-45f3-b1fe-9aedac38c682",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.103Z"
      },
      {
        "id": "ce660f80-2f67-49a4-95ae-43d65a266b45",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f02518d7-4da6-4857-901e-3833797a5c04 to ENZA_Demo_87085",
        "type": "system",
        "createdAt": "2025-12-14T10:13:15.730Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:57:33.531Z",
    "updatedAt": "2025-12-14T08:54:33.113Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41346252",
      "DOI": "https://doi.org10.1111/cts.70425",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:26:24",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Norton N, Larson NB, Jenkins GD, Beumer JH, Langevin B, Gobbaru J, Morris MJ, Nakamura Y, Kroetz DL, Zhu HJ, O'Donnell PH, Lewis LD, Hertz DL. Association of SULT2A1 Locus With Abiraterone Clearance in the Alliance A031201: Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer. Clin Transl Sci. 2025;18(12):e70425",
      "pubdate": "2025-12-5",
      "Lead_author": "Norton N",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/cts.70425",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Norton N, Larson NB, Jenkins GD, Beumer JH, Langevin B, Gobbaru J, Morris MJ, Nakamura Y, Kroetz DL, Zhu HJ, O'Donnell PH, Lewis LD, Hertz DL. Association of SULT2A1 Locus With Abiraterone Clearance in the Alliance A031201: Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer. Clin Transl Sci. 2025;18(12):e70425",
    "leadAuthor": "Norton N",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg+CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg+CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-430f980501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707195
  },
  {
    "id": "ENZA_Demo_72372",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41337882",
    "title": "Androgen receptor blockade and its effect on PSMA-localization in prostate cancer: Implications for radioligand therapy.",
    "authors": [
      "Devaux F",
      "Beltagi K",
      "Ermler TF",
      "Gerlach S",
      "Herrmann A",
      "Kranz J",
      "Alexa R",
      "Morgenroth A",
      "Vogg ATJ",
      "Schäfer L",
      "Mammadbayli N",
      "Saar M",
      "Hoffmann M"
    ],
    "journal": "Biomed Pharmacother",
    "publicationDate": "2025-12-4",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "c1061877-12d6-4b9e-8ab3-9d85e12c4407",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.136Z"
      },
      {
        "id": "18cbc49c-92db-4808-b1d9-d2c0dca2ce45",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 203f090f-3e2f-4412-9cdc-4b4f48140e48 to ENZA_Demo_72372",
        "type": "system",
        "createdAt": "2025-12-14T10:13:15.962Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:57:33.625Z",
    "updatedAt": "2025-12-14T08:54:33.147Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41337882",
      "DOI": "https://doi.org10.1016/j.biopha.2025.118849",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:26:39",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Devaux F, Beltagi K, Ermler TF, Gerlach S, Herrmann A, Kranz J, Alexa R, Morgenroth A, Vogg ATJ, Schäfer L, Mammadbayli N, Saar M, Hoffmann M. Androgen receptor blockade and its effect on PSMA-localization in prostate cancer: Implications for radioligand therapy. Biomed Pharmacother. 2025;193118849",
      "pubdate": "2025-12-4",
      "Lead_author": "Devaux F",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.biopha.2025.118849",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Devaux F, Beltagi K, Ermler TF, Gerlach S, Herrmann A, Kranz J, Alexa R, Morgenroth A, Vogg ATJ, Schäfer L, Mammadbayli N, Saar M, Hoffmann M. Androgen receptor blockade and its effect on PSMA-localization in prostate cancer: Implications for radioligand therapy. Biomed Pharmacother. 2025;193118849",
    "leadAuthor": "Devaux F",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUg-CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUg-CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4332980501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707196
  },
  {
    "id": "ENZA_Demo_12939",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41331871",
    "title": "STARD4 suppresses tumorigenesis and attenuates enzalutamide resistance via lipid metabolic reprogramming and AR stabilization in prostate cancer.",
    "authors": [
      "Zhang Y",
      "Wang X",
      "Wang J",
      "Ma K",
      "Jia L",
      "Liu B",
      "Yuan X",
      "Li Q",
      "Wang Q",
      "Li Q",
      "Zeng K"
    ],
    "journal": "J Exp Clin Cancer Res",
    "publicationDate": "2025-12-3",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "de79c612-c488-4198-bb8b-bdb052fa605f",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.164Z"
      },
      {
        "id": "532edca0-92b9-460b-8f9e-214b12c4bcc4",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a9240c3a-5c7e-41ad-a9db-eb6c5f01c5cc to ENZA_Demo_12939",
        "type": "system",
        "createdAt": "2025-12-14T10:13:16.208Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:57:33.660Z",
    "updatedAt": "2025-12-14T08:54:33.217Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41331871",
      "DOI": "https://doi.org10.1186/s13046-025-03600-7",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:26:32",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Zhang Y, Wang X, Wang J, Ma K, Jia L, Liu B, Yuan X, Li Q, Wang Q, Li Q, Zeng K. STARD4 suppresses tumorigenesis and attenuates enzalutamide resistance via lipid metabolic reprogramming and AR stabilization in prostate cancer. J Exp Clin Cancer Res. 2025;",
      "pubdate": "2025-12-3",
      "Lead_author": "Zhang Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s13046-025-03600-7",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Zhang Y, Wang X, Wang J, Ma K, Jia L, Liu B, Yuan X, Li Q, Wang Q, Li Q, Zeng K. STARD4 suppresses tumorigenesis and attenuates enzalutamide resistance via lipid metabolic reprogramming and AR stabilization in prostate cancer. J Exp Clin Cancer Res. 2025;",
    "leadAuthor": "Zhang Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhACAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhACAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4352d40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707196
  },
  {
    "id": "ENZA_Demo_63286",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41309998",
    "title": "Comparison of mCRPC [Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide medication in a real-world setting.",
    "authors": [
      "Rosar F",
      "Khreish F",
      "Burgard C",
      "Fursov A",
      "Blickle A",
      "Bartholomä M",
      "Maus S",
      "Bastian MB",
      "Speicher T",
      "Schaefer-Schuler A",
      "Ezziddin S"
    ],
    "journal": "Eur J Nucl Med Mol Imaging",
    "publicationDate": "2025-11-28",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "82d5fc6b-ac2c-4f06-84c3-069920ffde92",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.242Z"
      },
      {
        "id": "8eb86020-d009-4de1-8cf8-20023b113e88",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from dbb175db-ef89-4f30-ac21-56f7a85a2e8c to ENZA_Demo_63286",
        "type": "system",
        "createdAt": "2025-12-14T10:13:16.424Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:57:33.699Z",
    "updatedAt": "2025-12-14T08:54:33.255Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41309998",
      "DOI": "https://doi.org10.1007/s00259-025-07682-5",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:26:17",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Rosar F, Khreish F, Burgard C, Fursov A, Blickle A, Bartholomä M, Maus S, Bastian MB, Speicher T, Schaefer-Schuler A, Ezziddin S. Comparison of mCRPC [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide medication in a real-world setting. Eur J Nucl Med Mol Imaging. 2025;",
      "pubdate": "2025-11-28",
      "Lead_author": "Rosar F",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s00259-025-07682-5",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Rosar F, Khreish F, Burgard C, Fursov A, Blickle A, Bartholomä M, Maus S, Bastian MB, Speicher T, Schaefer-Schuler A, Ezziddin S. Comparison of mCRPC [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide medication in a real-world setting. Eur J Nucl Med Mol Imaging. 2025;",
    "leadAuthor": "Rosar F",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhBCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhBCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4379740501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707196
  },
  {
    "id": "ENZA_Demo_94916",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41274168",
    "title": "Enzalutamide with or without leuprolide in patients with high-risk biochemically recurrent prostate cancer: EMBARK post hoc analysis by age.",
    "authors": [
      "Shore ND",
      "De Giorgi U",
      "Kalac M",
      "Tang Y",
      "Croitoru R",
      "Rosales M",
      "Huynh MJ",
      "de Jong IJ",
      "Evans CP",
      "Carcano FM",
      "Freedland SJ"
    ],
    "journal": "Eur J Cancer",
    "publicationDate": "2025-11-23",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6feec733-62e2-4303-9bcc-cc4c423fce0a",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.271Z"
      },
      {
        "id": "c67d1bcf-9ad8-4f01-80c9-b1256c4f366f",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3ca87387-fff6-4fd3-8a07-d8a9953fde39 to ENZA_Demo_94916",
        "type": "system",
        "createdAt": "2025-12-14T10:13:16.640Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:57:33.737Z",
    "updatedAt": "2025-12-14T08:54:33.307Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41274168",
      "DOI": "https://doi.org10.1016/j.ejca.2025.116110",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:26:46",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Shore ND, De Giorgi U, Kalac M, Tang Y, Croitoru R, Rosales M, Huynh MJ, de Jong IJ, Evans CP, Carcano FM, Freedland SJ. Enzalutamide with or without leuprolide in patients with high-risk biochemically recurrent prostate cancer: EMBARK post hoc analysis by age. Eur J Cancer. 2025;232116110",
      "pubdate": "2025-11-23",
      "Lead_author": "Shore ND",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ejca.2025.116110",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Shore ND, De Giorgi U, Kalac M, Tang Y, Croitoru R, Rosales M, Huynh MJ, de Jong IJ, Evans CP, Carcano FM, Freedland SJ. Enzalutamide with or without leuprolide in patients with high-risk biochemically recurrent prostate cancer: EMBARK post hoc analysis by age. Eur J Cancer. 2025;232116110",
    "leadAuthor": "Shore ND",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhCCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhCCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-439cf00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707196
  },
  {
    "id": "ENZA_Demo_92042",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41247636",
    "title": "Histone methyltransferase KMT2D targets the SPOP-G3BP1 axis to enhance AR stability and drive castration-resistant prostate cancer progression.",
    "authors": [
      "Wen H",
      "Maheremu M",
      "Zhang K",
      "Bao L",
      "Luo M",
      "Zhang Y",
      "Liao Y",
      "Zhou M",
      "Wu C",
      "Lv S",
      "Qiu X",
      "Wei Q"
    ],
    "journal": "Mol Biomed",
    "publicationDate": "2025-11-17",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6cd044d2-ab9c-4e7d-a187-4928787e467d",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.335Z"
      },
      {
        "id": "3d21b1b1-db23-4379-b4bd-2205fb015700",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from eeb5b72c-ac24-4890-b306-5a880c17946d to ENZA_Demo_92042",
        "type": "system",
        "createdAt": "2025-12-14T10:13:16.858Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:57:33.769Z",
    "updatedAt": "2025-12-14T08:54:33.348Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41247636",
      "DOI": "https://doi.org10.1186/s43556-025-00354-8",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:26:54",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Wen H, Maheremu M, Zhang K, Bao L, Luo M, Zhang Y, Liao Y, Zhou M, Wu C, Lv S, Qiu X, Wei Q. Histone methyltransferase KMT2D targets the SPOP-G3BP1 axis to enhance AR stability and drive castration-resistant prostate cancer progression. Mol Biomed. 2025;6(1):112",
      "pubdate": "2025-11-17",
      "Lead_author": "Wen H",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s43556-025-00354-8",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Wen H, Maheremu M, Zhang K, Bao L, Luo M, Zhang Y, Liao Y, Zhou M, Wu C, Lv S, Qiu X, Wei Q. Histone methyltransferase KMT2D targets the SPOP-G3BP1 axis to enhance AR stability and drive castration-resistant prostate cancer progression. Mol Biomed. 2025;6(1):112",
    "leadAuthor": "Wen H",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhDCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhDCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-43c01c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707196
  },
  {
    "id": "ENZA_Demo_57139",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41170666",
    "title": "LC-MS/MS-based investigation of pharmacokinetic interactions between CYP3A4 substrates enzalutamide and repaglinide in rats.",
    "authors": [
      "Navitha Reddy G",
      "Kumar Palepu MS",
      "Sonti R"
    ],
    "journal": "Anal Methods",
    "publicationDate": "2025-10-31",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b345bdca-16b1-4a3c-bb50-55e7112e886e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.365Z"
      },
      {
        "id": "12f359e8-1c0c-4f91-a72a-c072aab071a3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6d68db4d-7bf4-4f53-9aef-6e9ada187152 to ENZA_Demo_57139",
        "type": "system",
        "createdAt": "2025-12-14T10:13:17.087Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:57:33.817Z",
    "updatedAt": "2025-12-14T08:54:33.414Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41170666",
      "DOI": "https://doi.org10.1039/d5ay01451d",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:27:23",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Navitha Reddy G, Kumar Palepu MS, Sonti R. LC-MS/MS-based investigation of pharmacokinetic interactions between CYP3A4 substrates enzalutamide and repaglinide in rats. Anal Methods. 2025;17(47):9565-74",
      "pubdate": "2025-10-31",
      "Lead_author": "Navitha Reddy G",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1039/d5ay01451d",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Navitha Reddy G, Kumar Palepu MS, Sonti R. LC-MS/MS-based investigation of pharmacokinetic interactions between CYP3A4 substrates enzalutamide and repaglinide in rats. Anal Methods. 2025;17(47):9565-74",
    "leadAuthor": "Navitha Reddy G",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhECAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhECAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-43e1540501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707197
  },
  {
    "id": "ENZA_Demo_64563",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41109641",
    "title": "French recommendations from the AFU Cancer Committee for prostate cancer: 2025 summary of changes.",
    "authors": [
      "Ploussard G",
      "Baboudjian M",
      "Barret E",
      "Brureau L",
      "Dariane C",
      "Fiard G",
      "Fromont G",
      "Mathieu R",
      "Olivier J",
      "Neuzillet Y",
      "Rozet F",
      "Peyrottes A",
      "Renard-Penna R",
      "Sargos P",
      "Supiot S",
      "Turpin L",
      "Roubaud G",
      "Rouprêt M"
    ],
    "journal": "Fr J Urol",
    "publicationDate": "2025-10-19",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ac09404d-11e7-493c-b8d7-2558e8a68691",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.430Z"
      },
      {
        "id": "d5d912e6-9fbb-4fb0-8a21-2b384c471eff",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from cc4df1d0-c00c-4cc3-95d5-93215f8efc6c to ENZA_Demo_64563",
        "type": "system",
        "createdAt": "2025-12-14T10:13:17.324Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:57:33.864Z",
    "updatedAt": "2025-12-14T08:54:33.438Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41109641",
      "DOI": "https://doi.org10.1016/j.fjurol.2025.103010",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:27:16",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Ploussard G, Baboudjian M, Barret E, Brureau L, Dariane C, Fiard G, Fromont G, Mathieu R, Olivier J, Neuzillet Y, Rozet F, Peyrottes A, Renard-Penna R, Sargos P, Supiot S, Turpin L, Roubaud G, Rouprêt M. French recommendations from the AFU Cancer Committee for prostate cancer: 2025 summary of changes. Fr J Urol. 2025;35(12):103010",
      "pubdate": "2025-10-19",
      "Lead_author": "Ploussard G",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.fjurol.2025.103010",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Ploussard G, Baboudjian M, Barret E, Brureau L, Dariane C, Fiard G, Fromont G, Mathieu R, Olivier J, Neuzillet Y, Rozet F, Peyrottes A, Renard-Penna R, Sargos P, Supiot S, Turpin L, Roubaud G, Rouprêt M. French recommendations from the AFU Cancer Committee for prostate cancer: 2025 summary of changes. Fr J Urol. 2025;35(12):103010",
    "leadAuthor": "Ploussard G",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhFCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhFCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4402b00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707197
  },
  {
    "id": "ENZA_Demo_83733",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41044801",
    "title": "Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study.",
    "authors": [
      "Suzuki K",
      "Khan N",
      "Taguchi T",
      "Hattori K",
      "Chen G",
      "Ghadessi M",
      "Constantinovici N",
      "Quintero V",
      "Suzuki H"
    ],
    "journal": "Int J Urol",
    "publicationDate": "2025-10-4",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "28bf3bdb-f26a-4495-a4fa-2ecdf60eefe9",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.485Z"
      },
      {
        "id": "386ac36b-0435-4a54-83f8-09074eaa408a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 261bfe81-857e-4a86-8b12-ca3e03db3992 to ENZA_Demo_83733",
        "type": "system",
        "createdAt": "2025-12-14T10:13:17.554Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:57:33.887Z",
    "updatedAt": "2025-12-14T08:54:33.519Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41044801",
      "DOI": "https://doi.org10.1111/iju.70235",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:27:09",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Suzuki K, Khan N, Taguchi T, Hattori K, Chen G, Ghadessi M, Constantinovici N, Quintero V, Suzuki H. Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study. Int J Urol. 2025;32(12):1853-61",
      "pubdate": "2025-10-4",
      "Lead_author": "Suzuki K",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/iju.70235",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Suzuki K, Khan N, Taguchi T, Hattori K, Chen G, Ghadessi M, Constantinovici N, Quintero V, Suzuki H. Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study. Int J Urol. 2025;32(12):1853-61",
    "leadAuthor": "Suzuki K",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhGCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhGCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4423880501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707197
  },
  {
    "id": "ENZA_Demo_59957",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40340699",
    "title": "Assessing the potential for in vivo modulation of  expression with small peptides to restore and enhance androgen receptor pathway inhibition in prostate cancer.",
    "authors": [
      "Currie C",
      "Bjerknes C",
      "Nicol M",
      "Kumar S",
      "Framroze B"
    ],
    "journal": "Cancer Biol Ther",
    "publicationDate": "2025-05-9",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "0a30c22b-f48e-46fa-bfd7-fc21dd329aab",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.548Z"
      },
      {
        "id": "5bae4470-bc9d-4d08-ba04-49da90b62313",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f13cd3b1-fafe-4ca9-87f6-9e98b6982f7b to ENZA_Demo_59957",
        "type": "system",
        "createdAt": "2025-12-14T10:13:17.818Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:57:33.920Z",
    "updatedAt": "2025-12-14T08:54:33.558Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40340699",
      "DOI": "https://doi.org10.1080/15384047.2025.2503417",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:27:03",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Currie C, Bjerknes C, Nicol M, Kumar S, Framroze B. Assessing the potential for in vivo modulation of <i>FTH1 gene</i> expression with small peptides to restore and enhance androgen receptor pathway inhibition in prostate cancer. Cancer Biol Ther. 2025;26(1):2503417",
      "pubdate": "2025-05-9",
      "Lead_author": "Currie C",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/15384047.2025.2503417",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Currie C, Bjerknes C, Nicol M, Kumar S, Framroze B. Assessing the potential for in vivo modulation of <i>FTH1 gene</i> expression with small peptides to restore and enhance androgen receptor pathway inhibition in prostate cancer. Cancer Biol Ther. 2025;26(1):2503417",
    "leadAuthor": "Currie C",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhHCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhHCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4448780501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707197
  },
  {
    "id": "ENZA_Demo_37916",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40280884",
    "title": "LGR5 interacts with HSP90AB1 to mediate enzalutamide resistance by activating the WNT/β-catenin/AR axis in prostate cancer.",
    "authors": [
      "Gao Z",
      "Xiong Z",
      "Tao Y",
      "Wang Q",
      "Guo K",
      "Xu K",
      "Huang H"
    ],
    "journal": "Chin Med J (Engl)",
    "publicationDate": "2025-04-26",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "e0a7c79c-397e-40cc-897c-63a3dc4a3820",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.579Z"
      },
      {
        "id": "a11ad95a-610c-40d5-8d6c-83d2cb19db80",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3408d82e-edea-45a8-bb61-728199f31c21 to ENZA_Demo_37916",
        "type": "system",
        "createdAt": "2025-12-14T10:13:18.014Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:57:33.954Z",
    "updatedAt": "2025-12-14T08:54:33.630Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40280884",
      "DOI": "https://doi.org10.1097/CM9.0000000000003538",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:27:31",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Gao Z, Xiong Z, Tao Y, Wang Q, Guo K, Xu K, Huang H. LGR5 interacts with HSP90AB1 to mediate enzalutamide resistance by activating the WNT/β-catenin/AR axis in prostate cancer. Chin Med J (Engl). 2025;138(23):3184-94",
      "pubdate": "2025-04-26",
      "Lead_author": "Gao Z",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/CM9.0000000000003538",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Gao Z, Xiong Z, Tao Y, Wang Q, Guo K, Xu K, Huang H. LGR5 interacts with HSP90AB1 to mediate enzalutamide resistance by activating the WNT/β-catenin/AR axis in prostate cancer. Chin Med J (Engl). 2025;138(23):3184-94",
    "leadAuthor": "Gao Z",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhICAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhICAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4465a80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707198
  },
  {
    "id": "ENZA_Demo_15190",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41276277",
    "title": "Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer.",
    "authors": [
      "Op 't Hoog CJP",
      "Mehra N",
      "van Kleef A",
      "Somford DM",
      "van Oort IM",
      "Imholz ALT",
      "Hamberg P",
      "van Erp NP",
      "Boerrigter E"
    ],
    "journal": "Br J Clin Pharmacol",
    "publicationDate": "2025-11-24",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9bcea8ff-018d-4c9a-9cca-a4982060fca8",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.661Z"
      },
      {
        "id": "f700d079-41c9-4367-aa70-e6fd12bcaa07",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 45ed086a-18aa-4c81-818f-03c5ee2617b2 to ENZA_Demo_15190",
        "type": "system",
        "createdAt": "2025-12-14T10:13:18.265Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:59:19.107Z",
    "updatedAt": "2025-12-14T08:54:33.674Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41276277",
      "DOI": "https://doi.org10.1002/bcp.70369",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:28:09",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Op 't Hoog CJP, Mehra N, van Kleef A, Somford DM, van Oort IM, Imholz ALT, Hamberg P, van Erp NP, Boerrigter E. Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer. Br J Clin Pharmacol. 2025;",
      "pubdate": "2025-11-24",
      "Lead_author": "Op 't Hoog CJP",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/bcp.70369",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Op 't Hoog CJP, Mehra N, van Kleef A, Somford DM, van Oort IM, Imholz ALT, Hamberg P, van Erp NP, Boerrigter E. Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer. Br J Clin Pharmacol. 2025;",
    "leadAuthor": "Op 't Hoog CJP",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhJCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhJCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-448cbc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707198
  },
  {
    "id": "ENZA_Demo_24453",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41247101",
    "title": "Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis.",
    "authors": [
      "Di Costanzo F",
      "Mercinelli C",
      "Signori A",
      "Messina C",
      "Conteduca V",
      "Dima G",
      "Santoni M",
      "Formisano L",
      "Oing C",
      "Fornarini G",
      "Rebuzzi SE",
      "Caffo O",
      "Banna GL",
      "De Giorgi U",
      "Procopio G",
      "Montorsi F",
      "Briganti A",
      "Galli L",
      "Di Maio M",
      "Necchi A",
      "Maiorano BA",
      "Rescigno P"
    ],
    "journal": "Oncologist",
    "publicationDate": "2025-11-17",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "002af33b-1522-48b4-9094-acdc551c8556",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.706Z"
      },
      {
        "id": "3c40cf80-5873-47e0-977b-c0d7c45325dd",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from c2fd6d40-359f-403e-b145-ee0709ed65ff to ENZA_Demo_24453",
        "type": "system",
        "createdAt": "2025-12-14T10:13:18.432Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:59:19.195Z",
    "updatedAt": "2025-12-14T08:54:33.719Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41247101",
      "DOI": "https://doi.org10.1093/oncolo/oyaf386",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:28:38",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Di Costanzo F, Mercinelli C, Signori A, Messina C, Conteduca V, Dima G, Santoni M, Formisano L, Oing C, Fornarini G, Rebuzzi SE, Caffo O, Banna GL, De Giorgi U, Procopio G, Montorsi F, Briganti A, Galli L, Di Maio M, Necchi A, Maiorano BA, Rescigno P. Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis. Oncologist. 2025;",
      "pubdate": "2025-11-17",
      "Lead_author": "Di Costanzo F",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1093/oncolo/oyaf386",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Di Costanzo F, Mercinelli C, Signori A, Messina C, Conteduca V, Dima G, Santoni M, Formisano L, Oing C, Fornarini G, Rebuzzi SE, Caffo O, Banna GL, De Giorgi U, Procopio G, Montorsi F, Briganti A, Galli L, Di Maio M, Necchi A, Maiorano BA, Rescigno P. Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis. Oncologist. 2025;",
    "leadAuthor": "Di Costanzo F",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhKCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhKCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-44b0740501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707198
  },
  {
    "id": "ENZA_Demo_77016",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41233445",
    "title": "Indirect treatment comparisons of darolutamide plus docetaxel and androgen deprivation therapy in patients with metastatic hormone-sensitive prostate cancer.",
    "authors": [
      "Wang H",
      "Fawsitt CG",
      "Orishaba P",
      "Thom H",
      "Paracha N",
      "Xue R",
      "Zhang Y",
      "Xing N"
    ],
    "journal": "Sci Rep",
    "publicationDate": "2025-11-14",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5cd3d4fd-20ae-4419-906d-bed9dba587be",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.753Z"
      },
      {
        "id": "6c69d390-c594-49f8-a758-302400119d63",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a7435df7-b1cd-4881-8567-4bf32a3a21a9 to ENZA_Demo_77016",
        "type": "system",
        "createdAt": "2025-12-14T10:13:18.661Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:59:19.235Z",
    "updatedAt": "2025-12-14T08:54:33.764Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41233445",
      "DOI": "https://doi.org10.1038/s41598-025-23491-0",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:29:09",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Wang H, Fawsitt CG, Orishaba P, Thom H, Paracha N, Xue R, Zhang Y, Xing N. Indirect treatment comparisons of darolutamide plus docetaxel and androgen deprivation therapy in patients with metastatic hormone-sensitive prostate cancer. Sci Rep. 2025;15(1):39857",
      "pubdate": "2025-11-14",
      "Lead_author": "Wang H",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41598-025-23491-0",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Wang H, Fawsitt CG, Orishaba P, Thom H, Paracha N, Xue R, Zhang Y, Xing N. Indirect treatment comparisons of darolutamide plus docetaxel and androgen deprivation therapy in patients with metastatic hormone-sensitive prostate cancer. Sci Rep. 2025;15(1):39857",
    "leadAuthor": "Wang H",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhLCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhLCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-44d4080501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707198
  },
  {
    "id": "ENZA_Demo_88862",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41216931",
    "title": "Androgen Receptors Promote Oxidative Phosphorylation and Resistance to Palmitate Lipotoxicity in ER-Mutant Breast Cancer.",
    "authors": [
      "Sessions DT",
      "Boulton DP",
      "Spoelstra NS",
      "Caino MC",
      "Yu M",
      "Goodspeed A",
      "Richer JK"
    ],
    "journal": "Endocrinology",
    "publicationDate": "2025-11-11",
    "abstract": "Article requires manual review",
    "drugName": "ENZALUTAMIDE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "f0ea5237-7157-491e-8f2c-9073fbc64511",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.783Z"
      },
      {
        "id": "7ba6e3a7-fc8f-420c-a48c-a3bd508d9053",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 2d6c719f-dabd-4177-9c61-396a5a7c1e83 to ENZA_Demo_88862",
        "type": "system",
        "createdAt": "2025-12-14T10:13:18.895Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T14:59:19.285Z",
    "updatedAt": "2025-12-14T08:54:33.816Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41216931",
      "DOI": "https://doi.org10.1210/endocr/bqaf168",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "ENZALUTAMIDE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:29:17",
      "Drugname": "ENZALUTAMIDE*",
      "Vancouver_citation": "Sessions DT, Boulton DP, Spoelstra NS, Caino MC, Yu M, Goodspeed A, Richer JK. Androgen Receptors Promote Oxidative Phosphorylation and Resistance to Palmitate Lipotoxicity in ER-Mutant Breast Cancer. Endocrinology. 2025;167(1):",
      "pubdate": "2025-11-11",
      "Lead_author": "Sessions DT",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1210/endocr/bqaf168",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "ENZALUTAMIDE*",
    "vancouverCitation": "Sessions DT, Boulton DP, Spoelstra NS, Caino MC, Yu M, Goodspeed A, Richer JK. Androgen Receptors Promote Oxidative Phosphorylation and Resistance to Palmitate Lipotoxicity in ER-Mutant Breast Cancer. Endocrinology. 2025;167(1):",
    "leadAuthor": "Sessions DT",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhMCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhMCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-44f45c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707198
  },
  {
    "id": "CLOZ_Demo_26303",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41380932",
    "title": "Population pharmacokinetic analysis for simultaneous fit of clozapine and norclozapine concentrations in adult psychiatric patients.",
    "authors": [
      "Panić B",
      "Lukić V",
      "Vučićević K",
      "Miljković B",
      "Milovanović S",
      "Jovanović M"
    ],
    "journal": "Prog Neuropsychopharmacol Biol Psychiatry",
    "publicationDate": "2025-12-12",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "d2f66598-0a61-4d68-a111-954c45e993d8",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.828Z"
      },
      {
        "id": "c2c00b7a-a30b-46c1-b06a-27959aabc7c0",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d5d23f66-3eca-46a5-9280-d8b2c194ebe5 to CLOZ_Demo_26303",
        "type": "system",
        "createdAt": "2025-12-14T10:13:19.156Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:03:15.148Z",
    "updatedAt": "2025-12-14T08:54:33.879Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41380932",
      "DOI": "https://doi.org10.1016/j.pnpbp.2025.111583",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:32:51",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Panić B, Lukić V, Vučićević K, Miljković B, Milovanović S, Jovanović M. Population pharmacokinetic analysis for simultaneous fit of clozapine and norclozapine concentrations in adult psychiatric patients. Prog Neuropsychopharmacol Biol Psychiatry. 2025;111583",
      "pubdate": "2025-12-12",
      "Lead_author": "Panić B",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.pnpbp.2025.111583",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Panić B, Lukić V, Vučićević K, Miljković B, Milovanović S, Jovanović M. Population pharmacokinetic analysis for simultaneous fit of clozapine and norclozapine concentrations in adult psychiatric patients. Prog Neuropsychopharmacol Biol Psychiatry. 2025;111583",
    "leadAuthor": "Panić B",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhNCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhNCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4514e00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707199
  },
  {
    "id": "CLOZ_Demo_56739",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41376506",
    "title": "Second-generation antipsychotics - Cardiac ion channel modulation and QT interval disturbances: A review.",
    "authors": [
      "Erkan O",
      "Dai AS",
      "Ozturk N",
      "Ozdemir S"
    ],
    "journal": "Biomol Biomed",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "e9b83b64-0cf0-4547-ae37-6b1e793cb113",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.906Z"
      },
      {
        "id": "e0b8992d-308a-4588-b77a-0ed7d986d268",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 24e88e96-031a-4926-a006-701c4c3f508a to CLOZ_Demo_56739",
        "type": "system",
        "createdAt": "2025-12-14T10:13:19.373Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:03:15.223Z",
    "updatedAt": "2025-12-14T08:54:33.915Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41376506",
      "DOI": "https://doi.org10.17305/bb.2025.13405",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:32:43",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Erkan O, Dai AS, Ozturk N, Ozdemir S. Second-generation antipsychotics - Cardiac ion channel modulation and QT interval disturbances: A review. Biomol Biomed. 2025;",
      "pubdate": "2025-12-11",
      "Lead_author": "Erkan O",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.17305/bb.2025.13405",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Erkan O, Dai AS, Ozturk N, Ozdemir S. Second-generation antipsychotics - Cardiac ion channel modulation and QT interval disturbances: A review. Biomol Biomed. 2025;",
    "leadAuthor": "Erkan O",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhOCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhOCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4535440501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707199
  },
  {
    "id": "CLOZ_Demo_72378",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41373088",
    "title": "Perceptions, Use, and Barriers of Clozapine Therapeutic Drug Monitoring in the United States: A Multidisciplinary Survey Study.",
    "authors": [
      "Leung JG",
      "Gatzlaff M",
      "Leloux MR",
      "Bye KN",
      "Gannon J",
      "Chengappa KNR",
      "Schoretsanitis G",
      "Markota M",
      "Allen ND",
      "Cole KC",
      "Cotes RO"
    ],
    "journal": "Ther Drug Monit",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6ae2e698-26ec-40bd-811d-306d6cab63f4",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.936Z"
      },
      {
        "id": "c711ec05-d6fc-4a8c-ba45-047b94709446",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 4d195cb5-5dcf-45ce-b77b-e0b73d106605 to CLOZ_Demo_72378",
        "type": "system",
        "createdAt": "2025-12-14T10:13:19.611Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:03:15.272Z",
    "updatedAt": "2025-12-14T08:54:33.946Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41373088",
      "DOI": "https://doi.org10.1097/FTD.0000000000001415",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:32:58",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Leung JG, Gatzlaff M, Leloux MR, Bye KN, Gannon J, Chengappa KNR, Schoretsanitis G, Markota M, Allen ND, Cole KC, Cotes RO. Perceptions, Use, and Barriers of Clozapine Therapeutic Drug Monitoring in the United States: A Multidisciplinary Survey Study. Ther Drug Monit. 2025;",
      "pubdate": "2025-12-11",
      "Lead_author": "Leung JG",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/FTD.0000000000001415",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Leung JG, Gatzlaff M, Leloux MR, Bye KN, Gannon J, Chengappa KNR, Schoretsanitis G, Markota M, Allen ND, Cole KC, Cotes RO. Perceptions, Use, and Barriers of Clozapine Therapeutic Drug Monitoring in the United States: A Multidisciplinary Survey Study. Ther Drug Monit. 2025;",
    "leadAuthor": "Leung JG",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhPCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhPCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4559f00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707199
  },
  {
    "id": "CLOZ_Demo_35100",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41372546",
    "title": "Activation of infralimbic cortex neurons projecting to the nucleus accumbens shell suppresses discriminative stimulus-triggered relapse to cocaine seeking in rats.",
    "authors": [
      "Algallal HE",
      "Laplante I",
      "Casale D",
      "Najafipashaki S",
      "Pomerleau A",
      "Paquette T",
      "Samaha AN"
    ],
    "journal": "Psychopharmacology (Berl)",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "69a7024a-7b74-45e4-a92c-08b94c83fbbf",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:33.967Z"
      },
      {
        "id": "b473611e-317d-459b-9038-7a26c91c9171",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 66fee3a7-e509-48d9-8736-8694781bc4b3 to CLOZ_Demo_35100",
        "type": "system",
        "createdAt": "2025-12-14T10:13:19.794Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:03:15.317Z",
    "updatedAt": "2025-12-14T08:54:34.029Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41372546",
      "DOI": "https://doi.org10.1007/s00213-025-06985-7",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:33:06",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Algallal HE, Laplante I, Casale D, Najafipashaki S, Pomerleau A, Paquette T, Samaha AN. Activation of infralimbic cortex neurons projecting to the nucleus accumbens shell suppresses discriminative stimulus-triggered relapse to cocaine seeking in rats. Psychopharmacology (Berl). 2025;",
      "pubdate": "2025-12-11",
      "Lead_author": "Algallal HE",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s00213-025-06985-7",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Algallal HE, Laplante I, Casale D, Najafipashaki S, Pomerleau A, Paquette T, Samaha AN. Activation of infralimbic cortex neurons projecting to the nucleus accumbens shell suppresses discriminative stimulus-triggered relapse to cocaine seeking in rats. Psychopharmacology (Berl). 2025;",
    "leadAuthor": "Algallal HE",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhQCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhQCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-457e480501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707199
  },
  {
    "id": "CLOZ_Demo_27564",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41364787",
    "title": "The Effect of Semaglutide With Lifestyle Intervention on the Physical Health of Patients Treated With Antipsychotic Drugs in a Secure Mental Health Setting: Protocol for an Uncontrolled Pretest-Posttest Pilot Mixed Methods Study.",
    "authors": [
      "Brenisin K",
      "Kinnafick F",
      "King J",
      "Millard L",
      "Arya D",
      "Hodgson E",
      "Huggins M",
      "Simmons-Roberts A",
      "O'Dowd M",
      "Rayment N",
      "Shah P",
      "Breen KC"
    ],
    "journal": "JMIR Res Protoc",
    "publicationDate": "2025-12-9",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5f588221-b5a2-46a1-a58b-217ceb275709",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.043Z"
      },
      {
        "id": "7096138f-2585-40fb-b085-52d2a66b1831",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a78e22d2-41ac-4ea5-8881-3ebfe5039500 to CLOZ_Demo_27564",
        "type": "system",
        "createdAt": "2025-12-14T10:13:20.008Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:03:15.368Z",
    "updatedAt": "2025-12-14T08:54:34.053Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41364787",
      "DOI": "https://doi.org10.2196/76013",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:33:13",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Brenisin K, Kinnafick F, King J, Millard L, Arya D, Hodgson E, Huggins M, Simmons-Roberts A, O'Dowd M, Rayment N, Shah P, Breen KC. The Effect of Semaglutide With Lifestyle Intervention on the Physical Health of Patients Treated With Antipsychotic Drugs in a Secure Mental Health Setting: Protocol for an Uncontrolled Pretest-Posttest Pilot Mixed Methods Study. JMIR Res Protoc. 2025;14e76013",
      "pubdate": "2025-12-9",
      "Lead_author": "Brenisin K",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.2196/76013",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Brenisin K, Kinnafick F, King J, Millard L, Arya D, Hodgson E, Huggins M, Simmons-Roberts A, O'Dowd M, Rayment N, Shah P, Breen KC. The Effect of Semaglutide With Lifestyle Intervention on the Physical Health of Patients Treated With Antipsychotic Drugs in a Secure Mental Health Setting: Protocol for an Uncontrolled Pretest-Posttest Pilot Mixed Methods Study. JMIR Res Protoc. 2025;14e76013",
    "leadAuthor": "Brenisin K",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhRCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhRCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-459f500501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707200
  },
  {
    "id": "CLOZ_Demo_19595",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41371684",
    "title": "Disproportionality and time-to-onset analyses of drug-induced weight gain using the Japanese Adverse Drug Event Report database.",
    "authors": [
      "Ide N",
      "Shibata R",
      "Sako KI",
      "Maeda T"
    ],
    "journal": "Drug Discov Ther",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "fd051e1e-adef-473b-93b8-bb0ca834036c",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.074Z"
      },
      {
        "id": "5b274d59-be4c-44ea-b887-95b8e2579c96",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 1d256995-aa22-496e-a2a3-a53d3f88e7a2 to CLOZ_Demo_19595",
        "type": "system",
        "createdAt": "2025-12-14T10:13:20.241Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:03:34.494Z",
    "updatedAt": "2025-12-14T08:54:34.129Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41371684",
      "DOI": "https://doi.org10.5582/ddt.2025.01096",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:33:25",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Ide N, Shibata R, Sako KI, Maeda T. Disproportionality and time-to-onset analyses of drug-induced weight gain using the Japanese Adverse Drug Event Report database. Drug Discov Ther. 2025;",
      "pubdate": "2025-12-11",
      "Lead_author": "Ide N",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.5582/ddt.2025.01096",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Ide N, Shibata R, Sako KI, Maeda T. Disproportionality and time-to-onset analyses of drug-induced weight gain using the Japanese Adverse Drug Event Report database. Drug Discov Ther. 2025;",
    "leadAuthor": "Ide N",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhSCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhSCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-45c1a80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707200
  },
  {
    "id": "CLOZ_Demo_63122",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41369975",
    "title": "The nitric oxide synthase inhibitor 7-nitroindazole attenuates social withdrawal and memory impairments induced by Blockade of the NMDA receptor in the rat.",
    "authors": [
      "Styla AM",
      "Begas E",
      "Pitsikas N"
    ],
    "journal": "Psychopharmacology (Berl)",
    "publicationDate": "2025-12-10",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "c6027ea0-c688-4727-be54-b7e4882a9c58",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.153Z"
      },
      {
        "id": "bf7300eb-a609-446a-8da2-0dd76b8d9aca",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3ed1ead2-c5dc-4320-8495-60865b7dbf91 to CLOZ_Demo_63122",
        "type": "system",
        "createdAt": "2025-12-14T10:13:20.485Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:03:34.593Z",
    "updatedAt": "2025-12-14T08:54:34.165Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41369975",
      "DOI": "https://doi.org10.1007/s00213-025-06979-5",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:33:33",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Styla AM, Begas E, Pitsikas N. The nitric oxide synthase inhibitor 7-nitroindazole attenuates social withdrawal and memory impairments induced by Blockade of the NMDA receptor in the rat. Psychopharmacology (Berl). 2025;",
      "pubdate": "2025-12-10",
      "Lead_author": "Styla AM",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s00213-025-06979-5",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Styla AM, Begas E, Pitsikas N. The nitric oxide synthase inhibitor 7-nitroindazole attenuates social withdrawal and memory impairments induced by Blockade of the NMDA receptor in the rat. Psychopharmacology (Berl). 2025;",
    "leadAuthor": "Styla AM",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhTCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhTCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-45e2340501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707200
  },
  {
    "id": "CLOZ_Demo_76157",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41327590",
    "title": "The effect of age on the clinical presentation and treatment of women with psychosis: secondary analysis of the IMPaCT Randomised Clinical Trial.",
    "authors": [
      "Nettis MA",
      "Ismail K",
      "Murray RM",
      "Dima A",
      "Greenwood K",
      "Atakan Z",
      "Smith S",
      "Gaughran F"
    ],
    "journal": "BJPsych Open",
    "publicationDate": "2025-12-2",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "2f84c270-a7e6-4962-b426-84741c9f7728",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.183Z"
      },
      {
        "id": "65b2f6ef-b0c8-47c6-9887-68054d265c19",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 93374cdc-3412-4414-8b1f-4ed7757ce2d7 to CLOZ_Demo_76157",
        "type": "system",
        "createdAt": "2025-12-14T10:13:20.712Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:56.597Z",
    "updatedAt": "2025-12-14T08:54:34.194Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41327590",
      "DOI": "https://doi.org10.1192/bjo.2025.10860",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:35:27",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Nettis MA, Ismail K, Murray RM, Dima A, Greenwood K, Atakan Z, Smith S, Gaughran F. The effect of age on the clinical presentation and treatment of women with psychosis: secondary analysis of the IMPaCT Randomised Clinical Trial. BJPsych Open. 2025;12(1):e5",
      "pubdate": "2025-12-2",
      "Lead_author": "Nettis MA",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1192/bjo.2025.10860",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Nettis MA, Ismail K, Murray RM, Dima A, Greenwood K, Atakan Z, Smith S, Gaughran F. The effect of age on the clinical presentation and treatment of women with psychosis: secondary analysis of the IMPaCT Randomised Clinical Trial. BJPsych Open. 2025;12(1):e5",
    "leadAuthor": "Nettis MA",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhUCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhUCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4601c40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707200
  },
  {
    "id": "CLOZ_Demo_97473",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41324504",
    "title": "Immune and Long Interspersed Nuclear Element-1 Dysregulation in Schizophrenia: An Exploratory Case-Control Study in a Brazilian Cohort with Ultra-Treatment Resistance.",
    "authors": [
      "de Pinho CSN",
      "Pinto JP",
      "Martins PLB",
      "Fiorenza NG",
      "Clemente DCDS",
      "Castro HIR",
      "Viana MDS",
      "Teles CBM",
      "Rebouças MO",
      "Silva MFS",
      "de Assis DF",
      "Tavares RF",
      "Silva BRDS",
      "de Oliveira CA",
      "de Lima Júnior DN",
      "Marques JAL",
      "Albuquerque SGC",
      "Hallak JEC",
      "Gama CS",
      "de Lucena DF",
      "Campos EM",
      "Sanders LLO",
      "Macedo DS"
    ],
    "journal": "Schizophr Bull",
    "publicationDate": "2025-12-1",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b318d642-b7c2-4310-9cd8-3f77716021a7",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.213Z"
      },
      {
        "id": "c3612ada-f5b8-40dc-b181-fd0ecdb053f7",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d5f1aa7b-1791-4810-b55d-4b7b9c4d98a3 to CLOZ_Demo_97473",
        "type": "system",
        "createdAt": "2025-12-14T10:13:20.960Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:56.699Z",
    "updatedAt": "2025-12-14T08:54:34.266Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41324504",
      "DOI": "https://doi.org10.1093/schbul/sbaf209",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:35:19",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "de Pinho CSN, Pinto JP, Martins PLB, Fiorenza NG, Clemente DCDS, Castro HIR, Viana MDS, Teles CBM, Rebouças MO, Silva MFS, de Assis DF, Tavares RF, Silva BRDS, de Oliveira CA, de Lima Júnior DN, Marques JAL, Albuquerque SGC, Hallak JEC, Gama CS, de Lucena DF, Campos EM, Sanders LLO, Macedo DS. Immune and Long Interspersed Nuclear Element-1 Dysregulation in Schizophrenia: An Exploratory Case-Control Study in a Brazilian Cohort with Ultra-Treatment Resistance. Schizophr Bull. 2025;",
      "pubdate": "2025-12-1",
      "Lead_author": "de Pinho CSN",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1093/schbul/sbaf209",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "de Pinho CSN, Pinto JP, Martins PLB, Fiorenza NG, Clemente DCDS, Castro HIR, Viana MDS, Teles CBM, Rebouças MO, Silva MFS, de Assis DF, Tavares RF, Silva BRDS, de Oliveira CA, de Lima Júnior DN, Marques JAL, Albuquerque SGC, Hallak JEC, Gama CS, de Lucena DF, Campos EM, Sanders LLO, Macedo DS. Immune and Long Interspersed Nuclear Element-1 Dysregulation in Schizophrenia: An Exploratory Case-Control Study in a Brazilian Cohort with Ultra-Treatment Resistance. Schizophr Bull. 2025;",
    "leadAuthor": "de Pinho CSN",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhVCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhVCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4628080501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707200
  },
  {
    "id": "CLOZ_Demo_85951",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41319237",
    "title": "Alcohol use, daily smoking, clozapine use and psychiatric symptom profile in persons with schizophrenia spectrum disorder.",
    "authors": [
      "Levola J",
      "Lång-Tonteri S",
      "Niemelä S",
      "Suvisaari J",
      "Eskelinen S"
    ],
    "journal": "Nord J Psychiatry",
    "publicationDate": "2025-11-30",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "68ba2c13-dfb2-4a1f-9367-20c3e4bc2e53",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.293Z"
      },
      {
        "id": "b13c7903-0ac4-4651-90b8-58349117ce09",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 4545fd23-a174-4b06-b8f0-9f710e351096 to CLOZ_Demo_85951",
        "type": "system",
        "createdAt": "2025-12-14T10:13:21.127Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:56.736Z",
    "updatedAt": "2025-12-14T08:54:34.305Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41319237",
      "DOI": "https://doi.org10.1080/08039488.2025.2590578",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:35:34",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Levola J, Lång-Tonteri S, Niemelä S, Suvisaari J, Eskelinen S. Alcohol use, daily smoking, clozapine use and psychiatric symptom profile in persons with schizophrenia spectrum disorder. Nord J Psychiatry. 2025;1-8",
      "pubdate": "2025-11-30",
      "Lead_author": "Levola J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/08039488.2025.2590578",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Levola J, Lång-Tonteri S, Niemelä S, Suvisaari J, Eskelinen S. Alcohol use, daily smoking, clozapine use and psychiatric symptom profile in persons with schizophrenia spectrum disorder. Nord J Psychiatry. 2025;1-8",
    "leadAuthor": "Levola J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhWCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhWCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4651100501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707201
  },
  {
    "id": "CLOZ_Demo_70337",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41317739",
    "title": "Joint detection of risk for psychotic disorders or bipolar disorders in clinical practice in the UK: development and validation of a clinical prediction model.",
    "authors": [
      "Arribas M",
      "de Micheli A",
      "Krakowski K",
      "Stahl D",
      "Correll CU",
      "Young AH",
      "Andreassen OA",
      "Vieta E",
      "Arango C",
      "McGuire P",
      "Oliver D",
      "Fusar-Poli P"
    ],
    "journal": "Lancet Psychiatry",
    "publicationDate": "2025-11-30",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6f800730-2b4d-493d-96f3-d3df5b8d94cc",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.339Z"
      },
      {
        "id": "e3a1574f-a196-4ca4-be51-3827526ef1d7",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 7f775fcd-f811-4ebc-b1ff-2f49820808ab to CLOZ_Demo_70337",
        "type": "system",
        "createdAt": "2025-12-14T10:13:21.360Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:56.782Z",
    "updatedAt": "2025-12-14T08:54:34.352Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41317739",
      "DOI": "https://doi.org10.1016/S2215-0366(25)00307-4",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:35:41",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Arribas M, de Micheli A, Krakowski K, Stahl D, Correll CU, Young AH, Andreassen OA, Vieta E, Arango C, McGuire P, Oliver D, Fusar-Poli P. Joint detection of risk for psychotic disorders or bipolar disorders in clinical practice in the UK: development and validation of a clinical prediction model. Lancet Psychiatry. 2025;",
      "pubdate": "2025-11-30",
      "Lead_author": "Arribas M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/S2215-0366(25)00307-4",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Arribas M, de Micheli A, Krakowski K, Stahl D, Correll CU, Young AH, Andreassen OA, Vieta E, Arango C, McGuire P, Oliver D, Fusar-Poli P. Joint detection of risk for psychotic disorders or bipolar disorders in clinical practice in the UK: development and validation of a clinical prediction model. Lancet Psychiatry. 2025;",
    "leadAuthor": "Arribas M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhXCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhXCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-46718c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707201
  },
  {
    "id": "CLOZ_Demo_33668",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41315510",
    "title": "A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole use.",
    "authors": [
      "Zinzi A",
      "Gaio M",
      "Ruggiero D",
      "Riccardi C",
      "Cagnotta C",
      "Pentella C",
      "Capuano A",
      "Rafaniello C"
    ],
    "journal": "Sci Rep",
    "publicationDate": "2025-11-29",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "2fe59202-bc60-48fb-972a-3873f3a0344d",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.384Z"
      },
      {
        "id": "0088ea3a-f0e5-4ebd-aaed-a4e0d85ca96d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 42b559a8-b864-4cca-99d2-ab5035c787a6 to CLOZ_Demo_33668",
        "type": "system",
        "createdAt": "2025-12-14T10:13:21.575Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:56.821Z",
    "updatedAt": "2025-12-14T08:54:34.392Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41315510",
      "DOI": "https://doi.org10.1038/s41598-025-27009-6",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:35:49",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Zinzi A, Gaio M, Ruggiero D, Riccardi C, Cagnotta C, Pentella C, Capuano A, Rafaniello C. A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole use. Sci Rep. 2025;15(1):42796",
      "pubdate": "2025-11-29",
      "Lead_author": "Zinzi A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41598-025-27009-6",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Zinzi A, Gaio M, Ruggiero D, Riccardi C, Cagnotta C, Pentella C, Capuano A, Rafaniello C. A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole use. Sci Rep. 2025;15(1):42796",
    "leadAuthor": "Zinzi A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhYCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhYCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4694880501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707201
  },
  {
    "id": "CLOZ_Demo_78411",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41280287",
    "title": "Investigating of the Experience of Subjective Well-Being of Clozapine Use in Patients with Treatment-Resistant Schizophrenia: A Mixed Method Study.",
    "authors": [
      "Khazaie H",
      "Rezaie L"
    ],
    "journal": "Patient Prefer Adherence",
    "publicationDate": "2025-11-24",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "232e9e94-6ee5-4f25-b7a0-d58575681ae1",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.447Z"
      },
      {
        "id": "bbb9ba66-cd2d-40e4-a482-0401c626e85a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from caf599f7-faef-4bea-85dd-83195c60fa34 to CLOZ_Demo_78411",
        "type": "system",
        "createdAt": "2025-12-14T10:13:21.821Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:56.858Z",
    "updatedAt": "2025-12-14T08:54:34.457Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41280287",
      "DOI": "https://doi.org10.2147/PPA.S550512",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:35:58",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Khazaie H, Rezaie L. Investigating of the Experience of Subjective Well-Being of Clozapine Use in Patients with Treatment-Resistant Schizophrenia: A Mixed Method Study. Patient Prefer Adherence. 2025;193673-82",
      "pubdate": "2025-11-24",
      "Lead_author": "Khazaie H",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.2147/PPA.S550512",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Khazaie H, Rezaie L. Investigating of the Experience of Subjective Well-Being of Clozapine Use in Patients with Treatment-Resistant Schizophrenia: A Mixed Method Study. Patient Prefer Adherence. 2025;193673-82",
    "leadAuthor": "Khazaie H",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhZCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhZCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-46b2f80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707201
  },
  {
    "id": "CLOZ_Demo_59846",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41278082",
    "title": "Assessment of the serum glucose/potassium ratio and leucocyte glucose index as predictors of poor outcomes in acute clozapine poisoning: a risk score model construction.",
    "authors": [
      "Elsharkawy RE",
      "Lashin HI",
      "Mohammed HS"
    ],
    "journal": "Toxicol Res (Camb)",
    "publicationDate": "2025-11-24",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "27eaae00-c607-4e2c-a3a9-631d4fe7257e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.475Z"
      },
      {
        "id": "1f659497-9461-495c-83e3-89216f3dbf8a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 59e5941d-ee07-4d0c-a1bd-6698391b5d55 to CLOZ_Demo_59846",
        "type": "system",
        "createdAt": "2025-12-14T10:13:22.035Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:56.902Z",
    "updatedAt": "2025-12-14T08:54:34.483Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41278082",
      "DOI": "https://doi.org10.1093/toxres/tfaf162",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:36:05",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Elsharkawy RE, Lashin HI, Mohammed HS. Assessment of the serum glucose/potassium ratio and leucocyte glucose index as predictors of poor outcomes in acute clozapine poisoning: a risk score model construction. Toxicol Res (Camb). 2025;14(6):tfaf162",
      "pubdate": "2025-11-24",
      "Lead_author": "Elsharkawy RE",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1093/toxres/tfaf162",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Elsharkawy RE, Lashin HI, Mohammed HS. Assessment of the serum glucose/potassium ratio and leucocyte glucose index as predictors of poor outcomes in acute clozapine poisoning: a risk score model construction. Toxicol Res (Camb). 2025;14(6):tfaf162",
    "leadAuthor": "Elsharkawy RE",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhaCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhaCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-46d8b40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707202
  },
  {
    "id": "CLOZ_Demo_27516",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41271626",
    "title": "The ventral hippocampus and nucleus accumbens as neural substrates for cocaine contextual memory reconsolidation.",
    "authors": [
      "Caban Rivera C",
      "Price R",
      "Petrilli Fortuna R",
      "Li C",
      "Do C",
      "Shinkle J",
      "Ghilotti MG",
      "Shi X",
      "Kirby LG",
      "Smith GM",
      "Unterwald EM"
    ],
    "journal": "Transl Psychiatry",
    "publicationDate": "2025-11-22",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b0e6c10f-0733-4017-a6f0-a0df31ba89e8",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.554Z"
      },
      {
        "id": "e2d13d5f-dd8b-44dd-bad9-27f88aca0c59",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 94dbe2e8-a90a-4906-96e7-85495534cac2 to CLOZ_Demo_27516",
        "type": "system",
        "createdAt": "2025-12-14T10:13:22.265Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:56.950Z",
    "updatedAt": "2025-12-14T08:54:34.563Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41271626",
      "DOI": "https://doi.org10.1038/s41398-025-03734-4",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:36:12",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Caban Rivera C, Price R, Petrilli Fortuna R, Li C, Do C, Shinkle J, Ghilotti MG, Shi X, Kirby LG, Smith GM, Unterwald EM. The ventral hippocampus and nucleus accumbens as neural substrates for cocaine contextual memory reconsolidation. Transl Psychiatry. 2025;",
      "pubdate": "2025-11-22",
      "Lead_author": "Caban Rivera C",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41398-025-03734-4",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Caban Rivera C, Price R, Petrilli Fortuna R, Li C, Do C, Shinkle J, Ghilotti MG, Shi X, Kirby LG, Smith GM, Unterwald EM. The ventral hippocampus and nucleus accumbens as neural substrates for cocaine contextual memory reconsolidation. Transl Psychiatry. 2025;",
    "leadAuthor": "Caban Rivera C",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhbCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhbCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-46f6f00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707202
  },
  {
    "id": "CLOZ_Demo_72860",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41271439",
    "title": "Sex and stress govern the function and innervation of a basolateral amygdala to nucleus accumbens corticotropin releasing hormone/GABA expressing projection.",
    "authors": [
      "Taniguchi L",
      "Goodpaster CM",
      "Chen Y",
      "de Carvalho GB",
      "Birnie MT",
      "Paul A",
      "Chiang A",
      "Chen LY",
      "Baram TZ",
      "DeNardo LA"
    ],
    "journal": "J Neurosci",
    "publicationDate": "2025-11-22",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "948402d1-cbd4-4b2f-9ee3-bcdbf583c180",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.584Z"
      },
      {
        "id": "388fb029-1fcf-490b-b08e-1c7cfc67a5b5",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 506f77cd-ea11-44dd-9f2f-e3bd422b77fd to CLOZ_Demo_72860",
        "type": "system",
        "createdAt": "2025-12-14T10:13:22.499Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:56.996Z",
    "updatedAt": "2025-12-14T08:54:34.596Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41271439",
      "DOI": "https://doi.org10.1523/JNEUROSCI.1239-25.2025",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:36:19",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Taniguchi L, Goodpaster CM, Chen Y, de Carvalho GB, Birnie MT, Paul A, Chiang A, Chen LY, Baram TZ, DeNardo LA. Sex and stress govern the function and innervation of a basolateral amygdala to nucleus accumbens corticotropin releasing hormone/GABA expressing projection. J Neurosci. 2025;",
      "pubdate": "2025-11-22",
      "Lead_author": "Taniguchi L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1523/JNEUROSCI.1239-25.2025",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Taniguchi L, Goodpaster CM, Chen Y, de Carvalho GB, Birnie MT, Paul A, Chiang A, Chen LY, Baram TZ, DeNardo LA. Sex and stress govern the function and innervation of a basolateral amygdala to nucleus accumbens corticotropin releasing hormone/GABA expressing projection. J Neurosci. 2025;",
    "leadAuthor": "Taniguchi L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhcCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhcCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-471ac80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707202
  },
  {
    "id": "CLOZ_Demo_22691",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41247632",
    "title": "Use of intravenous lipid emulsions in drug-induced toxicities: a 2025 narrative review.",
    "authors": [
      "Nendumba G",
      "Blackman S",
      "De Lissnyder N",
      "Cillis M",
      "Honore PM"
    ],
    "journal": "Ann Intensive Care",
    "publicationDate": "2025-11-17",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "62ed2f3b-bdc0-4b63-af99-7ac538f75ba9",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.614Z"
      },
      {
        "id": "5698e474-03e5-4467-9002-ddb5839b1efb",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 239c05a9-59f5-4b05-a2a7-d75682ef5368 to CLOZ_Demo_22691",
        "type": "system",
        "createdAt": "2025-12-14T10:13:22.716Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:57.043Z",
    "updatedAt": "2025-12-14T08:54:34.697Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41247632",
      "DOI": "https://doi.org10.1186/s13613-025-01601-5",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:36:27",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Nendumba G, Blackman S, De Lissnyder N, Cillis M, Honore PM. Use of intravenous lipid emulsions in drug-induced toxicities: a 2025 narrative review. Ann Intensive Care. 2025;15(1):181",
      "pubdate": "2025-11-17",
      "Lead_author": "Nendumba G",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s13613-025-01601-5",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Nendumba G, Blackman S, De Lissnyder N, Cillis M, Honore PM. Use of intravenous lipid emulsions in drug-induced toxicities: a 2025 narrative review. Ann Intensive Care. 2025;15(1):181",
    "leadAuthor": "Nendumba G",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhdCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhdCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-473e140501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707202
  },
  {
    "id": "CLOZ_Demo_30810",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41241755",
    "title": "Point-of-care nano zinc oxide carbon paste sensor for non-invasive determination of clozapine in saliva samples.",
    "authors": [
      "Abd El-Aziz MO",
      "Bekhet AM",
      "Monir HH",
      "Younis SE",
      "Nebsen M",
      "Nadim AH"
    ],
    "journal": "BMC Chem",
    "publicationDate": "2025-11-16",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "eb116d6f-bb6f-4895-8a64-66a20be7eba7",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.722Z"
      },
      {
        "id": "7a42923c-1cae-44e3-83a3-ed532a655268",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from aeeab6e5-c323-4116-bf17-6a2983a867d0 to CLOZ_Demo_30810",
        "type": "system",
        "createdAt": "2025-12-14T10:13:22.932Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:57.094Z",
    "updatedAt": "2025-12-14T08:54:34.731Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41241755",
      "DOI": "https://doi.org10.1186/s13065-025-01671-3",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:36:34",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Abd El-Aziz MO, Bekhet AM, Monir HH, Younis SE, Nebsen M, Nadim AH. Point-of-care nano zinc oxide carbon paste sensor for non-invasive determination of clozapine in saliva samples. BMC Chem. 2025;19(1):308",
      "pubdate": "2025-11-16",
      "Lead_author": "Abd El-Aziz MO",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s13065-025-01671-3",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Abd El-Aziz MO, Bekhet AM, Monir HH, Younis SE, Nebsen M, Nadim AH. Point-of-care nano zinc oxide carbon paste sensor for non-invasive determination of clozapine in saliva samples. BMC Chem. 2025;19(1):308",
    "leadAuthor": "Abd El-Aziz MO",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUheCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUheCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-475f5c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707203
  },
  {
    "id": "CLOZ_Demo_18288",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41220099",
    "title": "A Japanese Pregnant Woman With Treatment-Resistant Schizophrenia Who Continued Clozapine With Blood Concentration Monitoring During the Perinatal Period and Had a Healthy Baby: A Case Report.",
    "authors": [
      "Tsukiji M",
      "Yamazaki K",
      "Nakata Y",
      "Sasaki T",
      "Idemoto K",
      "Okada K",
      "Yamazaki S",
      "Omoto A",
      "Koga K",
      "Niitsu T",
      "Ishii I"
    ],
    "journal": "Neuropsychopharmacol Rep",
    "publicationDate": "2025-11-12",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "26ae60ae-c086-4312-996f-7bbbfa355c0e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.754Z"
      },
      {
        "id": "f94a0259-119c-4592-8efb-ca46f5b3e77e",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d9c792c9-17d2-434a-9eb2-995e68f8ccc4 to CLOZ_Demo_18288",
        "type": "system",
        "createdAt": "2025-12-14T10:13:23.161Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:57.133Z",
    "updatedAt": "2025-12-14T08:54:34.763Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41220099",
      "DOI": "https://doi.org10.1002/npr2.70074",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:36:56",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Tsukiji M, Yamazaki K, Nakata Y, Sasaki T, Idemoto K, Okada K, Yamazaki S, Omoto A, Koga K, Niitsu T, Ishii I. A Japanese Pregnant Woman With Treatment-Resistant Schizophrenia Who Continued Clozapine With Blood Concentration Monitoring During the Perinatal Period and Had a Healthy Baby: A Case Report. Neuropsychopharmacol Rep. 2025;45(4):e70074",
      "pubdate": "2025-11-12",
      "Lead_author": "Tsukiji M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/npr2.70074",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Tsukiji M, Yamazaki K, Nakata Y, Sasaki T, Idemoto K, Okada K, Yamazaki S, Omoto A, Koga K, Niitsu T, Ishii I. A Japanese Pregnant Woman With Treatment-Resistant Schizophrenia Who Continued Clozapine With Blood Concentration Monitoring During the Perinatal Period and Had a Healthy Baby: A Case Report. Neuropsychopharmacol Rep. 2025;45(4):e70074",
    "leadAuthor": "Tsukiji M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhfCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhfCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4784c80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707203
  },
  {
    "id": "CLOZ_Demo_51698",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41192461",
    "title": "Clozapine: superior yet underused.",
    "authors": [
      "Bschor T"
    ],
    "journal": "Lancet Psychiatry",
    "publicationDate": "2025-11-6",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "2757f224-e351-4cd8-9c7a-e167bf005fed",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.786Z"
      },
      {
        "id": "543d4c73-0172-41d4-8ea2-1398d6b3b2ce",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 824cf621-b4ab-47cb-8f24-c6d10eb487d3 to CLOZ_Demo_51698",
        "type": "system",
        "createdAt": "2025-12-14T10:13:23.393Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:57.291Z",
    "updatedAt": "2025-12-14T08:54:34.818Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41192461",
      "DOI": "https://doi.org10.1016/S2215-0366(25)00326-8",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:36:49",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Bschor T. Clozapine: superior yet underused. Lancet Psychiatry. 2025;12(12):873-4",
      "pubdate": "2025-11-6",
      "Lead_author": "Bschor T",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/S2215-0366(25)00326-8",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Bschor T. Clozapine: superior yet underused. Lancet Psychiatry. 2025;12(12):873-4",
    "leadAuthor": "Bschor T",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhgCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhgCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-47a1200501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707203
  },
  {
    "id": "CLOZ_Demo_58950",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41192460",
    "title": "Transdiagnostic effectiveness and safety of clozapine in individuals with psychotic, affective, and personality disorders: nationwide and meta-analytic comparisons with other antipsychotics.",
    "authors": [
      "Luykx JJ",
      "Colgan M",
      "Vieta E",
      "Hamina A",
      "Schulte PFJ",
      "Correll CU",
      "Mittendorfer-Rutz E",
      "Siskind D",
      "Lieslehto J",
      "Tanskanen A",
      "Tiihonen J",
      "Taipale H"
    ],
    "journal": "Lancet Psychiatry",
    "publicationDate": "2025-11-6",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5f5dfb65-35af-45a6-9529-920f9ff94f4e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.830Z"
      },
      {
        "id": "66e35f8a-086f-461c-98b4-01d7413f7385",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from c52008a7-72d6-48c4-86ae-4c7b964ce9d2 to CLOZ_Demo_58950",
        "type": "system",
        "createdAt": "2025-12-14T10:13:23.659Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:57.369Z",
    "updatedAt": "2025-12-14T08:54:34.864Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41192460",
      "DOI": "https://doi.org10.1016/S2215-0366(25)00297-4",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:36:42",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Luykx JJ, Colgan M, Vieta E, Hamina A, Schulte PFJ, Correll CU, Mittendorfer-Rutz E, Siskind D, Lieslehto J, Tanskanen A, Tiihonen J, Taipale H. Transdiagnostic effectiveness and safety of clozapine in individuals with psychotic, affective, and personality disorders: nationwide and meta-analytic comparisons with other antipsychotics. Lancet Psychiatry. 2025;12(12):921-31",
      "pubdate": "2025-11-6",
      "Lead_author": "Luykx JJ",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/S2215-0366(25)00297-4",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Luykx JJ, Colgan M, Vieta E, Hamina A, Schulte PFJ, Correll CU, Mittendorfer-Rutz E, Siskind D, Lieslehto J, Tanskanen A, Tiihonen J, Taipale H. Transdiagnostic effectiveness and safety of clozapine in individuals with psychotic, affective, and personality disorders: nationwide and meta-analytic comparisons with other antipsychotics. Lancet Psychiatry. 2025;12(12):921-31",
    "leadAuthor": "Luykx JJ",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhhCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhhCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-47c3f40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707203
  },
  {
    "id": "CLOZ_Demo_64396",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41135088",
    "title": "Clozapine and pharmacogenomics testing: opportunities and challenges for personalized treatment in schizophrenia.",
    "authors": [
      "Khoodoruth M",
      "Khoodoruth M"
    ],
    "journal": "Can J Physiol Pharmacol",
    "publicationDate": "2025-10-24",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "4f4a21da-db70-47ca-8ac5-10032ba01173",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.876Z"
      },
      {
        "id": "319f6999-ed35-4c99-a43b-293919da7271",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 4cf0ad67-65df-4aff-a8b9-413a5becefe8 to CLOZ_Demo_64396",
        "type": "system",
        "createdAt": "2025-12-14T10:13:23.846Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:57.555Z",
    "updatedAt": "2025-12-14T08:54:34.928Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41135088",
      "DOI": "https://doi.org10.1139/cjpp-2025-0174",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:37:03",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Khoodoruth M, Khoodoruth M. Clozapine and pharmacogenomics testing: opportunities and challenges for personalized treatment in schizophrenia. Can J Physiol Pharmacol. 2025;",
      "pubdate": "2025-10-24",
      "Lead_author": "Khoodoruth M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1139/cjpp-2025-0174",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Khoodoruth M, Khoodoruth M. Clozapine and pharmacogenomics testing: opportunities and challenges for personalized treatment in schizophrenia. Can J Physiol Pharmacol. 2025;",
    "leadAuthor": "Khoodoruth M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhiCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhiCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-47e8940501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707203
  },
  {
    "id": "CLOZ_Demo_77510",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41017289",
    "title": "Association of Atypical Antipsychotics With Lipid Abnormalities in Adult Patients With Schizophrenia: A Scoping Review.",
    "authors": [
      "Abavana V",
      "Sadiq S"
    ],
    "journal": "Neuropsychopharmacol Rep",
    "publicationDate": "2025-09-29",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "bd73922b-7a64-4eca-b215-469f50fa72f7",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.955Z"
      },
      {
        "id": "8d4dbee7-9b2e-4317-a499-0be42c32839b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 73995a7d-7135-446e-9c07-61ab29b97650 to CLOZ_Demo_77510",
        "type": "system",
        "createdAt": "2025-12-14T10:13:24.062Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:57.634Z",
    "updatedAt": "2025-12-14T08:54:34.966Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41017289",
      "DOI": "https://doi.org10.1002/npr2.70042",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:37:17",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Abavana V, Sadiq S. Association of Atypical Antipsychotics With Lipid Abnormalities in Adult Patients With Schizophrenia: A Scoping Review. Neuropsychopharmacol Rep. 2025;45(4):e70042",
      "pubdate": "2025-09-29",
      "Lead_author": "Abavana V",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/npr2.70042",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Abavana V, Sadiq S. Association of Atypical Antipsychotics With Lipid Abnormalities in Adult Patients With Schizophrenia: A Scoping Review. Neuropsychopharmacol Rep. 2025;45(4):e70042",
    "leadAuthor": "Abavana V",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhjCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhjCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4809280501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707204
  },
  {
    "id": "CLOZ_Demo_63370",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40892561",
    "title": "Chemogenetic modulation of PAC1-expressing neurons in the bed nucleus of the stria terminalis (BNST) alters anxiety-related behaviors in male mice.",
    "authors": [
      "Aktar M",
      "Cardarelli A",
      "May V",
      "Hammack SE"
    ],
    "journal": "Behav Neurosci",
    "publicationDate": "2025-09-2",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "3111e5fe-adba-4316-bec0-af17513a7796",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:34.984Z"
      },
      {
        "id": "60781318-38aa-4087-be75-d0c76921177d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 51e19497-a4e3-4798-a706-7f32f5c0e128 to CLOZ_Demo_63370",
        "type": "system",
        "createdAt": "2025-12-14T10:13:24.294Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:57.789Z",
    "updatedAt": "2025-12-14T08:54:35.019Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40892561",
      "DOI": "https://doi.org10.1037/bne0000632",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:37:10",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Aktar M, Cardarelli A, May V, Hammack SE. Chemogenetic modulation of PAC1-expressing neurons in the bed nucleus of the stria terminalis (BNST) alters anxiety-related behaviors in male mice. Behav Neurosci. 2025;139(6):277-83",
      "pubdate": "2025-09-2",
      "Lead_author": "Aktar M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1037/bne0000632",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Aktar M, Cardarelli A, May V, Hammack SE. Chemogenetic modulation of PAC1-expressing neurons in the bed nucleus of the stria terminalis (BNST) alters anxiety-related behaviors in male mice. Behav Neurosci. 2025;139(6):277-83",
    "leadAuthor": "Aktar M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhkCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhkCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4827c40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707204
  },
  {
    "id": "CLOZ_Demo_30026",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40830714",
    "title": "Patterns of Serum Prolactin Elevation Associated with Nine Second-Generation Antipsychotics in a Large Cohort of Patients with Schizophrenia.",
    "authors": [
      "Zhang L",
      "Zheng Y",
      "Huang J",
      "Yu W",
      "Zhou L",
      "He L",
      "Li Y",
      "Hu H",
      "Li G",
      "Shen Y",
      "Zhang J",
      "Li H"
    ],
    "journal": "CNS Drugs",
    "publicationDate": "2025-08-20",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "0398a27f-f90c-4a71-8ab7-db8b454ffba7",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.047Z"
      },
      {
        "id": "d530430e-6297-4822-9d2b-75ee2e9903d7",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 29830c21-295f-47ed-9f86-bc06317c33fd to CLOZ_Demo_30026",
        "type": "system",
        "createdAt": "2025-12-14T10:13:24.524Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:57.893Z",
    "updatedAt": "2025-12-14T08:54:35.060Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40830714",
      "DOI": "https://doi.org10.1007/s40263-025-01216-1",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:37:40",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Zhang L, Zheng Y, Huang J, Yu W, Zhou L, He L, Li Y, Hu H, Li G, Shen Y, Zhang J, Li H. Patterns of Serum Prolactin Elevation Associated with Nine Second-Generation Antipsychotics in a Large Cohort of Patients with Schizophrenia. CNS Drugs. 2025;39(12):1317-30",
      "pubdate": "2025-08-20",
      "Lead_author": "Zhang L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s40263-025-01216-1",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Zhang L, Zheng Y, Huang J, Yu W, Zhou L, He L, Li Y, Hu H, Li G, Shen Y, Zhang J, Li H. Patterns of Serum Prolactin Elevation Associated with Nine Second-Generation Antipsychotics in a Large Cohort of Patients with Schizophrenia. CNS Drugs. 2025;39(12):1317-30",
    "leadAuthor": "Zhang L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhlCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhlCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4847d40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707204
  },
  {
    "id": "CLOZ_Demo_97319",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40817129",
    "title": "Weight change from incretin-based weight loss medications across categories of second-generation antipsychotics.",
    "authors": [
      "Varghese JS",
      "Goldsmith DR",
      "Cotes RO",
      "Ravikumar V",
      "Ali MK",
      "Pasquel FJ"
    ],
    "journal": "Int J Obes (Lond)",
    "publicationDate": "2025-08-16",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a3ce7b5d-45ec-441b-b2d7-1ee3d0cec857",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.077Z"
      },
      {
        "id": "941e7c73-9c4e-4dd8-97b0-1c8e70f9cd97",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 417ed984-d9dd-4fd9-8a36-04147c5a8f68 to CLOZ_Demo_97319",
        "type": "system",
        "createdAt": "2025-12-14T10:13:24.742Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:58.036Z",
    "updatedAt": "2025-12-14T08:54:35.127Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40817129",
      "DOI": "https://doi.org10.1038/s41366-025-01885-4",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:37:47",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Varghese JS, Goldsmith DR, Cotes RO, Ravikumar V, Ali MK, Pasquel FJ. Weight change from incretin-based weight loss medications across categories of second-generation antipsychotics. Int J Obes (Lond). 2025;49(12):2544-",
      "pubdate": "2025-08-16",
      "Lead_author": "Varghese JS",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41366-025-01885-4",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Varghese JS, Goldsmith DR, Cotes RO, Ravikumar V, Ali MK, Pasquel FJ. Weight change from incretin-based weight loss medications across categories of second-generation antipsychotics. Int J Obes (Lond). 2025;49(12):2544-",
    "leadAuthor": "Varghese JS",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhmCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhmCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4869200501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707204
  },
  {
    "id": "CLOZ_Demo_24878",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40802671",
    "title": "Relationship Between Clozapine:Norclozapine Ratio, Cognitive Function, and Employment Status in Patients with Treatment-Resistant Schizophrenia.",
    "authors": [
      "Sun J",
      "Yee JY",
      "See YM",
      "Ng BT",
      "Tang C",
      "Zheng S",
      "Lee J"
    ],
    "journal": "Ther Drug Monit",
    "publicationDate": "2025-08-13",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "79e5ba4d-7d42-47a6-88ff-665f5a7a9792",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.139Z"
      },
      {
        "id": "2a8c14d8-94dd-44f0-96f0-990e868b9f4d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 20ce5ec7-ad7c-4834-bba8-ac0be8aeab64 to CLOZ_Demo_24878",
        "type": "system",
        "createdAt": "2025-12-14T10:13:24.980Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:58.132Z",
    "updatedAt": "2025-12-14T08:54:35.149Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40802671",
      "DOI": "https://doi.org10.1097/FTD.0000000000001365",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:37:25",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Sun J, Yee JY, See YM, Ng BT, Tang C, Zheng S, Lee J. Relationship Between Clozapine:Norclozapine Ratio, Cognitive Function, and Employment Status in Patients with Treatment-Resistant Schizophrenia. Ther Drug Monit. 2025;47(6):828-9",
      "pubdate": "2025-08-13",
      "Lead_author": "Sun J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/FTD.0000000000001365",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Sun J, Yee JY, See YM, Ng BT, Tang C, Zheng S, Lee J. Relationship Between Clozapine:Norclozapine Ratio, Cognitive Function, and Employment Status in Patients with Treatment-Resistant Schizophrenia. Ther Drug Monit. 2025;47(6):828-9",
    "leadAuthor": "Sun J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhnCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhnCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-488d300501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707204
  },
  {
    "id": "CLOZ_Demo_53783",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40690135",
    "title": "Repeated Clozapine Administration Causes Extensive Changes to the Expression of Coding and Non-coding RNAs, Including miR-124, in the Mouse Frontal Cortex.",
    "authors": [
      "Younis RM",
      "Al Saeedy DY",
      "Dozmorov MG",
      "Jahr FM",
      "Malay S",
      "Mahdiani S",
      "Idris B",
      "Castillo J",
      "Beardsley PM",
      "McClay JL"
    ],
    "journal": "Mol Neurobiol",
    "publicationDate": "2025-07-21",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "f5d811ee-b3ce-4050-9dc9-11dc1128952a",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.168Z"
      },
      {
        "id": "af1c8eef-73fb-47d1-9089-dec0302c85e9",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 4869cc72-9a0f-499b-9e38-9f53323d296b to CLOZ_Demo_53783",
        "type": "system",
        "createdAt": "2025-12-14T10:13:25.212Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:58.315Z",
    "updatedAt": "2025-12-14T08:54:35.236Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40690135",
      "DOI": "https://doi.org10.1007/s12035-025-05199-4",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:37:32",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Younis RM, Al Saeedy DY, Dozmorov MG, Jahr FM, Malay S, Mahdiani S, Idris B, Castillo J, Beardsley PM, McClay JL. Repeated Clozapine Administration Causes Extensive Changes to the Expression of Coding and Non-coding RNAs, Including miR-124, in the Mouse Frontal Cortex. Mol Neurobiol. 2025;62(12):15564-",
      "pubdate": "2025-07-21",
      "Lead_author": "Younis RM",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s12035-025-05199-4",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Younis RM, Al Saeedy DY, Dozmorov MG, Jahr FM, Malay S, Mahdiani S, Idris B, Castillo J, Beardsley PM, McClay JL. Repeated Clozapine Administration Causes Extensive Changes to the Expression of Coding and Non-coding RNAs, Including miR-124, in the Mouse Frontal Cortex. Mol Neurobiol. 2025;62(12):15564-",
    "leadAuthor": "Younis RM",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhoCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhoCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-48b0940501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707205
  },
  {
    "id": "CLOZ_Demo_39715",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40544885",
    "title": "Relationship between regional prescriptions of lithium and clozapine and suicide mortality in children and adolescents in France between 2014 and 2019.",
    "authors": [
      "Guez E",
      "Rojas-Chaves A",
      "Van Der Waerden J",
      "Melchior M",
      "Pellerin H",
      "Consoli A",
      "Cohen D",
      "Benarous X"
    ],
    "journal": "J Affect Disord",
    "publicationDate": "2025-06-23",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "8c0a8a22-3a05-4002-86d2-9f08e516037e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.263Z"
      },
      {
        "id": "6c0c2a16-e4db-4e8a-8032-a3cd196ad37b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a34e8cfc-24d5-45fd-acc4-3271866dfcc3 to CLOZ_Demo_39715",
        "type": "system",
        "createdAt": "2025-12-14T10:13:25.425Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:07:58.403Z",
    "updatedAt": "2025-12-14T08:54:35.272Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40544885",
      "DOI": "https://doi.org10.1016/j.jad.2025.119738",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:37:54",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Guez E, Rojas-Chaves A, Van Der Waerden J, Melchior M, Pellerin H, Consoli A, Cohen D, Benarous X. Relationship between regional prescriptions of lithium and clozapine and suicide mortality in children and adolescents in France between 2014 and 2019. J Affect Disord. 2025;389119738",
      "pubdate": "2025-06-23",
      "Lead_author": "Guez E",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jad.2025.119738",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Guez E, Rojas-Chaves A, Van Der Waerden J, Melchior M, Pellerin H, Consoli A, Cohen D, Benarous X. Relationship between regional prescriptions of lithium and clozapine and suicide mortality in children and adolescents in France between 2014 and 2019. J Affect Disord. 2025;389119738",
    "leadAuthor": "Guez E",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhpCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhpCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-48d1440501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707205
  },
  {
    "id": "CLOZ_Demo_85261",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41364823",
    "title": "Electroconvulsive Therapy Under Mechanical Ventilation for Catatonia-associated Respiratory Failure.",
    "authors": [
      "Fujiwara S",
      "Nagao T",
      "Inami M",
      "Misumi S",
      "Ogawa K",
      "Ito M",
      "Egawa N",
      "Ishida T"
    ],
    "journal": "J ECT",
    "publicationDate": "2025-12-9",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "c50a1343-21b2-4154-8a3d-b64a70fce824",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.293Z"
      },
      {
        "id": "2f649247-246d-4027-bb88-85cb2da9a5ab",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 21ba76a7-a370-4221-bb4b-0347abb08c00 to CLOZ_Demo_85261",
        "type": "system",
        "createdAt": "2025-12-14T10:13:25.640Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:14.579Z",
    "updatedAt": "2025-12-14T08:54:35.302Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41364823",
      "DOI": "https://doi.org10.1097/YCT.0000000000001201",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:38:21",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Fujiwara S, Nagao T, Inami M, Misumi S, Ogawa K, Ito M, Egawa N, Ishida T. Electroconvulsive Therapy Under Mechanical Ventilation for Catatonia-associated Respiratory Failure. J ECT. 2025;",
      "pubdate": "2025-12-9",
      "Lead_author": "Fujiwara S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/YCT.0000000000001201",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Fujiwara S, Nagao T, Inami M, Misumi S, Ogawa K, Ito M, Egawa N, Ishida T. Electroconvulsive Therapy Under Mechanical Ventilation for Catatonia-associated Respiratory Failure. J ECT. 2025;",
    "leadAuthor": "Fujiwara S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhqCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhqCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-48f23c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707205
  },
  {
    "id": "CLOZ_Demo_85476",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41356674",
    "title": "Case Report: Metabolic, inflammatory, and neurological improvements after a ketogenic diet in a woman with treatment-resistant schizophrenia and metabolic syndrome.",
    "authors": [
      "Murray SL",
      "Vyas G",
      "Eberhardt E",
      "Roche DJO",
      "Adams HA",
      "Harrington V",
      "Kearns A",
      "Glassman M",
      "Yuen A",
      "Chiappelli J",
      "Pugh S",
      "Barron B",
      "Sandow K",
      "Palmer CM",
      "Kelly DL"
    ],
    "journal": "Front Psychiatry",
    "publicationDate": "2025-12-8",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "93d2e967-342e-41e5-8467-942bf4c4bf93",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.325Z"
      },
      {
        "id": "45b3c956-b51a-4e12-bbcc-09b48235d164",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from de70350a-5eb0-44ab-a042-53a3198c0732 to CLOZ_Demo_85476",
        "type": "system",
        "createdAt": "2025-12-14T10:13:25.872Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:14.677Z",
    "updatedAt": "2025-12-14T08:54:35.372Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41356674",
      "DOI": "https://doi.org10.3389/fpsyt.2025.1710785",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:38:14",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Murray SL, Vyas G, Eberhardt E, Roche DJO, Adams HA, Harrington V, Kearns A, Glassman M, Yuen A, Chiappelli J, Pugh S, Barron B, Sandow K, Palmer CM, Kelly DL. Case Report: Metabolic, inflammatory, and neurological improvements after a ketogenic diet in a woman with treatment-resistant schizophrenia and metabolic syndrome. Front Psychiatry. 2025;161710785",
      "pubdate": "2025-12-8",
      "Lead_author": "Murray SL",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3389/fpsyt.2025.1710785",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Murray SL, Vyas G, Eberhardt E, Roche DJO, Adams HA, Harrington V, Kearns A, Glassman M, Yuen A, Chiappelli J, Pugh S, Barron B, Sandow K, Palmer CM, Kelly DL. Case Report: Metabolic, inflammatory, and neurological improvements after a ketogenic diet in a woman with treatment-resistant schizophrenia and metabolic syndrome. Front Psychiatry. 2025;161710785",
    "leadAuthor": "Murray SL",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhrCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhrCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4915900501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707205
  },
  {
    "id": "CLOZ_Demo_87214",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41356387",
    "title": "Clozapine (and norclozapine) concentrations are correlated with functioning, disability and side-effects when patients are treated with clozapine without the availability of therapeutic drug monitoring: A study of treatment-resistant schizophrenia inpatients.",
    "authors": [
      "Petrovic V",
      "Cohen D",
      "Bankovic D",
      "Radmanovic B",
      "Ignjatovic Ristic D"
    ],
    "journal": "Biomed Rep",
    "publicationDate": "2025-12-8",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "c4f5c928-de4e-4581-99d7-7c70060c90f4",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.384Z"
      },
      {
        "id": "2350705e-5320-4b5d-9dc9-1da90aab6d8a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from abad32fa-ee0f-48b1-be93-90af6632909c to CLOZ_Demo_87214",
        "type": "system",
        "createdAt": "2025-12-14T10:13:26.088Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:14.723Z",
    "updatedAt": "2025-12-14T08:54:35.394Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41356387",
      "DOI": "https://doi.org10.3892/br.2025.2087",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:38:28",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Petrovic V, Cohen D, Bankovic D, Radmanovic B, Ignjatovic Ristic D. Clozapine (and norclozapine) concentrations are correlated with functioning, disability and side-effects when patients are treated with clozapine without the availability of therapeutic drug monitoring: A study of treatment-resistant schizophrenia inpatients. Biomed Rep. 2026;24(1):14",
      "pubdate": "2025-12-8",
      "Lead_author": "Petrovic V",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3892/br.2025.2087",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Petrovic V, Cohen D, Bankovic D, Radmanovic B, Ignjatovic Ristic D. Clozapine (and norclozapine) concentrations are correlated with functioning, disability and side-effects when patients are treated with clozapine without the availability of therapeutic drug monitoring: A study of treatment-resistant schizophrenia inpatients. Biomed Rep. 2026;24(1):14",
    "leadAuthor": "Petrovic V",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhsCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhsCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-49369c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707206
  },
  {
    "id": "CLOZ_Demo_87113",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41349717",
    "title": "Consultation-Liaison Case Conference: Stimulant-Induced Tardive Dyskinesia.",
    "authors": [
      "Malik M",
      "Tran T",
      "Manalai P",
      "Latif Z"
    ],
    "journal": "J Acad Consult Liaison Psychiatry",
    "publicationDate": "2025-12-6",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "42bec9e5-79d8-475f-9c1c-c42082e61332",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.447Z"
      },
      {
        "id": "c7baeb8d-8df2-4663-8bdd-241f6ec2f300",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from e43015e1-2077-4d87-b428-d3a013f28499 to CLOZ_Demo_87113",
        "type": "system",
        "createdAt": "2025-12-14T10:13:26.302Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:14.763Z",
    "updatedAt": "2025-12-14T08:54:35.456Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41349717",
      "DOI": "https://doi.org10.1016/j.jaclp.2025.11.004",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:38:41",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Malik M, Tran T, Manalai P, Latif Z. Consultation-Liaison Case Conference: Stimulant-Induced Tardive Dyskinesia. J Acad Consult Liaison Psychiatry. 2025;",
      "pubdate": "2025-12-6",
      "Lead_author": "Malik M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jaclp.2025.11.004",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Malik M, Tran T, Manalai P, Latif Z. Consultation-Liaison Case Conference: Stimulant-Induced Tardive Dyskinesia. J Acad Consult Liaison Psychiatry. 2025;",
    "leadAuthor": "Malik M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhtCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhtCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4956f00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707206
  },
  {
    "id": "CLOZ_Demo_21237",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41335431",
    "title": "Semaglutide and Early-Stage Metabolic Abnormalities in Individuals With Schizophrenia Spectrum Disorders: A Randomized Clinical Trial.",
    "authors": [
      "Sass MR",
      "Klausen MK",
      "Schwarz CR",
      "Rasmussen L",
      "Giver MEB",
      "Hviid M",
      "Schilling C",
      "Zamorski A",
      "Jensen A",
      "Gefke M",
      "Storgaard H",
      "Oturai PS",
      "Kjaer A",
      "Hartmann B",
      "Holst JJ",
      "Ekstrøm CT",
      "Vinberg M",
      "Correll CU",
      "Vilsbøll T",
      "Fink-Jensen A"
    ],
    "journal": "JAMA Psychiatry",
    "publicationDate": "2025-12-3",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "773fd916-7c52-42ed-8bbc-5a538eeda850",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.477Z"
      },
      {
        "id": "066c83a2-edc2-4107-8c5a-eba334555343",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a5213ede-e3d3-46c9-be4b-959fffbb3452 to CLOZ_Demo_21237",
        "type": "system",
        "createdAt": "2025-12-14T10:13:26.549Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:14.801Z",
    "updatedAt": "2025-12-14T08:54:35.512Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41335431",
      "DOI": "https://doi.org10.1001/jamapsychiatry.2025.3639",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:38:34",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Sass MR, Klausen MK, Schwarz CR, Rasmussen L, Giver MEB, Hviid M, Schilling C, Zamorski A, Jensen A, Gefke M, Storgaard H, Oturai PS, Kjaer A, Hartmann B, Holst JJ, Ekstrøm CT, Vinberg M, Correll CU, Vilsbøll T, Fink-Jensen A. Semaglutide and Early-Stage Metabolic Abnormalities in Individuals With Schizophrenia Spectrum Disorders: A Randomized Clinical Trial. JAMA Psychiatry. 2025;",
      "pubdate": "2025-12-3",
      "Lead_author": "Sass MR",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1001/jamapsychiatry.2025.3639",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Sass MR, Klausen MK, Schwarz CR, Rasmussen L, Giver MEB, Hviid M, Schilling C, Zamorski A, Jensen A, Gefke M, Storgaard H, Oturai PS, Kjaer A, Hartmann B, Holst JJ, Ekstrøm CT, Vinberg M, Correll CU, Vilsbøll T, Fink-Jensen A. Semaglutide and Early-Stage Metabolic Abnormalities in Individuals With Schizophrenia Spectrum Disorders: A Randomized Clinical Trial. JAMA Psychiatry. 2025;",
    "leadAuthor": "Sass MR",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhuCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhuCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-497cc40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707206
  },
  {
    "id": "CLOZ_Demo_94248",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41308511",
    "title": "Exploring clozapine dose adjustment strategy in acute-phase reaction of inflammation based on free drug concentrations and K.",
    "authors": [
      "Han Y",
      "Guo J",
      "Wang G",
      "Wang F",
      "Wang W"
    ],
    "journal": "Eur Neuropsychopharmacol",
    "publicationDate": "2025-11-28",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "8f99e73b-86ba-48c6-bdef-4f428b1e266d",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.539Z"
      },
      {
        "id": "1ae6300a-222d-422b-9563-7a2a0df78eaf",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 68fa14ce-6f2c-4562-8b05-f1ca5d84e2e9 to CLOZ_Demo_94248",
        "type": "system",
        "createdAt": "2025-12-14T10:13:26.749Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:14.844Z",
    "updatedAt": "2025-12-14T08:54:35.548Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41308511",
      "DOI": "https://doi.org10.1016/j.euroneuro.2025.10.007",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:39:04",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Han Y, Guo J, Wang G, Wang F, Wang W. Exploring clozapine dose adjustment strategy in acute-phase reaction of inflammation based on free drug concentrations and K<sub>puu</sub>. Eur Neuropsychopharmacol. 2025;10239-40",
      "pubdate": "2025-11-28",
      "Lead_author": "Han Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.euroneuro.2025.10.007",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Han Y, Guo J, Wang G, Wang F, Wang W. Exploring clozapine dose adjustment strategy in acute-phase reaction of inflammation based on free drug concentrations and K<sub>puu</sub>. Eur Neuropsychopharmacol. 2025;10239-40",
    "leadAuthor": "Han Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhvCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhvCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-49a0d40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707206
  },
  {
    "id": "CLOZ_Demo_65322",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41307831",
    "title": "Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials.",
    "authors": [
      "Chimonas S",
      "Cosenza C",
      "Kesselheim AS",
      "Toyserkani GA",
      "Oswell KH",
      "LaCivita C",
      "Dal Pan GJ",
      "Sarpatwari A"
    ],
    "journal": "Drug Saf",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "e05089d0-2382-4f96-b343-5ae733fbb5e7",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.602Z"
      },
      {
        "id": "0e69e96f-d8b3-4049-93dd-c1815c569898",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from c6f5669e-9fe1-4c93-a3a0-d35f219d58ed to CLOZ_Demo_65322",
        "type": "system",
        "createdAt": "2025-12-14T10:13:26.964Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:14.892Z",
    "updatedAt": "2025-12-14T08:54:35.610Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41307831",
      "DOI": "https://doi.org10.1007/s40264-025-01636-4",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:39:11",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Chimonas S, Cosenza C, Kesselheim AS, Toyserkani GA, Oswell KH, LaCivita C, Dal Pan GJ, Sarpatwari A. Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials. Drug Saf. 2025;",
      "pubdate": "2025-11-27",
      "Lead_author": "Chimonas S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s40264-025-01636-4",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Chimonas S, Cosenza C, Kesselheim AS, Toyserkani GA, Oswell KH, LaCivita C, Dal Pan GJ, Sarpatwari A. Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials. Drug Saf. 2025;",
    "leadAuthor": "Chimonas S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhwCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhwCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-49c4480501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707207
  },
  {
    "id": "CLOZ_Demo_52181",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41306090",
    "title": "Myoclonic Movements and Catatonic-Like Symptoms After Abrupt Cessation of Clozapine: A Case Report and Discussion.",
    "authors": [
      "Sifford J",
      "Peng E",
      "Kriz C",
      "Metzner J",
      "Moorthy B"
    ],
    "journal": "J Clin Psychopharmacol",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a35daf1b-bf18-4835-8106-a9ab701de38d",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.633Z"
      },
      {
        "id": "34842bf2-a18b-4352-bd21-4a95678904bf",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a0b74890-3869-4fe5-ae54-c680eee26de6 to CLOZ_Demo_52181",
        "type": "system",
        "createdAt": "2025-12-14T10:13:27.212Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:14.941Z",
    "updatedAt": "2025-12-14T08:54:35.643Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41306090",
      "DOI": "https://doi.org10.1097/JCP.0000000000002105",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:38:56",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Sifford J, Peng E, Kriz C, Metzner J, Moorthy B. Myoclonic Movements and Catatonic-Like Symptoms After Abrupt Cessation of Clozapine: A Case Report and Discussion. J Clin Psychopharmacol. 2025;",
      "pubdate": "2025-11-27",
      "Lead_author": "Sifford J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/JCP.0000000000002105",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Sifford J, Peng E, Kriz C, Metzner J, Moorthy B. Myoclonic Movements and Catatonic-Like Symptoms After Abrupt Cessation of Clozapine: A Case Report and Discussion. J Clin Psychopharmacol. 2025;",
    "leadAuthor": "Sifford J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhxCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhxCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-49e1f40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707207
  },
  {
    "id": "CLOZ_Demo_16674",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41302331",
    "title": "Managing Symptoms in Adolescent-Onset Schizophrenia: A Narrative Review of Therapeutic Interventions.",
    "authors": [
      "Abedi K"
    ],
    "journal": "Healthcare (Basel)",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "0a5b9e65-648c-4706-a7f8-3af4076df6c4",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.711Z"
      },
      {
        "id": "33e329b9-70d1-4913-8067-035b822f04a3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 5c4f6ec1-d6f4-479d-bdb4-909b3d5a7ace to CLOZ_Demo_16674",
        "type": "system",
        "createdAt": "2025-12-14T10:13:27.429Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:14.979Z",
    "updatedAt": "2025-12-14T08:54:35.722Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41302331",
      "DOI": "https://doi.org10.3390/healthcare13222943",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:38:50",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Abedi K. Managing Symptoms in Adolescent-Onset Schizophrenia: A Narrative Review of Therapeutic Interventions. Healthcare (Basel). 2025;13(22):",
      "pubdate": "2025-11-27",
      "Lead_author": "Abedi K",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3390/healthcare13222943",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Abedi K. Managing Symptoms in Adolescent-Onset Schizophrenia: A Narrative Review of Therapeutic Interventions. Healthcare (Basel). 2025;13(22):",
    "leadAuthor": "Abedi K",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhyCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhyCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4a02e40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707207
  },
  {
    "id": "CLOZ_Demo_57006",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41298476",
    "title": "A spatiotemporal hypergraph self-attention neural networks framework for the identification and pharmacological efficacy assessment of Parkinson's disease motor symptoms.",
    "authors": [
      "An X",
      "Su L",
      "Yang Q",
      "Shen B",
      "Gan L",
      "Jun Ji J",
      "Wang J",
      "Su H"
    ],
    "journal": "NPJ Parkinsons Dis",
    "publicationDate": "2025-11-27",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "de31bdfc-029f-4603-a056-a95890260d29",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.739Z"
      },
      {
        "id": "7255cadb-79ef-436e-890c-f1403f0e6040",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 79b0f115-a2a4-4c59-9786-2be84875c423 to CLOZ_Demo_57006",
        "type": "system",
        "createdAt": "2025-12-14T10:13:27.660Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:15.012Z",
    "updatedAt": "2025-12-14T08:54:35.792Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41298476",
      "DOI": "https://doi.org10.1038/s41531-025-01187-6",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:39:25",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "An X, Su L, Yang Q, Shen B, Gan L, Jun Ji J, Wang J, Su H. A spatiotemporal hypergraph self-attention neural networks framework for the identification and pharmacological efficacy assessment of Parkinson's disease motor symptoms. NPJ Parkinsons Dis. 2025;11(1):338",
      "pubdate": "2025-11-27",
      "Lead_author": "An X",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41531-025-01187-6",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "An X, Su L, Yang Q, Shen B, Gan L, Jun Ji J, Wang J, Su H. A spatiotemporal hypergraph self-attention neural networks framework for the identification and pharmacological efficacy assessment of Parkinson's disease motor symptoms. NPJ Parkinsons Dis. 2025;11(1):338",
    "leadAuthor": "An X",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUhzCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUhzCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4a26380501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707207
  },
  {
    "id": "CLOZ_Demo_65237",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41287779",
    "title": "When Hormones Shape the Mind: Neuropsychiatric Manifestations in a Patient With Congenital Adrenal Hyperplasia and Genital Ambiguity.",
    "authors": [
      "Galindo D",
      "Gonzalez C",
      "Osorno D",
      "Baños Pabon LC"
    ],
    "journal": "Cureus",
    "publicationDate": "2025-11-25",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "356b0230-f292-4b9b-af34-c07f4de5d0f3",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.820Z"
      },
      {
        "id": "11e6d79e-6e8f-48bd-bd8f-ed5f62443f0b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3125d0a3-8728-4824-8059-03f99e733b40 to CLOZ_Demo_65237",
        "type": "system",
        "createdAt": "2025-12-14T10:13:27.877Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:15.059Z",
    "updatedAt": "2025-12-14T08:54:35.831Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41287779",
      "DOI": "https://doi.org10.7759/cureus.97582",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:39:18",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Galindo D, Gonzalez C, Osorno D, Baños Pabon LC. When Hormones Shape the Mind: Neuropsychiatric Manifestations in a Patient With Congenital Adrenal Hyperplasia and Genital Ambiguity. Cureus. 2025;17(11):e97582",
      "pubdate": "2025-11-25",
      "Lead_author": "Galindo D",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.7759/cureus.97582",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Galindo D, Gonzalez C, Osorno D, Baños Pabon LC. When Hormones Shape the Mind: Neuropsychiatric Manifestations in a Patient With Congenital Adrenal Hyperplasia and Genital Ambiguity. Cureus. 2025;17(11):e97582",
    "leadAuthor": "Galindo D",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh0CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh0CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4a477c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707207
  },
  {
    "id": "CLOZ_Demo_82934",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41282955",
    "title": "Impact of antipsychotics, antiparkinsonian drugs, and anthraquinone stimulant laxatives on severe constipation in patients with schizophrenia.",
    "authors": [
      "Nadaya T",
      "Inaguma T",
      "Nagao T",
      "Ishida T"
    ],
    "journal": "PCN Rep",
    "publicationDate": "2025-11-24",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "bd70c63a-5b66-43c1-8e84-829f8a1c5b87",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.850Z"
      },
      {
        "id": "56b122fc-7ab3-4f93-8318-0a1adaf5de35",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 05dd54a3-b27f-436e-87fc-429b6a034c18 to CLOZ_Demo_82934",
        "type": "system",
        "createdAt": "2025-12-14T10:13:28.080Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:15.106Z",
    "updatedAt": "2025-12-14T08:54:35.862Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41282955",
      "DOI": "https://doi.org10.1002/pcn5.70255",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:39:33",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Nadaya T, Inaguma T, Nagao T, Ishida T. Impact of antipsychotics, antiparkinsonian drugs, and anthraquinone stimulant laxatives on severe constipation in patients with schizophrenia. PCN Rep. 2025;4(4):e70255",
      "pubdate": "2025-11-24",
      "Lead_author": "Nadaya T",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/pcn5.70255",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Nadaya T, Inaguma T, Nagao T, Ishida T. Impact of antipsychotics, antiparkinsonian drugs, and anthraquinone stimulant laxatives on severe constipation in patients with schizophrenia. PCN Rep. 2025;4(4):e70255",
    "leadAuthor": "Nadaya T",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh1CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh1CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4a66b00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707208
  },
  {
    "id": "CLOZ_Demo_34278",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41264871",
    "title": "Clozapine Withdrawal-Induced Catatonia.",
    "authors": [
      "Wilkinson B",
      "Snyder W",
      "Shah Z",
      "Heming S"
    ],
    "journal": "Prim Care Companion CNS Disord",
    "publicationDate": "2025-11-20",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "07c05a2f-47c1-4e57-beda-f7bde5502f66",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.881Z"
      },
      {
        "id": "1edf1075-63eb-4682-98fa-f816485fa357",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f0d78e20-ff20-4cf5-ac83-8d3b53fe7949 to CLOZ_Demo_34278",
        "type": "system",
        "createdAt": "2025-12-14T10:13:28.323Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:15.132Z",
    "updatedAt": "2025-12-14T08:54:35.893Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41264871",
      "DOI": "https://doi.org10.4088/PCC.25cr04014",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:39:55",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Wilkinson B, Snyder W, Shah Z, Heming S. Clozapine Withdrawal-Induced Catatonia. Prim Care Companion CNS Disord. 2025;27(6):",
      "pubdate": "2025-11-20",
      "Lead_author": "Wilkinson B",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.4088/PCC.25cr04014",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Wilkinson B, Snyder W, Shah Z, Heming S. Clozapine Withdrawal-Induced Catatonia. Prim Care Companion CNS Disord. 2025;27(6):",
    "leadAuthor": "Wilkinson B",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh2CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh2CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4a8ae40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707208
  },
  {
    "id": "CLOZ_Demo_49149",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41263834",
    "title": "Duffy-null variant and practical implications for patient care: a scoping review.",
    "authors": [
      "Asiimwe E",
      "Ngo TP",
      "Ziv E",
      "Leavitt AD"
    ],
    "journal": "BMJ Open",
    "publicationDate": "2025-11-20",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "48bb7d83-31e5-43ed-97e8-618cd816981f",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.959Z"
      },
      {
        "id": "728c2332-b0f2-4378-92f8-2f0009415876",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from e0705c24-99c8-416a-8616-23f3eb8a4033 to CLOZ_Demo_49149",
        "type": "system",
        "createdAt": "2025-12-14T10:13:28.523Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:15.330Z",
    "updatedAt": "2025-12-14T08:54:35.971Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41263834",
      "DOI": "https://doi.org10.1136/bmjopen-2025-099049",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:39:40",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Asiimwe E, Ngo TP, Ziv E, Leavitt AD. Duffy-null variant and practical implications for patient care: a scoping review. BMJ Open. 2025;15(11):e099049",
      "pubdate": "2025-11-20",
      "Lead_author": "Asiimwe E",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1136/bmjopen-2025-099049",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Asiimwe E, Ngo TP, Ziv E, Leavitt AD. Duffy-null variant and practical implications for patient care: a scoping review. BMJ Open. 2025;15(11):e099049",
    "leadAuthor": "Asiimwe E",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh3CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh3CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4aa9800501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707208
  },
  {
    "id": "CLOZ_Demo_51424",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41262335",
    "title": "Clozapine Drug-Drug Interactions and Individualized Dosing in Bipolar Disorder: A Model-Informed Precision Dosing Approach.",
    "authors": [
      "Zhang Y",
      "Wang J",
      "Tian X",
      "Zhang YJ",
      "Li Y",
      "He SM",
      "Zhang C",
      "Chen X",
      "Wang DD"
    ],
    "journal": "Drug Des Devel Ther",
    "publicationDate": "2025-11-20",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "7292f167-1f5c-4355-9bb5-80e6839578d6",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:35.989Z"
      },
      {
        "id": "e38242dc-755d-4a46-b82c-f0d5bb4d5523",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from aa9931f2-d230-4fd2-9e71-053c9a35e367 to CLOZ_Demo_51424",
        "type": "system",
        "createdAt": "2025-12-14T10:13:28.782Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:15.423Z",
    "updatedAt": "2025-12-14T08:54:36.001Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41262335",
      "DOI": "https://doi.org10.2147/DDDT.S557624",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:39:47",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Zhang Y, Wang J, Tian X, Zhang YJ, Li Y, He SM, Zhang C, Chen X, Wang DD. Clozapine Drug-Drug Interactions and Individualized Dosing in Bipolar Disorder: A Model-Informed Precision Dosing Approach. Drug Des Devel Ther. 2025;1910119-",
      "pubdate": "2025-11-20",
      "Lead_author": "Zhang Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.2147/DDDT.S557624",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Zhang Y, Wang J, Tian X, Zhang YJ, Li Y, He SM, Zhang C, Chen X, Wang DD. Clozapine Drug-Drug Interactions and Individualized Dosing in Bipolar Disorder: A Model-Informed Precision Dosing Approach. Drug Des Devel Ther. 2025;1910119-",
    "leadAuthor": "Zhang Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh4CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh4CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4ad1240501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707208
  },
  {
    "id": "CLOZ_Demo_54108",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41257674",
    "title": "A multidisciplinary approach to establishing clozapine in a patient with schizophrenia and comorbid ASD: a case report.",
    "authors": [
      "Bridges M",
      "Secchi A",
      "Whiskey E",
      "Shergill S"
    ],
    "journal": "BMC Psychiatry",
    "publicationDate": "2025-11-19",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "adbb1dce-753f-4cb4-9e54-15b61f9ddf31",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.020Z"
      },
      {
        "id": "167aebde-8210-474c-ace3-fa4735dd3f72",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from b9c5c762-80d2-41ec-8f23-6c9d297c16da to CLOZ_Demo_54108",
        "type": "system",
        "createdAt": "2025-12-14T10:13:28.951Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:15.576Z",
    "updatedAt": "2025-12-14T08:54:36.073Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41257674",
      "DOI": "https://doi.org10.1186/s12888-025-07280-7",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:40:02",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Bridges M, Secchi A, Whiskey E, Shergill S. A multidisciplinary approach to establishing clozapine in a patient with schizophrenia and comorbid ASD: a case report. BMC Psychiatry. 2025;",
      "pubdate": "2025-11-19",
      "Lead_author": "Bridges M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s12888-025-07280-7",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Bridges M, Secchi A, Whiskey E, Shergill S. A multidisciplinary approach to establishing clozapine in a patient with schizophrenia and comorbid ASD: a case report. BMC Psychiatry. 2025;",
    "leadAuthor": "Bridges M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh5CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh5CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4af1180501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707209
  },
  {
    "id": "CLOZ_Demo_21282",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41229349",
    "title": "Economic evaluation of different haematological monitoring schemes for patients with treatment-resistant schizophrenia using clozapine.",
    "authors": [
      "Diederich F",
      "Oloyede E",
      "Taylor D",
      "Bachmann CJ"
    ],
    "journal": "Br J Psychiatry",
    "publicationDate": "2025-11-13",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "226224ea-790c-4495-b58d-62957534ba85",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.096Z"
      },
      {
        "id": "04af50f3-9458-473e-ac76-e3e758cbd453",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 8b0a06ec-280c-4acf-9e7b-9c06046cee7f to CLOZ_Demo_21282",
        "type": "system",
        "createdAt": "2025-12-14T10:13:29.184Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:15.674Z",
    "updatedAt": "2025-12-14T08:54:36.106Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41229349",
      "DOI": "https://doi.org10.1192/bjp.2025.10424",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:40:27",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Diederich F, Oloyede E, Taylor D, Bachmann CJ. Economic evaluation of different haematological monitoring schemes for patients with treatment-resistant schizophrenia using clozapine. Br J Psychiatry. 2025;1-8",
      "pubdate": "2025-11-13",
      "Lead_author": "Diederich F",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1192/bjp.2025.10424",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Diederich F, Oloyede E, Taylor D, Bachmann CJ. Economic evaluation of different haematological monitoring schemes for patients with treatment-resistant schizophrenia using clozapine. Br J Psychiatry. 2025;1-8",
    "leadAuthor": "Diederich F",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh6CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh6CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4b0e540501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707209
  },
  {
    "id": "CLOZ_Demo_34541",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41130544",
    "title": "A chemoproteomic strategy for identifying protein covalent binding targets of clozapine: An approach for advancing clozapine toxicity research.",
    "authors": [
      "Lockhart S",
      "Tabana Y",
      "Tabatabaei Dakhili SA",
      "Babu D",
      "Tran NH",
      "Eldalal O",
      "West FG",
      "Ussher JR",
      "Barakat KH",
      "Fahlman RP",
      "Siraki AG"
    ],
    "journal": "Toxicol Lett",
    "publicationDate": "2025-10-24",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "c20f0744-c69e-41cd-84d5-27123b0c02f7",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.126Z"
      },
      {
        "id": "6f2bc984-c8c3-4b52-ab13-820bbed0bc6e",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 13e177eb-6f54-434a-b337-730d235a8521 to CLOZ_Demo_34541",
        "type": "system",
        "createdAt": "2025-12-14T10:13:29.436Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:15.857Z",
    "updatedAt": "2025-12-14T08:54:36.193Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41130544",
      "DOI": "https://doi.org10.1016/j.toxlet.2025.111752",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:40:12",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Lockhart S, Tabana Y, Tabatabaei Dakhili SA, Babu D, Tran NH, Eldalal O, West FG, Ussher JR, Barakat KH, Fahlman RP, Siraki AG. A chemoproteomic strategy for identifying protein covalent binding targets of clozapine: An approach for advancing clozapine toxicity research. Toxicol Lett. 2025;414111752",
      "pubdate": "2025-10-24",
      "Lead_author": "Lockhart S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.toxlet.2025.111752",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Lockhart S, Tabana Y, Tabatabaei Dakhili SA, Babu D, Tran NH, Eldalal O, West FG, Ussher JR, Barakat KH, Fahlman RP, Siraki AG. A chemoproteomic strategy for identifying protein covalent binding targets of clozapine: An approach for advancing clozapine toxicity research. Toxicol Lett. 2025;414111752",
    "leadAuthor": "Lockhart S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh7CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh7CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4b352c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707209
  },
  {
    "id": "CLOZ_Demo_47261",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41103792",
    "title": "Risk of diabetes mellitus with olanzapine compared to clozapine: A systematic review and meta-analysis.",
    "authors": [
      "Onda K",
      "Ichwansyah R",
      "Boku S"
    ],
    "journal": "PCN Rep",
    "publicationDate": "2025-10-17",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "2ff51dc0-4027-437e-8940-12c5bdc328ea",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.204Z"
      },
      {
        "id": "89337943-e601-4a97-a198-7125c94e95a0",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 45087d65-71ba-4e67-8910-2c7901917daa to CLOZ_Demo_47261",
        "type": "system",
        "createdAt": "2025-12-14T10:13:29.607Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:15.959Z",
    "updatedAt": "2025-12-14T08:54:36.210Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41103792",
      "DOI": "https://doi.org10.1002/pcn5.70215",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:40:34",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Onda K, Ichwansyah R, Boku S. Risk of diabetes mellitus with olanzapine compared to clozapine: A systematic review and meta-analysis. PCN Rep. 2025;4(4):e70215",
      "pubdate": "2025-10-17",
      "Lead_author": "Onda K",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/pcn5.70215",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Onda K, Ichwansyah R, Boku S. Risk of diabetes mellitus with olanzapine compared to clozapine: A systematic review and meta-analysis. PCN Rep. 2025;4(4):e70215",
    "leadAuthor": "Onda K",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh8CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh8CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4b59840501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707209
  },
  {
    "id": "CLOZ_Demo_52678",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41016724",
    "title": "Barriers to Clozapine Use in Europe: A New Hope.",
    "authors": [
      "Verdoux H",
      "Lepetit A",
      "Schulte PFJ"
    ],
    "journal": "Acta Psychiatr Scand",
    "publicationDate": "2025-09-29",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "bd3045ee-f3b1-42e5-aa36-03734235a27c",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.234Z"
      },
      {
        "id": "532570a6-9710-43ce-a340-8735123ef782",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from e1fc7576-e3c6-4fa8-be27-3a3ad26e4f92 to CLOZ_Demo_52678",
        "type": "system",
        "createdAt": "2025-12-14T10:13:29.822Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:16.060Z",
    "updatedAt": "2025-12-14T08:54:36.267Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41016724",
      "DOI": "https://doi.org10.1111/acps.70040",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:40:19",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Verdoux H, Lepetit A, Schulte PFJ. Barriers to Clozapine Use in Europe: A New Hope. Acta Psychiatr Scand. 2025;152(6):473-5",
      "pubdate": "2025-09-29",
      "Lead_author": "Verdoux H",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/acps.70040",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Verdoux H, Lepetit A, Schulte PFJ. Barriers to Clozapine Use in Europe: A New Hope. Acta Psychiatr Scand. 2025;152(6):473-5",
    "leadAuthor": "Verdoux H",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh9CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh9CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4b7a800501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707209
  },
  {
    "id": "CLOZ_Demo_66663",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40999235",
    "title": "Clozapine induces perineuronal net remodeling in a developmental mouse model exhibiting schizophrenia-relevant phenotypes.",
    "authors": [
      "García-Cerro S",
      "Gómez-Garrido A",
      "Soria FN",
      "Loucera C",
      "Crespo-Facorro B"
    ],
    "journal": "Neuropsychopharmacology",
    "publicationDate": "2025-09-26",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9ba4ee70-27fa-452e-ac24-c8a2473dd971",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.295Z"
      },
      {
        "id": "84b18117-302a-4988-99fb-fbfcf36efd14",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 1548d9a0-7b4e-4875-b001-2ff5b4126bc5 to CLOZ_Demo_66663",
        "type": "system",
        "createdAt": "2025-12-14T10:13:30.069Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:16.226Z",
    "updatedAt": "2025-12-14T08:54:36.303Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40999235",
      "DOI": "https://doi.org10.1038/s41386-025-02210-3",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:40:41",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "García-Cerro S, Gómez-Garrido A, Soria FN, Loucera C, Crespo-Facorro B. Clozapine induces perineuronal net remodeling in a developmental mouse model exhibiting schizophrenia-relevant phenotypes. Neuropsychopharmacology. 2025;50(13):2026-39",
      "pubdate": "2025-09-26",
      "Lead_author": "García-Cerro S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41386-025-02210-3",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "García-Cerro S, Gómez-Garrido A, Soria FN, Loucera C, Crespo-Facorro B. Clozapine induces perineuronal net remodeling in a developmental mouse model exhibiting schizophrenia-relevant phenotypes. Neuropsychopharmacology. 2025;50(13):2026-39",
    "leadAuthor": "García-Cerro S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh+CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh+CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4b95980501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707210
  },
  {
    "id": "CLOZ_Demo_90222",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40897058",
    "title": "CNO induced Ca store and glutamate-dependent nonspecific Ca signalling in DREADD-free brain slices.",
    "authors": [
      "Zhang XY",
      "Wu X",
      "Bi RY",
      "Zhang S",
      "Gan YH"
    ],
    "journal": "Cell Calcium",
    "publicationDate": "2025-09-2",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "60f1ef34-dc1a-4e33-9db4-c562ec787c38",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.326Z"
      },
      {
        "id": "901056de-1e82-4469-a278-7ae2342216ae",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3aaf1bee-c910-4e1b-bb50-b54446806ed3 to CLOZ_Demo_90222",
        "type": "system",
        "createdAt": "2025-12-14T10:13:30.307Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:16.303Z",
    "updatedAt": "2025-12-14T08:54:36.377Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40897058",
      "DOI": "https://doi.org10.1016/j.ceca.2025.103070",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:40:50",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Zhang XY, Wu X, Bi RY, Zhang S, Gan YH. CNO induced Ca<sup>2+</sup> store and glutamate-dependent nonspecific Ca<sup>2+</sup> signalling in DREADD-free brain slices. Cell Calcium. 2025;132103070",
      "pubdate": "2025-09-2",
      "Lead_author": "Zhang XY",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ceca.2025.103070",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Zhang XY, Wu X, Bi RY, Zhang S, Gan YH. CNO induced Ca<sup>2+</sup> store and glutamate-dependent nonspecific Ca<sup>2+</sup> signalling in DREADD-free brain slices. Cell Calcium. 2025;132103070",
    "leadAuthor": "Zhang XY",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUh-CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUh-CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4bba680501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707210
  },
  {
    "id": "CLOZ_Demo_61105",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40509777",
    "title": "Social demographics and clinical characteristics of referred adult mental health patients to an Australian secure extended care unit: A 5-year retrospective study.",
    "authors": [
      "Das P",
      "Robertson E",
      "Harpwood V",
      "Tierney S"
    ],
    "journal": "Int J Soc Psychiatry",
    "publicationDate": "2025-06-13",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "66f66226-859c-4200-a069-72519b1542a8",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.405Z"
      },
      {
        "id": "2a0504b2-e4f2-44a2-b0ff-42320dfd422c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 064a7ee7-bdb3-41e4-bd87-f5845c83fa40 to CLOZ_Demo_61105",
        "type": "system",
        "createdAt": "2025-12-14T10:13:30.508Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:16.489Z",
    "updatedAt": "2025-12-14T08:54:36.417Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40509777",
      "DOI": "https://doi.org10.1177/00207640251343171",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:41:12",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Das P, Robertson E, Harpwood V, Tierney S. Social demographics and clinical characteristics of referred adult mental health patients to an Australian secure extended care unit: A 5-year retrospective study. Int J Soc Psychiatry. 2025;71(8):1489-500",
      "pubdate": "2025-06-13",
      "Lead_author": "Das P",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1177/00207640251343171",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Das P, Robertson E, Harpwood V, Tierney S. Social demographics and clinical characteristics of referred adult mental health patients to an Australian secure extended care unit: A 5-year retrospective study. Int J Soc Psychiatry. 2025;71(8):1489-500",
    "leadAuthor": "Das P",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiACAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiACAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4bd90c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707210
  },
  {
    "id": "CLOZ_Demo_80340",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40227520",
    "title": "Semaglutide Plus Metformin Versus Metformin Alone For Antipsychotic-Induced Weight Gain In Patients With Type 2 Diabetes Mellitus.",
    "authors": [
      "Vu C",
      "Thai R",
      "Dike D",
      "Sydner B"
    ],
    "journal": "Psychiatr Q",
    "publicationDate": "2025-04-14",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "aac302ff-4294-4105-afc3-fba65716469e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.436Z"
      },
      {
        "id": "bac7d928-414a-4239-8901-c6cdf872a94b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9da3e80d-4059-45e7-ac9a-4bf75f9ed69b to CLOZ_Demo_80340",
        "type": "system",
        "createdAt": "2025-12-14T10:13:30.742Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:16.581Z",
    "updatedAt": "2025-12-14T08:54:36.473Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40227520",
      "DOI": "https://doi.org10.1007/s11126-025-10137-7",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:40:57",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Vu C, Thai R, Dike D, Sydner B. Semaglutide Plus Metformin Versus Metformin Alone For Antipsychotic-Induced Weight Gain In Patients With Type 2 Diabetes Mellitus. Psychiatr Q. 2025;96(4):819-27",
      "pubdate": "2025-04-14",
      "Lead_author": "Vu C",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s11126-025-10137-7",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Vu C, Thai R, Dike D, Sydner B. Semaglutide Plus Metformin Versus Metformin Alone For Antipsychotic-Induced Weight Gain In Patients With Type 2 Diabetes Mellitus. Psychiatr Q. 2025;96(4):819-27",
    "leadAuthor": "Vu C",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiBCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiBCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4bfc9c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707210
  },
  {
    "id": "CLOZ_Demo_70851",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39957245",
    "title": "Chemogenetic inhibition of corticotropin releasing hormone neurons in the paraventricular nucleus attenuates traumatic stress-induced deficit of NREM sleep, but not REM sleep in mice.",
    "authors": [
      "Kostin A",
      "Suntsova N",
      "Kumar S",
      "Gvilia I"
    ],
    "journal": "Stress",
    "publicationDate": "2025-02-17",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "f7aa3f93-e466-46cb-82f2-a607202b6f69",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.500Z"
      },
      {
        "id": "5d6e2a79-1923-40b7-9444-16e1588692ca",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 11025356-43ad-4179-84fa-6414b49eb147 to CLOZ_Demo_70851",
        "type": "system",
        "createdAt": "2025-12-14T10:13:30.972Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:11:16.725Z",
    "updatedAt": "2025-12-14T08:54:36.510Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39957245",
      "DOI": "https://doi.org10.1080/10253890.2025.2465393",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:41:06",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Kostin A, Suntsova N, Kumar S, Gvilia I. Chemogenetic inhibition of corticotropin releasing hormone neurons in the paraventricular nucleus attenuates traumatic stress-induced deficit of NREM sleep, but not REM sleep in mice. Stress. 2025;28(1):2465393",
      "pubdate": "2025-02-17",
      "Lead_author": "Kostin A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/10253890.2025.2465393",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Kostin A, Suntsova N, Kumar S, Gvilia I. Chemogenetic inhibition of corticotropin releasing hormone neurons in the paraventricular nucleus attenuates traumatic stress-induced deficit of NREM sleep, but not REM sleep in mice. Stress. 2025;28(1):2465393",
    "leadAuthor": "Kostin A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiCCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiCCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4c1f940501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707210
  },
  {
    "id": "CLOZ_Demo_70067",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41353489",
    "title": "Dopaminergic tone inhibits spontaneous glutamate release and augments homeostatic synaptic plasticity.",
    "authors": [
      "Uzay B",
      "Zhang KJ",
      "Monteggia LM",
      "Kavalali ET"
    ],
    "journal": "Mol Psychiatry",
    "publicationDate": "2025-12-7",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6812898c-bb44-4915-a148-4817e8b6093e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.530Z"
      },
      {
        "id": "111313ff-1366-462d-bab4-033fc273d7f1",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 7e6ec5c8-ef21-4b89-bd50-a3b18ed1d81a to CLOZ_Demo_70067",
        "type": "system",
        "createdAt": "2025-12-14T10:13:31.170Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:12:43.056Z",
    "updatedAt": "2025-12-14T08:54:36.581Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41353489",
      "DOI": "https://doi.org10.1038/s41380-025-03374-6",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:41:49",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Uzay B, Zhang KJ, Monteggia LM, Kavalali ET. Dopaminergic tone inhibits spontaneous glutamate release and augments homeostatic synaptic plasticity. Mol Psychiatry. 2025;",
      "pubdate": "2025-12-7",
      "Lead_author": "Uzay B",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41380-025-03374-6",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Uzay B, Zhang KJ, Monteggia LM, Kavalali ET. Dopaminergic tone inhibits spontaneous glutamate release and augments homeostatic synaptic plasticity. Mol Psychiatry. 2025;",
    "leadAuthor": "Uzay B",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiDCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiDCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4c3d640501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707211
  },
  {
    "id": "CLOZ_Demo_32794",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41344981",
    "title": "Incidence and demographic patterns of neutropenia in clozapine-treated patients with schizophrenia: A 20-year retrospective cohort study.",
    "authors": [
      "Ahmed S",
      "Beyene E",
      "Bisrat M",
      "Falegan T",
      "Hemphill A",
      "Mack A",
      "Elkomi R",
      "Zinabu S",
      "Michael M"
    ],
    "journal": "J Natl Med Assoc",
    "publicationDate": "2025-12-5",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "bc061789-a76a-48fc-8afb-88710cb3d006",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.607Z"
      },
      {
        "id": "3713451b-e458-42c7-a09c-915b3417ba1a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6b483f8a-32e8-44bf-9dfc-3c5919033af0 to CLOZ_Demo_32794",
        "type": "system",
        "createdAt": "2025-12-14T10:13:31.417Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:12:43.152Z",
    "updatedAt": "2025-12-14T08:54:36.620Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41344981",
      "DOI": "https://doi.org10.1016/j.jnma.2025.11.010",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:41:27",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Ahmed S, Beyene E, Bisrat M, Falegan T, Hemphill A, Mack A, Elkomi R, Zinabu S, Michael M. Incidence and demographic patterns of neutropenia in clozapine-treated patients with schizophrenia: A 20-year retrospective cohort study. J Natl Med Assoc. 2025;",
      "pubdate": "2025-12-5",
      "Lead_author": "Ahmed S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jnma.2025.11.010",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Ahmed S, Beyene E, Bisrat M, Falegan T, Hemphill A, Mack A, Elkomi R, Zinabu S, Michael M. Incidence and demographic patterns of neutropenia in clozapine-treated patients with schizophrenia: A 20-year retrospective cohort study. J Natl Med Assoc. 2025;",
    "leadAuthor": "Ahmed S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiECAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiECAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4c632c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707211
  },
  {
    "id": "CLOZ_Demo_33426",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41340627",
    "title": "Integrating Bioinformatics Analysis with RT-qPCR Experimental Validation to Investigate Immune Cell and Telomere-Related Biomarkers in Chronic Obstructive Pulmonary Disease.",
    "authors": [
      "Wang S",
      "Tang W",
      "Yang H"
    ],
    "journal": "Int J Chron Obstruct Pulmon Dis",
    "publicationDate": "2025-12-4",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "47eca847-a320-4a2d-8d38-6629eb32477e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.639Z"
      },
      {
        "id": "8ecce948-f2d4-4c17-96d0-80ce0c5123f6",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 1ee9d386-b569-4366-8d8f-c86d1a25a464 to CLOZ_Demo_33426",
        "type": "system",
        "createdAt": "2025-12-14T10:13:31.603Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:12:43.189Z",
    "updatedAt": "2025-12-14T08:54:36.677Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41340627",
      "DOI": "https://doi.org10.2147/COPD.S556818",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:41:36",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Wang S, Tang W, Yang H. Integrating Bioinformatics Analysis with RT-qPCR Experimental Validation to Investigate Immune Cell and Telomere-Related Biomarkers in Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2025;203839-54",
      "pubdate": "2025-12-4",
      "Lead_author": "Wang S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.2147/COPD.S556818",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Wang S, Tang W, Yang H. Integrating Bioinformatics Analysis with RT-qPCR Experimental Validation to Investigate Immune Cell and Telomere-Related Biomarkers in Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2025;203839-54",
    "leadAuthor": "Wang S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiFCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiFCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4c856c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707211
  },
  {
    "id": "CLOZ_Demo_83837",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41334758",
    "title": "Evolving Trends and Drug Class Dynamics in Drug-Induced Myocarditis: A 2-Decade Comparative Analysis of Pharmacovigilance Data.",
    "authors": [
      "Si L",
      "Xiang H",
      "Zhang Q",
      "Xiao S",
      "Yuan H"
    ],
    "journal": "J Am Heart Assoc",
    "publicationDate": "2025-12-3",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "57a3506d-06ec-47ea-a1a6-7ad5c931e28b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.703Z"
      },
      {
        "id": "41fd08f3-131a-4574-bd48-1f8adad56f97",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from efc06434-ef7c-475d-90c2-6bf0fbf344ae to CLOZ_Demo_83837",
        "type": "system",
        "createdAt": "2025-12-14T10:13:31.817Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:12:43.237Z",
    "updatedAt": "2025-12-14T08:54:36.717Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41334758",
      "DOI": "https://doi.org10.1161/JAHA.125.043064",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:41:43",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Si L, Xiang H, Zhang Q, Xiao S, Yuan H. Evolving Trends and Drug Class Dynamics in Drug-Induced Myocarditis: A 2-Decade Comparative Analysis of Pharmacovigilance Data. J Am Heart Assoc. 2025;e043064",
      "pubdate": "2025-12-3",
      "Lead_author": "Si L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1161/JAHA.125.043064",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Si L, Xiang H, Zhang Q, Xiao S, Yuan H. Evolving Trends and Drug Class Dynamics in Drug-Induced Myocarditis: A 2-Decade Comparative Analysis of Pharmacovigilance Data. J Am Heart Assoc. 2025;e043064",
    "leadAuthor": "Si L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiGCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiGCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4ca5bc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707211
  },
  {
    "id": "CLOZ_Demo_66249",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41283277",
    "title": "Prescription Patterns of Antiseizure Medication in Adult Patients with Epilepsy in Kazakhstan (2021-2023).",
    "authors": [
      "Kalinina D",
      "Aimyshev T",
      "Muxunov A",
      "Utebekov Z",
      "Kyrgyzbay G",
      "Kimadiev D",
      "Zhumabaeva G",
      "Gaipov A",
      "Sarria-Santamera A"
    ],
    "journal": "Med Sci (Basel)",
    "publicationDate": "2025-11-24",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "7aa66f14-8c2d-49e9-a85e-2f7cac3515a8",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.749Z"
      },
      {
        "id": "bdc6552f-b001-4e33-8231-57fa63a4df0a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 2449cbe2-a55a-4d19-a8ea-a93ea561f82b to CLOZ_Demo_66249",
        "type": "system",
        "createdAt": "2025-12-14T10:13:32.064Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:12:43.278Z",
    "updatedAt": "2025-12-14T08:54:36.763Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41283277",
      "DOI": "https://doi.org10.3390/medsci13040276",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:41:56",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Kalinina D, Aimyshev T, Muxunov A, Utebekov Z, Kyrgyzbay G, Kimadiev D, Zhumabaeva G, Gaipov A, Sarria-Santamera A. Prescription Patterns of Antiseizure Medication in Adult Patients with Epilepsy in Kazakhstan (2021-2023). Med Sci (Basel). 2025;13(4):",
      "pubdate": "2025-11-24",
      "Lead_author": "Kalinina D",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.3390/medsci13040276",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Kalinina D, Aimyshev T, Muxunov A, Utebekov Z, Kyrgyzbay G, Kimadiev D, Zhumabaeva G, Gaipov A, Sarria-Santamera A. Prescription Patterns of Antiseizure Medication in Adult Patients with Epilepsy in Kazakhstan (2021-2023). Med Sci (Basel). 2025;13(4):",
    "leadAuthor": "Kalinina D",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiHCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiHCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4cc6100501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707212
  },
  {
    "id": "CLOZ_Demo_51639",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41248851",
    "title": "Clinical and molecular implications of antipsychotics in MASLD.",
    "authors": [
      "Gonzalez C",
      "Uribe M",
      "Chavez-Tapia NC"
    ],
    "journal": "Ann Hepatol",
    "publicationDate": "2025-11-18",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "2c965b7d-dc9e-49f7-924c-e9335d0144fb",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.780Z"
      },
      {
        "id": "e1c02681-2ec4-414d-80b8-4a305c777cb3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d17b6b1c-6257-4704-9311-1c7cf4599495 to CLOZ_Demo_51639",
        "type": "system",
        "createdAt": "2025-12-14T10:13:32.300Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:12:43.333Z",
    "updatedAt": "2025-12-14T08:54:36.832Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41248851",
      "DOI": "https://doi.org10.1016/j.aohep.2025.102158",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:42:11",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Gonzalez C, Uribe M, Chavez-Tapia NC. Clinical and molecular implications of antipsychotics in MASLD. Ann Hepatol. 2025;102158",
      "pubdate": "2025-11-18",
      "Lead_author": "Gonzalez C",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.aohep.2025.102158",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Gonzalez C, Uribe M, Chavez-Tapia NC. Clinical and molecular implications of antipsychotics in MASLD. Ann Hepatol. 2025;102158",
    "leadAuthor": "Gonzalez C",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiICAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiICAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4cea580501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707212
  },
  {
    "id": "CLOZ_Demo_46929",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41247448",
    "title": "The Impact of Fluvoxamine on Clozapine and Norclozapine Serum Concentrations.",
    "authors": [
      "van Weringh G",
      "de Haas HJ",
      "de Haan L",
      "Touw DJ",
      "de Koning MB"
    ],
    "journal": "Eur J Drug Metab Pharmacokinet",
    "publicationDate": "2025-11-17",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "68c71973-4e92-4dd8-b3f9-bc6bfdb022d9",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.858Z"
      },
      {
        "id": "85bcbbb9-f49f-4da2-bd76-d9078892ea63",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 2b4f340b-d798-4d6f-bfb1-1b038224ca4d to CLOZ_Demo_46929",
        "type": "system",
        "createdAt": "2025-12-14T10:13:32.499Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:12:43.373Z",
    "updatedAt": "2025-12-14T08:54:36.870Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41247448",
      "DOI": "https://doi.org10.1007/s13318-025-00972-1",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:42:04",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "van Weringh G, de Haas HJ, de Haan L, Touw DJ, de Koning MB. The Impact of Fluvoxamine on Clozapine and Norclozapine Serum Concentrations. Eur J Drug Metab Pharmacokinet. 2025;",
      "pubdate": "2025-11-17",
      "Lead_author": "van Weringh G",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s13318-025-00972-1",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "van Weringh G, de Haas HJ, de Haan L, Touw DJ, de Koning MB. The Impact of Fluvoxamine on Clozapine and Norclozapine Serum Concentrations. Eur J Drug Metab Pharmacokinet. 2025;",
    "leadAuthor": "van Weringh G",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiJCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiJCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4d08740501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707212
  },
  {
    "id": "CLOZ_Demo_42729",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41238905",
    "title": "Behavioral impact of chemogenetic manipulations of 5-HT DRN neurons in transgenic Tph2-iCre rats.",
    "authors": [
      "McCloskey NS",
      "Li C",
      "Kirby LG"
    ],
    "journal": "Psychopharmacology (Berl)",
    "publicationDate": "2025-11-15",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "02ccffb7-d873-443b-8bb9-eb532e14a143",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.887Z"
      },
      {
        "id": "6595e710-61dd-4f20-b416-4712a8522de0",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a774dfdd-ad9a-450e-8977-a96c5d012e9a to CLOZ_Demo_42729",
        "type": "system",
        "createdAt": "2025-12-14T10:13:32.731Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:12:43.422Z",
    "updatedAt": "2025-12-14T08:54:36.898Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41238905",
      "DOI": "https://doi.org10.1007/s00213-025-06947-z",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:42:18",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "McCloskey NS, Li C, Kirby LG. Behavioral impact of chemogenetic manipulations of 5-HT DRN neurons in transgenic Tph2-iCre rats. Psychopharmacology (Berl). 2025;",
      "pubdate": "2025-11-15",
      "Lead_author": "McCloskey NS",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s00213-025-06947-z",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "McCloskey NS, Li C, Kirby LG. Behavioral impact of chemogenetic manipulations of 5-HT DRN neurons in transgenic Tph2-iCre rats. Psychopharmacology (Berl). 2025;",
    "leadAuthor": "McCloskey NS",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiKCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiKCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4d2ba40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707212
  },
  {
    "id": "CLOZ_Demo_81844",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40977846",
    "title": "Survival following intentional overdose of veterinary insulin: A case report.",
    "authors": [
      "Sandeno E",
      "Karachenets S",
      "Zehlke K",
      "Khan R",
      "Kalinoski M",
      "Meshram P",
      "Harmon JV"
    ],
    "journal": "Toxicol Rep",
    "publicationDate": "2025-09-22",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "1da845ff-24fa-4364-8d7a-c7300dc93f59",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:36.919Z"
      },
      {
        "id": "ca08b5de-2b62-40a9-9d9b-016f1415c277",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 4911628c-b40b-4669-86e1-9cfee268c708 to CLOZ_Demo_81844",
        "type": "system",
        "createdAt": "2025-12-14T10:13:32.950Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:12:43.468Z",
    "updatedAt": "2025-12-14T08:54:36.989Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40977846",
      "DOI": "https://doi.org10.1016/j.toxrep.2025.102114",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:42:25",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Sandeno E, Karachenets S, Zehlke K, Khan R, Kalinoski M, Meshram P, Harmon JV. Survival following intentional overdose of veterinary insulin: A case report. Toxicol Rep. 2025;15102114",
      "pubdate": "2025-09-22",
      "Lead_author": "Sandeno E",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.toxrep.2025.102114",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Sandeno E, Karachenets S, Zehlke K, Khan R, Kalinoski M, Meshram P, Harmon JV. Survival following intentional overdose of veterinary insulin: A case report. Toxicol Rep. 2025;15102114",
    "leadAuthor": "Sandeno E",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiLCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiLCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4d4d740501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707212
  },
  {
    "id": "CLOZ_Demo_45016",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40974055",
    "title": "Adolescent-onset primary brain calcification: a case report presenting with neuropsychiatric symptoms.",
    "authors": [
      "Özaydın Y",
      "Ocakoğlu FT",
      "Ercan ES"
    ],
    "journal": "Neurocase",
    "publicationDate": "2025-09-20",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "74548292-85b4-409c-b784-8e612e528b34",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.013Z"
      },
      {
        "id": "c5841a8d-48c3-41e7-8502-81e4587006c2",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 25905982-1f25-40b4-956a-04377d7ac72e to CLOZ_Demo_45016",
        "type": "system",
        "createdAt": "2025-12-14T10:13:33.146Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:12:43.516Z",
    "updatedAt": "2025-12-14T08:54:37.024Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40974055",
      "DOI": "https://doi.org10.1080/13554794.2025.2562920",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:42:33",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Özaydın Y, Ocakoğlu FT, Ercan ES. Adolescent-onset primary brain calcification: a case report presenting with neuropsychiatric symptoms. Neurocase. 2025;31(6):278-84",
      "pubdate": "2025-09-20",
      "Lead_author": "Özaydın Y",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/13554794.2025.2562920",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Özaydın Y, Ocakoğlu FT, Ercan ES. Adolescent-onset primary brain calcification: a case report presenting with neuropsychiatric symptoms. Neurocase. 2025;31(6):278-84",
    "leadAuthor": "Özaydın Y",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiMCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiMCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4d6ef00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707213
  },
  {
    "id": "CLOZ_Demo_84690",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40923586",
    "title": "Repurposed antihypertensive drugs for negative symptoms in schizophrenia: A systematic review and meta-analysis.",
    "authors": [
      "Carnaval T",
      "Bui M",
      "Villoria J",
      "Rodríguez D",
      "Menchón JM",
      "Ciruela F",
      "Videla S"
    ],
    "journal": "Psychiatry Clin Neurosci",
    "publicationDate": "2025-09-9",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "e90632f0-5388-4819-998a-c1f80f8af474",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.041Z"
      },
      {
        "id": "731e1bf5-8657-456b-aebc-06066e70d11b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from baa26261-99f5-406a-8aec-a0dbea8bb6e8 to CLOZ_Demo_84690",
        "type": "system",
        "createdAt": "2025-12-14T10:13:33.380Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:12:43.562Z",
    "updatedAt": "2025-12-14T08:54:37.051Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40923586",
      "DOI": "https://doi.org10.1111/pcn.13892",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:42:40",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Carnaval T, Bui M, Villoria J, Rodríguez D, Menchón JM, Ciruela F, Videla S. Repurposed antihypertensive drugs for negative symptoms in schizophrenia: A systematic review and meta-analysis. Psychiatry Clin Neurosci. 2025;79(12):784-800",
      "pubdate": "2025-09-9",
      "Lead_author": "Carnaval T",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/pcn.13892",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Carnaval T, Bui M, Villoria J, Rodríguez D, Menchón JM, Ciruela F, Videla S. Repurposed antihypertensive drugs for negative symptoms in schizophrenia: A systematic review and meta-analysis. Psychiatry Clin Neurosci. 2025;79(12):784-800",
    "leadAuthor": "Carnaval T",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiNCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiNCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4d8f140501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707213
  },
  {
    "id": "CLOZ_Demo_90128",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41296204",
    "title": "Contrasting Effects of Clozapine and Risperidone on Cholesterol Metabolism, Synaptic Proteins, and Transcriptional Regulation in Human LUHMES Neurons.",
    "authors": [
      "Rybczyński P",
      "Cacala R",
      "Cepil Z",
      "Fic E",
      "Romanska W",
      "Marczak L",
      "Pustelny K",
      "Kedracka-Krok S"
    ],
    "journal": "Mol Neurobiol",
    "publicationDate": "2025-11-26",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "60c8ec67-6ab1-453b-bcab-27ac3e7c34bd",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.075Z"
      },
      {
        "id": "dbbb0d29-a1e0-4c60-a5ad-9d8cf04cfb06",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 50698545-6bd0-44ae-8f39-d9229b9c7ce5 to CLOZ_Demo_90128",
        "type": "system",
        "createdAt": "2025-12-14T10:13:33.627Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:13:34.262Z",
    "updatedAt": "2025-12-14T08:54:37.124Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41296204",
      "DOI": "https://doi.org10.1007/s12035-025-05515-y",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:43:03",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Rybczyński P, Cacala R, Cepil Z, Fic E, Romanska W, Marczak L, Pustelny K, Kedracka-Krok S. Contrasting Effects of Clozapine and Risperidone on Cholesterol Metabolism, Synaptic Proteins, and Transcriptional Regulation in Human LUHMES Neurons. Mol Neurobiol. 2025;63(1):175",
      "pubdate": "2025-11-26",
      "Lead_author": "Rybczyński P",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s12035-025-05515-y",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Rybczyński P, Cacala R, Cepil Z, Fic E, Romanska W, Marczak L, Pustelny K, Kedracka-Krok S. Contrasting Effects of Clozapine and Risperidone on Cholesterol Metabolism, Synaptic Proteins, and Transcriptional Regulation in Human LUHMES Neurons. Mol Neurobiol. 2025;63(1):175",
    "leadAuthor": "Rybczyński P",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiOCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiOCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4db4b80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707213
  },
  {
    "id": "CLOZ_Demo_15001",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41293932",
    "title": "Adverse Reactions to Clozapine: Plasma Clozapine in Relation to Smoking Status.",
    "authors": [
      "Flanagan RJ",
      "Rogers JP",
      "Sanchez PLV",
      "Evans L",
      "Obee SJ",
      "Kim AHM",
      "Every-Palmer S",
      "Reeves S"
    ],
    "journal": "J Clin Psychopharmacol",
    "publicationDate": "2025-11-26",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "676d090f-0e88-4efa-9e83-94ccda0ccd8e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.153Z"
      },
      {
        "id": "4b79f578-b760-43e0-9aa4-0cea4613b48d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3e7368fa-fd55-4963-a0e9-54cae8be2467 to CLOZ_Demo_15001",
        "type": "system",
        "createdAt": "2025-12-14T10:13:33.811Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:13:34.365Z",
    "updatedAt": "2025-12-14T08:54:37.162Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41293932",
      "DOI": "https://doi.org10.1097/JCP.0000000000002108",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:43:10",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Flanagan RJ, Rogers JP, Sanchez PLV, Evans L, Obee SJ, Kim AHM, Every-Palmer S, Reeves S. Adverse Reactions to Clozapine: Plasma Clozapine in Relation to Smoking Status. J Clin Psychopharmacol. 2025;",
      "pubdate": "2025-11-26",
      "Lead_author": "Flanagan RJ",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/JCP.0000000000002108",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Flanagan RJ, Rogers JP, Sanchez PLV, Evans L, Obee SJ, Kim AHM, Every-Palmer S, Reeves S. Adverse Reactions to Clozapine: Plasma Clozapine in Relation to Smoking Status. J Clin Psychopharmacol. 2025;",
    "leadAuthor": "Flanagan RJ",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiPCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiPCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4dd6940501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707213
  },
  {
    "id": "CLOZ_Demo_79692",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41287624",
    "title": "Association Between Specific Insomnia Symptoms and Aggression in Chinese Patients with Chronic Schizophrenia: A Large-Scale Cross-Sectional Study.",
    "authors": [
      "Wei L",
      "Zhou Y",
      "Peng P",
      "Zhang X"
    ],
    "journal": "Nat Sci Sleep",
    "publicationDate": "2025-11-25",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "faabe729-b9c2-43d5-ab0e-73ba6ae969b1",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.184Z"
      },
      {
        "id": "58a49acf-42b1-441c-baa2-ab4aa8e49dde",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 557d2e6b-42bb-4e51-a318-43f2ebaab490 to CLOZ_Demo_79692",
        "type": "system",
        "createdAt": "2025-12-14T10:13:34.045Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:13:34.417Z",
    "updatedAt": "2025-12-14T08:54:37.221Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41287624",
      "DOI": "https://doi.org10.2147/NSS.S552016",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:42:56",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Wei L, Zhou Y, Peng P, Zhang X. Association Between Specific Insomnia Symptoms and Aggression in Chinese Patients with Chronic Schizophrenia: A Large-Scale Cross-Sectional Study. Nat Sci Sleep. 2025;172991-3002",
      "pubdate": "2025-11-25",
      "Lead_author": "Wei L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.2147/NSS.S552016",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Wei L, Zhou Y, Peng P, Zhang X. Association Between Specific Insomnia Symptoms and Aggression in Chinese Patients with Chronic Schizophrenia: A Large-Scale Cross-Sectional Study. Nat Sci Sleep. 2025;172991-3002",
    "leadAuthor": "Wei L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiQCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiQCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4df7840501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707214
  },
  {
    "id": "CLOZ_Demo_11725",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41258376",
    "title": "Molecular and topographic mapping of antipsychotic effects: a meta-analysis of postsynaptic density proteins in animal models with translational implications.",
    "authors": [
      "De Simone G",
      "De Prisco M",
      "Oliva V",
      "Vellucci L",
      "Ciccarelli M",
      "Mazza B",
      "Fico G",
      "Fornaro M",
      "Iasevoli F",
      "Vieta E",
      "de Bartolomeis A"
    ],
    "journal": "Mol Psychiatry",
    "publicationDate": "2025-11-19",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "36dc7643-d319-4d59-b3ad-70cc7167a051",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.246Z"
      },
      {
        "id": "0168324e-6026-47a7-9503-5b54a4300cf1",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from b5b2bcc9-2456-46d6-91e4-3e6a48761426 to CLOZ_Demo_11725",
        "type": "system",
        "createdAt": "2025-12-14T10:13:34.292Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:13:34.460Z",
    "updatedAt": "2025-12-14T08:54:37.259Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41258376",
      "DOI": "https://doi.org10.1038/s41380-025-03351-z",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:43:18",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "De Simone G, De Prisco M, Oliva V, Vellucci L, Ciccarelli M, Mazza B, Fico G, Fornaro M, Iasevoli F, Vieta E, de Bartolomeis A. Molecular and topographic mapping of antipsychotic effects: a meta-analysis of postsynaptic density proteins in animal models with translational implications. Mol Psychiatry. 2025;",
      "pubdate": "2025-11-19",
      "Lead_author": "De Simone G",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41380-025-03351-z",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "De Simone G, De Prisco M, Oliva V, Vellucci L, Ciccarelli M, Mazza B, Fico G, Fornaro M, Iasevoli F, Vieta E, de Bartolomeis A. Molecular and topographic mapping of antipsychotic effects: a meta-analysis of postsynaptic density proteins in animal models with translational implications. Mol Psychiatry. 2025;",
    "leadAuthor": "De Simone G",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiRCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiRCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4e1a600501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707214
  },
  {
    "id": "CLOZ_Demo_39894",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40953812",
    "title": "Primary auditory cortex activity during early retrieval supports later extinction learning.",
    "authors": [
      "Cook NB",
      "Wasberg SM",
      "Henneghan TG",
      "Ogallar PM",
      "Ramos-Alvarez MM",
      "Muzzio IA"
    ],
    "journal": "Neurobiol Learn Mem",
    "publicationDate": "2025-09-16",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "2a02c80b-a240-4c94-bd9b-4a83a152e64d",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.275Z"
      },
      {
        "id": "73a54232-5704-4364-aeb9-6300d13dd094",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6fa95556-9c6d-4e12-9f02-7f2438f46903 to CLOZ_Demo_39894",
        "type": "system",
        "createdAt": "2025-12-14T10:13:34.476Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:13:34.501Z",
    "updatedAt": "2025-12-14T08:54:37.325Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40953812",
      "DOI": "https://doi.org10.1016/j.nlm.2025.108102",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:43:32",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Cook NB, Wasberg SM, Henneghan TG, Ogallar PM, Ramos-Alvarez MM, Muzzio IA. Primary auditory cortex activity during early retrieval supports later extinction learning. Neurobiol Learn Mem. 2025;222108102",
      "pubdate": "2025-09-16",
      "Lead_author": "Cook NB",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.nlm.2025.108102",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Cook NB, Wasberg SM, Henneghan TG, Ogallar PM, Ramos-Alvarez MM, Muzzio IA. Primary auditory cortex activity during early retrieval supports later extinction learning. Neurobiol Learn Mem. 2025;222108102",
    "leadAuthor": "Cook NB",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiSCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiSCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4e3e000501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707214
  },
  {
    "id": "CLOZ_Demo_15590",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40945568",
    "title": "A sensitive colorimetric immunosensor for clozapine, norclozapine, and clozapine-N-oxide simultaneous detection based on monoclonal antibodies preparation with homogeneous cross-reactivity.",
    "authors": [
      "Li J",
      "Guo L",
      "Zhu Y",
      "Wang J",
      "Xu C",
      "Kuang H",
      "Xu X"
    ],
    "journal": "Environ Pollut",
    "publicationDate": "2025-09-14",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "4cefa474-3b8b-40ea-b954-d1d2a47ae429",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.353Z"
      },
      {
        "id": "737adecc-5626-45ae-8f2f-d797fb2f3484",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 76dd6f7d-fd44-4498-b6db-2aee7b3563a8 to CLOZ_Demo_15590",
        "type": "system",
        "createdAt": "2025-12-14T10:13:34.693Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:13:34.533Z",
    "updatedAt": "2025-12-14T08:54:37.366Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40945568",
      "DOI": "https://doi.org10.1016/j.envpol.2025.127106",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:43:25",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Li J, Guo L, Zhu Y, Wang J, Xu C, Kuang H, Xu X. A sensitive colorimetric immunosensor for clozapine, norclozapine, and clozapine-N-oxide simultaneous detection based on monoclonal antibodies preparation with homogeneous cross-reactivity. Environ Pollut. 2025;385127106",
      "pubdate": "2025-09-14",
      "Lead_author": "Li J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.envpol.2025.127106",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Li J, Guo L, Zhu Y, Wang J, Xu C, Kuang H, Xu X. A sensitive colorimetric immunosensor for clozapine, norclozapine, and clozapine-N-oxide simultaneous detection based on monoclonal antibodies preparation with homogeneous cross-reactivity. Environ Pollut. 2025;385127106",
    "leadAuthor": "Li J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiTCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiTCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4e5f300501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707214
  },
  {
    "id": "CLOZ_Demo_64772",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41249957",
    "title": "A study on the effect of COVID-19 infection on the serum concentration of antipsychotic drugs.",
    "authors": [
      "Liu T",
      "Shi Z",
      "Chen R",
      "Zhang H",
      "Wang C",
      "Gao W",
      "Gao P",
      "Li W"
    ],
    "journal": "BMC Psychiatry",
    "publicationDate": "2025-11-18",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a3331cdf-86a7-4857-8e4c-9fdec3b7306e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.381Z"
      },
      {
        "id": "5445aae2-3544-487c-8142-10aa730833c7",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 47b05c73-d998-44aa-a677-8255ad5d4cab to CLOZ_Demo_64772",
        "type": "system",
        "createdAt": "2025-12-14T10:13:34.954Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T15:13:53.505Z",
    "updatedAt": "2025-12-14T08:54:37.391Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41249957",
      "DOI": "https://doi.org10.1186/s12888-025-07400-3",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 20:43:51",
      "Drugname": "CLOZAPINE*",
      "Vancouver_citation": "Liu T, Shi Z, Chen R, Zhang H, Wang C, Gao W, Gao P, Li W. A study on the effect of COVID-19 infection on the serum concentration of antipsychotic drugs. BMC Psychiatry. 2025;25(1):1094",
      "pubdate": "2025-11-18",
      "Lead_author": "Liu T",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s12888-025-07400-3",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE*",
    "vancouverCitation": "Liu T, Shi Z, Chen R, Zhang H, Wang C, Gao W, Gao P, Li W. A study on the effect of COVID-19 infection on the serum concentration of antipsychotic drugs. BMC Psychiatry. 2025;25(1):1094",
    "leadAuthor": "Liu T",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiUCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiUCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4e7f440501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707214
  },
  {
    "id": "CELE_Demo_47521",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41383439",
    "title": "Interdisciplinary pharmaceutical care model engaging patient participation alleviate the anticholinergic burden in community-dwelling older adults: subgroup analysis of a randomized controlled trial.",
    "authors": [
      "Chen LY",
      "Liao LC",
      "Chuang CJ",
      "Hsieh CY",
      "Huang YC",
      "Yang YH",
      "Chang WT",
      "Fu SH",
      "Yang FJ",
      "Chang KC",
      "Chan DC",
      "Shen LJ",
      "Hsiao FY",
      "Huang YM",
      "Hsu CC",
      "Wang CY"
    ],
    "journal": "Ther Adv Drug Saf",
    "publicationDate": "2025-12-12",
    "abstract": "Article requires manual review",
    "drugName": "CELECOXIB*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "62c41f3a-d21f-4871-ae58-cc3bd6005782",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.444Z"
      },
      {
        "id": "45a25f6d-dfe9-4a51-91f4-5f678f97cbfd",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from c6f7e259-b535-4a06-8e8f-56b8d1fa4278 to CELE_Demo_47521",
        "type": "system",
        "createdAt": "2025-12-14T10:13:35.169Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T16:26:06.902Z",
    "updatedAt": "2025-12-14T08:54:37.455Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41383439",
      "DOI": "https://doi.org10.1177/20420986251401128",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CELECOXIB*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 21:55:51",
      "Drugname": "CELECOXIB*",
      "Vancouver_citation": "Chen LY, Liao LC, Chuang CJ, Hsieh CY, Huang YC, Yang YH, Chang WT, Fu SH, Yang FJ, Chang KC, Chan DC, Shen LJ, Hsiao FY, Huang YM, Hsu CC, Wang CY. Interdisciplinary pharmaceutical care model engaging patient participation alleviate the anticholinergic burden in community-dwelling older adults: subgroup analysis of a randomized controlled trial. Ther Adv Drug Saf. 2025;1620420986251401128",
      "pubdate": "2025-12-12",
      "Lead_author": "Chen LY",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1177/20420986251401128",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CELECOXIB*",
    "vancouverCitation": "Chen LY, Liao LC, Chuang CJ, Hsieh CY, Huang YC, Yang YH, Chang WT, Fu SH, Yang FJ, Chang KC, Chan DC, Shen LJ, Hsiao FY, Huang YM, Hsu CC, Wang CY. Interdisciplinary pharmaceutical care model engaging patient participation alleviate the anticholinergic burden in community-dwelling older adults: subgroup analysis of a randomized controlled trial. Ther Adv Drug Saf. 2025;1620420986251401128",
    "leadAuthor": "Chen LY",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiVCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiVCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4e9ff40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707215
  },
  {
    "id": "CELE_Demo_78750",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41372605",
    "title": "Gentisic acid ameliorates lumbar disc herniation by regulating M1/M2 Polarization via the MAPK14/S100A9/Rac1/2 pathway.",
    "authors": [
      "Li S",
      "Chen T",
      "Shen X",
      "Su W",
      "Li X"
    ],
    "journal": "Cell Biol Toxicol",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "CELECOXIB*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "22a15c73-4378-4899-8483-c31ffdf5bb80",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.475Z"
      },
      {
        "id": "18466d65-09e9-4966-8816-5638ee45766a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 8a7c150d-ca71-49ea-816a-4aa227c07f4f to CELE_Demo_78750",
        "type": "system",
        "createdAt": "2025-12-14T10:13:35.401Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T16:26:06.945Z",
    "updatedAt": "2025-12-14T08:54:37.528Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41372605",
      "DOI": "https://doi.org10.1007/s10565-025-10117-4",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CELECOXIB*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 21:55:44",
      "Drugname": "CELECOXIB*",
      "Vancouver_citation": "Li S, Chen T, Shen X, Su W, Li X. Gentisic acid ameliorates lumbar disc herniation by regulating M1/M2 Polarization via the MAPK14/S100A9/Rac1/2 pathway. Cell Biol Toxicol. 2025;41(1):161",
      "pubdate": "2025-12-11",
      "Lead_author": "Li S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s10565-025-10117-4",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CELECOXIB*",
    "vancouverCitation": "Li S, Chen T, Shen X, Su W, Li X. Gentisic acid ameliorates lumbar disc herniation by regulating M1/M2 Polarization via the MAPK14/S100A9/Rac1/2 pathway. Cell Biol Toxicol. 2025;41(1):161",
    "leadAuthor": "Li S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiWCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiWCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4ec3600501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707215
  },
  {
    "id": "CELE_Demo_99672",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41371320",
    "title": "Current state of machine learning implementation in pharmaceutical process modeling for oral solid dosage forms.",
    "authors": [
      "Rezaeizadeh M",
      "Razavi SM",
      "Muzzio FJ"
    ],
    "journal": "Int J Pharm",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "CELECOXIB*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "1fc2bcd6-1335-4965-914b-72e050f6845a",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.554Z"
      },
      {
        "id": "ce18f734-96be-4702-8764-804bcc23d826",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 2d52f5d8-86c2-412e-aca2-568b700d0125 to CELE_Demo_99672",
        "type": "system",
        "createdAt": "2025-12-14T10:13:35.636Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T16:26:06.997Z",
    "updatedAt": "2025-12-14T08:54:37.565Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41371320",
      "DOI": "https://doi.org10.1016/j.ijpharm.2025.126479",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CELECOXIB*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 21:55:37",
      "Drugname": "CELECOXIB*",
      "Vancouver_citation": "Rezaeizadeh M, Razavi SM, Muzzio FJ. Current state of machine learning implementation in pharmaceutical process modeling for oral solid dosage forms. Int J Pharm. 2025;126479",
      "pubdate": "2025-12-11",
      "Lead_author": "Rezaeizadeh M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ijpharm.2025.126479",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CELECOXIB*",
    "vancouverCitation": "Rezaeizadeh M, Razavi SM, Muzzio FJ. Current state of machine learning implementation in pharmaceutical process modeling for oral solid dosage forms. Int J Pharm. 2025;126479",
    "leadAuthor": "Rezaeizadeh M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiXCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiXCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4ee7280501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707215
  },
  {
    "id": "CELE_Demo_11849",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41366055",
    "title": "Randomized open-label non-inferiority trial of paracetamol or celecoxib for patients with chronic low back pain.",
    "authors": [
      "Hayashi K",
      "Miki K",
      "Ueno H",
      "Sekiguchi M",
      "Arai YC",
      "Nikaido T",
      "Shiga Y",
      "Inoue M",
      "Kataoka H",
      "Kawarai Y",
      "Kimura Y",
      "Shimizu K",
      "Shimo K",
      "Shiro Y",
      "Tanaka K",
      "Tanaka S",
      "Hirakawa Y",
      "Miura K",
      "Yukioka M"
    ],
    "journal": "Sci Rep",
    "publicationDate": "2025-12-10",
    "abstract": "Article requires manual review",
    "drugName": "CELECOXIB*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "babf6c17-46e8-4b26-9dc3-166b7b51e265",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.584Z"
      },
      {
        "id": "85237faf-3454-434a-a6e5-8b3e0a8872d3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a14b9969-ce31-47c2-b72f-b7b57d5a5092 to CELE_Demo_11849",
        "type": "system",
        "createdAt": "2025-12-14T10:13:35.849Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T16:26:07.040Z",
    "updatedAt": "2025-12-14T08:54:37.597Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41366055",
      "DOI": "https://doi.org10.1038/s41598-025-31094-y",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CELECOXIB*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 21:55:00",
      "Drugname": "CELECOXIB*",
      "Vancouver_citation": "Hayashi K, Miki K, Ueno H, Sekiguchi M, Arai YC, Nikaido T, Shiga Y, Inoue M, Kataoka H, Kawarai Y, Kimura Y, Shimizu K, Shimo K, Shiro Y, Tanaka K, Tanaka S, Hirakawa Y, Miura K, Yukioka M. Randomized open-label non-inferiority trial of paracetamol or celecoxib for patients with chronic low back pain. Sci Rep. 2025;",
      "pubdate": "2025-12-10",
      "Lead_author": "Hayashi K",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1038/s41598-025-31094-y",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CELECOXIB*",
    "vancouverCitation": "Hayashi K, Miki K, Ueno H, Sekiguchi M, Arai YC, Nikaido T, Shiga Y, Inoue M, Kataoka H, Kawarai Y, Kimura Y, Shimizu K, Shimo K, Shiro Y, Tanaka K, Tanaka S, Hirakawa Y, Miura K, Yukioka M. Randomized open-label non-inferiority trial of paracetamol or celecoxib for patients with chronic low back pain. Sci Rep. 2025;",
    "leadAuthor": "Hayashi K",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiYCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiYCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4f07980501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707215
  },
  {
    "id": "CELE_Demo_57536",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41362953",
    "title": "Opportunities and challenges for the implementation of pharmacogenomics in supportive care for gastrointestinal cancer patients in Zimbabwe.",
    "authors": [
      "Mazhindu TA",
      "Ndlovu N",
      "Borok MZ",
      "Grimes K",
      "Masimirembwa C"
    ],
    "journal": "Pharmacogenomics",
    "publicationDate": "2025-12-9",
    "abstract": "Article requires manual review",
    "drugName": "CELECOXIB*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "2f27224e-3035-4154-b911-62c0e09b8b2c",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.648Z"
      },
      {
        "id": "50a0fae2-2183-4d2b-8391-bfdab0474dbc",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6f5814e3-1146-429b-8512-15ae42eba789 to CELE_Demo_57536",
        "type": "system",
        "createdAt": "2025-12-14T10:13:36.090Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T16:26:07.082Z",
    "updatedAt": "2025-12-14T08:54:37.661Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41362953",
      "DOI": "https://doi.org10.1080/14622416.2025.2600695",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CELECOXIB*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 21:56:05",
      "Drugname": "CELECOXIB*",
      "Vancouver_citation": "Mazhindu TA, Ndlovu N, Borok MZ, Grimes K, Masimirembwa C. Opportunities and challenges for the implementation of pharmacogenomics in supportive care for gastrointestinal cancer patients in Zimbabwe. Pharmacogenomics. 2025;1-9",
      "pubdate": "2025-12-9",
      "Lead_author": "Mazhindu TA",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/14622416.2025.2600695",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CELECOXIB*",
    "vancouverCitation": "Mazhindu TA, Ndlovu N, Borok MZ, Grimes K, Masimirembwa C. Opportunities and challenges for the implementation of pharmacogenomics in supportive care for gastrointestinal cancer patients in Zimbabwe. Pharmacogenomics. 2025;1-9",
    "leadAuthor": "Mazhindu TA",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiZCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiZCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4f2c600501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707216
  },
  {
    "id": "CELE_Demo_52068",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41324980",
    "title": "Electrochemical 2-Deoxyglycosylation of -Containing Molecules with β-Stereoselectivity.",
    "authors": [
      "Chang S",
      "Cao Z",
      "Jiang K",
      "Gao Y",
      "Zhou S",
      "He G"
    ],
    "journal": "Org Lett",
    "publicationDate": "2025-12-1",
    "abstract": "Article requires manual review",
    "drugName": "CELECOXIB*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "27778f08-d790-482b-9e3b-e88b129a2c68",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.678Z"
      },
      {
        "id": "5fec6f7b-df49-4b56-8c54-253915b92409",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 22e95917-fbfd-4961-8696-a6f55c007875 to CELE_Demo_52068",
        "type": "system",
        "createdAt": "2025-12-14T10:13:36.286Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T16:26:07.130Z",
    "updatedAt": "2025-12-14T08:54:37.713Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41324980",
      "DOI": "https://doi.org10.1021/acs.orglett.5c03784",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CELECOXIB*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 21:55:58",
      "Drugname": "CELECOXIB*",
      "Vancouver_citation": "Chang S, Cao Z, Jiang K, Gao Y, Zhou S, He G. Electrochemical 2-Deoxyglycosylation of <i>N</i>-Containing Molecules with β-Stereoselectivity. Org Lett. 2025;27(49):13412-",
      "pubdate": "2025-12-1",
      "Lead_author": "Chang S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1021/acs.orglett.5c03784",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CELECOXIB*",
    "vancouverCitation": "Chang S, Cao Z, Jiang K, Gao Y, Zhou S, He G. Electrochemical 2-Deoxyglycosylation of <i>N</i>-Containing Molecules with β-Stereoselectivity. Org Lett. 2025;27(49):13412-",
    "leadAuthor": "Chang S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiaCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiaCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4f4a700501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707216
  },
  {
    "id": "DEFE_Demo_30476",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41376340",
    "title": "A Cross-Sectional Study on Pain and Quality of Life of Adult Patients with Transfusion-Dependent Thalassemia in a Tertiary Hospital In Malaysia.",
    "authors": [
      "Tee PH",
      "Tuan Mahmood TM",
      "Tan S"
    ],
    "journal": "Hemoglobin",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "DEFERASIROX*",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "989b045b-1e68-4687-bd8e-ec73b7ff9299",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.740Z"
      },
      {
        "id": "3b1b4c3e-915a-4acf-b9a1-b3d7907a50ef",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 372db773-f600-4d57-b39e-f8cd934376eb to DEFE_Demo_30476",
        "type": "system",
        "createdAt": "2025-12-14T10:13:36.519Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T16:42:20.733Z",
    "updatedAt": "2025-12-14T08:54:37.750Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41376340",
      "DOI": "https://doi.org10.1080/03630269.2025.2596947",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEFERASIROX*",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 22:12:19",
      "Drugname": "DEFERASIROX*",
      "Vancouver_citation": "Tee PH, Tuan Mahmood TM, Tan S. A Cross-Sectional Study on Pain and Quality of Life of Adult Patients with Transfusion-Dependent Thalassemia in a Tertiary Hospital In Malaysia. Hemoglobin. 2025;1-9",
      "pubdate": "2025-12-11",
      "Lead_author": "Tee PH",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/03630269.2025.2596947",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEFERASIROX*",
    "vancouverCitation": "Tee PH, Tuan Mahmood TM, Tan S. A Cross-Sectional Study on Pain and Quality of Life of Adult Patients with Transfusion-Dependent Thalassemia in a Tertiary Hospital In Malaysia. Hemoglobin. 2025;1-9",
    "leadAuthor": "Tee PH",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUibCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUibCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4f6dc00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707216
  },
  {
    "id": "AXIT_Demo_88892",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41210278",
    "title": "From polymorphs to cocrystals and salts: successfully predicting axitinib's challenging crystal forms.",
    "authors": [
      "Beran GJO"
    ],
    "journal": "Chem Sci",
    "publicationDate": "2025-11-10",
    "abstract": "The article focuses on the computational challenges and methodologies involved in predicting the crystal forms of the cancer drug Axitinib, a tyrosine kinase inhibitor used for advanced renal cell carcinoma. Axitinib's development faced significant challenges due to its complex solid-form landscape, including multiple polymorphs, solvates, cocrystals, and salts. The study revisits the crystal structure prediction (CSP) of Axitinib, addressing previous failures in predicting its conformational polymorph lattice energies. Using modern computational techniques such as hybrid density functional theory (DFT) and intramolecular energy corrections, the study successfully predicts the problematic Axitinib crystal structures and distinguishes between salt and cocrystal forms in multi-component crystals. The research highlights the density-driven delocalization error in generalized gradient approximation (GGA) density functionals and demonstrates how hybrid DFT and intramolecular corrections mitigate these errors. The study also explores the salt versus cocrystal behavior of Axitinib with carboxylic acids, which has regulatory implications. The findings suggest that most of the low-energy predicted structures of Axitinib are already known experimentally, with form XLI identified as the global minimum structure at 0 K. The study emphasizes the complementarity of hybrid DFT and intramolecular corrections in improving the robustness of CSP predictions for challenging pharmaceutical systems. While the article does not involve human subjects or discuss adverse events, it provides valuable insights into the computational modeling of Axitinib's crystal forms, which are crucial for its formulation and regulatory approval.",
    "drugName": "AXITINIB",
    "adverseEvent": "No AE",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "585e8e5f-cd13-44c1-9e2c-9b9a32363852",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T17:01:39.980Z",
        "type": "system"
      },
      {
        "id": "985d8a1e-c3a7-43bb-a468-c9ab8c00575b",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-12T17:02:11.392Z",
        "type": "QC_approval"
      },
      {
        "id": "83cc76b1-45ef-4495-8f54-134ecbc1c940",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 4730e111-58b3-46f6-a16d-6519a811c3cf to AXIT_Demo_88892",
        "type": "system",
        "createdAt": "2025-12-14T10:13:36.748Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:01:20.814Z",
    "updatedAt": "2025-12-12T17:02:11.402Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41210278",
      "DOI": "https://doi.org/10.1039/d5sc06271c",
      "special_case": "No",
      "Country_of_first_author": "USA",
      "Country_of_occurrence": "USA",
      "Patient_details": "No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: Not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The article focuses on the computational challenges and methodologies involved in predicting the crystal forms of the cancer drug Axitinib, a tyrosine kinase inhibitor used for advanced renal cell carcinoma. Axitinib's development faced significant challenges due to its complex solid-form landscape, including multiple polymorphs, solvates, cocrystals, and salts. The study revisits the crystal structure prediction (CSP) of Axitinib, addressing previous failures in predicting its conformational polymorph lattice energies. Using modern computational techniques such as hybrid density functional theory (DFT) and intramolecular energy corrections, the study successfully predicts the problematic Axitinib crystal structures and distinguishes between salt and cocrystal forms in multi-component crystals. The research highlights the density-driven delocalization error in generalized gradient approximation (GGA) density functionals and demonstrates how hybrid DFT and intramolecular corrections mitigate these errors. The study also explores the salt versus cocrystal behavior of Axitinib with carboxylic acids, which has regulatory implications. The findings suggest that most of the low-energy predicted structures of Axitinib are already known experimentally, with form XLI identified as the global minimum structure at 0 K. The study emphasizes the complementarity of hybrid DFT and intramolecular corrections in improving the robustness of CSP predictions for challenging pharmaceutical systems. While the article does not involve human subjects or discuss adverse events, it provides valuable insights into the computational modeling of Axitinib's crystal forms, which are crucial for its formulation and regulatory approval.",
      "Identifiable_human_subject": "No",
      "Text_type": "Review Article",
      "Author_perspective": "The author comments positively on the effectiveness of hybrid DFT and intramolecular corrections in resolving computational challenges and accurately predicting Axitinib's crystal forms. The study highlights the progress made in CSP methodologies and their potential for improving pharmaceutical development.",
      "Adverse_event": "No AE",
      "Abstract": "The experimental development of cancer drug axitinib was disrupted by two surprise discoveries of new, more stable crystal polymorphs. Organic crystal structure prediction can help de-risk against such occurrences, but previous attempts failed to predict the theoretically challenging axitinib conformational polymorph lattice energies reliably. Here, we demonstrate how modern crystal structure prediction methodologies can not only successfully predict the problematic axitinib crystal structures, but how they can also accurately distinguish between salt and cocrystal forms in three axitinib multi-component crystals, which has been a long-standing challenge for organic crystal modeling. These successes derive from addressing the density-driven delocalization error found in commonly-used generalized gradient approximation density functional theory models through the application of intramolecular energy corrections and/or hybrid density functionals. Notably, the simultaneous combination of both approaches provides more robust lattice energy predictions than either individual approach.",
      "Title": "From polymorphs to cocrystals and salts: successfully predicting axitinib's challenging crystal forms.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "AXITINIB",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-12 22:31:18",
      "Vancouver_citation": "Beran GJO. From polymorphs to cocrystals and salts: successfully predicting axitinib's challenging crystal forms. Chem Sci. 2025;16(48):23026-",
      "pubdate": "2025-11-10",
      "Lead_author": "Beran GJO",
      "Serious": "No",
      "Test_subject": "Yes, the test subject involved in this study is the drug Axitinib itself, specifically its crystal forms and multi-component crystals. The study focuses on computational methods to predict and analyze the crystal energy landscape and structural behaviors of Axitinib.",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Axitinib, is conventionally used for the treatment of adult patients with advanced renal cell carcinoma (RCC) after failure of prior treatment with sunitinib or a cytokine. In this study, Axitinib was not administered to patients or used to treat any illness. Instead, the study focused on the computational prediction and analysis of its crystal forms and multi-component crystals. This does not qualify as off-label use.",
      "AOI_classification": "No",
      "Justification": "The study does not link the drug of study to any adverse effects or negative effects within a subject or group of subjects. It focuses on computational modeling and prediction of crystal structures rather than clinical or pharmacological effects.",
      "Client_name": "Demo",
      "Drugname": "AXITINIB"
    },
    "doi": "https://doi.org/10.1039/d5sc06271c",
    "specialCase": "No",
    "countryOfFirstAuthor": "USA",
    "countryOfOccurrence": "USA",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: Not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "The article focuses on the computational challenges and methodologies involved in predicting the crystal forms of the cancer drug Axitinib, a tyrosine kinase inhibitor used for advanced renal cell carcinoma. Axitinib's development faced significant challenges due to its complex solid-form landscape, including multiple polymorphs, solvates, cocrystals, and salts. The study revisits the crystal structure prediction (CSP) of Axitinib, addressing previous failures in predicting its conformational polymorph lattice energies. Using modern computational techniques such as hybrid density functional theory (DFT) and intramolecular energy corrections, the study successfully predicts the problematic Axitinib crystal structures and distinguishes between salt and cocrystal forms in multi-component crystals. The research highlights the density-driven delocalization error in generalized gradient approximation (GGA) density functionals and demonstrates how hybrid DFT and intramolecular corrections mitigate these errors. The study also explores the salt versus cocrystal behavior of Axitinib with carboxylic acids, which has regulatory implications. The findings suggest that most of the low-energy predicted structures of Axitinib are already known experimentally, with form XLI identified as the global minimum structure at 0 K. The study emphasizes the complementarity of hybrid DFT and intramolecular corrections in improving the robustness of CSP predictions for challenging pharmaceutical systems. While the article does not involve human subjects or discuss adverse events, it provides valuable insights into the computational modeling of Axitinib's crystal forms, which are crucial for its formulation and regulatory approval.",
    "identifiableHumanSubject": "No",
    "textType": "Review Article",
    "authorPerspective": "The author comments positively on the effectiveness of hybrid DFT and intramolecular corrections in resolving computational challenges and accurately predicting Axitinib's crystal forms. The study highlights the progress made in CSP methodologies and their potential for improving pharmaceutical development.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "AXITINIB",
    "vancouverCitation": "Beran GJO. From polymorphs to cocrystals and salts: successfully predicting axitinib's challenging crystal forms. Chem Sci. 2025;16(48):23026-",
    "leadAuthor": "Beran GJO",
    "serious": "No",
    "testSubject": "Yes, the test subject involved in this study is the drug Axitinib itself, specifically its crystal forms and multi-component crystals. The study focuses on computational methods to predict and analyze the crystal energy landscape and structural behaviors of Axitinib.",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Axitinib, is conventionally used for the treatment of adult patients with advanced renal cell carcinoma (RCC) after failure of prior treatment with sunitinib or a cytokine. In this study, Axitinib was not administered to patients or used to treat any illness. Instead, the study focused on the computational prediction and analysis of its crystal forms and multi-component crystals. This does not qualify as off-label use.",
    "aoiClassification": "No",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T17:02:11.392Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUicCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUicCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4f90c80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707216
  },
  {
    "id": "MORP_Demo_18182",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41379583",
    "title": "Presumed Envenoming by the Striped Eel-Tailed Catfish  in the Mascarene Islands: Experience of the Marseille Poison Control Center and the Indian Ocean Toxicovigilance Department.",
    "authors": [
      "Schmitt C",
      "Maillot A",
      "Glaizal M",
      "Simon N",
      "de Haro L"
    ],
    "journal": "Wilderness Environ Med",
    "publicationDate": "2025-12-11",
    "abstract": "The article discusses envenomation cases caused by the striped eel-tailed catfish Plotosus lineatus in the Mascarene Islands, specifically Reunion Island and Mayotte Island, between 2011 and 2023. A total of 30 cases were reported, predominantly involving male fishermen who were stung while handling the fish. The stings primarily affected the hand and caused intense pain, with swelling reported in 40% of cases. Most cases were classified as moderate severity, with persistent spinal pain syndrome type 2. Treatment included analgesics such as paracetamol, tramadol, and morphine, as well as exposure to hot water, alternating hot and cold cycles, and local anesthetics. Recovery was generally rapid, with most patients recovering within 24 hours and one patient recovering after 7 days. Morphine was specifically mentioned as part of the treatment regimen, and it was effective in managing pain without reported adverse effects. The study highlights the risk of envenomation for fishermen handling Plotosus lineatus and emphasizes the effectiveness of the treatment protocols used.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "65c523b8-3524-4794-a76e-baa08f90a66a",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-13T05:30:18.317Z",
        "type": "system"
      },
      {
        "id": "d53a4ff9-10d8-4aa9-88f3-550e8650501c",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-13T05:30:40.690Z",
        "type": "QC_approval"
      },
      {
        "id": "c660f2a6-03b3-4a6a-a882-18b8e8bea339",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Added comment to field listedness: Test",
        "timestamp": "2025-12-13T05:31:14.398Z",
        "type": "field_comment"
      },
      {
        "id": "3be50240-c904-4295-8e07-80ff089b522d",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Added comment to field seriousness: Was not added",
        "timestamp": "2025-12-13T05:31:22.898Z",
        "type": "field_comment"
      },
      {
        "id": "ba509ccc-381d-4d13-8dfb-aa49d3781b6a",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Study revoked by Medical Reviewer. Reason: Test Revoke. Returned to triage for corrections.",
        "timestamp": "2025-12-13T05:31:36.192Z",
        "type": "revocation"
      },
      {
        "id": "11a040cc-ddcd-4c0a-bc8a-e3eaf419e449",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-13T05:34:49.924Z",
        "type": "system"
      },
      {
        "id": "e94d53cd-09de-4eb6-ab09-8b3f5734f195",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-13T05:35:13.283Z",
        "type": "QC_approval"
      },
      {
        "id": "0b2c9a76-6187-4c40-828c-0b8a1469d71b",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Study revoked. Reason: Revoke Second Time. Returned to triage for corrections.",
        "timestamp": "2025-12-13T05:36:22.426Z",
        "type": "revocation"
      },
      {
        "id": "f2228935-bf73-4f39-a0f9-19e5fc4ca444",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-13T05:37:07.756Z",
        "type": "system"
      },
      {
        "id": "f622844b-df24-4b49-986b-a099b167bfae",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" rejected by QC. Reason: This is a revoke from QC Triage Page. Study returned to Triage for re-classification.",
        "timestamp": "2025-12-13T05:37:57.914Z",
        "type": "QC_rejection"
      },
      {
        "id": "606b0d3f-4aa7-4730-b24a-2e64496ec756",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to Data Entry.",
        "timestamp": "2025-12-13T05:39:03.324Z",
        "type": "system"
      },
      {
        "id": "d6b50fa5-c520-4089-8087-54bd8376e948",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Study revoked. Reason: Test Revoke 3. Returned to triage for corrections.",
        "timestamp": "2025-12-13T05:40:08.918Z",
        "type": "revocation"
      },
      {
        "id": "e0ae2b94-1d81-4c8e-ad58-8014122ab6ad",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-13T05:40:36.061Z",
        "type": "system"
      },
      {
        "id": "7c1348d6-9ddf-42ff-925e-56e5a62e6a47",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-13T05:40:48.127Z",
        "type": "QC_approval"
      },
      {
        "id": "b32bb0eb-48ff-4cc1-90ef-41e2eb2efcda",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Study revoked. Reason: Revoke 4. Returned to triage for corrections.",
        "timestamp": "2025-12-13T05:41:15.153Z",
        "type": "revocation"
      },
      {
        "id": "335672c0-eaa3-4ee6-a3ef-e5f623afe4eb",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-13T05:41:29.906Z",
        "type": "system"
      },
      {
        "id": "adef6fef-6997-49e0-af75-7f08a3ed4a87",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" approved by QC. Comments: QC Approved Comment",
        "timestamp": "2025-12-13T05:41:59.482Z",
        "type": "QC_approval"
      },
      {
        "id": "60f3aae0-0c2d-4142-802c-74a3777b0894",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-13T05:42:53.769Z",
        "type": "system"
      },
      {
        "id": "8f73c0a7-79c2-435a-96d7-8cefbfb9b116",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "R3 form completed and resubmitted after Medical Reviewer revocation. Awaiting QC approval before medical re-review.",
        "timestamp": "2025-12-13T05:42:53.945Z",
        "type": "resubmission"
      },
      {
        "id": "2a97812d-783e-4c1e-8453-647299653b81",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Added comment to field E.i.1.1a: This is QC Data Entry Comment",
        "timestamp": "2025-12-13T05:47:13.105Z",
        "type": "field_comment"
      },
      {
        "id": "e4a648be-7933-42f1-a3b9-90b71325ad58",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Added comment to field C.2.r.1: This is a test comment for QC Data entry",
        "timestamp": "2025-12-13T05:47:48.276Z",
        "type": "field_comment"
      },
      {
        "id": "f0973b8c-2af8-4c31-b635-d750752989d4",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Added comment to field E.i.7: This is a test comment",
        "timestamp": "2025-12-13T05:50:48.894Z",
        "type": "field_comment"
      },
      {
        "id": "1af42182-36d3-43c2-9a0c-33d7e08f1736",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "R3 XML form approved by QC. Medical Review skipped (disabled). Ready for Reports.",
        "timestamp": "2025-12-13T05:50:59.795Z",
        "type": "qc_r3_approval"
      },
      {
        "id": "8394b79c-605a-470a-b2a9-4fe9b6e36ac3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from c6d8ca31-8009-4e43-8da9-4ed863ab2923 to MORP_Demo_18182",
        "type": "system",
        "createdAt": "2025-12-14T10:13:36.949Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:22:01.231Z",
    "updatedAt": "2025-12-13T05:50:59.865Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41379583",
      "DOI": "https://doi.org/10.1177/10806032251397962",
      "special_case": "No",
      "Country_of_first_author": "France",
      "Country_of_occurrence": "France",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: Human envenomation cases by Plotosus lineatus were reported in the Mascarene Islands, specifically Reunion Island and Mayotte Island, from 2011 to 2023. Most stings occurred during fishing activities and involved the hand. Patients experienced pain and swelling, with moderate severity in most cases. Treatment included analgesics, exposure to hot water, alternating hot and cold cycles, and local anesthetics. Recovery was reported within 24 hours for most cases, with one patient recovering after 7 days.",
      "Relevant_dates": "Relevant dates: 2011-2023",
      "Administered_drugs": "Administered drugs: paracetamol, tramadol, morphine",
      "Attributability": "Attributability: Pain and swelling were attributed to envenomation by Plotosus lineatus. Analgesics, including morphine, were used to manage symptoms. No adverse effects from the drugs were reported.",
      "Drug_effect": "Drug effect: summary. Analgesics, including morphine, were effective in managing pain and symptoms. Most patients recovered fully within 24 hours, with one patient recovering after 7 days.",
      "Summary": "The article discusses envenomation cases caused by the striped eel-tailed catfish Plotosus lineatus in the Mascarene Islands, specifically Reunion Island and Mayotte Island, between 2011 and 2023. A total of 30 cases were reported, predominantly involving male fishermen who were stung while handling the fish. The stings primarily affected the hand and caused intense pain, with swelling reported in 40% of cases. Most cases were classified as moderate severity, with persistent spinal pain syndrome type 2. Treatment included analgesics such as paracetamol, tramadol, and morphine, as well as exposure to hot water, alternating hot and cold cycles, and local anesthetics. Recovery was generally rapid, with most patients recovering within 24 hours and one patient recovering after 7 days. Morphine was specifically mentioned as part of the treatment regimen, and it was effective in managing pain without reported adverse effects. The study highlights the risk of envenomation for fishermen handling Plotosus lineatus and emphasizes the effectiveness of the treatment protocols used.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Case Report",
      "Author_perspective": "The article comments on the effectiveness of the treatment protocols, including the use of morphine, in managing pain and symptoms caused by envenomation. It highlights the rapid recovery of most patients and the absence of sequelae.",
      "Adverse_event": "No AE",
      "Abstract": "Introduction<i>Plotosus lineatus</i>, also known as the striped eel-tailed catfish, is a marine catfish easily identifiable with its black and white stripes and 4 pairs of barbels. This beautiful species is capable of inflicting an intensely painful sting caused by heat-labile venom toxins. Its presence has been widely confirmed, particularly in the Indo-Pacific Ocean, but cases of human envenomation are rarely reported in the medical literature.MethodsIn this report, we describe a case series of presumed envenomations by <i>P lineatus</i> registered in the Indian Ocean French territories of Reunion Island and Mayotte Island from 2011 to 2023.ResultsA total of 30 cases were reported, most of which involved males (n=27; 90%). Most stings occurred when fishing (n=22; 73%) and involved the hand (n=29; 97%). All individuals reported pain (100%) that was accompanied by local or extensive swelling in 12 cases (40%). Most cases were of moderate severity (persistent spinal pain syndrome type 2, n=27; 90%). The main treatment involved the use of analgesics (ie, paracetamol, tramadol, or morphine), exposure to hot water or alternating cycle of exposure to hot and cold sources, and local anesthetics. For 10 patients (33%) for whom information was available, there was full recovery within 24 h in most cases (after 7 d in 1 patient) without sequelae.ConclusionThese findings show that stings by <i>P lineatus</i> may occur in the Mascarene Islands and that fishermen are the most likely to be stung because of handling <i>P lineatus</i>.",
      "Title": "Presumed Envenoming by the Striped Eel-Tailed Catfish <i>Plotosus lineatus</i> in the Mascarene Islands: Experience of the Marseille Poison Control Center and the Indian Ocean Toxicovigilance Department.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-12 22:49:27",
      "Vancouver_citation": "Schmitt C, Maillot A, Glaizal M, Simon N, de Haro L. Presumed Envenoming by the Striped Eel-Tailed Catfish <i>Plotosus lineatus</i> in the Mascarene Islands: Experience of the Marseille Poison Control Center and the Indian Ocean Toxicovigilance Department. Wilderness Environ Med. 2025;10806032251397962",
      "pubdate": "2025-12-11",
      "Lead_author": "Schmitt C",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Morphine, is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, Morphine was administered as an analgesic to treat pain caused by envenomation from the striped eel-tailed catfish. This use aligns with its conventional purpose of treating severe pain and does not qualify as off-label use.",
      "AOI_classification": "No",
      "Justification": "The study does not link Morphine to any adverse effects or negative outcomes.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.1177/10806032251397962",
    "specialCase": "No",
    "countryOfFirstAuthor": "France",
    "countryOfOccurrence": "France",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: Human envenomation cases by Plotosus lineatus were reported in the Mascarene Islands, specifically Reunion Island and Mayotte Island, from 2011 to 2023. Most stings occurred during fishing activities and involved the hand. Patients experienced pain and swelling, with moderate severity in most cases. Treatment included analgesics, exposure to hot water, alternating hot and cold cycles, and local anesthetics. Recovery was reported within 24 hours for most cases, with one patient recovering after 7 days.",
    "relevantDates": "Relevant dates: 2011-2023",
    "administeredDrugs": [
      "Administered drugs: paracetamol",
      "tramadol",
      "morphine"
    ],
    "attributability": "Attributability: Pain and swelling were attributed to envenomation by Plotosus lineatus. Analgesics, including morphine, were used to manage symptoms. No adverse effects from the drugs were reported.",
    "drugEffect": "Drug effect: summary. Analgesics, including morphine, were effective in managing pain and symptoms. Most patients recovered fully within 24 hours, with one patient recovering after 7 days.",
    "summary": "The article discusses envenomation cases caused by the striped eel-tailed catfish Plotosus lineatus in the Mascarene Islands, specifically Reunion Island and Mayotte Island, between 2011 and 2023. A total of 30 cases were reported, predominantly involving male fishermen who were stung while handling the fish. The stings primarily affected the hand and caused intense pain, with swelling reported in 40% of cases. Most cases were classified as moderate severity, with persistent spinal pain syndrome type 2. Treatment included analgesics such as paracetamol, tramadol, and morphine, as well as exposure to hot water, alternating hot and cold cycles, and local anesthetics. Recovery was generally rapid, with most patients recovering within 24 hours and one patient recovering after 7 days. Morphine was specifically mentioned as part of the treatment regimen, and it was effective in managing pain without reported adverse effects. The study highlights the risk of envenomation for fishermen handling Plotosus lineatus and emphasizes the effectiveness of the treatment protocols used.",
    "identifiableHumanSubject": "Yes",
    "textType": "Case Report",
    "authorPerspective": "The article comments on the effectiveness of the treatment protocols, including the use of morphine, in managing pain and symptoms caused by envenomation. It highlights the rapid recovery of most patients and the absence of sequelae.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Schmitt C, Maillot A, Glaizal M, Simon N, de Haro L. Presumed Envenoming by the Striped Eel-Tailed Catfish <i>Plotosus lineatus</i> in the Mascarene Islands: Experience of the Marseille Poison Control Center and the Indian Ocean Toxicovigilance Department. Wilderness Environ Med. 2025;10806032251397962",
    "leadAuthor": "Schmitt C",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Morphine, is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, Morphine was administered as an analgesic to treat pain caused by envenomation from the striped eel-tailed catfish. This use aligns with its conventional purpose of treating severe pain and does not qualify as off-label use.",
    "aoiClassification": "No",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-13T05:41:59.482Z",
    "qaRejectedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaRejectedAt": "2025-12-13T05:37:57.914Z",
    "qaComments": "QC Approved Comment",
    "r3FormData": {
      "D.2.3": "5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5",
      "D.5": "Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male, Male",
      "D.7.1.r": "Patient 1-30: Most patients were male and were stung while fishing, with stings primarily involving the hand.",
      "D.7.1.r.3": "Patient 1: false. Patient 2: false. Patient 3: false. Patient 4: false. Patient 5: false. Patient 6: false. Patient 7: false. Patient 8: false. Patient 9: false. Patient 10: false. Patient 11: false. Patient 12: false. Patient 13: false. Patient 14: false. Patient 15: false. Patient 16: false. Patient 17: false. Patient 18: false. Patient 19: false. Patient 20: false. Patient 21: false. Patient 22: false. Patient 23: false. Patient 24: false. Patient 25: false. Patient 26: false. Patient 27: false. Patient 28: false. Patient 29: false. Patient 30: false",
      "D.7.3": "Patient 1: true. Patient 2: true. Patient 3: true. Patient 4: true. Patient 5: true. Patient 6: true. Patient 7: true. Patient 8: true. Patient 9: true. Patient 10: true. Patient 11: true. Patient 12: true. Patient 13: true. Patient 14: true. Patient 15: true. Patient 16: true. Patient 17: true. Patient 18: true. Patient 19: true. Patient 20: true. Patient 21: true. Patient 22: true. Patient 23: true. Patient 24: true. Patient 25: true. Patient 26: true. Patient 27: true. Patient 28: true. Patient 29: true. Patient 30: true",
      "D.9.1": "Patient 1: No. Patient 2: No. Patient 3: No. Patient 4: No. Patient 5: No. Patient 6: No. Patient 7: No. Patient 8: No. Patient 9: No. Patient 10: No. Patient 11: No. Patient 12: No. Patient 13: No. Patient 14: No. Patient 15: No. Patient 16: No. Patient 17: No. Patient 18: No. Patient 19: No. Patient 20: No. Patient 21: No. Patient 22: No. Patient 23: No. Patient 24: No. Patient 25: No. Patient 26: No. Patient 27: No. Patient 28: No. Patient 29: No. Patient 30: No",
      "E.i.1.1a": "Patient 1-30: Pain accompanied by local or extensive swelling in some cases.",
      "E.i.3.2a": "False",
      "E.i.3.2b": "False",
      "E.i.3.2c": "False",
      "E.i.3.2d": "False",
      "E.i.3.2e": "False",
      "E.i.3.2f": "True",
      "E.i.7": "Patient 1: 1. Patient 2: 1. Patient 3: 1. Patient 4: 1. Patient 5: 1. Patient 6: 1. Patient 7: 1. Patient 8: 1. Patient 9: 1. Patient 10: 1. Patient 11: 1. Patient 12: 1. Patient 13: 1. Patient 14: 1. Patient 15: 1. Patient 16: 1. Patient 17: 1. Patient 18: 1. Patient 19: 1. Patient 20: 1. Patient 21: 1. Patient 22: 1. Patient 23: 1. Patient 24: 1. Patient 25: 1. Patient 26: 1. Patient 27: 1. Patient 28: 1. Patient 29: 1. Patient 30: 1",
      "C.2.r.1": "Schmitt C",
      "C.2.r.1.2": "Schmitt",
      "C.2.r.1.4": "C",
      "C.4.r.1": "Schmitt C, Maillot A, Glaizal M, Simon N, de Haro L. Presumed Envenoming by the Striped Eel-Tailed Catfish <i>Plotosus lineatus</i> in the Mascarene Islands: Experience of the Marseille Poison Control Center and the Indian Ocean Toxicovigilance Department. Wilderness Environ Med. 2025;10806032251397962",
      "D.7": "The article discusses envenomation cases caused by the striped eel-tailed catfish Plotosus lineatus in the Mascarene Islands, specifically Reunion Island and Mayotte Island, between 2011 and 2023. A total of 30 cases were reported, predominantly involving male fishermen who were stung while handling the fish. The stings primarily affected the hand and caused intense pain, with swelling reported in 40% of cases. Most cases were classified as moderate severity, with persistent spinal pain syndrome type 2. Treatment included analgesics such as paracetamol, tramadol, and morphine, as well as exposure to hot water, alternating hot and cold cycles, and local anesthetics. Recovery was generally rapid, with most patients recovering within 24 hours and one patient recovering after 7 days. Morphine was specifically mentioned as part of the treatment regimen, and it was effective in managing pain without reported adverse effects. The study highlights the risk of envenomation for fishermen handling Plotosus lineatus and emphasizes the effectiveness of the treatment protocols used.",
      "D.7.1.r.2": "Relevant dates: 2011-2023",
      "C.2.r.2.1": "Institution in France"
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-13T05:42:53.945Z",
    "qcR3Status": "approved",
    "qcR3ApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qcR3ApprovedAt": "2025-12-13T05:50:59.795Z",
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": "Listed",
    "seriousness": "Serious",
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "completed",
    "medicalReviewedBy": "system",
    "medicalReviewedAt": "2025-12-13T05:50:59.795Z",
    "fieldComments": [
      {
        "id": "042afae3-2999-4203-a4ae-98565dceedd6",
        "fieldKey": "listedness",
        "comment": "Test",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "createdAt": "2025-12-13T05:31:14.398Z"
      },
      {
        "id": "b22594d1-c818-4601-ba6e-47c259283f68",
        "fieldKey": "seriousness",
        "comment": "Was not added",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "createdAt": "2025-12-13T05:31:22.898Z"
      },
      {
        "id": "9b67ca9a-8211-4af2-b054-ae7762bd6b40",
        "fieldKey": "E.i.1.1a",
        "comment": "This is QC Data Entry Comment",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "createdAt": "2025-12-13T05:47:13.104Z"
      },
      {
        "id": "4dd8a99c-eb6e-4e76-801b-3c2c81d54e6c",
        "fieldKey": "C.2.r.1",
        "comment": "This is a test comment for QC Data entry",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "createdAt": "2025-12-13T05:47:48.276Z"
      },
      {
        "id": "6350ada5-7612-4114-8618-3bbcf99e7cae",
        "fieldKey": "E.i.7",
        "comment": "This is a test comment",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "createdAt": "2025-12-13T05:50:48.894Z"
      }
    ],
    "revokedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "revokedAt": "2025-12-13T05:41:15.153Z",
    "revocationReason": "Revoke 4",
    "_rid": "Vf9WAOX6zUidCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUidCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4fb7d80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707217
  },
  {
    "id": "MORP_Demo_47648",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41372449",
    "title": "Single-cell transcriptomics reveals probiotic reversal of neonatal morphine-induced gene disruptions underlying adolescent pain hypersensitivity.",
    "authors": [
      "Tao J",
      "Antoine D",
      "Jalodia R",
      "Valdes E",
      "Boyles SM",
      "Hulme W",
      "Roy S"
    ],
    "journal": "Commun Biol",
    "publicationDate": "2025-12-11",
    "abstract": "The study investigates the long-term neurodevelopmental effects of neonatal morphine exposure in adolescent mice, focusing on transcriptomic changes in the midbrain. Using single-cell RNA sequencing, researchers analyzed gene expression in 107,427 midbrain cells from mice exposed to morphine, saline, or morphine with the probiotic Bifidobacterium infantis for 5 days starting on postnatal day 6-7. Morphine exposure resulted in significant transcriptomic alterations, including downregulation of HOX genes and upregulation of pathways related to neurotransmitter signaling and pain. These changes were observed across various cell types, including neurons, astrocytes, oligodendrocytes, and microglial cells. Notably, the probiotic Bifidobacterium infantis mitigated the morphine-induced transcriptomic disruptions, suggesting a potential therapeutic role for microbiome-targeted interventions in addressing the adverse effects of early opioid exposure. While the study does not involve human subjects, it provides valuable insights into the neurodevelopmental impact of neonatal morphine and highlights the potential of probiotics in reversing opioid-induced gene disruptions.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "3d1ea446-8c7f-4710-bbb9-838fc4cc21b0",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.804Z"
      },
      {
        "id": "f3aecee7-3205-4b02-9021-07baec47786f",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3408887b-bb82-4523-ad9a-483c181eba9e to MORP_Demo_47648",
        "type": "system",
        "createdAt": "2025-12-14T10:13:37.358Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:22:01.261Z",
    "updatedAt": "2025-12-14T08:54:37.818Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41372449",
      "DOI": "https://doi.org/10.1038/s42003-025-09150-0",
      "special_case": "No",
      "Country_of_first_author": "USA",
      "Country_of_occurrence": "USA",
      "Patient_details": "No human subject",
      "Key_events": "Key events: The study involved adolescent mice that were neonatally exposed to morphine, saline, or morphine with the probiotic Bifidobacterium infantis for 5 days starting on postnatal day 6-7. The study aimed to investigate transcriptomic changes in the midbrain using single-cell RNA sequencing.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Morphine, saline, Bifidobacterium infantis",
      "Attributability": "Attributability: The study found that neonatal morphine exposure led to transcriptomic alterations in neurons, astrocytes, oligodendrocytes, and microglial cells, including downregulation of HOX genes and upregulation of pathways related to neurotransmitter signaling and pain. Probiotic supplementation with Bifidobacterium infantis mitigated these morphine-induced changes.",
      "Drug_effect": "Drug effect: Morphine caused transcriptomic disruptions in the midbrain, while Bifidobacterium infantis mitigated these effects.",
      "Summary": "The study investigates the long-term neurodevelopmental effects of neonatal morphine exposure in adolescent mice, focusing on transcriptomic changes in the midbrain. Using single-cell RNA sequencing, researchers analyzed gene expression in 107,427 midbrain cells from mice exposed to morphine, saline, or morphine with the probiotic Bifidobacterium infantis for 5 days starting on postnatal day 6-7. Morphine exposure resulted in significant transcriptomic alterations, including downregulation of HOX genes and upregulation of pathways related to neurotransmitter signaling and pain. These changes were observed across various cell types, including neurons, astrocytes, oligodendrocytes, and microglial cells. Notably, the probiotic Bifidobacterium infantis mitigated the morphine-induced transcriptomic disruptions, suggesting a potential therapeutic role for microbiome-targeted interventions in addressing the adverse effects of early opioid exposure. While the study does not involve human subjects, it provides valuable insights into the neurodevelopmental impact of neonatal morphine and highlights the potential of probiotics in reversing opioid-induced gene disruptions.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article comments on the therapeutic potential of probiotics, specifically Bifidobacterium infantis, in mitigating the adverse transcriptomic effects of neonatal morphine exposure in adolescent mice.",
      "Adverse_event": "No AE",
      "Abstract": "Neonatal morphine is commonly administered in the Neonatal Intensive Care Unit (NICU) to manage pain. However, its long-term effects on the neurodevelopment of pain pathways remain a significant concern. The midbrain is a core region that plays a central role in pain processing and opioid-mediated analgesia. Here, we perform single-cell RNA sequencing to study gene expression in 107,427 midbrain single cells from adolescent mice neonatally exposed to either saline, morphine, or morphine with the probiotic Bifidobacterium infantis (B. infantis) for 5 days starting on postnatal day 6-7. We find broad alterations in transcriptomics within neurons, astrocytes, oligodendrocytes, and microglial cells. Analysis of differentially regulated genes reveals down regulation of HOX genes and upregulation of pathways related to neurotransmitter signaling and pain in those adolescent mice neonatally treated with morphine. Interestingly, neonatal probiotic supplementation mitigates these morphine-induced alterations on the transcriptome. This study presents the first single-cell RNA sequencing dataset of the adolescent midbrain following neonatal morphine exposure and probiotic intervention. These findings offer new insights into the neurodevelopmental impact of early opioid exposure and highlight the therapeutic potential of microbiome-targeted interventions.",
      "Title": "Single-cell transcriptomics reveals probiotic reversal of neonatal morphine-induced gene disruptions underlying adolescent pain hypersensitivity.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-12 22:49:46",
      "Vancouver_citation": "Tao J, Antoine D, Jalodia R, Valdes E, Boyles SM, Hulme W, Roy S. Single-cell transcriptomics reveals probiotic reversal of neonatal morphine-induced gene disruptions underlying adolescent pain hypersensitivity. Commun Biol. 2025;8(1):1757",
      "pubdate": "2025-12-11",
      "Lead_author": "Tao J",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study are adolescent mice that were neonatally exposed to either saline, morphine (the drug of study), or morphine combined with the probiotic Bifidobacterium infantis (B. infantis). The exposure occurred for 5 days starting on postnatal day 6-7.",
      "AOI_drug_effect": "The drug of study, morphine, had a significant effect on the test subjects. Neonatal exposure to morphine caused broad alterations in gene expression within various cell types in the midbrain, including neurons, astrocytes, oligodendrocytes, and microglial cells. Specifically, it led to downregulation of HOX genes and upregulation of pathways related to neurotransmitter signaling and pain, which are associated with adolescent pain hypersensitivity.",
      "Approved_indication": "Morphine is conventionally used as an opioid analgesic to manage moderate to severe pain. It is typically administered to patients experiencing acute or chronic pain, including neonates in the NICU for pain management. In this study, morphine was administered neonatally to mice for 5 days starting on postnatal day 6-7 to manage pain. The study aimed to investigate its long-term neurodevelopmental impact and its role in adolescent pain hypersensitivity.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study links neonatal exposure to morphine to negative effects, including alterations in gene expression and pathways associated with pain hypersensitivity in adolescent mice.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.1038/s42003-025-09150-0",
    "specialCase": "No",
    "countryOfFirstAuthor": "USA",
    "countryOfOccurrence": "USA",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: The study involved adolescent mice that were neonatally exposed to morphine, saline, or morphine with the probiotic Bifidobacterium infantis for 5 days starting on postnatal day 6-7. The study aimed to investigate transcriptomic changes in the midbrain using single-cell RNA sequencing.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Morphine",
      "saline",
      "Bifidobacterium infantis"
    ],
    "attributability": "Attributability: The study found that neonatal morphine exposure led to transcriptomic alterations in neurons, astrocytes, oligodendrocytes, and microglial cells, including downregulation of HOX genes and upregulation of pathways related to neurotransmitter signaling and pain. Probiotic supplementation with Bifidobacterium infantis mitigated these morphine-induced changes.",
    "drugEffect": "Drug effect: Morphine caused transcriptomic disruptions in the midbrain, while Bifidobacterium infantis mitigated these effects.",
    "summary": "The study investigates the long-term neurodevelopmental effects of neonatal morphine exposure in adolescent mice, focusing on transcriptomic changes in the midbrain. Using single-cell RNA sequencing, researchers analyzed gene expression in 107,427 midbrain cells from mice exposed to morphine, saline, or morphine with the probiotic Bifidobacterium infantis for 5 days starting on postnatal day 6-7. Morphine exposure resulted in significant transcriptomic alterations, including downregulation of HOX genes and upregulation of pathways related to neurotransmitter signaling and pain. These changes were observed across various cell types, including neurons, astrocytes, oligodendrocytes, and microglial cells. Notably, the probiotic Bifidobacterium infantis mitigated the morphine-induced transcriptomic disruptions, suggesting a potential therapeutic role for microbiome-targeted interventions in addressing the adverse effects of early opioid exposure. While the study does not involve human subjects, it provides valuable insights into the neurodevelopmental impact of neonatal morphine and highlights the potential of probiotics in reversing opioid-induced gene disruptions.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article comments on the therapeutic potential of probiotics, specifically Bifidobacterium infantis, in mitigating the adverse transcriptomic effects of neonatal morphine exposure in adolescent mice.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Tao J, Antoine D, Jalodia R, Valdes E, Boyles SM, Hulme W, Roy S. Single-cell transcriptomics reveals probiotic reversal of neonatal morphine-induced gene disruptions underlying adolescent pain hypersensitivity. Commun Biol. 2025;8(1):1757",
    "leadAuthor": "Tao J",
    "serious": "No",
    "testSubject": "The test subjects involved in this study are adolescent mice that were neonatally exposed to either saline, morphine (the drug of study), or morphine combined with the probiotic Bifidobacterium infantis (B. infantis). The exposure occurred for 5 days starting on postnatal day 6-7.",
    "aoiDrugEffect": "The drug of study, morphine, had a significant effect on the test subjects. Neonatal exposure to morphine caused broad alterations in gene expression within various cell types in the midbrain, including neurons, astrocytes, oligodendrocytes, and microglial cells. Specifically, it led to downregulation of HOX genes and upregulation of pathways related to neurotransmitter signaling and pain, which are associated with adolescent pain hypersensitivity.",
    "approvedIndication": "Morphine is conventionally used as an opioid analgesic to manage moderate to severe pain. It is typically administered to patients experiencing acute or chronic pain, including neonates in the NICU for pain management. In this study, morphine was administered neonatally to mice for 5 days starting on postnatal day 6-7 to manage pain. The study aimed to investigate its long-term neurodevelopmental impact and its role in adolescent pain hypersensitivity.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The study links neonatal exposure to morphine to negative effects, including alterations in gene expression and pathways associated with pain hypersensitivity in adolescent mice.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUieCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUieCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-4ff24c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707217
  },
  {
    "id": "MORP_Demo_48539",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41363064",
    "title": "Intranasal ketamine for chronic cancer-related pain in the outpatient setting: a double-edged sword.",
    "authors": [
      "Nalbone J",
      "Levine A",
      "Welsh JW",
      "Zarrabi A",
      "Singh V"
    ],
    "journal": "Pain Manag",
    "publicationDate": "2025-12-9",
    "abstract": "Article requires manual review",
    "drugName": "MORPHINE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9414084d-8bb3-492c-bca5-e962388d4af5",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.851Z"
      },
      {
        "id": "f16476fa-b43e-484b-b5bf-34a252e37b86",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a57eb59b-9d1c-4f76-a184-eca1029b6641 to MORP_Demo_48539",
        "type": "system",
        "createdAt": "2025-12-14T10:13:37.619Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:22:01.295Z",
    "updatedAt": "2025-12-14T08:54:37.886Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41363064",
      "DOI": "https://doi.org10.1080/17581869.2025.2599730",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "MORPHINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 22:50:47",
      "Drugname": "MORPHINE",
      "Vancouver_citation": "Nalbone J, Levine A, Welsh JW, Zarrabi A, Singh V. Intranasal ketamine for chronic cancer-related pain in the outpatient setting: a double-edged sword. Pain Manag. 2025;1-5",
      "pubdate": "2025-12-9",
      "Lead_author": "Nalbone J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/17581869.2025.2599730",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Nalbone J, Levine A, Welsh JW, Zarrabi A, Singh V. Intranasal ketamine for chronic cancer-related pain in the outpatient setting: a double-edged sword. Pain Manag. 2025;1-5",
    "leadAuthor": "Nalbone J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUifCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUifCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-5016180501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707217
  },
  {
    "id": "MORP_Demo_36485",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41361899",
    "title": "Early intensivist driven analgesic intervention in ICU vs. surgeon driven analgesia in fast-track post-sternotomy patients in private community cardiac surgery center.",
    "authors": [
      "Sitta RD",
      "Yang Q",
      "Hirose H"
    ],
    "journal": "J Cardiothorac Surg",
    "publicationDate": "2025-12-9",
    "abstract": "Article requires manual review",
    "drugName": "MORPHINE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "739f16e2-9104-4a07-984f-9056bbd5cedb",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.911Z"
      },
      {
        "id": "6ce8b5c5-621f-4917-8fe9-c7bad4a06a0c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from f7d19cfc-f2d2-4099-a870-9fd121c9870f to MORP_Demo_36485",
        "type": "system",
        "createdAt": "2025-12-14T10:13:37.848Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:22:01.323Z",
    "updatedAt": "2025-12-14T08:54:37.923Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41361899",
      "DOI": "https://doi.org10.1186/s13019-025-03687-1",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "MORPHINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 22:50:25",
      "Drugname": "MORPHINE",
      "Vancouver_citation": "Sitta RD, Yang Q, Hirose H. Early intensivist driven analgesic intervention in ICU vs. surgeon driven analgesia in fast-track post-sternotomy patients in private community cardiac surgery center. J Cardiothorac Surg. 2025;",
      "pubdate": "2025-12-9",
      "Lead_author": "Sitta RD",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1186/s13019-025-03687-1",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Sitta RD, Yang Q, Hirose H. Early intensivist driven analgesic intervention in ICU vs. surgeon driven analgesia in fast-track post-sternotomy patients in private community cardiac surgery center. J Cardiothorac Surg. 2025;",
    "leadAuthor": "Sitta RD",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUigCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUigCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-5038840501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707217
  },
  {
    "id": "MORP_Demo_21312",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41359048",
    "title": "Evaluation In-Hospital Opioid Usage for Minimally Invasive Repair of Pelvic Organ Prolapse.",
    "authors": [
      "Koparal MY",
      "Rhodes S",
      "Sheyn D",
      "Hijaz A"
    ],
    "journal": "Int Urogynecol J",
    "publicationDate": "2025-12-8",
    "abstract": "Article requires manual review",
    "drugName": "MORPHINE",
    "adverseEvent": "Article requires manual review",
    "status": "triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "de8a9241-fec9-4a1e-a0dc-e00045b7f319",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-13T05:27:25.716Z",
        "type": "system"
      },
      {
        "id": "3cb71ea4-c7b0-42c1-9e97-1fb28174f532",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-13T05:27:52.776Z",
        "type": "QC_approval"
      },
      {
        "id": "32c3fb25-8b06-4395-a8e0-60754acb6ef4",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Added comment to field listedness: Test",
        "timestamp": "2025-12-13T05:28:16.163Z",
        "type": "field_comment"
      },
      {
        "id": "d51da977-5277-4d86-98f1-a814697b738f",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Study revoked by Medical Reviewer. Reason: Test revoke. Returned to triage for corrections.",
        "timestamp": "2025-12-13T05:28:29.942Z",
        "type": "revocation"
      },
      {
        "id": "92eef6a1-c9a0-4f46-ad37-47d7e470aa96",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 80f40d3d-eb46-476a-99d3-669a128247b1 to MORP_Demo_21312",
        "type": "system",
        "createdAt": "2025-12-14T10:13:38.049Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:22:01.355Z",
    "updatedAt": "2025-12-13T05:28:29.955Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41359048",
      "DOI": "https://doi.org10.1007/s00192-025-06478-3",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "MORPHINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 22:50:06",
      "Drugname": "MORPHINE",
      "Vancouver_citation": "Koparal MY, Rhodes S, Sheyn D, Hijaz A. Evaluation In-Hospital Opioid Usage for Minimally Invasive Repair of Pelvic Organ Prolapse. Int Urogynecol J. 2025;",
      "pubdate": "2025-12-8",
      "Lead_author": "Koparal MY",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s00192-025-06478-3",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Koparal MY, Rhodes S, Sheyn D, Hijaz A. Evaluation In-Hospital Opioid Usage for Minimally Invasive Repair of Pelvic Organ Prolapse. Int Urogynecol J. 2025;",
    "leadAuthor": "Koparal MY",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": null,
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": "Listed",
    "seriousness": "Serious",
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [
      {
        "id": "5ee9403f-9be1-48dc-a5be-2cdf815e2791",
        "fieldKey": "listedness",
        "comment": "Test",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "createdAt": "2025-12-13T05:28:16.163Z"
      }
    ],
    "revokedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "revokedAt": "2025-12-13T05:28:29.942Z",
    "revocationReason": "Test revoke",
    "_rid": "Vf9WAOX6zUihCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUihCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-505a980501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707218
  },
  {
    "id": "MORP_Demo_87828",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41269988",
    "title": "Gamma-aminobutyric acid A receptor alpha 4 in the nucleus accumbens mediates cue-induced heroin-seeking behavior in male rats via miR-7b.",
    "authors": [
      "Wu T",
      "Xu W",
      "Lin Z",
      "Xu Z",
      "Hong Q",
      "Chen W",
      "Xie X",
      "Fu D",
      "Lai M",
      "Zhou W",
      "Liu H"
    ],
    "journal": "Neuroreport",
    "publicationDate": "2025-11-21",
    "abstract": "The study investigates the role of miR-7b and gamma-aminobutyric acid A receptor alpha 4 (GABRA4) in the nucleus accumbens (NAc) during cue-induced heroin-seeking behavior in male rats. A heroin self-administration model was established in rats, and cue-induced reinstatement was assessed postextinction. The study utilized adeno-associated virus (AAV)-mediated miR-7b overexpression and GABRA4 knockdown to explore their effects on reinstatement behavior. Results showed that reinstatement behavior correlated with reduced miR-7b and elevated GABRA4 expression in the NAc. Luciferase assays confirmed miR-7b's direct regulation of GABRA4's 3'-UTR. Targeted overexpression of miR-7b in the NAc increased reinstatement behavior, while GABRA4 silencing also enhanced reinstatement responses. The study identifies a compensatory miR-7b/GABRA4 axis in the NAc that promotes cue-induced heroin-seeking reinstatement, suggesting potential targets for addiction intervention. The article does not mention human subjects, nor does it provide data on the administration or effects of drugs like Morphine.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "488c266d-1836-4390-b138-0054b96e3d73",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-13T04:54:31.190Z",
        "type": "system"
      },
      {
        "id": "9ee3b263-c533-4468-984c-1e21ffb2d492",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-13T04:54:47.174Z",
        "type": "QC_approval"
      },
      {
        "id": "8bc633d8-8ed8-4868-b2ff-1be6d32b672e",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-13T04:55:15.300Z",
        "type": "system"
      },
      {
        "id": "894bd612-80e0-4755-ba57-2d1d8e0c6995",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. Awaiting QC approval before Medical Reviewer review.",
        "timestamp": "2025-12-13T04:55:15.537Z",
        "type": "system"
      },
      {
        "id": "8bb00af3-c8ab-4a1e-bc60-37a09ecba834",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 XML form approved by QC. Medical Review skipped (disabled). Ready for Reports.",
        "timestamp": "2025-12-13T04:55:27.208Z",
        "type": "qc_r3_approval"
      },
      {
        "id": "67cc4d1c-7bd1-4262-9982-548a686f858b",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 8fcf2a5c-5f9c-4859-8e90-84e420dc89bc to MORP_Demo_87828",
        "type": "system",
        "createdAt": "2025-12-14T10:13:38.293Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:22:01.383Z",
    "updatedAt": "2025-12-13T04:55:27.218Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41269988",
      "DOI": "https://doi.org/10.1097/WNR.0000000000002225",
      "special_case": "No",
      "Country_of_first_author": "China",
      "Country_of_occurrence": "China",
      "Patient_details": "No human subject",
      "Key_events": "No human subject",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: no human subject",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The study investigates the role of miR-7b and gamma-aminobutyric acid A receptor alpha 4 (GABRA4) in the nucleus accumbens (NAc) during cue-induced heroin-seeking behavior in male rats. A heroin self-administration model was established in rats, and cue-induced reinstatement was assessed postextinction. The study utilized adeno-associated virus (AAV)-mediated miR-7b overexpression and GABRA4 knockdown to explore their effects on reinstatement behavior. Results showed that reinstatement behavior correlated with reduced miR-7b and elevated GABRA4 expression in the NAc. Luciferase assays confirmed miR-7b's direct regulation of GABRA4's 3'-UTR. Targeted overexpression of miR-7b in the NAc increased reinstatement behavior, while GABRA4 silencing also enhanced reinstatement responses. The study identifies a compensatory miR-7b/GABRA4 axis in the NAc that promotes cue-induced heroin-seeking reinstatement, suggesting potential targets for addiction intervention. The article does not mention human subjects, nor does it provide data on the administration or effects of drugs like Morphine.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article comments on the compensatory miR-7b/GABRA4 axis in the NAc and its role in promoting cue-induced heroin-seeking reinstatement, proposing it as a novel target for addiction intervention.",
      "Adverse_event": "No AE",
      "Abstract": "This study investigated miR-7b's regulatory role in the nucleus accumbens (NAc) and its interaction with gamma-aminobutyric acid A receptor alpha 4 (GABRA4) during cue-induced heroin-seeking reinstatement.\n\nA heroin self-administration model (4 h/day) was established in rats. Cue-induced reinstatement was assessed postextinction. Dual-luciferase reporter assays validated miR-7b/GABRA4 binding. Gain- and loss-of-function approaches via adeno-associated virus (AAV)-mediated miR-7b overexpression (AAV-miR-7b-OE) and GABRA4 knockdown [AAV-small interfering RNA (siRNA)-GABRA4] were applied in the NAc.\n\nReinstatement correlated with reduced miR-7b (P < 0.05) and elevated GABRA4 expression in the NAc. Luciferase assays confirmed miR-7b's direct regulation of the GABRA4 3'-untranslated region (3'-UTR) (P < 0.01). NAc-targeted AAV-miR-7b-OE significantly increased reinstatement behavior (P < 0.01), concomitant with decreased GABRA4 mRNA. Meanwhile, AAV-siRNA-GABRA4-mediated GABRA4 silencing increased reinstatement responses postextinction (P < 0.05).\n\nMiR-7b suppression and GABRA4 upregulation form a feedback loop promoting cue-induced heroin-seeking reinstatement. These findings identify a compensatory miR-7b/GABRA4 axis in the NAc that counteracts relapse vulnerability, proposing novel targets for addiction intervention.",
      "Title": "Gamma-aminobutyric acid A receptor alpha 4 in the nucleus accumbens mediates cue-induced heroin-seeking behavior in male rats via miR-7b.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-12 22:51:22",
      "Vancouver_citation": "Wu T, Xu W, Lin Z, Xu Z, Hong Q, Chen W, Xie X, Fu D, Lai M, Zhou W, Liu H. Gamma-aminobutyric acid A receptor alpha 4 in the nucleus accumbens mediates cue-induced heroin-seeking behavior in male rats via miR-7b. Neuroreport. 2025;36(18):1037-46",
      "pubdate": "2025-11-21",
      "Lead_author": "Wu T",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study are male rats. These rats were exposed to heroin in a self-administration model to investigate cue-induced heroin-seeking behavior and the regulatory role of miR-7b and GABRA4 in the nucleus accumbens.",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Morphine, is conventionally used as a potent opioid analgesic for the treatment of severe pain. It is typically administered via oral, intravenous, or intramuscular routes to patients suffering from acute or chronic pain conditions. In this study, the drug of study was not directly administered or investigated; instead, heroin was used as the substance of interest to study addiction and cue-induced seeking behavior in rats.",
      "AOI_classification": "No",
      "Justification": "The study does not mention Morphine or link it to any adverse effects or negative outcomes. The focus is on heroin and its interaction with miR-7b and GABRA4 in addiction-related behavior.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.1097/WNR.0000000000002225",
    "specialCase": "No",
    "countryOfFirstAuthor": "China",
    "countryOfOccurrence": "China",
    "patientDetails": "No human subject",
    "keyEvents": "No human subject",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: no human subject",
    "drugEffect": "Drug effect: no data",
    "summary": "The study investigates the role of miR-7b and gamma-aminobutyric acid A receptor alpha 4 (GABRA4) in the nucleus accumbens (NAc) during cue-induced heroin-seeking behavior in male rats. A heroin self-administration model was established in rats, and cue-induced reinstatement was assessed postextinction. The study utilized adeno-associated virus (AAV)-mediated miR-7b overexpression and GABRA4 knockdown to explore their effects on reinstatement behavior. Results showed that reinstatement behavior correlated with reduced miR-7b and elevated GABRA4 expression in the NAc. Luciferase assays confirmed miR-7b's direct regulation of GABRA4's 3'-UTR. Targeted overexpression of miR-7b in the NAc increased reinstatement behavior, while GABRA4 silencing also enhanced reinstatement responses. The study identifies a compensatory miR-7b/GABRA4 axis in the NAc that promotes cue-induced heroin-seeking reinstatement, suggesting potential targets for addiction intervention. The article does not mention human subjects, nor does it provide data on the administration or effects of drugs like Morphine.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article comments on the compensatory miR-7b/GABRA4 axis in the NAc and its role in promoting cue-induced heroin-seeking reinstatement, proposing it as a novel target for addiction intervention.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Wu T, Xu W, Lin Z, Xu Z, Hong Q, Chen W, Xie X, Fu D, Lai M, Zhou W, Liu H. Gamma-aminobutyric acid A receptor alpha 4 in the nucleus accumbens mediates cue-induced heroin-seeking behavior in male rats via miR-7b. Neuroreport. 2025;36(18):1037-46",
    "leadAuthor": "Wu T",
    "serious": "No",
    "testSubject": "The test subjects involved in this study are male rats. These rats were exposed to heroin in a self-administration model to investigate cue-induced heroin-seeking behavior and the regulatory role of miR-7b and GABRA4 in the nucleus accumbens.",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Morphine, is conventionally used as a potent opioid analgesic for the treatment of severe pain. It is typically administered via oral, intravenous, or intramuscular routes to patients suffering from acute or chronic pain conditions. In this study, the drug of study was not directly administered or investigated; instead, heroin was used as the substance of interest to study addiction and cue-induced seeking behavior in rats.",
    "aoiClassification": "No",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-13T04:54:47.174Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": {
      "E.i.3.2a": "false",
      "E.i.3.2b": "false",
      "E.i.3.2c": "false",
      "E.i.3.2d": "false",
      "E.i.3.2e": "false",
      "E.i.3.2f": "false",
      "E.i.7": "0",
      "C.2.r.1": "Wu T",
      "C.2.r.1.2": "Wu",
      "C.2.r.1.4": "T",
      "C.4.r.1": "Wu T, Xu W, Lin Z, Xu Z, Hong Q, Chen W, Xie X, Fu D, Lai M, Zhou W, Liu H. Gamma-aminobutyric acid A receptor alpha 4 in the nucleus accumbens mediates cue-induced heroin-seeking behavior in male rats via miR-7b. Neuroreport. 2025;36(18):1037-46",
      "D.7.1.r": "No human subject",
      "D.7": "The study investigates the role of miR-7b and gamma-aminobutyric acid A receptor alpha 4 (GABRA4) in the nucleus accumbens (NAc) during cue-induced heroin-seeking behavior in male rats. A heroin self-administration model was established in rats, and cue-induced reinstatement was assessed postextinction. The study utilized adeno-associated virus (AAV)-mediated miR-7b overexpression and GABRA4 knockdown to explore their effects on reinstatement behavior. Results showed that reinstatement behavior correlated with reduced miR-7b and elevated GABRA4 expression in the NAc. Luciferase assays confirmed miR-7b's direct regulation of GABRA4's 3'-UTR. Targeted overexpression of miR-7b in the NAc increased reinstatement behavior, while GABRA4 silencing also enhanced reinstatement responses. The study identifies a compensatory miR-7b/GABRA4 axis in the NAc that promotes cue-induced heroin-seeking reinstatement, suggesting potential targets for addiction intervention. The article does not mention human subjects, nor does it provide data on the administration or effects of drugs like Morphine.",
      "D.7.1.r.2": "Relevant dates: not mentioned",
      "E.i.1.1a": "No AE",
      "C.2.r.2.1": "Institution in China"
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-13T04:55:15.537Z",
    "qcR3Status": "approved",
    "qcR3ApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qcR3ApprovedAt": "2025-12-13T04:55:27.208Z",
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": "Listed",
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "completed",
    "medicalReviewedBy": "system",
    "medicalReviewedAt": "2025-12-13T04:55:27.208Z",
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiiCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiiCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-50801c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707218
  },
  {
    "id": "MORP_Demo_14807",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41219131",
    "title": "Chemogenetic Inhibition and Optogenetic Depotentiation of the Prelimbic Cortex to Paraventricular Thalamus Pathway Attenuate Abstinence-Induced Plasticity and Heroin Seeking in Rats.",
    "authors": [
      "Jensen AL",
      "Lis CA",
      "Ackerman SN",
      "Willard TK",
      "Kipp CAT",
      "Nash MA",
      "Huston NJ",
      "Giannotti G"
    ],
    "journal": "J Neurosci",
    "publicationDate": "2025-11-12",
    "abstract": "This study investigates the neurobiological mechanisms underlying opioid use disorder (OUD) with a focus on the prelimbic cortex (PL) to paraventricular thalamus (PVT) pathway in rats. The research highlights the role of this pathway in heroin-seeking behavior and abstinence-induced synaptic plasticity. Using chemogenetic inhibition, researchers transiently suppressed PL → PVT projections during a heroin-seeking test after 14 days of abstinence, which significantly reduced heroin-seeking behavior. Additionally, synaptic plasticity changes were observed at PL → PVT synapses, with an increase in AMPA/NMDA ratio during withdrawal. Optogenetic long-term depression (LTD) protocols applied ex vivo normalized these synaptic changes, and in vivo application of the same protocol before the heroin-seeking test also reduced heroin-seeking behavior. The study identifies the PL → PVT pathway as a critical driver of heroin-seeking behavior and demonstrates that weakening this pathway can mitigate opioid-seeking tendencies. While the study does not involve human subjects, it provides valuable insights into potential therapeutic targets for OUD.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9a7d4d40-c954-49b9-bad2-84b1758df29a",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-13T04:46:13.122Z",
        "type": "system"
      },
      {
        "id": "18bb1e5d-6894-40ae-a44f-b5862efe0416",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-13T04:48:11.442Z",
        "type": "QC_approval"
      },
      {
        "id": "44b59dcc-9850-4dd5-a71f-b67930b1b665",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from bc6d2704-ef8d-45f4-91f8-9713dd20c9d9 to MORP_Demo_14807",
        "type": "system",
        "createdAt": "2025-12-14T10:13:38.588Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:22:01.419Z",
    "updatedAt": "2025-12-13T04:48:11.455Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41219131",
      "DOI": "https://doi.org/10.1523/JNEUROSCI.1017-25.2025",
      "special_case": "No",
      "Country_of_first_author": "United States",
      "Country_of_occurrence": "United States",
      "Patient_details": "No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: Not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "This study investigates the neurobiological mechanisms underlying opioid use disorder (OUD) with a focus on the prelimbic cortex (PL) to paraventricular thalamus (PVT) pathway in rats. The research highlights the role of this pathway in heroin-seeking behavior and abstinence-induced synaptic plasticity. Using chemogenetic inhibition, researchers transiently suppressed PL → PVT projections during a heroin-seeking test after 14 days of abstinence, which significantly reduced heroin-seeking behavior. Additionally, synaptic plasticity changes were observed at PL → PVT synapses, with an increase in AMPA/NMDA ratio during withdrawal. Optogenetic long-term depression (LTD) protocols applied ex vivo normalized these synaptic changes, and in vivo application of the same protocol before the heroin-seeking test also reduced heroin-seeking behavior. The study identifies the PL → PVT pathway as a critical driver of heroin-seeking behavior and demonstrates that weakening this pathway can mitigate opioid-seeking tendencies. While the study does not involve human subjects, it provides valuable insights into potential therapeutic targets for OUD.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article comments on the effect of chemogenetic and optogenetic interventions on heroin-seeking behavior in rats, suggesting that targeting the PL → PVT pathway can reduce opioid-seeking tendencies.",
      "Adverse_event": "No AE",
      "Abstract": "Opioid use disorder (OUD) is characterized by high relapse rates, underscoring an urgent need to identify neurobiological mechanisms of opioid seeking. The paraventricular thalamus (PVT) is a key brain region implicated in drug seeking in humans and rodents. While the role of its downstream targets is beginning to be clarified, the upstream inputs that regulate PVT activity during opioid seeking remain poorly understood. The prelimbic cortex (PL) provides substantial excitatory input to the PVT and has a well-established role in cue-guided behaviors and drug seeking. However, the contribution of the PL → PVT pathway to heroin seeking is yet to be elucidated. To address this knowledge gap, we trained male and female rats to self-administer heroin for 12 d and then used a pathway-specific chemogenetic approach to transiently inhibit PL → PVT projections during a cued heroin seeking test following 14 d of abstinence. We found that chemogenetic inhibition of this pathway significantly reduced heroin seeking. We next examined synaptic plasticity at PL → PVT synapses ex vivo on withdrawal day 14 and found that abstinence from heroin self-administration induced an increase in AMPA/NMDA ratio compared with saline controls. Importantly, the increase in synaptic strength was normalized by applying an ex vivo optogenetic long-term depression (LTD) protocol. Finally, we applied the same optogenetic LTD protocol in vivo immediately before the cued seeking test and found that depotentiation of PL → PVT synaptic activity significantly reduced heroin seeking. These findings identify PL → PVT inputs as key drivers of heroin seeking and demonstrate that weakening this pathway reduces opioid seeking.",
      "Title": "Chemogenetic Inhibition and Optogenetic Depotentiation of the Prelimbic Cortex to Paraventricular Thalamus Pathway Attenuate Abstinence-Induced Plasticity and Heroin Seeking in Rats.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-12 22:51:59",
      "Vancouver_citation": "Jensen AL, Lis CA, Ackerman SN, Willard TK, Kipp CAT, Nash MA, Huston NJ, Giannotti G. Chemogenetic Inhibition and Optogenetic Depotentiation of the Prelimbic Cortex to Paraventricular Thalamus Pathway Attenuate Abstinence-Induced Plasticity and Heroin Seeking in Rats. J Neurosci. 2025;45(50):",
      "pubdate": "2025-11-12",
      "Lead_author": "Jensen AL",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study were male and female rats. These rats were trained to self-administer heroin for 12 days, followed by a 14-day abstinence period. The study focused on the effects of chemogenetic and optogenetic interventions on heroin-seeking behavior in these rats.",
      "AOI_drug_effect": "No Drug Effect. The study does not mention the drug of study (Morphine) being administered or causing any medical event. Instead, the study focuses on heroin, another opioid, and its effects on synaptic plasticity and drug-seeking behavior.",
      "Approved_indication": "The drug of study, Morphine, is conventionally used as a potent opioid analgesic to treat moderate to severe pain. It is typically administered orally, intravenously, or via intramuscular injection to patients suffering from pain due to surgery, injury, or chronic conditions like cancer. In this study, Morphine was not administered; instead, heroin was used to investigate opioid-seeking behavior in rats.",
      "AOI_classification": "No",
      "Justification": "The study does not mention Morphine or link it to any adverse effects. It focuses solely on heroin and its impact on synaptic plasticity and drug-seeking behavior.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.1523/JNEUROSCI.1017-25.2025",
    "specialCase": "No",
    "countryOfFirstAuthor": "United States",
    "countryOfOccurrence": "United States",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: Not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "This study investigates the neurobiological mechanisms underlying opioid use disorder (OUD) with a focus on the prelimbic cortex (PL) to paraventricular thalamus (PVT) pathway in rats. The research highlights the role of this pathway in heroin-seeking behavior and abstinence-induced synaptic plasticity. Using chemogenetic inhibition, researchers transiently suppressed PL → PVT projections during a heroin-seeking test after 14 days of abstinence, which significantly reduced heroin-seeking behavior. Additionally, synaptic plasticity changes were observed at PL → PVT synapses, with an increase in AMPA/NMDA ratio during withdrawal. Optogenetic long-term depression (LTD) protocols applied ex vivo normalized these synaptic changes, and in vivo application of the same protocol before the heroin-seeking test also reduced heroin-seeking behavior. The study identifies the PL → PVT pathway as a critical driver of heroin-seeking behavior and demonstrates that weakening this pathway can mitigate opioid-seeking tendencies. While the study does not involve human subjects, it provides valuable insights into potential therapeutic targets for OUD.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article comments on the effect of chemogenetic and optogenetic interventions on heroin-seeking behavior in rats, suggesting that targeting the PL → PVT pathway can reduce opioid-seeking tendencies.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Jensen AL, Lis CA, Ackerman SN, Willard TK, Kipp CAT, Nash MA, Huston NJ, Giannotti G. Chemogenetic Inhibition and Optogenetic Depotentiation of the Prelimbic Cortex to Paraventricular Thalamus Pathway Attenuate Abstinence-Induced Plasticity and Heroin Seeking in Rats. J Neurosci. 2025;45(50):",
    "leadAuthor": "Jensen AL",
    "serious": "No",
    "testSubject": "The test subjects involved in this study were male and female rats. These rats were trained to self-administer heroin for 12 days, followed by a 14-day abstinence period. The study focused on the effects of chemogenetic and optogenetic interventions on heroin-seeking behavior in these rats.",
    "aoiDrugEffect": "No Drug Effect. The study does not mention the drug of study (Morphine) being administered or causing any medical event. Instead, the study focuses on heroin, another opioid, and its effects on synaptic plasticity and drug-seeking behavior.",
    "approvedIndication": "The drug of study, Morphine, is conventionally used as a potent opioid analgesic to treat moderate to severe pain. It is typically administered orally, intravenously, or via intramuscular injection to patients suffering from pain due to surgery, injury, or chronic conditions like cancer. In this study, Morphine was not administered; instead, heroin was used to investigate opioid-seeking behavior in rats.",
    "aoiClassification": "No",
    "justification": "Potential Valid case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-13T04:48:11.442Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": "Listed",
    "seriousness": "Serious",
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUijCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUijCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-50ac900501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707218
  },
  {
    "id": "MORP_Demo_74721",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41145214",
    "title": "Prehabilitation Reimagined as Policy: A Multidimensional Framework to Reduce Pain, Opioid Use, and Surgical Risk.",
    "authors": [
      "Lewandrowski KU",
      "Lorio MP",
      "Elman I",
      "Blum K",
      "Pinhasov A",
      "Thanos PK",
      "Schmidt SL",
      "Fiorelli RKA"
    ],
    "journal": "Int J Spine Surg",
    "publicationDate": "2025-10-28",
    "abstract": "The article discusses a multidimensional framework for surgical prehabilitation aimed at reducing pain, opioid use, and surgical risk. It critiques traditional biomechanical approaches and proposes a whole-person readiness model integrating biological, psychological, social, spiritual, and existential domains. The framework includes evidence-based interventions such as physical therapy, cognitive behavioral therapy, social support, chaplaincy, and reflective practices. It operationalizes a pathway involving screening, triage, targeted interventions, and outcome tracking, focusing on metrics like pain, opioid exposure (measured in morphine milligram equivalents), depression, anxiety, and pain catastrophizing. The model aligns with risk-adjusted payment systems and enhanced recovery programs, offering a nonpharmacological strategy to improve postoperative outcomes and reduce opioid reliance. While morphine is mentioned in the context of opioid exposure tracking, the article does not provide specific details about human subjects, drug administration, or adverse events.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "70f61f84-c530-4de1-be1e-2a3133685b2d",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-13T04:45:57.454Z",
        "type": "system"
      },
      {
        "id": "cf119734-f340-4a39-973d-18d435d42826",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-13T07:37:41.606Z",
        "type": "QC_approval"
      },
      {
        "id": "f8852191-c5d6-4883-90d9-af334472d491",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 4e9da64c-cf19-4d45-9f99-064898c4505f to MORP_Demo_74721",
        "type": "system",
        "createdAt": "2025-12-14T10:13:38.837Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:22:01.446Z",
    "updatedAt": "2025-12-13T07:37:41.616Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41145214",
      "DOI": "https://doi.org/10.14444/8807",
      "special_case": "No",
      "Country_of_first_author": "USA",
      "Country_of_occurrence": "USA",
      "Patient_details": "No human subject",
      "Key_events": "Key events: not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The article discusses a multidimensional framework for surgical prehabilitation aimed at reducing pain, opioid use, and surgical risk. It critiques traditional biomechanical approaches and proposes a whole-person readiness model integrating biological, psychological, social, spiritual, and existential domains. The framework includes evidence-based interventions such as physical therapy, cognitive behavioral therapy, social support, chaplaincy, and reflective practices. It operationalizes a pathway involving screening, triage, targeted interventions, and outcome tracking, focusing on metrics like pain, opioid exposure (measured in morphine milligram equivalents), depression, anxiety, and pain catastrophizing. The model aligns with risk-adjusted payment systems and enhanced recovery programs, offering a nonpharmacological strategy to improve postoperative outcomes and reduce opioid reliance. While morphine is mentioned in the context of opioid exposure tracking, the article does not provide specific details about human subjects, drug administration, or adverse events.",
      "Identifiable_human_subject": "No",
      "Text_type": "Review Article",
      "Author_perspective": "The article emphasizes the potential benefits of a multidimensional prehabilitation framework in reducing opioid reliance, improving postoperative pain control, and enhancing recovery. It suggests that integrating neurobiological and behavioral theory with policy and billing structures could lead to better outcomes and reduced suffering.",
      "Adverse_event": "No AE",
      "Abstract": "Traditional surgical prehabilitation emphasizes biomechanical conditioning. In a pain landscape shaped by opioid exposure, trauma histories, and psychosocial distress, this reductionist approach is insufficient.\n\nTo propose a multidimensional, whole-person framework for perioperative readiness that integrates neurobiological mechanisms with practical clinical and policy levers.\n\nFive synergistic domains-biological, psychological, social, spiritual, and existential-address discrete readiness deficits linked to dopaminergic tone, central sensitization, stress reactivity, connection, and meaning. Each domain is mapped to mechanisms, evidence-based interventions (eg, physical therapy, cognitive behavioral therapy/screening, social support linkage, chaplaincy, reflective practices), and relevant billing structures (Current Procedural Terminology Healthcare Common Procedure Coding System, International Classification of Diseases, 10th Revision Z codes).\n\nThe model operationalizes a deliverables-based pathway-screen → triage → targeted interventions → outcome tracking-monitoring pain, function, opioid exposure (morphine milligram equivalents), length of stay/readmissions, depression and anxiety (Paitent Health Questionnaire-4), and pain catastrophizing (Pain Catastrophizing Scale). It aligns with risk-adjusted payment models and can be embedded within enhanced recovery after surgery programs.\n\nReframing prehabilitation as neurobiologically informed whole-person readiness provides a low-risk, nonpharmacological strategy to reduce suffering, improve engagement, enhance postoperative pain control and recovery, and decrease opioid reliance.\n\n5 (Expert Opinion). This perspective integrates neurobiological and behavioral theory with policy and billing frameworks to enable hypothesis-generating implementation and outcomes research.",
      "Title": "Prehabilitation Reimagined as Policy: A Multidimensional Framework to Reduce Pain, Opioid Use, and Surgical Risk.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-12 22:51:40",
      "Vancouver_citation": "Lewandrowski KU, Lorio MP, Elman I, Blum K, Pinhasov A, Thanos PK, Schmidt SL, Fiorelli RKA. Prehabilitation Reimagined as Policy: A Multidimensional Framework to Reduce Pain, Opioid Use, and Surgical Risk. Int J Spine Surg. 2025;19(S3):S30-47",
      "pubdate": "2025-10-28",
      "Lead_author": "Lewandrowski KU",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Morphine, is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, Morphine is mentioned in the context of monitoring opioid exposure (morphine milligram equivalents) as part of a multidimensional framework for perioperative readiness. However, there is no indication that Morphine was administered to any test subject or used to treat any illness directly. Therefore, the study does not qualify as off-label use.",
      "AOI_classification": "No",
      "Justification": "The study does not link the drug of study to any negative effect or adverse effect, as Morphine was not administered or directly studied in this publication.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.14444/8807",
    "specialCase": "No",
    "countryOfFirstAuthor": "USA",
    "countryOfOccurrence": "USA",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "The article discusses a multidimensional framework for surgical prehabilitation aimed at reducing pain, opioid use, and surgical risk. It critiques traditional biomechanical approaches and proposes a whole-person readiness model integrating biological, psychological, social, spiritual, and existential domains. The framework includes evidence-based interventions such as physical therapy, cognitive behavioral therapy, social support, chaplaincy, and reflective practices. It operationalizes a pathway involving screening, triage, targeted interventions, and outcome tracking, focusing on metrics like pain, opioid exposure (measured in morphine milligram equivalents), depression, anxiety, and pain catastrophizing. The model aligns with risk-adjusted payment systems and enhanced recovery programs, offering a nonpharmacological strategy to improve postoperative outcomes and reduce opioid reliance. While morphine is mentioned in the context of opioid exposure tracking, the article does not provide specific details about human subjects, drug administration, or adverse events.",
    "identifiableHumanSubject": "No",
    "textType": "Review Article",
    "authorPerspective": "The article emphasizes the potential benefits of a multidimensional prehabilitation framework in reducing opioid reliance, improving postoperative pain control, and enhancing recovery. It suggests that integrating neurobiological and behavioral theory with policy and billing structures could lead to better outcomes and reduced suffering.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Lewandrowski KU, Lorio MP, Elman I, Blum K, Pinhasov A, Thanos PK, Schmidt SL, Fiorelli RKA. Prehabilitation Reimagined as Policy: A Multidimensional Framework to Reduce Pain, Opioid Use, and Surgical Risk. Int J Spine Surg. 2025;19(S3):S30-47",
    "leadAuthor": "Lewandrowski KU",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Morphine, is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, Morphine is mentioned in the context of monitoring opioid exposure (morphine milligram equivalents) as part of a multidimensional framework for perioperative readiness. However, there is no indication that Morphine was administered to any test subject or used to treat any illness directly. Therefore, the study does not qualify as off-label use.",
    "aoiClassification": "No",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-13T07:37:41.606Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUikCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUikCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-50d4d40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707218
  },
  {
    "id": "MORP_Demo_66467",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41061858",
    "title": "Innate immune mechanisms underlying the efficacy of a next-generation nanoparticle-based vaccine against opioid use disorders.",
    "authors": [
      "Hamid FA",
      "Rostamizadeh K",
      "Skiados N",
      "Le NN",
      "Walter DL",
      "Hannon B",
      "Marecki C",
      "Bian Y",
      "Luengas D",
      "Zhang C",
      "Pravetoni M"
    ],
    "journal": "J Control Release",
    "publicationDate": "2025-10-9",
    "abstract": "The article discusses the development and testing of next-generation nanoparticle-based vaccines targeting opioid use disorders (OUD), specifically focusing on oxycodone and fentanyl. The study highlights the efficacy of hybrid lipid-polymer nanoparticle (hNP)-based vaccines in animal models, including mice and rats, and explores their potential as a therapeutic and preventative strategy against OUD and overdose. The research also investigates the role of the toll-like receptor 7 and 8 (TLR7/8) agonist R848 in enhancing vaccine efficacy. While the hNP-formulated oxycodone vaccine demonstrated improved immunogenicity and efficacy in rats compared to traditional aluminum salt-based vaccines, the hNP-based fentanyl vaccine initially showed diminished efficacy. However, the addition of R848 to the hNP formulation restored its effectiveness. The study further assessed immune responses using murine macrophage and dendritic cell lines, as well as human whole blood, to evaluate cytokine profiles and immune cell activation. Although the article does not mention human subjects or the administration of drugs like morphine, it provides valuable insights into the design and development of innovative vaccines for combating the opioid epidemic.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b7d23054-600f-4a07-968a-f533bbec333e",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T19:20:48.684Z",
        "type": "system"
      },
      {
        "id": "4add60c9-8129-408d-b18e-137259a9ff7c",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-12T19:21:22.385Z",
        "type": "QC_approval"
      },
      {
        "id": "4f76b678-9bd4-48a7-8bb3-dd3e4fb9d66e",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 290512aa-d130-4433-9b83-29265ea1fbc0 to MORP_Demo_66467",
        "type": "system",
        "createdAt": "2025-12-14T10:13:39.097Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:22:01.480Z",
    "updatedAt": "2025-12-12T19:21:22.398Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41061858",
      "DOI": "https://doi.org/10.1016/j.jconrel.2025.114294",
      "special_case": "No",
      "Country_of_first_author": "USA",
      "Country_of_occurrence": "USA",
      "Patient_details": "No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: Not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The article discusses the development and testing of next-generation nanoparticle-based vaccines targeting opioid use disorders (OUD), specifically focusing on oxycodone and fentanyl. The study highlights the efficacy of hybrid lipid-polymer nanoparticle (hNP)-based vaccines in animal models, including mice and rats, and explores their potential as a therapeutic and preventative strategy against OUD and overdose. The research also investigates the role of the toll-like receptor 7 and 8 (TLR7/8) agonist R848 in enhancing vaccine efficacy. While the hNP-formulated oxycodone vaccine demonstrated improved immunogenicity and efficacy in rats compared to traditional aluminum salt-based vaccines, the hNP-based fentanyl vaccine initially showed diminished efficacy. However, the addition of R848 to the hNP formulation restored its effectiveness. The study further assessed immune responses using murine macrophage and dendritic cell lines, as well as human whole blood, to evaluate cytokine profiles and immune cell activation. Although the article does not mention human subjects or the administration of drugs like morphine, it provides valuable insights into the design and development of innovative vaccines for combating the opioid epidemic.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article comments on the efficacy of hNP-based vaccines in animal models, noting improved immunogenicity and activation of immune cells compared to traditional formulations. It also highlights the role of R848 in rescuing the efficacy of the hNP-based fentanyl vaccine.",
      "Adverse_event": "No AE",
      "Abstract": "Since 1999, the opioid use disorder (OUD) and overdose epidemic has claimed millions of lives with ∼3 million people currently diagnosed with OUD and ∼ 100,000 fatal overdoses occurring annually. Curbing this public health crisis requires accelerating the translation of innovative, effective, and safe treatments. Our team is advancing vaccines against a variety of opioids as a preventative and therapeutic strategy against OUD and overdose. Previously, we reported that a hybrid lipid-polymer nanoparticle (hNP)-based vaccine targeting oxycodone demonstrated superior immunogenicity and efficacy in mice compared to an equivalent conjugate vaccine formulated in aluminum salts. Here, we extended our investigation of the hNP-based oxycodone vaccine to rats and applied the hNP platform to a lead vaccine targeting fentanyl and its analogs. Additionally, this study tested whether hNPs offer a suitable delivery system for vaccines adjuvanted with the toll-like receptor 7 and 8 (TLR7/8) agonist R848. This study assessed vaccine efficacy in blocking opioid-induced antinociception, respiratory/cardiovascular depression, and drug distribution to the brain. Innate immune responses to the anti-oxycodone nanovaccines were tested in murine macrophage and dendritic cell (DC) lines using cellular activation co-stimulatory/maturation markers. Cytokine profiles and immune cell activation in response to anti-fentanyl nanovaccines were assessed in human whole blood using multiplex cytokine assays paired with flow cytometry. Results demonstrate that hNP-formulated oxycodone vaccines exhibit improved efficacy in rats and superior activation of macrophage and DC compared to aluminum formulated conjugate vaccines. While the hNP-based fentanyl vaccine showed diminished efficacy relative to the unformulated vaccine in rats, adding R848 to the hNP formulation rescued its efficacy. These comprehensive immune profiling studies advance our understanding of OUD vaccines, providing a rational blueprint for next-generation vaccine design.",
      "Title": "Innate immune mechanisms underlying the efficacy of a next-generation nanoparticle-based vaccine against opioid use disorders.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-12 22:51:05",
      "Vancouver_citation": "Hamid FA, Rostamizadeh K, Skiados N, Le NN, Walter DL, Hannon B, Marecki C, Bian Y, Luengas D, Zhang C, Pravetoni M. Innate immune mechanisms underlying the efficacy of a next-generation nanoparticle-based vaccine against opioid use disorders. J Control Release. 2025;388(Pt 1):114294",
      "pubdate": "2025-10-9",
      "Lead_author": "Hamid FA",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study include rats, murine macrophage and dendritic cell lines, and human whole blood samples. These subjects were used to assess the efficacy and immune responses of nanoparticle-based vaccines targeting opioids such as oxycodone and fentanyl.",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Morphine, is conventionally used as a potent opioid analgesic for the treatment of moderate to severe pain. It is typically administered via oral, intravenous, intramuscular, or subcutaneous routes. In this study, Morphine is not directly mentioned or administered; the focus is on vaccines targeting other opioids like oxycodone and fentanyl.",
      "AOI_classification": "No",
      "Justification": "The study does not mention Morphine or link it to any adverse effects or negative outcomes. It focuses on vaccines targeting other opioids.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.1016/j.jconrel.2025.114294",
    "specialCase": "No",
    "countryOfFirstAuthor": "USA",
    "countryOfOccurrence": "USA",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: Not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "The article discusses the development and testing of next-generation nanoparticle-based vaccines targeting opioid use disorders (OUD), specifically focusing on oxycodone and fentanyl. The study highlights the efficacy of hybrid lipid-polymer nanoparticle (hNP)-based vaccines in animal models, including mice and rats, and explores their potential as a therapeutic and preventative strategy against OUD and overdose. The research also investigates the role of the toll-like receptor 7 and 8 (TLR7/8) agonist R848 in enhancing vaccine efficacy. While the hNP-formulated oxycodone vaccine demonstrated improved immunogenicity and efficacy in rats compared to traditional aluminum salt-based vaccines, the hNP-based fentanyl vaccine initially showed diminished efficacy. However, the addition of R848 to the hNP formulation restored its effectiveness. The study further assessed immune responses using murine macrophage and dendritic cell lines, as well as human whole blood, to evaluate cytokine profiles and immune cell activation. Although the article does not mention human subjects or the administration of drugs like morphine, it provides valuable insights into the design and development of innovative vaccines for combating the opioid epidemic.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article comments on the efficacy of hNP-based vaccines in animal models, noting improved immunogenicity and activation of immune cells compared to traditional formulations. It also highlights the role of R848 in rescuing the efficacy of the hNP-based fentanyl vaccine.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Hamid FA, Rostamizadeh K, Skiados N, Le NN, Walter DL, Hannon B, Marecki C, Bian Y, Luengas D, Zhang C, Pravetoni M. Innate immune mechanisms underlying the efficacy of a next-generation nanoparticle-based vaccine against opioid use disorders. J Control Release. 2025;388(Pt 1):114294",
    "leadAuthor": "Hamid FA",
    "serious": "No",
    "testSubject": "The test subjects involved in this study include rats, murine macrophage and dendritic cell lines, and human whole blood samples. These subjects were used to assess the efficacy and immune responses of nanoparticle-based vaccines targeting opioids such as oxycodone and fentanyl.",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Morphine, is conventionally used as a potent opioid analgesic for the treatment of moderate to severe pain. It is typically administered via oral, intravenous, intramuscular, or subcutaneous routes. In this study, Morphine is not directly mentioned or administered; the focus is on vaccines targeting other opioids like oxycodone and fentanyl.",
    "aoiClassification": "No",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T19:21:22.385Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUilCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUilCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-50f7840501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707219
  },
  {
    "id": "MORP_Demo_48606",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41380146",
    "title": "Delivery of Intrathecal Morphine Through Baclofen Pump for Perioperative Analgesia.",
    "authors": [
      "Li AW",
      "Hardesty CK"
    ],
    "journal": "J Am Acad Orthop Surg Glob Res Rev",
    "publicationDate": "2025-12-11",
    "abstract": "The article discusses the use of intrathecal morphine delivered through baclofen pumps for perioperative analgesia in children with abnormal tone, often associated with conditions like neuromuscular scoliosis. The study highlights the effectiveness of this method in managing pain during extensive surgeries while minimizing risks of complications such as respiratory depression, pruritis, and nausea/vomiting. Although specific patient details are not provided, the study emphasizes the safety measures required to ensure the technique's success. Morphine and baclofen were administered, and the study demonstrates that the baclofen pumps can be repurposed for delivering intrathecal morphine effectively. The article does not provide specific adverse events or detailed outcomes for individual patients but suggests that the method is generally safe and effective for perioperative pain management.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "8e6d0cd6-70ad-4a60-a808-9f8039d21ca2",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T19:16:48.206Z",
        "type": "system"
      },
      {
        "id": "d1140dad-ede9-44ae-8423-e470ed7efa72",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-12T19:17:14.655Z",
        "type": "QC_approval"
      },
      {
        "id": "918e12ec-c6ea-4cf4-85ce-0338dafd2039",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 67810388-0ee6-499d-ba4c-423bdc1b57a9 to MORP_Demo_48606",
        "type": "system",
        "createdAt": "2025-12-14T10:13:39.377Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:23:38.885Z",
    "updatedAt": "2025-12-12T19:17:14.666Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41380146",
      "DOI": "https://doi.org/10.5435/JAAOSGlobal-D-25-00169",
      "special_case": "No",
      "Country_of_first_author": "United States",
      "Country_of_occurrence": "United States",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: Human subjects with abnormal tone and baclofen pumps were treated with intrathecal morphine for perioperative analgesia. The study aimed to manage pain effectively during surgery for conditions like neuromuscular scoliosis. Safety measures were highlighted to minimize complications such as respiratory depression, pruritis, and nausea/vomiting.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Morphine, Baclofen",
      "Attributability": "Attributability: The study mentions the use of intrathecal morphine delivered through baclofen pumps for perioperative analgesia. It highlights minimal risk of complications such as respiratory depression, pruritis, and nausea/vomiting, which may be attributed to the administration of morphine.",
      "Drug_effect": "Drug effect: summary. Intrathecal morphine delivered through baclofen pumps was effective for perioperative analgesia with minimal risk of complications.",
      "Summary": "The article discusses the use of intrathecal morphine delivered through baclofen pumps for perioperative analgesia in children with abnormal tone, often associated with conditions like neuromuscular scoliosis. The study highlights the effectiveness of this method in managing pain during extensive surgeries while minimizing risks of complications such as respiratory depression, pruritis, and nausea/vomiting. Although specific patient details are not provided, the study emphasizes the safety measures required to ensure the technique's success. Morphine and baclofen were administered, and the study demonstrates that the baclofen pumps can be repurposed for delivering intrathecal morphine effectively. The article does not provide specific adverse events or detailed outcomes for individual patients but suggests that the method is generally safe and effective for perioperative pain management.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Case Report",
      "Author_perspective": "The article comments positively on the use of intrathecal morphine delivered through baclofen pumps for perioperative analgesia, noting its effectiveness and minimal risk of complications. It emphasizes the safety measures required for successful implementation of this technique.",
      "Adverse_event": "No AE",
      "Abstract": "A number of children with abnormal tone are implanted with pumps that deliver baclofen to the intrathecal space through an attached catheter. These pumps contain a catheter access port that allows for withdrawal or introduction of fluids to the intrathecal space. Patients treated with baclofen pumps often also present with neuromuscular scoliosis or other conditions that require extensive surgery and perioperative analgesia. In this article, we describe cases in which intrathecal morphine (Duramorph) was delivered through implanted baclofen pumps to manage perioperative pain. We demonstrate that baclofen pumps can be used to deliver intrathecal morphine for effective perioperative analgesia with minimal risk of complications such as respiratory depression, pruritis, and nausea/vomiting. We also highlight steps which must be taken to ensure safety when using this technique.",
      "Title": "Delivery of Intrathecal Morphine Through Baclofen Pump for Perioperative Analgesia.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-12 22:52:22",
      "Vancouver_citation": "Li AW, Hardesty CK. Delivery of Intrathecal Morphine Through Baclofen Pump for Perioperative Analgesia. J Am Acad Orthop Surg Glob Res Rev. 2025;9(12):",
      "pubdate": "2025-12-11",
      "Lead_author": "Li AW",
      "Serious": "No",
      "Test_subject": "The test subjects in this study are children with abnormal tone who are implanted with baclofen pumps. These children often present with conditions such as neuromuscular scoliosis and require extensive surgery and perioperative analgesia.",
      "AOI_drug_effect": "The drug of study, intrathecal morphine (Duramorph), was delivered through baclofen pumps to manage perioperative pain in the test subjects. The study mentions that this method provided effective analgesia with minimal risk of complications such as respiratory depression, pruritis, and nausea/vomiting.",
      "Approved_indication": "The drug of study, morphine, is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, morphine was administered intrathecally through baclofen pumps to children for perioperative analgesia, which qualifies as off-label use since it is outside the scope of its accepted indications.",
      "AOI_classification": "Yes",
      "Justification": "The study describes the off-label use of the drug of study and mentions potential complications such as respiratory depression, pruritis, and nausea/vomiting, even though these risks were minimal.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.5435/JAAOSGlobal-D-25-00169",
    "specialCase": "No",
    "countryOfFirstAuthor": "United States",
    "countryOfOccurrence": "United States",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: Human subjects with abnormal tone and baclofen pumps were treated with intrathecal morphine for perioperative analgesia. The study aimed to manage pain effectively during surgery for conditions like neuromuscular scoliosis. Safety measures were highlighted to minimize complications such as respiratory depression, pruritis, and nausea/vomiting.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Morphine",
      "Baclofen"
    ],
    "attributability": "Attributability: The study mentions the use of intrathecal morphine delivered through baclofen pumps for perioperative analgesia. It highlights minimal risk of complications such as respiratory depression, pruritis, and nausea/vomiting, which may be attributed to the administration of morphine.",
    "drugEffect": "Drug effect: summary. Intrathecal morphine delivered through baclofen pumps was effective for perioperative analgesia with minimal risk of complications.",
    "summary": "The article discusses the use of intrathecal morphine delivered through baclofen pumps for perioperative analgesia in children with abnormal tone, often associated with conditions like neuromuscular scoliosis. The study highlights the effectiveness of this method in managing pain during extensive surgeries while minimizing risks of complications such as respiratory depression, pruritis, and nausea/vomiting. Although specific patient details are not provided, the study emphasizes the safety measures required to ensure the technique's success. Morphine and baclofen were administered, and the study demonstrates that the baclofen pumps can be repurposed for delivering intrathecal morphine effectively. The article does not provide specific adverse events or detailed outcomes for individual patients but suggests that the method is generally safe and effective for perioperative pain management.",
    "identifiableHumanSubject": "Yes",
    "textType": "Case Report",
    "authorPerspective": "The article comments positively on the use of intrathecal morphine delivered through baclofen pumps for perioperative analgesia, noting its effectiveness and minimal risk of complications. It emphasizes the safety measures required for successful implementation of this technique.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Li AW, Hardesty CK. Delivery of Intrathecal Morphine Through Baclofen Pump for Perioperative Analgesia. J Am Acad Orthop Surg Glob Res Rev. 2025;9(12):",
    "leadAuthor": "Li AW",
    "serious": "No",
    "testSubject": "The test subjects in this study are children with abnormal tone who are implanted with baclofen pumps. These children often present with conditions such as neuromuscular scoliosis and require extensive surgery and perioperative analgesia.",
    "aoiDrugEffect": "The drug of study, intrathecal morphine (Duramorph), was delivered through baclofen pumps to manage perioperative pain in the test subjects. The study mentions that this method provided effective analgesia with minimal risk of complications such as respiratory depression, pruritis, and nausea/vomiting.",
    "approvedIndication": "The drug of study, morphine, is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, morphine was administered intrathecally through baclofen pumps to children for perioperative analgesia, which qualifies as off-label use since it is outside the scope of its accepted indications.",
    "aoiClassification": "Yes",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T19:17:14.655Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUimCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUimCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-51224c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707219
  },
  {
    "id": "MORP_Demo_57320",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41380145",
    "title": "Adductor Canal Block Preserves Quadriceps Function Despite Transient Sensory Deficits Following Total Knee Arthroplasty: A Randomized Controlled Trial.",
    "authors": [
      "Srungboonmee K",
      "Tubtim C",
      "Sukhonthamarn K",
      "Witayakom W",
      "Wittayapairoj A",
      "Oraintara S",
      "Apinyankul R"
    ],
    "journal": "J Am Acad Orthop Surg Glob Res Rev",
    "publicationDate": "2025-12-11",
    "abstract": "The study aimed to evaluate the effects of adductor canal block (ACB) on motor and sensory functions following total knee arthroplasty. Twenty-five patients were enrolled and divided into ACB and non-ACB groups. The study assessed motor function using electromyography, sensory function through pain scores, cutaneous sensation, and morphine consumption over postoperative days 1 to 4. Results showed no significant differences in quadriceps muscle strength, pain scores, or morphine consumption between the groups. However, sensory recovery was delayed in the ACB group compared to the non-ACB group, with non-ACB subjects recovering sensory function by postoperative day 1. The study concluded that ACB preserves quadriceps strength and effectively manages pain after total knee arthroplasty, although temporary sensory deficits should be anticipated during early mobility. Morphine was administered, but no specific adverse effects or drug-related complications were reported. The study highlights the importance of considering sensory recovery timelines when using ACB in postoperative pain management.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "1573f898-a1e1-4b12-b4e0-0705be8d8183",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"No Case\". Moving to QC Triage.",
        "timestamp": "2025-12-12T19:01:31.264Z",
        "type": "system"
      },
      {
        "id": "a641e1be-d7f6-4a22-8cb3-b40096ca8b7c",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"No Case\" approved by QC",
        "timestamp": "2025-12-12T19:01:40.538Z",
        "type": "QC_approval"
      },
      {
        "id": "3b96d33b-8337-44a5-99b0-4247eb36af60",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 492fdd20-f790-4086-82bf-451e9fb5f738 to MORP_Demo_57320",
        "type": "system",
        "createdAt": "2025-12-14T10:13:39.575Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:23:38.906Z",
    "updatedAt": "2025-12-12T19:01:40.546Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41380145",
      "DOI": "https://doi.org/10.5435/JAAOSGlobal-D-25-00271",
      "special_case": "No",
      "Country_of_first_author": "Thailand",
      "Country_of_occurrence": "Thailand",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: Human patients underwent total knee arthroplasty and were allocated to either adductor canal block (ACB) or non-ACB groups. The study evaluated motor and sensory functions, pain scores, morphine consumption, and cutaneous sensory recovery from postoperative days 1 to 4. Sensory recovery was delayed in the ACB group compared to the non-ACB group.",
      "Relevant_dates": "Relevant dates: Clinical Trials Registry and institutional ethical approval, March 2021. Postoperative days 1 to 4 were mentioned for sensory recovery and other evaluations.",
      "Administered_drugs": "Administered drugs: Morphine",
      "Attributability": "Attributability: Temporary sensory deficits were observed in the ACB group, which may be attributed to the adductor canal block. No adverse effects were directly linked to morphine consumption.",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The study aimed to evaluate the effects of adductor canal block (ACB) on motor and sensory functions following total knee arthroplasty. Twenty-five patients were enrolled and divided into ACB and non-ACB groups. The study assessed motor function using electromyography, sensory function through pain scores, cutaneous sensation, and morphine consumption over postoperative days 1 to 4. Results showed no significant differences in quadriceps muscle strength, pain scores, or morphine consumption between the groups. However, sensory recovery was delayed in the ACB group compared to the non-ACB group, with non-ACB subjects recovering sensory function by postoperative day 1. The study concluded that ACB preserves quadriceps strength and effectively manages pain after total knee arthroplasty, although temporary sensory deficits should be anticipated during early mobility. Morphine was administered, but no specific adverse effects or drug-related complications were reported. The study highlights the importance of considering sensory recovery timelines when using ACB in postoperative pain management.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article comments that adductor canal block (ACB) preserves quadriceps strength and effectively manages pain after total knee arthroplasty, although temporary sensory deficits should be anticipated during early mobility.",
      "Adverse_event": "No AE",
      "Abstract": "To evaluate the effects of adductor canal block (ACB) on motor and sensory functions following total knee arthroplasty. Motor function was quantified using median frequency of surface electromyography, whereas sensory function was assessed through pain scores, cutaneous sensation, and morphine consumption in patients with and without ACB.\n\nThis randomized controlled trial enrolled 25 total knee arthroplasty patients allocated to either ACB or non-ACB groups. Measurements included median frequency of rectus femoris and vastus medialis muscles during standardized 2-minute leg extension tasks, visual analog scale pain scores, morphine consumption, and cutaneous sensory function on postoperative days 1 to 4.\n\nNo notable differences were detected between the groups regarding median frequency of rectus femoris and vastus medialis, visual analog scale pain scores, or morphine consumption across all postoperative days. These findings suggest that ACB did not compromise postoperative quadriceps muscle strength or pain control. However, cutaneous sensory recovery occurred on postoperative day 1 for all non-ACB subjects, whereas sensory recovery was delayed in the ACB group.\n\nACB preserves quadriceps strength while effectively managing pain after TKA, although temporary sensory deficits should be anticipated during early mobility.\n\nClinical Trials Registry and institutional ethical approval, March 2021.",
      "Title": "Adductor Canal Block Preserves Quadriceps Function Despite Transient Sensory Deficits Following Total Knee Arthroplasty: A Randomized Controlled Trial.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-12 22:52:43",
      "Vancouver_citation": "Srungboonmee K, Tubtim C, Sukhonthamarn K, Witayakom W, Wittayapairoj A, Oraintara S, Apinyankul R. Adductor Canal Block Preserves Quadriceps Function Despite Transient Sensory Deficits Following Total Knee Arthroplasty: A Randomized Controlled Trial. J Am Acad Orthop Surg Glob Res Rev. 2025;9(12):",
      "pubdate": "2025-12-11",
      "Lead_author": "Srungboonmee K",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study are 25 patients who underwent total knee arthroplasty. These patients were divided into two groups: those who received adductor canal block (ACB) and those who did not.",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, morphine, is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, morphine was administered to patients postoperatively to manage pain following total knee arthroplasty. This use aligns with its conventional purpose and does not qualify as off-label use.",
      "AOI_classification": "No",
      "Justification": "The study does not link morphine to any adverse effects or negative outcomes.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.5435/JAAOSGlobal-D-25-00271",
    "specialCase": "No",
    "countryOfFirstAuthor": "Thailand",
    "countryOfOccurrence": "Thailand",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: Human patients underwent total knee arthroplasty and were allocated to either adductor canal block (ACB) or non-ACB groups. The study evaluated motor and sensory functions, pain scores, morphine consumption, and cutaneous sensory recovery from postoperative days 1 to 4. Sensory recovery was delayed in the ACB group compared to the non-ACB group.",
    "relevantDates": "Relevant dates: Clinical Trials Registry and institutional ethical approval, March 2021. Postoperative days 1 to 4 were mentioned for sensory recovery and other evaluations.",
    "administeredDrugs": [
      "Administered drugs: Morphine"
    ],
    "attributability": "Attributability: Temporary sensory deficits were observed in the ACB group, which may be attributed to the adductor canal block. No adverse effects were directly linked to morphine consumption.",
    "drugEffect": "Drug effect: no data",
    "summary": "The study aimed to evaluate the effects of adductor canal block (ACB) on motor and sensory functions following total knee arthroplasty. Twenty-five patients were enrolled and divided into ACB and non-ACB groups. The study assessed motor function using electromyography, sensory function through pain scores, cutaneous sensation, and morphine consumption over postoperative days 1 to 4. Results showed no significant differences in quadriceps muscle strength, pain scores, or morphine consumption between the groups. However, sensory recovery was delayed in the ACB group compared to the non-ACB group, with non-ACB subjects recovering sensory function by postoperative day 1. The study concluded that ACB preserves quadriceps strength and effectively manages pain after total knee arthroplasty, although temporary sensory deficits should be anticipated during early mobility. Morphine was administered, but no specific adverse effects or drug-related complications were reported. The study highlights the importance of considering sensory recovery timelines when using ACB in postoperative pain management.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article comments that adductor canal block (ACB) preserves quadriceps strength and effectively manages pain after total knee arthroplasty, although temporary sensory deficits should be anticipated during early mobility.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Srungboonmee K, Tubtim C, Sukhonthamarn K, Witayakom W, Wittayapairoj A, Oraintara S, Apinyankul R. Adductor Canal Block Preserves Quadriceps Function Despite Transient Sensory Deficits Following Total Knee Arthroplasty: A Randomized Controlled Trial. J Am Acad Orthop Surg Glob Res Rev. 2025;9(12):",
    "leadAuthor": "Srungboonmee K",
    "serious": "No",
    "testSubject": "The test subjects involved in this study are 25 patients who underwent total knee arthroplasty. These patients were divided into two groups: those who received adductor canal block (ACB) and those who did not.",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, morphine, is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, morphine was administered to patients postoperatively to manage pain following total knee arthroplasty. This use aligns with its conventional purpose and does not qualify as off-label use.",
    "aoiClassification": "No",
    "justification": "Secondary analysis",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T19:01:40.538Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUinCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUinCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-51463c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707219
  },
  {
    "id": "MORP_Demo_75221",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41380089",
    "title": "Pain management guidelines reduce opioids in post-operative and mechanically ventilated neonates.",
    "authors": [
      "Do J",
      "Kutcher SA",
      "McGregor E",
      "Sucha E",
      "Webster RJ",
      "Joly C",
      "Blazevic A",
      "van Zanten SV",
      "Ferretti E"
    ],
    "journal": "Pain",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "MORPHINE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "01152be8-0147-4aef-9fd6-3c84f4810ac4",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"No Case\". Moving to QC Triage.",
        "timestamp": "2025-12-12T19:00:05.834Z",
        "type": "system"
      },
      {
        "id": "24b7a06b-1a0b-43fe-8eb0-18663f58bfda",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"No Case\" approved by QC",
        "timestamp": "2025-12-12T19:00:29.912Z",
        "type": "QC_approval"
      },
      {
        "id": "4a88be0d-9145-49fb-b9e8-696b157b934d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from e0bc850a-2aa6-4196-991a-b06db55cef31 to MORP_Demo_75221",
        "type": "system",
        "createdAt": "2025-12-14T10:13:39.845Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:23:38.973Z",
    "updatedAt": "2025-12-12T19:00:29.920Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41380089",
      "DOI": "https://doi.org10.1097/j.pain.0000000000003875",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "MORPHINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 22:53:00",
      "Drugname": "MORPHINE",
      "Vancouver_citation": "Do J, Kutcher SA, McGregor E, Sucha E, Webster RJ, Joly C, Blazevic A, van Zanten SV, Ferretti E. Pain management guidelines reduce opioids in post-operative and mechanically ventilated neonates. Pain. 2025;",
      "pubdate": "2025-12-11",
      "Lead_author": "Do J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/j.pain.0000000000003875",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Do J, Kutcher SA, McGregor E, Sucha E, Webster RJ, Joly C, Blazevic A, van Zanten SV, Ferretti E. Pain management guidelines reduce opioids in post-operative and mechanically ventilated neonates. Pain. 2025;",
    "leadAuthor": "Do J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Treatment Medication",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T19:00:29.912Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUioCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUioCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-5169840501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707219
  },
  {
    "id": "MORP_Demo_35301",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41379453",
    "title": "Independent Factors Associated With Opioid Refills After Inpatient Otolaryngology-Head and Neck Surgery.",
    "authors": [
      "Zhang L",
      "Ly T",
      "Luu K",
      "Durr M",
      "Pletcher S",
      "Likhterov I",
      "Murr A",
      "Guan Z"
    ],
    "journal": "JAMA Otolaryngol Head Neck Surg",
    "publicationDate": "2025-12-11",
    "abstract": "Article requires manual review",
    "drugName": "MORPHINE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "66e6db2f-8ab5-416e-a74a-de7c8c5e0ad9",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"No Case\". Moving to QC Triage.",
        "timestamp": "2025-12-12T18:59:11.261Z",
        "type": "system"
      },
      {
        "id": "b227000c-00ad-4c69-b3c8-f438c863a735",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"No Case\" approved by QC",
        "timestamp": "2025-12-13T07:37:45.709Z",
        "type": "QC_approval"
      },
      {
        "id": "bb872094-fccd-4022-9eb6-e2efee7ca4cb",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 059ca7bf-2fce-4f56-b648-8fa35fe3fe05 to MORP_Demo_35301",
        "type": "system",
        "createdAt": "2025-12-14T10:13:40.071Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:23:39.015Z",
    "updatedAt": "2025-12-13T07:37:45.718Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41379453",
      "DOI": "https://doi.org10.1001/jamaoto.2025.4576",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "MORPHINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 22:53:16",
      "Drugname": "MORPHINE",
      "Vancouver_citation": "Zhang L, Ly T, Luu K, Durr M, Pletcher S, Likhterov I, Murr A, Guan Z. Independent Factors Associated With Opioid Refills After Inpatient Otolaryngology-Head and Neck Surgery. JAMA Otolaryngol Head Neck Surg. 2025;",
      "pubdate": "2025-12-11",
      "Lead_author": "Zhang L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1001/jamaoto.2025.4576",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Zhang L, Ly T, Luu K, Durr M, Pletcher S, Likhterov I, Murr A, Guan Z. Independent Factors Associated With Opioid Refills After Inpatient Otolaryngology-Head and Neck Surgery. JAMA Otolaryngol Head Neck Surg. 2025;",
    "leadAuthor": "Zhang L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Pre-Clinical study",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-13T07:37:45.709Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUipCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUipCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-518c600501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707220
  },
  {
    "id": "MORP_Demo_49111",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41359313",
    "title": "Medical Cannabis and Opioid Receipt Among Adults With Chronic Pain.",
    "authors": [
      "Slawek DE",
      "Zhang C",
      "Dahmer S",
      "Sohler N",
      "Zolotov Y",
      "Starrels JL",
      "Deng Y",
      "Calderon DiFrancesca G",
      "Levin FR",
      "Ross J",
      "Minami H",
      "Cunningham CO",
      "Arnsten JH"
    ],
    "journal": "JAMA Intern Med",
    "publicationDate": "2025-12-8",
    "abstract": "This cohort study investigated the association between participation in the New York State medical cannabis program and prescription opioid receipt among adults with chronic pain. The study recruited 204 participants from a large academic medical center and nearby medical cannabis dispensaries in the Bronx, New York. Participants were monitored for 18 months, with monthly dispensation of medical cannabis tracked. The study found that the mean daily morphine milliequivalents (MME) decreased from 73.3 at baseline to 57.4 during the follow-up period. This reduction was associated with the monthly portion of days covered with medical cannabis. Participants dispensed a 30-day supply of medical cannabis experienced a reduction of 3.53 fewer MME per day compared to those who did not receive medical cannabis. The study accounted for unregulated cannabis use and nonprescribed opioid use during the study period. While the study highlights the potential of medical cannabis as an alternative to prescription opioids, no specific adverse events or complications were reported in relation to morphine or medical cannabis use.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "15f63d35-b266-4da1-8fe5-0b2d3df627b1",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T18:34:05.072Z",
        "type": "system"
      },
      {
        "id": "63c8fdfb-7244-4968-96ae-c2bd8071825d",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-13T07:37:49.750Z",
        "type": "QC_approval"
      },
      {
        "id": "fffa8b90-7229-400f-8fcd-ee05bafd0514",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d60c70e1-78a1-47d5-8c6c-61dbdab77f80 to MORP_Demo_49111",
        "type": "system",
        "createdAt": "2025-12-14T10:13:40.322Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:23:39.042Z",
    "updatedAt": "2025-12-13T07:37:49.761Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41359313",
      "DOI": "https://doi.org/10.1001/jamainternmed.2025.6496",
      "special_case": "No",
      "Country_of_first_author": "United States",
      "Country_of_occurrence": "United States",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: Adults with chronic pain who were prescribed opioids and newly certified for medical cannabis use in New York State were monitored for 18 months. The study assessed the association between medical cannabis dispensation and prescription opioid receipt, including unregulated cannabis use and nonprescribed opioid use.",
      "Relevant_dates": "Relevant dates: September 2018 through July 2023 (study period), February 3, 2025, to July 15, 2025 (data analysis period).",
      "Administered_drugs": "Administered drugs: Morphine, medical cannabis",
      "Attributability": "Attributability: The study observed a reduction in mean daily morphine milliequivalents (MME) associated with medical cannabis dispensation. No specific adverse events or complications were attributed to morphine or medical cannabis.",
      "Drug_effect": "Drug effect: The study found that participation in the medical cannabis program was associated with reduced prescription opioid receipt, specifically a decrease in daily morphine milliequivalents (MME).",
      "Summary": "This cohort study investigated the association between participation in the New York State medical cannabis program and prescription opioid receipt among adults with chronic pain. The study recruited 204 participants from a large academic medical center and nearby medical cannabis dispensaries in the Bronx, New York. Participants were monitored for 18 months, with monthly dispensation of medical cannabis tracked. The study found that the mean daily morphine milliequivalents (MME) decreased from 73.3 at baseline to 57.4 during the follow-up period. This reduction was associated with the monthly portion of days covered with medical cannabis. Participants dispensed a 30-day supply of medical cannabis experienced a reduction of 3.53 fewer MME per day compared to those who did not receive medical cannabis. The study accounted for unregulated cannabis use and nonprescribed opioid use during the study period. While the study highlights the potential of medical cannabis as an alternative to prescription opioids, no specific adverse events or complications were reported in relation to morphine or medical cannabis use.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article comments on the effect of medical cannabis on reducing prescription opioid receipt, specifically morphine milliequivalents (MME), among adults with chronic pain. It highlights the potential of medical cannabis as an alternative to opioids.",
      "Adverse_event": "No AE",
      "Abstract": "Medical cannabis is increasingly considered a substitute for prescription opioid medications for chronic pain, driven by the urgent need for opioid alternatives to combat the ongoing epidemic.\n\nTo determine the association between participation in the New York State (NYS) medical cannabis program and prescription opioid receipt among adults with chronic pain.\n\nThis cohort study used data from the NYS Prescription Monitoring Program (PMP) from September 2018 through July 2023. Adults prescribed opioids for chronic pain who were newly certified for medical cannabis use in NYS were recruited from a large academic medical center and nearby medical cannabis dispensaries in the Bronx, New York. Monthly dispensation of medical cannabis to study participants was monitored for 18 months. Data analyses were performed from February 3, 2025, to July 15, 2025.\n\nPortion of days covered each month by pharmacist report of dispensed medical cannabis.\n\nPrescription opioid receipt, defined as NYS PMP-reported prescription monthly opioid dispensation (mean daily dose in morphine milliequivalents [MME]), was assessed with marginal structural models adjusted for time-invariant and time-varying confounders, including self-reported unregulated cannabis use. Nonprescribed opioid use was also assessed during the study period.\n\nAmong 204 participants, the mean (SD) age at baseline was 56.8 (12.8) years, and 113 (55.4%) were female. At baseline, participants' mean (SD) pain severity score was 6.6 (1.8) out of 10, and mean (SD) pain interference score was 6.8 (1.9) out of 10. Baseline mean (SD) daily MME was 73.3 (133.0). During the 18-month follow-up period, participants' mean (SD) daily MME decreased to 57.4 (127.8). This reduction in mean daily MME was associated with the monthly portion of days covered with medical cannabis; compared with no medical cannabis dispensed, participants dispensed a 30-day supply of medical cannabis were exposed to 3.53 fewer MME per day (β = -3.53; 95% CI, -6.68 to -0.04; P = .03).\n\nIn this cohort study, participation in NYS's medical cannabis program was associated with reduced prescription opioid receipt during 18 months of prospective follow-up, accounting for unregulated cannabis use.",
      "Title": "Medical Cannabis and Opioid Receipt Among Adults With Chronic Pain.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-12 22:53:37",
      "Vancouver_citation": "Slawek DE, Zhang C, Dahmer S, Sohler N, Zolotov Y, Starrels JL, Deng Y, Calderon DiFrancesca G, Levin FR, Ross J, Minami H, Cunningham CO, Arnsten JH. Medical Cannabis and Opioid Receipt Among Adults With Chronic Pain. JAMA Intern Med. 2025;",
      "pubdate": "2025-12-8",
      "Lead_author": "Slawek DE",
      "Serious": "No",
      "Test_subject": "The test subjects in this study were adults with chronic pain who were prescribed opioids and newly certified for medical cannabis use in New York State. A total of 204 participants were involved in the study.",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Morphine, is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, Morphine was administered as part of prescription opioid therapy to adults with chronic pain. This use aligns with its conventional indications and does not qualify as off-label use.",
      "AOI_classification": "No",
      "Justification": "The study does not link Morphine to any adverse effects or negative outcomes. It primarily focuses on the association between medical cannabis use and reduced prescription opioid receipt, without detailing adverse events related to Morphine.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.1001/jamainternmed.2025.6496",
    "specialCase": "No",
    "countryOfFirstAuthor": "United States",
    "countryOfOccurrence": "United States",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: Adults with chronic pain who were prescribed opioids and newly certified for medical cannabis use in New York State were monitored for 18 months. The study assessed the association between medical cannabis dispensation and prescription opioid receipt, including unregulated cannabis use and nonprescribed opioid use.",
    "relevantDates": "Relevant dates: September 2018 through July 2023 (study period), February 3, 2025, to July 15, 2025 (data analysis period).",
    "administeredDrugs": [
      "Administered drugs: Morphine",
      "medical cannabis"
    ],
    "attributability": "Attributability: The study observed a reduction in mean daily morphine milliequivalents (MME) associated with medical cannabis dispensation. No specific adverse events or complications were attributed to morphine or medical cannabis.",
    "drugEffect": "Drug effect: The study found that participation in the medical cannabis program was associated with reduced prescription opioid receipt, specifically a decrease in daily morphine milliequivalents (MME).",
    "summary": "This cohort study investigated the association between participation in the New York State medical cannabis program and prescription opioid receipt among adults with chronic pain. The study recruited 204 participants from a large academic medical center and nearby medical cannabis dispensaries in the Bronx, New York. Participants were monitored for 18 months, with monthly dispensation of medical cannabis tracked. The study found that the mean daily morphine milliequivalents (MME) decreased from 73.3 at baseline to 57.4 during the follow-up period. This reduction was associated with the monthly portion of days covered with medical cannabis. Participants dispensed a 30-day supply of medical cannabis experienced a reduction of 3.53 fewer MME per day compared to those who did not receive medical cannabis. The study accounted for unregulated cannabis use and nonprescribed opioid use during the study period. While the study highlights the potential of medical cannabis as an alternative to prescription opioids, no specific adverse events or complications were reported in relation to morphine or medical cannabis use.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article comments on the effect of medical cannabis on reducing prescription opioid receipt, specifically morphine milliequivalents (MME), among adults with chronic pain. It highlights the potential of medical cannabis as an alternative to opioids.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Slawek DE, Zhang C, Dahmer S, Sohler N, Zolotov Y, Starrels JL, Deng Y, Calderon DiFrancesca G, Levin FR, Ross J, Minami H, Cunningham CO, Arnsten JH. Medical Cannabis and Opioid Receipt Among Adults With Chronic Pain. JAMA Intern Med. 2025;",
    "leadAuthor": "Slawek DE",
    "serious": "No",
    "testSubject": "The test subjects in this study were adults with chronic pain who were prescribed opioids and newly certified for medical cannabis use in New York State. A total of 204 participants were involved in the study.",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Morphine, is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, Morphine was administered as part of prescription opioid therapy to adults with chronic pain. This use aligns with its conventional indications and does not qualify as off-label use.",
    "aoiClassification": "No",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-13T07:37:49.750Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": "Listed",
    "seriousness": "Serious",
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiqCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiqCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-51b2900501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707220
  },
  {
    "id": "MORP_Demo_55556",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41379283",
    "title": "Prevalence and Patterns of Off-Label Transmucosal Immediate-Release Fentanyl Use in French General Practice: A Mixed-Methods Study Based on a Voluntary Online Survey.",
    "authors": [
      "Guastella V",
      "Gueganno E",
      "Bertin C",
      "Balayssac D",
      "Pereira B",
      "Authier N"
    ],
    "journal": "Pain Ther",
    "publicationDate": "2025-12-11",
    "abstract": "The study focuses on the prevalence and patterns of off-label use of transmucosal immediate-release fentanyl (TIRF) among French general practitioners (GPs). It highlights the increasing prescription rates of TIRF due to its rapid onset and ease of administration, particularly for breakthrough pain. The study utilized a mixed-methods approach, combining qualitative interviews and a quantitative cross-sectional survey, with data collected through a national online survey. A total of 682 completed questionnaires were analyzed, revealing that 46% of GPs reported off-label prescribing of TIRFs for various clinical indications, including procedural pain, alertness disorders, swallowing disorders, and acute rheumatological pain. The findings emphasize the widespread off-label use of TIRF, with varying perceptions of efficacy and tolerability. Concerns such as limited training, dose titration difficulties, and the risk of use disorder were noted. The study suggests that targeted education and clearer prescribing guidelines could improve the safety and appropriateness of TIRF use in general practice. Morphine is mentioned in the abstract as a comparison to TIRF, but no specific data on its administration or effects is provided.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "46b6c36b-da18-406a-998f-6a907cb95a4e",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T18:28:54.710Z",
        "type": "system"
      },
      {
        "id": "ac8888b1-3b6a-44bd-8654-93180e925fdb",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-12T18:29:36.664Z",
        "type": "QC_approval"
      },
      {
        "id": "9a205cda-f956-4f16-976e-9488a44e6205",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Added comment to field listedness: Test",
        "timestamp": "2025-12-13T05:11:15.616Z",
        "type": "field_comment"
      },
      {
        "id": "31630abc-e234-42fe-b171-28bb3b2a3e2d",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Added comment to field listedness: Second change",
        "timestamp": "2025-12-13T05:13:59.253Z",
        "type": "field_comment"
      },
      {
        "id": "ddfba334-bc18-4bb9-9dc7-1fe4fbb3af56",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Study revoked by Medical Reviewer. Reason: Test revoke. Returned to triage for corrections.",
        "timestamp": "2025-12-13T05:14:23.834Z",
        "type": "revocation"
      },
      {
        "id": "f5b8fc32-ee92-400d-9564-5f2455cfe57d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from df54cc65-afaa-4e30-aa9f-d8d35e0f4014 to MORP_Demo_55556",
        "type": "system",
        "createdAt": "2025-12-14T10:13:40.568Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:25:00.118Z",
    "updatedAt": "2025-12-13T05:14:23.843Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41379283",
      "DOI": "https://doi.org/10.1007/s40122-025-00801-y",
      "special_case": "Abuse/Misuse",
      "Country_of_first_author": "France",
      "Country_of_occurrence": "France",
      "Patient_details": "No human subject",
      "Key_events": "Key events: not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The study focuses on the prevalence and patterns of off-label use of transmucosal immediate-release fentanyl (TIRF) among French general practitioners (GPs). It highlights the increasing prescription rates of TIRF due to its rapid onset and ease of administration, particularly for breakthrough pain. The study utilized a mixed-methods approach, combining qualitative interviews and a quantitative cross-sectional survey, with data collected through a national online survey. A total of 682 completed questionnaires were analyzed, revealing that 46% of GPs reported off-label prescribing of TIRFs for various clinical indications, including procedural pain, alertness disorders, swallowing disorders, and acute rheumatological pain. The findings emphasize the widespread off-label use of TIRF, with varying perceptions of efficacy and tolerability. Concerns such as limited training, dose titration difficulties, and the risk of use disorder were noted. The study suggests that targeted education and clearer prescribing guidelines could improve the safety and appropriateness of TIRF use in general practice. Morphine is mentioned in the abstract as a comparison to TIRF, but no specific data on its administration or effects is provided.",
      "Identifiable_human_subject": "No",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article comments on the widespread off-label use of TIRF and highlights varying perceptions of its efficacy and tolerability. It also notes concerns regarding limited training, dose titration difficulties, and the risk of use disorder, suggesting the need for targeted education and clearer prescribing guidelines.",
      "Adverse_event": "No AE",
      "Abstract": "Prescriptions of transmucosal immediate-release fentanyl (TIRF) have increased in recent years, driven by their rapid onset and ease of administration compared to other opioids like morphine and oxycodone, especially for breakthrough pain. A 2022 study reported high rates of off-label TIRF use, particularly among general practitioners (GPs). This study aimed to assess the prevalence and patterns of off-label TIRF use by GPs, and perceived efficacy for predictable pain associated with medical procedures. Secondary objectives included evaluating its use in other specific contexts such as swallowing or alertness disorders, acute pain, and overall tolerability.\n\nA mixed-methods study was designed to combine qualitative interviews exploring clinical contexts with a quantitative cross-sectional survey assessing the prevalence of off-label use of TIRF among French GPs. Data were collected through a national online survey.\n\nA total of 682 completed questionnaires were analyzed. The study focused exclusively on off-label prescribing of TIRFs. Off-label use was reported by 46% of GPs across a variety of clinical indications. Specifically, 244 GPs (36%; 95% CI 32-40) reported prescribing TIRFs for procedural pain. Other off-label indications were also reported, including use for alertness disorders (24%; 95% CI 21-27), swallowing disorders (32%; 95% CI 28-35), and acute rheumatological pain (12%; 95% CI 9-14). These findings highlight a substantial level of off-label prescribing, with varying perceptions of efficacy and tolerability across different clinical contexts.\n\nThis study confirms widespread off-label TIRF use in well-defined clinical situations. While many GPs report positive outcomes, important concerns remain, including limited training, difficulty with dose titration, and the risk of use disorder. Targeted education and clearer prescribing guidelines could help ensure a safer and more appropriate use of TIRF in GPs practice.",
      "Title": "Prevalence and Patterns of Off-Label Transmucosal Immediate-Release Fentanyl Use in French General Practice: A Mixed-Methods Study Based on a Voluntary Online Survey.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-12 22:53:56",
      "Vancouver_citation": "Guastella V, Gueganno E, Bertin C, Balayssac D, Pereira B, Authier N. Prevalence and Patterns of Off-Label Transmucosal Immediate-Release Fentanyl Use in French General Practice: A Mixed-Methods Study Based on a Voluntary Online Survey. Pain Ther. 2025;",
      "pubdate": "2025-12-11",
      "Lead_author": "Guastella V",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Morphine, is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. This study focuses on transmucosal immediate-release fentanyl (TIRF) and does not mention the administration or use of Morphine.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study does not involve Morphine or its effects.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.1007/s40122-025-00801-y",
    "specialCase": "Abuse/Misuse",
    "countryOfFirstAuthor": "France",
    "countryOfOccurrence": "France",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "The study focuses on the prevalence and patterns of off-label use of transmucosal immediate-release fentanyl (TIRF) among French general practitioners (GPs). It highlights the increasing prescription rates of TIRF due to its rapid onset and ease of administration, particularly for breakthrough pain. The study utilized a mixed-methods approach, combining qualitative interviews and a quantitative cross-sectional survey, with data collected through a national online survey. A total of 682 completed questionnaires were analyzed, revealing that 46% of GPs reported off-label prescribing of TIRFs for various clinical indications, including procedural pain, alertness disorders, swallowing disorders, and acute rheumatological pain. The findings emphasize the widespread off-label use of TIRF, with varying perceptions of efficacy and tolerability. Concerns such as limited training, dose titration difficulties, and the risk of use disorder were noted. The study suggests that targeted education and clearer prescribing guidelines could improve the safety and appropriateness of TIRF use in general practice. Morphine is mentioned in the abstract as a comparison to TIRF, but no specific data on its administration or effects is provided.",
    "identifiableHumanSubject": "No",
    "textType": "Clinical Trial",
    "authorPerspective": "The article comments on the widespread off-label use of TIRF and highlights varying perceptions of its efficacy and tolerability. It also notes concerns regarding limited training, dose titration difficulties, and the risk of use disorder, suggesting the need for targeted education and clearer prescribing guidelines.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Guastella V, Gueganno E, Bertin C, Balayssac D, Pereira B, Authier N. Prevalence and Patterns of Off-Label Transmucosal Immediate-Release Fentanyl Use in French General Practice: A Mixed-Methods Study Based on a Voluntary Online Survey. Pain Ther. 2025;",
    "leadAuthor": "Guastella V",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Morphine, is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. This study focuses on transmucosal immediate-release fentanyl (TIRF) and does not mention the administration or use of Morphine.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": null,
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": "Unlisted",
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [
      {
        "id": "9d84af33-b97e-43de-a772-f784640729ae",
        "fieldKey": "listedness",
        "comment": "Test",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "createdAt": "2025-12-13T05:11:15.616Z"
      },
      {
        "id": "88d8af48-f9a8-4e2c-9a1f-f0bc2aa28090",
        "fieldKey": "listedness",
        "comment": "Second change",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "createdAt": "2025-12-13T05:13:59.253Z"
      }
    ],
    "revokedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "revokedAt": "2025-12-13T05:14:23.834Z",
    "revocationReason": "Test revoke",
    "_rid": "Vf9WAOX6zUirCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUirCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-51d7b00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707220
  },
  {
    "id": "MORP_Demo_45351",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41372547",
    "title": "Individual differences in behavioral effects of xylazine and opioid-xylazine mixtures in male rats.",
    "authors": [
      "Woodhouse KL",
      "Li JX"
    ],
    "journal": "Psychopharmacology (Berl)",
    "publicationDate": "2025-12-11",
    "abstract": "This study investigates the behavioral effects of xylazine and opioid-xylazine mixtures in male rats, focusing on the pharmacological interactions underlying the emerging trend of xylazine use in combination with opioids. The research examines sedative, hypothermic, subjective, and respiratory effects of xylazine and opioid-xylazine mixtures. Locomotor activity and body temperature changes were measured, and rats were trained to discriminate specific doses of fentanyl and xylazine from saline. The study found that xylazine depressed locomotor activity and core body temperature, with significant variability between subjects. In some cases, xylazine fully substituted for fentanyl and prolonged its subjective effects. Additionally, xylazine exacerbated the respiratory depressant effects of opioids, which were reversed by atipamezole. The findings highlight individual differences in behavioral responses to xylazine, which may reflect the divisiveness of xylazine use reported among people who use drugs. The study does not involve human subjects, and no specific mention of morphine's effects or adverse events is provided.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9e840b04-3e32-4a23-bd60-6d444c38650f",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T18:11:35.164Z",
        "type": "system"
      },
      {
        "id": "95e39622-9f61-418f-a429-1f80b6c2f190",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-12T18:11:59.107Z",
        "type": "QC_approval"
      },
      {
        "id": "2771845f-5a86-4c9a-8057-f6e4f7f23726",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Added comment to field listedness: It is not appropriate",
        "timestamp": "2025-12-13T05:06:42.726Z",
        "type": "field_comment"
      },
      {
        "id": "f238e2ba-8af7-4d58-87c4-ffa7f4177513",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-13T05:06:53.880Z",
        "type": "system"
      },
      {
        "id": "40e75dd5-0b35-4859-91c2-18eff27ea5a3",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. Awaiting QC approval before Medical Reviewer review.",
        "timestamp": "2025-12-13T05:06:54.037Z",
        "type": "system"
      },
      {
        "id": "da3632ba-37e1-4847-8541-55c4fd326135",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "R3 XML form approved by QC. Medical Review skipped (disabled). Ready for Reports.",
        "timestamp": "2025-12-13T08:30:36.259Z",
        "type": "qc_r3_approval"
      },
      {
        "id": "f61223ed-1cef-4a97-a9aa-08e6e30a9548",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 3fa6a2f4-9232-4eda-becd-2d828f0363f9 to MORP_Demo_45351",
        "type": "system",
        "createdAt": "2025-12-14T10:13:40.828Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:25:00.153Z",
    "updatedAt": "2025-12-13T08:30:36.271Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41372547",
      "DOI": "https://doi.org/10.1007/s00213-025-06988-4",
      "special_case": "No",
      "Country_of_first_author": "United States",
      "Country_of_occurrence": "United States",
      "Patient_details": "No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: Not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "This study investigates the behavioral effects of xylazine and opioid-xylazine mixtures in male rats, focusing on the pharmacological interactions underlying the emerging trend of xylazine use in combination with opioids. The research examines sedative, hypothermic, subjective, and respiratory effects of xylazine and opioid-xylazine mixtures. Locomotor activity and body temperature changes were measured, and rats were trained to discriminate specific doses of fentanyl and xylazine from saline. The study found that xylazine depressed locomotor activity and core body temperature, with significant variability between subjects. In some cases, xylazine fully substituted for fentanyl and prolonged its subjective effects. Additionally, xylazine exacerbated the respiratory depressant effects of opioids, which were reversed by atipamezole. The findings highlight individual differences in behavioral responses to xylazine, which may reflect the divisiveness of xylazine use reported among people who use drugs. The study does not involve human subjects, and no specific mention of morphine's effects or adverse events is provided.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article comments on the variability in behavioral effects of xylazine and its interaction with opioids, noting that xylazine exacerbates opioid-induced respiratory depression and that atipamezole can reverse this effect. It highlights individual differences in responses to xylazine, which may parallel human reports of divisiveness in xylazine use.",
      "Adverse_event": "No AE",
      "Abstract": "Recent work in animals suggests xylazine neither enhances the rewarding effects nor intake of fentanyl. Anecdotal evidence from people who use drugs indicates some individuals prefer fentanyl adulterated with xylazine. Systematic examination of pharmacological interactions between xylazine and opioids is needed to understand the disparate findings between preclinical studies and human reports.\n\nThis study examined behavioral interactions between xylazine and opioids in rats to investigate the pharmacology underlying an emerging trend in drug use.\n\nThe sedative, hypothermic, subjective, and respiratory effects of xylazine and opioid-xylazine mixtures were examined in male rats. Locomotor activity was measured in an open field, and body temperature changes were measured with a rectal probe. Rats were trained to discriminate 0.04 mg/kg fentanyl, 0.02 mg/kg fentanyl, or 1.5 mg/kg xylazine from saline and were probed with fentanyl, xylazine, or both to observe whether the drug(s) generalized with the training dose. Whole body plethysmography was used to assess the effects of xylazine on respiration.\n\nXylazine depressed locomotor activity and core body temperature, but considerable variability between subjects was observed. In some subjects, xylazine fully substituted for fentanyl, and prolonged the subjective effects of fentanyl. Doses of 1 and 1.78 mg/kg xylazine only partially generalized to the training dose of 1.5 mg/kg xylazine. Xylazine exacerbated the respiratory depressant effects of opioids, and atipamezole reversed the xylazine enhancement of morphine-induced respiratory depression.\n\nIndividual differences were observed in multiple behavioral measures following xylazine administration and may recapitulate the divisiveness of xylazine reported in people who use drugs.",
      "Title": "Individual differences in behavioral effects of xylazine and opioid-xylazine mixtures in male rats.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-12 22:54:34",
      "Vancouver_citation": "Woodhouse KL, Li JX. Individual differences in behavioral effects of xylazine and opioid-xylazine mixtures in male rats. Psychopharmacology (Berl). 2025;",
      "pubdate": "2025-12-11",
      "Lead_author": "Woodhouse KL",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study were male rats. These rats were exposed to xylazine and opioid-xylazine mixtures, including the drug of study, morphine, as part of the investigation into behavioral and pharmacological interactions.",
      "AOI_drug_effect": "The drug of study, morphine, had an effect on the test subjects. Specifically, morphine-induced respiratory depression was observed, and xylazine exacerbated this effect. Additionally, atipamezole was able to reverse the enhancement of morphine-induced respiratory depression caused by xylazine.",
      "Approved_indication": "The drug of study, morphine, is conventionally used as a potent opioid analgesic for the treatment of severe pain. It is typically administered via oral, intravenous, intramuscular, or subcutaneous routes to patients suffering from acute or chronic pain conditions. In this study, morphine was administered to male rats as part of the investigation into its interaction with xylazine, particularly focusing on respiratory depression effects.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study explicitly mentions that xylazine exacerbated the respiratory depressant effects of morphine, indicating a negative or adverse effect linked to the drug of study.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.1007/s00213-025-06988-4",
    "specialCase": "No",
    "countryOfFirstAuthor": "United States",
    "countryOfOccurrence": "United States",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: Not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "This study investigates the behavioral effects of xylazine and opioid-xylazine mixtures in male rats, focusing on the pharmacological interactions underlying the emerging trend of xylazine use in combination with opioids. The research examines sedative, hypothermic, subjective, and respiratory effects of xylazine and opioid-xylazine mixtures. Locomotor activity and body temperature changes were measured, and rats were trained to discriminate specific doses of fentanyl and xylazine from saline. The study found that xylazine depressed locomotor activity and core body temperature, with significant variability between subjects. In some cases, xylazine fully substituted for fentanyl and prolonged its subjective effects. Additionally, xylazine exacerbated the respiratory depressant effects of opioids, which were reversed by atipamezole. The findings highlight individual differences in behavioral responses to xylazine, which may reflect the divisiveness of xylazine use reported among people who use drugs. The study does not involve human subjects, and no specific mention of morphine's effects or adverse events is provided.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article comments on the variability in behavioral effects of xylazine and its interaction with opioids, noting that xylazine exacerbates opioid-induced respiratory depression and that atipamezole can reverse this effect. It highlights individual differences in responses to xylazine, which may parallel human reports of divisiveness in xylazine use.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Woodhouse KL, Li JX. Individual differences in behavioral effects of xylazine and opioid-xylazine mixtures in male rats. Psychopharmacology (Berl). 2025;",
    "leadAuthor": "Woodhouse KL",
    "serious": "No",
    "testSubject": "The test subjects involved in this study were male rats. These rats were exposed to xylazine and opioid-xylazine mixtures, including the drug of study, morphine, as part of the investigation into behavioral and pharmacological interactions.",
    "aoiDrugEffect": "The drug of study, morphine, had an effect on the test subjects. Specifically, morphine-induced respiratory depression was observed, and xylazine exacerbated this effect. Additionally, atipamezole was able to reverse the enhancement of morphine-induced respiratory depression caused by xylazine.",
    "approvedIndication": "The drug of study, morphine, is conventionally used as a potent opioid analgesic for the treatment of severe pain. It is typically administered via oral, intravenous, intramuscular, or subcutaneous routes to patients suffering from acute or chronic pain conditions. In this study, morphine was administered to male rats as part of the investigation into its interaction with xylazine, particularly focusing on respiratory depression effects.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "Potential Valid case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T18:11:59.107Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": {
      "E.i.3.2a": "false",
      "C.2.r.1": "Woodhouse KL",
      "C.2.r.1.2": "Woodhouse",
      "C.2.r.1.4": "KL",
      "C.4.r.1": "Woodhouse KL, Li JX. Individual differences in behavioral effects of xylazine and opioid-xylazine mixtures in male rats. Psychopharmacology (Berl). 2025;",
      "D.7.1.r": "No human subject",
      "D.7": "This study investigates the behavioral effects of xylazine and opioid-xylazine mixtures in male rats, focusing on the pharmacological interactions underlying the emerging trend of xylazine use in combination with opioids. The research examines sedative, hypothermic, subjective, and respiratory effects of xylazine and opioid-xylazine mixtures. Locomotor activity and body temperature changes were measured, and rats were trained to discriminate specific doses of fentanyl and xylazine from saline. The study found that xylazine depressed locomotor activity and core body temperature, with significant variability between subjects. In some cases, xylazine fully substituted for fentanyl and prolonged its subjective effects. Additionally, xylazine exacerbated the respiratory depressant effects of opioids, which were reversed by atipamezole. The findings highlight individual differences in behavioral responses to xylazine, which may reflect the divisiveness of xylazine use reported among people who use drugs. The study does not involve human subjects, and no specific mention of morphine's effects or adverse events is provided.",
      "D.7.1.r.2": "Relevant dates: not mentioned",
      "E.i.1.1a": "No AE",
      "C.2.r.2.1": "Institution in United States"
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-13T05:06:54.037Z",
    "qcR3Status": "approved",
    "qcR3ApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qcR3ApprovedAt": "2025-12-13T08:30:36.259Z",
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": "Listed",
    "seriousness": "Serious",
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "completed",
    "medicalReviewedBy": "system",
    "medicalReviewedAt": "2025-12-13T08:30:36.259Z",
    "fieldComments": [
      {
        "id": "0486dbaa-0a43-4175-ab72-4c615c4c3e6d",
        "fieldKey": "listedness",
        "comment": "It is not appropriate",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "createdAt": "2025-12-13T05:06:42.726Z"
      }
    ],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUisCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUisCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-51ffb00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707220
  },
  {
    "id": "MORP_Demo_83377",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41365712",
    "title": "The analgesic effects of novel fascial plane blocks compared with intrathecal morphine after Caesarean delivery. Response to Br J Anaesth 2025; 135: 1854-5.",
    "authors": [
      "Hussain N",
      "D'Souza R",
      "Abdallah FW"
    ],
    "journal": "Br J Anaesth",
    "publicationDate": "2025-12-10",
    "abstract": "Article requires manual review",
    "drugName": "MORPHINE",
    "adverseEvent": "Article requires manual review",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "89a3390a-14ce-4536-bfb7-6a643b2c2283",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T18:10:13.351Z",
        "type": "system"
      },
      {
        "id": "2e722d9c-10f5-404e-a96c-959d2eb806bb",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-12T18:10:36.678Z",
        "type": "QC_approval"
      },
      {
        "id": "32094a10-1b93-4826-94f9-9b074cc3da87",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-13T04:49:53.995Z",
        "type": "system"
      },
      {
        "id": "7c3b4c49-0a0c-4fa5-89c5-24820246162e",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. Awaiting QC approval before Medical Reviewer review.",
        "timestamp": "2025-12-13T04:49:54.233Z",
        "type": "system"
      },
      {
        "id": "86e632b7-ed50-4645-aebb-c85b72b59942",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "R3 XML form approved by QC. Medical Review skipped (disabled). Ready for Reports.",
        "timestamp": "2025-12-13T08:30:45.403Z",
        "type": "qc_r3_approval"
      },
      {
        "id": "b41648cf-b3ac-4237-8ea2-dc33c501ba84",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a5295bfa-b91a-4263-9fe1-9e08b03a121b to MORP_Demo_83377",
        "type": "system",
        "createdAt": "2025-12-14T10:13:41.127Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:25:00.183Z",
    "updatedAt": "2025-12-13T08:30:45.413Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41365712",
      "DOI": "https://doi.org10.1016/j.bja.2025.10.058",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "MORPHINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-12 22:54:41",
      "Drugname": "MORPHINE",
      "Vancouver_citation": "Hussain N, D'Souza R, Abdallah FW. The analgesic effects of novel fascial plane blocks compared with intrathecal morphine after Caesarean delivery. Response to Br J Anaesth 2025; 135: 1854-5. Br J Anaesth. 2025;",
      "pubdate": "2025-12-10",
      "Lead_author": "Hussain N",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.bja.2025.10.058",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Hussain N, D'Souza R, Abdallah FW. The analgesic effects of novel fascial plane blocks compared with intrathecal morphine after Caesarean delivery. Response to Br J Anaesth 2025; 135: 1854-5. Br J Anaesth. 2025;",
    "leadAuthor": "Hussain N",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Potential Valid case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T18:10:36.678Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": {
      "E.i.3.2a": "false",
      "E.i.3.2b": "false",
      "E.i.3.2c": "false",
      "E.i.3.2d": "false",
      "E.i.3.2e": "false",
      "E.i.3.2f": "false",
      "E.i.7": "0",
      "C.2.r.1": "Hussain N",
      "C.2.r.1.2": "Hussain",
      "C.2.r.1.4": "N",
      "C.4.r.1": "Hussain N, D'Souza R, Abdallah FW. The analgesic effects of novel fascial plane blocks compared with intrathecal morphine after Caesarean delivery. Response to Br J Anaesth 2025; 135: 1854-5. Br J Anaesth. 2025;",
      "D.7.1.r": "Article requires manual review",
      "D.7": "Article requires manual review",
      "D.7.1.r.2": "Article requires manual review",
      "E.i.1.1a": "Article requires manual review",
      "C.2.r.2.1": "Institution in Article requires manual review"
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-13T04:49:54.233Z",
    "qcR3Status": "approved",
    "qcR3ApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qcR3ApprovedAt": "2025-12-13T08:30:45.403Z",
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": "Listed",
    "seriousness": "Serious",
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "completed",
    "medicalReviewedBy": "system",
    "medicalReviewedAt": "2025-12-13T08:30:45.403Z",
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUitCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUitCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-522d340501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707221
  },
  {
    "id": "MORP_Demo_84973",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41365300",
    "title": "Tegileridine for moderate-to-severe acute pain following abdominal surgery: A randomized, double-blind, phase 3 clinical trial.",
    "authors": [
      "Wang T",
      "Wang Y",
      "Xie H",
      "Wu Z",
      "Yu S",
      "Ou Y",
      "Xu M",
      "Jiang W",
      "Ge L",
      "Gao J",
      "Wang Q",
      "Gao H",
      "Huang Y",
      "Zhao P",
      "Yu Y",
      "Huang H",
      "Ren J",
      "Xia Z",
      "Zhang J",
      "Yu J",
      "Chen X"
    ],
    "journal": "Cell Rep Med",
    "publicationDate": "2025-12-10",
    "abstract": "The study evaluates the efficacy of tegileridine, a biased μ-opioid receptor agonist, in managing moderate-to-severe acute pain following abdominal surgery. A total of 526 patients were randomized to receive placebo, tegileridine at doses of 0.75 mg or 1.0 mg, or morphine. Tegileridine demonstrated effective analgesia, with summed pain intensity difference scores at rest over the first 24 hours significantly superior to placebo and comparable to morphine. The total pain relief scores at 24 hours also showed that tegileridine provided comparable relief to morphine and was superior to placebo. While the study highlights the analgesic efficacy of tegileridine, specific details regarding adverse events, patient demographics, or the duration of drug administration are not provided. Morphine was used as a comparator in the study, but no specific adverse events or complications related to morphine were mentioned. The study concludes that tegileridine offers effective pain relief comparable to morphine, with fewer opioid-related adverse effects implied but not explicitly detailed.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "medical_review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "27a87f6e-b86f-45d6-aed3-aaeaf38a1fe7",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T17:47:11.266Z",
        "type": "system"
      },
      {
        "id": "da292f86-efd6-4566-96bb-444ae0aebad1",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-12T18:25:36.845Z",
        "type": "QC_approval"
      },
      {
        "id": "1fca5b15-9bb5-486a-9fbd-02b659580fe7",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-12T18:53:13.768Z",
        "type": "system"
      },
      {
        "id": "3f00b363-1943-485e-9e44-3ac7a66257b4",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. Awaiting QC approval before Medical Reviewer review.",
        "timestamp": "2025-12-12T18:53:13.889Z",
        "type": "system"
      },
      {
        "id": "12e91e8f-37d6-44c8-bc9b-228b7f39d16d",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "R3 XML form approved by QC. Ready for Medical Reviewer",
        "timestamp": "2025-12-13T08:31:25.134Z",
        "type": "qc_r3_approval"
      },
      {
        "id": "119363e5-09a5-441c-9383-3c66dea62bc0",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 14ad16c7-1b98-4047-810a-0c08882885ce to MORP_Demo_84973",
        "type": "system",
        "createdAt": "2025-12-14T10:13:41.402Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:25:00.209Z",
    "updatedAt": "2025-12-13T08:31:25.141Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41365300",
      "DOI": "https://doi.org/10.1016/j.xcrm.2025.102477",
      "special_case": "No",
      "Country_of_first_author": "China",
      "Country_of_occurrence": "China",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: Patients with postoperative pain following abdominal surgery were randomized to receive placebo, tegileridine at varying doses, or morphine. The study aimed to evaluate the analgesic efficacy of tegileridine compared to morphine and placebo.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Tegileridine, Morphine",
      "Attributability": "Attributability: The study compares the analgesic effects of tegileridine and morphine, but specific adverse events or complications attributable to either drug are not detailed in the provided text.",
      "Drug_effect": "Drug effect: Tegileridine provided effective analgesia that was significantly superior to placebo and comparable to morphine.",
      "Summary": "The study evaluates the efficacy of tegileridine, a biased μ-opioid receptor agonist, in managing moderate-to-severe acute pain following abdominal surgery. A total of 526 patients were randomized to receive placebo, tegileridine at doses of 0.75 mg or 1.0 mg, or morphine. Tegileridine demonstrated effective analgesia, with summed pain intensity difference scores at rest over the first 24 hours significantly superior to placebo and comparable to morphine. The total pain relief scores at 24 hours also showed that tegileridine provided comparable relief to morphine and was superior to placebo. While the study highlights the analgesic efficacy of tegileridine, specific details regarding adverse events, patient demographics, or the duration of drug administration are not provided. Morphine was used as a comparator in the study, but no specific adverse events or complications related to morphine were mentioned. The study concludes that tegileridine offers effective pain relief comparable to morphine, with fewer opioid-related adverse effects implied but not explicitly detailed.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article comments that tegileridine provides effective analgesia significantly superior to placebo and comparable to morphine, suggesting its potential as an alternative with fewer opioid-related adverse effects.",
      "Adverse_event": "No AE",
      "Abstract": "Tegileridine is a biased μ-opioid receptor agonist that selectively activates the G protein pathway, designed to provide analgesia with fewer opioid-related adverse effects. In this phase 3 study, 526 patients with postoperative pain after abdominal surgery were randomized and received placebo, tegileridine at 0.75 mg, tegileridine at 1.0 mg, or morphine. For the primary outcome of effective analgesia, the mean (SD) summed pain intensity difference at rest over the first 24 h from time 0 (SPID<sub>24</sub>) scores are -61.15 (28.25) and -68.98 (30.33) for the 0.5 and 0.75 mg doses of tegileridine, respectively, compared with -49.63 (29.35) in the placebo group (all p < 0.001) and -71.16 (34.76) in the morphine group. The total pain relief scores (mean [SD]) at 24 h were 58.76 (21.79) with 0.75 mg tegileridine and 61.95 (18.94) with 1.0 mg tegileridine, compared with 47.56 (21.00) with placebo and 59.09 (19.34) with morphine. In summary, tegileridine provides effective analgesia that was significantly superior to placebo and comparable to morphine.",
      "Title": "Tegileridine for moderate-to-severe acute pain following abdominal surgery: A randomized, double-blind, phase 3 clinical trial.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-12 22:54:17",
      "Vancouver_citation": "Wang T, Wang Y, Xie H, Wu Z, Yu S, Ou Y, Xu M, Jiang W, Ge L, Gao J, Wang Q, Gao H, Huang Y, Zhao P, Yu Y, Huang H, Ren J, Xia Z, Zhang J, Yu J, Chen X. Tegileridine for moderate-to-severe acute pain following abdominal surgery: A randomized, double-blind, phase 3 clinical trial. Cell Rep Med. 2025;102477",
      "pubdate": "2025-12-10",
      "Lead_author": "Wang T",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study were 526 patients with postoperative pain after abdominal surgery. These patients were randomized to receive placebo, tegileridine at varying doses, or the drug of study (morphine).",
      "AOI_drug_effect": "The drug of study (morphine) had an effect on the test subjects. It provided effective analgesia for postoperative pain after abdominal surgery, with pain relief scores comparable to tegileridine and significantly superior to placebo.",
      "Approved_indication": "The drug of study is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, morphine was administered to patients with postoperative pain following abdominal surgery, which aligns with its conventional use. Therefore, this does not qualify as off-label use.",
      "AOI_classification": "No",
      "Justification": "The study does not link the drug of study to any negative or adverse effects. It focuses on comparing the analgesic efficacy of tegileridine and morphine, with no mention of adverse events caused by morphine. Additionally, the drug was used conventionally.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.1016/j.xcrm.2025.102477",
    "specialCase": "No",
    "countryOfFirstAuthor": "China",
    "countryOfOccurrence": "China",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: Patients with postoperative pain following abdominal surgery were randomized to receive placebo, tegileridine at varying doses, or morphine. The study aimed to evaluate the analgesic efficacy of tegileridine compared to morphine and placebo.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Tegileridine",
      "Morphine"
    ],
    "attributability": "Attributability: The study compares the analgesic effects of tegileridine and morphine, but specific adverse events or complications attributable to either drug are not detailed in the provided text.",
    "drugEffect": "Drug effect: Tegileridine provided effective analgesia that was significantly superior to placebo and comparable to morphine.",
    "summary": "The study evaluates the efficacy of tegileridine, a biased μ-opioid receptor agonist, in managing moderate-to-severe acute pain following abdominal surgery. A total of 526 patients were randomized to receive placebo, tegileridine at doses of 0.75 mg or 1.0 mg, or morphine. Tegileridine demonstrated effective analgesia, with summed pain intensity difference scores at rest over the first 24 hours significantly superior to placebo and comparable to morphine. The total pain relief scores at 24 hours also showed that tegileridine provided comparable relief to morphine and was superior to placebo. While the study highlights the analgesic efficacy of tegileridine, specific details regarding adverse events, patient demographics, or the duration of drug administration are not provided. Morphine was used as a comparator in the study, but no specific adverse events or complications related to morphine were mentioned. The study concludes that tegileridine offers effective pain relief comparable to morphine, with fewer opioid-related adverse effects implied but not explicitly detailed.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article comments that tegileridine provides effective analgesia significantly superior to placebo and comparable to morphine, suggesting its potential as an alternative with fewer opioid-related adverse effects.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Wang T, Wang Y, Xie H, Wu Z, Yu S, Ou Y, Xu M, Jiang W, Ge L, Gao J, Wang Q, Gao H, Huang Y, Zhao P, Yu Y, Huang H, Ren J, Xia Z, Zhang J, Yu J, Chen X. Tegileridine for moderate-to-severe acute pain following abdominal surgery: A randomized, double-blind, phase 3 clinical trial. Cell Rep Med. 2025;102477",
    "leadAuthor": "Wang T",
    "serious": "No",
    "testSubject": "The test subjects involved in this study were 526 patients with postoperative pain after abdominal surgery. These patients were randomized to receive placebo, tegileridine at varying doses, or the drug of study (morphine).",
    "aoiDrugEffect": "The drug of study (morphine) had an effect on the test subjects. It provided effective analgesia for postoperative pain after abdominal surgery, with pain relief scores comparable to tegileridine and significantly superior to placebo.",
    "approvedIndication": "The drug of study is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, morphine was administered to patients with postoperative pain following abdominal surgery, which aligns with its conventional use. Therefore, this does not qualify as off-label use.",
    "aoiClassification": "No",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T18:25:36.845Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": {
      "D.9.1": "No",
      "E.i.3.2a": "False",
      "E.i.3.2b": "False",
      "E.i.3.2c": "False",
      "E.i.3.2d": "False",
      "E.i.3.2e": "False",
      "E.i.3.2f": "False",
      "E.i.7": "0",
      "C.2.r.1": "Wang T",
      "C.2.r.1.2": "Wang",
      "C.2.r.1.4": "T",
      "C.4.r.1": "Wang T, Wang Y, Xie H, Wu Z, Yu S, Ou Y, Xu M, Jiang W, Ge L, Gao J, Wang Q, Gao H, Huang Y, Zhao P, Yu Y, Huang H, Ren J, Xia Z, Zhang J, Yu J, Chen X. Tegileridine for moderate-to-severe acute pain following abdominal surgery: A randomized, double-blind, phase 3 clinical trial. Cell Rep Med. 2025;102477",
      "D.7.1.r": "Human involved, no specific data",
      "D.7": "The study evaluates the efficacy of tegileridine, a biased μ-opioid receptor agonist, in managing moderate-to-severe acute pain following abdominal surgery. A total of 526 patients were randomized to receive placebo, tegileridine at doses of 0.75 mg or 1.0 mg, or morphine. Tegileridine demonstrated effective analgesia, with summed pain intensity difference scores at rest over the first 24 hours significantly superior to placebo and comparable to morphine. The total pain relief scores at 24 hours also showed that tegileridine provided comparable relief to morphine and was superior to placebo. While the study highlights the analgesic efficacy of tegileridine, specific details regarding adverse events, patient demographics, or the duration of drug administration are not provided. Morphine was used as a comparator in the study, but no specific adverse events or complications related to morphine were mentioned. The study concludes that tegileridine offers effective pain relief comparable to morphine, with fewer opioid-related adverse effects implied but not explicitly detailed.",
      "D.7.1.r.2": "Relevant dates: not mentioned",
      "E.i.1.1a": "No AE",
      "C.2.r.2.1": "Institution in China"
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-12T18:53:13.889Z",
    "qcR3Status": "approved",
    "qcR3ApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qcR3ApprovedAt": "2025-12-13T08:31:25.134Z",
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": "Unlisted",
    "seriousness": "Serious",
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiuCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiuCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-52576c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707221
  },
  {
    "id": "MORP_Demo_20460",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41361891",
    "title": "Comparison of oliceridine and fentanyl intraoperative analgesia on postoperative nausea and vomiting in female patients undergoing laparoscopic cholecystectomy: study protocol for a randomized, double-blind, controlled trial.",
    "authors": [
      "Xu F",
      "Cui Y",
      "Wang Z",
      "Wu F",
      "Zhang W",
      "Liu R",
      "Xu Y",
      "Tang J",
      "Pu J",
      "Wang M"
    ],
    "journal": "Trials",
    "publicationDate": "2025-12-9",
    "abstract": "The study protocol outlines a randomized, double-blind, controlled trial comparing the intraoperative analgesic effects of oliceridine and fentanyl in female patients undergoing laparoscopic cholecystectomy. The primary focus is on the incidence of postoperative nausea and vomiting (PONV) within the first 24 hours after surgery. Secondary endpoints include the severity and timing of PONV, the need for antiemetics and rescue analgesia, postoperative pain assessments, and perioperative adverse effects. Oliceridine, a μ-opioid receptor agonist with G protein bias, is hypothesized to offer effective analgesia with fewer opioid-related adverse events (ORAEs) than fentanyl. The study aims to enroll 228 female patients at Changshu No. 2 People's Hospital in China, with participants randomly assigned to receive either oliceridine or fentanyl for intraoperative pain management. While the abstract does not provide specific data on adverse events or drug effects, it suggests that oliceridine may reduce the incidence of PONV compared to fentanyl. The findings are expected to contribute to optimizing perioperative pain management strategies and improving patient recovery outcomes. Morphine is mentioned as a comparator in terms of ORAEs but is not directly involved in the study.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "medical_review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "827783d3-b5bb-4cf2-9d3b-8a8b5e43a53a",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T17:36:53.298Z",
        "type": "system"
      },
      {
        "id": "61d99959-21ef-4a4d-9712-d96f2f7dc4c8",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-12T18:26:06.414Z",
        "type": "QC_approval"
      },
      {
        "id": "4b052ca7-8c7c-4f7a-b46e-44933623fb6b",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-12T18:52:36.718Z",
        "type": "system"
      },
      {
        "id": "a64d0204-8774-4262-aca0-6df2c61155ba",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. Awaiting QC approval before Medical Reviewer review.",
        "timestamp": "2025-12-12T18:52:36.835Z",
        "type": "system"
      },
      {
        "id": "e5cdf510-72c9-4971-a1fb-260260092174",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 XML form approved by QC. Ready for Medical Reviewer",
        "timestamp": "2025-12-12T18:52:44.593Z",
        "type": "qc_r3_approval"
      },
      {
        "id": "8a661de8-5dc7-4413-b983-0c3f3a7862b2",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 364e03af-45a2-4a68-a66e-e9abf5820f71 to MORP_Demo_20460",
        "type": "system",
        "createdAt": "2025-12-14T10:13:41.681Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:25:00.238Z",
    "updatedAt": "2025-12-12T18:52:44.601Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41361891",
      "DOI": "https://doi.org/10.1186/s13063-025-09336-1",
      "special_case": "No",
      "Country_of_first_author": "China",
      "Country_of_occurrence": "China",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: The study involves female patients undergoing laparoscopic cholecystectomy. It aims to compare the effects of oliceridine and fentanyl on postoperative nausea and vomiting (PONV) during the first 24 hours postoperatively. Patients are randomly assigned to receive either oliceridine or fentanyl for intraoperative analgesia. Secondary endpoints include severity and timing of PONV, antiemetic and rescue analgesia requirements, postoperative pain assessments, and perioperative adverse effects.",
      "Relevant_dates": "Relevant dates: Registered on 26 January 2025",
      "Administered_drugs": "Administered drugs: oliceridine, fentanyl",
      "Attributability": "Attributability: No specific events or adverse effects are attributed to the drugs in the abstract. The study hypothesizes that oliceridine may result in fewer opioid-related adverse events compared to fentanyl.",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The study protocol outlines a randomized, double-blind, controlled trial comparing the intraoperative analgesic effects of oliceridine and fentanyl in female patients undergoing laparoscopic cholecystectomy. The primary focus is on the incidence of postoperative nausea and vomiting (PONV) within the first 24 hours after surgery. Secondary endpoints include the severity and timing of PONV, the need for antiemetics and rescue analgesia, postoperative pain assessments, and perioperative adverse effects. Oliceridine, a μ-opioid receptor agonist with G protein bias, is hypothesized to offer effective analgesia with fewer opioid-related adverse events (ORAEs) than fentanyl. The study aims to enroll 228 female patients at Changshu No. 2 People's Hospital in China, with participants randomly assigned to receive either oliceridine or fentanyl for intraoperative pain management. While the abstract does not provide specific data on adverse events or drug effects, it suggests that oliceridine may reduce the incidence of PONV compared to fentanyl. The findings are expected to contribute to optimizing perioperative pain management strategies and improving patient recovery outcomes. Morphine is mentioned as a comparator in terms of ORAEs but is not directly involved in the study.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article hypothesizes that oliceridine may offer effective analgesia and a lower incidence of PONV compared to fentanyl, suggesting a potential advantage in perioperative pain management for the studied patient group.",
      "Adverse_event": "No AE",
      "Abstract": "Postoperative nausea and vomiting (PONV) is significantly associated with intraoperative opioid use. Oliceridine, a μ-opioid receptor agonist with G protein bias, exhibits fewer opioid-related adverse events (ORAEs) than morphine. This study aims to evaluate the effect of oliceridine versus fentanyl on the incidence of PONV in female patients undergoing laparoscopic cholecystectomy.\n\nThis is a single-center, randomized controlled trial conducted at Changshu No. 2 People's Hospital in China. A total of 228 female patients scheduled for elective laparoscopic cholecystectomy will be enrolled in this trial and randomly assigned in a 1:1 ratio to receive either oliceridine (Group O) or fentanyl (Group F) for intraoperative analgesia. The primary endpoint is the incidence of PONV during the first 24 h postoperatively. The secondary endpoints consist of the severity and timing of the initial occurrence of PONV, the requirement for antiemetics and rescue analgesia, postoperative pain assessments, time to first flatus and extubation, postoperative sleep quality, intraoperative consumption of anesthetics and vasopressors, and perioperative adverse effects.\n\nWe hypothesize that oliceridine may offer effective analgesia and a lower incidence of PONV than fentanyl in intraoperative pain management for this high-risk group. The findings may provide valuable insights into optimizing perioperative pain management strategies and enhancing patient recovery.\n\nChinese Clinical Trial Registry ChiCTR2500096538. Registered on 26 January 2025.",
      "Title": "Comparison of oliceridine and fentanyl intraoperative analgesia on postoperative nausea and vomiting in female patients undergoing laparoscopic cholecystectomy: study protocol for a randomized, double-blind, controlled trial.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-12 22:54:58",
      "Vancouver_citation": "Xu F, Cui Y, Wang Z, Wu F, Zhang W, Liu R, Xu Y, Tang J, Pu J, Wang M. Comparison of oliceridine and fentanyl intraoperative analgesia on postoperative nausea and vomiting in female patients undergoing laparoscopic cholecystectomy: study protocol for a randomized, double-blind, controlled trial. Trials. 2025;",
      "pubdate": "2025-12-9",
      "Lead_author": "Xu F",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Morphine, is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, Morphine is not administered to any subject, nor is it used in any context. The study focuses on comparing oliceridine and fentanyl for intraoperative analgesia, and Morphine is only mentioned as a reference for opioid-related adverse events.",
      "AOI_classification": "No",
      "Justification": "The study does not involve the drug of study directly, nor does it link Morphine to any adverse effects or events.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.1186/s13063-025-09336-1",
    "specialCase": "No",
    "countryOfFirstAuthor": "China",
    "countryOfOccurrence": "China",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: The study involves female patients undergoing laparoscopic cholecystectomy. It aims to compare the effects of oliceridine and fentanyl on postoperative nausea and vomiting (PONV) during the first 24 hours postoperatively. Patients are randomly assigned to receive either oliceridine or fentanyl for intraoperative analgesia. Secondary endpoints include severity and timing of PONV, antiemetic and rescue analgesia requirements, postoperative pain assessments, and perioperative adverse effects.",
    "relevantDates": "Relevant dates: Registered on 26 January 2025",
    "administeredDrugs": [
      "Administered drugs: oliceridine",
      "fentanyl"
    ],
    "attributability": "Attributability: No specific events or adverse effects are attributed to the drugs in the abstract. The study hypothesizes that oliceridine may result in fewer opioid-related adverse events compared to fentanyl.",
    "drugEffect": "Drug effect: no data",
    "summary": "The study protocol outlines a randomized, double-blind, controlled trial comparing the intraoperative analgesic effects of oliceridine and fentanyl in female patients undergoing laparoscopic cholecystectomy. The primary focus is on the incidence of postoperative nausea and vomiting (PONV) within the first 24 hours after surgery. Secondary endpoints include the severity and timing of PONV, the need for antiemetics and rescue analgesia, postoperative pain assessments, and perioperative adverse effects. Oliceridine, a μ-opioid receptor agonist with G protein bias, is hypothesized to offer effective analgesia with fewer opioid-related adverse events (ORAEs) than fentanyl. The study aims to enroll 228 female patients at Changshu No. 2 People's Hospital in China, with participants randomly assigned to receive either oliceridine or fentanyl for intraoperative pain management. While the abstract does not provide specific data on adverse events or drug effects, it suggests that oliceridine may reduce the incidence of PONV compared to fentanyl. The findings are expected to contribute to optimizing perioperative pain management strategies and improving patient recovery outcomes. Morphine is mentioned as a comparator in terms of ORAEs but is not directly involved in the study.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article hypothesizes that oliceridine may offer effective analgesia and a lower incidence of PONV compared to fentanyl, suggesting a potential advantage in perioperative pain management for the studied patient group.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Xu F, Cui Y, Wang Z, Wu F, Zhang W, Liu R, Xu Y, Tang J, Pu J, Wang M. Comparison of oliceridine and fentanyl intraoperative analgesia on postoperative nausea and vomiting in female patients undergoing laparoscopic cholecystectomy: study protocol for a randomized, double-blind, controlled trial. Trials. 2025;",
    "leadAuthor": "Xu F",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Morphine, is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, Morphine is not administered to any subject, nor is it used in any context. The study focuses on comparing oliceridine and fentanyl for intraoperative analgesia, and Morphine is only mentioned as a reference for opioid-related adverse events.",
    "aoiClassification": "No",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T18:26:06.413Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": {
      "D.5": "Female",
      "D.9.1": "No",
      "E.i.3.2a": "False",
      "E.i.3.2b": "False",
      "E.i.3.2c": "False",
      "E.i.3.2d": "False",
      "E.i.3.2e": "False",
      "E.i.3.2f": "False",
      "E.i.7": "0",
      "C.2.r.1": "Xu F",
      "C.2.r.1.2": "Xu",
      "C.2.r.1.4": "F",
      "C.4.r.1": "Xu F, Cui Y, Wang Z, Wu F, Zhang W, Liu R, Xu Y, Tang J, Pu J, Wang M. Comparison of oliceridine and fentanyl intraoperative analgesia on postoperative nausea and vomiting in female patients undergoing laparoscopic cholecystectomy: study protocol for a randomized, double-blind, controlled trial. Trials. 2025;",
      "D.7.1.r": "Human involved, no specific data",
      "D.7": "The study protocol outlines a randomized, double-blind, controlled trial comparing the intraoperative analgesic effects of oliceridine and fentanyl in female patients undergoing laparoscopic cholecystectomy. The primary focus is on the incidence of postoperative nausea and vomiting (PONV) within the first 24 hours after surgery. Secondary endpoints include the severity and timing of PONV, the need for antiemetics and rescue analgesia, postoperative pain assessments, and perioperative adverse effects. Oliceridine, a μ-opioid receptor agonist with G protein bias, is hypothesized to offer effective analgesia with fewer opioid-related adverse events (ORAEs) than fentanyl. The study aims to enroll 228 female patients at Changshu No. 2 People's Hospital in China, with participants randomly assigned to receive either oliceridine or fentanyl for intraoperative pain management. While the abstract does not provide specific data on adverse events or drug effects, it suggests that oliceridine may reduce the incidence of PONV compared to fentanyl. The findings are expected to contribute to optimizing perioperative pain management strategies and improving patient recovery outcomes. Morphine is mentioned as a comparator in terms of ORAEs but is not directly involved in the study.",
      "D.7.1.r.2": "Relevant dates: Registered on 26 January 2025",
      "E.i.1.1a": "No AE",
      "C.2.r.2.1": "Institution in China"
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-12T18:52:36.835Z",
    "qcR3Status": "approved",
    "qcR3ApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qcR3ApprovedAt": "2025-12-12T18:52:44.593Z",
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": "Listed",
    "seriousness": "Serious",
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUivCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUivCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-5287240501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707221
  },
  {
    "id": "MORP_Demo_84888",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41360841",
    "title": "Differential effects of amphetamine on ultrasonic vocalizations and locomotor activity in a rat model of endogenous depression.",
    "authors": [
      "Banjac A",
      "Elersič K",
      "Živin M",
      "Zorović M"
    ],
    "journal": "Sci Rep",
    "publicationDate": "2025-12-9",
    "abstract": "This study investigates the differential effects of amphetamine and morphine on ultrasonic vocalizations and locomotor activity in Wistar-Kyoto (WKY) rats, a model for treatment-resistant depression, compared to control Wistar rats. The research focuses on the use of 50-kHz ultrasonic vocalizations (USVs) as a complementary behavioral marker for assessing anhedonia, a core symptom of depression. WKY rats emitted fewer basal 50-kHz calls and showed reduced responses to amphetamine administration, including fewer calls and diminished locomotor activity. Morphine, however, did not affect USVs or locomotion in either strain. The study highlights the potential of 50-kHz calls as a non-invasive measure of anhedonia in preclinical models of depression. While amphetamine elicited sensitization of 50-kHz calls in WKY rats after repeated administration, morphine failed to produce any significant effects on vocalizations or locomotion. The findings suggest that morphine does not influence the emotional or behavioral markers assessed in this study, contrasting with amphetamine's effects. The study provides insights into strain-specific differences in response to pharmacological agents and emphasizes the utility of USVs in evaluating affective states in animal models.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "medical_review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "abd2a7ca-f2e5-451f-aaba-dfe34f29fc0f",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-12T17:26:49.266Z",
        "type": "system"
      },
      {
        "id": "203da2f9-4a2a-4331-8e38-3e9a3e744677",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-12T17:27:06.534Z",
        "type": "QC_approval"
      },
      {
        "id": "e4e1fdfd-a45a-4fe5-8721-1c573a4b536b",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-12T18:47:08.457Z",
        "type": "system"
      },
      {
        "id": "9034e451-cefc-484e-882e-c33a429c0f92",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 form completed. Awaiting QC approval before Medical Reviewer review.",
        "timestamp": "2025-12-12T18:47:08.542Z",
        "type": "system"
      },
      {
        "id": "151f586a-e86c-4de9-8864-8ab71420fc6a",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "comment": "R3 XML form approved by QC. Ready for Medical Reviewer",
        "timestamp": "2025-12-12T18:47:41.929Z",
        "type": "qc_r3_approval"
      },
      {
        "id": "38491918-ed3d-4441-a008-7dd2acd008cd",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 8907e931-0be0-4c5f-82fc-7d93999e60b1 to MORP_Demo_84888",
        "type": "system",
        "createdAt": "2025-12-14T10:13:41.975Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-12T17:26:00.040Z",
    "updatedAt": "2025-12-12T18:47:41.939Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41360841",
      "DOI": "https://doi.org/10.1038/s41598-025-27298-x",
      "special_case": "No",
      "Country_of_first_author": "Slovenia",
      "Country_of_occurrence": "Slovenia",
      "Patient_details": "No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Morphine, Amphetamine",
      "Attributability": "Attributability: Not applicable",
      "Drug_effect": "Drug effect: Morphine did not affect ultrasonic vocalizations or locomotion in either rat strain.",
      "Summary": "This study investigates the differential effects of amphetamine and morphine on ultrasonic vocalizations and locomotor activity in Wistar-Kyoto (WKY) rats, a model for treatment-resistant depression, compared to control Wistar rats. The research focuses on the use of 50-kHz ultrasonic vocalizations (USVs) as a complementary behavioral marker for assessing anhedonia, a core symptom of depression. WKY rats emitted fewer basal 50-kHz calls and showed reduced responses to amphetamine administration, including fewer calls and diminished locomotor activity. Morphine, however, did not affect USVs or locomotion in either strain. The study highlights the potential of 50-kHz calls as a non-invasive measure of anhedonia in preclinical models of depression. While amphetamine elicited sensitization of 50-kHz calls in WKY rats after repeated administration, morphine failed to produce any significant effects on vocalizations or locomotion. The findings suggest that morphine does not influence the emotional or behavioral markers assessed in this study, contrasting with amphetamine's effects. The study provides insights into strain-specific differences in response to pharmacological agents and emphasizes the utility of USVs in evaluating affective states in animal models.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article comments that morphine did not affect ultrasonic vocalizations or locomotion in either strain, indicating no significant impact on the behavioral markers assessed.",
      "Adverse_event": "No AE",
      "Abstract": "The Wistar-Kyoto rat strain (WKY) is a model for treatment-resistant depression, exhibiting behaviors indicative of anhedonia. Although anhedonia is measured using the sucrose preference test (SPT), 50-kHz ultrasonic vocalizations (USVs) hold promise as a complementary assessment tool. This study aimed to detect whether 50-kHz USVs differ in the WKY rats compared to control Wistar (W) rats. First, WKY and W rats were compared for their basal 50-kHz calls. Then, rats were repeatedly treated with four administrations of either amphetamine (AMPH) or morphine (MORPH), and 50-kHz calls were recorded. In addition, the drug-evoked locomotor activity, sucrose consumption in the SPT, and the time spent in the drug- vs. saline-paired compartment in the conditioned place preference (CPP) test were collected. WKY rats emitted fewer basal calls and fewer calls following the first and the fourth AMPH administration. Contrary to controls, AMPH did not affect the number of calls in WKY rats following the first administration. WKY also displayed reduced AMPH-induced locomotor activity and sucrose consumption in the SPT. MORPH did not affect USVs or locomotion in either strain. The results highlight the benefits of 50-kHz calls as a complementary behavioral marker for assessing anhedonia in preclinical models of depression.",
      "Title": "Differential effects of amphetamine on ultrasonic vocalizations and locomotor activity in a rat model of endogenous depression.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-12 22:55:58",
      "Vancouver_citation": "Banjac A, Elersič K, Živin M, Zorović M. Differential effects of amphetamine on ultrasonic vocalizations and locomotor activity in a rat model of endogenous depression. Sci Rep. 2025;15(1):43328",
      "pubdate": "2025-12-9",
      "Lead_author": "Banjac A",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study were male Wistar-Kyoto (WKY) rats and control Wistar (W) rats. These rats were exposed to morphine (MORPH), amphetamine (AMPH), and saline (SAL) as part of the experimental protocol. The study aimed to investigate the effects of these drugs on ultrasonic vocalizations (USVs), locomotor activity, sucrose consumption, and conditioned place preference (CPP).",
      "AOI_drug_effect": "Morphine (the drug of study) did not have any significant effect on the test subjects. The study reported that morphine did not affect the emission of 50-kHz ultrasonic vocalizations or locomotor activity in either WKY or W rats. Additionally, morphine did not influence sucrose consumption or conditioned place preference behavior in the rats. Therefore, \"No Drug Effect.\"",
      "Approved_indication": "Morphine is conventionally used as an opioid analgesic to treat moderate to severe pain. It is typically administered to patients suffering from pain-related conditions, often through oral, intravenous, or subcutaneous routes. In this study, morphine hydrochloride was administered subcutaneously at a dose of 1 mg/kg to the hip region of the rats. The drug was not intended to treat any illness but was used to evaluate its effects on ultrasonic vocalizations, locomotor activity, and other behavioral measures in the context of depression and anhedonia in WKY rats.",
      "AOI_classification": "No",
      "Justification": "The study explicitly states that morphine did not produce any significant effects on ultrasonic vocalizations, locomotor activity, sucrose consumption, or conditioned place preference behavior in the test subjects. There is no mention of morphine causing any adverse effects or negative outcomes in the rats.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.1038/s41598-025-27298-x",
    "specialCase": "No",
    "countryOfFirstAuthor": "Slovenia",
    "countryOfOccurrence": "Slovenia",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Morphine",
      "Amphetamine"
    ],
    "attributability": "Attributability: Not applicable",
    "drugEffect": "Drug effect: Morphine did not affect ultrasonic vocalizations or locomotion in either rat strain.",
    "summary": "This study investigates the differential effects of amphetamine and morphine on ultrasonic vocalizations and locomotor activity in Wistar-Kyoto (WKY) rats, a model for treatment-resistant depression, compared to control Wistar rats. The research focuses on the use of 50-kHz ultrasonic vocalizations (USVs) as a complementary behavioral marker for assessing anhedonia, a core symptom of depression. WKY rats emitted fewer basal 50-kHz calls and showed reduced responses to amphetamine administration, including fewer calls and diminished locomotor activity. Morphine, however, did not affect USVs or locomotion in either strain. The study highlights the potential of 50-kHz calls as a non-invasive measure of anhedonia in preclinical models of depression. While amphetamine elicited sensitization of 50-kHz calls in WKY rats after repeated administration, morphine failed to produce any significant effects on vocalizations or locomotion. The findings suggest that morphine does not influence the emotional or behavioral markers assessed in this study, contrasting with amphetamine's effects. The study provides insights into strain-specific differences in response to pharmacological agents and emphasizes the utility of USVs in evaluating affective states in animal models.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article comments that morphine did not affect ultrasonic vocalizations or locomotion in either strain, indicating no significant impact on the behavioral markers assessed.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Banjac A, Elersič K, Živin M, Zorović M. Differential effects of amphetamine on ultrasonic vocalizations and locomotor activity in a rat model of endogenous depression. Sci Rep. 2025;15(1):43328",
    "leadAuthor": "Banjac A",
    "serious": "No",
    "testSubject": "The test subjects involved in this study were male Wistar-Kyoto (WKY) rats and control Wistar (W) rats. These rats were exposed to morphine (MORPH), amphetamine (AMPH), and saline (SAL) as part of the experimental protocol. The study aimed to investigate the effects of these drugs on ultrasonic vocalizations (USVs), locomotor activity, sucrose consumption, and conditioned place preference (CPP).",
    "aoiDrugEffect": "Morphine (the drug of study) did not have any significant effect on the test subjects. The study reported that morphine did not affect the emission of 50-kHz ultrasonic vocalizations or locomotor activity in either WKY or W rats. Additionally, morphine did not influence sucrose consumption or conditioned place preference behavior in the rats. Therefore, \"No Drug Effect.\"",
    "approvedIndication": "Morphine is conventionally used as an opioid analgesic to treat moderate to severe pain. It is typically administered to patients suffering from pain-related conditions, often through oral, intravenous, or subcutaneous routes. In this study, morphine hydrochloride was administered subcutaneously at a dose of 1 mg/kg to the hip region of the rats. The drug was not intended to treat any illness but was used to evaluate its effects on ultrasonic vocalizations, locomotor activity, and other behavioral measures in the context of depression and anhedonia in WKY rats.",
    "aoiClassification": "No",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-12T17:27:06.534Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": {
      "E.i.3.2a": "false",
      "E.i.3.2b": "false",
      "E.i.3.2c": "false",
      "E.i.3.2d": "false",
      "E.i.3.2e": "false",
      "E.i.3.2f": "false",
      "E.i.7": "0",
      "C.2.r.1": "Banjac A",
      "C.2.r.1.2": "Banjac",
      "C.2.r.1.4": "A",
      "C.4.r.1": "Banjac A, Elersič K, Živin M, Zorović M. Differential effects of amphetamine on ultrasonic vocalizations and locomotor activity in a rat model of endogenous depression. Sci Rep. 2025;15(1):43328",
      "D.7.1.r": "No human subject",
      "D.7": "This study investigates the differential effects of amphetamine and morphine on ultrasonic vocalizations and locomotor activity in Wistar-Kyoto (WKY) rats, a model for treatment-resistant depression, compared to control Wistar rats. The research focuses on the use of 50-kHz ultrasonic vocalizations (USVs) as a complementary behavioral marker for assessing anhedonia, a core symptom of depression. WKY rats emitted fewer basal 50-kHz calls and showed reduced responses to amphetamine administration, including fewer calls and diminished locomotor activity. Morphine, however, did not affect USVs or locomotion in either strain. The study highlights the potential of 50-kHz calls as a non-invasive measure of anhedonia in preclinical models of depression. While amphetamine elicited sensitization of 50-kHz calls in WKY rats after repeated administration, morphine failed to produce any significant effects on vocalizations or locomotion. The findings suggest that morphine does not influence the emotional or behavioral markers assessed in this study, contrasting with amphetamine's effects. The study provides insights into strain-specific differences in response to pharmacological agents and emphasizes the utility of USVs in evaluating affective states in animal models.",
      "D.7.1.r.2": "Relevant dates: not mentioned",
      "E.i.1.1a": "No AE",
      "C.2.r.2.1": "Institution in Slovenia"
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-12T18:47:08.541Z",
    "qcR3Status": "approved",
    "qcR3ApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qcR3ApprovedAt": "2025-12-12T18:47:41.929Z",
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiwCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiwCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-52b3ec0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707222
  },
  {
    "id": "RASA_Demo_42661",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41247590",
    "title": "Nocturnal Hypokinesia and Early Morning OFF in Parkinson's Disease: State-of-the-Art and Systematic Review of Treatment Availability.",
    "authors": [
      "Sringean J",
      "Carandang RAM",
      "Zhunusova E",
      "Bhidayasiri R"
    ],
    "journal": "Curr Neurol Neurosci Rep",
    "publicationDate": "2025-11-17",
    "abstract": "The article systematically reviews treatment strategies for nocturnal hypokinesia and early morning OFF in Parkinson's disease, focusing on pharmacologic and non-pharmacologic approaches. It identifies 31 clinical trials and discusses the use of various drugs, including levodopa, dopamine agonists, MAO-B inhibitors like rasagiline and safinamide, COMT inhibitors, and rescue therapies such as inhaled or dispersible levodopa or apomorphine injection. The study proposes a tiered treatment algorithm based on disease stage and symptom severity, recommending non-pharmacological treatments at all stages. For mild symptoms in early Parkinson's disease, inhaled or dispersible levodopa or apomorphine injection are suggested, while moderate to advanced stages may benefit from long-acting dopamine agonists, MAO-B inhibitors, sustained-release levodopa, or COMT inhibitors. Although rasagiline is mentioned as part of the treatment options, the article does not provide specific details on its effects, adverse events, or outcomes in human subjects. The absence of the full article limits the ability to assess the impact of rasagiline or other drugs on the subjects, including any adverse events or therapeutic efficacy.",
    "drugName": "RASAGILINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "312d5991-3447-4eaf-9b58-b4a576aae359",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:37.940Z"
      },
      {
        "id": "ebc1e3f8-2419-49a3-8c7e-5d3aad21d216",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6030f58b-02b2-4099-b376-887ffcddedc0 to RASA_Demo_42661",
        "type": "system",
        "createdAt": "2025-12-14T10:13:42.301Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:06:59.214Z",
    "updatedAt": "2025-12-14T08:54:38.005Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41247590",
      "DOI": "https://doi.org/10.1007/s11910-025-01467-x",
      "special_case": "No",
      "Country_of_first_author": "Thailand",
      "Country_of_occurrence": "Thailand",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: Human subjects were involved in clinical trials to evaluate treatment strategies for nocturnal hypokinesia and early morning OFF in Parkinson's disease. The study reviewed pharmacologic and non-pharmacologic treatments based on disease stage and symptom severity.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: levodopa, rotigotine, ropinirol, pramipexole, apomorphine, rasagiline, safinamide, opicapone",
      "Attributability": "Attributability: The study mentions various pharmacologic treatments for Parkinson's disease symptoms, but specific adverse events or complications attributable to these drugs are not detailed in the provided text.",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The article systematically reviews treatment strategies for nocturnal hypokinesia and early morning OFF in Parkinson's disease, focusing on pharmacologic and non-pharmacologic approaches. It identifies 31 clinical trials and discusses the use of various drugs, including levodopa, dopamine agonists, MAO-B inhibitors like rasagiline and safinamide, COMT inhibitors, and rescue therapies such as inhaled or dispersible levodopa or apomorphine injection. The study proposes a tiered treatment algorithm based on disease stage and symptom severity, recommending non-pharmacological treatments at all stages. For mild symptoms in early Parkinson's disease, inhaled or dispersible levodopa or apomorphine injection are suggested, while moderate to advanced stages may benefit from long-acting dopamine agonists, MAO-B inhibitors, sustained-release levodopa, or COMT inhibitors. Although rasagiline is mentioned as part of the treatment options, the article does not provide specific details on its effects, adverse events, or outcomes in human subjects. The absence of the full article limits the ability to assess the impact of rasagiline or other drugs on the subjects, including any adverse events or therapeutic efficacy.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article does not provide specific opinions or comments on the effect of rasagiline or other drugs on subjects, nor does it detail the results of the study.",
      "Adverse_event": "No AE",
      "Abstract": "To review the pathophysiology, clinical presentation, evaluation methods, and current treatment strategies of nocturnal hypokinesia and early morning OFF in Parkinson's disease. A comprehensive literature search was conducted using PubMed, ScienceDirect, and the Cochrane Library for relevant treatment strategies.\n\nWe identified 31 clinical trials. Pharmacologic treatments include standard and sustained-release levodopa, dopamine agonists (rotigotine, ropinirol, pramipexole, and apomorphine), MAO-B inhibitors (rasagiline, safinamide), COMT inhibitors (opicapone), and rescue therapies like inhaled or dispersible levodopa or apomorphine injection. We propose a tiered treatment algorithm based on disease stage and symptom severity. Non-pharmacological treatment is recommended in all stages. For mild, disturbing symptoms in early PD, inhaled or dispersible levodopa or apomorphine injection are advised. In moderate to advanced stages, treatment options include long-acting dopamine agonists, MAO-B inhibitors, sustained-release levodopa, or COMT inhibitors selected based on factors such as daytime motor symptoms, and non-motor symptoms.",
      "Title": "Nocturnal Hypokinesia and Early Morning OFF in Parkinson's Disease: State-of-the-Art and Systematic Review of Treatment Availability.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "RASAGILINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:34:34",
      "Vancouver_citation": "Sringean J, Carandang RAM, Zhunusova E, Bhidayasiri R. Nocturnal Hypokinesia and Early Morning OFF in Parkinson's Disease: State-of-the-Art and Systematic Review of Treatment Availability. Curr Neurol Neurosci Rep. 2025;25(1):80",
      "pubdate": "2025-11-17",
      "Lead_author": "Sringean J",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Rasagiline, is conventionally used for the treatment of Parkinson's disease (PD). In this study, Rasagiline is mentioned as part of the pharmacologic treatment options for nocturnal hypokinesia and early morning OFF in Parkinson's disease. The study does not indicate any off-label use or non-conventional administration of Rasagiline.",
      "AOI_classification": "No",
      "Justification": "The study does not link Rasagiline to any adverse effects or negative outcomes.",
      "Client_name": "Demo",
      "Drugname": "RASAGILINE"
    },
    "doi": "https://doi.org/10.1007/s11910-025-01467-x",
    "specialCase": "No",
    "countryOfFirstAuthor": "Thailand",
    "countryOfOccurrence": "Thailand",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: Human subjects were involved in clinical trials to evaluate treatment strategies for nocturnal hypokinesia and early morning OFF in Parkinson's disease. The study reviewed pharmacologic and non-pharmacologic treatments based on disease stage and symptom severity.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: levodopa",
      "rotigotine",
      "ropinirol",
      "pramipexole",
      "apomorphine",
      "rasagiline",
      "safinamide",
      "opicapone"
    ],
    "attributability": "Attributability: The study mentions various pharmacologic treatments for Parkinson's disease symptoms, but specific adverse events or complications attributable to these drugs are not detailed in the provided text.",
    "drugEffect": "Drug effect: no data",
    "summary": "The article systematically reviews treatment strategies for nocturnal hypokinesia and early morning OFF in Parkinson's disease, focusing on pharmacologic and non-pharmacologic approaches. It identifies 31 clinical trials and discusses the use of various drugs, including levodopa, dopamine agonists, MAO-B inhibitors like rasagiline and safinamide, COMT inhibitors, and rescue therapies such as inhaled or dispersible levodopa or apomorphine injection. The study proposes a tiered treatment algorithm based on disease stage and symptom severity, recommending non-pharmacological treatments at all stages. For mild symptoms in early Parkinson's disease, inhaled or dispersible levodopa or apomorphine injection are suggested, while moderate to advanced stages may benefit from long-acting dopamine agonists, MAO-B inhibitors, sustained-release levodopa, or COMT inhibitors. Although rasagiline is mentioned as part of the treatment options, the article does not provide specific details on its effects, adverse events, or outcomes in human subjects. The absence of the full article limits the ability to assess the impact of rasagiline or other drugs on the subjects, including any adverse events or therapeutic efficacy.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article does not provide specific opinions or comments on the effect of rasagiline or other drugs on subjects, nor does it detail the results of the study.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "RASAGILINE",
    "vancouverCitation": "Sringean J, Carandang RAM, Zhunusova E, Bhidayasiri R. Nocturnal Hypokinesia and Early Morning OFF in Parkinson's Disease: State-of-the-Art and Systematic Review of Treatment Availability. Curr Neurol Neurosci Rep. 2025;25(1):80",
    "leadAuthor": "Sringean J",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Rasagiline, is conventionally used for the treatment of Parkinson's disease (PD). In this study, Rasagiline is mentioned as part of the pharmacologic treatment options for nocturnal hypokinesia and early morning OFF in Parkinson's disease. The study does not indicate any off-label use or non-conventional administration of Rasagiline.",
    "aoiClassification": "No",
    "justification": "The study does not link Rasagiline to any adverse effects or negative outcomes.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUixCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUixCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-52e0940501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707222
  },
  {
    "id": "RASA_Demo_55364",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41199509",
    "title": "Effects of MAO-B and COMT inhibitors on sleep disturbances in Parkinson's disease: A network meta-analysis.",
    "authors": [
      "Lee SM",
      "Shim SR",
      "Kwon KY",
      "Rhee TG",
      "Jung YJ"
    ],
    "journal": "J Mov Disord",
    "publicationDate": "2025-11-7",
    "abstract": "This network meta-analysis aimed to evaluate the effects of MAO-B and COMT inhibitors on sleep disturbances in Parkinson's disease (PD), a common non-motor symptom that significantly impacts quality of life. Seven studies were included in the analysis, focusing on subjective sleep quality, daytime sleepiness, and objective polysomnography (PSG) parameters. While no significant differences were observed among MAO-B and COMT inhibitors in improving subjective sleep quality or daytime sleepiness, safinamide demonstrated notable effects on PSG data. Specifically, safinamide significantly increased REM sleep duration and decreased wake time after sleep onset compared to rasagiline and placebo. These findings suggest safinamide may provide additional benefits for managing sleep disruptions in PD patients, beyond its established motor benefits. However, the limited number and small scale of trials necessitate cautious interpretation of the results. The study emphasizes the need for further high-quality trials to better understand the personalized use of MAO-B and COMT inhibitors for sleep disturbances in PD. Rasagiline was mentioned in the study but did not show significant effects on sleep disturbances compared to safinamide.",
    "drugName": "RASAGILINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "1dad0377-6f93-4123-bb76-51a3299089d5",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:38.032Z"
      },
      {
        "id": "d6c27507-57de-40fc-8f02-a91549503942",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 44558fef-11b5-47e3-baf3-db6f605a2438 to RASA_Demo_55364",
        "type": "system",
        "createdAt": "2025-12-14T10:13:42.517Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:06:59.270Z",
    "updatedAt": "2025-12-14T08:54:38.043Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41199509",
      "DOI": "https://doi.org/10.14802/jmd.25253",
      "special_case": "No",
      "Country_of_first_author": "Republic of Korea",
      "Country_of_occurrence": "Republic of Korea",
      "Patient_details": "No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: Not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "This network meta-analysis aimed to evaluate the effects of MAO-B and COMT inhibitors on sleep disturbances in Parkinson's disease (PD), a common non-motor symptom that significantly impacts quality of life. Seven studies were included in the analysis, focusing on subjective sleep quality, daytime sleepiness, and objective polysomnography (PSG) parameters. While no significant differences were observed among MAO-B and COMT inhibitors in improving subjective sleep quality or daytime sleepiness, safinamide demonstrated notable effects on PSG data. Specifically, safinamide significantly increased REM sleep duration and decreased wake time after sleep onset compared to rasagiline and placebo. These findings suggest safinamide may provide additional benefits for managing sleep disruptions in PD patients, beyond its established motor benefits. However, the limited number and small scale of trials necessitate cautious interpretation of the results. The study emphasizes the need for further high-quality trials to better understand the personalized use of MAO-B and COMT inhibitors for sleep disturbances in PD. Rasagiline was mentioned in the study but did not show significant effects on sleep disturbances compared to safinamide.",
      "Identifiable_human_subject": "No",
      "Text_type": "Meta-analysis",
      "Author_perspective": "The article comments on the effect of safinamide, noting its significant impact on REM sleep duration and wake time after sleep onset compared to rasagiline and placebo. It suggests safinamide may offer additional benefits for managing sleep disturbances in PD patients, but emphasizes the need for further high-quality trials to confirm these findings.",
      "Adverse_event": "No AE",
      "Abstract": "Sleep disturbances are common and debilitating non-motor symptoms (NMS) in Parkinson's disease (PD), profoundly affecting quality of life. Despite emerging evidence suggesting that monoamine oxidase B (MAO-B) and catechol-O-methyltransferase (COMT) inhibitors may alleviate NMS, their specific effects on sleep remain unclear. This network meta-analysis (NMA) aimed to compare the efficacy of these inhibitors on sleep problems in PD.\n\nFollowing a systematic search of PubMed, Cochrane, and EMBASE, studies comparing MAO-B or COMT inhibitors and assessing sleep outcomes in PD were identified. An NMA was conducted using data from the seven studies that met our inclusion criteria. Outcomes included subjective sleep quality, daytime sleepiness, and objective polysomnography (PSG) parameters.\n\nNo statistically significant differences were found among MAO-B and COMT inhibitors in improving subjective sleep quality or daytime sleepiness. However, in analyses of objective PSG data, safinamide was found to significantly increase REM sleep duration (mean difference, 5.70 [95% CI, 2.26, 9.14]) and decrease wake time after sleep onset (mean difference, -10.20 [-19.38, -1.02]) compared to rasagiline and placebo.\n\nThese findings suggest that safinamide may offer additional value for managing sleep disruptions beyond its known motor benefits in patients with PD. Given the limited number and small scale of available trials, the overall evidence should be interpreted cautiously. Nonetheless, this analysis highlights the need for further high-quality trials focused on sleep outcomes to guide personalized use of MAO-B and COMT inhibitors for sleep disturbances in PD.",
      "Title": "Effects of MAO-B and COMT inhibitors on sleep disturbances in Parkinson's disease: A network meta-analysis.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "RASAGILINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:35:36",
      "Vancouver_citation": "Lee SM, Shim SR, Kwon KY, Rhee TG, Jung YJ. Effects of MAO-B and COMT inhibitors on sleep disturbances in Parkinson's disease: A network meta-analysis. J Mov Disord. 2025;",
      "pubdate": "2025-11-7",
      "Lead_author": "Lee SM",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Rasagiline, is conventionally used for the treatment of Parkinson's disease (PD). In this study, Rasagiline was analyzed in the context of its effects on sleep disturbances in PD patients, which aligns with its conventional use. There is no indication of off-label use or non-conventional administration.",
      "AOI_classification": "No",
      "Justification": "The study does not link Rasagiline to any adverse effects or negative outcomes.",
      "Client_name": "Demo",
      "Drugname": "RASAGILINE"
    },
    "doi": "https://doi.org/10.14802/jmd.25253",
    "specialCase": "No",
    "countryOfFirstAuthor": "Republic of Korea",
    "countryOfOccurrence": "Republic of Korea",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: Not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "This network meta-analysis aimed to evaluate the effects of MAO-B and COMT inhibitors on sleep disturbances in Parkinson's disease (PD), a common non-motor symptom that significantly impacts quality of life. Seven studies were included in the analysis, focusing on subjective sleep quality, daytime sleepiness, and objective polysomnography (PSG) parameters. While no significant differences were observed among MAO-B and COMT inhibitors in improving subjective sleep quality or daytime sleepiness, safinamide demonstrated notable effects on PSG data. Specifically, safinamide significantly increased REM sleep duration and decreased wake time after sleep onset compared to rasagiline and placebo. These findings suggest safinamide may provide additional benefits for managing sleep disruptions in PD patients, beyond its established motor benefits. However, the limited number and small scale of trials necessitate cautious interpretation of the results. The study emphasizes the need for further high-quality trials to better understand the personalized use of MAO-B and COMT inhibitors for sleep disturbances in PD. Rasagiline was mentioned in the study but did not show significant effects on sleep disturbances compared to safinamide.",
    "identifiableHumanSubject": "No",
    "textType": "Meta-analysis",
    "authorPerspective": "The article comments on the effect of safinamide, noting its significant impact on REM sleep duration and wake time after sleep onset compared to rasagiline and placebo. It suggests safinamide may offer additional benefits for managing sleep disturbances in PD patients, but emphasizes the need for further high-quality trials to confirm these findings.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "RASAGILINE",
    "vancouverCitation": "Lee SM, Shim SR, Kwon KY, Rhee TG, Jung YJ. Effects of MAO-B and COMT inhibitors on sleep disturbances in Parkinson's disease: A network meta-analysis. J Mov Disord. 2025;",
    "leadAuthor": "Lee SM",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Rasagiline, is conventionally used for the treatment of Parkinson's disease (PD). In this study, Rasagiline was analyzed in the context of its effects on sleep disturbances in PD patients, which aligns with its conventional use. There is no indication of off-label use or non-conventional administration.",
    "aoiClassification": "No",
    "justification": "The study does not link Rasagiline to any adverse effects or negative outcomes.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUiyCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUiyCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-53064c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707222
  },
  {
    "id": "RASA_Demo_76081",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41188875",
    "title": "Interaction between rasagiline and Pueraria radix in in vitro models of parkinson's disease.",
    "authors": [
      "Huh E",
      "Kim JH",
      "Lee S",
      "Oh MS"
    ],
    "journal": "BMC Complement Med Ther",
    "publicationDate": "2025-11-5",
    "abstract": "This study investigates the pharmacodynamic and pharmacokinetic interactions between Rasagiline (RASA), a monoamine oxidase-B (MAO-B) inhibitor, and Pueraria root (PR), a traditional East Asian medicine, in in vitro models of Parkinson's disease (PD). The research focuses on the synergistic effects of RASA and PR on MAO-B inhibition and neuroprotection against 6-OHDA-induced toxicity in PC12 cells. The study revealed that co-administration of RASA and PR at specific ratios significantly enhanced MAO-B inhibition and increased cell survival rates compared to individual treatments. The combination index analysis confirmed strong synergistic effects, suggesting that lower doses of each compound could achieve therapeutic effects while reducing side effects. Additionally, the investigation of CYP450 metabolism demonstrated minimal interference between RASA and PR, indicating favorable metabolic compatibility. The findings establish a scientific foundation for integrating traditional herbal medicine with conventional pharmaceuticals in PD management, potentially improving therapeutic outcomes and reducing conventional drug dosages. However, the study is limited to in vitro models, and further validation in primary dopaminergic neuron cultures, in vivo PD models, and clinical trials is necessary to confirm the translational relevance of the observed synergistic interactions.",
    "drugName": "RASAGILINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5777c913-1a9d-4667-8d0d-19e8f65332a7",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:38.061Z"
      },
      {
        "id": "ca55a8e6-2511-4f3b-b7db-82f2208e60b5",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9b3cc664-9ec4-445a-b5ba-244da3940f2a to RASA_Demo_76081",
        "type": "system",
        "createdAt": "2025-12-14T10:13:42.746Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:06:59.326Z",
    "updatedAt": "2025-12-14T08:54:38.145Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41188875",
      "DOI": "https://doi.org/10.1186/s12906-025-05154-9",
      "special_case": "No",
      "Country_of_first_author": "Republic of Korea",
      "Country_of_occurrence": "Republic of Korea",
      "Patient_details": "No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: Not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "This study investigates the pharmacodynamic and pharmacokinetic interactions between Rasagiline (RASA), a monoamine oxidase-B (MAO-B) inhibitor, and Pueraria root (PR), a traditional East Asian medicine, in in vitro models of Parkinson's disease (PD). The research focuses on the synergistic effects of RASA and PR on MAO-B inhibition and neuroprotection against 6-OHDA-induced toxicity in PC12 cells. The study revealed that co-administration of RASA and PR at specific ratios significantly enhanced MAO-B inhibition and increased cell survival rates compared to individual treatments. The combination index analysis confirmed strong synergistic effects, suggesting that lower doses of each compound could achieve therapeutic effects while reducing side effects. Additionally, the investigation of CYP450 metabolism demonstrated minimal interference between RASA and PR, indicating favorable metabolic compatibility. The findings establish a scientific foundation for integrating traditional herbal medicine with conventional pharmaceuticals in PD management, potentially improving therapeutic outcomes and reducing conventional drug dosages. However, the study is limited to in vitro models, and further validation in primary dopaminergic neuron cultures, in vivo PD models, and clinical trials is necessary to confirm the translational relevance of the observed synergistic interactions.",
      "Identifiable_human_subject": "No",
      "Text_type": "In Vitro Study",
      "Author_perspective": "The article comments positively on the synergistic effects of Rasagiline and Pueraria root, highlighting their enhanced therapeutic potential and favorable metabolic compatibility in in vitro models of Parkinson's disease.",
      "Adverse_event": "No AE",
      "Abstract": "The management of Parkinson's disease (PD) remains challenging owing to the limitations of current therapies. Although rasagiline (RASA), a monoamine oxidase-B (MAO-B) inhibitor, offers advantages over levodopa, its efficacy as a monotherapy is moderate. Pueraria root (PR), a traditional East Asian medicine, has demonstrated neuroprotective potential against several neurodegenerative conditions. This study investigated the pharmacodynamic and pharmacokinetic interactions between RASA and PR to evaluate their potential as a combination therapy for PD.\n\nWe examined synergistic effects on MAO-B inhibition by performing MAO-B enzyme reaction assay. We measured the cell viability for evaluating the neuroprotective effects of their co-administration against 6-OHDA-induced toxicity in PC12 cells. For investigating the interaction of drug metabolism, CYP450 expressions were measured in hepatocytes using quantitative real-time polymerase chain reaction.\n\nConcentration-dependent studies revealed a significant synergistic inhibition of MAO-B activity when RASA and PR were co-administered at specific ratios, as confirmed by combination index analysis. Although neither of the two drugs alone provided significant neuroprotection at concentrations effective for MAO-B inhibition, their co-administration significantly increased the survival of in 6-OHDA-treated cells. Importantly, investigation of CYP450 metabolism demonstrated minimal interference between these compounds, with no significant alterations in the expression patterns of relevant CYP isoforms during co-administration.\n\nThese findings suggest that the RASA - PR combination offers enhanced therapeutic potential through synergistic effects, while maintaining favourable metabolic compatibility. This study establishes a scientific foundation for integrating traditional herbal medicine with conventional pharmaceuticals in PD management, potentially allowing for reduced conventional drug dosages while improving therapeutic outcomes.",
      "Title": "Interaction between rasagiline and Pueraria radix in in vitro models of parkinson's disease.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "RASAGILINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:36:37",
      "Vancouver_citation": "Huh E, Kim JH, Lee S, Oh MS. Interaction between rasagiline and Pueraria radix in in vitro models of parkinson's disease. BMC Complement Med Ther. 2025;25(1):409",
      "pubdate": "2025-11-5",
      "Lead_author": "Huh E",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study include PC12 cells, which are derived from rat adrenal pheochromocytoma and are used as a model for neuronal studies. Additionally, liver tissues from Sprague-Dawley rats were utilized to measure MAO-B activity and investigate CYP450 enzyme expression. ",
      "AOI_drug_effect": "The drug of study, Rasagiline (RASA), demonstrated significant effects in this study. It exhibited MAO-B inhibitory activity and, when co-administered with Pueraria radix (PR), showed synergistic effects on MAO-B inhibition and enhanced neuroprotection against 6-OHDA-induced toxicity in PC12 cells. The combination therapy significantly increased cell survival rates compared to individual treatments.",
      "Approved_indication": "Rasagiline is conventionally used as a monoamine oxidase-B (MAO-B) inhibitor for the treatment of Parkinson's disease (PD). It is administered orally to patients with mild symptoms to maintain brain dopamine levels and provide neuroprotective effects. In this study, Rasagiline was administered in vitro to PC12 cells and rat liver tissues to evaluate its pharmacodynamic and pharmacokinetic interactions with Pueraria radix. The study aimed to explore its potential as part of a combination therapy for PD.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study mentions Rasagiline's potential side effects and food interactions, necessitating dietary guidance during treatment. Additionally, the investigation into CYP450 enzyme expression highlights the importance of understanding metabolic interactions to ensure safety in combination therapies.",
      "Client_name": "Demo",
      "Drugname": "RASAGILINE"
    },
    "doi": "https://doi.org/10.1186/s12906-025-05154-9",
    "specialCase": "No",
    "countryOfFirstAuthor": "Republic of Korea",
    "countryOfOccurrence": "Republic of Korea",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: Not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "This study investigates the pharmacodynamic and pharmacokinetic interactions between Rasagiline (RASA), a monoamine oxidase-B (MAO-B) inhibitor, and Pueraria root (PR), a traditional East Asian medicine, in in vitro models of Parkinson's disease (PD). The research focuses on the synergistic effects of RASA and PR on MAO-B inhibition and neuroprotection against 6-OHDA-induced toxicity in PC12 cells. The study revealed that co-administration of RASA and PR at specific ratios significantly enhanced MAO-B inhibition and increased cell survival rates compared to individual treatments. The combination index analysis confirmed strong synergistic effects, suggesting that lower doses of each compound could achieve therapeutic effects while reducing side effects. Additionally, the investigation of CYP450 metabolism demonstrated minimal interference between RASA and PR, indicating favorable metabolic compatibility. The findings establish a scientific foundation for integrating traditional herbal medicine with conventional pharmaceuticals in PD management, potentially improving therapeutic outcomes and reducing conventional drug dosages. However, the study is limited to in vitro models, and further validation in primary dopaminergic neuron cultures, in vivo PD models, and clinical trials is necessary to confirm the translational relevance of the observed synergistic interactions.",
    "identifiableHumanSubject": "No",
    "textType": "In Vitro Study",
    "authorPerspective": "The article comments positively on the synergistic effects of Rasagiline and Pueraria root, highlighting their enhanced therapeutic potential and favorable metabolic compatibility in in vitro models of Parkinson's disease.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "RASAGILINE",
    "vancouverCitation": "Huh E, Kim JH, Lee S, Oh MS. Interaction between rasagiline and Pueraria radix in in vitro models of parkinson's disease. BMC Complement Med Ther. 2025;25(1):409",
    "leadAuthor": "Huh E",
    "serious": "No",
    "testSubject": "The test subjects involved in this study include PC12 cells, which are derived from rat adrenal pheochromocytoma and are used as a model for neuronal studies. Additionally, liver tissues from Sprague-Dawley rats were utilized to measure MAO-B activity and investigate CYP450 enzyme expression. ",
    "aoiDrugEffect": "The drug of study, Rasagiline (RASA), demonstrated significant effects in this study. It exhibited MAO-B inhibitory activity and, when co-administered with Pueraria radix (PR), showed synergistic effects on MAO-B inhibition and enhanced neuroprotection against 6-OHDA-induced toxicity in PC12 cells. The combination therapy significantly increased cell survival rates compared to individual treatments.",
    "approvedIndication": "Rasagiline is conventionally used as a monoamine oxidase-B (MAO-B) inhibitor for the treatment of Parkinson's disease (PD). It is administered orally to patients with mild symptoms to maintain brain dopamine levels and provide neuroprotective effects. In this study, Rasagiline was administered in vitro to PC12 cells and rat liver tissues to evaluate its pharmacodynamic and pharmacokinetic interactions with Pueraria radix. The study aimed to explore its potential as part of a combination therapy for PD.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The study mentions Rasagiline's potential side effects and food interactions, necessitating dietary guidance during treatment. Additionally, the investigation into CYP450 enzyme expression highlights the importance of understanding metabolic interactions to ensure safety in combination therapies.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUizCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUizCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-532c2c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707222
  },
  {
    "id": "RASA_Demo_62542",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40939528",
    "title": "Add-on therapies to levodopa improve pain modulation in Parkinson's disease with motor fluctuations: A prospective cohort study.",
    "authors": [
      "Andrenelli E",
      "Baldini N",
      "Barbini FA",
      "Benedetti M",
      "Brambatti J",
      "Capecci M",
      "Ceravolo MG"
    ],
    "journal": "Parkinsonism Relat Disord",
    "publicationDate": "2025-09-13",
    "abstract": "This prospective cohort study aimed to evaluate the effect of MAO-B and COMT inhibitors, including rasagiline, as add-on therapies to levodopa on pain thresholds in people with Parkinson's disease (pwPD) experiencing motor fluctuations. Forty pwPD were enrolled, and their pain thresholds were assessed at baseline, 3 months, and 6 months. Normative data from 11 healthy subjects were used for comparison. The study revealed that pwPD had altered pain processing, with higher tactile thresholds and lower pain and pain tolerance thresholds compared to controls. Rasagiline and safinamide significantly improved pain thresholds and tolerance at 6 months, outperforming opicapone. Pain was more frequent in women and associated with anxiety, poor sleep, and motor complications. Regression analyses identified cognitive status, sex, disease duration, age, anxiety levels, and treatment with MAO-B inhibitors as key modulators of pain processing. The study concluded that MAO-B inhibitors, particularly safinamide and rasagiline, restore pain thresholds and improve QOL, supporting their role in managing pain in PD.",
    "drugName": "RASAGILINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "f603710b-5b43-49e9-a070-9e1686bb3cf7",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:38.172Z"
      },
      {
        "id": "cf9baf9c-ab75-434d-bff3-a865d53b3146",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 4dc53fc6-2176-49da-8631-46cf6ea06205 to RASA_Demo_62542",
        "type": "system",
        "createdAt": "2025-12-14T10:13:42.975Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:06:59.346Z",
    "updatedAt": "2025-12-14T08:54:38.183Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40939528",
      "DOI": "https://doi.org/10.1016/j.parkreldis.2025.108019",
      "special_case": "No",
      "Country_of_first_author": "Italy",
      "Country_of_occurrence": "Italy",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: The study enrolled 40 people with Parkinson's disease (pwPD) experiencing motor fluctuations. These individuals were started on selegiline, rasagiline, safinamide, or opicapone as add-on therapies to levodopa. Pain thresholds were assessed at baseline, 3 months, and 6 months. Normative data were collected from 11 healthy subjects for comparison. The study focused on motor impairment, pain perception, mood, fatigue, sleep, and quality of life (QOL). Pain was more frequent in women and associated with anxiety, poor sleep, and motor complications.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: selegiline, rasagiline, safinamide, opicapone",
      "Attributability": "Attributability: Pain thresholds and tolerance improved significantly with rasagiline and safinamide compared to opicapone. Experiencing pain was associated with anxiety, poor sleep, and motor complications. MAO-B inhibitors, particularly safinamide and rasagiline, were identified as modulators of pain processing.",
      "Drug_effect": "Drug effect: Rasagiline and safinamide significantly improved pain thresholds and tolerance, restoring pain thresholds and improving QOL.",
      "Summary": "This prospective cohort study aimed to evaluate the effect of MAO-B and COMT inhibitors, including rasagiline, as add-on therapies to levodopa on pain thresholds in people with Parkinson's disease (pwPD) experiencing motor fluctuations. Forty pwPD were enrolled, and their pain thresholds were assessed at baseline, 3 months, and 6 months. Normative data from 11 healthy subjects were used for comparison. The study revealed that pwPD had altered pain processing, with higher tactile thresholds and lower pain and pain tolerance thresholds compared to controls. Rasagiline and safinamide significantly improved pain thresholds and tolerance at 6 months, outperforming opicapone. Pain was more frequent in women and associated with anxiety, poor sleep, and motor complications. Regression analyses identified cognitive status, sex, disease duration, age, anxiety levels, and treatment with MAO-B inhibitors as key modulators of pain processing. The study concluded that MAO-B inhibitors, particularly safinamide and rasagiline, restore pain thresholds and improve QOL, supporting their role in managing pain in PD.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article comments positively on the effect of MAO-B inhibitors, particularly safinamide and rasagiline, in restoring pain thresholds and improving QOL in people with Parkinson's disease.",
      "Adverse_event": "No AE",
      "Abstract": "Pain is a common and often underestimated non-motor symptom in Parkinson's disease (PD), affecting quality of life (QOL) and frequently associated with motor fluctuations. Although the pathophysiological mechanisms underlying pain in PD remain unclear, most hypothesize the involvement of dopaminergic and non-dopaminergic pathways.\n\nTo evaluate the effect of MAO-B and COMT inhibitors, used as add-on therapies to levodopa, on pain thresholds in people with PD (pwPD) with motor fluctuations, either with or without pain.\n\nThis prospective cohort study enrolled 40 pwPD with motor fluctuations who were started on selegiline, rasagiline, safinamide, or opicapone. Pain thresholds (tactile, pain, and tolerance) were assessed using electrical stimulation at baseline and after 3 and 6 months. Normative data were collected from 11 healthy subjects. Outcome measures in pwPD targeted motor impairment (UPDRS), pain perception (King's PD Pain Scale), mood, fatigue, sleep, and QOL.\n\nPwPD showed higher tactile thresholds and lower pain and pain tolerance thresholds than controls. At 6 months, both rasagiline and safinamide significantly improved pain thresholds and tolerance compared to opicapone. Experiencing pain was more frequent in women and was associated with anxiety, poor sleep, and motor complications. Regression analyses revealed that cognitive status, sex, disease duration, age, anxiety levels and treatment with MAO-B inhibitors were key modulators of pain processing.\n\nPain processing is altered in pwPD, independently of subjective pain complaints. MAO-B inhibitors, particularly safinamide and rasagiline, appear to restore pain thresholds and improve QOL, supporting their role in managing pain in PD.",
      "Title": "Add-on therapies to levodopa improve pain modulation in Parkinson's disease with motor fluctuations: A prospective cohort study.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "RASAGILINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:36:55",
      "Vancouver_citation": "Andrenelli E, Baldini N, Barbini FA, Benedetti M, Brambatti J, Capecci M, Ceravolo MG. Add-on therapies to levodopa improve pain modulation in Parkinson's disease with motor fluctuations: A prospective cohort study. Parkinsonism Relat Disord. 2025;140108019",
      "pubdate": "2025-09-13",
      "Lead_author": "Andrenelli E",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study were 40 people with Parkinson's disease (pwPD) experiencing motor fluctuations. Additionally, 11 healthy subjects were included for normative data comparison.",
      "AOI_drug_effect": "The drug of study, rasagiline, had an effect on the test subjects. It significantly improved pain thresholds and tolerance in pwPD after 6 months of treatment, compared to opicapone.",
      "Approved_indication": "The drug of study, rasagiline, is conventionally used for the treatment of Parkinson's disease (PD). In this study, it was administered as an add-on therapy to levodopa for pwPD with motor fluctuations, aiming to manage pain thresholds and improve quality of life. This use aligns with its conventional application and does not qualify as off-label use.",
      "AOI_classification": "No",
      "Justification": "The study does not link rasagiline to any adverse effects or negative outcomes. It was used conventionally and demonstrated beneficial effects on pain thresholds and quality of life in pwPD.",
      "Client_name": "Demo",
      "Drugname": "RASAGILINE"
    },
    "doi": "https://doi.org/10.1016/j.parkreldis.2025.108019",
    "specialCase": "No",
    "countryOfFirstAuthor": "Italy",
    "countryOfOccurrence": "Italy",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: The study enrolled 40 people with Parkinson's disease (pwPD) experiencing motor fluctuations. These individuals were started on selegiline, rasagiline, safinamide, or opicapone as add-on therapies to levodopa. Pain thresholds were assessed at baseline, 3 months, and 6 months. Normative data were collected from 11 healthy subjects for comparison. The study focused on motor impairment, pain perception, mood, fatigue, sleep, and quality of life (QOL). Pain was more frequent in women and associated with anxiety, poor sleep, and motor complications.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: selegiline",
      "rasagiline",
      "safinamide",
      "opicapone"
    ],
    "attributability": "Attributability: Pain thresholds and tolerance improved significantly with rasagiline and safinamide compared to opicapone. Experiencing pain was associated with anxiety, poor sleep, and motor complications. MAO-B inhibitors, particularly safinamide and rasagiline, were identified as modulators of pain processing.",
    "drugEffect": "Drug effect: Rasagiline and safinamide significantly improved pain thresholds and tolerance, restoring pain thresholds and improving QOL.",
    "summary": "This prospective cohort study aimed to evaluate the effect of MAO-B and COMT inhibitors, including rasagiline, as add-on therapies to levodopa on pain thresholds in people with Parkinson's disease (pwPD) experiencing motor fluctuations. Forty pwPD were enrolled, and their pain thresholds were assessed at baseline, 3 months, and 6 months. Normative data from 11 healthy subjects were used for comparison. The study revealed that pwPD had altered pain processing, with higher tactile thresholds and lower pain and pain tolerance thresholds compared to controls. Rasagiline and safinamide significantly improved pain thresholds and tolerance at 6 months, outperforming opicapone. Pain was more frequent in women and associated with anxiety, poor sleep, and motor complications. Regression analyses identified cognitive status, sex, disease duration, age, anxiety levels, and treatment with MAO-B inhibitors as key modulators of pain processing. The study concluded that MAO-B inhibitors, particularly safinamide and rasagiline, restore pain thresholds and improve QOL, supporting their role in managing pain in PD.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article comments positively on the effect of MAO-B inhibitors, particularly safinamide and rasagiline, in restoring pain thresholds and improving QOL in people with Parkinson's disease.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "RASAGILINE",
    "vancouverCitation": "Andrenelli E, Baldini N, Barbini FA, Benedetti M, Brambatti J, Capecci M, Ceravolo MG. Add-on therapies to levodopa improve pain modulation in Parkinson's disease with motor fluctuations: A prospective cohort study. Parkinsonism Relat Disord. 2025;140108019",
    "leadAuthor": "Andrenelli E",
    "serious": "No",
    "testSubject": "The test subjects involved in this study were 40 people with Parkinson's disease (pwPD) experiencing motor fluctuations. Additionally, 11 healthy subjects were included for normative data comparison.",
    "aoiDrugEffect": "The drug of study, rasagiline, had an effect on the test subjects. It significantly improved pain thresholds and tolerance in pwPD after 6 months of treatment, compared to opicapone.",
    "approvedIndication": "The drug of study, rasagiline, is conventionally used for the treatment of Parkinson's disease (PD). In this study, it was administered as an add-on therapy to levodopa for pwPD with motor fluctuations, aiming to manage pain thresholds and improve quality of life. This use aligns with its conventional application and does not qualify as off-label use.",
    "aoiClassification": "No",
    "justification": "The study does not link rasagiline to any adverse effects or negative outcomes. It was used conventionally and demonstrated beneficial effects on pain thresholds and quality of life in pwPD.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi0CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi0CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-534ef00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707223
  },
  {
    "id": "CLOZ_Demo_89915",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40190853",
    "title": "Antipsychotic Polypharmacy for Treatment Resistant Schizoaffective Disorder: A Case Report.",
    "authors": [
      "Moriarty SE",
      "Parhami P",
      "Parikh J",
      "Galicki L"
    ],
    "journal": "Cureus",
    "publicationDate": "2025-04-7",
    "abstract": "This case report discusses a male patient in his early 20s with treatment-resistant schizoaffective disorder and cannabis use disorder. Despite multiple trials of antipsychotics, including lithium, risperidone, olanzapine, and divalproex, the patient experienced persistent psychotic symptoms such as hyper-religiosity, hallucinations, mood lability, agitation, and aggression. Clozapine was considered but not administered due to concerns about monitoring requirements. The patient was treated with paliperidone LAI, divalproex, and haloperidol, which led to significant improvement in his symptoms. Haloperidol was introduced at a low dose and titrated to 2 mg BID, resulting in rapid symptom stabilization and reduced intensity of perceptual disturbances. The patient was discharged with a stable medication regimen, including paliperidone LAI 234 mg every four weeks, divalproex 750 mg BID, and haloperidol 2 mg BID. He did not experience any adverse effects or extrapyramidal symptoms during hospitalization. The case highlights the potential benefits of antipsychotic polypharmacy in managing treatment-resistant psychosis and emphasizes the importance of individualized treatment plans. While clozapine is often preferred for treatment-resistant schizophrenia, this case demonstrates the utility of alternative antipsychotic combinations in achieving symptom resolution. The study also discusses the challenges and limitations of antipsychotic polypharmacy, including the need for further research on safety and efficacy.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a0f42563-4fab-430e-80ea-64ef9186f95e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:38.200Z"
      },
      {
        "id": "a02dbfa8-1900-4a40-8c8d-e039246f42d4",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from cfee6e26-8bfe-4106-94b5-d3d02ba2fee8 to CLOZ_Demo_89915",
        "type": "system",
        "createdAt": "2025-12-14T10:13:43.254Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:17:59.395Z",
    "updatedAt": "2025-12-14T08:54:38.278Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40190853",
      "DOI": "https://doi.org/10.7759/cureus.80204",
      "special_case": "No",
      "Country_of_first_author": "USA",
      "Country_of_occurrence": "USA",
      "Patient_details": "Patient details: Male, early 20s, military veteran, diagnosed with schizoaffective disorder and cannabis use disorder, history of substance use, two previous psychiatric hospitalizations, family history of bipolar disorder.",
      "Key_events": "Key events: The patient presented with acute exacerbation of psychosis, including hyper-religiosity, hallucinations, mood lability, agitation, and aggression. He had previously failed multiple antipsychotic trials and was resistant to treatment. Clozapine was considered but not administered due to concerns about monitoring requirements. He was treated with paliperidone LAI, divalproex, and haloperidol, which led to marked improvement in symptoms. The patient was discharged with a stable medication regimen and plans for outpatient follow-up.",
      "Relevant_dates": "Relevant dates: September, October, November, December (hospitalizations and medication changes occurred during these months).",
      "Administered_drugs": "Administered drugs: Paliperidone LAI, divalproex, haloperidol, lithium, risperidone, olanzapine, trazodone, hydroxyzine.",
      "Attributability": "Attributability: The patient's improvement in psychotic and mood symptoms was attributed to the addition of haloperidol to his existing regimen of paliperidone LAI and divalproex. No adverse effects or extrapyramidal symptoms were reported.",
      "Drug_effect": "Drug effect: The patient exhibited marked improvement in psychotic and mood symptoms, with resolution of distressing symptoms and return to premorbid functioning. He expressed future-oriented thinking and mood stability.",
      "Summary": "This case report discusses a male patient in his early 20s with treatment-resistant schizoaffective disorder and cannabis use disorder. Despite multiple trials of antipsychotics, including lithium, risperidone, olanzapine, and divalproex, the patient experienced persistent psychotic symptoms such as hyper-religiosity, hallucinations, mood lability, agitation, and aggression. Clozapine was considered but not administered due to concerns about monitoring requirements. The patient was treated with paliperidone LAI, divalproex, and haloperidol, which led to significant improvement in his symptoms. Haloperidol was introduced at a low dose and titrated to 2 mg BID, resulting in rapid symptom stabilization and reduced intensity of perceptual disturbances. The patient was discharged with a stable medication regimen, including paliperidone LAI 234 mg every four weeks, divalproex 750 mg BID, and haloperidol 2 mg BID. He did not experience any adverse effects or extrapyramidal symptoms during hospitalization. The case highlights the potential benefits of antipsychotic polypharmacy in managing treatment-resistant psychosis and emphasizes the importance of individualized treatment plans. While clozapine is often preferred for treatment-resistant schizophrenia, this case demonstrates the utility of alternative antipsychotic combinations in achieving symptom resolution. The study also discusses the challenges and limitations of antipsychotic polypharmacy, including the need for further research on safety and efficacy.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Case Report",
      "Author_perspective": "The article comments positively on the effect of haloperidol in combination with paliperidone LAI and divalproex, noting marked improvement in the patient's psychotic and mood symptoms. It emphasizes the importance of individualized treatment plans and highlights the potential benefits of antipsychotic polypharmacy for treatment-resistant schizoaffective disorder.",
      "Adverse_event": "No AE",
      "Abstract": "This case presents a male in his early 20s with schizoaffective disorder and cannabis use disorder presenting with treatment resistance demonstrated by inadequate control of psychotic symptoms despite multiple trials of antipsychotics. The patient was experiencing positive symptoms, including hyper-religiosity, hallucinations, mood lability, agitation, and aggression. The patient and next of kin were unable to provide consent for clozapine due to concerns for monitoring requirements. The patient continued paliperidone long-acting injectable (LAI) 234 milligrams (mg) every four weeks and divalproex 750 mg twice per day (BID) and was started on haloperidol with titration to 2 mg BID. Following the addition of a second antipsychotic agent, the patient exhibited marked improvement with reduced intensity of perceptual disturbances. This case underscores the potential benefits and challenges of antipsychotic polypharmacy in addressing residual psychosis and improving functional outcomes. We also provide an overview of available evidence for and against antipsychotic polypharmacy, defined as two or more antipsychotic medications used in a patient concurrently, as well as alternative non-antipsychotic agents for treatment-resistant schizophrenia.",
      "Title": "Antipsychotic Polypharmacy for Treatment Resistant Schizoaffective Disorder: A Case Report.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:43:24",
      "Vancouver_citation": "Moriarty SE, Parhami P, Parikh J, Galicki L. Antipsychotic Polypharmacy for Treatment Resistant Schizoaffective Disorder: A Case Report. Cureus. 2025;17(3):e80204",
      "pubdate": "2025-04-7",
      "Lead_author": "Moriarty SE",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. It is administered orally and requires monitoring due to potential severe side effects. In this study, Clozapine was not administered to the patient due to concerns about monitoring requirements. The patient was treated with other antipsychotics and anticonvulsants instead. Therefore, Clozapine was not used in a non-conventional or off-label manner in this study.",
      "AOI_classification": "No",
      "Justification": "Clozapine was not administered in this study, and no adverse effects or negative outcomes related to its use were reported.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.7759/cureus.80204",
    "specialCase": "No",
    "countryOfFirstAuthor": "USA",
    "countryOfOccurrence": "USA",
    "patientDetails": "Patient details: Male, early 20s, military veteran, diagnosed with schizoaffective disorder and cannabis use disorder, history of substance use, two previous psychiatric hospitalizations, family history of bipolar disorder.",
    "keyEvents": "Key events: The patient presented with acute exacerbation of psychosis, including hyper-religiosity, hallucinations, mood lability, agitation, and aggression. He had previously failed multiple antipsychotic trials and was resistant to treatment. Clozapine was considered but not administered due to concerns about monitoring requirements. He was treated with paliperidone LAI, divalproex, and haloperidol, which led to marked improvement in symptoms. The patient was discharged with a stable medication regimen and plans for outpatient follow-up.",
    "relevantDates": "Relevant dates: September, October, November, December (hospitalizations and medication changes occurred during these months).",
    "administeredDrugs": [
      "Administered drugs: Paliperidone LAI",
      "divalproex",
      "haloperidol",
      "lithium",
      "risperidone",
      "olanzapine",
      "trazodone",
      "hydroxyzine."
    ],
    "attributability": "Attributability: The patient's improvement in psychotic and mood symptoms was attributed to the addition of haloperidol to his existing regimen of paliperidone LAI and divalproex. No adverse effects or extrapyramidal symptoms were reported.",
    "drugEffect": "Drug effect: The patient exhibited marked improvement in psychotic and mood symptoms, with resolution of distressing symptoms and return to premorbid functioning. He expressed future-oriented thinking and mood stability.",
    "summary": "This case report discusses a male patient in his early 20s with treatment-resistant schizoaffective disorder and cannabis use disorder. Despite multiple trials of antipsychotics, including lithium, risperidone, olanzapine, and divalproex, the patient experienced persistent psychotic symptoms such as hyper-religiosity, hallucinations, mood lability, agitation, and aggression. Clozapine was considered but not administered due to concerns about monitoring requirements. The patient was treated with paliperidone LAI, divalproex, and haloperidol, which led to significant improvement in his symptoms. Haloperidol was introduced at a low dose and titrated to 2 mg BID, resulting in rapid symptom stabilization and reduced intensity of perceptual disturbances. The patient was discharged with a stable medication regimen, including paliperidone LAI 234 mg every four weeks, divalproex 750 mg BID, and haloperidol 2 mg BID. He did not experience any adverse effects or extrapyramidal symptoms during hospitalization. The case highlights the potential benefits of antipsychotic polypharmacy in managing treatment-resistant psychosis and emphasizes the importance of individualized treatment plans. While clozapine is often preferred for treatment-resistant schizophrenia, this case demonstrates the utility of alternative antipsychotic combinations in achieving symptom resolution. The study also discusses the challenges and limitations of antipsychotic polypharmacy, including the need for further research on safety and efficacy.",
    "identifiableHumanSubject": "Yes",
    "textType": "Case Report",
    "authorPerspective": "The article comments positively on the effect of haloperidol in combination with paliperidone LAI and divalproex, noting marked improvement in the patient's psychotic and mood symptoms. It emphasizes the importance of individualized treatment plans and highlights the potential benefits of antipsychotic polypharmacy for treatment-resistant schizoaffective disorder.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Moriarty SE, Parhami P, Parikh J, Galicki L. Antipsychotic Polypharmacy for Treatment Resistant Schizoaffective Disorder: A Case Report. Cureus. 2025;17(3):e80204",
    "leadAuthor": "Moriarty SE",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. It is administered orally and requires monitoring due to potential severe side effects. In this study, Clozapine was not administered to the patient due to concerns about monitoring requirements. The patient was treated with other antipsychotics and anticonvulsants instead. Therefore, Clozapine was not used in a non-conventional or off-label manner in this study.",
    "aoiClassification": "No",
    "justification": "Clozapine was not administered in this study, and no adverse effects or negative outcomes related to its use were reported.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi1CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi1CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-5371d40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707223
  },
  {
    "id": "CLOZ_Demo_68337",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40151211",
    "title": "Acute exposure to clozapine and sodium valproate impairs oxidative phosphorylation in human cardiac mitochondria.",
    "authors": [
      "Groenewald A",
      "Burns KE",
      "Tingle MD",
      "Ward ML",
      "Power AS"
    ],
    "journal": "Toxicol Rep",
    "publicationDate": "2025-03-28",
    "abstract": "This study investigated the acute effects of Clozapine (CLZ) and Sodium Valproate (VPA) on human cardiac mitochondria, focusing on their role in cardiotoxicity. Tissue samples from 24 consenting patients undergoing coronary artery bypass grafting were used to assess mitochondrial O2 consumption via high-resolution respirometry. Results showed that CLZ exposure decreased mitochondrial O2 consumption by 32% during complex I- and II-linked oxidative phosphorylation, while VPA exposure reduced it by 25% and 31% in combined CI+II- and CII-linked pathways, respectively. Combined exposure to CLZ and VPA caused similar reductions in O2 consumption, with a 25% decrease in combined CI+II-linked respiration and a 34% decrease in CII-linked respiration. The study highlighted that CLZ-induced cardiotoxicity may stem from mitochondrial dysfunction, with VPA potentially exacerbating these effects. The findings suggest that CLZ impairs oxidative phosphorylation without affecting mitochondrial coupling, possibly through direct inhibition of respiratory complexes or upstream enzymes. VPA's effects on mitochondrial function were also significant, though its role in exacerbating CLZ-induced cardiotoxicity remains unclear. The study emphasizes the need for further research into the mechanisms of CLZ and VPA-induced mitochondrial dysfunction to improve diagnostic and treatment guidelines for cardiotoxicity associated with these drugs.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Clozapine and Sodium Valproate exposure caused mitochondrial dysfunction, reducing O2 consumption during oxidative phosphorylation. No specific adverse events such as death or drug toxicity were reported, but the study highlights the cardiotoxic potential of these drugs.",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "5f7c0199-0fe7-4da4-a4df-c811d8517d57",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:38.306Z"
      },
      {
        "id": "46bed9bc-527b-4769-b8e3-57abf9c72e5f",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from fef72224-8935-4004-ae5b-3da90af54799 to CLOZ_Demo_68337",
        "type": "system",
        "createdAt": "2025-12-14T10:13:43.504Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:17:59.442Z",
    "updatedAt": "2025-12-14T08:54:38.314Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40151211",
      "DOI": "https://doi.org/10.1016/j.toxrep.2025.101990",
      "special_case": "No",
      "Country_of_first_author": "New Zealand",
      "Country_of_occurrence": "New Zealand",
      "Patient_details": "Patient details: 24 patients, average age 67 ± 9 years, BMI 27.90 ± 4.84 kg/m², mostly male (20/24), predominantly of European ethnicity (15/24), with 10/24 diagnosed with Type 2 Diabetes. None were prescribed Clozapine or Sodium Valproate.",
      "Key_events": "Key events: Tissue samples were collected from consenting patients undergoing coronary artery bypass grafting at Auckland City Hospital. The study investigated the acute effects of Clozapine and Sodium Valproate on mitochondrial function in human cardiac tissue using high-resolution respirometry.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Clozapine, Sodium Valproate",
      "Attributability": "Attributability: Clozapine and Sodium Valproate exposure were associated with decreased mitochondrial O2 consumption during oxidative phosphorylation, indicating bioenergetic dysfunction. Clozapine impaired OXPHOS through complexes I and II, while Sodium Valproate affected complex II and combined CI+II-linked respiration. Combined exposure to both drugs showed similar effects.",
      "Drug_effect": "Drug effect: Clozapine and Sodium Valproate caused significant mitochondrial dysfunction, reducing O2 consumption during oxidative phosphorylation. No recovery or other effects were mentioned.",
      "Summary": "This study investigated the acute effects of Clozapine (CLZ) and Sodium Valproate (VPA) on human cardiac mitochondria, focusing on their role in cardiotoxicity. Tissue samples from 24 consenting patients undergoing coronary artery bypass grafting were used to assess mitochondrial O2 consumption via high-resolution respirometry. Results showed that CLZ exposure decreased mitochondrial O2 consumption by 32% during complex I- and II-linked oxidative phosphorylation, while VPA exposure reduced it by 25% and 31% in combined CI+II- and CII-linked pathways, respectively. Combined exposure to CLZ and VPA caused similar reductions in O2 consumption, with a 25% decrease in combined CI+II-linked respiration and a 34% decrease in CII-linked respiration. The study highlighted that CLZ-induced cardiotoxicity may stem from mitochondrial dysfunction, with VPA potentially exacerbating these effects. The findings suggest that CLZ impairs oxidative phosphorylation without affecting mitochondrial coupling, possibly through direct inhibition of respiratory complexes or upstream enzymes. VPA's effects on mitochondrial function were also significant, though its role in exacerbating CLZ-induced cardiotoxicity remains unclear. The study emphasizes the need for further research into the mechanisms of CLZ and VPA-induced mitochondrial dysfunction to improve diagnostic and treatment guidelines for cardiotoxicity associated with these drugs.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article comments on the significant mitochondrial dysfunction caused by Clozapine and Sodium Valproate, suggesting their role in cardiotoxicity. It emphasizes the need for further research to understand the mechanisms and improve treatment guidelines.",
      "Adverse_event": "Clozapine and Sodium Valproate exposure caused mitochondrial dysfunction, reducing O2 consumption during oxidative phosphorylation. No specific adverse events such as death or drug toxicity were reported, but the study highlights the cardiotoxic potential of these drugs.",
      "Abstract": "The only antipsychotic that is approved and recommended for the treatment of otherwise treatment-resistant schizophrenia is clozapine (CLZ). Unfortunately, CLZ can cause serious cardiotoxicities such as myocarditis and cardiomyopathy. The co-administration of sodium valproate (VPA) during initiation is a well-established risk factor for the development of CLZ-induced myocarditis. However, the mechanisms behind these cardiac adverse effects and the role of VPA co-administration are not understood. Preliminary evidence for the development of cardiac mitochondrial dysfunction has previously been reported in both rodent models and immortalised cell lines. This investigation aimed to determine the functional effects of CLZ and VPA on human cardiac mitochondria to improve the current understanding of how cardiotoxicity develops. Small samples of human atrial tissue from consenting patients undergoing a coronary artery bypass grafting procedure were freshly collected and utilised to investigate the acute effects of each drug on mitochondrial O<sub>2</sub> consumption using high-resolution respirometry. Both drugs significantly decreased mitochondrial O<sub>2</sub> consumption by a magnitude of 32 % following CLZ exposure, 25 % following VPA exposure, and 25 % following combined CLZ+VPA exposure during complex I- and II-linked oxidative phosphorylation. These results demonstrate acute bioenergetic dysfunction with exposure to both drugs, alone and in combination. We propose that cardiac mitochondria become a key focus in future research seeking to improve the risk-predictive, diagnostic, and treatment guidelines surrounding CLZ-induced cardiotoxicity.",
      "Title": "Acute exposure to clozapine and sodium valproate impairs oxidative phosphorylation in human cardiac mitochondria.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:43:57",
      "Vancouver_citation": "Groenewald A, Burns KE, Tingle MD, Ward ML, Power AS. Acute exposure to clozapine and sodium valproate impairs oxidative phosphorylation in human cardiac mitochondria. Toxicol Rep. 2025;14101990",
      "pubdate": "2025-03-28",
      "Lead_author": "Groenewald A",
      "Serious": "No",
      "Test_subject": "The test subject involved in this study is human cardiac tissue samples obtained from consenting patients undergoing coronary artery bypass grafting procedures. These tissue samples were used to investigate the acute effects of clozapine and sodium valproate on mitochondrial function.",
      "AOI_drug_effect": "The drug of study, clozapine, had a significant effect on the test subject. It impaired oxidative phosphorylation in human cardiac mitochondria, decreasing oxygen consumption during complex I- and II-linked oxidative phosphorylation by 32%. This indicates acute bioenergetic dysfunction caused by the drug.",
      "Approved_indication": "Clozapine is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. It is administered orally to patients with these conditions. In this study, clozapine was used in an experimental setting to investigate its acute effects on human cardiac tissue samples, which is a non-conventional use and qualifies as off-label use.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study links clozapine to cardiotoxic effects, specifically mitochondrial dysfunction in human cardiac tissue, and investigates its role in the development of adverse cardiac events. Additionally, the drug was used in a non-conventional way.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1016/j.toxrep.2025.101990",
    "specialCase": "No",
    "countryOfFirstAuthor": "New Zealand",
    "countryOfOccurrence": "New Zealand",
    "patientDetails": "Patient details: 24 patients, average age 67 ± 9 years, BMI 27.90 ± 4.84 kg/m², mostly male (20/24), predominantly of European ethnicity (15/24), with 10/24 diagnosed with Type 2 Diabetes. None were prescribed Clozapine or Sodium Valproate.",
    "keyEvents": "Key events: Tissue samples were collected from consenting patients undergoing coronary artery bypass grafting at Auckland City Hospital. The study investigated the acute effects of Clozapine and Sodium Valproate on mitochondrial function in human cardiac tissue using high-resolution respirometry.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Clozapine",
      "Sodium Valproate"
    ],
    "attributability": "Attributability: Clozapine and Sodium Valproate exposure were associated with decreased mitochondrial O2 consumption during oxidative phosphorylation, indicating bioenergetic dysfunction. Clozapine impaired OXPHOS through complexes I and II, while Sodium Valproate affected complex II and combined CI+II-linked respiration. Combined exposure to both drugs showed similar effects.",
    "drugEffect": "Drug effect: Clozapine and Sodium Valproate caused significant mitochondrial dysfunction, reducing O2 consumption during oxidative phosphorylation. No recovery or other effects were mentioned.",
    "summary": "This study investigated the acute effects of Clozapine (CLZ) and Sodium Valproate (VPA) on human cardiac mitochondria, focusing on their role in cardiotoxicity. Tissue samples from 24 consenting patients undergoing coronary artery bypass grafting were used to assess mitochondrial O2 consumption via high-resolution respirometry. Results showed that CLZ exposure decreased mitochondrial O2 consumption by 32% during complex I- and II-linked oxidative phosphorylation, while VPA exposure reduced it by 25% and 31% in combined CI+II- and CII-linked pathways, respectively. Combined exposure to CLZ and VPA caused similar reductions in O2 consumption, with a 25% decrease in combined CI+II-linked respiration and a 34% decrease in CII-linked respiration. The study highlighted that CLZ-induced cardiotoxicity may stem from mitochondrial dysfunction, with VPA potentially exacerbating these effects. The findings suggest that CLZ impairs oxidative phosphorylation without affecting mitochondrial coupling, possibly through direct inhibition of respiratory complexes or upstream enzymes. VPA's effects on mitochondrial function were also significant, though its role in exacerbating CLZ-induced cardiotoxicity remains unclear. The study emphasizes the need for further research into the mechanisms of CLZ and VPA-induced mitochondrial dysfunction to improve diagnostic and treatment guidelines for cardiotoxicity associated with these drugs.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article comments on the significant mitochondrial dysfunction caused by Clozapine and Sodium Valproate, suggesting their role in cardiotoxicity. It emphasizes the need for further research to understand the mechanisms and improve treatment guidelines.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Groenewald A, Burns KE, Tingle MD, Ward ML, Power AS. Acute exposure to clozapine and sodium valproate impairs oxidative phosphorylation in human cardiac mitochondria. Toxicol Rep. 2025;14101990",
    "leadAuthor": "Groenewald A",
    "serious": "No",
    "testSubject": "The test subject involved in this study is human cardiac tissue samples obtained from consenting patients undergoing coronary artery bypass grafting procedures. These tissue samples were used to investigate the acute effects of clozapine and sodium valproate on mitochondrial function.",
    "aoiDrugEffect": "The drug of study, clozapine, had a significant effect on the test subject. It impaired oxidative phosphorylation in human cardiac mitochondria, decreasing oxygen consumption during complex I- and II-linked oxidative phosphorylation by 32%. This indicates acute bioenergetic dysfunction caused by the drug.",
    "approvedIndication": "Clozapine is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. It is administered orally to patients with these conditions. In this study, clozapine was used in an experimental setting to investigate its acute effects on human cardiac tissue samples, which is a non-conventional use and qualifies as off-label use.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The study links clozapine to cardiotoxic effects, specifically mitochondrial dysfunction in human cardiac tissue, and investigates its role in the development of adverse cardiac events. Additionally, the drug was used in a non-conventional way.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi2CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi2CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-5397dc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707223
  },
  {
    "id": "CLOZ_Demo_92209",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40123570",
    "title": "Hippocampal Inhibitory Interneuron-Specific DREADDs Treatment Alters mTORC1-4E-BP Signaling and Impairs Memory Formation.",
    "authors": [
      "Huang Z",
      "Mahmood N",
      "Lacaille JC",
      "Wiebe S",
      "Sonenberg N"
    ],
    "journal": "J Neurochem",
    "publicationDate": "2025-03-24",
    "abstract": "The study investigates the role of mTORC1 signaling in memory formation, focusing on hippocampal inhibitory and excitatory neurons in mice. Using Designer Receptors Exclusively Activated by Designer Drugs (DREADDs), the researchers modulated neuronal activity through synthetic agonist Clozapine-N-oxide (CNO). The findings revealed that activation or inhibition of mTORC1 signaling in inhibitory neurons impaired long-term memory formation, as evidenced by changes in phosphorylation of downstream targets like 4E-BP1/2 and S6. However, similar modulation in excitatory neurons did not affect memory formation, highlighting the cell-type-specific role of mTORC1 signaling. The study underscores the importance of precise timing and activity-dependent regulation of mTORC1 signaling in inhibitory neurons for memory processes. While the study does not involve human subjects, it provides insights into potential therapeutic strategies for neurological disorders linked to dysregulated mTORC1 signaling, such as Alzheimer's disease and epilepsy. Clozapine-N-oxide was used to activate DREADDs, enabling spatiotemporal control of neuronal activity, which disrupted memory formation in inhibitory neurons but not in excitatory neurons.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9b8d8990-b7f7-400d-9cd5-38191057d2c2",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:38.338Z"
      },
      {
        "id": "33f5d830-6a0c-4996-a377-79a04e902bfe",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6fd7f900-6b61-40ea-b47b-3ffb288d8585 to CLOZ_Demo_92209",
        "type": "system",
        "createdAt": "2025-12-14T10:13:43.718Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:17:59.480Z",
    "updatedAt": "2025-12-14T08:54:38.400Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40123570",
      "DOI": "https://doi.org/10.1111/jnc.70048",
      "special_case": "No",
      "Country_of_first_author": "Canada",
      "Country_of_occurrence": "Canada",
      "Patient_details": "No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Clozapine-N-oxide",
      "Attributability": "Attributability: Not applicable",
      "Drug_effect": "Drug effect: summary: Clozapine-N-oxide was used as a synthetic agonist for DREADDs to modulate neuronal activity, impacting mTORC1 signaling and memory formation in mice.",
      "Summary": "The study investigates the role of mTORC1 signaling in memory formation, focusing on hippocampal inhibitory and excitatory neurons in mice. Using Designer Receptors Exclusively Activated by Designer Drugs (DREADDs), the researchers modulated neuronal activity through synthetic agonist Clozapine-N-oxide (CNO). The findings revealed that activation or inhibition of mTORC1 signaling in inhibitory neurons impaired long-term memory formation, as evidenced by changes in phosphorylation of downstream targets like 4E-BP1/2 and S6. However, similar modulation in excitatory neurons did not affect memory formation, highlighting the cell-type-specific role of mTORC1 signaling. The study underscores the importance of precise timing and activity-dependent regulation of mTORC1 signaling in inhibitory neurons for memory processes. While the study does not involve human subjects, it provides insights into potential therapeutic strategies for neurological disorders linked to dysregulated mTORC1 signaling, such as Alzheimer's disease and epilepsy. Clozapine-N-oxide was used to activate DREADDs, enabling spatiotemporal control of neuronal activity, which disrupted memory formation in inhibitory neurons but not in excitatory neurons.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article comments on the effect of Clozapine-N-oxide as a synthetic agonist for DREADDs, demonstrating its role in modulating mTORC1 signaling and its impact on memory formation in mice.",
      "Adverse_event": "No AE",
      "Abstract": "Control of protein synthesis via the mechanistic target of rapamycin complex 1 (mTORC1) is essential for learning and memory. However, the cell-type-specific and spatiotemporal regulation of this pathway during memory formation is not well understood. In this study, we expressed artificial human muscarinic M3 [hM3D(Gq)] or M4 [hM4D(Gi)] designer receptors exclusively activated by designer drugs (DREADDs) in hippocampal CA1 excitatory or inhibitory neurons of adult mice. We studied the impact of clozapine-N-oxide (CNO), a synthetic DREADDs agonist, on the mTORC1 pathway and long-term memory. hM3D(Gq) and hM4D(Gi) activate or inactivate, respectively, mTORC1 signaling in hippocampal interneurons, as indicated by the phosphorylation of its targets, eukaryotic initiation factor 4E-binding proteins (4E-BP1/2) and ribosomal protein S6 (S6). Activation of either hM3D(Gq) or hM4D(Gi) in mice immediately after training in memory tasks impaired long-term memory formation in inhibitory, but not in excitatory neurons. The findings underscore the importance of activity-dependent mTORC1-4E-BP1/2 signaling in hippocampal inhibitory interneurons for memory formation.",
      "Title": "Hippocampal Inhibitory Interneuron-Specific DREADDs Treatment Alters mTORC1-4E-BP Signaling and Impairs Memory Formation.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:45:06",
      "Vancouver_citation": "Huang Z, Mahmood N, Lacaille JC, Wiebe S, Sonenberg N. Hippocampal Inhibitory Interneuron-Specific DREADDs Treatment Alters mTORC1-4E-BP Signaling and Impairs Memory Formation. J Neurochem. 2025;169(3):e70048",
      "pubdate": "2025-03-24",
      "Lead_author": "Huang Z",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study are adult mice. The study utilized chemogenetic tools (DREADDs) to manipulate neuronal activity in the hippocampus of these mice. Specifically, the mice were genetically modified to express designer receptors activated by clozapine-N-oxide (CNO), a synthetic agonist, in either inhibitory or excitatory neurons.",
      "AOI_drug_effect": "The drug of study, clozapine-N-oxide (CNO), had an effect on the test subjects. It was used to activate or inhibit specific designer receptors in the hippocampal neurons of mice, which in turn modulated mTORC1 signaling pathways. This modulation disrupted long-term memory formation in inhibitory neurons but not in excitatory neurons. The study demonstrated that CNO-induced activation or inhibition of mTORC1 signaling in inhibitory neurons impaired memory tasks such as novel object location (NOL), object place learning (OPL), and novel object recognition (NOR).",
      "Approved_indication": "The drug of study, clozapine-N-oxide (CNO), is conventionally used as a synthetic agonist for designer receptors in research settings. It is not used clinically for treating illnesses but is employed in experimental studies to selectively activate or inhibit engineered receptors (DREADDs). In this study, CNO was administered intraperitoneally (i.p.) at a dose of 0.1 mg/kg to genetically modified mice expressing DREADDs in their hippocampal neurons. The drug was used to modulate neuronal activity and investigate its effects on memory formation.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study links the drug of study, clozapine-N-oxide (CNO), to negative effects on memory formation in mice. Specifically, CNO-induced activation or inhibition of mTORC1 signaling in hippocampal inhibitory neurons impaired long-term memory tasks, highlighting its role in disrupting normal neuronal function.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1111/jnc.70048",
    "specialCase": "No",
    "countryOfFirstAuthor": "Canada",
    "countryOfOccurrence": "Canada",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Clozapine-N-oxide"
    ],
    "attributability": "Attributability: Not applicable",
    "drugEffect": "Drug effect: summary: Clozapine-N-oxide was used as a synthetic agonist for DREADDs to modulate neuronal activity, impacting mTORC1 signaling and memory formation in mice.",
    "summary": "The study investigates the role of mTORC1 signaling in memory formation, focusing on hippocampal inhibitory and excitatory neurons in mice. Using Designer Receptors Exclusively Activated by Designer Drugs (DREADDs), the researchers modulated neuronal activity through synthetic agonist Clozapine-N-oxide (CNO). The findings revealed that activation or inhibition of mTORC1 signaling in inhibitory neurons impaired long-term memory formation, as evidenced by changes in phosphorylation of downstream targets like 4E-BP1/2 and S6. However, similar modulation in excitatory neurons did not affect memory formation, highlighting the cell-type-specific role of mTORC1 signaling. The study underscores the importance of precise timing and activity-dependent regulation of mTORC1 signaling in inhibitory neurons for memory processes. While the study does not involve human subjects, it provides insights into potential therapeutic strategies for neurological disorders linked to dysregulated mTORC1 signaling, such as Alzheimer's disease and epilepsy. Clozapine-N-oxide was used to activate DREADDs, enabling spatiotemporal control of neuronal activity, which disrupted memory formation in inhibitory neurons but not in excitatory neurons.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article comments on the effect of Clozapine-N-oxide as a synthetic agonist for DREADDs, demonstrating its role in modulating mTORC1 signaling and its impact on memory formation in mice.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Huang Z, Mahmood N, Lacaille JC, Wiebe S, Sonenberg N. Hippocampal Inhibitory Interneuron-Specific DREADDs Treatment Alters mTORC1-4E-BP Signaling and Impairs Memory Formation. J Neurochem. 2025;169(3):e70048",
    "leadAuthor": "Huang Z",
    "serious": "No",
    "testSubject": "The test subjects involved in this study are adult mice. The study utilized chemogenetic tools (DREADDs) to manipulate neuronal activity in the hippocampus of these mice. Specifically, the mice were genetically modified to express designer receptors activated by clozapine-N-oxide (CNO), a synthetic agonist, in either inhibitory or excitatory neurons.",
    "aoiDrugEffect": "The drug of study, clozapine-N-oxide (CNO), had an effect on the test subjects. It was used to activate or inhibit specific designer receptors in the hippocampal neurons of mice, which in turn modulated mTORC1 signaling pathways. This modulation disrupted long-term memory formation in inhibitory neurons but not in excitatory neurons. The study demonstrated that CNO-induced activation or inhibition of mTORC1 signaling in inhibitory neurons impaired memory tasks such as novel object location (NOL), object place learning (OPL), and novel object recognition (NOR).",
    "approvedIndication": "The drug of study, clozapine-N-oxide (CNO), is conventionally used as a synthetic agonist for designer receptors in research settings. It is not used clinically for treating illnesses but is employed in experimental studies to selectively activate or inhibit engineered receptors (DREADDs). In this study, CNO was administered intraperitoneally (i.p.) at a dose of 0.1 mg/kg to genetically modified mice expressing DREADDs in their hippocampal neurons. The drug was used to modulate neuronal activity and investigate its effects on memory formation.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The study links the drug of study, clozapine-N-oxide (CNO), to negative effects on memory formation in mice. Specifically, CNO-induced activation or inhibition of mTORC1 signaling in hippocampal inhibitory neurons impaired long-term memory tasks, highlighting its role in disrupting normal neuronal function.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi3CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi3CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-53bdd40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707223
  },
  {
    "id": "CLOZ_Demo_38754",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40060028",
    "title": "Optimal Treatment of Magnetic Seizure Therapy (MST) in Patients with Clozapine-Resistant Schizophrenia (CRS).",
    "authors": [
      "Xiang Q",
      "Xu P",
      "Zhai Z",
      "Jia Y",
      "Li C",
      "Liu D"
    ],
    "journal": "Neuropsychiatr Dis Treat",
    "publicationDate": "2025-03-10",
    "abstract": "The study focused on evaluating the efficacy and cognitive side effects of magnetic seizure therapy (MST) and modified electroconvulsive therapy (MECT) in patients with clozapine-resistant schizophrenia (CRS). Sixteen patients were randomized to receive either MST or MECT as add-on therapy to clozapine treatment, with 10 sessions conducted over 4 weeks. Clozapine doses were maintained between 300–600 mg/day throughout the study. Both MST and MECT significantly improved positive symptoms of schizophrenia, as measured by PANSS scores, with MST showing greater efficacy in reducing negative symptoms compared to MECT. Cognitive assessments revealed negligible adverse effects for both treatments, with MST demonstrating less impact on immediate memory than MECT. No serious adverse events were reported, and minor side effects such as headache or dizziness resolved within hours. The study concluded that MST is a promising alternative to MECT for CRS, with comparable efficacy and fewer cognitive side effects. Further research in larger clinical populations is recommended to validate these findings.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Two patients reported minor adverse reactions, including headache and dizziness, which resolved within hours. No serious adverse events, drug toxicity, or detrimental effects were observed.",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "c6ede278-c824-4a61-a117-283a83b9a415",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:38.413Z"
      },
      {
        "id": "9cf8a23d-b4b2-4942-8343-86c086296e72",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 73b0699f-8151-4f88-a316-4e1f91007720 to CLOZ_Demo_38754",
        "type": "system",
        "createdAt": "2025-12-14T10:13:43.949Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:17:59.511Z",
    "updatedAt": "2025-12-14T08:54:38.446Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40060028",
      "DOI": "https://doi.org/10.2147/NDT.S497725",
      "special_case": "No",
      "Country_of_first_author": "China",
      "Country_of_occurrence": "China",
      "Patient_details": "Patient details: Sixteen patients with clozapine-resistant schizophrenia (CRS) were enrolled in the study. Inclusion criteria included ages 18–55, DSM-5 diagnosis of schizophrenia, failure to respond to ≥2 adequate trials of first-line antipsychotic medication, persistence of moderate symptoms after clozapine trial, and specific PANSS scale scores. Exclusion criteria included severe physical disease, substance abuse, pregnancy, implants, recent MECT, or depressive symptoms.",
      "Key_events": "Key events: Patients were randomized into two groups to receive either magnetic seizure therapy (MST) or modified electroconvulsive therapy (MECT) as add-on therapy to clozapine treatment. Each group underwent 10 sessions over 4 weeks, with follow-up assessments at 4 and 8 weeks. The study aimed to evaluate clinical efficacy and cognitive side effects of MST and MECT in CRS patients.",
      "Relevant_dates": "Relevant dates: \n- Study approval: 2016\n- Publication date: 05/Mar/2025\n- Follow-up assessments: 4 weeks and 8 weeks after treatment initiation",
      "Administered_drugs": "Administered drugs: Clozapine, atropine, etomidate, propofol, succinylcholine",
      "Attributability": "Attributability: MST and MECT were associated with significant improvements in positive symptoms of schizophrenia. MST showed greater efficacy in reducing negative symptoms compared to MECT. Both treatments demonstrated negligible cognitive side effects, with MST having less impact on immediate memory than MECT. No serious adverse events were reported.",
      "Drug_effect": "Drug effect: summary: Clozapine combined with MST or MECT improved positive symptoms of CRS. MST was more effective in reducing negative symptoms and had fewer cognitive side effects compared to MECT.",
      "Summary": "The study focused on evaluating the efficacy and cognitive side effects of magnetic seizure therapy (MST) and modified electroconvulsive therapy (MECT) in patients with clozapine-resistant schizophrenia (CRS). Sixteen patients were randomized to receive either MST or MECT as add-on therapy to clozapine treatment, with 10 sessions conducted over 4 weeks. Clozapine doses were maintained between 300–600 mg/day throughout the study. Both MST and MECT significantly improved positive symptoms of schizophrenia, as measured by PANSS scores, with MST showing greater efficacy in reducing negative symptoms compared to MECT. Cognitive assessments revealed negligible adverse effects for both treatments, with MST demonstrating less impact on immediate memory than MECT. No serious adverse events were reported, and minor side effects such as headache or dizziness resolved within hours. The study concluded that MST is a promising alternative to MECT for CRS, with comparable efficacy and fewer cognitive side effects. Further research in larger clinical populations is recommended to validate these findings.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article comments positively on the efficacy of MST and MECT in improving positive symptoms of CRS, with MST showing unique advantages in reducing negative symptoms and having fewer cognitive side effects compared to MECT. The study suggests MST as a promising alternative to MECT for CRS patients.",
      "Adverse_event": "Two patients reported minor adverse reactions, including headache and dizziness, which resolved within hours. No serious adverse events, drug toxicity, or detrimental effects were observed.",
      "Abstract": "The study aims to compare the clinical efficacy and cognitive side effect of magnetic seizure therapy (MST) and modified electroconvulsive therapy (MECT) on clozapine resistant schizophrenia (CRS).\n\nSixteen patients with CRS were enrolled in this randomized, parallel-group, controlled clinical trial. Patients were randomly allocated to receive 10 sessions of add-on MST or MECT over 4 weeks (1:1 ratio) and continued clozapine therapy during the study. Efficacy and neurocognition were assessed at baseline, 4-week and 8-week follow-up.\n\n(1) Clinical efficacy: MST significantly improved symptoms of schizophrenia from baseline to 4 weeks, as shown in PANSS total (p = 0.009), PANSS positive (p = 0.026), PANSS negative (p = 0.031) and PANSS general psychopathology (p = 0.023); we also observed significant reductions in PANSS total (p = 0.049) and PANSS positive (p = 0.037) at 8-week follow-up. MECT group also witnessed clinical improvement from baseline to 4-week in PANSS total (p = 0.035) and PANSS positive (p = 0.001); significant reduction in PANSS positive was also observed at 8-week follow-up (p = 0.041). From baseline to 8 weeks, PANSS negative had greater reduction in MST group compared with MECT group (p = 0.042). (2) Neurocognition: Pre-and post-treatment data showed no significant cognitive adverse effects in both groups. Immediate memory is better in patients who received MST than MECT at 4-week follow-up (p = 0.030).\n\nIn this pilot study, MST and MECT equally improved positive symptoms of CRS, while MST was more effective in relieving negative symptoms. Evidence showed negligible cognitive side effects in MST, with less adverse effect on immediate memory than MECT. As a promising alternative to MECT, MST requires further research in larger clinical population.",
      "Title": "Optimal Treatment of Magnetic Seizure Therapy (MST) in Patients with Clozapine-Resistant Schizophrenia (CRS).",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:44:19",
      "Vancouver_citation": "Xiang Q, Xu P, Zhai Z, Jia Y, Li C, Liu D. Optimal Treatment of Magnetic Seizure Therapy (MST) in Patients with Clozapine-Resistant Schizophrenia (CRS). Neuropsychiatr Dis Treat. 2025;21491-501",
      "pubdate": "2025-03-10",
      "Lead_author": "Xiang Q",
      "Serious": "No",
      "Test_subject": "Sixteen patients with clozapine-resistant schizophrenia (CRS) were involved in this study. These patients were exposed to the drug of study, Clozapine, as part of their ongoing treatment during the trial.",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, Clozapine was administered to patients with CRS, which aligns with its conventional use. The drug was not used in a non-conventional or off-label manner.",
      "AOI_classification": "No",
      "Justification": "The study does not link the drug of study to any adverse effects or negative outcomes. It focuses on the efficacy and cognitive side effects of MST and MECT in CRS patients while continuing Clozapine therapy.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.2147/NDT.S497725",
    "specialCase": "No",
    "countryOfFirstAuthor": "China",
    "countryOfOccurrence": "China",
    "patientDetails": "Patient details: Sixteen patients with clozapine-resistant schizophrenia (CRS) were enrolled in the study. Inclusion criteria included ages 18–55, DSM-5 diagnosis of schizophrenia, failure to respond to ≥2 adequate trials of first-line antipsychotic medication, persistence of moderate symptoms after clozapine trial, and specific PANSS scale scores. Exclusion criteria included severe physical disease, substance abuse, pregnancy, implants, recent MECT, or depressive symptoms.",
    "keyEvents": "Key events: Patients were randomized into two groups to receive either magnetic seizure therapy (MST) or modified electroconvulsive therapy (MECT) as add-on therapy to clozapine treatment. Each group underwent 10 sessions over 4 weeks, with follow-up assessments at 4 and 8 weeks. The study aimed to evaluate clinical efficacy and cognitive side effects of MST and MECT in CRS patients.",
    "relevantDates": "Relevant dates: \n- Study approval: 2016\n- Publication date: 05/Mar/2025\n- Follow-up assessments: 4 weeks and 8 weeks after treatment initiation",
    "administeredDrugs": [
      "Administered drugs: Clozapine",
      "atropine",
      "etomidate",
      "propofol",
      "succinylcholine"
    ],
    "attributability": "Attributability: MST and MECT were associated with significant improvements in positive symptoms of schizophrenia. MST showed greater efficacy in reducing negative symptoms compared to MECT. Both treatments demonstrated negligible cognitive side effects, with MST having less impact on immediate memory than MECT. No serious adverse events were reported.",
    "drugEffect": "Drug effect: summary: Clozapine combined with MST or MECT improved positive symptoms of CRS. MST was more effective in reducing negative symptoms and had fewer cognitive side effects compared to MECT.",
    "summary": "The study focused on evaluating the efficacy and cognitive side effects of magnetic seizure therapy (MST) and modified electroconvulsive therapy (MECT) in patients with clozapine-resistant schizophrenia (CRS). Sixteen patients were randomized to receive either MST or MECT as add-on therapy to clozapine treatment, with 10 sessions conducted over 4 weeks. Clozapine doses were maintained between 300–600 mg/day throughout the study. Both MST and MECT significantly improved positive symptoms of schizophrenia, as measured by PANSS scores, with MST showing greater efficacy in reducing negative symptoms compared to MECT. Cognitive assessments revealed negligible adverse effects for both treatments, with MST demonstrating less impact on immediate memory than MECT. No serious adverse events were reported, and minor side effects such as headache or dizziness resolved within hours. The study concluded that MST is a promising alternative to MECT for CRS, with comparable efficacy and fewer cognitive side effects. Further research in larger clinical populations is recommended to validate these findings.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article comments positively on the efficacy of MST and MECT in improving positive symptoms of CRS, with MST showing unique advantages in reducing negative symptoms and having fewer cognitive side effects compared to MECT. The study suggests MST as a promising alternative to MECT for CRS patients.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Xiang Q, Xu P, Zhai Z, Jia Y, Li C, Liu D. Optimal Treatment of Magnetic Seizure Therapy (MST) in Patients with Clozapine-Resistant Schizophrenia (CRS). Neuropsychiatr Dis Treat. 2025;21491-501",
    "leadAuthor": "Xiang Q",
    "serious": "No",
    "testSubject": "Sixteen patients with clozapine-resistant schizophrenia (CRS) were involved in this study. These patients were exposed to the drug of study, Clozapine, as part of their ongoing treatment during the trial.",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, Clozapine was administered to patients with CRS, which aligns with its conventional use. The drug was not used in a non-conventional or off-label manner.",
    "aoiClassification": "No",
    "justification": "The study does not link the drug of study to any adverse effects or negative outcomes. It focuses on the efficacy and cognitive side effects of MST and MECT in CRS patients while continuing Clozapine therapy.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi4CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi4CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-53e3c40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707224
  },
  {
    "id": "CLOZ_Demo_20515",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40037577",
    "title": "Default Mode Network, Disorganization, and Treatment-Resistant Schizophrenia.",
    "authors": [
      "Huang H",
      "Qin X",
      "Xu R",
      "Xiong Y",
      "Hao K",
      "Chen C",
      "Wan Q",
      "Liu H",
      "Yuan W",
      "Peng Y",
      "Zhou Y",
      "Wang H",
      "Palaniyappan L"
    ],
    "journal": "Schizophr Bull",
    "publicationDate": "2025-03-5",
    "abstract": "The study investigates the default mode network (DMN) in schizophrenia, focusing on treatment-resistant schizophrenia (TRS) and its relationship with disorganized thinking. Using resting-state functional magnetic resonance imaging, the researchers analyzed DMN in 48 TRS patients, 76 non-TRS patients, and 64 healthy controls. The study found that TRS patients exhibited higher spatial loading on the DMN pattern but lower entropy compared to healthy controls, indicating excessive spatial contribution and exaggerated temporal stability of the DMN. Non-TRS patients showed intermediate alterations, suggesting a continuum between TRS and non-TRS groups. The study also found that higher spatial loading of the DMN was associated with more severe disorganization in patients. These findings suggest that TRS represents the severe end of a spectrum of DMN dysfunction in schizophrenia. While the study highlights the role of DMN alterations in schizophrenia, particularly in treatment-resistant cases, it does not provide specific data on drug administration, adverse events, or the role of Clozapine in the study.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "adea20b1-74e8-4bdb-a859-be16847c3350",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:38.475Z"
      },
      {
        "id": "6c60b00b-9c56-46c2-9907-806dd1ee990a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9a4859ff-70f3-47a8-ab44-db605c97a7da to CLOZ_Demo_20515",
        "type": "system",
        "createdAt": "2025-12-14T10:13:44.182Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:17:59.543Z",
    "updatedAt": "2025-12-14T08:54:38.556Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40037577",
      "DOI": "https://doi.org/10.1093/schbul/sbaf018",
      "special_case": "No",
      "Country_of_first_author": "China",
      "Country_of_occurrence": "China",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: The study investigated the default mode network (DMN) in 48 treatment-resistant schizophrenia (TRS) patients, 76 non-TRS patients, and 64 healthy controls using resting-state functional magnetic resonance imaging. The study aimed to explore the relationship between DMN measures and disorganization in schizophrenia, particularly in treatment-resistant cases.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: The study suggests that excessive spatial contribution and exaggerated temporal stability of the DMN are features of schizophrenia, which become more pronounced in treatment-resistant cases. However, no specific medication or therapy is directly attributed to these findings.",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The study investigates the default mode network (DMN) in schizophrenia, focusing on treatment-resistant schizophrenia (TRS) and its relationship with disorganized thinking. Using resting-state functional magnetic resonance imaging, the researchers analyzed DMN in 48 TRS patients, 76 non-TRS patients, and 64 healthy controls. The study found that TRS patients exhibited higher spatial loading on the DMN pattern but lower entropy compared to healthy controls, indicating excessive spatial contribution and exaggerated temporal stability of the DMN. Non-TRS patients showed intermediate alterations, suggesting a continuum between TRS and non-TRS groups. The study also found that higher spatial loading of the DMN was associated with more severe disorganization in patients. These findings suggest that TRS represents the severe end of a spectrum of DMN dysfunction in schizophrenia. While the study highlights the role of DMN alterations in schizophrenia, particularly in treatment-resistant cases, it does not provide specific data on drug administration, adverse events, or the role of Clozapine in the study.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article comments on the effect of DMN alterations in schizophrenia, particularly in treatment-resistant cases, emphasizing the association between excessive spatial contribution and disorganization. However, it does not provide specific opinions on the effect of any drug.",
      "Adverse_event": "No AE",
      "Abstract": "Disorganized thinking is a prominent feature of schizophrenia that becomes persistent in the presence of treatment resistance. Disruption of the default mode network (DMN), which regulates self-referential thinking, is now a well-established feature of schizophrenia. However, we do not know if DMN disruption affects disorganization and contributes to treatment-resistant schizophrenia (TRS).\n\nThis study investigated the DMN in 48 TRS, 76 non-TRS, and 64 healthy controls (HC) using a spatiotemporal approach with resting-state functional magnetic resonance imaging. We recovered DMN as an integrated network using multivariate group independent component analysis and estimated its loading coefficient (reflecting spatial prominence) and Shannon Entropy (reflecting temporal variability). Additionally, voxel-level analyses were conducted to examine network homogeneity and entropy within the DMN. We explored the relationship between DMN measures and disorganization using regression analysis.\n\nTRS had higher spatial loading on population-level DMN pattern, but lower entropy compared to HC. Non-TRS patients showed intermediate DMN alterations, not significantly differing from either TRS or HC. No voxel-level differences were noted between TRS and non-TRS, emphasizing the continuum between the two groups. DMN's loading coefficient was higher in patients with more severe disorganization.\n\nTRS may represent the most severe end of a spectrum of spatiotemporal DMN dysfunction in schizophrenia. While excessive spatial contribution of the DMN (high loading coefficient) is specifically associated with disorganization, both excessive spatial contribution and exaggerated temporal stability of DMN are features of schizophrenia that become more pronounced with refractoriness to first-line treatments.",
      "Title": "Default Mode Network, Disorganization, and Treatment-Resistant Schizophrenia.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:43:37",
      "Vancouver_citation": "Huang H, Qin X, Xu R, Xiong Y, Hao K, Chen C, Wan Q, Liu H, Yuan W, Peng Y, Zhou Y, Wang H, Palaniyappan L. Default Mode Network, Disorganization, and Treatment-Resistant Schizophrenia. Schizophr Bull. 2025;",
      "pubdate": "2025-03-5",
      "Lead_author": "Huang H",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. The study does not mention the administration of Clozapine or any other drug to the subjects, nor does it specify any treatment methods. Therefore, there is no indication of off-label use or non-conventional administration of the drug of study.",
      "AOI_classification": "No",
      "Justification": "The study does not mention the use of Clozapine or link it to any adverse effects or negative outcomes.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1093/schbul/sbaf018",
    "specialCase": "No",
    "countryOfFirstAuthor": "China",
    "countryOfOccurrence": "China",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: The study investigated the default mode network (DMN) in 48 treatment-resistant schizophrenia (TRS) patients, 76 non-TRS patients, and 64 healthy controls using resting-state functional magnetic resonance imaging. The study aimed to explore the relationship between DMN measures and disorganization in schizophrenia, particularly in treatment-resistant cases.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: The study suggests that excessive spatial contribution and exaggerated temporal stability of the DMN are features of schizophrenia, which become more pronounced in treatment-resistant cases. However, no specific medication or therapy is directly attributed to these findings.",
    "drugEffect": "Drug effect: no data",
    "summary": "The study investigates the default mode network (DMN) in schizophrenia, focusing on treatment-resistant schizophrenia (TRS) and its relationship with disorganized thinking. Using resting-state functional magnetic resonance imaging, the researchers analyzed DMN in 48 TRS patients, 76 non-TRS patients, and 64 healthy controls. The study found that TRS patients exhibited higher spatial loading on the DMN pattern but lower entropy compared to healthy controls, indicating excessive spatial contribution and exaggerated temporal stability of the DMN. Non-TRS patients showed intermediate alterations, suggesting a continuum between TRS and non-TRS groups. The study also found that higher spatial loading of the DMN was associated with more severe disorganization in patients. These findings suggest that TRS represents the severe end of a spectrum of DMN dysfunction in schizophrenia. While the study highlights the role of DMN alterations in schizophrenia, particularly in treatment-resistant cases, it does not provide specific data on drug administration, adverse events, or the role of Clozapine in the study.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article comments on the effect of DMN alterations in schizophrenia, particularly in treatment-resistant cases, emphasizing the association between excessive spatial contribution and disorganization. However, it does not provide specific opinions on the effect of any drug.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Huang H, Qin X, Xu R, Xiong Y, Hao K, Chen C, Wan Q, Liu H, Yuan W, Peng Y, Zhou Y, Wang H, Palaniyappan L. Default Mode Network, Disorganization, and Treatment-Resistant Schizophrenia. Schizophr Bull. 2025;",
    "leadAuthor": "Huang H",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. The study does not mention the administration of Clozapine or any other drug to the subjects, nor does it specify any treatment methods. Therefore, there is no indication of off-label use or non-conventional administration of the drug of study.",
    "aoiClassification": "No",
    "justification": "The study does not mention the use of Clozapine or link it to any adverse effects or negative outcomes.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi5CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi5CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-5409f40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707224
  },
  {
    "id": "CLOZ_Demo_54490",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40014466",
    "title": "Second-Generation Antipsychotic-Associated Serious Adverse Events in Women: An Analysis of a National Pharmacoepidemiologic Database.",
    "authors": [
      "McCall KL",
      "Leppien EE",
      "Piper BJ",
      "Falco BM",
      "Fleck KK",
      "Govel JC",
      "Nasta GN",
      "Zheng SR"
    ],
    "journal": "J Clin Psychopharmacol",
    "publicationDate": "2025-02-27",
    "abstract": "The study analyzed adverse events associated with second-generation antipsychotics (SGAs) in women using the US adverse event reporting system. It focused on six SGAs, including clozapine, and examined five specific adverse events: Torsades de pointes (TdP), neuroleptic malignant syndrome (NMS), tardive dyskinesia (TD), agranulocytosis (AG), and cerebrovascular adverse events (CVAE). The cohort consisted of 87,356 reports, with clozapine accounting for 25,096 (28.7%) of the cases. Females comprised 48.7% of the cohort, with a mean age of 48.6 years. The study found that females had significantly higher odds of hospitalization or death with TdP compared to males, with a reporting odds ratio (ROR) of 3.09. Other adverse events such as NMS, TD, AG, and CVAE were also analyzed, but TdP was highlighted as having worse outcomes in females. The study suggests that females exposed to SGAs, including clozapine, may be at higher risk for TdP and associated complications. Further research is recommended to confirm these findings.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Females exposed to SGAs had higher odds of experiencing Torsades de pointes (TdP) and worse TdP-associated outcomes, including hospitalization or death. No specific drug toxicity or death was directly attributed to clozapine, but TdP was highlighted as a significant adverse event among females exposed to SGAs.",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b98f4dc3-eec4-4357-855c-e6f2435d9198",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:38.566Z"
      },
      {
        "id": "0711efe2-a018-4402-a74f-4eb1ff6cc1a4",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9fc90a10-9a51-408b-8b34-e85f87b02269 to CLOZ_Demo_54490",
        "type": "system",
        "createdAt": "2025-12-14T10:13:44.426Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:17:59.574Z",
    "updatedAt": "2025-12-14T08:54:38.573Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40014466",
      "DOI": "https://doi.org/10.1097/JCP.0000000000001962",
      "special_case": "No",
      "Country_of_first_author": "United States",
      "Country_of_occurrence": "United States",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: The study analyzed adverse events associated with second-generation antipsychotics (SGAs) in women using the US adverse event reporting system. It focused on six SGAs: aripiprazole, clozapine, olanzapine, quetiapine, risperidone, and ziprasidone. Five adverse events were examined: Torsades de pointes (TdP), neuroleptic malignant syndrome (NMS), tardive dyskinesia (TD), agranulocytosis (AG), and cerebrovascular adverse events (CVAE). Females were found to have higher odds of hospitalization or death with TdP compared to males.",
      "Relevant_dates": "Relevant dates: January 1, 2019, to July 8, 2024",
      "Administered_drugs": "Administered drugs: aripiprazole, clozapine, olanzapine, quetiapine, risperidone, ziprasidone",
      "Attributability": "Attributability: The study found higher odds of TdP and worse TdP-associated outcomes among females exposed to SGAs compared to males. Specific adverse events such as TdP, NMS, TD, AG, and CVAE were analyzed, with TdP being significantly associated with hospitalization or death in females.",
      "Drug_effect": "Drug effect: summary: The study suggests that females exposed to SGAs have higher odds of experiencing TdP and worse TdP-associated outcomes compared to males. Other adverse events were also analyzed, but the focus was on TdP.",
      "Summary": "The study analyzed adverse events associated with second-generation antipsychotics (SGAs) in women using the US adverse event reporting system. It focused on six SGAs, including clozapine, and examined five specific adverse events: Torsades de pointes (TdP), neuroleptic malignant syndrome (NMS), tardive dyskinesia (TD), agranulocytosis (AG), and cerebrovascular adverse events (CVAE). The cohort consisted of 87,356 reports, with clozapine accounting for 25,096 (28.7%) of the cases. Females comprised 48.7% of the cohort, with a mean age of 48.6 years. The study found that females had significantly higher odds of hospitalization or death with TdP compared to males, with a reporting odds ratio (ROR) of 3.09. Other adverse events such as NMS, TD, AG, and CVAE were also analyzed, but TdP was highlighted as having worse outcomes in females. The study suggests that females exposed to SGAs, including clozapine, may be at higher risk for TdP and associated complications. Further research is recommended to confirm these findings.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Meta-analysis",
      "Author_perspective": "The article comments on the higher odds of TdP and worse TdP-associated outcomes among females exposed to SGAs compared to males. It suggests that further studies are needed to confirm these findings.",
      "Adverse_event": "Females exposed to SGAs had higher odds of experiencing Torsades de pointes (TdP) and worse TdP-associated outcomes, including hospitalization or death. No specific drug toxicity or death was directly attributed to clozapine, but TdP was highlighted as a significant adverse event among females exposed to SGAs.",
      "Abstract": "Women have historically been underrepresented in second-generation antipsychotic (SGA) clinical trials, accounting for less than 35% of participants, which raises concerns about the generalizability of the safety profile for these medications.\n\nThe US adverse event reporting system was queried for the dates January 1, 2019, to July 8, 2024, to examine the following 6 SGAs: aripiprazole, clozapine, olanzapine, quetiapine, risperidone, and ziprasidone. Reports were excluded if patients were under 18 years old, contained an unknown age or gender, or were duplicated. Five adverse events were examined: Torsades de pointes (TdP), neuroleptic malignant syndrome (NMS), tardive dyskinesia (TD), agranulocytosis (AG), and cerebrovascular adverse events (CVAE). Counts of these events were noted, and reporting odds ratios (ROR) were calculated.\n\nThe total study cohort was 87,356 reports, consisting of aripiprazole (n = 10,715, 12.2%), clozapine (n = 25,096, 28.7%), olanzapine (n = 11,587, 13.3%), quetiapine (n = 28,746, 32.9%), risperidone (n = 10,467, 12%), and ziprasidone (n = 745, 0.9%). The cohort's mean age was 48.6 ± 18.5 years and comprised 42,584 females (48.7%). Most cases were reported by healthcare professionals (74,836, 85.7%). A total of 3,754 reports contained at least 1 of the 5 adverse events. The RORs among females compared to males for TdP (5.55, 95% confidence interval [CI] = 3.78-8.47), NMS (0.59, 95% CI = 0.53-0.65), TD (0.88, 95% CI = 0.76-1.02), AG (0.59, 95% CI = 0.51-0.70), and CVAE (1.12, 95% CI = 0.89-1.41) were observed. Females had a significantly higher odds of hospitalization or death with TdP compared to males (ROR = 3.09, 95% CI = 1.36-7.01).\n\nOur findings suggest higher odds of TdP and worse TdP-associated outcomes among females exposed to SGAs compared to males. Further studies are needed to confirm these preliminary findings.",
      "Title": "Second-Generation Antipsychotic-Associated Serious Adverse Events in Women: An Analysis of a National Pharmacoepidemiologic Database.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:46:29",
      "Vancouver_citation": "McCall KL, Leppien EE, Piper BJ, Falco BM, Fleck KK, Govel JC, Nasta GN, Zheng SR. Second-Generation Antipsychotic-Associated Serious Adverse Events in Women: An Analysis of a National Pharmacoepidemiologic Database. J Clin Psychopharmacol. 45(2):111-5",
      "pubdate": "2025-02-27",
      "Lead_author": "McCall KL",
      "Serious": "Serious",
      "Test_subject": "The test subjects in this study are humans, specifically adult patients aged 18 years and older, with a focus on females. The study analyzed reports from a national pharmacoepidemiologic database regarding adverse events associated with six second-generation antipsychotics, including the drug of study, clozapine.",
      "AOI_drug_effect": "The drug of study, clozapine, was associated with adverse events in the study. The analysis included reports of five specific adverse events: Torsades de pointes (TdP), neuroleptic malignant syndrome (NMS), tardive dyskinesia (TD), agranulocytosis (AG), and cerebrovascular adverse events (CVAE). While the study does not specify the exact impact of clozapine on these events, it is included in the cohort of drugs analyzed for these adverse events.",
      "Approved_indication": "The drug of study, clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders occurring during Parkinson's disease when standard treatments fail. The study does not specify how clozapine was administered or the exact conditions it was used to treat in the analyzed reports. However, there is no indication that clozapine was used in a non-conventional or off-label manner in this study.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study links clozapine, along with other SGAs, to adverse events such as TdP, NMS, TD, AG, and CVAE, and mentions adverse outcomes like hospitalization or death associated with these events.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1097/JCP.0000000000001962",
    "specialCase": "No",
    "countryOfFirstAuthor": "United States",
    "countryOfOccurrence": "United States",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: The study analyzed adverse events associated with second-generation antipsychotics (SGAs) in women using the US adverse event reporting system. It focused on six SGAs: aripiprazole, clozapine, olanzapine, quetiapine, risperidone, and ziprasidone. Five adverse events were examined: Torsades de pointes (TdP), neuroleptic malignant syndrome (NMS), tardive dyskinesia (TD), agranulocytosis (AG), and cerebrovascular adverse events (CVAE). Females were found to have higher odds of hospitalization or death with TdP compared to males.",
    "relevantDates": "Relevant dates: January 1, 2019, to July 8, 2024",
    "administeredDrugs": [
      "Administered drugs: aripiprazole",
      "clozapine",
      "olanzapine",
      "quetiapine",
      "risperidone",
      "ziprasidone"
    ],
    "attributability": "Attributability: The study found higher odds of TdP and worse TdP-associated outcomes among females exposed to SGAs compared to males. Specific adverse events such as TdP, NMS, TD, AG, and CVAE were analyzed, with TdP being significantly associated with hospitalization or death in females.",
    "drugEffect": "Drug effect: summary: The study suggests that females exposed to SGAs have higher odds of experiencing TdP and worse TdP-associated outcomes compared to males. Other adverse events were also analyzed, but the focus was on TdP.",
    "summary": "The study analyzed adverse events associated with second-generation antipsychotics (SGAs) in women using the US adverse event reporting system. It focused on six SGAs, including clozapine, and examined five specific adverse events: Torsades de pointes (TdP), neuroleptic malignant syndrome (NMS), tardive dyskinesia (TD), agranulocytosis (AG), and cerebrovascular adverse events (CVAE). The cohort consisted of 87,356 reports, with clozapine accounting for 25,096 (28.7%) of the cases. Females comprised 48.7% of the cohort, with a mean age of 48.6 years. The study found that females had significantly higher odds of hospitalization or death with TdP compared to males, with a reporting odds ratio (ROR) of 3.09. Other adverse events such as NMS, TD, AG, and CVAE were also analyzed, but TdP was highlighted as having worse outcomes in females. The study suggests that females exposed to SGAs, including clozapine, may be at higher risk for TdP and associated complications. Further research is recommended to confirm these findings.",
    "identifiableHumanSubject": "Yes",
    "textType": "Meta-analysis",
    "authorPerspective": "The article comments on the higher odds of TdP and worse TdP-associated outcomes among females exposed to SGAs compared to males. It suggests that further studies are needed to confirm these findings.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "McCall KL, Leppien EE, Piper BJ, Falco BM, Fleck KK, Govel JC, Nasta GN, Zheng SR. Second-Generation Antipsychotic-Associated Serious Adverse Events in Women: An Analysis of a National Pharmacoepidemiologic Database. J Clin Psychopharmacol. 45(2):111-5",
    "leadAuthor": "McCall KL",
    "serious": "Serious",
    "testSubject": "The test subjects in this study are humans, specifically adult patients aged 18 years and older, with a focus on females. The study analyzed reports from a national pharmacoepidemiologic database regarding adverse events associated with six second-generation antipsychotics, including the drug of study, clozapine.",
    "aoiDrugEffect": "The drug of study, clozapine, was associated with adverse events in the study. The analysis included reports of five specific adverse events: Torsades de pointes (TdP), neuroleptic malignant syndrome (NMS), tardive dyskinesia (TD), agranulocytosis (AG), and cerebrovascular adverse events (CVAE). While the study does not specify the exact impact of clozapine on these events, it is included in the cohort of drugs analyzed for these adverse events.",
    "approvedIndication": "The drug of study, clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders occurring during Parkinson's disease when standard treatments fail. The study does not specify how clozapine was administered or the exact conditions it was used to treat in the analyzed reports. However, there is no indication that clozapine was used in a non-conventional or off-label manner in this study.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The study links clozapine, along with other SGAs, to adverse events such as TdP, NMS, TD, AG, and CVAE, and mentions adverse outcomes like hospitalization or death associated with these events.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi6CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi6CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-542f800501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707224
  },
  {
    "id": "CLOZ_Demo_21697",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39978031",
    "title": "Unlocking the molecular mechanisms of anticancer and immunomodulatory potentials of cariprazine in triple negative breast cancer.",
    "authors": [
      "Lazovic A",
      "Markovic BS",
      "Corovic I",
      "Markovic T",
      "Andjelkovic M",
      "Stojanovic B",
      "Jovanovic I",
      "Mitrovic M"
    ],
    "journal": "Biomed Pharmacother",
    "publicationDate": "2025-02-21",
    "abstract": "The study investigates the anticancer and immunomodulatory effects of Cariprazine (CAR), Olanzapine (OLZ), and Clozapine (CLZ) in triple-negative breast cancer (TNBC) models. TNBC is a challenging cancer type due to its invasive nature and lack of specific targets, often leading to drug resistance or relapse. The research focuses on repurposing antipsychotic drugs to address these challenges. In vitro experiments demonstrated that CAR, OLZ, and CLZ significantly inhibited TNBC cell proliferation by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest, and suppressing autophagy. These effects were linked to molecular changes such as the downregulation of Bcl-2, p62, and pAKT, and the upregulation of Bax and active caspase 3. CAR also inhibited cell migration in MDA-MB-231 cells. In vivo, CAR showed potent anticancer activity in the 4T1 xenograft model, reducing tumor growth without adverse effects. It also modulated the immune response by promoting proinflammatory cytokines and increasing specific immune cell populations. Compared to other antipsychotics, 5-FU, and cisplatin, CAR exhibited the strongest anticancer activity, attributed to its ability to regulate apoptosis, autophagy, and immune responses. The study highlights CAR's therapeutic potential in TNBC treatment. However, the absence of human subject data limits the direct applicability of findings to clinical settings.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "084ec34a-cb0a-49c0-a9de-81aab0870b0a",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:38.598Z"
      },
      {
        "id": "945195d3-367e-47a1-8ae0-39ec8aa49cac",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a4ba1d96-ca7d-4c0a-8f4a-54a34e431222 to CLOZ_Demo_21697",
        "type": "system",
        "createdAt": "2025-12-14T10:13:44.704Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:17:59.605Z",
    "updatedAt": "2025-12-14T08:54:38.691Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39978031",
      "DOI": "https://doi.org/10.1016/j.biopha.2025.117931",
      "special_case": "No",
      "Country_of_first_author": "Serbia",
      "Country_of_occurrence": "Serbia",
      "Patient_details": "No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: Not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The study investigates the anticancer and immunomodulatory effects of Cariprazine (CAR), Olanzapine (OLZ), and Clozapine (CLZ) in triple-negative breast cancer (TNBC) models. TNBC is a challenging cancer type due to its invasive nature and lack of specific targets, often leading to drug resistance or relapse. The research focuses on repurposing antipsychotic drugs to address these challenges. In vitro experiments demonstrated that CAR, OLZ, and CLZ significantly inhibited TNBC cell proliferation by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest, and suppressing autophagy. These effects were linked to molecular changes such as the downregulation of Bcl-2, p62, and pAKT, and the upregulation of Bax and active caspase 3. CAR also inhibited cell migration in MDA-MB-231 cells. In vivo, CAR showed potent anticancer activity in the 4T1 xenograft model, reducing tumor growth without adverse effects. It also modulated the immune response by promoting proinflammatory cytokines and increasing specific immune cell populations. Compared to other antipsychotics, 5-FU, and cisplatin, CAR exhibited the strongest anticancer activity, attributed to its ability to regulate apoptosis, autophagy, and immune responses. The study highlights CAR's therapeutic potential in TNBC treatment. However, the absence of human subject data limits the direct applicability of findings to clinical settings.",
      "Identifiable_human_subject": "No",
      "Text_type": "In Vitro Study",
      "Author_perspective": "The article comments positively on Cariprazine's potent anticancer activity in TNBC models, emphasizing its ability to regulate apoptosis, autophagy, and immune responses, suggesting its therapeutic potential in breast cancer.",
      "Adverse_event": "No AE",
      "Abstract": "Triple-negative breast cancer (TNBC), a highly invasive type of cancer, is difficult to treat due to insufficient specific targets and low survival rates. Current therapy often encounters drug resistance or relapse; thus, repurposing existing drugs could revolutionize cancer treatment. This study examined the anticancer effects of the antipsychotics Cariprazine (CAR), Olanzapine (OLZ), and Clozapine (CLZ), and the immunomodulatory potential of CAR, in vitro and in vivo in TNBC models. In vitro, CAR, OLZ, and CLZ significantly inhibited the proliferation of TNBC cells. This inhibition occurred via the induction of mitochondrial apoptosis, G0/G1 cell cycle arrest, and the suppression of autophagy, as evidenced by the down-regulation of Bcl-2, p62, and pAKT; the upregulation of Bax and active caspase 3; the decrease of ΔΨM; and the promotion of cytochrome c release. In addition, CAR inhibited MDA-MB-231 cells migration. In vivo, CAR inhibited tumor growth in the 4T1 xenograft model without causing adverse effects and resulted in the mRNA upregulation caspase 9, p53, p21, and Beclin-1. In addition, CAR influenced the immune response by promoting the production of proinflammatory cytokines TNF-α, IFN-γ, IL-17, and IL-1β and increasing the percentage of TNF-α<sup>+</sup>, IL-17<sup>+</sup>, IL-1β<sup>+</sup>, and IFN-γ<sup>+</sup> CD3<sup>+</sup> splenocytes. In conclusion, compared with other antipsychotics, 5-FU, and cisplatin, CAR exerted the most potent anticancer activity in TNBC in vitro and in vivo. This efficacy may be attributed to its ability to regulate apoptosis and autophagy, promote G0/G1 cell cycle arrest, and modulate antitumor immune response, suggesting its therapeutic potential in breast cancer.",
      "Title": "Unlocking the molecular mechanisms of anticancer and immunomodulatory potentials of cariprazine in triple negative breast cancer.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:46:12",
      "Vancouver_citation": "Lazovic A, Markovic BS, Corovic I, Markovic T, Andjelkovic M, Stojanovic B, Jovanovic I, Mitrovic M. Unlocking the molecular mechanisms of anticancer and immunomodulatory potentials of cariprazine in triple negative breast cancer. Biomed Pharmacother. 2025;184117931",
      "pubdate": "2025-02-21",
      "Lead_author": "Lazovic A",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study include TNBC (Triple-Negative Breast Cancer) cells in vitro and the 4T1 xenograft model in vivo. These test subjects were exposed to the drug of study, Clozapine (CLZ), along with other antipsychotics such as Cariprazine (CAR) and Olanzapine (OLZ).",
      "AOI_drug_effect": "The drug of study, Clozapine (CLZ), had an effect on the test subjects. It significantly inhibited the proliferation of TNBC cells in vitro by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest, and suppressing autophagy. These effects were evidenced by molecular changes such as the down-regulation of Bcl-2, p62, and pAKT, and the upregulation of Bax and active caspase 3. However, the study does not specify whether Clozapine was tested in vivo or its effects in the xenograft model.",
      "Approved_indication": "Clozapine is conventionally used as an antipsychotic medication, primarily administered orally to treat schizophrenia and schizoaffective disorders. In this study, Clozapine was administered to TNBC cells in vitro to investigate its anticancer effects. It was not specified whether Clozapine was used in vivo or how it was administered in the xenograft model. The drug was intended to treat TNBC by inhibiting cancer cell proliferation and inducing apoptosis.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study mentions that Clozapine induced mitochondrial apoptosis, cell cycle arrest, and suppressed autophagy in TNBC cells, which are significant cellular events. While these effects are beneficial in the context of cancer treatment, they could potentially be linked to adverse effects in other contexts or systems.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1016/j.biopha.2025.117931",
    "specialCase": "No",
    "countryOfFirstAuthor": "Serbia",
    "countryOfOccurrence": "Serbia",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: Not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "The study investigates the anticancer and immunomodulatory effects of Cariprazine (CAR), Olanzapine (OLZ), and Clozapine (CLZ) in triple-negative breast cancer (TNBC) models. TNBC is a challenging cancer type due to its invasive nature and lack of specific targets, often leading to drug resistance or relapse. The research focuses on repurposing antipsychotic drugs to address these challenges. In vitro experiments demonstrated that CAR, OLZ, and CLZ significantly inhibited TNBC cell proliferation by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest, and suppressing autophagy. These effects were linked to molecular changes such as the downregulation of Bcl-2, p62, and pAKT, and the upregulation of Bax and active caspase 3. CAR also inhibited cell migration in MDA-MB-231 cells. In vivo, CAR showed potent anticancer activity in the 4T1 xenograft model, reducing tumor growth without adverse effects. It also modulated the immune response by promoting proinflammatory cytokines and increasing specific immune cell populations. Compared to other antipsychotics, 5-FU, and cisplatin, CAR exhibited the strongest anticancer activity, attributed to its ability to regulate apoptosis, autophagy, and immune responses. The study highlights CAR's therapeutic potential in TNBC treatment. However, the absence of human subject data limits the direct applicability of findings to clinical settings.",
    "identifiableHumanSubject": "No",
    "textType": "In Vitro Study",
    "authorPerspective": "The article comments positively on Cariprazine's potent anticancer activity in TNBC models, emphasizing its ability to regulate apoptosis, autophagy, and immune responses, suggesting its therapeutic potential in breast cancer.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Lazovic A, Markovic BS, Corovic I, Markovic T, Andjelkovic M, Stojanovic B, Jovanovic I, Mitrovic M. Unlocking the molecular mechanisms of anticancer and immunomodulatory potentials of cariprazine in triple negative breast cancer. Biomed Pharmacother. 2025;184117931",
    "leadAuthor": "Lazovic A",
    "serious": "No",
    "testSubject": "The test subjects involved in this study include TNBC (Triple-Negative Breast Cancer) cells in vitro and the 4T1 xenograft model in vivo. These test subjects were exposed to the drug of study, Clozapine (CLZ), along with other antipsychotics such as Cariprazine (CAR) and Olanzapine (OLZ).",
    "aoiDrugEffect": "The drug of study, Clozapine (CLZ), had an effect on the test subjects. It significantly inhibited the proliferation of TNBC cells in vitro by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest, and suppressing autophagy. These effects were evidenced by molecular changes such as the down-regulation of Bcl-2, p62, and pAKT, and the upregulation of Bax and active caspase 3. However, the study does not specify whether Clozapine was tested in vivo or its effects in the xenograft model.",
    "approvedIndication": "Clozapine is conventionally used as an antipsychotic medication, primarily administered orally to treat schizophrenia and schizoaffective disorders. In this study, Clozapine was administered to TNBC cells in vitro to investigate its anticancer effects. It was not specified whether Clozapine was used in vivo or how it was administered in the xenograft model. The drug was intended to treat TNBC by inhibiting cancer cell proliferation and inducing apoptosis.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The study mentions that Clozapine induced mitochondrial apoptosis, cell cycle arrest, and suppressed autophagy in TNBC cells, which are significant cellular events. While these effects are beneficial in the context of cancer treatment, they could potentially be linked to adverse effects in other contexts or systems.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi7CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi7CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-5452100501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707224
  },
  {
    "id": "CLOZ_Demo_82285",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39961232",
    "title": "Temporal trends of antipsychotic utilization patterns in 62,607 patients with schizophrenia-spectrum disorders in Hong Kong: An 11-year population-based study with joinpoint regression analysis.",
    "authors": [
      "Fang CZ",
      "Lau N",
      "Chan JKN",
      "Wong CSM",
      "Chang WC"
    ],
    "journal": "J Psychiatr Res",
    "publicationDate": "2025-02-18",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "142ef453-0245-452a-8ddd-948d17193588",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:38.704Z"
      },
      {
        "id": "0c40fdf5-ba88-48d2-aff7-aee9fb6eeaf7",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9a4bacff-f69d-4c65-b5e7-fbe9ff5f4639 to CLOZ_Demo_82285",
        "type": "system",
        "createdAt": "2025-12-14T10:13:44.955Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:17:59.634Z",
    "updatedAt": "2025-12-14T08:54:38.708Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39961232",
      "DOI": "https://doi.org10.1016/j.jpsychires.2025.02.017",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:46:44",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Fang CZ, Lau N, Chan JKN, Wong CSM, Chang WC. Temporal trends of antipsychotic utilization patterns in 62,607 patients with schizophrenia-spectrum disorders in Hong Kong: An 11-year population-based study with joinpoint regression analysis. J Psychiatr Res. 2025;183144-9",
      "pubdate": "2025-02-18",
      "Lead_author": "Fang CZ",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jpsychires.2025.02.017",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Fang CZ, Lau N, Chan JKN, Wong CSM, Chang WC. Temporal trends of antipsychotic utilization patterns in 62,607 patients with schizophrenia-spectrum disorders in Hong Kong: An 11-year population-based study with joinpoint regression analysis. J Psychiatr Res. 2025;183144-9",
    "leadAuthor": "Fang CZ",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi8CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi8CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-5475280501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707224
  },
  {
    "id": "CLOZ_Demo_53656",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39955176",
    "title": "Effects of chemogenetic virus injection and clozapine administration in spinal cord injury.",
    "authors": [
      "Kim JH",
      "Hwang SY",
      "Lee HL",
      "Yoon SL",
      "Ha Y",
      "Lee HY",
      "Ryu S"
    ],
    "journal": "Neurotherapeutics",
    "publicationDate": "2025-02-16",
    "abstract": "This study investigates the effects of chemogenetic stimulation using Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) in conjunction with clozapine administration on spinal cord injury (SCI) in rats. The research focuses on enhancing motor recovery and neuroregeneration through targeted neuromodulation during the acute phase of SCI. Clozapine, administered at a dose of 0.1 mg/kg intraperitoneally, served as the ligand for DREADDs activation. Weekly behavioral assessments demonstrated significant improvements in motor skills and neuronal regeneration in treated animals compared to controls, with the most pronounced effects observed when stimulation was initiated early after injury. Histological analyses confirmed increased neuronal density, enhanced signaling protein expression, and reduced inflammatory markers in the treatment group. The study highlights the importance of early intervention, as acute-phase treatment yielded superior motor recovery and neuroregeneration outcomes compared to chronic-phase treatment. Clozapine's role in activating the Gq-signaling pathway was associated with increased intracellular calcium levels, promoting neuroplasticity and neuronal regeneration. The findings suggest that chemogenetic stimulation combined with clozapine administration effectively promotes neuroregeneration and motor recovery in SCI models. However, the study does not involve human subjects, and no adverse events or specific drug effects were reported.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "73574921-ead4-4214-8095-0f620c4bc3cb",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:38.752Z"
      },
      {
        "id": "0c6e39ef-9db0-4c52-a30b-7edb0777ddfe",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 5c95cbb1-2d96-452e-b622-974b469ca72f to CLOZ_Demo_53656",
        "type": "system",
        "createdAt": "2025-12-14T10:13:45.168Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:17:59.665Z",
    "updatedAt": "2025-12-14T08:54:38.761Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39955176",
      "DOI": "https://doi.org/10.1016/j.neurot.2025.e00547",
      "special_case": "No",
      "Country_of_first_author": "Country of the first author: Republic of Korea",
      "Country_of_occurrence": "Country of occurrence: Republic of Korea",
      "Patient_details": "Patient details: No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Clozapine",
      "Attributability": "Attributability: Not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "This study investigates the effects of chemogenetic stimulation using Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) in conjunction with clozapine administration on spinal cord injury (SCI) in rats. The research focuses on enhancing motor recovery and neuroregeneration through targeted neuromodulation during the acute phase of SCI. Clozapine, administered at a dose of 0.1 mg/kg intraperitoneally, served as the ligand for DREADDs activation. Weekly behavioral assessments demonstrated significant improvements in motor skills and neuronal regeneration in treated animals compared to controls, with the most pronounced effects observed when stimulation was initiated early after injury. Histological analyses confirmed increased neuronal density, enhanced signaling protein expression, and reduced inflammatory markers in the treatment group. The study highlights the importance of early intervention, as acute-phase treatment yielded superior motor recovery and neuroregeneration outcomes compared to chronic-phase treatment. Clozapine's role in activating the Gq-signaling pathway was associated with increased intracellular calcium levels, promoting neuroplasticity and neuronal regeneration. The findings suggest that chemogenetic stimulation combined with clozapine administration effectively promotes neuroregeneration and motor recovery in SCI models. However, the study does not involve human subjects, and no adverse events or specific drug effects were reported.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article does not provide any specific opinion on the drug's effect on human subjects, but it highlights the potential of clozapine in enhancing neuroregeneration and motor recovery in animal models of SCI.",
      "Adverse_event": "No AE",
      "Abstract": "Neuromodulation therapy using chemogenetic stimulation has shown potential in enhancing motor recovery and neuroregeneration following spinal cord injury (SCI). These therapeutic benefits are hypothesized to result from the promotion of neuroplasticity, particularly when administered during the acute phase of injury. In this study, we investigated the effects of chemogenetic stimulation using Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) in conjunction with clozapine, a ligand for receptor activation. DREADDs enable targeted, reversible neuromodulation, facilitating the histological characterization of engineered neurons. We utilized these receptors to modulate G-protein-coupled receptor (GPCR) signaling pathways, leading to the activation or inhibition of intracellular signaling. The objective was to determine whether the administration of DREADDs and clozapine (0.1 ​mg/kg) could enhance motor function and neuronal recovery, particularly when applied during the acute phase of SCI. Weekly behavioral assessments demonstrated significant improvements in motor skills and neuronal regeneration in treated animals compared to controls, with the most pronounced effects observed when stimulation was initiated early after injury. These enhancements in neuroplasticity were reflected in improved ladder rung test scores and Basso, Beattie, and Bresnahan (BBB) scale results in DREADDs-treated rats. Histological analyses, including immunohistochemistry (IHC) staining, Western blotting, and quantitative reverse transcription PCR (qRT-PCR), confirmed that the treatment group exhibited a higher density of neurons, increased signaling protein expression, and reduced inflammatory markers. These findings suggest that chemogenetic stimulation, particularly when administered during the acute phase, effectively promotes neuroregeneration and motor recovery. Future research should focus on assessing the long-term safety and efficacy of chemogenetic virus injection and clozapine administration, with an emphasis on the timing of intervention.",
      "Title": "Effects of chemogenetic virus injection and clozapine administration in spinal cord injury.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:45:56",
      "Vancouver_citation": "Kim JH, Hwang SY, Lee HL, Yoon SL, Ha Y, Lee HY, Ryu S. Effects of chemogenetic virus injection and clozapine administration in spinal cord injury. Neurotherapeutics. 2025;22(2):e00547",
      "pubdate": "2025-02-16",
      "Lead_author": "Kim JH",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study were male Sprague-Dawley rats. These rats were subjected to spinal cord injury (SCI) and subsequently treated with chemogenetic viruses and the drug of study, Clozapine, to investigate its effects on neuroregeneration and motor recovery.",
      "AOI_drug_effect": "The drug of study, Clozapine, had a significant effect on the test subjects. It was used as a ligand to activate Designer Receptors Exclusively Activated by Designer Drugs (DREADDs), which facilitated targeted neuromodulation. The study demonstrated that Clozapine administration, in combination with chemogenetic stimulation, enhanced motor function recovery, neuronal regeneration, and neuroplasticity. It also reduced inflammatory markers and glial scar formation, promoting remyelination and functional recovery in the injured spinal cord.",
      "Approved_indication": "Clozapine is conventionally used as an antipsychotic medication for the treatment of schizophrenia and schizoaffective disorders, typically administered orally. In this study, Clozapine was administered intraperitoneally at a dose of 0.1 mg/kg daily to rats with spinal cord injuries. It was used as a ligand to activate DREADDs for the purpose of promoting neuroregeneration and motor recovery following SCI.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study mentions potential off-target effects of Clozapine due to its broad pharmacological profile, including actions on other CNS receptors such as dopamine, serotonin, norepinephrine, and histamine receptors. While no behavioral side effects were observed in this study, the possibility of off-target effects is acknowledged, necessitating careful consideration of dosing and safety in future research.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1016/j.neurot.2025.e00547",
    "specialCase": "No",
    "countryOfFirstAuthor": "Country of the first author: Republic of Korea",
    "countryOfOccurrence": "Country of occurrence: Republic of Korea",
    "patientDetails": "Patient details: No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Clozapine"
    ],
    "attributability": "Attributability: Not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "This study investigates the effects of chemogenetic stimulation using Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) in conjunction with clozapine administration on spinal cord injury (SCI) in rats. The research focuses on enhancing motor recovery and neuroregeneration through targeted neuromodulation during the acute phase of SCI. Clozapine, administered at a dose of 0.1 mg/kg intraperitoneally, served as the ligand for DREADDs activation. Weekly behavioral assessments demonstrated significant improvements in motor skills and neuronal regeneration in treated animals compared to controls, with the most pronounced effects observed when stimulation was initiated early after injury. Histological analyses confirmed increased neuronal density, enhanced signaling protein expression, and reduced inflammatory markers in the treatment group. The study highlights the importance of early intervention, as acute-phase treatment yielded superior motor recovery and neuroregeneration outcomes compared to chronic-phase treatment. Clozapine's role in activating the Gq-signaling pathway was associated with increased intracellular calcium levels, promoting neuroplasticity and neuronal regeneration. The findings suggest that chemogenetic stimulation combined with clozapine administration effectively promotes neuroregeneration and motor recovery in SCI models. However, the study does not involve human subjects, and no adverse events or specific drug effects were reported.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article does not provide any specific opinion on the drug's effect on human subjects, but it highlights the potential of clozapine in enhancing neuroregeneration and motor recovery in animal models of SCI.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Kim JH, Hwang SY, Lee HL, Yoon SL, Ha Y, Lee HY, Ryu S. Effects of chemogenetic virus injection and clozapine administration in spinal cord injury. Neurotherapeutics. 2025;22(2):e00547",
    "leadAuthor": "Kim JH",
    "serious": "No",
    "testSubject": "The test subjects involved in this study were male Sprague-Dawley rats. These rats were subjected to spinal cord injury (SCI) and subsequently treated with chemogenetic viruses and the drug of study, Clozapine, to investigate its effects on neuroregeneration and motor recovery.",
    "aoiDrugEffect": "The drug of study, Clozapine, had a significant effect on the test subjects. It was used as a ligand to activate Designer Receptors Exclusively Activated by Designer Drugs (DREADDs), which facilitated targeted neuromodulation. The study demonstrated that Clozapine administration, in combination with chemogenetic stimulation, enhanced motor function recovery, neuronal regeneration, and neuroplasticity. It also reduced inflammatory markers and glial scar formation, promoting remyelination and functional recovery in the injured spinal cord.",
    "approvedIndication": "Clozapine is conventionally used as an antipsychotic medication for the treatment of schizophrenia and schizoaffective disorders, typically administered orally. In this study, Clozapine was administered intraperitoneally at a dose of 0.1 mg/kg daily to rats with spinal cord injuries. It was used as a ligand to activate DREADDs for the purpose of promoting neuroregeneration and motor recovery following SCI.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The study mentions potential off-target effects of Clozapine due to its broad pharmacological profile, including actions on other CNS receptors such as dopamine, serotonin, norepinephrine, and histamine receptors. While no behavioral side effects were observed in this study, the possibility of off-target effects is acknowledged, necessitating careful consideration of dosing and safety in future research.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi9CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi9CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-54960c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707225
  },
  {
    "id": "CLOZ_Demo_34118",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39804780",
    "title": "Clozapine Use in Down Syndrome: A Surprising Paucity of Evidence.",
    "authors": [
      "Colijn MA"
    ],
    "journal": "J Clin Psychopharmacol",
    "publicationDate": "2025-01-13",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b5fed1cd-4fbf-45c0-87d3-55ba393b3f45",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:38.781Z"
      },
      {
        "id": "85d4bde7-c3c6-4d0d-81f5-104d29029ed2",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9971b249-50d1-4c88-8ab8-556543622309 to CLOZ_Demo_34118",
        "type": "system",
        "createdAt": "2025-12-14T10:13:45.404Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:17:59.714Z",
    "updatedAt": "2025-12-14T08:54:38.875Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39804780",
      "DOI": "https://doi.org10.1097/JCP.0000000000001953",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:46:59",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Colijn MA. Clozapine Use in Down Syndrome: A Surprising Paucity of Evidence. J Clin Psychopharmacol. 45(2):170-1",
      "pubdate": "2025-01-13",
      "Lead_author": "Colijn MA",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/JCP.0000000000001953",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Colijn MA. Clozapine Use in Down Syndrome: A Surprising Paucity of Evidence. J Clin Psychopharmacol. 45(2):170-1",
    "leadAuthor": "Colijn MA",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi+CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi+CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-54bc080501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707225
  },
  {
    "id": "CLOZ_Demo_31223",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39804779",
    "title": "Clozapine Dosage in Treatment-Refractory Schizophrenia: A Reply to Dr Grover and Colleagues.",
    "authors": [
      "Flanagan RJ",
      "Obee SJ",
      "Kim AHM",
      "Every-Palmer S"
    ],
    "journal": "J Clin Psychopharmacol",
    "publicationDate": "2025-01-13",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "49a3939f-3337-4f84-a7bb-102127ac7ef7",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:38.888Z"
      },
      {
        "id": "d42bf701-11d6-49a2-9d89-dbf16919411d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9df19d7f-f348-470c-8c29-983fbe1332f2 to CLOZ_Demo_31223",
        "type": "system",
        "createdAt": "2025-12-14T10:13:45.646Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:17:59.751Z",
    "updatedAt": "2025-12-14T08:54:38.896Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39804779",
      "DOI": "https://doi.org10.1097/JCP.0000000000001955",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:46:52",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Flanagan RJ, Obee SJ, Kim AHM, Every-Palmer S. Clozapine Dosage in Treatment-Refractory Schizophrenia: A Reply to Dr Grover and Colleagues. J Clin Psychopharmacol. 45(2):172-3",
      "pubdate": "2025-01-13",
      "Lead_author": "Flanagan RJ",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/JCP.0000000000001955",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Flanagan RJ, Obee SJ, Kim AHM, Every-Palmer S. Clozapine Dosage in Treatment-Refractory Schizophrenia: A Reply to Dr Grover and Colleagues. J Clin Psychopharmacol. 45(2):172-3",
    "leadAuthor": "Flanagan RJ",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUi-CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUi-CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-54dedc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707225
  },
  {
    "id": "CLOZ_Demo_62815",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39804775",
    "title": "Expanding Insights on Clozapine Dosing: The Role of Gender, Smoking, and the Clozapine/Norclozapine Ratio.",
    "authors": [
      "Grover S",
      "Mehta R",
      "Sah S",
      "Singh MP",
      "Patil AN"
    ],
    "journal": "J Clin Psychopharmacol",
    "publicationDate": "2025-01-13",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "28f058ff-a340-42ac-8e16-9552805201a3",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:38.919Z"
      },
      {
        "id": "8996f844-a380-424c-b54e-2b4d5f77bd08",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from cb47b8a3-eeb9-4e59-bec9-7f6bba26399c to CLOZ_Demo_62815",
        "type": "system",
        "createdAt": "2025-12-14T10:13:45.846Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:17:59.941Z",
    "updatedAt": "2025-12-14T08:54:38.927Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39804775",
      "DOI": "https://doi.org10.1097/JCP.0000000000001954",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:47:21",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Grover S, Mehta R, Sah S, Singh MP, Patil AN. Expanding Insights on Clozapine Dosing: The Role of Gender, Smoking, and the Clozapine/Norclozapine Ratio. J Clin Psychopharmacol. 45(2):171-2",
      "pubdate": "2025-01-13",
      "Lead_author": "Grover S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/JCP.0000000000001954",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Grover S, Mehta R, Sah S, Singh MP, Patil AN. Expanding Insights on Clozapine Dosing: The Role of Gender, Smoking, and the Clozapine/Norclozapine Ratio. J Clin Psychopharmacol. 45(2):171-2",
    "leadAuthor": "Grover S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjACAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjACAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-54fff80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707225
  },
  {
    "id": "CLOZ_Demo_94719",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39799532",
    "title": "Negative Symptoms in Schizophrenia: An Update on Research Assessment and the Current and Upcoming Treatment Landscape.",
    "authors": [
      "Govil P",
      "Kantrowitz JT"
    ],
    "journal": "CNS Drugs",
    "publicationDate": "2025-01-12",
    "abstract": "This article is a narrative review focusing on the negative symptoms of schizophrenia, which include diminished emotional expression, avolition, alogia, anhedonia, and asociality. These symptoms are noted to be poorly responsive to current treatments and are significant contributors to functional disability in schizophrenia. The review discusses various mechanisms of action and potential treatments, including antipsychotics, glutamatergic modulators, serotonin receptor modulators, anti-inflammatory agents, antidepressants, pro-dopaminergic modulators, acetylcholine modulators, oxytocin, and phosphodiesterase inhibitors. Among the medications mentioned, clozapine is highlighted as a potentially beneficial off-label treatment for negative symptoms in schizophrenia, alongside other drugs like cariprazine, olanzapine, and amisulpride. The article emphasizes that while no definitive gold-standard treatment exists for broadly defined negative symptoms, these medications are generally tolerable and could be considered for off-label trials. The review also discusses investigational treatments such as NMDAR agonists, muscarinic agonists, and LB-102, which are still under study. Suggestions for future research include improving study designs to reduce placebo effects, using more precise rating scales for negative symptoms, and focusing on individuals with predominant negative symptoms. The article does not provide specific data on human subjects, drug administration, or adverse events, as it is a review rather than a clinical study.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "6d4531cd-3215-4f30-91c3-9630060955af",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:38.950Z"
      },
      {
        "id": "9bb1e5d4-7d92-4ddb-b2f3-7f56a1dbd560",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 692d27b9-0ede-4116-8e2a-06adbf7d9799 to CLOZ_Demo_94719",
        "type": "system",
        "createdAt": "2025-12-14T10:13:46.061Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:18:00.032Z",
    "updatedAt": "2025-12-14T08:54:38.998Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39799532",
      "DOI": "https://doi.org/10.1007/s40263-024-01151-7",
      "special_case": "No",
      "Country_of_first_author": "United States",
      "Country_of_occurrence": "United States",
      "Patient_details": "No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: Not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "This article is a narrative review focusing on the negative symptoms of schizophrenia, which include diminished emotional expression, avolition, alogia, anhedonia, and asociality. These symptoms are noted to be poorly responsive to current treatments and are significant contributors to functional disability in schizophrenia. The review discusses various mechanisms of action and potential treatments, including antipsychotics, glutamatergic modulators, serotonin receptor modulators, anti-inflammatory agents, antidepressants, pro-dopaminergic modulators, acetylcholine modulators, oxytocin, and phosphodiesterase inhibitors. Among the medications mentioned, clozapine is highlighted as a potentially beneficial off-label treatment for negative symptoms in schizophrenia, alongside other drugs like cariprazine, olanzapine, and amisulpride. The article emphasizes that while no definitive gold-standard treatment exists for broadly defined negative symptoms, these medications are generally tolerable and could be considered for off-label trials. The review also discusses investigational treatments such as NMDAR agonists, muscarinic agonists, and LB-102, which are still under study. Suggestions for future research include improving study designs to reduce placebo effects, using more precise rating scales for negative symptoms, and focusing on individuals with predominant negative symptoms. The article does not provide specific data on human subjects, drug administration, or adverse events, as it is a review rather than a clinical study.",
      "Identifiable_human_subject": "No",
      "Text_type": "Review Article",
      "Author_perspective": "The article comments on the potential utility of clozapine and other medications for treating negative symptoms in schizophrenia, suggesting they could be considered for off-label trials. It also discusses investigational treatments and provides recommendations for future research directions.",
      "Adverse_event": "No AE",
      "Abstract": "The negative symptoms of schizophrenia include diminished emotional expression, avolition, alogia, anhedonia, and asociality, and due to their low responsiveness to available treatments, are a primary driver of functional disability in schizophrenia. This narrative review has the aim of providing a comprehensive overview of the current research developments in the treatment of negative symptoms in schizophrenia, and begins by introducing the concepts of primary, secondary, prominent, predominant, and broadly defined negative symptoms. We then compare and contrast commonly used research assessment scales for negative symptoms and review the evidence for the specific utility of widely available off-label and investigational treatments that have been studied for negative symptoms. Mechanism of action/putative treatments included are antipsychotics (D<sub>2</sub>R antagonists), N-methyl-D-aspartate receptor (NMDAR) and other glutamatergic modulators, serotonin receptor (5-HTR) modulators, anti-inflammatory agents, antidepressants, pro-dopaminergic modulators (non-D<sub>2</sub>R antagonists), acetylcholine modulators, oxytocin, and phosphodiesterase (PDE) inhibitors. With the caveat that no compounds are definitively proven as gold-standard treatments for broadly defined negative symptoms, the evidence base supports several potentially beneficial off-label and investigational medications for treating negative symptoms in schizophrenia, such as monotherapy with cariprazine, olanzapine, clozapine, and amisulpride, or adjunctive use of memantine, setrons such as ondansetron, minocycline, and antidepressants. These medications are widely available worldwide, generally tolerable and could be considered for an off-label, time-limited trial for a predesignated period of time, after which a decision to switch or stay can be made based on clinical response. Among investigational medications, NMDAR agonists, muscarinic agonists, and LB-102 remain under study. Suggestions for future research include reducing placebo effects by designing studies with a smaller number of high-quality study sites, potentially increasing the use of more precise rating scales for negative symptoms, and focused studies in people with predominant negative symptoms.",
      "Title": "Negative Symptoms in Schizophrenia: An Update on Research Assessment and the Current and Upcoming Treatment Landscape.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:47:13",
      "Vancouver_citation": "Govil P, Kantrowitz JT. Negative Symptoms in Schizophrenia: An Update on Research Assessment and the Current and Upcoming Treatment Landscape. CNS Drugs. 2025;39(3):243-62",
      "pubdate": "2025-01-12",
      "Lead_author": "Govil P",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, Clozapine is mentioned as a potential off-label treatment for negative symptoms of schizophrenia, which is outside its conventional scope of use. This qualifies as off-label use.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study mentions the off-label use of Clozapine for treating negative symptoms of schizophrenia.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1007/s40263-024-01151-7",
    "specialCase": "No",
    "countryOfFirstAuthor": "United States",
    "countryOfOccurrence": "United States",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: Not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "This article is a narrative review focusing on the negative symptoms of schizophrenia, which include diminished emotional expression, avolition, alogia, anhedonia, and asociality. These symptoms are noted to be poorly responsive to current treatments and are significant contributors to functional disability in schizophrenia. The review discusses various mechanisms of action and potential treatments, including antipsychotics, glutamatergic modulators, serotonin receptor modulators, anti-inflammatory agents, antidepressants, pro-dopaminergic modulators, acetylcholine modulators, oxytocin, and phosphodiesterase inhibitors. Among the medications mentioned, clozapine is highlighted as a potentially beneficial off-label treatment for negative symptoms in schizophrenia, alongside other drugs like cariprazine, olanzapine, and amisulpride. The article emphasizes that while no definitive gold-standard treatment exists for broadly defined negative symptoms, these medications are generally tolerable and could be considered for off-label trials. The review also discusses investigational treatments such as NMDAR agonists, muscarinic agonists, and LB-102, which are still under study. Suggestions for future research include improving study designs to reduce placebo effects, using more precise rating scales for negative symptoms, and focusing on individuals with predominant negative symptoms. The article does not provide specific data on human subjects, drug administration, or adverse events, as it is a review rather than a clinical study.",
    "identifiableHumanSubject": "No",
    "textType": "Review Article",
    "authorPerspective": "The article comments on the potential utility of clozapine and other medications for treating negative symptoms in schizophrenia, suggesting they could be considered for off-label trials. It also discusses investigational treatments and provides recommendations for future research directions.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Govil P, Kantrowitz JT. Negative Symptoms in Schizophrenia: An Update on Research Assessment and the Current and Upcoming Treatment Landscape. CNS Drugs. 2025;39(3):243-62",
    "leadAuthor": "Govil P",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, Clozapine is mentioned as a potential off-label treatment for negative symptoms of schizophrenia, which is outside its conventional scope of use. This qualifies as off-label use.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The study mentions the off-label use of Clozapine for treating negative symptoms of schizophrenia.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjBCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjBCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-5523840501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707226
  },
  {
    "id": "CLOZ_Demo_91142",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39641288",
    "title": "Real-World Treatment of Schizophrenia in Adults With a 22q11.2 Microdeletion: Traitement dans le monde réel de la schizophrénie chez des adultes atteints du syndrome de microdélétion 22q11.2.",
    "authors": [
      "Van L",
      "Heung T",
      "Reyes NGD",
      "Boot E",
      "Chow EWC",
      "Corral M",
      "Bassett AS"
    ],
    "journal": "Can J Psychiatry",
    "publicationDate": "2024-12-6",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9bc3bb04-d643-414e-b562-ae9b09ab676d",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:39.011Z"
      },
      {
        "id": "1049a99f-bd60-4dfb-90a9-8ba2058ecac7",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 6d6f1da5-320e-4fe4-ac3b-bc0fed756c9a to CLOZ_Demo_91142",
        "type": "system",
        "createdAt": "2025-12-14T10:13:46.296Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:18:00.198Z",
    "updatedAt": "2025-12-14T08:54:39.060Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39641288",
      "DOI": "https://doi.org10.1177/07067437241293983",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:47:38",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Van L, Heung T, Reyes NGD, Boot E, Chow EWC, Corral M, Bassett AS. Real-World Treatment of Schizophrenia in Adults With a 22q11.2 Microdeletion: Traitement dans le monde réel de la schizophrénie chez des adultes atteints du syndrome de microdélétion 22q11.2. Can J Psychiatry. 2025;70(3):160-70",
      "pubdate": "2024-12-6",
      "Lead_author": "Van L",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1177/07067437241293983",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Van L, Heung T, Reyes NGD, Boot E, Chow EWC, Corral M, Bassett AS. Real-World Treatment of Schizophrenia in Adults With a 22q11.2 Microdeletion: Traitement dans le monde réel de la schizophrénie chez des adultes atteints du syndrome de microdélétion 22q11.2. Can J Psychiatry. 2025;70(3):160-70",
    "leadAuthor": "Van L",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjCCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjCCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-5547540501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707226
  },
  {
    "id": "CLOZ_Demo_85048",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "38233353",
    "title": "Inhibition of the glutamatergic PVT-NAc projections attenuates local anesthetic-induced neurotoxic behaviors.",
    "authors": [
      "Zou Y",
      "He X",
      "Ye Z",
      "Li Z",
      "Guo Q",
      "Zou W",
      "Peng Q"
    ],
    "journal": "Reg Anesth Pain Med",
    "publicationDate": "2024-01-18",
    "abstract": "The study investigates the role of the paraventricular thalamus (PVT)-nucleus accumbens (NAc) projections in neurotoxicity induced by ropivacaine, a local anesthetic agent, using a mouse model. Ropivacaine was administered intraperitoneally at a dose of 58 mg/kg to construct the local anesthetic systemic toxicity (LAST) model in C57BL/6 mice. The study identified neural projections from the PVT to the NAc using retrograde tracers and viruses. Inhibitory viruses were injected into the mice model to assess the effects of specific inhibition of the PVT-NAc pathway on neurological behaviors in the presence of clozapine-N-oxide. The inhibition of the pathway was evaluated through immunofluorescence staining of c-Fos-positive neurons and calcium signals in CaMKIIa neurons. The study successfully identified a circuit connecting the PVT and NAc, and ropivacaine administration was found to activate this pathway, leading to seizures. Specific inhibition of NAc-projecting CaMKII neurons in the PVT reduced neuronal activity in the NAc and decreased ropivacaine-induced neurotoxicity. The findings suggest a dedicated PVT-NAc circuit that regulates local anesthetic-induced neurotoxicity and provide insights into potential mechanisms for the treatment and prevention of LAST. The study does not involve human subjects, and no adverse events related to clozapine were reported.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "0e448b4d-3aa9-44ea-a7bb-c007b2063e7b",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:39.075Z"
      },
      {
        "id": "7c7d3190-c086-49e6-92cf-0a74d4053cd9",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from b80c9e0e-5411-4326-9e84-706160f640be to CLOZ_Demo_85048",
        "type": "system",
        "createdAt": "2025-12-14T10:13:46.524Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:18:00.277Z",
    "updatedAt": "2025-12-14T08:54:39.107Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "38233353",
      "DOI": "https://doi.org/10.1136/rapm-2023-104964",
      "special_case": "No",
      "Country_of_first_author": "China",
      "Country_of_occurrence": "China",
      "Patient_details": "No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: Not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The study investigates the role of the paraventricular thalamus (PVT)-nucleus accumbens (NAc) projections in neurotoxicity induced by ropivacaine, a local anesthetic agent, using a mouse model. Ropivacaine was administered intraperitoneally at a dose of 58 mg/kg to construct the local anesthetic systemic toxicity (LAST) model in C57BL/6 mice. The study identified neural projections from the PVT to the NAc using retrograde tracers and viruses. Inhibitory viruses were injected into the mice model to assess the effects of specific inhibition of the PVT-NAc pathway on neurological behaviors in the presence of clozapine-N-oxide. The inhibition of the pathway was evaluated through immunofluorescence staining of c-Fos-positive neurons and calcium signals in CaMKIIa neurons. The study successfully identified a circuit connecting the PVT and NAc, and ropivacaine administration was found to activate this pathway, leading to seizures. Specific inhibition of NAc-projecting CaMKII neurons in the PVT reduced neuronal activity in the NAc and decreased ropivacaine-induced neurotoxicity. The findings suggest a dedicated PVT-NAc circuit that regulates local anesthetic-induced neurotoxicity and provide insights into potential mechanisms for the treatment and prevention of LAST. The study does not involve human subjects, and no adverse events related to clozapine were reported.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article comments on the effect of ropivacaine and the inhibition of the PVT-NAc pathway in reducing neurotoxicity in the mouse model. It highlights the potential mechanistic explanation for the treatment and prevention of LAST.",
      "Adverse_event": "No AE",
      "Abstract": "Local anesthetic-induced neurotoxicity contributes to perioperative nerve damage; however, the underlying mechanisms remain unclear. Here, we investigated the role of the paraventricular thalamus (PVT)-nucleus accumbens (NAc) projections in neurotoxicity induced by ropivacaine, a local anesthetic agent.\n\nRopivacaine (58 mg/kg, intraperitoneal administration) was used to construct the local anesthetic systemic toxicity (LAST) mice model. We first identified neural projections from the PVT to the NAc through the expression of a retrograde tracer and virus. The inhibitory viruses (rAAV-EF1α-DIO-hm4D(Gi)-mCherry-WPREs: AAV2/retro and rAAV-CaMKII-CRE-WPRE-hGh: AAV2/9) were injected into the mice model to assess the effects of the specific inhibition of the PVT-NAc pathway on neurological behaviors in the presence of clozapine-N-oxide. The inhibition of the PVT-NAc pathway was evaluated by immunofluorescence staining of c-Fos-positive neurons and Ca<sup>2+</sup> signals in CaMKIIa neurons.\n\nWe successfully identified a circuit connecting the PVT and NAc in C57BL/6 mice. Ropivacaine administration induced the activation of the PVT-NAc pathway and seizures. Specific inhibition of NAc-projecting CaMKII neurons in the PVT was sufficient to inhibit the neuronal activity in the NAc, which subsequently decreased ropivacaine-induced neurotoxicity.\n\nThese results reveal the presence of a dedicated PVT-NAc circuit that regulates local anesthetic-induced neurotoxicity and provide a potential mechanistic explanation for the treatment and prevention of LAST.",
      "Title": "Inhibition of the glutamatergic PVT-NAc projections attenuates local anesthetic-induced neurotoxic behaviors.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:47:56",
      "Vancouver_citation": "Zou Y, He X, Ye Z, Li Z, Guo Q, Zou W, Peng Q. Inhibition of the glutamatergic PVT-NAc projections attenuates local anesthetic-induced neurotoxic behaviors. Reg Anesth Pain Med. 2025;50(3):243-51",
      "pubdate": "2024-01-18",
      "Lead_author": "Zou Y",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study are C57BL/6 mice. These mice were used to construct a local anesthetic systemic toxicity (LAST) model through the administration of ropivacaine, a local anesthetic agent. Additionally, clozapine-N-oxide was used in conjunction with inhibitory viruses to assess the effects of specific pathway inhibition.",
      "AOI_drug_effect": "  \n2. The drug of study, clozapine-N-oxide, was used in this study to facilitate the inhibition of the PVT-NAc pathway in the mice model. However, the study does not indicate that clozapine-N-oxide itself induced any medical event or adverse effect in the test subjects. Its role was limited to enabling the inhibition of specific neural pathways. No Drug Effect.",
      "Approved_indication": "  \n3. Clozapine-N-oxide is conventionally used as a pharmacological tool in neuroscience research, particularly in chemogenetic studies, to activate or inhibit designer receptors exclusively activated by designer drugs (DREADDs). It is not typically used for treating illnesses in patients. In this study, clozapine-N-oxide was administered to mice to inhibit the PVT-NAc pathway as part of the investigation into ropivacaine-induced neurotoxicity.",
      "AOI_classification": "No",
      "Justification": "  \n5. The study does not link clozapine-N-oxide to any negative or adverse effects within the test subjects. Its role was solely to facilitate pathway inhibition in the experimental model.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1136/rapm-2023-104964",
    "specialCase": "No",
    "countryOfFirstAuthor": "China",
    "countryOfOccurrence": "China",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: Not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "The study investigates the role of the paraventricular thalamus (PVT)-nucleus accumbens (NAc) projections in neurotoxicity induced by ropivacaine, a local anesthetic agent, using a mouse model. Ropivacaine was administered intraperitoneally at a dose of 58 mg/kg to construct the local anesthetic systemic toxicity (LAST) model in C57BL/6 mice. The study identified neural projections from the PVT to the NAc using retrograde tracers and viruses. Inhibitory viruses were injected into the mice model to assess the effects of specific inhibition of the PVT-NAc pathway on neurological behaviors in the presence of clozapine-N-oxide. The inhibition of the pathway was evaluated through immunofluorescence staining of c-Fos-positive neurons and calcium signals in CaMKIIa neurons. The study successfully identified a circuit connecting the PVT and NAc, and ropivacaine administration was found to activate this pathway, leading to seizures. Specific inhibition of NAc-projecting CaMKII neurons in the PVT reduced neuronal activity in the NAc and decreased ropivacaine-induced neurotoxicity. The findings suggest a dedicated PVT-NAc circuit that regulates local anesthetic-induced neurotoxicity and provide insights into potential mechanisms for the treatment and prevention of LAST. The study does not involve human subjects, and no adverse events related to clozapine were reported.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article comments on the effect of ropivacaine and the inhibition of the PVT-NAc pathway in reducing neurotoxicity in the mouse model. It highlights the potential mechanistic explanation for the treatment and prevention of LAST.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Zou Y, He X, Ye Z, Li Z, Guo Q, Zou W, Peng Q. Inhibition of the glutamatergic PVT-NAc projections attenuates local anesthetic-induced neurotoxic behaviors. Reg Anesth Pain Med. 2025;50(3):243-51",
    "leadAuthor": "Zou Y",
    "serious": "No",
    "testSubject": "The test subjects involved in this study are C57BL/6 mice. These mice were used to construct a local anesthetic systemic toxicity (LAST) model through the administration of ropivacaine, a local anesthetic agent. Additionally, clozapine-N-oxide was used in conjunction with inhibitory viruses to assess the effects of specific pathway inhibition.",
    "aoiDrugEffect": "  \n2. The drug of study, clozapine-N-oxide, was used in this study to facilitate the inhibition of the PVT-NAc pathway in the mice model. However, the study does not indicate that clozapine-N-oxide itself induced any medical event or adverse effect in the test subjects. Its role was limited to enabling the inhibition of specific neural pathways. No Drug Effect.",
    "approvedIndication": "  \n3. Clozapine-N-oxide is conventionally used as a pharmacological tool in neuroscience research, particularly in chemogenetic studies, to activate or inhibit designer receptors exclusively activated by designer drugs (DREADDs). It is not typically used for treating illnesses in patients. In this study, clozapine-N-oxide was administered to mice to inhibit the PVT-NAc pathway as part of the investigation into ropivacaine-induced neurotoxicity.",
    "aoiClassification": "No",
    "justification": "  \n5. The study does not link clozapine-N-oxide to any negative or adverse effects within the test subjects. Its role was solely to facilitate pathway inhibition in the experimental model.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjDCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjDCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-5567f00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707226
  },
  {
    "id": "CLOZ_Demo_52210",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40331229",
    "title": "A case of invasive pulmonary aspergillosis associated with clozapine-induced agranulocytosis.",
    "authors": [
      "Yokode A",
      "Fujiwara M",
      "Terao T",
      "Sakamoto S",
      "Yamada Y",
      "Sato R",
      "Mishima M",
      "Yada Y",
      "Matsuoka KI",
      "Takaki M"
    ],
    "journal": "PCN Rep",
    "publicationDate": "2025-05-7",
    "abstract": "This article describes the first documented case of invasive pulmonary aspergillosis (IPA) associated with clozapine-induced agranulocytosis (CLIA). A 51-year-old man with treatment-resistant schizophrenia developed CLIA nine months after starting clozapine therapy. The patient presented with fever, cough, leukopenia, and neutropenia, leading to the diagnosis of CLIA. Clozapine was discontinued, and empirical treatments with filgrastim and cefepime were initiated. Serum β-D-glucan and Aspergillus galactomannan antigen tests confirmed IPA, and chest CT revealed nodular lesions. Antifungal therapy was switched from micafungin to voriconazole, which led to resolution of the fungal infection and improvement in neutropenia and fever. The patient was re-transferred to a psychiatric hospital for continued treatment. This case highlights the importance of considering fungal infections in patients with CLIA presenting with fever and the utility of serological tests for early diagnosis and appropriate antifungal therapy. The study emphasizes the need for vigilance in monitoring clozapine-treated patients for agranulocytosis and its complications, including fungal infections.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Agranulocytosis and neutropenia were attributed to clozapine. IPA was a complication of CLIA. No adverse events were reported from risperidone or voriconazole.",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "cf3deff2-c0e3-49b5-9175-ef941cfea2ac",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:39.122Z"
      },
      {
        "id": "28920bda-ffd7-4f7a-aa34-2f8f408b3dbd",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 1cd02c39-36a9-4d5a-ab3d-96fb2e381391 to CLOZ_Demo_52210",
        "type": "system",
        "createdAt": "2025-12-14T10:13:46.787Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:20.979Z",
    "updatedAt": "2025-12-14T08:54:39.201Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40331229",
      "DOI": "https://doi.org/10.1002/pcn5.70077",
      "special_case": "No",
      "Country_of_first_author": "Japan",
      "Country_of_occurrence": "Japan",
      "Patient_details": "Patient details: 51-year-old man with schizophrenia, history of treatment-resistant schizophrenia, presented with fever, cough, leukopenia, and neutropenia.",
      "Key_events": "Key events: The patient was diagnosed with clozapine-induced agranulocytosis (CLIA) and invasive pulmonary aspergillosis (IPA) nine months after starting clozapine therapy. He was hospitalized, clozapine was discontinued, and treatments with filgrastim and cefepime were initiated. Antifungal therapy was switched from micafungin to voriconazole following diagnosis of IPA. The patient improved and was re-transferred to a psychiatric hospital.",
      "Relevant_dates": "Relevant dates: Clozapine initiated, dose titrated to 250 mg/day; risperidone added 7 months later; fever and symptoms presented 9 months after clozapine initiation; serum β-D-glucan detected on day 2; Aspergillus galactomannan antigen detected on day 7; filgrastim and cefepime discontinued on day 9; re-transferred to psychiatric hospital on day 13.",
      "Administered_drugs": "Administered drugs: Clozapine, olanzapine, lurasidone, risperidone, filgrastim, cefepime, micafungin, voriconazole.",
      "Attributability": "Attributability: Agranulocytosis and subsequent neutropenia were attributed to clozapine. IPA was diagnosed as a complication of CLIA. No adverse effects were observed from risperidone or voriconazole.",
      "Drug_effect": "Drug effect: The discontinuation of clozapine led to improvement in neutropenia. Antifungal therapy with voriconazole resolved IPA, and the patient's fever and neutropenia improved.",
      "Summary": "This article describes the first documented case of invasive pulmonary aspergillosis (IPA) associated with clozapine-induced agranulocytosis (CLIA). A 51-year-old man with treatment-resistant schizophrenia developed CLIA nine months after starting clozapine therapy. The patient presented with fever, cough, leukopenia, and neutropenia, leading to the diagnosis of CLIA. Clozapine was discontinued, and empirical treatments with filgrastim and cefepime were initiated. Serum β-D-glucan and Aspergillus galactomannan antigen tests confirmed IPA, and chest CT revealed nodular lesions. Antifungal therapy was switched from micafungin to voriconazole, which led to resolution of the fungal infection and improvement in neutropenia and fever. The patient was re-transferred to a psychiatric hospital for continued treatment. This case highlights the importance of considering fungal infections in patients with CLIA presenting with fever and the utility of serological tests for early diagnosis and appropriate antifungal therapy. The study emphasizes the need for vigilance in monitoring clozapine-treated patients for agranulocytosis and its complications, including fungal infections.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Case Report",
      "Author_perspective": "The article comments on the importance of early diagnosis and appropriate antifungal therapy for fungal infections in CLIA patients. It highlights the utility of serological tests and the need for vigilance in monitoring clozapine-treated patients.",
      "Adverse_event": "Agranulocytosis and neutropenia were attributed to clozapine. IPA was a complication of CLIA. No adverse events were reported from risperidone or voriconazole.",
      "Abstract": "Clozapine-induced agranulocytosis (CLIA) is a rare but serious complication. Fever associated with CLIA is typically treated with broad-spectrum antimicrobials, but empiric antifungal therapy is rarely used. While bacterial and viral infections have been reported in CLIA cases, no cases of fungal infections complicated by CLIA have been documented. We report the first case of CLIA complicated by invasive pulmonary aspergillosis (IPA) in a patient with schizophrenia. The diagnosis of IPA was made using serum β-D-glucan, <i>Aspergillus</i> galactomannan antigen tests, and chest computed tomography (CT).\n\nWe present a case of a 51-year-old man with schizophrenia who developed CLIA complicated by IPA. The patient, diagnosed with treatment-resistant schizophrenia, was started on clozapine, but 9 months later he presented with fever, cough, leukopenia, and neutropenia. Clozapine was discontinued, and empirical treatments with cefepime and filgrastim were initiated. Serum β-D-glucan and <i>Aspergillus</i> galactomannan antigen tests were positive, and chest CT showed well-circumscribed nodules, leading to a probable diagnosis of IPA. Antifungal therapy was switched from micafungin to voriconazole according to guidelines. His neutropenia and fever improved, and he was re-transferred to a psychiatric hospital.\n\nCLIA can be complicated by fungal infections. When patients with CLIA present with fever, fungal infections, including IPA, should be considered in the differential diagnosis. Serological tests, including β-D-glucan and <i>Aspergillus</i> galactomannan, are useful for the diagnosis of IPA as well as the appropriate use of antifungal agents in patients with CLIA.",
      "Title": "A case of invasive pulmonary aspergillosis associated with clozapine-induced agranulocytosis.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:48:17",
      "Vancouver_citation": "Yokode A, Fujiwara M, Terao T, Sakamoto S, Yamada Y, Sato R, Mishima M, Yada Y, Matsuoka KI, Takaki M. A case of invasive pulmonary aspergillosis associated with clozapine-induced agranulocytosis. PCN Rep. 2025;4(1):e70077",
      "pubdate": "2025-05-7",
      "Lead_author": "Yokode A",
      "Serious": "Serious",
      "Test_subject": "The test subject in this study is a 51-year-old man diagnosed with treatment-resistant schizophrenia. He was exposed to the drug of study, Clozapine, as part of his treatment regimen.",
      "AOI_drug_effect": "The drug of study had a significant effect on the test subject. It induced agranulocytosis, a rare but serious complication, which was further complicated by invasive pulmonary aspergillosis (IPA). The study investigates the outcomes of these adverse events.",
      "Approved_indication": "The drug of study, Clozapine, is conventionally used to treat treatment-resistant schizophrenia and psychotic disorders occurring during Parkinson's disease when standard treatments fail. In this study, Clozapine was administered to a patient with treatment-resistant schizophrenia, which aligns with its conventional use. The method of administration and the patient group are consistent with the drug's intended use, and there is no indication of off-label use.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study links the drug of study to agranulocytosis, a serious adverse effect, and further complications including invasive pulmonary aspergillosis.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1002/pcn5.70077",
    "specialCase": "No",
    "countryOfFirstAuthor": "Japan",
    "countryOfOccurrence": "Japan",
    "patientDetails": "Patient details: 51-year-old man with schizophrenia, history of treatment-resistant schizophrenia, presented with fever, cough, leukopenia, and neutropenia.",
    "keyEvents": "Key events: The patient was diagnosed with clozapine-induced agranulocytosis (CLIA) and invasive pulmonary aspergillosis (IPA) nine months after starting clozapine therapy. He was hospitalized, clozapine was discontinued, and treatments with filgrastim and cefepime were initiated. Antifungal therapy was switched from micafungin to voriconazole following diagnosis of IPA. The patient improved and was re-transferred to a psychiatric hospital.",
    "relevantDates": "Relevant dates: Clozapine initiated, dose titrated to 250 mg/day; risperidone added 7 months later; fever and symptoms presented 9 months after clozapine initiation; serum β-D-glucan detected on day 2; Aspergillus galactomannan antigen detected on day 7; filgrastim and cefepime discontinued on day 9; re-transferred to psychiatric hospital on day 13.",
    "administeredDrugs": [
      "Administered drugs: Clozapine",
      "olanzapine",
      "lurasidone",
      "risperidone",
      "filgrastim",
      "cefepime",
      "micafungin",
      "voriconazole."
    ],
    "attributability": "Attributability: Agranulocytosis and subsequent neutropenia were attributed to clozapine. IPA was diagnosed as a complication of CLIA. No adverse effects were observed from risperidone or voriconazole.",
    "drugEffect": "Drug effect: The discontinuation of clozapine led to improvement in neutropenia. Antifungal therapy with voriconazole resolved IPA, and the patient's fever and neutropenia improved.",
    "summary": "This article describes the first documented case of invasive pulmonary aspergillosis (IPA) associated with clozapine-induced agranulocytosis (CLIA). A 51-year-old man with treatment-resistant schizophrenia developed CLIA nine months after starting clozapine therapy. The patient presented with fever, cough, leukopenia, and neutropenia, leading to the diagnosis of CLIA. Clozapine was discontinued, and empirical treatments with filgrastim and cefepime were initiated. Serum β-D-glucan and Aspergillus galactomannan antigen tests confirmed IPA, and chest CT revealed nodular lesions. Antifungal therapy was switched from micafungin to voriconazole, which led to resolution of the fungal infection and improvement in neutropenia and fever. The patient was re-transferred to a psychiatric hospital for continued treatment. This case highlights the importance of considering fungal infections in patients with CLIA presenting with fever and the utility of serological tests for early diagnosis and appropriate antifungal therapy. The study emphasizes the need for vigilance in monitoring clozapine-treated patients for agranulocytosis and its complications, including fungal infections.",
    "identifiableHumanSubject": "Yes",
    "textType": "Case Report",
    "authorPerspective": "The article comments on the importance of early diagnosis and appropriate antifungal therapy for fungal infections in CLIA patients. It highlights the utility of serological tests and the need for vigilance in monitoring clozapine-treated patients.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Yokode A, Fujiwara M, Terao T, Sakamoto S, Yamada Y, Sato R, Mishima M, Yada Y, Matsuoka KI, Takaki M. A case of invasive pulmonary aspergillosis associated with clozapine-induced agranulocytosis. PCN Rep. 2025;4(1):e70077",
    "leadAuthor": "Yokode A",
    "serious": "Serious",
    "testSubject": "The test subject in this study is a 51-year-old man diagnosed with treatment-resistant schizophrenia. He was exposed to the drug of study, Clozapine, as part of his treatment regimen.",
    "aoiDrugEffect": "The drug of study had a significant effect on the test subject. It induced agranulocytosis, a rare but serious complication, which was further complicated by invasive pulmonary aspergillosis (IPA). The study investigates the outcomes of these adverse events.",
    "approvedIndication": "The drug of study, Clozapine, is conventionally used to treat treatment-resistant schizophrenia and psychotic disorders occurring during Parkinson's disease when standard treatments fail. In this study, Clozapine was administered to a patient with treatment-resistant schizophrenia, which aligns with its conventional use. The method of administration and the patient group are consistent with the drug's intended use, and there is no indication of off-label use.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The study links the drug of study to agranulocytosis, a serious adverse effect, and further complications including invasive pulmonary aspergillosis.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjECAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjECAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-558c880501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707226
  },
  {
    "id": "CLOZ_Demo_72734",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40226304",
    "title": "Clozapine for Quetiapine-Refractory Psychosis in Parkinson's Disease: A Long-Term Single-Center Retrospective Study.",
    "authors": [
      "Pirker W"
    ],
    "journal": "Parkinsons Dis",
    "publicationDate": "2025-04-14",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "36895c6c-f4d4-42b6-8832-4bba2d8154b9",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:39.212Z"
      },
      {
        "id": "621063c7-28cb-4c21-82c3-c7e3877a3609",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d4b51b1c-76f1-4bf3-9be3-02bd390c459f to CLOZ_Demo_72734",
        "type": "system",
        "createdAt": "2025-12-14T10:13:47.051Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:21.015Z",
    "updatedAt": "2025-12-14T08:54:39.218Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40226304",
      "DOI": "https://doi.org10.1155/padi/1068722",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:49:12",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Pirker W. Clozapine for Quetiapine-Refractory Psychosis in Parkinson's Disease: A Long-Term Single-Center Retrospective Study. Parkinsons Dis. 2025;20251068722",
      "pubdate": "2025-04-14",
      "Lead_author": "Pirker W",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1155/padi/1068722",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Pirker W. Clozapine for Quetiapine-Refractory Psychosis in Parkinson's Disease: A Long-Term Single-Center Retrospective Study. Parkinsons Dis. 2025;20251068722",
    "leadAuthor": "Pirker W",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjFCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjFCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-55b5280501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707227
  },
  {
    "id": "CLOZ_Demo_30160",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40190876",
    "title": "Bugs Bugging the Body and the Brain: A Case of a Bed Bug Infestation Progressing to Delusions of Parasitosis Treated With Clozapine.",
    "authors": [
      "Hahn D",
      "Miller D",
      "Fung J",
      "Mo H",
      "Lind S"
    ],
    "journal": "Cureus",
    "publicationDate": "2025-04-7",
    "abstract": "This article discusses a unique case of a 50-year-old man with bipolar-type schizoaffective disorder who developed delusional parasitosis following a bed bug infestation in his group home. The patient presented with auditory and tactile hallucinations, believing bugs were controlling his brain. He was admitted to the psychiatric department, where his medication regimen was adjusted, including an increase in clozapine dosage from 25 mg to 75 mg twice daily and valproic acid from 500 mg to 750 mg twice daily. Clozapine, an atypical antipsychotic, played a significant role in treating the patient’s symptoms, which is notable as delusional parasitosis is typically treated with second-generation antipsychotics like risperidone or olanzapine. During his three-week hospitalization, the patient’s auditory hallucinations resolved by day 7, and no new hematologic adverse effects were noted. After discharge, the patient continued his prescribed medications and therapy sessions, reporting no recurrence of delusional parasitosis symptoms or hallucinations. The study highlights clozapine’s potential as an effective treatment for refractory delusional parasitosis, despite its known risks of severe side effects such as agranulocytosis. The case underscores the importance of tailored treatment regimens and patient compliance in managing psychiatric conditions.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "525324b2-3c8e-438a-9065-421a9a4135a9",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:39.259Z"
      },
      {
        "id": "aa6cd128-fbff-4920-b53e-737bbb879c6a",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 4b2ebe90-45ec-4531-9937-55a905a860ed to CLOZ_Demo_30160",
        "type": "system",
        "createdAt": "2025-12-14T10:13:47.219Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:21.043Z",
    "updatedAt": "2025-12-14T08:54:39.326Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40190876",
      "DOI": "https://doi.org/10.7759/cureus.80110",
      "special_case": "No",
      "Country_of_first_author": "USA",
      "Country_of_occurrence": "USA",
      "Patient_details": "Patient details: A 50-year-old man with bipolar-type schizoaffective disorder, unemployed for six years, residing in a bed bug-infested group home, with no notable family history of psychiatric illness.",
      "Key_events": "Key events: The patient developed delusional parasitosis after living in a bed bug-infested group home. He presented to the emergency department with bed bug bites and later reported auditory and tactile hallucinations, believing bugs were controlling his brain. He was admitted to the psychiatric department, where his medication regimen was adjusted, including an increase in clozapine dosage. He was monitored for three weeks, during which his symptoms improved, and he was discharged with ongoing therapy and follow-ups.",
      "Relevant_dates": "Relevant dates: \n- Bed bug infestation and relocation to a relative’s house: Not specified.\n- Onset of auditory hallucinations: After relocation.\n- Admission to the psychiatric department: Not specified.\n- Day 7: Resolution of auditory hallucinations.\n- Three-week hospitalization: Not specified.",
      "Administered_drugs": "Administered drugs: Clozapine, valproic acid, benztropine, trazodone, paliperidone palmitate.",
      "Attributability": "Attributability: The patient’s delusional parasitosis symptoms were attributed to inadequate adherence to prescribed medications and psychological distress from the bed bug infestation. Clozapine and valproic acid were effective in minimizing auditory and visual hallucinations.",
      "Drug_effect": "Drug effect: The patient’s auditory and visual hallucinations were minimized, and his overall affect improved. He reported no additional delusional parasitosis symptoms or hallucinations after discharge and continued to experience improvements in mood, appetite, and sleep.",
      "Summary": "This article discusses a unique case of a 50-year-old man with bipolar-type schizoaffective disorder who developed delusional parasitosis following a bed bug infestation in his group home. The patient presented with auditory and tactile hallucinations, believing bugs were controlling his brain. He was admitted to the psychiatric department, where his medication regimen was adjusted, including an increase in clozapine dosage from 25 mg to 75 mg twice daily and valproic acid from 500 mg to 750 mg twice daily. Clozapine, an atypical antipsychotic, played a significant role in treating the patient’s symptoms, which is notable as delusional parasitosis is typically treated with second-generation antipsychotics like risperidone or olanzapine. During his three-week hospitalization, the patient’s auditory hallucinations resolved by day 7, and no new hematologic adverse effects were noted. After discharge, the patient continued his prescribed medications and therapy sessions, reporting no recurrence of delusional parasitosis symptoms or hallucinations. The study highlights clozapine’s potential as an effective treatment for refractory delusional parasitosis, despite its known risks of severe side effects such as agranulocytosis. The case underscores the importance of tailored treatment regimens and patient compliance in managing psychiatric conditions.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Case Report",
      "Author_perspective": "The article comments positively on the effect of clozapine in treating delusional parasitosis, highlighting its successful role in minimizing auditory and visual hallucinations and improving the patient’s overall affect. It suggests clozapine as a potential treatment for refractory cases of delusional parasitosis.",
      "Adverse_event": "No AE",
      "Abstract": "Delusions of parasitosis, also known as delusional parasitosis or Ekbom syndrome, is a rare psychiatric disorder characterized by a fixed belief in a bug infestation, despite the absence of clinical evidence. It often co-occurs with other psychiatric conditions such as depression, anxiety, and schizophrenia. In this case, a 50-year-old man with bipolar-type schizoaffective disorder developed delusional parasitosis after a bed bug infestation in his group home. His inadequate adherence to prescribed medications likely exacerbated his symptoms. Treatment involved the consistent administration of clozapine and valproic acid, with dosage adjustments and close monitoring by a psychiatric team. Notably, clozapine's successful role in this case is unique, as delusional parasitosis is typically treated with second-generation atypical antipsychotics.",
      "Title": "Bugs Bugging the Body and the Brain: A Case of a Bed Bug Infestation Progressing to Delusions of Parasitosis Treated With Clozapine.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:48:52",
      "Vancouver_citation": "Hahn D, Miller D, Fung J, Mo H, Lind S. Bugs Bugging the Body and the Brain: A Case of a Bed Bug Infestation Progressing to Delusions of Parasitosis Treated With Clozapine. Cureus. 2025;17(3):e80110",
      "pubdate": "2025-04-7",
      "Lead_author": "Hahn D",
      "Serious": "No",
      "Test_subject": "Yes, there is a test subject involved in this study. The test subject is a 50-year-old man with bipolar-type schizoaffective disorder who developed delusional parasitosis after a bed bug infestation in his group home.",
      "AOI_drug_effect": "Yes, the drug of study had an effect on the test subject. Clozapine was administered to treat the patient's delusional parasitosis and schizoaffective disorder. The drug was effective in minimizing auditory and visual hallucinations and resolving delusional parasitosis symptoms.",
      "Approved_indication": "Clozapine is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, clozapine was administered orally to a patient with bipolar-type schizoaffective disorder and delusional parasitosis. Delusional parasitosis is not a conventional indication for clozapine, making this an off-label use.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study links clozapine to off-label use for treating delusional parasitosis, which qualifies as non-conventional use.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.7759/cureus.80110",
    "specialCase": "No",
    "countryOfFirstAuthor": "USA",
    "countryOfOccurrence": "USA",
    "patientDetails": "Patient details: A 50-year-old man with bipolar-type schizoaffective disorder, unemployed for six years, residing in a bed bug-infested group home, with no notable family history of psychiatric illness.",
    "keyEvents": "Key events: The patient developed delusional parasitosis after living in a bed bug-infested group home. He presented to the emergency department with bed bug bites and later reported auditory and tactile hallucinations, believing bugs were controlling his brain. He was admitted to the psychiatric department, where his medication regimen was adjusted, including an increase in clozapine dosage. He was monitored for three weeks, during which his symptoms improved, and he was discharged with ongoing therapy and follow-ups.",
    "relevantDates": "Relevant dates: \n- Bed bug infestation and relocation to a relative’s house: Not specified.\n- Onset of auditory hallucinations: After relocation.\n- Admission to the psychiatric department: Not specified.\n- Day 7: Resolution of auditory hallucinations.\n- Three-week hospitalization: Not specified.",
    "administeredDrugs": [
      "Administered drugs: Clozapine",
      "valproic acid",
      "benztropine",
      "trazodone",
      "paliperidone palmitate."
    ],
    "attributability": "Attributability: The patient’s delusional parasitosis symptoms were attributed to inadequate adherence to prescribed medications and psychological distress from the bed bug infestation. Clozapine and valproic acid were effective in minimizing auditory and visual hallucinations.",
    "drugEffect": "Drug effect: The patient’s auditory and visual hallucinations were minimized, and his overall affect improved. He reported no additional delusional parasitosis symptoms or hallucinations after discharge and continued to experience improvements in mood, appetite, and sleep.",
    "summary": "This article discusses a unique case of a 50-year-old man with bipolar-type schizoaffective disorder who developed delusional parasitosis following a bed bug infestation in his group home. The patient presented with auditory and tactile hallucinations, believing bugs were controlling his brain. He was admitted to the psychiatric department, where his medication regimen was adjusted, including an increase in clozapine dosage from 25 mg to 75 mg twice daily and valproic acid from 500 mg to 750 mg twice daily. Clozapine, an atypical antipsychotic, played a significant role in treating the patient’s symptoms, which is notable as delusional parasitosis is typically treated with second-generation antipsychotics like risperidone or olanzapine. During his three-week hospitalization, the patient’s auditory hallucinations resolved by day 7, and no new hematologic adverse effects were noted. After discharge, the patient continued his prescribed medications and therapy sessions, reporting no recurrence of delusional parasitosis symptoms or hallucinations. The study highlights clozapine’s potential as an effective treatment for refractory delusional parasitosis, despite its known risks of severe side effects such as agranulocytosis. The case underscores the importance of tailored treatment regimens and patient compliance in managing psychiatric conditions.",
    "identifiableHumanSubject": "Yes",
    "textType": "Case Report",
    "authorPerspective": "The article comments positively on the effect of clozapine in treating delusional parasitosis, highlighting its successful role in minimizing auditory and visual hallucinations and improving the patient’s overall affect. It suggests clozapine as a potential treatment for refractory cases of delusional parasitosis.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Hahn D, Miller D, Fung J, Mo H, Lind S. Bugs Bugging the Body and the Brain: A Case of a Bed Bug Infestation Progressing to Delusions of Parasitosis Treated With Clozapine. Cureus. 2025;17(3):e80110",
    "leadAuthor": "Hahn D",
    "serious": "No",
    "testSubject": "Yes, there is a test subject involved in this study. The test subject is a 50-year-old man with bipolar-type schizoaffective disorder who developed delusional parasitosis after a bed bug infestation in his group home.",
    "aoiDrugEffect": "Yes, the drug of study had an effect on the test subject. Clozapine was administered to treat the patient's delusional parasitosis and schizoaffective disorder. The drug was effective in minimizing auditory and visual hallucinations and resolving delusional parasitosis symptoms.",
    "approvedIndication": "Clozapine is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, clozapine was administered orally to a patient with bipolar-type schizoaffective disorder and delusional parasitosis. Delusional parasitosis is not a conventional indication for clozapine, making this an off-label use.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The study links clozapine to off-label use for treating delusional parasitosis, which qualifies as non-conventional use.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjGCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjGCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-55d7100501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707227
  },
  {
    "id": "CLOZ_Demo_16434",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40171356",
    "title": "Clozapine-Induced Acute Pericarditis and Cardiac Tamponade: Early Recognition Improves Clinical Outcomes.",
    "authors": [
      "Elahi MW",
      "Shi D",
      "Huang E",
      "Bhushan B"
    ],
    "journal": "Cureus",
    "publicationDate": "2025-04-2",
    "abstract": "This article discusses a case of clozapine-induced acute pericarditis and cardiac tamponade in a 26-year-old male with schizoaffective disorder. The patient had been started on clozapine four months prior, titrated to 250 mg daily, and began experiencing symptoms of sharp chest pain and shortness of breath one week after discharge from a psychiatric facility. Diagnostic imaging revealed a large pericardial effusion with cardiac tamponade physiology, necessitating emergent pericardiocentesis and pericardial drain placement. Treatment with ibuprofen and colchicine led to resolution of symptoms, and clozapine was discontinued during hospitalization and upon discharge. The article emphasizes the importance of early recognition and monitoring of cardiovascular side effects associated with clozapine, including pericarditis and cardiac tamponade, which are rare but potentially life-threatening. The authors recommend implementing cardiac monitoring protocols for patients on clozapine to prevent such adverse effects. The case highlights the need for further research to establish consensus guidelines for optimal cardiac monitoring during clozapine therapy.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "The adverse events included acute pericarditis and cardiac tamponade due to pericardial effusion, which were attributed to clozapine. Emergent pericardiocentesis and pericardial drain placement were required to manage the life-threatening condition. Clozapine was discontinued, and the patient recovered following treatment with ibuprofen and colchicine.",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "fabc12b2-ada7-464a-bc6b-a0c36b9914bd",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:39.339Z"
      },
      {
        "id": "c57ae276-eca0-4631-be5c-cfa5515af17d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from eb3ef778-0a08-4dcf-9c52-e6577b193760 to CLOZ_Demo_16434",
        "type": "system",
        "createdAt": "2025-12-14T10:13:47.467Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:21.077Z",
    "updatedAt": "2025-12-14T08:54:39.346Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40171356",
      "DOI": "https://doi.org/10.7759/cureus.79927",
      "special_case": "No",
      "Country_of_first_author": "USA",
      "Country_of_occurrence": "USA",
      "Patient_details": "Patient details: A 26-year-old male with schizoaffective disorder, bipolar type; catatonia; a cerebrovascular accident at age 15 with residual right-sided weakness; and seizure disorder.",
      "Key_events": "Key events: The patient presented with progressively worsening shortness of breath and intermittent sharp chest pain radiating to the back. He had been started on clozapine four months prior, titrated to 250 mg daily. Symptoms began one week after discharge from a psychiatric facility but were intermittent and not severe enough to warrant an emergency visit initially. Upon presentation to the emergency department, diagnostic imaging revealed a large pericardial effusion with cardiac tamponade physiology. Emergent pericardiocentesis and pericardial drain placement were performed, followed by treatment with ibuprofen and colchicine. Clozapine was discontinued during hospitalization and upon discharge.",
      "Relevant_dates": "Relevant dates: Clozapine initiation occurred four months prior to presentation. Symptoms began one week after discharge from the psychiatric facility. Pericardiocentesis and pericardial drain placement occurred during hospitalization, and the pericardial drain was removed six days later.",
      "Administered_drugs": "Administered drugs: Clozapine, ibuprofen, colchicine.",
      "Attributability": "Attributability: The acute pericarditis and cardiac tamponade were attributed to clozapine-induced pericardial effusion. The exact mechanism is unclear but may involve hypersensitivity reactions or pro-inflammatory cytokine activity.",
      "Drug_effect": "Drug effect: Symptoms of pericarditis and cardiac tamponade resolved after discontinuation of clozapine and treatment with ibuprofen and colchicine.",
      "Summary": "This article discusses a case of clozapine-induced acute pericarditis and cardiac tamponade in a 26-year-old male with schizoaffective disorder. The patient had been started on clozapine four months prior, titrated to 250 mg daily, and began experiencing symptoms of sharp chest pain and shortness of breath one week after discharge from a psychiatric facility. Diagnostic imaging revealed a large pericardial effusion with cardiac tamponade physiology, necessitating emergent pericardiocentesis and pericardial drain placement. Treatment with ibuprofen and colchicine led to resolution of symptoms, and clozapine was discontinued during hospitalization and upon discharge. The article emphasizes the importance of early recognition and monitoring of cardiovascular side effects associated with clozapine, including pericarditis and cardiac tamponade, which are rare but potentially life-threatening. The authors recommend implementing cardiac monitoring protocols for patients on clozapine to prevent such adverse effects. The case highlights the need for further research to establish consensus guidelines for optimal cardiac monitoring during clozapine therapy.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Case Report",
      "Author_perspective": "The authors strongly recommend implementing monitoring protocols to prevent life-threatening cardiovascular complications associated with clozapine, emphasizing the importance of early recognition and treatment to improve clinical outcomes. They highlight the need for further research to establish optimal cardiac monitoring guidelines.",
      "Adverse_event": "The adverse events included acute pericarditis and cardiac tamponade due to pericardial effusion, which were attributed to clozapine. Emergent pericardiocentesis and pericardial drain placement were required to manage the life-threatening condition. Clozapine was discontinued, and the patient recovered following treatment with ibuprofen and colchicine.",
      "Abstract": "Clozapine is approved for treatment-resistant schizophrenia. Many cardiovascular side effects are associated with clozapine, including QTc prolongation and myocarditis, which is a black box warning. Few cases of pericarditis have been reported in recent literature. We report a case of a 26-year-old male with schizoaffective disorder who presented with sharp chest pain and shortness of breath. The patient was started on clozapine three months prior to his current presentation. The workup revealed a large pericardial effusion with cardiac tamponade physiology and signs consistent with acute pericarditis. He required emergent pericardiocentesis and pericardial drain placement. Symptoms resolved after treatment with ibuprofen and colchicine. This case report highlights the importance of early diagnosis of life-threatening cardiovascular complications associated with clozapine, especially acute pericarditis and cardiac tamponade due to pericardial effusion. We strongly recommend implementing monitoring protocols to prevent this potentially life-threatening adverse effect in patients taking clozapine.",
      "Title": "Clozapine-Induced Acute Pericarditis and Cardiac Tamponade: Early Recognition Improves Clinical Outcomes.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:48:34",
      "Vancouver_citation": "Elahi MW, Shi D, Huang E, Bhushan B. Clozapine-Induced Acute Pericarditis and Cardiac Tamponade: Early Recognition Improves Clinical Outcomes. Cureus. 2025;17(3):e79927",
      "pubdate": "2025-04-2",
      "Lead_author": "Elahi MW",
      "Serious": "Serious",
      "Test_subject": "The test subject in this study is a 26-year-old male with schizoaffective disorder, bipolar type, who was exposed to the drug of study, Clozapine. ",
      "AOI_drug_effect": "The drug of study had a significant effect on the test subject. The patient developed acute pericarditis with a large pericardial effusion leading to cardiac tamponade, which required emergent pericardiocentesis and pericardial drain placement. ",
      "Approved_indication": "Clozapine is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, the drug was administered to a patient with schizoaffective disorder, which is not explicitly listed as an indicated use for Clozapine. This qualifies as off-label use.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study links Clozapine to life-threatening cardiovascular side effects, including acute pericarditis and cardiac tamponade, and the drug was used in an off-label manner.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.7759/cureus.79927",
    "specialCase": "No",
    "countryOfFirstAuthor": "USA",
    "countryOfOccurrence": "USA",
    "patientDetails": "Patient details: A 26-year-old male with schizoaffective disorder, bipolar type; catatonia; a cerebrovascular accident at age 15 with residual right-sided weakness; and seizure disorder.",
    "keyEvents": "Key events: The patient presented with progressively worsening shortness of breath and intermittent sharp chest pain radiating to the back. He had been started on clozapine four months prior, titrated to 250 mg daily. Symptoms began one week after discharge from a psychiatric facility but were intermittent and not severe enough to warrant an emergency visit initially. Upon presentation to the emergency department, diagnostic imaging revealed a large pericardial effusion with cardiac tamponade physiology. Emergent pericardiocentesis and pericardial drain placement were performed, followed by treatment with ibuprofen and colchicine. Clozapine was discontinued during hospitalization and upon discharge.",
    "relevantDates": "Relevant dates: Clozapine initiation occurred four months prior to presentation. Symptoms began one week after discharge from the psychiatric facility. Pericardiocentesis and pericardial drain placement occurred during hospitalization, and the pericardial drain was removed six days later.",
    "administeredDrugs": [
      "Administered drugs: Clozapine",
      "ibuprofen",
      "colchicine."
    ],
    "attributability": "Attributability: The acute pericarditis and cardiac tamponade were attributed to clozapine-induced pericardial effusion. The exact mechanism is unclear but may involve hypersensitivity reactions or pro-inflammatory cytokine activity.",
    "drugEffect": "Drug effect: Symptoms of pericarditis and cardiac tamponade resolved after discontinuation of clozapine and treatment with ibuprofen and colchicine.",
    "summary": "This article discusses a case of clozapine-induced acute pericarditis and cardiac tamponade in a 26-year-old male with schizoaffective disorder. The patient had been started on clozapine four months prior, titrated to 250 mg daily, and began experiencing symptoms of sharp chest pain and shortness of breath one week after discharge from a psychiatric facility. Diagnostic imaging revealed a large pericardial effusion with cardiac tamponade physiology, necessitating emergent pericardiocentesis and pericardial drain placement. Treatment with ibuprofen and colchicine led to resolution of symptoms, and clozapine was discontinued during hospitalization and upon discharge. The article emphasizes the importance of early recognition and monitoring of cardiovascular side effects associated with clozapine, including pericarditis and cardiac tamponade, which are rare but potentially life-threatening. The authors recommend implementing cardiac monitoring protocols for patients on clozapine to prevent such adverse effects. The case highlights the need for further research to establish consensus guidelines for optimal cardiac monitoring during clozapine therapy.",
    "identifiableHumanSubject": "Yes",
    "textType": "Case Report",
    "authorPerspective": "The authors strongly recommend implementing monitoring protocols to prevent life-threatening cardiovascular complications associated with clozapine, emphasizing the importance of early recognition and treatment to improve clinical outcomes. They highlight the need for further research to establish optimal cardiac monitoring guidelines.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Elahi MW, Shi D, Huang E, Bhushan B. Clozapine-Induced Acute Pericarditis and Cardiac Tamponade: Early Recognition Improves Clinical Outcomes. Cureus. 2025;17(3):e79927",
    "leadAuthor": "Elahi MW",
    "serious": "Serious",
    "testSubject": "The test subject in this study is a 26-year-old male with schizoaffective disorder, bipolar type, who was exposed to the drug of study, Clozapine. ",
    "aoiDrugEffect": "The drug of study had a significant effect on the test subject. The patient developed acute pericarditis with a large pericardial effusion leading to cardiac tamponade, which required emergent pericardiocentesis and pericardial drain placement. ",
    "approvedIndication": "Clozapine is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, the drug was administered to a patient with schizoaffective disorder, which is not explicitly listed as an indicated use for Clozapine. This qualifies as off-label use.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The study links Clozapine to life-threatening cardiovascular side effects, including acute pericarditis and cardiac tamponade, and the drug was used in an off-label manner.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjHCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjHCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-55fc740501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707227
  },
  {
    "id": "CLOZ_Demo_38681",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40048118",
    "title": "Challenging the impostor: a scoping review of the pharmacological management of Capgras syndrome in Parkinson's disease and Lewy bodies dementia.",
    "authors": [
      "Luca A",
      "Luca M",
      "Ferri R",
      "Serretti A"
    ],
    "journal": "Neurol Sci",
    "publicationDate": "2025-03-6",
    "abstract": "The article is a scoping review that examines the pharmacological management of Capgras syndrome (CS) in patients with Parkinson's disease (PD) and Lewy Body Dementia (LBD). It highlights that most PD patients with CS experienced cognitive decline and visual hallucinations. These patients were managed by reducing dopaminergic therapy and prescribing neuroleptics, including quetiapine, clozapine, and pimavanserin, which often led to improvement. Neuroleptics were also used in LBD patients, but their efficacy was inconsistent. The review emphasizes the lack of robust evidence for the pharmacological treatment of CS in these conditions and calls for future prospective studies to establish evidence-based guidelines. Clozapine is specifically mentioned as one of the neuroleptics used in the management of CS, and it appears to have contributed to improvement in some cases. However, the variability in efficacy, particularly in LBD patients, underscores the need for further research.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "116adfc4-415d-4968-8f40-1b580951bdc3",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:39.421Z"
      },
      {
        "id": "10c7c4df-0410-45f1-9a49-292950616e56",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 96f10a5a-f805-41dc-8394-807725e6549e to CLOZ_Demo_38681",
        "type": "system",
        "createdAt": "2025-12-14T10:13:47.701Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:21.106Z",
    "updatedAt": "2025-12-14T08:54:39.440Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40048118",
      "DOI": "https://doi.org/10.1007/s10072-025-08078-x",
      "special_case": "No",
      "Country_of_first_author": "Italy",
      "Country_of_occurrence": "Italy",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: The article discusses the pharmacological management of Capgras syndrome (CS) in patients with Parkinson's disease (PD) and Lewy Body Dementia (LBD). It mentions that most PD patients with CS experienced cognitive decline and visual hallucinations. These patients were managed by reducing dopaminergic therapy and prescribing neuroleptics such as quetiapine, clozapine, or pimavanserin, which often resulted in improvement. Neuroleptics were also used in LBD patients, but their efficacy was variable.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: quetiapine, clozapine, pimavanserin",
      "Attributability": "Attributability: The article suggests that neuroleptics and adjustments in dopaminergic therapy may be beneficial for managing Capgras syndrome in patients with Parkinson's disease and Lewy Body Dementia. However, the efficacy of neuroleptics in LBD patients was variable, and robust evidence is lacking.",
      "Drug_effect": "Drug effect: summary. Neuroleptics and dopaminergic dose adjustments often resulted in improvement in patients with Parkinson's disease and Capgras syndrome. However, the efficacy of neuroleptics in Lewy Body Dementia patients was variable.",
      "Summary": "The article is a scoping review that examines the pharmacological management of Capgras syndrome (CS) in patients with Parkinson's disease (PD) and Lewy Body Dementia (LBD). It highlights that most PD patients with CS experienced cognitive decline and visual hallucinations. These patients were managed by reducing dopaminergic therapy and prescribing neuroleptics, including quetiapine, clozapine, and pimavanserin, which often led to improvement. Neuroleptics were also used in LBD patients, but their efficacy was inconsistent. The review emphasizes the lack of robust evidence for the pharmacological treatment of CS in these conditions and calls for future prospective studies to establish evidence-based guidelines. Clozapine is specifically mentioned as one of the neuroleptics used in the management of CS, and it appears to have contributed to improvement in some cases. However, the variability in efficacy, particularly in LBD patients, underscores the need for further research.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Review Article",
      "Author_perspective": "The article comments on the effect of neuroleptics and dopaminergic dose adjustments on patients with Capgras syndrome in Parkinson's disease and Lewy Body Dementia. It notes that these treatments often resulted in improvement in PD patients but had variable efficacy in LBD patients. The authors emphasize the need for future studies to establish evidence-based guidelines for managing this syndrome.",
      "Adverse_event": "No AE",
      "Abstract": "Capgras syndrome (CS) is a delusional misidentification phenomenon increasingly reported in patients with Parkinson's disease (PD) and Lewy Body Dementia (LBD). Aim of the present scoping review was to provide an overview on current evidence on the pharmacological treatment of CS in PD and LBD, identifying knowledge gaps in the literature.\n\nThe following databases were consulted: PubMed, Google Scholar, the Cochrane Database and Web of Science.\n\nThe search query covered a time period from 1976 until 2022. Fourteen studies on PD (11 single case reports, 3 case series) and five on LBD (all single case reports) met the inclusion criteria. Most PD patients with CS had cognitive decline and visual hallucinations, and were managed by reducing dopaminergic therapy and prescribing neuroleptics (quetiapine, clozapine or pimavanserin), which often resulted in improvement. Neuroleptics have also been used in LBD, but with variable efficacy.\n\nAlthough neuroleptics and dopaminergic dose adjustments appear to be beneficial for CS in PD and LBD, robust evidence is lacking. Future prospective studies are essential to establish evidence-based guidelines for this challenging syndrome.",
      "Title": "Challenging the impostor: a scoping review of the pharmacological management of Capgras syndrome in Parkinson's disease and Lewy bodies dementia.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:49:42",
      "Vancouver_citation": "Luca A, Luca M, Ferri R, Serretti A. Challenging the impostor: a scoping review of the pharmacological management of Capgras syndrome in Parkinson's disease and Lewy bodies dementia. Neurol Sci. 2025;46(7):2979-84",
      "pubdate": "2025-03-6",
      "Lead_author": "Luca A",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study are patients with Parkinson's disease (PD) and Lewy Body Dementia (LBD) who experienced Capgras syndrome (CS). These patients were managed with neuroleptics, including the drug of study, Clozapine.",
      "AOI_drug_effect": "The drug of study, Clozapine, was used as part of the pharmacological management for patients with CS in PD and LBD. The study mentions that the use of neuroleptics, including Clozapine, often resulted in improvement in managing CS in PD patients. However, the efficacy in LBD patients was variable. There is no specific mention of adverse events caused by Clozapine in this study.",
      "Approved_indication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders in Parkinson's disease when standard treatments fail. In this study, Clozapine was administered to patients with Parkinson's disease and Lewy Body Dementia to manage Capgras syndrome, which is a delusional misidentification phenomenon. This qualifies as off-label use since Capgras syndrome is not listed as an accepted indication for Clozapine.",
      "AOI_classification": "Yes",
      "Justification": "The study mentions off-label use of Clozapine for Capgras syndrome in Parkinson's disease and Lewy Body Dementia patients.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1007/s10072-025-08078-x",
    "specialCase": "No",
    "countryOfFirstAuthor": "Italy",
    "countryOfOccurrence": "Italy",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: The article discusses the pharmacological management of Capgras syndrome (CS) in patients with Parkinson's disease (PD) and Lewy Body Dementia (LBD). It mentions that most PD patients with CS experienced cognitive decline and visual hallucinations. These patients were managed by reducing dopaminergic therapy and prescribing neuroleptics such as quetiapine, clozapine, or pimavanserin, which often resulted in improvement. Neuroleptics were also used in LBD patients, but their efficacy was variable.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: quetiapine",
      "clozapine",
      "pimavanserin"
    ],
    "attributability": "Attributability: The article suggests that neuroleptics and adjustments in dopaminergic therapy may be beneficial for managing Capgras syndrome in patients with Parkinson's disease and Lewy Body Dementia. However, the efficacy of neuroleptics in LBD patients was variable, and robust evidence is lacking.",
    "drugEffect": "Drug effect: summary. Neuroleptics and dopaminergic dose adjustments often resulted in improvement in patients with Parkinson's disease and Capgras syndrome. However, the efficacy of neuroleptics in Lewy Body Dementia patients was variable.",
    "summary": "The article is a scoping review that examines the pharmacological management of Capgras syndrome (CS) in patients with Parkinson's disease (PD) and Lewy Body Dementia (LBD). It highlights that most PD patients with CS experienced cognitive decline and visual hallucinations. These patients were managed by reducing dopaminergic therapy and prescribing neuroleptics, including quetiapine, clozapine, and pimavanserin, which often led to improvement. Neuroleptics were also used in LBD patients, but their efficacy was inconsistent. The review emphasizes the lack of robust evidence for the pharmacological treatment of CS in these conditions and calls for future prospective studies to establish evidence-based guidelines. Clozapine is specifically mentioned as one of the neuroleptics used in the management of CS, and it appears to have contributed to improvement in some cases. However, the variability in efficacy, particularly in LBD patients, underscores the need for further research.",
    "identifiableHumanSubject": "Yes",
    "textType": "Review Article",
    "authorPerspective": "The article comments on the effect of neuroleptics and dopaminergic dose adjustments on patients with Capgras syndrome in Parkinson's disease and Lewy Body Dementia. It notes that these treatments often resulted in improvement in PD patients but had variable efficacy in LBD patients. The authors emphasize the need for future studies to establish evidence-based guidelines for managing this syndrome.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Luca A, Luca M, Ferri R, Serretti A. Challenging the impostor: a scoping review of the pharmacological management of Capgras syndrome in Parkinson's disease and Lewy bodies dementia. Neurol Sci. 2025;46(7):2979-84",
    "leadAuthor": "Luca A",
    "serious": "No",
    "testSubject": "The test subjects involved in this study are patients with Parkinson's disease (PD) and Lewy Body Dementia (LBD) who experienced Capgras syndrome (CS). These patients were managed with neuroleptics, including the drug of study, Clozapine.",
    "aoiDrugEffect": "The drug of study, Clozapine, was used as part of the pharmacological management for patients with CS in PD and LBD. The study mentions that the use of neuroleptics, including Clozapine, often resulted in improvement in managing CS in PD patients. However, the efficacy in LBD patients was variable. There is no specific mention of adverse events caused by Clozapine in this study.",
    "approvedIndication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders in Parkinson's disease when standard treatments fail. In this study, Clozapine was administered to patients with Parkinson's disease and Lewy Body Dementia to manage Capgras syndrome, which is a delusional misidentification phenomenon. This qualifies as off-label use since Capgras syndrome is not listed as an accepted indication for Clozapine.",
    "aoiClassification": "Yes",
    "justification": "The study mentions off-label use of Clozapine for Capgras syndrome in Parkinson's disease and Lewy Body Dementia patients.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjICAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjICAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-561fc40501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707227
  },
  {
    "id": "CLOZ_Demo_23323",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39947104",
    "title": "Continuous theta burst stimulation (cTBS) as a safe and effective treatment for auditory verbal hallucinations (AVHs) unresponsive to ECT, tDCS, and Clozapine: A case report.",
    "authors": [
      "Pandey S",
      "Gupta B",
      "Kar SK"
    ],
    "journal": "Asian J Psychiatr",
    "publicationDate": "2025-02-14",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9bcad3ad-c995-4c9e-ac2b-29e1e8761e9d",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:39.462Z"
      },
      {
        "id": "2dac8cca-e2bf-4cc1-b22c-870f6eed7492",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 888e88be-60c5-4064-a5ea-079f2f1c7ee6 to CLOZ_Demo_23323",
        "type": "system",
        "createdAt": "2025-12-14T10:13:47.943Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:21.141Z",
    "updatedAt": "2025-12-14T08:54:39.496Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39947104",
      "DOI": "https://doi.org10.1016/j.ajp.2025.104393",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:49:20",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Pandey S, Gupta B, Kar SK. Continuous theta burst stimulation (cTBS) as a safe and effective treatment for auditory verbal hallucinations (AVHs) unresponsive to ECT, tDCS, and Clozapine: A case report. Asian J Psychiatr. 2025;105104393",
      "pubdate": "2025-02-14",
      "Lead_author": "Pandey S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.ajp.2025.104393",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Pandey S, Gupta B, Kar SK. Continuous theta burst stimulation (cTBS) as a safe and effective treatment for auditory verbal hallucinations (AVHs) unresponsive to ECT, tDCS, and Clozapine: A case report. Asian J Psychiatr. 2025;105104393",
    "leadAuthor": "Pandey S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjJCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjJCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-56479c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707228
  },
  {
    "id": "CLOZ_Demo_42751",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39933175",
    "title": "Pharmacogenetic Variant Related Higher-Than-Expected Clozapine Concentrations and Clozapine/Norclozapine Ratios in a Patient With Treatment-Resistant Schizoaffective Disorder: A Case Report.",
    "authors": [
      "Yalçın N",
      "Bayraktar İ",
      "Akyol A",
      "Deger I",
      "İman MF",
      "Mutlu E",
      "Ak S",
      "Özmen F",
      "Babaoglu MÖ"
    ],
    "journal": "J Clin Psychopharmacol",
    "publicationDate": "2025-02-11",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "11c09cc0-728f-4e27-9e77-de00e7139ba3",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:39.510Z"
      },
      {
        "id": "bd324a4b-319d-4756-b060-66bc485487c3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from ba2ff60b-8c64-4935-8861-1add15fbaad0 to CLOZ_Demo_42751",
        "type": "system",
        "createdAt": "2025-12-14T10:13:48.157Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:21.165Z",
    "updatedAt": "2025-12-14T08:54:39.542Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39933175",
      "DOI": "https://doi.org10.1097/JCP.0000000000001973",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:49:27",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Yalçın N, Bayraktar İ, Akyol A, Deger I, İman MF, Mutlu E, Ak S, Özmen F, Babaoglu MÖ. Pharmacogenetic Variant Related Higher-Than-Expected Clozapine Concentrations and Clozapine/Norclozapine Ratios in a Patient With Treatment-Resistant Schizoaffective Disorder: A Case Report. J Clin Psychopharmacol. 45(2):163-5",
      "pubdate": "2025-02-11",
      "Lead_author": "Yalçın N",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/JCP.0000000000001973",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Yalçın N, Bayraktar İ, Akyol A, Deger I, İman MF, Mutlu E, Ak S, Özmen F, Babaoglu MÖ. Pharmacogenetic Variant Related Higher-Than-Expected Clozapine Concentrations and Clozapine/Norclozapine Ratios in a Patient With Treatment-Resistant Schizoaffective Disorder: A Case Report. J Clin Psychopharmacol. 45(2):163-5",
    "leadAuthor": "Yalçın N",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjKCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjKCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-5668a00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707228
  },
  {
    "id": "CLOZ_Demo_78550",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39930323",
    "title": "Separation and Quantitative Estimation of Pharmacopeial Organic Impurities, Process-Related Impurities, and Degradation Products of the Anti-Schizophrenia Drug Clozapine in Pharmaceutical Formulations by Using Stability-Indicating HPLC Method.",
    "authors": [
      "Sharma A",
      "Pedavenkatagari NR",
      "Nagulancha BR",
      "Lakka NS"
    ],
    "journal": "Biomed Chromatogr",
    "publicationDate": "2025-02-11",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "edb4604b-43aa-47a0-897a-f486b8a2c316",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:39.555Z"
      },
      {
        "id": "aad28c91-bddc-4a52-82fd-1fedc5af9d44",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from e1a7be60-98a0-4a9c-b255-02dffc51fa6c to CLOZ_Demo_78550",
        "type": "system",
        "createdAt": "2025-12-14T10:13:48.392Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:21.201Z",
    "updatedAt": "2025-12-14T08:54:39.606Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39930323",
      "DOI": "https://doi.org10.1002/bmc.70021",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:49:55",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Sharma A, Pedavenkatagari NR, Nagulancha BR, Lakka NS. Separation and Quantitative Estimation of Pharmacopeial Organic Impurities, Process-Related Impurities, and Degradation Products of the Anti-Schizophrenia Drug Clozapine in Pharmaceutical Formulations by Using Stability-Indicating HPLC Method. Biomed Chromatogr. 2025;39(3):e70021",
      "pubdate": "2025-02-11",
      "Lead_author": "Sharma A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/bmc.70021",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Sharma A, Pedavenkatagari NR, Nagulancha BR, Lakka NS. Separation and Quantitative Estimation of Pharmacopeial Organic Impurities, Process-Related Impurities, and Degradation Products of the Anti-Schizophrenia Drug Clozapine in Pharmaceutical Formulations by Using Stability-Indicating HPLC Method. Biomed Chromatogr. 2025;39(3):e70021",
    "leadAuthor": "Sharma A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjLCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjLCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-568c640501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707228
  },
  {
    "id": "CLOZ_Demo_41894",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39928693",
    "title": "Oculogyric Crisis Associated With Clozapine: Case Report and Review of Literature.",
    "authors": [
      "Shukla R",
      "Thomas A"
    ],
    "journal": "J Clin Psychopharmacol",
    "publicationDate": "2025-02-10",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9fe1e43a-d4de-4e02-a177-cebff2045763",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:39.633Z"
      },
      {
        "id": "be301192-2490-4a1e-95ed-21cf623a79cc",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 47daa1ae-3147-41c1-a5bc-c5fc73ea0399 to CLOZ_Demo_41894",
        "type": "system",
        "createdAt": "2025-12-14T10:13:48.607Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:21.231Z",
    "updatedAt": "2025-12-14T08:54:39.641Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39928693",
      "DOI": "https://doi.org10.1097/JCP.0000000000001960",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:50:02",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Shukla R, Thomas A. Oculogyric Crisis Associated With Clozapine: Case Report and Review of Literature. J Clin Psychopharmacol. 45(2):156-7",
      "pubdate": "2025-02-10",
      "Lead_author": "Shukla R",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/JCP.0000000000001960",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Shukla R, Thomas A. Oculogyric Crisis Associated With Clozapine: Case Report and Review of Literature. J Clin Psychopharmacol. 45(2):156-7",
    "leadAuthor": "Shukla R",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjMCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjMCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-56ad9c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707228
  },
  {
    "id": "CLOZ_Demo_17863",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39835595",
    "title": "Cross-titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report.",
    "authors": [
      "Centanni N",
      "Garvey K",
      "Mullany E",
      "Nichols S"
    ],
    "journal": "Pharmacotherapy",
    "publicationDate": "2025-01-21",
    "abstract": "This article describes the case of a 68-year-old female patient with schizophrenia and Parkinson's disease who was admitted to the hospital after a fall. She was taking risperidone and fluoxetine at the time of admission. During her hospital stay, the patient underwent a cross-titration from risperidone to clozapine over 17 days, with the final dose of clozapine being 75 mg daily. The transition was guided by serum clozapine levels and clinical status, particularly in the context of multiple drug-drug interactions. The study highlights the lack of evidence-based guidelines for transitioning patients between antipsychotics, especially when drug interactions are involved. It emphasizes the potential utility of serum clozapine levels in guiding dose adjustments during antipsychotic cross-titration. The patient was successfully transitioned without any reported adverse events or complications, demonstrating the feasibility of this approach in clinical practice.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "96ec91ed-9a7c-4691-af01-b311582676ce",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:39.662Z"
      },
      {
        "id": "10315290-c79e-465f-9e29-f56a77e28800",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 64725204-8571-4538-bf67-01f9edadb824 to CLOZ_Demo_17863",
        "type": "system",
        "createdAt": "2025-12-14T10:13:48.822Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:21.262Z",
    "updatedAt": "2025-12-14T08:54:39.725Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39835595",
      "DOI": "https://doi.org/10.1002/phar.4649",
      "special_case": "No",
      "Country_of_first_author": "USA",
      "Country_of_occurrence": "USA",
      "Patient_details": "Patient details: 68-year-old female patient with a history of schizophrenia, taking risperidone and fluoxetine, and a recent diagnosis of Parkinson's disease.",
      "Key_events": "Key events: The patient was admitted to the hospital after a fall at home. During the hospital stay, she was cross-titrated from risperidone to clozapine over 17 days, utilizing serum clozapine levels to guide dosing in the context of multiple drug-drug interactions.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: risperidone, fluoxetine, clozapine",
      "Attributability": "Attributability: The patient was successfully transitioned from risperidone to clozapine using serum clozapine levels and clinical status to guide decision-making. No adverse events or complications directly attributed to the medications were mentioned.",
      "Drug_effect": "Drug effect: summary: The transition from risperidone to clozapine was successful, guided by serum clozapine levels and clinical status.",
      "Summary": "This article describes the case of a 68-year-old female patient with schizophrenia and Parkinson's disease who was admitted to the hospital after a fall. She was taking risperidone and fluoxetine at the time of admission. During her hospital stay, the patient underwent a cross-titration from risperidone to clozapine over 17 days, with the final dose of clozapine being 75 mg daily. The transition was guided by serum clozapine levels and clinical status, particularly in the context of multiple drug-drug interactions. The study highlights the lack of evidence-based guidelines for transitioning patients between antipsychotics, especially when drug interactions are involved. It emphasizes the potential utility of serum clozapine levels in guiding dose adjustments during antipsychotic cross-titration. The patient was successfully transitioned without any reported adverse events or complications, demonstrating the feasibility of this approach in clinical practice.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Case Report",
      "Author_perspective": "The article comments positively on the use of serum clozapine levels to guide dose adjustments during antipsychotic cross-titration, especially in the presence of multiple drug-drug interactions. It highlights the successful transition of the patient from risperidone to clozapine and suggests that this approach may be helpful in similar clinical scenarios.",
      "Adverse_event": "No AE",
      "Abstract": "Clozapine and risperidone are second-generation antipsychotics used in the treatment of schizophrenia. There are no guidelines on cross-titration of antipsychotics and, additionally, there is a paucity of published data to support the potential utility of using serum drug levels to guide dosing in these situations.\n\nA 68-year-old female patient with a history of schizophrenia, taking risperidone and fluoxetine, and a recent diagnosis of Parkinson's disease was admitted to the hospital after a fall at home. During the patient's hospital stay, utilizing serum clozapine levels as guidance, the patient was cross-titrated from risperidone 12 mg daily to a final dose of clozapine 75 mg daily over the span of 17 days, in the setting of multiple possible drug-drug interactions.\n\nThere is no evidence-based guidance on transitioning patients from one antipsychotic to another especially in the setting of drug-drug interactions. In this case, the patient was successfully transitioned from risperidone to clozapine using serum clozapine levels and clinical status to guide decision-making.\n\nUtilizing serum clozapine levels may be helpful in guiding dose changes during antipsychotic cross-titration, especially when multiple drug interactions are involved.",
      "Title": "Cross-titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:50:33",
      "Vancouver_citation": "Centanni N, Garvey K, Mullany E, Nichols S. Cross-titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report. Pharmacotherapy. 2025;45(3):187-90",
      "pubdate": "2025-01-21",
      "Lead_author": "Centanni N",
      "Serious": "No",
      "Test_subject": "The test subject in this study is a 68-year-old female patient with a history of schizophrenia and a recent diagnosis of Parkinson's disease. She was exposed to the drug of study, Clozapine, during her hospital stay.",
      "AOI_drug_effect": "The drug of study did not induce any specific adverse event or medical significance in the test subject. The study focuses on the successful cross-titration from risperidone to clozapine using serum clozapine levels as guidance. No Drug Effect.",
      "Approved_indication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders occurring during Parkinson's disease when standard treatments fail. In this study, the drug was administered to a patient with schizophrenia and Parkinson's disease, which aligns with its conventional use. The method of administration and purpose of treatment were conventional, and this does not qualify as off-label use.",
      "AOI_classification": "No",
      "Justification": "The study does not link the drug of study to any adverse effects or negative outcomes, nor was it used in a non-conventional way.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1002/phar.4649",
    "specialCase": "No",
    "countryOfFirstAuthor": "USA",
    "countryOfOccurrence": "USA",
    "patientDetails": "Patient details: 68-year-old female patient with a history of schizophrenia, taking risperidone and fluoxetine, and a recent diagnosis of Parkinson's disease.",
    "keyEvents": "Key events: The patient was admitted to the hospital after a fall at home. During the hospital stay, she was cross-titrated from risperidone to clozapine over 17 days, utilizing serum clozapine levels to guide dosing in the context of multiple drug-drug interactions.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: risperidone",
      "fluoxetine",
      "clozapine"
    ],
    "attributability": "Attributability: The patient was successfully transitioned from risperidone to clozapine using serum clozapine levels and clinical status to guide decision-making. No adverse events or complications directly attributed to the medications were mentioned.",
    "drugEffect": "Drug effect: summary: The transition from risperidone to clozapine was successful, guided by serum clozapine levels and clinical status.",
    "summary": "This article describes the case of a 68-year-old female patient with schizophrenia and Parkinson's disease who was admitted to the hospital after a fall. She was taking risperidone and fluoxetine at the time of admission. During her hospital stay, the patient underwent a cross-titration from risperidone to clozapine over 17 days, with the final dose of clozapine being 75 mg daily. The transition was guided by serum clozapine levels and clinical status, particularly in the context of multiple drug-drug interactions. The study highlights the lack of evidence-based guidelines for transitioning patients between antipsychotics, especially when drug interactions are involved. It emphasizes the potential utility of serum clozapine levels in guiding dose adjustments during antipsychotic cross-titration. The patient was successfully transitioned without any reported adverse events or complications, demonstrating the feasibility of this approach in clinical practice.",
    "identifiableHumanSubject": "Yes",
    "textType": "Case Report",
    "authorPerspective": "The article comments positively on the use of serum clozapine levels to guide dose adjustments during antipsychotic cross-titration, especially in the presence of multiple drug-drug interactions. It highlights the successful transition of the patient from risperidone to clozapine and suggests that this approach may be helpful in similar clinical scenarios.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Centanni N, Garvey K, Mullany E, Nichols S. Cross-titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report. Pharmacotherapy. 2025;45(3):187-90",
    "leadAuthor": "Centanni N",
    "serious": "No",
    "testSubject": "The test subject in this study is a 68-year-old female patient with a history of schizophrenia and a recent diagnosis of Parkinson's disease. She was exposed to the drug of study, Clozapine, during her hospital stay.",
    "aoiDrugEffect": "The drug of study did not induce any specific adverse event or medical significance in the test subject. The study focuses on the successful cross-titration from risperidone to clozapine using serum clozapine levels as guidance. No Drug Effect.",
    "approvedIndication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders occurring during Parkinson's disease when standard treatments fail. In this study, the drug was administered to a patient with schizophrenia and Parkinson's disease, which aligns with its conventional use. The method of administration and purpose of treatment were conventional, and this does not qualify as off-label use.",
    "aoiClassification": "No",
    "justification": "The study does not link the drug of study to any adverse effects or negative outcomes, nor was it used in a non-conventional way.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjNCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjNCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-56cddc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707228
  },
  {
    "id": "CLOZ_Demo_67047",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39834274",
    "title": "Second-generation antipsychotic-induced dystonia: Analysis using the Japanese Adverse Drug Event Report (JADER) database.",
    "authors": [
      "Ebina T",
      "Iwamoto K",
      "Ando M",
      "Ikeda M"
    ],
    "journal": "Psychiatry Clin Neurosci",
    "publicationDate": "2025-01-21",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "845a20ae-0f31-46d2-bdf3-1f3f5e6917fd",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:39.738Z"
      },
      {
        "id": "1c34341b-081b-4b72-86f5-3f49d6e39b10",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 15dcd374-983d-4bbe-9427-ca98d7478564 to CLOZ_Demo_67047",
        "type": "system",
        "createdAt": "2025-12-14T10:13:49.073Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:21.294Z",
    "updatedAt": "2025-12-14T08:54:39.792Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39834274",
      "DOI": "https://doi.org10.1111/pcn.13785",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:50:19",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Ebina T, Iwamoto K, Ando M, Ikeda M. Second-generation antipsychotic-induced dystonia: Analysis using the Japanese Adverse Drug Event Report (JADER) database. Psychiatry Clin Neurosci. 2025;79(3):117-24",
      "pubdate": "2025-01-21",
      "Lead_author": "Ebina T",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/pcn.13785",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Ebina T, Iwamoto K, Ando M, Ikeda M. Second-generation antipsychotic-induced dystonia: Analysis using the Japanese Adverse Drug Event Report (JADER) database. Psychiatry Clin Neurosci. 2025;79(3):117-24",
    "leadAuthor": "Ebina T",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjOCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjOCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-56f1800501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707229
  },
  {
    "id": "CLOZ_Demo_38139",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39804782",
    "title": "Clinical and Demographic Predictors of Early Clozapine Discontinuation Across Mood and Psychotic Disorders.",
    "authors": [
      "Ercis M",
      "Cole KC",
      "Dierkhising RA",
      "Ozerdem A",
      "Markota M",
      "Singh B",
      "McElroy SL",
      "Frye MA",
      "Leung JG"
    ],
    "journal": "J Clin Psychopharmacol",
    "publicationDate": "2025-01-13",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "06c5fa63-6ba7-4ef6-94b0-cfabc91bbbca",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:39.815Z"
      },
      {
        "id": "54419474-5403-4082-b184-bbc33dbc43ef",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9679bc4a-ae48-4a14-bb86-bdd469720177 to CLOZ_Demo_38139",
        "type": "system",
        "createdAt": "2025-12-14T10:13:49.307Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:21.460Z",
    "updatedAt": "2025-12-14T08:54:39.823Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39804782",
      "DOI": "https://doi.org10.1097/JCP.0000000000001951",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:50:51",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Ercis M, Cole KC, Dierkhising RA, Ozerdem A, Markota M, Singh B, McElroy SL, Frye MA, Leung JG. Clinical and Demographic Predictors of Early Clozapine Discontinuation Across Mood and Psychotic Disorders. J Clin Psychopharmacol. 45(2):85-91",
      "pubdate": "2025-01-13",
      "Lead_author": "Ercis M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/JCP.0000000000001951",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Ercis M, Cole KC, Dierkhising RA, Ozerdem A, Markota M, Singh B, McElroy SL, Frye MA, Leung JG. Clinical and Demographic Predictors of Early Clozapine Discontinuation Across Mood and Psychotic Disorders. J Clin Psychopharmacol. 45(2):85-91",
    "leadAuthor": "Ercis M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjPCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjPCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-5710680501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707229
  },
  {
    "id": "CLOZ_Demo_84654",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39776141",
    "title": "A retrospective analysis of cardiovascular outcomes of clozapine treated individuals within Hunter New England.",
    "authors": [
      "Sritharan S",
      "Murray K",
      "Lam D",
      "Wittaker D",
      "Sverdlov A",
      "Boyle A",
      "Davies A",
      "Williams T",
      "Collins N"
    ],
    "journal": "Intern Med J",
    "publicationDate": "2025-01-8",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "206f6a49-5970-4d76-b289-8dd27c430ea5",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:39.846Z"
      },
      {
        "id": "fc51b5f1-7ce5-4ec3-bc09-a0386009c461",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from db5145d2-1c1d-48b0-8c28-4e14ad4d9b98 to CLOZ_Demo_84654",
        "type": "system",
        "createdAt": "2025-12-14T10:13:49.534Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:21.612Z",
    "updatedAt": "2025-12-14T08:54:39.855Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39776141",
      "DOI": "https://doi.org10.1111/imj.16617",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:51:06",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Sritharan S, Murray K, Lam D, Wittaker D, Sverdlov A, Boyle A, Davies A, Williams T, Collins N. A retrospective analysis of cardiovascular outcomes of clozapine treated individuals within Hunter New England. Intern Med J. 2025;55(3):474-82",
      "pubdate": "2025-01-8",
      "Lead_author": "Sritharan S",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1111/imj.16617",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Sritharan S, Murray K, Lam D, Wittaker D, Sverdlov A, Boyle A, Davies A, Williams T, Collins N. A retrospective analysis of cardiovascular outcomes of clozapine treated individuals within Hunter New England. Intern Med J. 2025;55(3):474-82",
    "leadAuthor": "Sritharan S",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjQCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjQCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-5735f00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707229
  },
  {
    "id": "CLOZ_Demo_56762",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39730140",
    "title": "Low-Frequency rTMS in the Management of Auditory Hallucination Nonresponsive to ECT, Clozapine, and Continuous Theta Burst Stimulation: A Case Study.",
    "authors": [
      "Kar SK",
      "Joshi M"
    ],
    "journal": "J ECT",
    "publicationDate": "2024-12-28",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "1be72530-d409-43b7-9c65-fd765e38f7d3",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:39.877Z"
      },
      {
        "id": "e989cbdd-bb7c-4ffb-bc78-f6b66cf7e42c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 1f27a68a-ce16-41a8-a08a-b7379da6b937 to CLOZ_Demo_56762",
        "type": "system",
        "createdAt": "2025-12-14T10:13:49.768Z"
      },
      {
        "id": "464c2415-ba22-44e0-98e9-5cbd4448e9bf",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"No Case\". Moving to QC Triage.",
        "timestamp": "2025-12-15T20:13:18.694Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:21.755Z",
    "updatedAt": "2025-12-15T20:13:24.779Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39730140",
      "DOI": "https://doi.org10.1097/YCT.0000000000001077",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:51:13",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Kar SK, Joshi M. Low-Frequency rTMS in the Management of Auditory Hallucination Nonresponsive to ECT, Clozapine, and Continuous Theta Burst Stimulation: A Case Study. J ECT. 2025;41(1):e12-3",
      "pubdate": "2024-12-28",
      "Lead_author": "Kar SK",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/YCT.0000000000001077",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Kar SK, Joshi M. Low-Frequency rTMS in the Management of Auditory Hallucination Nonresponsive to ECT, Clozapine, and Continuous Theta Burst Stimulation: A Case Study. J ECT. 2025;41(1):e12-3",
    "leadAuthor": "Kar SK",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "In Vitro Study",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-15T20:13:24.769Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Auto approved QC",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjRCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjRCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dff-4484380501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765829604
  },
  {
    "id": "CLOZ_Demo_91016",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39476092",
    "title": "Clozapine for Parkinson's disease psychosis in a septuagenarian: a nightmare turned into bliss.",
    "authors": [
      "Makani J",
      "Kumar A",
      "Hussain I",
      "Kumar N",
      "Joshi D"
    ],
    "journal": "Neurol Sci",
    "publicationDate": "2024-10-30",
    "abstract": "The article discusses the use of Clozapine in treating Parkinson's disease psychosis (PDP) in an elderly patient. Parkinson's disease psychosis is characterized by confusion, visual hallucinations, and delusions, which significantly impact the quality of life for both patients and caregivers. Classic neuroleptics are known to worsen motor symptoms in Parkinson's disease, making the search for effective atypical antipsychotics crucial. While Pimavanserin is the only approved drug for PDP, its limited availability poses challenges. Clozapine, on the other hand, is highlighted for its excellent antipsychotic profile, cost-effectiveness, and easy accessibility, without exacerbating motor symptoms. The article describes a septuagenarian patient with PDP who showed an excellent response to low-dose Clozapine, improving their quality of life. However, specific details about the patient's condition, timeline, and adverse events are not provided due to the unavailability of the full article. The abstract emphasizes Clozapine's potential in transcending boundaries to improve the lives of PD patients with psychosis, but no adverse events or specific outcomes are mentioned.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "9ac6a0df-62fd-4a66-8bb2-4ccf77e7334e",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:39.982Z"
      },
      {
        "id": "736ef60e-6c5b-4758-b689-4b95597ce9a3",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 38f706c3-29a1-43af-b58b-3085509f325d to CLOZ_Demo_91016",
        "type": "system",
        "createdAt": "2025-12-14T10:13:49.989Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:21.829Z",
    "updatedAt": "2025-12-14T08:54:39.989Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39476092",
      "DOI": "https://doi.org/10.1007/s10072-024-07852-7",
      "special_case": "No",
      "Country_of_first_author": "India",
      "Country_of_occurrence": "India",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: Human involved, no specific data",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Clozapine",
      "Attributability": "Attributability: Human involved, no specific data",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The article discusses the use of Clozapine in treating Parkinson's disease psychosis (PDP) in an elderly patient. Parkinson's disease psychosis is characterized by confusion, visual hallucinations, and delusions, which significantly impact the quality of life for both patients and caregivers. Classic neuroleptics are known to worsen motor symptoms in Parkinson's disease, making the search for effective atypical antipsychotics crucial. While Pimavanserin is the only approved drug for PDP, its limited availability poses challenges. Clozapine, on the other hand, is highlighted for its excellent antipsychotic profile, cost-effectiveness, and easy accessibility, without exacerbating motor symptoms. The article describes a septuagenarian patient with PDP who showed an excellent response to low-dose Clozapine, improving their quality of life. However, specific details about the patient's condition, timeline, and adverse events are not provided due to the unavailability of the full article. The abstract emphasizes Clozapine's potential in transcending boundaries to improve the lives of PD patients with psychosis, but no adverse events or specific outcomes are mentioned.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Case Report",
      "Author_perspective": "The article comments positively on Clozapine's effect on Parkinson's disease psychosis, highlighting its excellent antipsychotic profile, cost-effectiveness, and ability to improve the quality of life without worsening motor symptoms.",
      "Adverse_event": "No AE",
      "Abstract": "Parkinson's disease psychosis, characterized by confusion, visual hallucinations, and delusions is a nightmare for the patients and caregivers. Classic neuroleptics aggravate the motor symptoms, hence the need for an effective atypical antipsychotic. Currently Pimavanserin is the only approved drug for Parkinson's disease psychosis (PDP), however it is not readily available. Clozapine with its excellent anti psychotic profile, without worsening of motor features, cost effectiveness and easy availability transcends all boundaries in improving the Quality of life in PD patients with psychosis. We describe an elderly patient with PDP with an excellent response to low dose clozapine.",
      "Title": "Clozapine for Parkinson's disease psychosis in a septuagenarian: a nightmare turned into bliss.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:52:18",
      "Vancouver_citation": "Makani J, Kumar A, Hussain I, Kumar N, Joshi D. Clozapine for Parkinson's disease psychosis in a septuagenarian: a nightmare turned into bliss. Neurol Sci. 2025;46(3):1415-",
      "pubdate": "2024-10-30",
      "Lead_author": "Makani J",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders occurring during Parkinson's disease when standard treatments fail. In this study, Clozapine was administered to an elderly patient with Parkinson's disease psychosis (PDP), which aligns with its conventional use. Therefore, this does not qualify as off-label use.",
      "AOI_classification": "No",
      "Justification": "The study does not mention any adverse effects or negative outcomes linked to the drug of study. It describes an excellent response to low-dose Clozapine in the patient.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1007/s10072-024-07852-7",
    "specialCase": "No",
    "countryOfFirstAuthor": "India",
    "countryOfOccurrence": "India",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: Human involved, no specific data",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Clozapine"
    ],
    "attributability": "Attributability: Human involved, no specific data",
    "drugEffect": "Drug effect: no data",
    "summary": "The article discusses the use of Clozapine in treating Parkinson's disease psychosis (PDP) in an elderly patient. Parkinson's disease psychosis is characterized by confusion, visual hallucinations, and delusions, which significantly impact the quality of life for both patients and caregivers. Classic neuroleptics are known to worsen motor symptoms in Parkinson's disease, making the search for effective atypical antipsychotics crucial. While Pimavanserin is the only approved drug for PDP, its limited availability poses challenges. Clozapine, on the other hand, is highlighted for its excellent antipsychotic profile, cost-effectiveness, and easy accessibility, without exacerbating motor symptoms. The article describes a septuagenarian patient with PDP who showed an excellent response to low-dose Clozapine, improving their quality of life. However, specific details about the patient's condition, timeline, and adverse events are not provided due to the unavailability of the full article. The abstract emphasizes Clozapine's potential in transcending boundaries to improve the lives of PD patients with psychosis, but no adverse events or specific outcomes are mentioned.",
    "identifiableHumanSubject": "Yes",
    "textType": "Case Report",
    "authorPerspective": "The article comments positively on Clozapine's effect on Parkinson's disease psychosis, highlighting its excellent antipsychotic profile, cost-effectiveness, and ability to improve the quality of life without worsening motor symptoms.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Makani J, Kumar A, Hussain I, Kumar N, Joshi D. Clozapine for Parkinson's disease psychosis in a septuagenarian: a nightmare turned into bliss. Neurol Sci. 2025;46(3):1415-",
    "leadAuthor": "Makani J",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders occurring during Parkinson's disease when standard treatments fail. In this study, Clozapine was administered to an elderly patient with Parkinson's disease psychosis (PDP), which aligns with its conventional use. Therefore, this does not qualify as off-label use.",
    "aoiClassification": "No",
    "justification": "The study does not mention any adverse effects or negative outcomes linked to the drug of study. It describes an excellent response to low-dose Clozapine in the patient.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjSCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjSCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-57755c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707229
  },
  {
    "id": "CLOZ_Demo_55089",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39472495",
    "title": "Clozapine impaired glucose-stimulated insulin secretion partly by increasing plasma 5-HT levels due to the inhibition of OCT1-mediated hepatic 5-HT uptake in mice.",
    "authors": [
      "Wu WH",
      "Zhi H",
      "Feng WK",
      "Jiang L",
      "Yang L",
      "Qian LQ",
      "Zhao RX",
      "Tan YM",
      "Yang HY",
      "Liu XD",
      "Liu L"
    ],
    "journal": "Acta Pharmacol Sin",
    "publicationDate": "2024-10-30",
    "abstract": "The study investigates the effects of clozapine, an atypical antipsychotic, on glucose-stimulated insulin secretion (GSIS) and glucose tolerance in mice. Clozapine was found to impair GSIS and glucose tolerance by increasing plasma serotonin (5-HT) levels through the inhibition of OCT1-mediated hepatic 5-HT uptake. Elevated 5-HT levels were shown to impair GSIS by activating islet 5-HTR3a receptors, while clozapine's antagonistic effect on islet 5-HTR2a receptors also contributed to GSIS impairment. The study utilized normal mice, high-fat diet-fed mice, INS-1 cells, and HEK293-OCT1 cells to explore the mechanisms underlying clozapine-induced hyperglycemia. The findings suggest that clozapine-induced GSIS impairment and hyperglycemia may be partly explained by increased plasma 5-HT levels due to the inhibition of OCT1-mediated hepatic 5-HT uptake. This research provides insights into the metabolic side effects of clozapine and potentially other atypical antipsychotics.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "05cfc7c0-aaf1-4729-b1ba-803544b24316",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:40.003Z"
      },
      {
        "id": "d05c1612-c353-4cd2-a8cd-ba42cb60dfb8",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from e0496487-8860-4733-8908-7c616bf276c3 to CLOZ_Demo_55089",
        "type": "system",
        "createdAt": "2025-12-14T10:13:50.267Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:22.063Z",
    "updatedAt": "2025-12-14T08:54:40.018Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39472495",
      "DOI": "https://doi.org/10.1038/s41401-024-01401-w",
      "special_case": "No",
      "Country_of_first_author": "China",
      "Country_of_occurrence": "China",
      "Patient_details": "No human subject",
      "Key_events": "Key events: not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The study investigates the effects of clozapine, an atypical antipsychotic, on glucose-stimulated insulin secretion (GSIS) and glucose tolerance in mice. Clozapine was found to impair GSIS and glucose tolerance by increasing plasma serotonin (5-HT) levels through the inhibition of OCT1-mediated hepatic 5-HT uptake. Elevated 5-HT levels were shown to impair GSIS by activating islet 5-HTR3a receptors, while clozapine's antagonistic effect on islet 5-HTR2a receptors also contributed to GSIS impairment. The study utilized normal mice, high-fat diet-fed mice, INS-1 cells, and HEK293-OCT1 cells to explore the mechanisms underlying clozapine-induced hyperglycemia. The findings suggest that clozapine-induced GSIS impairment and hyperglycemia may be partly explained by increased plasma 5-HT levels due to the inhibition of OCT1-mediated hepatic 5-HT uptake. This research provides insights into the metabolic side effects of clozapine and potentially other atypical antipsychotics.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article comments on the effect of clozapine on glucose tolerance and insulin secretion in mice, attributing the impairment to increased plasma serotonin levels and the inhibition of OCT1-mediated hepatic serotonin uptake.",
      "Adverse_event": "No AE",
      "Abstract": "Patients taking atypical antipsychotics (AAPs), especially clozapine, are often associated with hyperglycaemia. Here, clozapine served as a representative agent for investigating how AAPs induce hyperglycaemia. In normal mice and mice fed a high fat diet (HFD), clozapine impaired glucose tolerance and glucose-stimulated insulin secretion (GSIS) following intraperitoneal glucose administration and increased plasma 5-HT levels. Intraperitoneal 5-HT administration also impaired glucose tolerance and GSIS in mice. In INS-1 cells, high 5-HT levels impaired GSIS, which was attenuated by the 5-HTR<sub>3</sub> antagonist tropisetron or by silencing 5-HTR<sub>3a</sub>. The 5-HTR<sub>2a</sub> agonist TCB2 attenuated clozapine-induced GSIS impairment. Silencing 5-HTR<sub>2a</sub> or the 5-HTR<sub>2a</sub> antagonist ketanserin impaired GSIS. In mice, 5-HT administration impaired GSIS, which was attenuated by tropisetron but aggravated by clozapine. Clozapine increased plasma [<sup>2</sup>H]5-HT exposure following intravenous administration to mice. In HEK293-OCT1 cells, clozapine inhibited [<sup>2</sup>H]5-HT and MPP<sup>+</sup> uptake. Clozapine or OCT1 silencing impaired 5-HT metabolism in mouse primary hepatocytes, demonstrating that clozapine increased plasma 5-HT levels via the inhibition of OCT1-mediated hepatic 5-HT uptake. Liver-specific silencing of OCT1 increased plasma [<sup>2</sup>H]5-HT exposure and 5-HT levels and impaired GSIS and glucose tolerance in mice. In conclusion, clozapine impaired GSIS and glucose tolerance by increasing plasma 5-HT levels via the inhibition of OCT1-mediated hepatic 5-HT uptake. Increased 5-HT impaired GSIS by activating islet 5-HTR<sub>3a</sub>. The antagonistic effect of clozapine on islet 5-HTR<sub>2a</sub> also contributed to GSIS impairment. The finding that clozapine-induced GSIS impairment was attributed to increased 5-HT levels via the inhibition of OCT1-mediated hepatic 5-HT uptake may partly explain hyperglycaemia caused by other AAPs.",
      "Title": "Clozapine impaired glucose-stimulated insulin secretion partly by increasing plasma 5-HT levels due to the inhibition of OCT1-mediated hepatic 5-HT uptake in mice.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:51:30",
      "Vancouver_citation": "Wu WH, Zhi H, Feng WK, Jiang L, Yang L, Qian LQ, Zhao RX, Tan YM, Yang HY, Liu XD, Liu L. Clozapine impaired glucose-stimulated insulin secretion partly by increasing plasma 5-HT levels due to the inhibition of OCT1-mediated hepatic 5-HT uptake in mice. Acta Pharmacol Sin. 2025;46(3):687-701",
      "pubdate": "2024-10-30",
      "Lead_author": "Wu WH",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study were mice, including normal mice and mice fed a high-fat diet (HFD). Additionally, INS-1 cells and HEK293-OCT1 cells were used for cellular studies. Mouse primary hepatocytes were also studied, and liver-specific silencing of OCT1 was performed in mice.",
      "AOI_drug_effect": "The drug of study, clozapine, had a significant effect on the test subjects. It impaired glucose tolerance and glucose-stimulated insulin secretion (GSIS) in mice and increased plasma 5-HT levels. In INS-1 cells, high 5-HT levels induced by clozapine impaired GSIS. Clozapine also inhibited OCT1-mediated hepatic 5-HT uptake, leading to increased plasma 5-HT levels, which further impaired GSIS and glucose tolerance.",
      "Approved_indication": "Clozapine is conventionally used as an atypical antipsychotic medication, primarily administered orally to treat schizophrenia and schizoaffective disorders in patients who are resistant to other antipsychotics. In this study, clozapine was administered to mice, and its effects on glucose tolerance and insulin secretion were investigated. The study aimed to understand the mechanism behind clozapine-induced hyperglycaemia.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study links clozapine to negative effects, specifically impaired glucose tolerance and glucose-stimulated insulin secretion, which are adverse effects associated with hyperglycaemia.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1038/s41401-024-01401-w",
    "specialCase": "No",
    "countryOfFirstAuthor": "China",
    "countryOfOccurrence": "China",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "The study investigates the effects of clozapine, an atypical antipsychotic, on glucose-stimulated insulin secretion (GSIS) and glucose tolerance in mice. Clozapine was found to impair GSIS and glucose tolerance by increasing plasma serotonin (5-HT) levels through the inhibition of OCT1-mediated hepatic 5-HT uptake. Elevated 5-HT levels were shown to impair GSIS by activating islet 5-HTR3a receptors, while clozapine's antagonistic effect on islet 5-HTR2a receptors also contributed to GSIS impairment. The study utilized normal mice, high-fat diet-fed mice, INS-1 cells, and HEK293-OCT1 cells to explore the mechanisms underlying clozapine-induced hyperglycemia. The findings suggest that clozapine-induced GSIS impairment and hyperglycemia may be partly explained by increased plasma 5-HT levels due to the inhibition of OCT1-mediated hepatic 5-HT uptake. This research provides insights into the metabolic side effects of clozapine and potentially other atypical antipsychotics.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article comments on the effect of clozapine on glucose tolerance and insulin secretion in mice, attributing the impairment to increased plasma serotonin levels and the inhibition of OCT1-mediated hepatic serotonin uptake.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Wu WH, Zhi H, Feng WK, Jiang L, Yang L, Qian LQ, Zhao RX, Tan YM, Yang HY, Liu XD, Liu L. Clozapine impaired glucose-stimulated insulin secretion partly by increasing plasma 5-HT levels due to the inhibition of OCT1-mediated hepatic 5-HT uptake in mice. Acta Pharmacol Sin. 2025;46(3):687-701",
    "leadAuthor": "Wu WH",
    "serious": "No",
    "testSubject": "The test subjects involved in this study were mice, including normal mice and mice fed a high-fat diet (HFD). Additionally, INS-1 cells and HEK293-OCT1 cells were used for cellular studies. Mouse primary hepatocytes were also studied, and liver-specific silencing of OCT1 was performed in mice.",
    "aoiDrugEffect": "The drug of study, clozapine, had a significant effect on the test subjects. It impaired glucose tolerance and glucose-stimulated insulin secretion (GSIS) in mice and increased plasma 5-HT levels. In INS-1 cells, high 5-HT levels induced by clozapine impaired GSIS. Clozapine also inhibited OCT1-mediated hepatic 5-HT uptake, leading to increased plasma 5-HT levels, which further impaired GSIS and glucose tolerance.",
    "approvedIndication": "Clozapine is conventionally used as an atypical antipsychotic medication, primarily administered orally to treat schizophrenia and schizoaffective disorders in patients who are resistant to other antipsychotics. In this study, clozapine was administered to mice, and its effects on glucose tolerance and insulin secretion were investigated. The study aimed to understand the mechanism behind clozapine-induced hyperglycaemia.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The study links clozapine to negative effects, specifically impaired glucose tolerance and glucose-stimulated insulin secretion, which are adverse effects associated with hyperglycaemia.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjTCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjTCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-579fbc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707230
  },
  {
    "id": "CLOZ_Demo_11343",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39164821",
    "title": "Multiple Adverse Reactions Associated With the Use of Second-Generation Antipsychotics in People With Alzheimer's Disease: A Pharmacovigilance Analysis Based on the FDA Adverse Event Reporting System.",
    "authors": [
      "Zhou J",
      "Wei Z",
      "Huang W",
      "Liu M",
      "Wu X"
    ],
    "journal": "Ann Pharmacother",
    "publicationDate": "2024-08-21",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a488814a-f614-4d92-ae71-4c9af2ccfaad",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:40.034Z"
      },
      {
        "id": "e7a1ea94-8e66-4061-a848-565a2d84f145",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from ba93db4b-4b08-4960-b7da-77b93d11bdbd to CLOZ_Demo_11343",
        "type": "system",
        "createdAt": "2025-12-14T10:13:50.455Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:22.101Z",
    "updatedAt": "2025-12-14T08:54:40.129Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39164821",
      "DOI": "https://doi.org10.1177/10600280241271093",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:51:49",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Zhou J, Wei Z, Huang W, Liu M, Wu X. Multiple Adverse Reactions Associated With the Use of Second-Generation Antipsychotics in People With Alzheimer's Disease: A Pharmacovigilance Analysis Based on the FDA Adverse Event Reporting System. Ann Pharmacother. 2025;59(3):213-22",
      "pubdate": "2024-08-21",
      "Lead_author": "Zhou J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1177/10600280241271093",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Zhou J, Wei Z, Huang W, Liu M, Wu X. Multiple Adverse Reactions Associated With the Use of Second-Generation Antipsychotics in People With Alzheimer's Disease: A Pharmacovigilance Analysis Based on the FDA Adverse Event Reporting System. Ann Pharmacother. 2025;59(3):213-22",
    "leadAuthor": "Zhou J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjUCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjUCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-57c2400501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707230
  },
  {
    "id": "CLOZ_Demo_57985",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "38502208",
    "title": "Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication.",
    "authors": [
      "Haddad NM",
      "De Jesus LP",
      "Serpa M",
      "Van De Bilt M",
      "Talib L",
      "Costa A",
      "Gattaz W",
      "Loch AA"
    ],
    "journal": "Eur Arch Psychiatry Clin Neurosci",
    "publicationDate": "2024-03-19",
    "abstract": "The study investigated the modulation of the endocannabinoid system (ECS) in individuals with schizophrenia, focusing on the influence of cannabis use and antipsychotic medications, including clozapine. Ninety-three individuals were divided into three groups: patients with schizophrenia using clozapine (treatment-resistant), patients using other antipsychotics, and controls. Proteins and metabolites involved in ECS pathways, such as AEA, 2-AG, and CB2 receptor levels, were measured in peripheral blood. Cannabis use was found to significantly lower 2-AG plasma levels, while non-clozapine antipsychotics were marginally associated with changes in CB2 receptor levels. The study did not provide specific data on adverse events or complications related to clozapine use. The findings suggest that cannabis use and non-clozapine antipsychotics may influence ECS modulation, which could be relevant to the physiopathology of schizophrenia. Further research is needed to explore the role of the ECS in schizophrenia and its interaction with antipsychotic medications.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ba986f28-b3cc-416b-b1dd-cb032d04716c",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-13T07:55:50.243Z",
        "type": "system"
      },
      {
        "id": "68d7000b-e24b-4d7a-8b9e-a69bddecd459",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" rejected by QC. Reason: Test Revocation. Study returned to Triage for re-classification.",
        "timestamp": "2025-12-13T07:57:41.905Z",
        "type": "QC_rejection"
      },
      {
        "id": "05317cae-aa33-4299-9c1c-8a72b48572ba",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 7b5a4187-3859-4016-ac99-7444d7745813 to CLOZ_Demo_57985",
        "type": "system",
        "createdAt": "2025-12-14T10:13:50.684Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:22:22.325Z",
    "updatedAt": "2025-12-13T07:57:41.917Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "38502208",
      "DOI": "https://doi.org/10.1007/s00406-024-01788-x",
      "special_case": "No",
      "Country_of_first_author": "Brazil",
      "Country_of_occurrence": "Brazil",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: Human subjects were recruited from the outpatient clinic of the Psychosis Group of the University of São Paulo, Brazil. The study involved 93 individuals divided into three groups: patients with schizophrenia using clozapine (treatment-resistant), patients with schizophrenia using other antipsychotics, and controls. The study measured proteins and metabolites involved in the endocannabinoid system pathways in peripheral blood, including AEA, 2-AG, and CB2 receptor levels. Cannabis use and antipsychotic medication were analyzed for their influence on these levels.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Clozapine, other antipsychotics",
      "Attributability": "Attributability: Cannabis use was associated with lower 2-AG plasma levels. Non-clozapine antipsychotics were marginally associated with changes in CB2 receptor levels. No specific adverse effects or medical complications were attributed to clozapine.",
      "Drug_effect": "Drug effect: summary. Cannabis use influenced 2-AG levels, and non-clozapine antipsychotics marginally influenced CB2 receptor levels. No specific data on the effect of clozapine was provided.",
      "Summary": "The study investigated the modulation of the endocannabinoid system (ECS) in individuals with schizophrenia, focusing on the influence of cannabis use and antipsychotic medications, including clozapine. Ninety-three individuals were divided into three groups: patients with schizophrenia using clozapine (treatment-resistant), patients using other antipsychotics, and controls. Proteins and metabolites involved in ECS pathways, such as AEA, 2-AG, and CB2 receptor levels, were measured in peripheral blood. Cannabis use was found to significantly lower 2-AG plasma levels, while non-clozapine antipsychotics were marginally associated with changes in CB2 receptor levels. The study did not provide specific data on adverse events or complications related to clozapine use. The findings suggest that cannabis use and non-clozapine antipsychotics may influence ECS modulation, which could be relevant to the physiopathology of schizophrenia. Further research is needed to explore the role of the ECS in schizophrenia and its interaction with antipsychotic medications.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article comments on the influence of cannabis use and non-clozapine antipsychotics on ECS modulation, specifically 2-AG and CB2 receptor levels. It suggests that these factors may play a role in the physiopathology of schizophrenia and calls for further studies on the ECS.",
      "Adverse_event": "No AE",
      "Abstract": "Determining peripheral modulation of the endocannabinoid system (ECS) may be important for differentiating individuals with schizophrenia. Such differentiation can also be extended to subgroups of individuals, those who use cannabis and antipsychotic medications, particularly those who are treatment resistant. Patients and controls were recruited from the outpatient clinic of the Psychosis Group of the University of São Paulo, Brazil. A final sample of 93 individuals was divided into 3 groups: patients with schizophrenia using clozapine (treatment-resistant) (n = 29), patients with schizophrenia using another antipsychotic (n = 31), and controls (n = 33). By measuring the proteins and metabolites involved in the ECS pathways in the peripheral blood, AEA (anandamide), 2-AG (2-arachidonoyl ethanolamine), and CB2 receptor (peripheral) were quantified. Individuals reporting lifetime cannabis use had lower 2-AG plasma levels (p = 0.011). Regarding the CB2 receptor, the values of patients with schizophrenia and controls were similar, but those of patients using antipsychotics other than clozapine differed (p = 0.022). In generalized linear models to control for confounders, the use of cannabis remained the only factor that significantly influenced 2-AG levels. The relationship for non-clozapine antipsychotics as the only factor related to CB2 changes was marginally significant. We found for the first time that cannabis use and non-clozapine antipsychotic medication are potentially involved in the modulation of the ECS, specifically influencing 2-AG endocannabinoid and CB2 receptor levels. More studies regarding the ECS are needed since it has been increasingly related to the physiopathology of schizophrenia.",
      "Title": "Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:52:05",
      "Vancouver_citation": "Haddad NM, De Jesus LP, Serpa M, Van De Bilt M, Talib L, Costa A, Gattaz W, Loch AA. Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication. Eur Arch Psychiatry Clin Neurosci. 2025;275(2):545-53",
      "pubdate": "2024-03-19",
      "Lead_author": "Haddad NM",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study include 93 individuals divided into three groups: patients with schizophrenia using clozapine (n=29), patients with schizophrenia using another antipsychotic (n=31), and controls (n=33). The study specifically includes patients exposed to the drug of study, clozapine.",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, clozapine was administered to patients with treatment-resistant schizophrenia, which aligns with its conventional use. There is no indication of off-label use in this study.",
      "AOI_classification": "No",
      "Justification": "The study does not link the drug of study to any adverse effects or negative effects within the subjects. It focuses on the modulation of the endocannabinoid system and does not report adverse events related to clozapine.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1007/s00406-024-01788-x",
    "specialCase": "No",
    "countryOfFirstAuthor": "Brazil",
    "countryOfOccurrence": "Brazil",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: Human subjects were recruited from the outpatient clinic of the Psychosis Group of the University of São Paulo, Brazil. The study involved 93 individuals divided into three groups: patients with schizophrenia using clozapine (treatment-resistant), patients with schizophrenia using other antipsychotics, and controls. The study measured proteins and metabolites involved in the endocannabinoid system pathways in peripheral blood, including AEA, 2-AG, and CB2 receptor levels. Cannabis use and antipsychotic medication were analyzed for their influence on these levels.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Clozapine",
      "other antipsychotics"
    ],
    "attributability": "Attributability: Cannabis use was associated with lower 2-AG plasma levels. Non-clozapine antipsychotics were marginally associated with changes in CB2 receptor levels. No specific adverse effects or medical complications were attributed to clozapine.",
    "drugEffect": "Drug effect: summary. Cannabis use influenced 2-AG levels, and non-clozapine antipsychotics marginally influenced CB2 receptor levels. No specific data on the effect of clozapine was provided.",
    "summary": "The study investigated the modulation of the endocannabinoid system (ECS) in individuals with schizophrenia, focusing on the influence of cannabis use and antipsychotic medications, including clozapine. Ninety-three individuals were divided into three groups: patients with schizophrenia using clozapine (treatment-resistant), patients using other antipsychotics, and controls. Proteins and metabolites involved in ECS pathways, such as AEA, 2-AG, and CB2 receptor levels, were measured in peripheral blood. Cannabis use was found to significantly lower 2-AG plasma levels, while non-clozapine antipsychotics were marginally associated with changes in CB2 receptor levels. The study did not provide specific data on adverse events or complications related to clozapine use. The findings suggest that cannabis use and non-clozapine antipsychotics may influence ECS modulation, which could be relevant to the physiopathology of schizophrenia. Further research is needed to explore the role of the ECS in schizophrenia and its interaction with antipsychotic medications.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article comments on the influence of cannabis use and non-clozapine antipsychotics on ECS modulation, specifically 2-AG and CB2 receptor levels. It suggests that these factors may play a role in the physiopathology of schizophrenia and calls for further studies on the ECS.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Haddad NM, De Jesus LP, Serpa M, Van De Bilt M, Talib L, Costa A, Gattaz W, Loch AA. Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication. Eur Arch Psychiatry Clin Neurosci. 2025;275(2):545-53",
    "leadAuthor": "Haddad NM",
    "serious": "No",
    "testSubject": "The test subjects involved in this study include 93 individuals divided into three groups: patients with schizophrenia using clozapine (n=29), patients with schizophrenia using another antipsychotic (n=31), and controls (n=33). The study specifically includes patients exposed to the drug of study, clozapine.",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, clozapine was administered to patients with treatment-resistant schizophrenia, which aligns with its conventional use. There is no indication of off-label use in this study.",
    "aoiClassification": "No",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "rejected",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaRejectedAt": "2025-12-13T07:57:41.905Z",
    "qaComments": "Test Revocation",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjVCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjVCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-57df980501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707230
  },
  {
    "id": "CLOZ_Demo_43606",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40170211",
    "title": "Low-dose clozapine for first-episode, early-onset, treatment-resistant schizophrenia in an adolescent female: a case report.",
    "authors": [
      "Hui NY",
      "Lee EHM",
      "Chan SKW"
    ],
    "journal": "East Asian Arch Psychiatry",
    "publicationDate": "2025-04-2",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "319155e8-a9c6-4c1f-b62b-dfaea14cd052",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:40.141Z"
      },
      {
        "id": "5134175d-bdbc-4a6e-b4b6-2b55777fac59",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 7e27e2ef-bfb0-4829-bad8-6fd802071c3b to CLOZ_Demo_43606",
        "type": "system",
        "createdAt": "2025-12-14T10:13:50.939Z"
      },
      {
        "id": "bc52329d-062c-44c4-958a-1f6e28b978a6",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-15T20:24:10.722Z",
        "type": "system"
      },
      {
        "id": "bdd948ad-cb0e-4fbd-bcfe-6f68133d773d",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-15T20:24:33.548Z",
        "type": "QC_approval"
      },
      {
        "id": "96b44170-4b85-4ece-b8f7-83b41e16db2f",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-15T20:24:48.201Z",
        "type": "system"
      },
      {
        "id": "4d403482-a798-4ee8-927d-106bf3d25cf2",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "R3 form completed. Awaiting QC approval before Medical Reviewer review.",
        "timestamp": "2025-12-15T20:24:48.323Z",
        "type": "system"
      },
      {
        "id": "58ea2eff-a474-4424-8fe2-bf03b65b2465",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "R3 XML form approved by QC. Ready for Medical Reviewer",
        "timestamp": "2025-12-15T20:24:58.231Z",
        "type": "qc_r3_approval"
      },
      {
        "id": "01ee706e-d286-4b1d-be7c-04fa83f26822",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Medical review completed. Study approved for final processing.",
        "timestamp": "2025-12-15T20:25:14.641Z",
        "type": "medical_approval"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:25:23.673Z",
    "updatedAt": "2025-12-15T20:25:14.648Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40170211",
      "DOI": "https://doi.org10.12809/eaap2465",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:53:08",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Hui NY, Lee EHM, Chan SKW. Low-dose clozapine for first-episode, early-onset, treatment-resistant schizophrenia in an adolescent female: a case report. East Asian Arch Psychiatry. 2025;35(1):50-2",
      "pubdate": "2025-04-2",
      "Lead_author": "Hui NY",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.12809/eaap2465",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Hui NY, Lee EHM, Chan SKW. Low-dose clozapine for first-episode, early-onset, treatment-resistant schizophrenia in an adolescent female: a case report. East Asian Arch Psychiatry. 2025;35(1):50-2",
    "leadAuthor": "Hui NY",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-15T20:24:33.548Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": {
      "D.2.3": "4",
      "D.5": "Female",
      "D.7.1.r": "Patient 1: Adolescent female with first-episode, early-onset, treatment-resistant schizophrenia.",
      "D.9.1": "No",
      "E.i.1.1a": "Patient 1: First-episode, early-onset, treatment-resistant schizophrenia.",
      "E.i.3.2a": "False",
      "E.i.3.2b": "False",
      "E.i.3.2c": "False",
      "E.i.3.2d": "False",
      "E.i.3.2e": "False",
      "E.i.3.2f": "True",
      "E.i.7": "0",
      "C.2.r.1": "Hui NY",
      "C.2.r.1.2": "Hui",
      "C.2.r.1.4": "NY",
      "C.4.r.1": "Hui NY, Lee EHM, Chan SKW. Low-dose clozapine for first-episode, early-onset, treatment-resistant schizophrenia in an adolescent female: a case report. East Asian Arch Psychiatry. 2025;35(1):50-2",
      "D.7": "Article requires manual review",
      "D.7.1.r.2": "Article requires manual review",
      "C.2.r.2.1": "Institution in Article requires manual review"
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-15T20:24:48.323Z",
    "qcR3Status": "approved",
    "qcR3ApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qcR3ApprovedAt": "2025-12-15T20:24:58.231Z",
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "completed",
    "medicalReviewedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "medicalReviewedAt": "2025-12-15T20:25:14.641Z",
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjWCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjWCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6e00-eba1380501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765830314
  },
  {
    "id": "CLOZ_Demo_97219",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40157874",
    "title": "Effectiveness of Clozapine Compared to Nonclozapine Antipsychotics in Older Adults With Schizophrenia in Brazil in a 16-Year Follow-Up.",
    "authors": [
      "Vieira JCM",
      "Reis EA",
      "Prata WM",
      "de Oliveira HN",
      "Ruas CM",
      "Guerra AA"
    ],
    "journal": "Am J Geriatr Psychiatry",
    "publicationDate": "2025-03-30",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "64a105db-6052-4da4-a5e5-8e7683cf0ddb",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:40.172Z"
      },
      {
        "id": "69e372c9-a78f-4f2e-8c24-2eea25f13b19",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 2a889974-6934-4df6-aa3d-0438c5a69ab7 to CLOZ_Demo_97219",
        "type": "system",
        "createdAt": "2025-12-14T10:13:51.157Z"
      },
      {
        "id": "70cda531-c8eb-491f-a947-f4cfdea878f6",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"AOI\". Moving to QC Triage.",
        "timestamp": "2025-12-15T20:13:11.202Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:25:23.704Z",
    "updatedAt": "2025-12-15T20:13:24.826Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40157874",
      "DOI": "https://doi.org10.1016/j.jagp.2025.02.016",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:52:42",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Vieira JCM, Reis EA, Prata WM, de Oliveira HN, Ruas CM, Guerra AA. Effectiveness of Clozapine Compared to Nonclozapine Antipsychotics in Older Adults With Schizophrenia in Brazil in a 16-Year Follow-Up. Am J Geriatr Psychiatry. 2025;33(11):1184-96",
      "pubdate": "2025-03-30",
      "Lead_author": "Vieira JCM",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.jagp.2025.02.016",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Vieira JCM, Reis EA, Prata WM, de Oliveira HN, Ruas CM, Guerra AA. Effectiveness of Clozapine Compared to Nonclozapine Antipsychotics in Older Adults With Schizophrenia in Brazil in a 16-Year Follow-Up. Am J Geriatr Psychiatry. 2025;33(11):1184-96",
    "leadAuthor": "Vieira JCM",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Special Situations",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "AOI",
    "effectiveClassification": "AOI",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjXCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjXCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dff-448b800501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765829604
  },
  {
    "id": "CLOZ_Demo_31298",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40093097",
    "title": "Parabrachial  neurons influence aversive and appetitive taste function.",
    "authors": [
      "Lemon CH",
      "Li J",
      "Ali MSS",
      "Ngum NM",
      "Zumpano KT",
      "Roberts CJ"
    ],
    "journal": "bioRxiv",
    "publicationDate": "2025-03-17",
    "abstract": "The study investigates the role of parabrachial (PB) neurons expressing the Calca gene in taste-guided behaviors using chemogenetic methods in mice. Clozapine-N-oxide (CNO) was administered to activate inhibitory designer receptors (hM4Di) expressed in PB-Calca neurons. The study found that CNO administration reduced avoidance of the bitter taste stimulus quinine in hM4Di mice, with variability in response magnitude across individuals. However, responses to another bitter stimulus, cycloheximide, were unaffected. Additionally, CNO selectively reduced sucrose preference in male hM4Di mice, indicating a sex-dependent effect on appetitive taste-guided behavior. The findings suggest that PB-Calca neurons play a role in both aversive and appetitive taste responses, with their involvement in appetitive taste being influenced by sex. The study highlights the complex role of PB-Calca neurons in taste processing and their potential to encode opposing valences through frequency-dependent neurotransmission.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "bea2fc2d-ab64-4356-a869-5b98b7778e50",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-13T08:00:55.705Z",
        "type": "system"
      },
      {
        "id": "abb83f77-01da-4905-8cbb-f26edca3adb8",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" approved by QC. Comments: Approve Comment 2",
        "timestamp": "2025-12-13T08:01:39.566Z",
        "type": "QC_approval"
      },
      {
        "id": "3cd089ad-7cd1-4081-8c03-443cf0f58031",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Added comment to field listedness: Test Change",
        "timestamp": "2025-12-13T08:02:40.175Z",
        "type": "field_comment"
      },
      {
        "id": "c90a97c1-0031-4c0d-9ff5-d4d2ce01ae64",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-13T08:03:09.099Z",
        "type": "system"
      },
      {
        "id": "53af4ad3-a5ed-44ab-a035-7c20eca3a627",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "R3 form completed. Awaiting QC approval before Medical Reviewer review.",
        "timestamp": "2025-12-13T08:03:09.210Z",
        "type": "system"
      },
      {
        "id": "98c32978-7ba1-445b-878c-4616fcd725c5",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Added comment to field C.2.r.1.3: Please enter data",
        "timestamp": "2025-12-13T08:05:07.798Z",
        "type": "field_comment"
      },
      {
        "id": "0b06d663-43ff-4cb5-8529-651bcdb6d880",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "R3 XML form rejected by QC. Reason: This is rejected. Returned to Data Entry for corrections.",
        "timestamp": "2025-12-13T08:05:24.419Z",
        "type": "qc_r3_rejection"
      },
      {
        "id": "0c8df045-49c0-4b47-9631-dbd89a7b0380",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-13T08:20:44.633Z",
        "type": "system"
      },
      {
        "id": "608c6989-e7ea-4cab-969f-72839ffd740d",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "R3 form completed. Awaiting QC approval before Medical Reviewer review.",
        "timestamp": "2025-12-13T08:20:44.741Z",
        "type": "system"
      },
      {
        "id": "adbc4b02-054f-476a-b84b-d83fd7200ac4",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "R3 XML form approved by QC. Medical Review skipped (disabled). Ready for Reports.",
        "timestamp": "2025-12-13T08:23:51.883Z",
        "type": "qc_r3_approval"
      },
      {
        "id": "9cfe770c-6b6e-4532-a628-16256533e82f",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 9704d649-0914-4e39-bc52-31b1b0aa5851 to CLOZ_Demo_31298",
        "type": "system",
        "createdAt": "2025-12-14T10:13:51.392Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:25:23.729Z",
    "updatedAt": "2025-12-13T08:23:51.895Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40093097",
      "DOI": "https://doi.org/10.1101/2025.02.28.640892",
      "special_case": "No",
      "Country_of_first_author": "USA",
      "Country_of_occurrence": "USA",
      "Patient_details": "No human subject",
      "Key_events": "Key events: not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Clozapine-N-oxide",
      "Attributability": "Attributability: not applicable",
      "Drug_effect": "Drug effect: summary: Clozapine-N-oxide (CNO) was used to activate inhibitory designer receptors in mice, leading to altered licking behavior in response to taste stimuli. The drug influenced aversive and appetitive taste responses, with sex-dependent effects observed in sucrose preference.",
      "Summary": "The study investigates the role of parabrachial (PB) neurons expressing the Calca gene in taste-guided behaviors using chemogenetic methods in mice. Clozapine-N-oxide (CNO) was administered to activate inhibitory designer receptors (hM4Di) expressed in PB-Calca neurons. The study found that CNO administration reduced avoidance of the bitter taste stimulus quinine in hM4Di mice, with variability in response magnitude across individuals. However, responses to another bitter stimulus, cycloheximide, were unaffected. Additionally, CNO selectively reduced sucrose preference in male hM4Di mice, indicating a sex-dependent effect on appetitive taste-guided behavior. The findings suggest that PB-Calca neurons play a role in both aversive and appetitive taste responses, with their involvement in appetitive taste being influenced by sex. The study highlights the complex role of PB-Calca neurons in taste processing and their potential to encode opposing valences through frequency-dependent neurotransmission.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article comments on the effects of Clozapine-N-oxide (CNO) on taste-guided behaviors in mice, highlighting its influence on aversive and appetitive taste responses and the sex-dependent effects observed in sucrose preference.",
      "Adverse_event": "No AE",
      "Abstract": "The parabrachial (PB) nucleus participates in taste processing and integration with other senses. PB neurons that express the <i>Calca</i> gene support sensory-integrative responses, albeit only limited data have addressed their influence on taste. Here we studied how chemogenetic dampening of PB-<i>Calca</i> neurons impacted mouse orosensory preferences for diverse taste stimuli in brief-access fluid exposure tests, which capture oral sensory/tongue control of licking behavior. Intracranial delivery of Cre-dependent viruses in female and male <i>Calca</i> <sup>Cre/+</sup> mice induced expression of the inhibitory designer receptor hM4Di:mCherry (hM4Di mice) or fluorophore mCherry alone (mCherry mice) in PB-<i>Calca</i> neurons. Several weeks later, hM4Di and mCherry mice entered brief-access tests where they could lick taste solutions on discrete seconds-long trials. Stimuli included the behaviorally avoided, but functionally different, bitter taste stimuli quinine (0 [water], 0.1, 0.3, and 1.0 mM) and cycloheximide (0, 0.001, 0.003, and 0.01 mM), and the appetitive sugar sucrose (0, 100, 300, 500, and 1000 mM). Both hM4Di and mCherry mice received the hM4Di ligand clozapine-N-oxide (CNO, 5 mg/kg, i.p.) prior to daily tests performed by blinded experimenters. With CNO, hM4Di mice displayed greater average licking (i.e., less avoidance) of quinine (p < 0.05), but not cycloheximide (p > 0.3), than mCherry mice, implying PB-<i>Calca</i> neurons variably influence orosensory responses across bitter stimuli. Moreover, male hM4Di mice selectively showed reduced mean licking preferences for sucrose under CNO (p < 0.05). These data suggest that PB-<i>Calca</i> neurons participate in both aversive and appetitive taste-guided behaviors, with their role in appetitive taste dependent on sex.",
      "Title": "Parabrachial <i>Calca</i> neurons influence aversive and appetitive taste function.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:53:01",
      "Vancouver_citation": "Lemon CH, Li J, Ali MSS, Ngum NM, Zumpano KT, Roberts CJ. Parabrachial <i>Calca</i> neurons influence aversive and appetitive taste function. bioRxiv. 2025;",
      "pubdate": "2025-03-17",
      "Lead_author": "Lemon CH",
      "Serious": "No",
      "Test_subject": "Yes, there is a test subject involved in this study. The test subjects are adult female and male mice genetically modified to express Cre-dependent genes (CalcaCre/+ mice). These mice were divided into experimental groups (hM4Di mice) and control groups (mCherry mice) to study the effects of chemogenetic dampening of PB-Calca neurons on taste-guided behaviors.",
      "AOI_drug_effect": "Yes, the drug of study, Clozapine-N-oxide (CNO), had an effect on the test subjects. CNO was administered to activate the inhibitory designer receptor hM4Di expressed in PB-Calca neurons of hM4Di mice. This resulted in altered taste-guided behaviors, including reduced avoidance of the bitter taste stimulus quinine and sex-dependent reductions in sucrose taste preference in male hM4Di mice.",
      "Approved_indication": "The drug of study, Clozapine, is conventionally used as an antipsychotic medication for treatment-resistant schizophrenia and schizoaffective disorders. It is typically administered orally to human patients. In this study, Clozapine-N-oxide (CNO), a derivative of Clozapine, was administered intraperitoneally (i.p.) at a dose of 5 mg/kg to mice. It was used as a ligand to activate the inhibitory designer receptor hM4Di expressed in PB-Calca neurons, aiming to study its effects on taste-guided behaviors.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study links the drug of study, Clozapine-N-oxide (CNO), to negative effects, specifically sex-dependent reductions in sucrose taste preference in male hM4Di mice. This suggests that the drug-induced suppression of PB-Calca neurons can influence appetitive taste-guided behaviors adversely.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1101/2025.02.28.640892",
    "specialCase": "No",
    "countryOfFirstAuthor": "USA",
    "countryOfOccurrence": "USA",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Clozapine-N-oxide"
    ],
    "attributability": "Attributability: not applicable",
    "drugEffect": "Drug effect: summary: Clozapine-N-oxide (CNO) was used to activate inhibitory designer receptors in mice, leading to altered licking behavior in response to taste stimuli. The drug influenced aversive and appetitive taste responses, with sex-dependent effects observed in sucrose preference.",
    "summary": "The study investigates the role of parabrachial (PB) neurons expressing the Calca gene in taste-guided behaviors using chemogenetic methods in mice. Clozapine-N-oxide (CNO) was administered to activate inhibitory designer receptors (hM4Di) expressed in PB-Calca neurons. The study found that CNO administration reduced avoidance of the bitter taste stimulus quinine in hM4Di mice, with variability in response magnitude across individuals. However, responses to another bitter stimulus, cycloheximide, were unaffected. Additionally, CNO selectively reduced sucrose preference in male hM4Di mice, indicating a sex-dependent effect on appetitive taste-guided behavior. The findings suggest that PB-Calca neurons play a role in both aversive and appetitive taste responses, with their involvement in appetitive taste being influenced by sex. The study highlights the complex role of PB-Calca neurons in taste processing and their potential to encode opposing valences through frequency-dependent neurotransmission.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article comments on the effects of Clozapine-N-oxide (CNO) on taste-guided behaviors in mice, highlighting its influence on aversive and appetitive taste responses and the sex-dependent effects observed in sucrose preference.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Lemon CH, Li J, Ali MSS, Ngum NM, Zumpano KT, Roberts CJ. Parabrachial <i>Calca</i> neurons influence aversive and appetitive taste function. bioRxiv. 2025;",
    "leadAuthor": "Lemon CH",
    "serious": "No",
    "testSubject": "Yes, there is a test subject involved in this study. The test subjects are adult female and male mice genetically modified to express Cre-dependent genes (CalcaCre/+ mice). These mice were divided into experimental groups (hM4Di mice) and control groups (mCherry mice) to study the effects of chemogenetic dampening of PB-Calca neurons on taste-guided behaviors.",
    "aoiDrugEffect": "Yes, the drug of study, Clozapine-N-oxide (CNO), had an effect on the test subjects. CNO was administered to activate the inhibitory designer receptor hM4Di expressed in PB-Calca neurons of hM4Di mice. This resulted in altered taste-guided behaviors, including reduced avoidance of the bitter taste stimulus quinine and sex-dependent reductions in sucrose taste preference in male hM4Di mice.",
    "approvedIndication": "The drug of study, Clozapine, is conventionally used as an antipsychotic medication for treatment-resistant schizophrenia and schizoaffective disorders. It is typically administered orally to human patients. In this study, Clozapine-N-oxide (CNO), a derivative of Clozapine, was administered intraperitoneally (i.p.) at a dose of 5 mg/kg to mice. It was used as a ligand to activate the inhibitory designer receptor hM4Di expressed in PB-Calca neurons, aiming to study its effects on taste-guided behaviors.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-13T08:01:39.566Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Approve Comment 2",
    "r3FormData": {
      "D.2.2": "34 weeks",
      "D.2.2.1a": "34 weeks",
      "D.2.3": "5",
      "D.3": "23.4 kg, 31.5 kg",
      "D.5": "Female, Male",
      "D.7": "All study mice were adult CalcaCre/+ mice generated by crossing homozygous CalcaCre mice with C57BL/6J mice. Before surgery, mice were group housed with ad libitum access to standard mouse chow and filtered water.",
      "D.7.1.r": "Patient 1: Adult CalcaCre/+ mice, both female and male, were used in the study. They were surgically prepared and tested for taste-guided behaviors.",
      "D.7.3": "True",
      "D.9.1": "No",
      "E.i.3.2a": "False",
      "E.i.3.2b": "False",
      "E.i.3.2c": "False",
      "E.i.3.2d": "False",
      "E.i.3.2e": "False",
      "E.i.3.2f": "True",
      "E.i.7": "0",
      "C.2.r.1": "Lemon CH",
      "C.2.r.1.2": "Lemon",
      "C.2.r.1.4": "CH",
      "C.4.r.1": "Lemon CH, Li J, Ali MSS, Ngum NM, Zumpano KT, Roberts CJ. Parabrachial <i>Calca</i> neurons influence aversive and appetitive taste function. bioRxiv. 2025;",
      "D.7.1.r.2": "Relevant dates: not mentioned",
      "E.i.1.1a": "No AE",
      "C.2.r.2.1": "Institution in USA",
      "D.7.1.r.3": "Patient 1: False. Patient 2: False.",
      "D.2.1": ""
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-13T08:20:44.741Z",
    "qcR3Status": "approved",
    "qcR3ApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qcR3ApprovedAt": "2025-12-13T08:23:51.883Z",
    "qcR3RejectedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qcR3RejectedAt": "2025-12-13T08:05:24.419Z",
    "qcR3Comments": null,
    "listedness": "Unlisted",
    "seriousness": "Serious",
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "completed",
    "medicalReviewedBy": "system",
    "medicalReviewedAt": "2025-12-13T08:23:51.883Z",
    "fieldComments": [
      {
        "id": "6bbdabcb-5825-4993-a06e-432b51d378e7",
        "fieldKey": "listedness",
        "comment": "Test Change",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "createdAt": "2025-12-13T08:02:40.175Z"
      },
      {
        "id": "aa3bbce9-47a1-496f-aa2d-df1afb95741f",
        "fieldKey": "C.2.r.1.3",
        "comment": "Please enter data",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "createdAt": "2025-12-13T08:05:07.798Z"
      }
    ],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjYCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjYCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-584bcc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707231
  },
  {
    "id": "CLOZ_Demo_44345",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40070369",
    "title": "A Review of Clinical Advances and Challenges in Clozapine-Induced Myocarditis.",
    "authors": [
      "Li M",
      "Bai Y",
      "Wang Y",
      "Xing H",
      "Zhang Y",
      "Ding W",
      "Ye H",
      "Ma L",
      "Wang W",
      "Bao T"
    ],
    "journal": "Neuropsychiatr Dis Treat",
    "publicationDate": "2025-03-12",
    "abstract": "Clozapine is highlighted as the first-choice treatment for TRS due to its efficacy in managing schizophrenia symptoms, reducing suicide risk, and minimizing extrapyramidal side effects. However, its use is limited by severe adverse effects, including clozapine-induced myocarditis (CIM). The article reviews the clinical features, mechanisms, and management strategies for CIM, emphasizing its insidious onset and nonspecific symptoms such as fever, tachycardia, and fatigue. These symptoms can be misinterpreted during the initial titration of clozapine, complicating early detection. The pathogenesis of CIM is linked to immune-mediated mechanisms, oxidative stress, and catecholamine-induced injury. Discontinuation of clozapine is the primary treatment, with supportive care involving diuretics, beta-blockers, ACE inhibitors, and glucocorticoids in severe cases. The article discusses the challenges of reintroducing clozapine after CIM, noting a 60% success rate for re-challenge under stringent monitoring. It highlights the importance of slow titration, close monitoring of biomarkers like CRP and troponin, and individualized treatment regimens to minimize the risk of CIM. The review underscores the need for further research on CIM's pathogenesis, diagnostic criteria, and management protocols, as well as the development of globally harmonized guidelines for clozapine therapy.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "The article discusses adverse events related to clozapine therapy, particularly myocarditis and cardiomyopathy. CIM can lead to severe outcomes such as malignant arrhythmias and sudden cardiac death. Rapid titration of clozapine and co-administration with other medications are identified as risk factors for CIM. The article emphasizes the importance of early detection and management to prevent fatal outcomes.",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "8a56c7ee-5e8c-4e4a-bc20-7be65f7ea0f4",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-13T07:38:32.262Z",
        "type": "system"
      },
      {
        "id": "845bd0da-5733-4cb5-9fc8-47777798015a",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-13T07:42:50.599Z",
        "type": "QC_approval"
      },
      {
        "id": "af1b6592-b245-41a8-86af-bb29179ef496",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 258b9bc3-a349-4899-a5e0-cc927c7d9249 to CLOZ_Demo_44345",
        "type": "system",
        "createdAt": "2025-12-14T10:13:51.715Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:25:23.762Z",
    "updatedAt": "2025-12-13T07:42:50.606Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40070369",
      "DOI": "https://doi.org/10.2147/NDT.S502312",
      "special_case": "No",
      "Country_of_first_author": "Country of the first author: China",
      "Country_of_occurrence": "Country of occurrence: China",
      "Patient_details": "Patient details: Human involved, no specific data",
      "Key_events": "Key events: The article discusses clozapine-induced myocarditis (CIM) as a significant adverse effect of clozapine therapy, particularly in patients with treatment-resistant schizophrenia (TRS). It highlights the clinical manifestations, mechanisms, and challenges in monitoring and managing CIM. The review does not provide specific patient case details but emphasizes the importance of early detection and management strategies.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Clozapine",
      "Attributability": "Attributability: The article attributes myocarditis and cardiomyopathy to clozapine therapy, particularly during the initial titration phase. It discusses the immune-mediated mechanisms, oxidative stress, and catecholamine-induced injury as potential causes of CIM.",
      "Drug_effect": "Drug effect: summary. The article discusses the adverse effects of clozapine, particularly myocarditis, which can lead to severe outcomes such as malignant arrhythmias and sudden cardiac death. Discontinuation of clozapine is the primary treatment for CIM, and supportive care is recommended. Re-challenge of clozapine is controversial but may be considered under strict monitoring.",
      "Summary": "Clozapine is highlighted as the first-choice treatment for TRS due to its efficacy in managing schizophrenia symptoms, reducing suicide risk, and minimizing extrapyramidal side effects. However, its use is limited by severe adverse effects, including clozapine-induced myocarditis (CIM). The article reviews the clinical features, mechanisms, and management strategies for CIM, emphasizing its insidious onset and nonspecific symptoms such as fever, tachycardia, and fatigue. These symptoms can be misinterpreted during the initial titration of clozapine, complicating early detection. The pathogenesis of CIM is linked to immune-mediated mechanisms, oxidative stress, and catecholamine-induced injury. Discontinuation of clozapine is the primary treatment, with supportive care involving diuretics, beta-blockers, ACE inhibitors, and glucocorticoids in severe cases. The article discusses the challenges of reintroducing clozapine after CIM, noting a 60% success rate for re-challenge under stringent monitoring. It highlights the importance of slow titration, close monitoring of biomarkers like CRP and troponin, and individualized treatment regimens to minimize the risk of CIM. The review underscores the need for further research on CIM's pathogenesis, diagnostic criteria, and management protocols, as well as the development of globally harmonized guidelines for clozapine therapy.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Review Article",
      "Author_perspective": "The article comments on the adverse effects of clozapine, particularly CIM, and discusses the challenges in monitoring, diagnosis, and management. It highlights the need for individualized treatment regimens and globally harmonized guidelines to improve patient safety and therapeutic outcomes.",
      "Adverse_event": "The article discusses adverse events related to clozapine therapy, particularly myocarditis and cardiomyopathy. CIM can lead to severe outcomes such as malignant arrhythmias and sudden cardiac death. Rapid titration of clozapine and co-administration with other medications are identified as risk factors for CIM. The article emphasizes the importance of early detection and management to prevent fatal outcomes.",
      "Abstract": "Currently, the treatment of schizophrenia remains primarily pharmacological, with approximately 30% of patients diagnosed with treatment-resistant schizophrenia (TRS). Clozapine continues to be the first choice treatment for this subgroup of patients. As the preferred treatment, clozapine offers clear advantages in efficacy; however, its complex and troublesome adverse effects pose significant challenges for psychiatrists. Common side effects include granulocytopenia, intestinal obstruction, myocarditis, cardiomyopathy, constipation, and seizures. The first two complications are easier to manage due to the availability of laboratory monitoring, and improved management strategies are now in place in clinical practice. In recent years, clozapine-induced myocarditis (CIM) has gained considerable attention because of its potentially severe outcomes. However, the mechanism behind its lethality remains unclear, and there is no widely accepted consensus or treatment guideline, which complicates the implementation of targeted prevention in clinical practice. This review aims to summarize the clinical manifestations of CIM, explore the underlying mechanisms, and discuss recent advances in monitoring, diagnosis, and treatment, with the goal of offering constructive recommendations for future clinical management.",
      "Title": "A Review of Clinical Advances and Challenges in Clozapine-Induced Myocarditis.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:53:54",
      "Vancouver_citation": "Li M, Bai Y, Wang Y, Xing H, Zhang Y, Ding W, Ye H, Ma L, Wang W, Bao T. A Review of Clinical Advances and Challenges in Clozapine-Induced Myocarditis. Neuropsychiatr Dis Treat. 2025;21525-38",
      "pubdate": "2025-03-12",
      "Lead_author": "Li M",
      "Serious": "Serious",
      "Test_subject": "The test subjects involved in this study are patients diagnosed with treatment-resistant schizophrenia (TRS) who were treated with clozapine. The study focuses on the clinical manifestations, mechanisms, and management of clozapine-induced myocarditis (CIM) in these patients.",
      "AOI_drug_effect": "Yes, the drug of study had an effect on the test subjects. The study investigates clozapine-induced myocarditis (CIM), a potentially severe adverse event associated with clozapine use. It discusses the clinical features, mechanisms, and outcomes of CIM, including its association with rapid titration and co-administration with other medications.",
      "Approved_indication": "Clozapine is conventionally used to treat treatment-resistant schizophrenia and psychotic disorders occurring during Parkinson's disease when standard treatments fail. It is administered orally to patients who meet these criteria. In this study, clozapine was used to treat patients with TRS, which aligns with its conventional use. However, the study highlights the adverse event of myocarditis associated with clozapine, particularly in cases of rapid titration or co-administration with other drugs, which may not strictly adhere to conventional administration protocols.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study links clozapine to the adverse effect of myocarditis, discusses its clinical manifestations, and highlights risk factors such as rapid titration and co-administration with other medications.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.2147/NDT.S502312",
    "specialCase": "No",
    "countryOfFirstAuthor": "Country of the first author: China",
    "countryOfOccurrence": "Country of occurrence: China",
    "patientDetails": "Patient details: Human involved, no specific data",
    "keyEvents": "Key events: The article discusses clozapine-induced myocarditis (CIM) as a significant adverse effect of clozapine therapy, particularly in patients with treatment-resistant schizophrenia (TRS). It highlights the clinical manifestations, mechanisms, and challenges in monitoring and managing CIM. The review does not provide specific patient case details but emphasizes the importance of early detection and management strategies.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Clozapine"
    ],
    "attributability": "Attributability: The article attributes myocarditis and cardiomyopathy to clozapine therapy, particularly during the initial titration phase. It discusses the immune-mediated mechanisms, oxidative stress, and catecholamine-induced injury as potential causes of CIM.",
    "drugEffect": "Drug effect: summary. The article discusses the adverse effects of clozapine, particularly myocarditis, which can lead to severe outcomes such as malignant arrhythmias and sudden cardiac death. Discontinuation of clozapine is the primary treatment for CIM, and supportive care is recommended. Re-challenge of clozapine is controversial but may be considered under strict monitoring.",
    "summary": "Clozapine is highlighted as the first-choice treatment for TRS due to its efficacy in managing schizophrenia symptoms, reducing suicide risk, and minimizing extrapyramidal side effects. However, its use is limited by severe adverse effects, including clozapine-induced myocarditis (CIM). The article reviews the clinical features, mechanisms, and management strategies for CIM, emphasizing its insidious onset and nonspecific symptoms such as fever, tachycardia, and fatigue. These symptoms can be misinterpreted during the initial titration of clozapine, complicating early detection. The pathogenesis of CIM is linked to immune-mediated mechanisms, oxidative stress, and catecholamine-induced injury. Discontinuation of clozapine is the primary treatment, with supportive care involving diuretics, beta-blockers, ACE inhibitors, and glucocorticoids in severe cases. The article discusses the challenges of reintroducing clozapine after CIM, noting a 60% success rate for re-challenge under stringent monitoring. It highlights the importance of slow titration, close monitoring of biomarkers like CRP and troponin, and individualized treatment regimens to minimize the risk of CIM. The review underscores the need for further research on CIM's pathogenesis, diagnostic criteria, and management protocols, as well as the development of globally harmonized guidelines for clozapine therapy.",
    "identifiableHumanSubject": "Yes",
    "textType": "Review Article",
    "authorPerspective": "The article comments on the adverse effects of clozapine, particularly CIM, and discusses the challenges in monitoring, diagnosis, and management. It highlights the need for individualized treatment regimens and globally harmonized guidelines to improve patient safety and therapeutic outcomes.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Li M, Bai Y, Wang Y, Xing H, Zhang Y, Ding W, Ye H, Ma L, Wang W, Bao T. A Review of Clinical Advances and Challenges in Clozapine-Induced Myocarditis. Neuropsychiatr Dis Treat. 2025;21525-38",
    "leadAuthor": "Li M",
    "serious": "Serious",
    "testSubject": "The test subjects involved in this study are patients diagnosed with treatment-resistant schizophrenia (TRS) who were treated with clozapine. The study focuses on the clinical manifestations, mechanisms, and management of clozapine-induced myocarditis (CIM) in these patients.",
    "aoiDrugEffect": "Yes, the drug of study had an effect on the test subjects. The study investigates clozapine-induced myocarditis (CIM), a potentially severe adverse event associated with clozapine use. It discusses the clinical features, mechanisms, and outcomes of CIM, including its association with rapid titration and co-administration with other medications.",
    "approvedIndication": "Clozapine is conventionally used to treat treatment-resistant schizophrenia and psychotic disorders occurring during Parkinson's disease when standard treatments fail. It is administered orally to patients who meet these criteria. In this study, clozapine was used to treat patients with TRS, which aligns with its conventional use. However, the study highlights the adverse event of myocarditis associated with clozapine, particularly in cases of rapid titration or co-administration with other drugs, which may not strictly adhere to conventional administration protocols.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-13T07:42:50.598Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjZCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjZCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-587cfc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707231
  },
  {
    "id": "CLOZ_Demo_73897",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39835733",
    "title": "Successful Clozapine Treatment for Treatment-Resistant Schizophrenia With Zinc Deficiency Severe Anemia: A Case Report.",
    "authors": [
      "Matsuo-Yamamoto K",
      "Uenishi S",
      "Ishiyama Y",
      "Yamada S",
      "Kitabata Y",
      "Okamura K",
      "Kimoto S"
    ],
    "journal": "Neuropsychopharmacol Rep",
    "publicationDate": "2025-01-21",
    "abstract": "This case report discusses the successful treatment of a 51-year-old Japanese woman with treatment-resistant schizophrenia (TRS) using clozapine, despite complications of severe anemia potentially linked to zinc deficiency. The patient had been hospitalized multiple times due to worsening psychiatric symptoms and had previously failed treatment with various antipsychotics. Clozapine therapy was initiated, leading to a reduction in psychiatric symptoms, as evidenced by a decrease in PANSS scores. However, the patient developed severe anemia over a nine-week period, with hemoglobin levels dropping to 8.4 g/dL. Despite dose adjustments, anemia progressed to 6.7 g/dL at 19 weeks, necessitating multiple blood transfusions. Detailed blood tests revealed zinc deficiency, prompting zinc supplementation, which improved hemoglobin levels and allowed the continuation of clozapine therapy at a therapeutic dose. The patient's psychiatric symptoms remained stable, and no further anemia progression was observed. This case highlights the potential link between clozapine-induced anemia and zinc deficiency, suggesting the need for regular monitoring of serum zinc levels in patients undergoing clozapine therapy. While clozapine demonstrated efficacy in managing TRS, its use requires careful consideration due to potential adverse effects, including hematologic complications. Further research is needed to elucidate the mechanism of clozapine-induced anemia and its relationship with zinc deficiency.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Severe anemia occurred, potentially triggered by clozapine therapy. Zinc deficiency was identified as a contributing factor. The anemia required multiple blood transfusions and zinc supplementation for management.",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "90116009-0e45-47f6-9dd4-f780f69356d5",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"No Case\". Moving to QC Triage.",
        "timestamp": "2025-12-13T07:38:18.558Z",
        "type": "system"
      },
      {
        "id": "b027f96e-b104-45a5-be32-1cb482cb44c5",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 680438b9-9595-4943-8d74-63b86cd065e4 to CLOZ_Demo_73897",
        "type": "system",
        "createdAt": "2025-12-14T10:13:51.979Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:25:23.792Z",
    "updatedAt": "2025-12-13T07:39:49.196Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39835733",
      "DOI": "https://doi.org/10.1002/npr2.12526",
      "special_case": "No",
      "Country_of_first_author": "Japan",
      "Country_of_occurrence": "Japan",
      "Patient_details": "Patient details: A 51-year-old Japanese woman diagnosed with treatment-resistant schizophrenia (TRS) without physical complications.",
      "Key_events": "Key events: The patient had been hospitalized eight times due to worsening psychiatric symptoms, including severe auditory hallucinations, delusions, and impulsivity. She was previously treated with multiple antipsychotics, which were ineffective, leading to the initiation of clozapine therapy. During clozapine treatment, she developed severe anemia, requiring blood transfusions and zinc supplementation. Zinc deficiency was identified as a contributing factor to the anemia, and zinc supplementation improved her hemoglobin levels, allowing the continuation of clozapine therapy.",
      "Relevant_dates": "Relevant dates: Clozapine treatment was initiated, and over nine weeks, hemoglobin levels decreased to 8.4 g/dL. At 19 weeks, anemia progressed to 6.7 g/dL, requiring blood transfusions. Zinc supplementation was administered, and hemoglobin levels improved subsequently.",
      "Administered_drugs": "Administered drugs: Clozapine, zinc acetate hydrate.",
      "Attributability": "Attributability: Severe anemia was attributed to clozapine therapy, potentially linked to zinc deficiency. Zinc supplementation improved hemoglobin levels, suggesting a relationship between zinc deficiency and clozapine-induced anemia.",
      "Drug_effect": "Drug effect: summary: Clozapine improved psychiatric symptoms, as evidenced by a reduction in PANSS scores. Zinc supplementation improved hemoglobin levels, enabling the continuation of clozapine therapy without further anemia progression.",
      "Summary": "This case report discusses the successful treatment of a 51-year-old Japanese woman with treatment-resistant schizophrenia (TRS) using clozapine, despite complications of severe anemia potentially linked to zinc deficiency. The patient had been hospitalized multiple times due to worsening psychiatric symptoms and had previously failed treatment with various antipsychotics. Clozapine therapy was initiated, leading to a reduction in psychiatric symptoms, as evidenced by a decrease in PANSS scores. However, the patient developed severe anemia over a nine-week period, with hemoglobin levels dropping to 8.4 g/dL. Despite dose adjustments, anemia progressed to 6.7 g/dL at 19 weeks, necessitating multiple blood transfusions. Detailed blood tests revealed zinc deficiency, prompting zinc supplementation, which improved hemoglobin levels and allowed the continuation of clozapine therapy at a therapeutic dose. The patient's psychiatric symptoms remained stable, and no further anemia progression was observed. This case highlights the potential link between clozapine-induced anemia and zinc deficiency, suggesting the need for regular monitoring of serum zinc levels in patients undergoing clozapine therapy. While clozapine demonstrated efficacy in managing TRS, its use requires careful consideration due to potential adverse effects, including hematologic complications. Further research is needed to elucidate the mechanism of clozapine-induced anemia and its relationship with zinc deficiency.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Case Report",
      "Author_perspective": "The authors suggest that clozapine is highly effective for TRS but may lead to severe anemia potentially associated with zinc deficiency. They emphasize the importance of monitoring serum zinc levels and further research to understand the mechanism of clozapine-induced anemia.",
      "Adverse_event": "Severe anemia occurred, potentially triggered by clozapine therapy. Zinc deficiency was identified as a contributing factor. The anemia required multiple blood transfusions and zinc supplementation for management.",
      "Abstract": "Clozapine is an atypical antipsychotic drug approved for treatment-resistant schizophrenia (TRS). Despite its high efficacy for TRS, clozapine is associated with several serious adverse effects, such as neutropenia and diabetes, so it requires vigilant monitoring. Severe anemia has also been documented as a rare but serious complication with an unclear mechanism. We present a case report of severe anemia potentially associated with zinc deficiency during clozapine therapy.\n\nA 51-year-old woman was diagnosed with TRS without physical complications. Zinc deficiency was identified as a potential contributing factor. Zinc supplementation improved her hemoglobin levels, enabling the patient to continue clozapine at a therapeutic dose. The patient has remained stable, with no recurrence of anemia.\n\nClozapine is a highly effective antipsychotic, despite side effects including blood dyscrasias. While zinc deficiency is most likely to be implicated in clozapine-induced anemia, the exact mechanism remains unclear. Further research is required to explore this relationship between clozapine and zinc decrement.",
      "Title": "Successful Clozapine Treatment for Treatment-Resistant Schizophrenia With Zinc Deficiency Severe Anemia: A Case Report.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:54:36",
      "Vancouver_citation": "Matsuo-Yamamoto K, Uenishi S, Ishiyama Y, Yamada S, Kitabata Y, Okamura K, Kimoto S. Successful Clozapine Treatment for Treatment-Resistant Schizophrenia With Zinc Deficiency Severe Anemia: A Case Report. Neuropsychopharmacol Rep. 2025;45(1):e12526",
      "pubdate": "2025-01-21",
      "Lead_author": "Matsuo-Yamamoto K",
      "Serious": "Serious",
      "Test_subject": "The test subject in this study is a 51-year-old Japanese woman diagnosed with treatment-resistant schizophrenia (TRS). She was exposed to the drug of study, Clozapine, as part of her treatment regimen.",
      "AOI_drug_effect": "  \n2. The drug of study had an effect on the test subject. Clozapine was associated with severe anemia in the patient, potentially linked to zinc deficiency. The anemia required blood transfusions and zinc supplementation to manage the condition and allow continuation of Clozapine therapy.",
      "Approved_indication": "  \n3. Clozapine is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, Clozapine was administered to a patient with treatment-resistant schizophrenia, which aligns with its conventional use. The drug was administered orally, starting at 12.5 mg/day and titrated up to 250 mg/day. This does not qualify as off-label use, as the drug was used within its approved scope.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "  \n5. The study links Clozapine to severe anemia, a rare but serious adverse effect, potentially associated with zinc deficiency.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1002/npr2.12526",
    "specialCase": "No",
    "countryOfFirstAuthor": "Japan",
    "countryOfOccurrence": "Japan",
    "patientDetails": "Patient details: A 51-year-old Japanese woman diagnosed with treatment-resistant schizophrenia (TRS) without physical complications.",
    "keyEvents": "Key events: The patient had been hospitalized eight times due to worsening psychiatric symptoms, including severe auditory hallucinations, delusions, and impulsivity. She was previously treated with multiple antipsychotics, which were ineffective, leading to the initiation of clozapine therapy. During clozapine treatment, she developed severe anemia, requiring blood transfusions and zinc supplementation. Zinc deficiency was identified as a contributing factor to the anemia, and zinc supplementation improved her hemoglobin levels, allowing the continuation of clozapine therapy.",
    "relevantDates": "Relevant dates: Clozapine treatment was initiated, and over nine weeks, hemoglobin levels decreased to 8.4 g/dL. At 19 weeks, anemia progressed to 6.7 g/dL, requiring blood transfusions. Zinc supplementation was administered, and hemoglobin levels improved subsequently.",
    "administeredDrugs": [
      "Administered drugs: Clozapine",
      "zinc acetate hydrate."
    ],
    "attributability": "Attributability: Severe anemia was attributed to clozapine therapy, potentially linked to zinc deficiency. Zinc supplementation improved hemoglobin levels, suggesting a relationship between zinc deficiency and clozapine-induced anemia.",
    "drugEffect": "Drug effect: summary: Clozapine improved psychiatric symptoms, as evidenced by a reduction in PANSS scores. Zinc supplementation improved hemoglobin levels, enabling the continuation of clozapine therapy without further anemia progression.",
    "summary": "This case report discusses the successful treatment of a 51-year-old Japanese woman with treatment-resistant schizophrenia (TRS) using clozapine, despite complications of severe anemia potentially linked to zinc deficiency. The patient had been hospitalized multiple times due to worsening psychiatric symptoms and had previously failed treatment with various antipsychotics. Clozapine therapy was initiated, leading to a reduction in psychiatric symptoms, as evidenced by a decrease in PANSS scores. However, the patient developed severe anemia over a nine-week period, with hemoglobin levels dropping to 8.4 g/dL. Despite dose adjustments, anemia progressed to 6.7 g/dL at 19 weeks, necessitating multiple blood transfusions. Detailed blood tests revealed zinc deficiency, prompting zinc supplementation, which improved hemoglobin levels and allowed the continuation of clozapine therapy at a therapeutic dose. The patient's psychiatric symptoms remained stable, and no further anemia progression was observed. This case highlights the potential link between clozapine-induced anemia and zinc deficiency, suggesting the need for regular monitoring of serum zinc levels in patients undergoing clozapine therapy. While clozapine demonstrated efficacy in managing TRS, its use requires careful consideration due to potential adverse effects, including hematologic complications. Further research is needed to elucidate the mechanism of clozapine-induced anemia and its relationship with zinc deficiency.",
    "identifiableHumanSubject": "Yes",
    "textType": "Case Report",
    "authorPerspective": "The authors suggest that clozapine is highly effective for TRS but may lead to severe anemia potentially associated with zinc deficiency. They emphasize the importance of monitoring serum zinc levels and further research to understand the mechanism of clozapine-induced anemia.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Matsuo-Yamamoto K, Uenishi S, Ishiyama Y, Yamada S, Kitabata Y, Okamura K, Kimoto S. Successful Clozapine Treatment for Treatment-Resistant Schizophrenia With Zinc Deficiency Severe Anemia: A Case Report. Neuropsychopharmacol Rep. 2025;45(1):e12526",
    "leadAuthor": "Matsuo-Yamamoto K",
    "serious": "Serious",
    "testSubject": "The test subject in this study is a 51-year-old Japanese woman diagnosed with treatment-resistant schizophrenia (TRS). She was exposed to the drug of study, Clozapine, as part of her treatment regimen.",
    "aoiDrugEffect": "  \n2. The drug of study had an effect on the test subject. Clozapine was associated with severe anemia in the patient, potentially linked to zinc deficiency. The anemia required blood transfusions and zinc supplementation to manage the condition and allow continuation of Clozapine therapy.",
    "approvedIndication": "  \n3. Clozapine is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, Clozapine was administered to a patient with treatment-resistant schizophrenia, which aligns with its conventional use. The drug was administered orally, starting at 12.5 mg/day and titrated up to 250 mg/day. This does not qualify as off-label use, as the drug was used within its approved scope.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "In Vitro Study",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-13T07:39:49.183Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Auto approved QC",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjaCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjaCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-58a5480501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707231
  },
  {
    "id": "CLOZ_Demo_55893",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39680599",
    "title": "Recognition of Clozapine-Associated Eosinopenia in Patients With Treatment-Resistant Schizophrenia: A Report of 3 Cases and Literature Review.",
    "authors": [
      "Buesking SC",
      "Kriz CR",
      "Jarvis SP",
      "Nelson LA"
    ],
    "journal": "J Clin Psychopharmacol",
    "publicationDate": "2024-12-16",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "345ab788-83ef-47b8-9f0f-c2bf86263461",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"AOI\". Moving to QC Triage.",
        "timestamp": "2025-12-13T07:38:11.857Z",
        "type": "system"
      },
      {
        "id": "fddb4f52-21c0-45ca-b73a-b7b4b987c8d1",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"AOI\" approved by QC. Comments: Test Comment",
        "timestamp": "2025-12-13T07:43:58.618Z",
        "type": "QC_approval"
      },
      {
        "id": "ab37fe5b-daf1-4230-838a-d16e71510250",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from abd84f1e-f1ab-45d2-a318-fd5d3cc2f541 to CLOZ_Demo_55893",
        "type": "system",
        "createdAt": "2025-12-14T10:13:52.225Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:25:23.823Z",
    "updatedAt": "2025-12-13T07:43:58.628Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39680599",
      "DOI": "https://doi.org10.1097/JCP.0000000000001947",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:54:03",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Buesking SC, Kriz CR, Jarvis SP, Nelson LA. Recognition of Clozapine-Associated Eosinopenia in Patients With Treatment-Resistant Schizophrenia: A Report of 3 Cases and Literature Review. J Clin Psychopharmacol. 45(2):148-50",
      "pubdate": "2024-12-16",
      "Lead_author": "Buesking SC",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1097/JCP.0000000000001947",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Buesking SC, Kriz CR, Jarvis SP, Nelson LA. Recognition of Clozapine-Associated Eosinopenia in Patients With Treatment-Resistant Schizophrenia: A Report of 3 Cases and Literature Review. J Clin Psychopharmacol. 45(2):148-50",
    "leadAuthor": "Buesking SC",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Adverse Event",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "AOI",
    "effectiveClassification": "AOI",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-13T07:43:58.618Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Test Comment",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjbCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjbCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-58ca800501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707232
  },
  {
    "id": "CLOZ_Demo_61426",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39592247",
    "title": "Current status and features of antipsychotic prescriptions in Japanese forensic psychiatric wards based on a forensic inpatient database.",
    "authors": [
      "Takeda K",
      "Kashiwagi H",
      "Takanobu K",
      "Kubota R",
      "Naoe R",
      "Yamada Y",
      "Koike J",
      "Kono T",
      "Kako Y",
      "Hirabayasi N"
    ],
    "journal": "Neuropsychopharmacol Rep",
    "publicationDate": "2024-11-27",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "data_entry",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "24c97ce2-7263-4e71-af74-2727f850aeda",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:40.205Z"
      },
      {
        "id": "73e45af2-9131-458f-b14a-28b8ee5de8bc",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 490142ce-f34c-4040-8ece-1790b21bc572 to CLOZ_Demo_61426",
        "type": "system",
        "createdAt": "2025-12-14T10:13:52.442Z"
      },
      {
        "id": "35dde51c-1720-42b2-bb55-7698c576306d",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-15T20:13:02.065Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:25:23.851Z",
    "updatedAt": "2025-12-15T20:13:24.714Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39592247",
      "DOI": "https://doi.org10.1002/npr2.12505",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:55:01",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Takeda K, Kashiwagi H, Takanobu K, Kubota R, Naoe R, Yamada Y, Koike J, Kono T, Kako Y, Hirabayasi N. Current status and features of antipsychotic prescriptions in Japanese forensic psychiatric wards based on a forensic inpatient database. Neuropsychopharmacol Rep. 2025;45(1):e12505",
      "pubdate": "2024-11-27",
      "Lead_author": "Takeda K",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1002/npr2.12505",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Takeda K, Kashiwagi H, Takanobu K, Kubota R, Naoe R, Yamada Y, Koike J, Kono T, Kako Y, Hirabayasi N. Current status and features of antipsychotic prescriptions in Japanese forensic psychiatric wards based on a forensic inpatient database. Neuropsychopharmacol Rep. 2025;45(1):e12505",
    "leadAuthor": "Takeda K",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-15T20:13:24.703Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Auto approved QC",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjcCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjcCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dff-447a500501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765829604
  },
  {
    "id": "CLOZ_Demo_77720",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39560766",
    "title": "The lateral habenula regulates stress-related respiratory responses via the monoaminergic system.",
    "authors": [
      "Mizukami R",
      "Matsumoto M",
      "Koganezawa T"
    ],
    "journal": "Pflugers Arch",
    "publicationDate": "2024-11-19",
    "abstract": "The study investigated the role of the lateral habenula (LHb) in stress-induced respiratory responses using anesthetized Wistar male rats. Electrical stimulation of the LHb increased respiratory frequency and minute ventilation. The involvement of the monoaminergic system was analyzed by administering receptor antagonists. Clozapine, a dopaminergic receptor antagonist, suppressed LHb-induced respiratory responses, while methysergide, a serotonergic receptor antagonist, enhanced respiratory frequency and suppressed thoracic movement amplitude. To further explore the dopaminergic modulation, muscimol, a GABA receptor agonist, was administered to inhibit the ventral tegmental area (VTA), which contains dopaminergic neurons receiving inputs from the LHb. Bilateral inhibition of the VTA almost abolished LHb-induced respiratory responses, suggesting that LHb activation accelerates respiration primarily through dopaminergic neurons in the VTA, with suppressive modulation by the serotonergic system. The study highlights the LHb-monoaminergic pathway, particularly the LHb-VTA circuit, as a critical regulator of respiratory movements during stress events. Clozapine's role in suppressing LHb-induced respiratory responses underscores its potential impact on stress-related respiratory modulation.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "ed8a2d85-d3b8-4ada-b1b5-fac1d14f938f",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-13T07:32:43.996Z",
        "type": "system"
      },
      {
        "id": "4efbea5c-1c85-4c89-9125-f94a75a6ddae",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-13T07:37:37.867Z",
        "type": "QC_approval"
      },
      {
        "id": "db79383f-055e-4e63-a710-a0b8d3d67eb1",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 24fdd6f0-5701-4283-a4f7-d22e8c04b799 to CLOZ_Demo_77720",
        "type": "system",
        "createdAt": "2025-12-14T10:13:52.676Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:25:23.883Z",
    "updatedAt": "2025-12-13T07:37:37.879Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39560766",
      "DOI": "https://doi.org/10.1007/s00424-024-03043-7",
      "special_case": "No",
      "Country_of_first_author": "Japan",
      "Country_of_occurrence": "Japan",
      "Patient_details": "No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Clozapine, Methysergide, Muscimol",
      "Attributability": "Attributability: The study demonstrated that clozapine suppressed LHb-induced respiratory responses, while methysergide enhanced respiratory frequency and suppressed thoracic movement amplitude. Muscimol inactivation of the VTA abolished LHb-induced respiratory responses, indicating the involvement of dopaminergic neurons in the VTA.",
      "Drug_effect": "Drug effect: Clozapine suppressed LHb-induced respiratory responses, methysergide enhanced respiratory frequency while suppressing thoracic movement amplitude, and muscimol abolished LHb-induced respiratory responses.",
      "Summary": "The study investigated the role of the lateral habenula (LHb) in stress-induced respiratory responses using anesthetized Wistar male rats. Electrical stimulation of the LHb increased respiratory frequency and minute ventilation. The involvement of the monoaminergic system was analyzed by administering receptor antagonists. Clozapine, a dopaminergic receptor antagonist, suppressed LHb-induced respiratory responses, while methysergide, a serotonergic receptor antagonist, enhanced respiratory frequency and suppressed thoracic movement amplitude. To further explore the dopaminergic modulation, muscimol, a GABA receptor agonist, was administered to inhibit the ventral tegmental area (VTA), which contains dopaminergic neurons receiving inputs from the LHb. Bilateral inhibition of the VTA almost abolished LHb-induced respiratory responses, suggesting that LHb activation accelerates respiration primarily through dopaminergic neurons in the VTA, with suppressive modulation by the serotonergic system. The study highlights the LHb-monoaminergic pathway, particularly the LHb-VTA circuit, as a critical regulator of respiratory movements during stress events. Clozapine's role in suppressing LHb-induced respiratory responses underscores its potential impact on stress-related respiratory modulation.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article comments on the effects of clozapine, methysergide, and muscimol on LHb-induced respiratory responses, highlighting the suppressive role of clozapine and the modulatory effects of methysergide and muscimol. It concludes that the LHb regulates respiratory movements via the monoaminergic system, particularly through dopaminergic neurons in the VTA.",
      "Adverse_event": "No AE",
      "Abstract": "Psychologic stress induces behavioral and autonomic responses such as acceleration of respiration. The lateral habenula (LHb) is noted to be involved in stress-induced behavioral responses. However, its involvement in stress-induced respiratory responses is unknown. In this study, we aimed to analyze whether and how the LHb regulates respiration. Electrical stimulation of the LHb of anesthetized Wistar male rats increased respiratory frequency and minute ventilation, calculated by respiratory frequency × thoracic movement amplitude. Systemic administration of a dopaminergic receptor antagonist, clozapine, suppressed the LHb-induced respiratory responses. On the other hand, administration of a serotonergic receptor antagonist, methysergide, significantly accelerated the LHb-induced increase in respiratory frequency, together with suppressing the thoracic movement amplitude. To clarify the source of dopaminergic modulation, we inhibited the ventral tegmental area (VTA), which contains dopaminergic neurons and receives inputs from the LHb, by administering microinjections of a GABA<sub>A</sub> agonist, muscimol. The bilateral inhibition of the VTA almost abolished the LHb-induced respiratory responses. These results suggest that LHb activation causes respiration acceleration, mainly mediated by dopaminergic neurons in the VTA and suppressively modulated by the serotonergic system. Neural circuits originating in the LHb may be a key modulator for respiration during psychological stress.",
      "Title": "The lateral habenula regulates stress-related respiratory responses via the monoaminergic system.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:54:19",
      "Vancouver_citation": "Mizukami R, Matsumoto M, Koganezawa T. The lateral habenula regulates stress-related respiratory responses via the monoaminergic system. Pflugers Arch. 2025;477(3):441-52",
      "pubdate": "2024-11-19",
      "Lead_author": "Mizukami R",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study were anesthetized Wistar male rats. These rats were subjected to electrical stimulation of the lateral habenula (LHb) and systemic administration of various receptor antagonists, including the drug of study, clozapine.",
      "AOI_drug_effect": "The drug of study, clozapine, had an effect on the test subjects. Specifically, systemic administration of clozapine, a dopaminergic receptor antagonist, strongly suppressed the LHb-induced respiratory responses in the rats. This indicates that clozapine played a role in modulating the respiratory effects induced by LHb activation.",
      "Approved_indication": "The drug of study, clozapine, is conventionally used as an antipsychotic medication primarily for treatment-resistant schizophrenia. It is typically administered orally or intravenously to patients with severe psychiatric conditions. In this study, clozapine was administered intravenously to anesthetized rats to investigate its role in suppressing LHb-induced respiratory responses, which were part of the stress-related respiratory modulation.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study explicitly mentions that clozapine suppressed LHb-induced respiratory responses, indicating its pharmacological effect on the dopaminergic system. This suppression could be considered a negative or adverse effect in the context of the study's focus on respiratory modulation.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1007/s00424-024-03043-7",
    "specialCase": "No",
    "countryOfFirstAuthor": "Japan",
    "countryOfOccurrence": "Japan",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Clozapine",
      "Methysergide",
      "Muscimol"
    ],
    "attributability": "Attributability: The study demonstrated that clozapine suppressed LHb-induced respiratory responses, while methysergide enhanced respiratory frequency and suppressed thoracic movement amplitude. Muscimol inactivation of the VTA abolished LHb-induced respiratory responses, indicating the involvement of dopaminergic neurons in the VTA.",
    "drugEffect": "Drug effect: Clozapine suppressed LHb-induced respiratory responses, methysergide enhanced respiratory frequency while suppressing thoracic movement amplitude, and muscimol abolished LHb-induced respiratory responses.",
    "summary": "The study investigated the role of the lateral habenula (LHb) in stress-induced respiratory responses using anesthetized Wistar male rats. Electrical stimulation of the LHb increased respiratory frequency and minute ventilation. The involvement of the monoaminergic system was analyzed by administering receptor antagonists. Clozapine, a dopaminergic receptor antagonist, suppressed LHb-induced respiratory responses, while methysergide, a serotonergic receptor antagonist, enhanced respiratory frequency and suppressed thoracic movement amplitude. To further explore the dopaminergic modulation, muscimol, a GABA receptor agonist, was administered to inhibit the ventral tegmental area (VTA), which contains dopaminergic neurons receiving inputs from the LHb. Bilateral inhibition of the VTA almost abolished LHb-induced respiratory responses, suggesting that LHb activation accelerates respiration primarily through dopaminergic neurons in the VTA, with suppressive modulation by the serotonergic system. The study highlights the LHb-monoaminergic pathway, particularly the LHb-VTA circuit, as a critical regulator of respiratory movements during stress events. Clozapine's role in suppressing LHb-induced respiratory responses underscores its potential impact on stress-related respiratory modulation.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article comments on the effects of clozapine, methysergide, and muscimol on LHb-induced respiratory responses, highlighting the suppressive role of clozapine and the modulatory effects of methysergide and muscimol. It concludes that the LHb regulates respiratory movements via the monoaminergic system, particularly through dopaminergic neurons in the VTA.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Mizukami R, Matsumoto M, Koganezawa T. The lateral habenula regulates stress-related respiratory responses via the monoaminergic system. Pflugers Arch. 2025;477(3):441-52",
    "leadAuthor": "Mizukami R",
    "serious": "No",
    "testSubject": "The test subjects involved in this study were anesthetized Wistar male rats. These rats were subjected to electrical stimulation of the lateral habenula (LHb) and systemic administration of various receptor antagonists, including the drug of study, clozapine.",
    "aoiDrugEffect": "The drug of study, clozapine, had an effect on the test subjects. Specifically, systemic administration of clozapine, a dopaminergic receptor antagonist, strongly suppressed the LHb-induced respiratory responses in the rats. This indicates that clozapine played a role in modulating the respiratory effects induced by LHb activation.",
    "approvedIndication": "The drug of study, clozapine, is conventionally used as an antipsychotic medication primarily for treatment-resistant schizophrenia. It is typically administered orally or intravenously to patients with severe psychiatric conditions. In this study, clozapine was administered intravenously to anesthetized rats to investigate its role in suppressing LHb-induced respiratory responses, which were part of the stress-related respiratory modulation.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-13T07:37:37.866Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": "Listed",
    "seriousness": "Serious",
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjdCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjdCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-590fb80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707232
  },
  {
    "id": "CLOZ_Demo_59956",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39497431",
    "title": "Formal Thought Disorders and Neurocognition in Treatment-Resistant Schizophrenia: Trouble du cours de la pensée et neurocognition dans la schizophrénie réfractaire.",
    "authors": [
      "Alarabi M",
      "Burton L",
      "Powell V",
      "Isinger T",
      "Agarwal SM",
      "Remington G"
    ],
    "journal": "Can J Psychiatry",
    "publicationDate": "2024-11-5",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "a12c6ca6-7b9c-4b6c-b5b1-6a16acef2328",
        "userId": "system",
        "userName": "System Migration",
        "text": "Status automatically updated from \"Study in Process\" to \"Under Triage Review\"",
        "type": "system",
        "createdAt": "2025-12-14T08:54:40.285Z"
      },
      {
        "id": "773897ff-acb2-4642-a761-cfaf9fef9b29",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 4fe06c7f-2f95-4839-84f4-b9e43acc661a to CLOZ_Demo_59956",
        "type": "system",
        "createdAt": "2025-12-14T10:13:52.910Z"
      },
      {
        "id": "9efe7373-1cf9-4eb2-b3e7-e6eea5216f05",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-15T20:12:23.700Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:25:23.915Z",
    "updatedAt": "2025-12-15T20:12:32.885Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39497431",
      "DOI": "https://doi.org10.1177/07067437241293985",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-13 12:55:20",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Alarabi M, Burton L, Powell V, Isinger T, Agarwal SM, Remington G. Formal Thought Disorders and Neurocognition in Treatment-Resistant Schizophrenia: Trouble du cours de la pensée et neurocognition dans la schizophrénie réfractaire. Can J Psychiatry. 2025;70(3):229-39",
      "pubdate": "2024-11-5",
      "Lead_author": "Alarabi M",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1177/07067437241293985",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Alarabi M, Burton L, Powell V, Isinger T, Agarwal SM, Remington G. Formal Thought Disorders and Neurocognition in Treatment-Resistant Schizophrenia: Trouble du cours de la pensée et neurocognition dans la schizophrénie réfractaire. Can J Psychiatry. 2025;70(3):229-39",
    "leadAuthor": "Alarabi M",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": "Unlisted",
    "seriousness": "Serious",
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjeCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjeCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6dff-2595dc0501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765829552
  },
  {
    "id": "CLOZ_Demo_64083",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40056667",
    "title": "Antipsychotic drug dosing and study discontinuation in schizophrenia: A systematic review and dose-response meta-analysis.",
    "authors": [
      "Tian J",
      "Siafis S",
      "Lin X",
      "Wu H",
      "Schneider-Thoma J",
      "Leucht S"
    ],
    "journal": "Eur Neuropsychopharmacol",
    "publicationDate": "2025-03-9",
    "abstract": "This systematic review and dose-response meta-analysis investigated the relationship between antipsychotic drug doses and discontinuation rates in patients with acute exacerbation of schizophrenia and related disorders. The study analyzed data from 136 trials involving 44,126 participants, focusing on discontinuation due to inefficacy and side effects. Clozapine was among the antipsychotics studied, and its dose-response curve showed a plateau, suggesting no additional benefit from increasing doses beyond specific points. The study highlighted that amisulpride, cariprazine, olanzapine, and quetiapine demonstrated U-shaped dose-response curves, where higher doses led to increased discontinuation rates due to side effects. For clozapine and other drugs like aripiprazole, asenapine, brexpiprazole, paliperidone, and risperidone, the dose-response curves plateaued, indicating optimal dosing thresholds. The study emphasized the importance of identifying these thresholds to maximize treatment adherence and minimize discontinuation. It also noted that discontinuation due to side effects sharply increased with higher doses for most antipsychotics. The findings suggest that future studies should separately present disease-related and side-effect-related dropouts due to adverse events to better understand the impact of antipsychotic dosing on treatment adherence.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "aoi_assessment",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "db07016f-ba40-4072-8dcf-e6d8c9a63b8b",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"AOI\". Moving to QC Triage.",
        "timestamp": "2025-12-13T07:32:06.201Z",
        "type": "system"
      },
      {
        "id": "57d5d9b7-71d4-4df1-895b-b5f23462df7d",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 114106b6-ff4b-43c5-870c-ff98bfd303d1 to CLOZ_Demo_64083",
        "type": "system",
        "createdAt": "2025-12-14T10:13:53.106Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:26:32.950Z",
    "updatedAt": "2025-12-13T07:36:59.606Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40056667",
      "DOI": "https://doi.org/10.1016/j.euroneuro.2025.02.012",
      "special_case": "No",
      "Country_of_first_author": "Germany",
      "Country_of_occurrence": "Germany",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: The study analyzed dose-response relationships of antipsychotics in patients with acute exacerbation of schizophrenia and related disorders. It focused on discontinuation rates due to inefficacy and side effects, aiming to identify optimal dosing thresholds.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: amisulpride, cariprazine, olanzapine, quetiapine, aripiprazole, asenapine, brexpiprazole, clozapine, paliperidone, risperidone, haloperidol, iloperidone, lumateperone, lurasidone, sertindole, ziprasidone",
      "Attributability": "Attributability: Discontinuation rates were attributed to inefficacy and side effects of antipsychotics. Higher doses of amisulpride, cariprazine, olanzapine, and quetiapine led to increased discontinuation due to side effects. Clozapine and other drugs showed plateaus in dose-response curves, indicating no additional benefit from higher doses.",
      "Drug_effect": "Drug effect: summary: The study identified optimal dosing thresholds for certain antipsychotics, where further increases in dosage led to heightened discontinuation rates due to side effects. For clozapine and other drugs, increasing doses beyond specific points showed no additional benefit.",
      "Summary": "This systematic review and dose-response meta-analysis investigated the relationship between antipsychotic drug doses and discontinuation rates in patients with acute exacerbation of schizophrenia and related disorders. The study analyzed data from 136 trials involving 44,126 participants, focusing on discontinuation due to inefficacy and side effects. Clozapine was among the antipsychotics studied, and its dose-response curve showed a plateau, suggesting no additional benefit from increasing doses beyond specific points. The study highlighted that amisulpride, cariprazine, olanzapine, and quetiapine demonstrated U-shaped dose-response curves, where higher doses led to increased discontinuation rates due to side effects. For clozapine and other drugs like aripiprazole, asenapine, brexpiprazole, paliperidone, and risperidone, the dose-response curves plateaued, indicating optimal dosing thresholds. The study emphasized the importance of identifying these thresholds to maximize treatment adherence and minimize discontinuation. It also noted that discontinuation due to side effects sharply increased with higher doses for most antipsychotics. The findings suggest that future studies should separately present disease-related and side-effect-related dropouts due to adverse events to better understand the impact of antipsychotic dosing on treatment adherence.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Meta-analysis",
      "Author_perspective": "The article comments on the dose-response relationships of antipsychotics, including clozapine, and highlights the importance of identifying optimal dosing thresholds to minimize discontinuation rates due to inefficacy and side effects. It suggests that higher doses of certain antipsychotics lead to increased side effects and discontinuation, while others like clozapine show no additional benefit beyond specific doses.",
      "Adverse_event": "No AE",
      "Abstract": "High discontinuation rates compromise the effectiveness of treatment regimens for schizophrenia, because consistent medication adherence is essential for the efficacy of antipsychotics. Understanding the relationship between antipsychotic doses and discontinuation rates is important. This study explores this relationship to identify doses that maximize treatment adherence and minimize discontinuation.\n\nWe systematically searched multiple electronic databases for fixed-dose RCTs assessing 20 antipsychotics in patients with acute exacerbation of schizophrenia and related disorders. We analyzed dose-response relationships using a one-stage dose-response meta-analysis within a frequentist framework, employing restricted cubic splines to model the relationships. The primary outcome was discontinuation for any reason, and secondary outcomes were discontinuation due to inefficacy and side effects.\n\nAnalysis of 136 trials involving 44,126 participants revealed various dose-response relationships for antipsychotics. For the primary outcome, all-cause discontinuation, amisulpride, cariprazine, olanzapine (Zyprexa), and quetiapine demonstrated U-shaped curves, indicating optimal dosing thresholds where further increases in dosage led to heightened discontinuation rates, possibly due to side effects. Aripiprazole, asenapine, brexpiprazole, clozapine, paliperidone, and risperidone (Risperdal) had plateaus, suggesting no additional benefit from increasing doses beyond specific points. For haloperidol, iloperidone, lumateperone, lurasidone, sertindole, and ziprasidone, the dose-response curves did not reach a plateau within the examined doses. Inefficacy discontinuation curves were similar to total discontinuation. Most discontinuation for side-effects curves showed sharp increases in side-effects associated with higher doses.\n\nDose discontinuation curves varied between the antipsychotics and included U-shaped, monotonic, and hyperbolic patterns. Future studies should consistently present disease-related and side-effect-related dropouts due to adverse events separately.",
      "Title": "Antipsychotic drug dosing and study discontinuation in schizophrenia: A systematic review and dose-response meta-analysis.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:56:03",
      "Vancouver_citation": "Tian J, Siafis S, Lin X, Wu H, Schneider-Thoma J, Leucht S. Antipsychotic drug dosing and study discontinuation in schizophrenia: A systematic review and dose-response meta-analysis. Eur Neuropsychopharmacol. 2025;9451-8",
      "pubdate": "2025-03-9",
      "Lead_author": "Tian J",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study were human participants. Specifically, the study analyzed data from 136 randomized controlled trials (RCTs) involving 44,126 participants with acute exacerbation of schizophrenia and related disorders.",
      "AOI_drug_effect": "The drug of study, clozapine, was included in the analysis of dose-response relationships. The study found that clozapine exhibited a plateau in its dose-response curve, indicating no additional benefit from increasing doses beyond specific points. However, the study did not specify any direct adverse events or medical significance induced by clozapine itself. \"No Drug Effect\"",
      "Approved_indication": "Clozapine is conventionally used for treatment-resistant schizophrenia and psychotic disorders occurring during Parkinson's disease when standard treatments fail. In this study, clozapine was administered to patients with acute exacerbation of schizophrenia and related disorders, which aligns with its conventional use. There is no indication of off-label use or non-conventional administration in this study.",
      "AOI_classification": "Yes",
      "Justification": "The study mentions adverse events and discontinuation due to side effects associated with antipsychotics, including clozapine, even though specific adverse effects of clozapine are not detailed. Additionally, the study analyzed dose-response relationships, which inherently involve the potential for adverse effects at higher doses.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1016/j.euroneuro.2025.02.012",
    "specialCase": "No",
    "countryOfFirstAuthor": "Germany",
    "countryOfOccurrence": "Germany",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: The study analyzed dose-response relationships of antipsychotics in patients with acute exacerbation of schizophrenia and related disorders. It focused on discontinuation rates due to inefficacy and side effects, aiming to identify optimal dosing thresholds.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: amisulpride",
      "cariprazine",
      "olanzapine",
      "quetiapine",
      "aripiprazole",
      "asenapine",
      "brexpiprazole",
      "clozapine",
      "paliperidone",
      "risperidone",
      "haloperidol",
      "iloperidone",
      "lumateperone",
      "lurasidone",
      "sertindole",
      "ziprasidone"
    ],
    "attributability": "Attributability: Discontinuation rates were attributed to inefficacy and side effects of antipsychotics. Higher doses of amisulpride, cariprazine, olanzapine, and quetiapine led to increased discontinuation due to side effects. Clozapine and other drugs showed plateaus in dose-response curves, indicating no additional benefit from higher doses.",
    "drugEffect": "Drug effect: summary: The study identified optimal dosing thresholds for certain antipsychotics, where further increases in dosage led to heightened discontinuation rates due to side effects. For clozapine and other drugs, increasing doses beyond specific points showed no additional benefit.",
    "summary": "This systematic review and dose-response meta-analysis investigated the relationship between antipsychotic drug doses and discontinuation rates in patients with acute exacerbation of schizophrenia and related disorders. The study analyzed data from 136 trials involving 44,126 participants, focusing on discontinuation due to inefficacy and side effects. Clozapine was among the antipsychotics studied, and its dose-response curve showed a plateau, suggesting no additional benefit from increasing doses beyond specific points. The study highlighted that amisulpride, cariprazine, olanzapine, and quetiapine demonstrated U-shaped dose-response curves, where higher doses led to increased discontinuation rates due to side effects. For clozapine and other drugs like aripiprazole, asenapine, brexpiprazole, paliperidone, and risperidone, the dose-response curves plateaued, indicating optimal dosing thresholds. The study emphasized the importance of identifying these thresholds to maximize treatment adherence and minimize discontinuation. It also noted that discontinuation due to side effects sharply increased with higher doses for most antipsychotics. The findings suggest that future studies should separately present disease-related and side-effect-related dropouts due to adverse events to better understand the impact of antipsychotic dosing on treatment adherence.",
    "identifiableHumanSubject": "Yes",
    "textType": "Meta-analysis",
    "authorPerspective": "The article comments on the dose-response relationships of antipsychotics, including clozapine, and highlights the importance of identifying optimal dosing thresholds to minimize discontinuation rates due to inefficacy and side effects. It suggests that higher doses of certain antipsychotics lead to increased side effects and discontinuation, while others like clozapine show no additional benefit beyond specific doses.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Tian J, Siafis S, Lin X, Wu H, Schneider-Thoma J, Leucht S. Antipsychotic drug dosing and study discontinuation in schizophrenia: A systematic review and dose-response meta-analysis. Eur Neuropsychopharmacol. 2025;9451-8",
    "leadAuthor": "Tian J",
    "serious": "No",
    "testSubject": "The test subjects involved in this study were human participants. Specifically, the study analyzed data from 136 randomized controlled trials (RCTs) involving 44,126 participants with acute exacerbation of schizophrenia and related disorders.",
    "aoiDrugEffect": "The drug of study, clozapine, was included in the analysis of dose-response relationships. The study found that clozapine exhibited a plateau in its dose-response curve, indicating no additional benefit from increasing doses beyond specific points. However, the study did not specify any direct adverse events or medical significance induced by clozapine itself. \"No Drug Effect\"",
    "approvedIndication": "Clozapine is conventionally used for treatment-resistant schizophrenia and psychotic disorders occurring during Parkinson's disease when standard treatments fail. In this study, clozapine was administered to patients with acute exacerbation of schizophrenia and related disorders, which aligns with its conventional use. There is no indication of off-label use or non-conventional administration in this study.",
    "aoiClassification": "Yes",
    "justification": "Adverse Event",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "AOI",
    "effectiveClassification": "AOI",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-13T07:36:59.596Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Auto approved QC",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjfCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjfCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-595bd00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707233
  },
  {
    "id": "CLOZ_Demo_90582",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40048458",
    "title": "Predictors of clozapine concentration and psychiatric symptoms in patients with schizophrenia.",
    "authors": [
      "Park SI",
      "Kim S",
      "Park K",
      "Yu U",
      "Jang Y",
      "Kim BH",
      "Lee JH",
      "Kim E"
    ],
    "journal": "PLoS One",
    "publicationDate": "2025-03-6",
    "abstract": "This study investigated the clinical and genetic factors influencing clozapine pharmacokinetics and psychiatric symptoms in patients with schizophrenia. A total of 45 patients were enrolled, with clozapine administered for 18 weeks. Blood samples were collected at specific intervals to assess clozapine concentration, and symptom severity was evaluated using the PANSS. Smoking status and cumulative clozapine dose were significantly associated with clozapine concentration, while genetic factors such as SNPs in CYP2D6, UGT1A1, and UGT1A4 also played a role. Psychiatric symptoms, as measured by PANSS scores, were influenced by BMI, total bilirubin levels, and genetic variations in ABCB1 and DRD4. The study highlighted the importance of individualized clozapine treatment strategies, considering both clinical and genetic predictors. Adverse effects were monitored, but no specific adverse events were detailed in the study. The findings suggest that genetic and clinical factors should be considered to optimize clozapine dosing and improve treatment outcomes for schizophrenia patients.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "reporting",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "30a78673-783a-4cc4-ad26-31048ed1db19",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"No Case\". Moving to QC Triage.",
        "timestamp": "2025-12-13T07:32:28.741Z",
        "type": "system"
      },
      {
        "id": "f56d577f-bc63-42ac-aa08-275410e0b35c",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from 5e260448-e0e3-443b-893b-0f00527f29e0 to CLOZ_Demo_90582",
        "type": "system",
        "createdAt": "2025-12-14T10:13:53.370Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:26:32.991Z",
    "updatedAt": "2025-12-13T07:36:59.538Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40048458",
      "DOI": "https://doi.org/10.1371/journal.pone.0319037",
      "special_case": "No",
      "Country_of_first_author": "Republic of Korea",
      "Country_of_occurrence": "Republic of Korea",
      "Patient_details": "Patient details: 45 patients diagnosed with schizophrenia and other psychotic disorders, aged ≥19 years, were enrolled in the study.",
      "Key_events": "Key events: Patients were part of a prospective observational study conducted from November 27, 2018, to January 27, 2021. Blood samples for clozapine pharmacokinetic assessment were collected at weeks 2, 8, and 18 from the initiation of clozapine treatment. Symptom severity and treatment response were assessed using the Positive and Negative Syndrome Scale (PANSS) at baseline and weeks 8 and 18. The study involved individualized clozapine dose-titration schedules and close monitoring of adverse effects.",
      "Relevant_dates": "Relevant dates: November 27, 2018 - January 27, 2021",
      "Administered_drugs": "Administered drugs: Clozapine, administered for 18 weeks with doses ranging from 19.2 mg/day to 790.9 mg/day.",
      "Attributability": "Attributability: Clozapine concentration was influenced by smoking status, cumulative dose, and genetic factors such as SNPs in CYP2D6, UGT1A1, and UGT1A4. Psychiatric symptoms were associated with BMI, total bilirubin levels, and SNPs in ABCB1 and DRD4.",
      "Drug_effect": "Drug effect: summary: Clozapine showed efficacy in managing psychiatric symptoms, with significant associations between clozapine concentration and genetic/clinical factors. PANSS scores improved over time, indicating treatment response.",
      "Summary": "This study investigated the clinical and genetic factors influencing clozapine pharmacokinetics and psychiatric symptoms in patients with schizophrenia. A total of 45 patients were enrolled, with clozapine administered for 18 weeks. Blood samples were collected at specific intervals to assess clozapine concentration, and symptom severity was evaluated using the PANSS. Smoking status and cumulative clozapine dose were significantly associated with clozapine concentration, while genetic factors such as SNPs in CYP2D6, UGT1A1, and UGT1A4 also played a role. Psychiatric symptoms, as measured by PANSS scores, were influenced by BMI, total bilirubin levels, and genetic variations in ABCB1 and DRD4. The study highlighted the importance of individualized clozapine treatment strategies, considering both clinical and genetic predictors. Adverse effects were monitored, but no specific adverse events were detailed in the study. The findings suggest that genetic and clinical factors should be considered to optimize clozapine dosing and improve treatment outcomes for schizophrenia patients.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article comments on the effect of clozapine, highlighting its efficacy in managing psychiatric symptoms and the influence of clinical and genetic factors on its pharmacokinetics and pharmacodynamics. It emphasizes the importance of individualized treatment strategies based on these predictors.",
      "Adverse_event": "No AE",
      "Abstract": "Clozapine has superior efficacy to other antipsychotics, especially in patients with treatment-resistant schizophrenia. However, its pharmacokinetics and pharmacodynamics vary largely among patients. We aimed to evaluate the clinical and genetic factors associated with the pharmacokinetics and pharmacodynamics of clozapine in patients with schizophrenia. Blood samples for clozapine pharmacokinetic assessment were collected from patients with schizophrenia at weeks 2 (visit 2), 8 (visit 3), and 18 (visit 4) from the initiation of clozapine treatment. The Positive and Negative Syndrome Scale (PANSS) score was assessed at baseline (visit 1) and visits 3 and 4. Linear mixed models were used to identify the clinical and genetic variables associated with the clozapine concentration and total PANSS score. A total of 45 patients were included in the pharmacogenomic analysis. Owing to the small sample size, we categorized concomitant medications into four groups. However, individual drugs may have different effects on clozapine concentration. Clozapine concentration was significantly associated with smoking status and cumulative clozapine dose. Clozapine concentration was significantly associated with five single nucleotide polymorphisms (SNPs) in three genes (rs28371726 and rs202102799 in CYP2D6, rs4148323 and rs34946978 in UGT1A1, and rs2011404 in UGT1A4). Furthermore, follow-up time, body mass index, and total bilirubin levels were significantly associated with the total PANSS scores. The PANSS score was significantly associated with four SNPs in two genes (rs7787082 and rs10248420 in ABCB1 and rs2133251840 and rs762502 in DRD4). This study suggests potential clinical and genetic predictors of clozapine concentration and psychiatric symptoms in patients with schizophrenia treated with clozapine. With further investigations in diverse populations, our findings may provide important information on variables to be considered in individualized clozapine treatment.",
      "Title": "Predictors of clozapine concentration and psychiatric symptoms in patients with schizophrenia.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:55:47",
      "Vancouver_citation": "Park SI, Kim S, Park K, Yu U, Jang Y, Kim BH, Lee JH, Kim E. Predictors of clozapine concentration and psychiatric symptoms in patients with schizophrenia. PLoS One. 2025;20(3):e0319037",
      "pubdate": "2025-03-6",
      "Lead_author": "Park SI",
      "Serious": "No",
      "Test_subject": "The test subjects in this study were humans diagnosed with schizophrenia and other psychotic disorders. A total of 45 patients were enrolled, with 41 completing the study. These patients were exposed to the drug of study, Clozapine, as part of their treatment regimen.",
      "AOI_drug_effect": "The drug of study had an effect on the test subjects. The study investigated the pharmacokinetics and pharmacodynamics of Clozapine, its concentration in the blood, and its association with psychiatric symptoms measured by the Positive and Negative Syndrome Scale (PANSS). The study also explored genetic and clinical factors influencing Clozapine concentration and treatment response. However, specific adverse events or medical significance induced by the drug were not detailed in the abstract. \"No Drug Effect\"",
      "Approved_indication": "Clozapine is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, Clozapine was administered to patients with schizophrenia, which aligns with its conventional use. The drug was given in a flexible dosing schedule based on the patients' clinical status, with close monitoring of adverse effects. There is no indication of off-label use or non-conventional administration in this study.",
      "AOI_classification": "Yes",
      "Justification": "The study mentions monitoring adverse effects of Clozapine treatment and investigates its pharmacokinetics and pharmacodynamics, which are associated with variability in treatment response and potential adverse effects.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1371/journal.pone.0319037",
    "specialCase": "No",
    "countryOfFirstAuthor": "Republic of Korea",
    "countryOfOccurrence": "Republic of Korea",
    "patientDetails": "Patient details: 45 patients diagnosed with schizophrenia and other psychotic disorders, aged ≥19 years, were enrolled in the study.",
    "keyEvents": "Key events: Patients were part of a prospective observational study conducted from November 27, 2018, to January 27, 2021. Blood samples for clozapine pharmacokinetic assessment were collected at weeks 2, 8, and 18 from the initiation of clozapine treatment. Symptom severity and treatment response were assessed using the Positive and Negative Syndrome Scale (PANSS) at baseline and weeks 8 and 18. The study involved individualized clozapine dose-titration schedules and close monitoring of adverse effects.",
    "relevantDates": "Relevant dates: November 27, 2018 - January 27, 2021",
    "administeredDrugs": [
      "Administered drugs: Clozapine",
      "administered for 18 weeks with doses ranging from 19.2 mg/day to 790.9 mg/day."
    ],
    "attributability": "Attributability: Clozapine concentration was influenced by smoking status, cumulative dose, and genetic factors such as SNPs in CYP2D6, UGT1A1, and UGT1A4. Psychiatric symptoms were associated with BMI, total bilirubin levels, and SNPs in ABCB1 and DRD4.",
    "drugEffect": "Drug effect: summary: Clozapine showed efficacy in managing psychiatric symptoms, with significant associations between clozapine concentration and genetic/clinical factors. PANSS scores improved over time, indicating treatment response.",
    "summary": "This study investigated the clinical and genetic factors influencing clozapine pharmacokinetics and psychiatric symptoms in patients with schizophrenia. A total of 45 patients were enrolled, with clozapine administered for 18 weeks. Blood samples were collected at specific intervals to assess clozapine concentration, and symptom severity was evaluated using the PANSS. Smoking status and cumulative clozapine dose were significantly associated with clozapine concentration, while genetic factors such as SNPs in CYP2D6, UGT1A1, and UGT1A4 also played a role. Psychiatric symptoms, as measured by PANSS scores, were influenced by BMI, total bilirubin levels, and genetic variations in ABCB1 and DRD4. The study highlighted the importance of individualized clozapine treatment strategies, considering both clinical and genetic predictors. Adverse effects were monitored, but no specific adverse events were detailed in the study. The findings suggest that genetic and clinical factors should be considered to optimize clozapine dosing and improve treatment outcomes for schizophrenia patients.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article comments on the effect of clozapine, highlighting its efficacy in managing psychiatric symptoms and the influence of clinical and genetic factors on its pharmacokinetics and pharmacodynamics. It emphasizes the importance of individualized treatment strategies based on these predictors.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Park SI, Kim S, Park K, Yu U, Jang Y, Kim BH, Lee JH, Kim E. Predictors of clozapine concentration and psychiatric symptoms in patients with schizophrenia. PLoS One. 2025;20(3):e0319037",
    "leadAuthor": "Park SI",
    "serious": "No",
    "testSubject": "The test subjects in this study were humans diagnosed with schizophrenia and other psychotic disorders. A total of 45 patients were enrolled, with 41 completing the study. These patients were exposed to the drug of study, Clozapine, as part of their treatment regimen.",
    "aoiDrugEffect": "The drug of study had an effect on the test subjects. The study investigated the pharmacokinetics and pharmacodynamics of Clozapine, its concentration in the blood, and its association with psychiatric symptoms measured by the Positive and Negative Syndrome Scale (PANSS). The study also explored genetic and clinical factors influencing Clozapine concentration and treatment response. However, specific adverse events or medical significance induced by the drug were not detailed in the abstract. \"No Drug Effect\"",
    "approvedIndication": "Clozapine is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, Clozapine was administered to patients with schizophrenia, which aligns with its conventional use. The drug was given in a flexible dosing schedule based on the patients' clinical status, with close monitoring of adverse effects. There is no indication of off-label use or non-conventional administration in this study.",
    "aoiClassification": "Yes",
    "justification": "Treatment Medication",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "No Case",
    "effectiveClassification": "No Case",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-13T07:36:59.523Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Auto approved QC",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjgCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjgCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-59815c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707233
  },
  {
    "id": "CLOZ_Demo_97799",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39913268",
    "title": "Comparison of Effectiveness and Tolerability of Clonidine and Trihexyphenidyl in Clozapine-Induced Hypersalivation.",
    "authors": [
      "Pansawat P",
      "Pansawat W",
      "Silaket S",
      "Supapaan TS",
      "Boonlue T"
    ],
    "journal": "J Clin Psychopharmacol",
    "publicationDate": "2025-02-6",
    "abstract": "Summary: Human involved, no specific data",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "329d9673-47f7-402c-a481-00068a1a9868",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-13T07:55:36.988Z",
        "type": "system"
      },
      {
        "id": "3ce1de7d-f694-480e-91cc-b6307ca96eb5",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" approved by QC. Comments: Test comment for approval",
        "timestamp": "2025-12-13T07:59:26.827Z",
        "type": "QC_approval"
      },
      {
        "id": "7569e887-679e-493e-bb4b-4495f8f66006",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from a50dea91-e91e-4aee-b639-e6f85ee94153 to CLOZ_Demo_97799",
        "type": "system",
        "createdAt": "2025-12-14T10:13:53.617Z"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:26:33.021Z",
    "updatedAt": "2025-12-13T07:59:26.839Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39913268",
      "DOI": "https://doi.org/10.1097/JCP.0000000000001968",
      "special_case": "No",
      "Country_of_first_author": "Country of the first author: Human involved, no specific data",
      "Country_of_occurrence": "Country of occurrence: Human involved, no specific data",
      "Patient_details": "Patient details: Human involved, no specific data",
      "Key_events": "Key events: Human involved, no specific data",
      "Relevant_dates": "Relevant dates: Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Human involved, no specific data",
      "Attributability": "Attributability: Human involved, no specific data",
      "Drug_effect": "Drug effect: Human involved, no specific data",
      "Summary": "Summary: Human involved, no specific data",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "Human involved, no specific data",
      "Adverse_event": "No AE",
      "Abstract": "Clozapine-induced hypersalivation is one of the most common bothersome adverse reactions of clozapine. The management strategies for this condition remain inadequately studied and understood. The objective of the study is to compare the effectiveness and tolerability of (1) trihexyphenidyl 5 mg/d, (2) clonidine 0.15 mg/d, or (3) a reduction of clozapine dosage by 25 to 50 mg/d for managing clozapine-induced hypersalivation.\n\nA randomized, open-label, non-placebo-controlled clinical trial was conducted from December 2023 to May 2024. Eligible patients were randomly assigned to 1 of 3 groups. Primary outcomes were assessed using the Drooling Severity and Frequency Scale (DSFS) and the Nocturnal Hypersalivation Rating Scale (NHRS) at baseline, week 4, and week 8. Quality of life assessed using the pharmaceutical therapy for quality of life short version and adverse drug reactions were recorded as secondary outcomes.\n\nA total of 67 patients were randomly assigned to 1 of 3 treatment groups. By week 8, significant reductions in DSFS and NHRS scores were observed in all groups, with clonidine showing the greatest improvement. Trihexyphenidyl was also effective, whereas reducing clozapine dose resulted in more modest improvements. Quality of life improved significantly across all groups, with the greatest improvement observed in the clonidine group. The most common adverse effects were dry mouth, constipation, drowsiness, and dizziness.\n\nClonidine and trihexyphenidyl appear to be more effective options for managing clozapine-induced hypersalivation compared to clozapine dose reduction.",
      "Title": "Comparison of Effectiveness and Tolerability of Clonidine and Trihexyphenidyl in Clozapine-Induced Hypersalivation.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:56:29",
      "Vancouver_citation": "Pansawat P, Pansawat W, Silaket S, Supapaan TS, Boonlue T. Comparison of Effectiveness and Tolerability of Clonidine and Trihexyphenidyl in Clozapine-Induced Hypersalivation. J Clin Psychopharmacol. 45(2):76-84",
      "pubdate": "2025-02-6",
      "Lead_author": "Pansawat P",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study were 67 patients who were exposed to the drug of study, Clozapine. These patients were experiencing clozapine-induced hypersalivation and were randomly assigned to one of three treatment groups.",
      "AOI_drug_effect": "The drug of study, Clozapine, induced hypersalivation, which is described as a bothersome adverse reaction. The study investigated management strategies for this specific adverse event caused by the drug.",
      "Approved_indication": "Clozapine is conventionally used for treatment-resistant schizophrenia and psychotic disorders occurring during Parkinson's disease when standard treatments fail. In this study, the drug was administered to patients with schizophrenia or related conditions, as inferred from the context of clozapine use. The study does not indicate off-label use of Clozapine itself, but it does explore management strategies for an adverse effect caused by the drug.",
      "AOI_classification": "Yes",
      "Justification": "The study links Clozapine to hypersalivation, an adverse effect, and investigates management strategies for this condition.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1097/JCP.0000000000001968",
    "specialCase": "No",
    "countryOfFirstAuthor": "Country of the first author: Human involved, no specific data",
    "countryOfOccurrence": "Country of occurrence: Human involved, no specific data",
    "patientDetails": "Patient details: Human involved, no specific data",
    "keyEvents": "Key events: Human involved, no specific data",
    "relevantDates": "Relevant dates: Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Human involved",
      "no specific data"
    ],
    "attributability": "Attributability: Human involved, no specific data",
    "drugEffect": "Drug effect: Human involved, no specific data",
    "summary": "Summary: Human involved, no specific data",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "Human involved, no specific data",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Pansawat P, Pansawat W, Silaket S, Supapaan TS, Boonlue T. Comparison of Effectiveness and Tolerability of Clonidine and Trihexyphenidyl in Clozapine-Induced Hypersalivation. J Clin Psychopharmacol. 45(2):76-84",
    "leadAuthor": "Pansawat P",
    "serious": "No",
    "testSubject": "The test subjects involved in this study were 67 patients who were exposed to the drug of study, Clozapine. These patients were experiencing clozapine-induced hypersalivation and were randomly assigned to one of three treatment groups.",
    "aoiDrugEffect": "The drug of study, Clozapine, induced hypersalivation, which is described as a bothersome adverse reaction. The study investigated management strategies for this specific adverse event caused by the drug.",
    "approvedIndication": "Clozapine is conventionally used for treatment-resistant schizophrenia and psychotic disorders occurring during Parkinson's disease when standard treatments fail. In this study, the drug was administered to patients with schizophrenia or related conditions, as inferred from the context of clozapine use. The study does not indicate off-label use of Clozapine itself, but it does explore management strategies for an adverse effect caused by the drug.",
    "aoiClassification": "Yes",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-13T07:59:26.827Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Test comment for approval",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjhCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjhCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6ce2-59a7100501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765707233
  },
  {
    "id": "CLOZ_Demo_35020",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39903866",
    "title": "Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines.",
    "authors": [
      "Brenner LA",
      "Capaldi V",
      "Constans J",
      "Dobscha S",
      "Fuller M",
      "Matarazzo B",
      "McGraw K",
      "Richter K",
      "Sall J",
      "Smolenski D",
      "Williams S",
      "Davis-Arnold S",
      "Bahraini N"
    ],
    "journal": "Ann Intern Med",
    "publicationDate": "2025-02-4",
    "abstract": "The article provides a synopsis of the updated 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines for assessing and managing patients at risk for suicide. It highlights the recommendations for primary care physicians regarding the evaluation and management of military members and veterans. The VA/DOD Evidence-Based Practice Work Group systematically reviewed literature from 1 April 2018 to 15 March 2023 and developed 24 recommendations using the GRADE system. The guidelines emphasize the use of validated tools to identify populations at higher risk for suicide-related behaviors, cognitive behavioral therapy to reduce suicide attempts and suicidal ideation, and periodic communications as a prevention strategy. Pharmacologic treatments, including clozapine for schizophrenia and ketamine infusion for major depressive disorder, are also recommended for managing suicide risk. While the article mentions clozapine as a treatment option, it does not provide specific details about its administration, duration, or effects on human subjects. Additionally, no adverse events or complications related to clozapine are reported in the provided text. The synopsis underscores the importance of evidence-based approaches in suicide prevention but does not elaborate on the outcomes or effectiveness of the mentioned treatments.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "qc_data_entry",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "8bf12597-00ec-4193-a454-9aa58c348487",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-13T07:53:07.204Z",
        "type": "system"
      },
      {
        "id": "249a72c6-48ac-4616-8296-891ad41f896f",
        "userId": "system",
        "userName": "System Migration",
        "text": "ID migrated from d1a2a1aa-c3c9-4064-93a4-a630979aaa02 to CLOZ_Demo_35020",
        "type": "system",
        "createdAt": "2025-12-14T10:13:53.865Z"
      },
      {
        "id": "2e2551a1-97f6-45b1-a787-896ce472e659",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "R3 form data updated",
        "timestamp": "2025-12-15T20:19:06.183Z",
        "type": "system"
      },
      {
        "id": "11c4f35b-13a9-4067-ba87-79459a064c3c",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "R3 form completed. Awaiting QC approval before Medical Reviewer review.",
        "timestamp": "2025-12-15T20:19:06.284Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-13T07:26:33.051Z",
    "updatedAt": "2025-12-15T20:19:06.295Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39903866",
      "DOI": "https://doi.org/10.7326/ANNALS-24-01938",
      "special_case": "No",
      "Country_of_first_author": "United States",
      "Country_of_occurrence": "United States",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: The article discusses the assessment and management of military members and veterans at risk for suicide. It mentions the use of validated tools for identifying populations at higher risk for suicide-related behaviors, cognitive behavioral therapy for reducing suicide attempts and suicidal ideation, and periodic communications as a prevention strategy. Pharmacologic treatments, including clozapine for schizophrenia and ketamine infusion for major depressive disorder, are also highlighted as part of the management approach.",
      "Relevant_dates": "Relevant dates: 1 April 2018 to 15 March 2023 (literature review period), 2023 (VA/DOD Evidence-Based Practice Work Group convened), 2024 (updated recommendations published).",
      "Administered_drugs": "Administered drugs: Clozapine, ketamine infusion",
      "Attributability": "Attributability: The article mentions clozapine and ketamine infusion as pharmacologic treatments for managing suicide risk among individuals with schizophrenia and major depressive disorder, respectively. No specific adverse events or complications are attributed to these treatments in the provided text.",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The article provides a synopsis of the updated 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines for assessing and managing patients at risk for suicide. It highlights the recommendations for primary care physicians regarding the evaluation and management of military members and veterans. The VA/DOD Evidence-Based Practice Work Group systematically reviewed literature from 1 April 2018 to 15 March 2023 and developed 24 recommendations using the GRADE system. The guidelines emphasize the use of validated tools to identify populations at higher risk for suicide-related behaviors, cognitive behavioral therapy to reduce suicide attempts and suicidal ideation, and periodic communications as a prevention strategy. Pharmacologic treatments, including clozapine for schizophrenia and ketamine infusion for major depressive disorder, are also recommended for managing suicide risk. While the article mentions clozapine as a treatment option, it does not provide specific details about its administration, duration, or effects on human subjects. Additionally, no adverse events or complications related to clozapine are reported in the provided text. The synopsis underscores the importance of evidence-based approaches in suicide prevention but does not elaborate on the outcomes or effectiveness of the mentioned treatments.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Review Article",
      "Author_perspective": "The article comments on the role of clozapine and ketamine infusion in managing suicide risk among individuals with schizophrenia and major depressive disorder, respectively, but does not provide specific opinions or detailed results regarding their effects.",
      "Adverse_event": "No AE",
      "Abstract": "The U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DOD) updated the 2019 joint clinical practice guideline (CPG) for assessing and managing patients who are at risk for suicide. This synopsis provides primary care physicians with a summary of the updated 2024 recommendations regarding evaluation and management of military members and veterans at risk for suicide.\n\nIn 2023, the VA/DOD Evidence-Based Practice Work Group convened to develop a joint VA/DOD guideline, including clinical stakeholders, which conformed to the National Academy of Medicine's tenets for trustworthy CPGs. The Work Group drafted 12 key questions, reviewed systematically identified literature (1 April 2018 to 15 March 2023), evaluated the evidence, created algorithms, and advanced 24 recommendations in accordance with the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system.\n\nDespite insufficient evidence to recommend for or against suicide risk screening programs as a means for reducing suicide attempts or deaths, the VA/DOD Work Group identified validated tools that could be used to identify populations at higher risk for suicide-related behaviors. Cognitive behavioral therapy was also recommended for reducing the risk for suicide attempts and decreasing suicidal ideation among those with a history of suicidal behavior or a history of self-directed violence. Periodic communications after previous suicide attempts were also recommended as a prevention strategy. Pharmacologic treatments, such as clozapine or ketamine infusion, also have a role in the management of suicide risk among those with schizophrenia or major depressive disorder, respectively.",
      "Title": "Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-13 12:56:18",
      "Vancouver_citation": "Brenner LA, Capaldi V, Constans J, Dobscha S, Fuller M, Matarazzo B, McGraw K, Richter K, Sall J, Smolenski D, Williams S, Davis-Arnold S, Bahraini N. Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines. Ann Intern Med. 2025;178(3):416-25",
      "pubdate": "2025-02-4",
      "Lead_author": "Brenner LA",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, Clozapine is mentioned as a pharmacologic treatment for managing suicide risk among individuals with schizophrenia, which aligns with its conventional use. There is no indication of off-label use.",
      "AOI_classification": "No",
      "Justification": "The study does not link the drug of study to any negative or adverse effects.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.7326/ANNALS-24-01938",
    "specialCase": "No",
    "countryOfFirstAuthor": "United States",
    "countryOfOccurrence": "United States",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: The article discusses the assessment and management of military members and veterans at risk for suicide. It mentions the use of validated tools for identifying populations at higher risk for suicide-related behaviors, cognitive behavioral therapy for reducing suicide attempts and suicidal ideation, and periodic communications as a prevention strategy. Pharmacologic treatments, including clozapine for schizophrenia and ketamine infusion for major depressive disorder, are also highlighted as part of the management approach.",
    "relevantDates": "Relevant dates: 1 April 2018 to 15 March 2023 (literature review period), 2023 (VA/DOD Evidence-Based Practice Work Group convened), 2024 (updated recommendations published).",
    "administeredDrugs": [
      "Administered drugs: Clozapine",
      "ketamine infusion"
    ],
    "attributability": "Attributability: The article mentions clozapine and ketamine infusion as pharmacologic treatments for managing suicide risk among individuals with schizophrenia and major depressive disorder, respectively. No specific adverse events or complications are attributed to these treatments in the provided text.",
    "drugEffect": "Drug effect: no data",
    "summary": "The article provides a synopsis of the updated 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines for assessing and managing patients at risk for suicide. It highlights the recommendations for primary care physicians regarding the evaluation and management of military members and veterans. The VA/DOD Evidence-Based Practice Work Group systematically reviewed literature from 1 April 2018 to 15 March 2023 and developed 24 recommendations using the GRADE system. The guidelines emphasize the use of validated tools to identify populations at higher risk for suicide-related behaviors, cognitive behavioral therapy to reduce suicide attempts and suicidal ideation, and periodic communications as a prevention strategy. Pharmacologic treatments, including clozapine for schizophrenia and ketamine infusion for major depressive disorder, are also recommended for managing suicide risk. While the article mentions clozapine as a treatment option, it does not provide specific details about its administration, duration, or effects on human subjects. Additionally, no adverse events or complications related to clozapine are reported in the provided text. The synopsis underscores the importance of evidence-based approaches in suicide prevention but does not elaborate on the outcomes or effectiveness of the mentioned treatments.",
    "identifiableHumanSubject": "Yes",
    "textType": "Review Article",
    "authorPerspective": "The article comments on the role of clozapine and ketamine infusion in managing suicide risk among individuals with schizophrenia and major depressive disorder, respectively, but does not provide specific opinions or detailed results regarding their effects.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Brenner LA, Capaldi V, Constans J, Dobscha S, Fuller M, Matarazzo B, McGraw K, Richter K, Sall J, Smolenski D, Williams S, Davis-Arnold S, Bahraini N. Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines. Ann Intern Med. 2025;178(3):416-25",
    "leadAuthor": "Brenner LA",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, Clozapine is mentioned as a pharmacologic treatment for managing suicide risk among individuals with schizophrenia, which aligns with its conventional use. There is no indication of off-label use.",
    "aoiClassification": "No",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-13T07:53:14.857Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Auto approved QC",
    "r3FormData": {
      "D.9.1": "No",
      "E.i.3.2a": "False",
      "E.i.3.2b": "False",
      "E.i.3.2c": "False",
      "E.i.3.2d": "False",
      "E.i.3.2e": "False",
      "E.i.3.2f": "False",
      "E.i.7": "0",
      "C.2.r.1": "Brenner LA",
      "C.2.r.1.2": "Brenner",
      "C.2.r.1.4": "LA",
      "C.4.r.1": "Brenner LA, Capaldi V, Constans J, Dobscha S, Fuller M, Matarazzo B, McGraw K, Richter K, Sall J, Smolenski D, Williams S, Davis-Arnold S, Bahraini N. Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines. Ann Intern Med. 2025;178(3):416-25",
      "D.7.1.r": "Human involved, no specific data",
      "D.7": "The article provides a synopsis of the updated 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines for assessing and managing patients at risk for suicide. It highlights the recommendations for primary care physicians regarding the evaluation and management of military members and veterans. The VA/DOD Evidence-Based Practice Work Group systematically reviewed literature from 1 April 2018 to 15 March 2023 and developed 24 recommendations using the GRADE system. The guidelines emphasize the use of validated tools to identify populations at higher risk for suicide-related behaviors, cognitive behavioral therapy to reduce suicide attempts and suicidal ideation, and periodic communications as a prevention strategy. Pharmacologic treatments, including clozapine for schizophrenia and ketamine infusion for major depressive disorder, are also recommended for managing suicide risk. While the article mentions clozapine as a treatment option, it does not provide specific details about its administration, duration, or effects on human subjects. Additionally, no adverse events or complications related to clozapine are reported in the provided text. The synopsis underscores the importance of evidence-based approaches in suicide prevention but does not elaborate on the outcomes or effectiveness of the mentioned treatments.",
      "D.7.1.r.2": "Relevant dates: 1 April 2018 to 15 March 2023 (literature review period), 2023 (VA/DOD Evidence-Based Practice Work Group convened), 2024 (updated recommendations published).",
      "E.i.1.1a": "No AE",
      "C.2.r.2.1": "Institution in United States"
    },
    "r3FormStatus": "completed",
    "r3FormCompletedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "r3FormCompletedAt": "2025-12-15T20:19:06.284Z",
    "qcR3Status": "pending",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "_rid": "Vf9WAOX6zUjiCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjiCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6e00-1013640501dc\"",
    "_attachments": "attachments/",
    "assignedTo": null,
    "lockedAt": null,
    "_ts": 1765829946
  },
  {
    "id": "5b3adb30-200c-4713-843d-a61f8a705dd4",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41396569",
    "title": "Efficacy of Combined Suprascapular Block and Axillary Nerve Block for Post-Operative Pain Management in Shoulder Arthroplasty: A Narrative Review.",
    "authors": [
      "Tyler SD",
      "Bhuchakra HP",
      "Kim J",
      "Ahmadzadeh S",
      "Allampalli V",
      "Shekoohi S",
      "Abd-Elsayed A",
      "Kaye AD"
    ],
    "journal": "Curr Pain Headache Rep",
    "publicationDate": "2025-12-15",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:00:45.759Z",
    "updatedAt": "2025-12-17T19:21:29.686Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41396569",
      "DOI": "https://doi.org10.1007/s11916-025-01442-8",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Unknown",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-16 05:30:20",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Tyler SD, Bhuchakra HP, Kim J, Ahmadzadeh S, Allampalli V, Shekoohi S, Abd-Elsayed A, Kaye AD. Efficacy of Combined Suprascapular Block and Axillary Nerve Block for Post-Operative Pain Management in Shoulder Arthroplasty: A Narrative Review. Curr Pain Headache Rep. 2025;30(1):7",
      "pubdate": "2025-12-15",
      "Lead_author": "Tyler SD",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s11916-025-01442-8",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Tyler SD, Bhuchakra HP, Kim J, Ahmadzadeh S, Allampalli V, Shekoohi S, Abd-Elsayed A, Kaye AD. Efficacy of Combined Suprascapular Block and Axillary Nerve Block for Post-Operative Pain Management in Shoulder Arthroplasty: A Narrative Review. Curr Pain Headache Rep. 2025;30(1):7",
    "leadAuthor": "Tyler SD",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Unknown",
    "sponsor": "Unknown",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUjlCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjlCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-589a740501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999289
  },
  {
    "id": "caaad7b1-dd94-4996-820e-f93d1f2ddd12",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41396214",
    "title": "In vitro development and evaluation of chitosan-cellulose nanocrystal microspheres for controlled dexamethasone delivery in rheumatoid arthritis.",
    "authors": [
      "Hacholli VB",
      "Patil SM",
      "Szeleszczuk Ł",
      "Prabhanjan BH",
      "Sindhu H",
      "Shubha MR",
      "Lavanya M",
      "Pramod S",
      "Devi VK",
      "Gackowski M"
    ],
    "journal": "Rheumatol Int",
    "publicationDate": "2025-12-15",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:00:45.879Z",
    "updatedAt": "2025-12-17T19:21:30.037Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41396214",
      "DOI": "https://doi.org10.1007/s00296-025-06030-y",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Unknown",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-16 05:30:28",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Hacholli VB, Patil SM, Szeleszczuk Ł, Prabhanjan BH, Sindhu H, Shubha MR, Lavanya M, Pramod S, Devi VK, Gackowski M. In vitro development and evaluation of chitosan-cellulose nanocrystal microspheres for controlled dexamethasone delivery in rheumatoid arthritis. Rheumatol Int. 2025;46(1):12",
      "pubdate": "2025-12-15",
      "Lead_author": "Hacholli VB",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1007/s00296-025-06030-y",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Hacholli VB, Patil SM, Szeleszczuk Ł, Prabhanjan BH, Sindhu H, Shubha MR, Lavanya M, Pramod S, Devi VK, Gackowski M. In vitro development and evaluation of chitosan-cellulose nanocrystal microspheres for controlled dexamethasone delivery in rheumatoid arthritis. Rheumatol Int. 2025;46(1):12",
    "leadAuthor": "Hacholli VB",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Unknown",
    "sponsor": "Unknown",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUjmCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjmCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-58cfb00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999290
  },
  {
    "id": "a60d81f3-0448-4ee4-bcda-abdf8adcc2bb",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40914322",
    "title": "The Glucocorticoid Receptor Inhibits NRF2-Mediated Expression of SLC7A11.",
    "authors": [
      "Lacher SE",
      "Krznarich J",
      "Levings DC",
      "Pathak SS",
      "Pufall M",
      "Yang YM",
      "Slattery M"
    ],
    "journal": "Free Radic Biol Med",
    "publicationDate": "2025-09-7",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:00:45.909Z",
    "updatedAt": "2025-12-17T19:21:30.598Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40914322",
      "DOI": "https://doi.org10.1016/j.freeradbiomed.2025.09.008",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Unknown",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-16 05:30:37",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Lacher SE, Krznarich J, Levings DC, Pathak SS, Pufall M, Yang YM, Slattery M. The Glucocorticoid Receptor Inhibits NRF2-Mediated Expression of SLC7A11. Free Radic Biol Med. 2025;24153-63",
      "pubdate": "2025-09-7",
      "Lead_author": "Lacher SE",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.freeradbiomed.2025.09.008",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Lacher SE, Krznarich J, Levings DC, Pathak SS, Pufall M, Yang YM, Slattery M. The Glucocorticoid Receptor Inhibits NRF2-Mediated Expression of SLC7A11. Free Radic Biol Med. 2025;24153-63",
    "leadAuthor": "Lacher SE",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Unknown",
    "sponsor": "Unknown",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUjnCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjnCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-5925600501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999290
  },
  {
    "id": "aa585bee-f540-4445-a806-4748cb58ceb1",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "40577958",
    "title": "Precisely engineered dual-antenna europium MOF with intrinsic dual-state luminescence for sensitive dexamethasone sensing.",
    "authors": [
      "Mohammed Ameen SS",
      "Algethami FK",
      "Omer KM"
    ],
    "journal": "Spectrochim Acta A Mol Biomol Spectrosc",
    "publicationDate": "2025-06-28",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:00:45.945Z",
    "updatedAt": "2025-12-17T19:21:30.745Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "40577958",
      "DOI": "https://doi.org10.1016/j.saa.2025.126598",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Unknown",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-16 05:30:44",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Mohammed Ameen SS, Algethami FK, Omer KM. Precisely engineered dual-antenna europium MOF with intrinsic dual-state luminescence for sensitive dexamethasone sensing. Spectrochim Acta A Mol Biomol Spectrosc. 2025;343126598",
      "pubdate": "2025-06-28",
      "Lead_author": "Mohammed Ameen SS",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.saa.2025.126598",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Mohammed Ameen SS, Algethami FK, Omer KM. Precisely engineered dual-antenna europium MOF with intrinsic dual-state luminescence for sensitive dexamethasone sensing. Spectrochim Acta A Mol Biomol Spectrosc. 2025;343126598",
    "leadAuthor": "Mohammed Ameen SS",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Unknown",
    "sponsor": "Unknown",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUjoCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjoCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-593b880501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999290
  },
  {
    "id": "cb6ff8aa-ae13-4e4d-9814-a26fc1350ede",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41394230",
    "title": "Investigating Why Comparing Intravenous and Perineural Dexamethasone Is Scientifically Unfounded.",
    "authors": [
      "Sonawane K"
    ],
    "journal": "Cureus",
    "publicationDate": "2025-12-15",
    "abstract": "The article focuses on the pharmacological differences between intravenous and perineural administration of dexamethasone in regional anesthesia. It argues that comparing these routes is scientifically unfounded due to their distinct mechanisms of action and clinical effects. Intravenous dexamethasone is described as having systemic anti-inflammatory and antiemetic effects, which are beneficial in enhanced recovery pathways. In contrast, perineural dexamethasone creates a high-concentration depot at the neural interface, providing localized benefits such as prolonged block reliability, reduced vascular uptake, and neuroprotection through antiedema, antifibrotic, microcirculatory, and antineurotoxic actions. The article critiques the methodological flaw of milligram dosing parity across routes and suggests concentration- or exposure-matched designs for future studies. It recommends using intravenous dexamethasone for systemic modulation and perineural dexamethasone for extending block duration and nerve protection, with combined use being synergistic when both aims are relevant. The editorial reframes the debate from competition to context-specific integration to align practice with pharmacology and improve patient-centered outcomes. No specific adverse events or complications related to dexamethasone are mentioned.",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:02:31.685Z",
    "updatedAt": "2025-12-17T19:21:31.014Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41394230",
      "DOI": "https://doi.org/10.7759/cureus.98950",
      "special_case": "No",
      "Country_of_first_author": "India",
      "Country_of_occurrence": "India",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: Human subjects were involved in the study, but specific details about their admission to a hospital or participation in a study are not provided. The article discusses the use of dexamethasone in regional anesthesia and compares intravenous and perineural administration routes.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Dexamethasone",
      "Attributability": "Attributability: The article discusses the pharmacological effects of dexamethasone administered via intravenous and perineural routes. It mentions systemic anti-inflammatory and antiemetic effects for intravenous administration and localized anti-inflammatory, antiedema, antifibrotic, microcirculatory, and antineurotoxic actions for perineural administration. No specific adverse events or complications are attributed to the drug.",
      "Drug_effect": "Drug effect: summary. The article highlights the systemic benefits of intravenous dexamethasone, such as anti-inflammatory and antiemetic effects, and the localized benefits of perineural dexamethasone, including prolonged block duration and neuroprotection.",
      "Summary": "The article focuses on the pharmacological differences between intravenous and perineural administration of dexamethasone in regional anesthesia. It argues that comparing these routes is scientifically unfounded due to their distinct mechanisms of action and clinical effects. Intravenous dexamethasone is described as having systemic anti-inflammatory and antiemetic effects, which are beneficial in enhanced recovery pathways. In contrast, perineural dexamethasone creates a high-concentration depot at the neural interface, providing localized benefits such as prolonged block reliability, reduced vascular uptake, and neuroprotection through antiedema, antifibrotic, microcirculatory, and antineurotoxic actions. The article critiques the methodological flaw of milligram dosing parity across routes and suggests concentration- or exposure-matched designs for future studies. It recommends using intravenous dexamethasone for systemic modulation and perineural dexamethasone for extending block duration and nerve protection, with combined use being synergistic when both aims are relevant. The editorial reframes the debate from competition to context-specific integration to align practice with pharmacology and improve patient-centered outcomes. No specific adverse events or complications related to dexamethasone are mentioned.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Review Article",
      "Author_perspective": "The author comments on the distinct pharmacological effects of intravenous and perineural dexamethasone, emphasizing their context-specific benefits and advocating for their combined use when appropriate. The article critiques the methodological flaws in existing studies and suggests reframing the debate to improve patient-centered outcomes.",
      "Adverse_event": "No AE",
      "Abstract": "Dexamethasone is a widely used adjuvant in regional anesthesia, yet debate persists over whether intravenous (IV) and perineural routes are interchangeable. This editorial argues that head-to-head comparisons are mechanistically unsound and clinically misleading. IV dexamethasone distributes systemically after cardiopulmonary transit, yielding low, variable target-site bioavailability at the nerve; systemic anti-inflammatory and antiemetic effects within enhanced recovery pathways dominate its benefits. Perineural dexamethasone creates a high-concentration depot at the neural interface, prolonging block reliability through reduced vascular uptake and a locally anti-inflammatory microenvironment, while conferring neuroprotection via antiedema, antifibrotic, microcirculatory, and antineurotoxic actions. Published studies reporting either superiority of perineural dosing or equivalence between routes likely reflect heterogeneity in populations, procedures, timing, anesthetic strategies, and adjuvant regimens rather than true pharmacologic parity. Methodological parity of milligram dosing across routes is a key flaw; concentration- or exposure-matched designs are needed. Clinically, IV dexamethasone should be used for systemic modulation (including postoperative nausea and vomiting reduction), whereas perineural dexamethasone should be selected to extend block duration and protect the nerve; combined use can be synergistic when both aims matter. Reframing the debate from competition to context-specific integration aligns practice with pharmacology and may improve patient-centered outcomes.",
      "Title": "Investigating Why Comparing Intravenous and Perineural Dexamethasone Is Scientifically Unfounded.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-16 05:32:07",
      "Vancouver_citation": "Sonawane K. Investigating Why Comparing Intravenous and Perineural Dexamethasone Is Scientifically Unfounded. Cureus. 2025;17(12):e98950",
      "pubdate": "2025-12-15",
      "Lead_author": "Sonawane K",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Dexamethasone, is conventionally used for various medical conditions, including cerebral oedema, severe asthma attacks, autoimmune diseases, severe infectious diseases, palliative oncology treatment, and prevention/treatment of postoperative vomiting. In this study, the drug was discussed in the context of regional anesthesia, specifically comparing intravenous and perineural administration routes. This use does not align with the conventional uses listed, and therefore qualifies as off-label use.",
      "AOI_classification": "Yes",
      "Justification": "The study discusses off-label use of the drug of study in regional anesthesia, which qualifies as non-conventional use.",
      "Client_name": "Demo",
      "Drugname": "DEXAMETHASONE"
    },
    "doi": "https://doi.org/10.7759/cureus.98950",
    "specialCase": "No",
    "countryOfFirstAuthor": "India",
    "countryOfOccurrence": "India",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: Human subjects were involved in the study, but specific details about their admission to a hospital or participation in a study are not provided. The article discusses the use of dexamethasone in regional anesthesia and compares intravenous and perineural administration routes.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Dexamethasone"
    ],
    "attributability": "Attributability: The article discusses the pharmacological effects of dexamethasone administered via intravenous and perineural routes. It mentions systemic anti-inflammatory and antiemetic effects for intravenous administration and localized anti-inflammatory, antiedema, antifibrotic, microcirculatory, and antineurotoxic actions for perineural administration. No specific adverse events or complications are attributed to the drug.",
    "drugEffect": "Drug effect: summary. The article highlights the systemic benefits of intravenous dexamethasone, such as anti-inflammatory and antiemetic effects, and the localized benefits of perineural dexamethasone, including prolonged block duration and neuroprotection.",
    "summary": "The article focuses on the pharmacological differences between intravenous and perineural administration of dexamethasone in regional anesthesia. It argues that comparing these routes is scientifically unfounded due to their distinct mechanisms of action and clinical effects. Intravenous dexamethasone is described as having systemic anti-inflammatory and antiemetic effects, which are beneficial in enhanced recovery pathways. In contrast, perineural dexamethasone creates a high-concentration depot at the neural interface, providing localized benefits such as prolonged block reliability, reduced vascular uptake, and neuroprotection through antiedema, antifibrotic, microcirculatory, and antineurotoxic actions. The article critiques the methodological flaw of milligram dosing parity across routes and suggests concentration- or exposure-matched designs for future studies. It recommends using intravenous dexamethasone for systemic modulation and perineural dexamethasone for extending block duration and nerve protection, with combined use being synergistic when both aims are relevant. The editorial reframes the debate from competition to context-specific integration to align practice with pharmacology and improve patient-centered outcomes. No specific adverse events or complications related to dexamethasone are mentioned.",
    "identifiableHumanSubject": "Yes",
    "textType": "Review Article",
    "authorPerspective": "The author comments on the distinct pharmacological effects of intravenous and perineural dexamethasone, emphasizing their context-specific benefits and advocating for their combined use when appropriate. The article critiques the methodological flaws in existing studies and suggests reframing the debate to improve patient-centered outcomes.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Sonawane K. Investigating Why Comparing Intravenous and Perineural Dexamethasone Is Scientifically Unfounded. Cureus. 2025;17(12):e98950",
    "leadAuthor": "Sonawane K",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Dexamethasone, is conventionally used for various medical conditions, including cerebral oedema, severe asthma attacks, autoimmune diseases, severe infectious diseases, palliative oncology treatment, and prevention/treatment of postoperative vomiting. In this study, the drug was discussed in the context of regional anesthesia, specifically comparing intravenous and perineural administration routes. This use does not align with the conventional uses listed, and therefore qualifies as off-label use.",
    "aoiClassification": "Yes",
    "justification": "The study discusses off-label use of the drug of study in regional anesthesia, which qualifies as non-conventional use.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUjpCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjpCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-5965300501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999291
  },
  {
    "id": "7a174e8b-fff0-4717-9d4d-2cdc42219120",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41391974",
    "title": "Polymeric nanoparticles functionalized with dexamethasone attenuate the osteogenic inhibition induced by titanium debris.",
    "authors": [
      "Toledano M",
      "Vallecillo C",
      "Toledano-Osorio M",
      "Osorio R",
      "Gil J",
      "Gutiérrez JL",
      "Torres-Lagares D"
    ],
    "journal": "Dent Mater",
    "publicationDate": "2025-12-15",
    "abstract": "The study investigates the impact of titanium debris on bone regeneration potential and evaluates the efficacy of dexamethasone-doped polymeric nanoparticles (DexNPs) combined with calcium phosphate (CaP) in overcoming the inhibitory effects of titanium debris. The research was conducted on six New Zealand-bred rabbits, where four critical bone defects were created on their skulls. Different biomaterials were placed in the defects, including unfilled control, calcium phosphate granules, titanium debris combined with calcium phosphate, and dexamethasone-doped polymeric nanoparticles combined with calcium phosphate and titanium debris. After six weeks, the rabbits were euthanized, and the bone architecture was analyzed radiographically and histologically. The study found that titanium debris reduced bone healing, while the presence of DexNPs restored defect closure values and improved osteogenic potential. Bone filling area and bone area fraction were highest in the presence of DexNPs, indicating enhanced bone regeneration. The study highlights the potential of DexNPs in improving bone healing in the presence of titanium debris. However, as the study involves animal subjects, no human data or adverse events are reported.",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:02:31.726Z",
    "updatedAt": "2025-12-17T19:21:31.089Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41391974",
      "DOI": "https://doi.org/10.1016/j.dental.2025.12.002",
      "special_case": "No",
      "Country_of_first_author": "Spain",
      "Country_of_occurrence": "Spain",
      "Patient_details": "No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: Not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The study investigates the impact of titanium debris on bone regeneration potential and evaluates the efficacy of dexamethasone-doped polymeric nanoparticles (DexNPs) combined with calcium phosphate (CaP) in overcoming the inhibitory effects of titanium debris. The research was conducted on six New Zealand-bred rabbits, where four critical bone defects were created on their skulls. Different biomaterials were placed in the defects, including unfilled control, calcium phosphate granules, titanium debris combined with calcium phosphate, and dexamethasone-doped polymeric nanoparticles combined with calcium phosphate and titanium debris. After six weeks, the rabbits were euthanized, and the bone architecture was analyzed radiographically and histologically. The study found that titanium debris reduced bone healing, while the presence of DexNPs restored defect closure values and improved osteogenic potential. Bone filling area and bone area fraction were highest in the presence of DexNPs, indicating enhanced bone regeneration. The study highlights the potential of DexNPs in improving bone healing in the presence of titanium debris. However, as the study involves animal subjects, no human data or adverse events are reported.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article comments positively on the effect of dexamethasone-doped polymeric nanoparticles (DexNPs) in improving bone healing and osteogenic potential in the presence of titanium debris.",
      "Adverse_event": "No AE",
      "Abstract": "Implantoplasty is sometimes performed to eliminate the contaminated titanium surface of peri-implantitis affected implants. Bone regeneration treatments are performed in conjuction with implantoplasty. The aim of this study was to evaluate if produced titanium debris alter the bone-regeneration potential and if dexamethasone-doped polymeric nanoparticles, combined with calcium phosphate, may help to overcome this situation.\n\nFour critical bone defects were performed on six New Zealand-bred rabbit skulls. In each of the four bone defects, the following biomaterials were placed: 1) unfilled (control), 2) calcium phosphate granules (CaP), 3) titanium debris (Tid) and CaP, 4) dexamethasone-doped polymeric nanoparticles (DexNPs) doped onto CaP and Tid. After six weeks, animals were euthanized and the bone architecture was evaluated radiographically with micro computed tomography through BoneJ pluging and ImageJ script, and histologically after Von Kossa staining.\n\nBone defects filled with CaP plus Tid showed lower defect closure than those filled with CaP. The presence of DexNPs restored the defect closure values, being similar to those of the CaP group. Bone filling area and bone area fraction attained the highest values in the presence of DexNPs. Aligned new bone islands were formed and grew up around the CaP granules, infiltrating its porous structure. In the CaP+Tid group a lower bone ingrowth was formed. When applying DexNPs, bone bridging processes were located surrounding the CaP biomaterial.\n\nThe presence of Tid reduces the bone healing and DexNPs doped on CaP produced an increase in the osteogenic potential, improving the bone defect closure.",
      "Title": "Polymeric nanoparticles functionalized with dexamethasone attenuate the osteogenic inhibition induced by titanium debris.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-16 05:31:07",
      "Vancouver_citation": "Toledano M, Vallecillo C, Toledano-Osorio M, Osorio R, Gil J, Gutiérrez JL, Torres-Lagares D. Polymeric nanoparticles functionalized with dexamethasone attenuate the osteogenic inhibition induced by titanium debris. Dent Mater. 2025;",
      "pubdate": "2025-12-15",
      "Lead_author": "Toledano M",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study were six New Zealand-bred rabbits. Four critical bone defects were created on the skulls of these rabbits, and various biomaterials, including dexamethasone-doped polymeric nanoparticles (DexNPs), were applied to evaluate their effects on bone regeneration.",
      "AOI_drug_effect": "The drug of study, dexamethasone, was incorporated into polymeric nanoparticles (DexNPs) and applied to bone defects in the rabbits. The study found that DexNPs improved the osteogenic potential and bone defect closure, restoring values similar to those of the calcium phosphate (CaP) group. DexNPs enhanced bone filling area and bone area fraction, promoting bone bridging processes and aligned new bone formation around the CaP granules. Thus, the drug had a positive effect on the test subjects.",
      "Approved_indication": "Dexamethasone is conventionally used as a corticosteroid to treat inflammatory conditions, autoimmune diseases, and certain types of cancer. It is typically administered orally, intravenously, or via injection, depending on the condition being treated. In this study, dexamethasone was administered in the form of polymeric nanoparticles (DexNPs) doped onto calcium phosphate granules and titanium debris. It was given to rabbits with critical bone defects to evaluate its potential in improving bone regeneration and defect closure.",
      "AOI_classification": "No",
      "Justification": "The study does not link dexamethasone to any negative or adverse effects. Instead, it highlights its positive impact on bone regeneration and defect closure in the test subjects.",
      "Client_name": "Demo",
      "Drugname": "DEXAMETHASONE"
    },
    "doi": "https://doi.org/10.1016/j.dental.2025.12.002",
    "specialCase": "No",
    "countryOfFirstAuthor": "Spain",
    "countryOfOccurrence": "Spain",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: Not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "The study investigates the impact of titanium debris on bone regeneration potential and evaluates the efficacy of dexamethasone-doped polymeric nanoparticles (DexNPs) combined with calcium phosphate (CaP) in overcoming the inhibitory effects of titanium debris. The research was conducted on six New Zealand-bred rabbits, where four critical bone defects were created on their skulls. Different biomaterials were placed in the defects, including unfilled control, calcium phosphate granules, titanium debris combined with calcium phosphate, and dexamethasone-doped polymeric nanoparticles combined with calcium phosphate and titanium debris. After six weeks, the rabbits were euthanized, and the bone architecture was analyzed radiographically and histologically. The study found that titanium debris reduced bone healing, while the presence of DexNPs restored defect closure values and improved osteogenic potential. Bone filling area and bone area fraction were highest in the presence of DexNPs, indicating enhanced bone regeneration. The study highlights the potential of DexNPs in improving bone healing in the presence of titanium debris. However, as the study involves animal subjects, no human data or adverse events are reported.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article comments positively on the effect of dexamethasone-doped polymeric nanoparticles (DexNPs) in improving bone healing and osteogenic potential in the presence of titanium debris.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Toledano M, Vallecillo C, Toledano-Osorio M, Osorio R, Gil J, Gutiérrez JL, Torres-Lagares D. Polymeric nanoparticles functionalized with dexamethasone attenuate the osteogenic inhibition induced by titanium debris. Dent Mater. 2025;",
    "leadAuthor": "Toledano M",
    "serious": "No",
    "testSubject": "The test subjects involved in this study were six New Zealand-bred rabbits. Four critical bone defects were created on the skulls of these rabbits, and various biomaterials, including dexamethasone-doped polymeric nanoparticles (DexNPs), were applied to evaluate their effects on bone regeneration.",
    "aoiDrugEffect": "The drug of study, dexamethasone, was incorporated into polymeric nanoparticles (DexNPs) and applied to bone defects in the rabbits. The study found that DexNPs improved the osteogenic potential and bone defect closure, restoring values similar to those of the calcium phosphate (CaP) group. DexNPs enhanced bone filling area and bone area fraction, promoting bone bridging processes and aligned new bone formation around the CaP granules. Thus, the drug had a positive effect on the test subjects.",
    "approvedIndication": "Dexamethasone is conventionally used as a corticosteroid to treat inflammatory conditions, autoimmune diseases, and certain types of cancer. It is typically administered orally, intravenously, or via injection, depending on the condition being treated. In this study, dexamethasone was administered in the form of polymeric nanoparticles (DexNPs) doped onto calcium phosphate granules and titanium debris. It was given to rabbits with critical bone defects to evaluate its potential in improving bone regeneration and defect closure.",
    "aoiClassification": "No",
    "justification": "The study does not link dexamethasone to any negative or adverse effects. Instead, it highlights its positive impact on bone regeneration and defect closure in the test subjects.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUjqCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjqCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-5970680501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999291
  },
  {
    "id": "7b45198d-8093-4062-bde9-f0da398c4bd6",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41391513",
    "title": "From liquid nanocapsules to 3D-printed medicines: effect of freeze-drying on dexamethasone release and intestinal permeation.",
    "authors": [
      "Dos Santos J",
      "Vogel-Kindgen S",
      "Jung N",
      "Leão J",
      "Windbergs M",
      "Ruver Beck RC"
    ],
    "journal": "Int J Pharm",
    "publicationDate": "2025-12-15",
    "abstract": "The study investigates the impact of freeze-drying on dexamethasone-loaded ethylcellulose nanocapsules (NC-EC-DEX) and their subsequent use in 3D-printed medicines. The research focuses on the physicochemical properties, drug release behavior, and intestinal permeation of these nanocapsules using in vitro Caco-2 cell models. The freshly prepared NC-EC-DEX demonstrated nanometric size, narrow size distribution, negative zeta potential, and specific drug content. Mannitol was tested as a cryoprotectant, with the highest concentration ensuring full recovery of nanometric size after freeze-drying. The freeze-dried formulation exhibited sustained drug release and slower permeation across Caco-2 cells while maintaining high cell viability. The freeze-dried powder was further processed into solid dosage forms via semi-solid extrusion 3D printing, showcasing a continuous workflow from liquid nanosuspension to stable intermediate powder and ultimately to 3D-printed medicines. This study highlights the potential of 3D printing as a downstream manufacturing solution for nanomedicines, providing a versatile platform for innovative drug delivery systems. No human subjects were involved, and no adverse events were reported.",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:02:31.768Z",
    "updatedAt": "2025-12-17T19:21:30.704Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41391513",
      "DOI": "https://doi.org/10.1016/j.ijpharm.2025.126497",
      "special_case": "No",
      "Country_of_first_author": "Brazil",
      "Country_of_occurrence": "Brazil",
      "Patient_details": "No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: Not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The study investigates the impact of freeze-drying on dexamethasone-loaded ethylcellulose nanocapsules (NC-EC-DEX) and their subsequent use in 3D-printed medicines. The research focuses on the physicochemical properties, drug release behavior, and intestinal permeation of these nanocapsules using in vitro Caco-2 cell models. The freshly prepared NC-EC-DEX demonstrated nanometric size, narrow size distribution, negative zeta potential, and specific drug content. Mannitol was tested as a cryoprotectant, with the highest concentration ensuring full recovery of nanometric size after freeze-drying. The freeze-dried formulation exhibited sustained drug release and slower permeation across Caco-2 cells while maintaining high cell viability. The freeze-dried powder was further processed into solid dosage forms via semi-solid extrusion 3D printing, showcasing a continuous workflow from liquid nanosuspension to stable intermediate powder and ultimately to 3D-printed medicines. This study highlights the potential of 3D printing as a downstream manufacturing solution for nanomedicines, providing a versatile platform for innovative drug delivery systems. No human subjects were involved, and no adverse events were reported.",
      "Identifiable_human_subject": "No",
      "Text_type": "In Vitro Study",
      "Author_perspective": "The article comments on the technological feasibility and effectiveness of freeze-drying and 3D printing in creating stable and innovative drug delivery systems, particularly for dexamethasone-loaded nanocapsules.",
      "Adverse_event": "No AE",
      "Abstract": "Liquid nanocapsule (NC) suspensions are recognised as effective carriers for drug delivery. Freeze-drying offers a valuable strategy to enhance their storage stability and enable their incorporation into solid dosage forms, thereby facilitating clinical translation. However, limited information is available regarding the effects of freeze-drying on the drug release behaviour and intestinal permeation of drug-loaded NCs. In this study, dexamethasone-loaded ethylcellulose NCs (NC-EC-DEX) were produced and subjected to freeze-drying to assess the influence of this process on their physicochemical and in vitro performance using Caco-2 cell models. The freshly prepared NC-EC-DEX showed a nanometric size (136 ± 3 nm), narrow size distribution (polydispersity index, 0.10 ± 0.02), negative zeta potential (-16.4 ± 1.3 mV), and drug content of 0.47 mg mL<sup>-1</sup>. Mannitol was tested as a cryoprotectant at concentrations of 3 %, 5 %, and 10 % (w/v), with only the highest concentration ensuring full recovery of nanometric size after drying (232 ± 19 nm; polydispersity index, 0.33 ± 0.02). The freeze-dried formulation (FD<sub>NC-EC-DEX</sub>) exhibited a more sustained drug release and slower permeation across Caco-2 cells compared with the liquid suspension, while maintaining high cell viability (>80 %). This preservation of nanoscale behaviour after reconstitution was essential to demonstrate that the freeze-dried powder could function as an intermediate suitable for further processing. The freeze-dried powder was subsequently used as feedstock for the fabrication of solid dosage forms via semi-solid extrusion 3D printing, thereby establishing a rational technological sequence in which the liquid nanosuspension is first stabilised through lyophilisation and then transformed into a printable matrix. Overall, this study provides a proof of concept for a continuous workflow, from liquid nanosuspension to a more stable intermediate powder, and ultimately to 3D-printed solid dosage forms-highlighting its potential for processing powders with limited flowability, such as those obtained through freeze-drying. This integrated approach strengthens the technological justification for employing 3D printing as a downstream manufacturing solution for nanomedicines, establishing a versatile technological platform for the development of innovative 3D-printed nanomedicines.",
      "Title": "From liquid nanocapsules to 3D-printed medicines: effect of freeze-drying on dexamethasone release and intestinal permeation.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-16 05:31:41",
      "Vancouver_citation": "Dos Santos J, Vogel-Kindgen S, Jung N, Leão J, Windbergs M, Ruver Beck RC. From liquid nanocapsules to 3D-printed medicines: effect of freeze-drying on dexamethasone release and intestinal permeation. Int J Pharm. 2025;126497",
      "pubdate": "2025-12-15",
      "Lead_author": "Dos Santos J",
      "Serious": "No",
      "Test_subject": "The test subject involved in this study is the Caco-2 cell model, which is an in vitro model commonly used to simulate human intestinal epithelial cells for drug permeability and absorption studies.",
      "AOI_drug_effect": "The drug of study, dexamethasone, was loaded into ethylcellulose nanocapsules and subjected to freeze-drying. The study observed that the freeze-dried formulation exhibited a more sustained drug release and slower permeation across Caco-2 cells compared to the liquid suspension. However, the drug did not induce any adverse medical events or significant effects on cell viability, as cell viability remained high (>80%). Therefore, \"No Drug Effect.\"",
      "Approved_indication": "The drug of study, dexamethasone, is conventionally used as a corticosteroid to treat inflammatory conditions, autoimmune diseases, and certain types of cancer. It is typically administered orally, intravenously, or via injection. In this study, dexamethasone was incorporated into ethylcellulose nanocapsules and tested in vitro using Caco-2 cells to evaluate its release and intestinal permeation. The study aimed to assess the impact of freeze-drying on the drug's delivery and performance, rather than treating a specific illness.",
      "AOI_classification": "No",
      "Justification": "The study does not link the drug of study to any negative or adverse effects, as cell viability remained high (>80%) and no adverse events were reported.",
      "Client_name": "Demo",
      "Drugname": "DEXAMETHASONE"
    },
    "doi": "https://doi.org/10.1016/j.ijpharm.2025.126497",
    "specialCase": "No",
    "countryOfFirstAuthor": "Brazil",
    "countryOfOccurrence": "Brazil",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: Not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "The study investigates the impact of freeze-drying on dexamethasone-loaded ethylcellulose nanocapsules (NC-EC-DEX) and their subsequent use in 3D-printed medicines. The research focuses on the physicochemical properties, drug release behavior, and intestinal permeation of these nanocapsules using in vitro Caco-2 cell models. The freshly prepared NC-EC-DEX demonstrated nanometric size, narrow size distribution, negative zeta potential, and specific drug content. Mannitol was tested as a cryoprotectant, with the highest concentration ensuring full recovery of nanometric size after freeze-drying. The freeze-dried formulation exhibited sustained drug release and slower permeation across Caco-2 cells while maintaining high cell viability. The freeze-dried powder was further processed into solid dosage forms via semi-solid extrusion 3D printing, showcasing a continuous workflow from liquid nanosuspension to stable intermediate powder and ultimately to 3D-printed medicines. This study highlights the potential of 3D printing as a downstream manufacturing solution for nanomedicines, providing a versatile platform for innovative drug delivery systems. No human subjects were involved, and no adverse events were reported.",
    "identifiableHumanSubject": "No",
    "textType": "In Vitro Study",
    "authorPerspective": "The article comments on the technological feasibility and effectiveness of freeze-drying and 3D printing in creating stable and innovative drug delivery systems, particularly for dexamethasone-loaded nanocapsules.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Dos Santos J, Vogel-Kindgen S, Jung N, Leão J, Windbergs M, Ruver Beck RC. From liquid nanocapsules to 3D-printed medicines: effect of freeze-drying on dexamethasone release and intestinal permeation. Int J Pharm. 2025;126497",
    "leadAuthor": "Dos Santos J",
    "serious": "No",
    "testSubject": "The test subject involved in this study is the Caco-2 cell model, which is an in vitro model commonly used to simulate human intestinal epithelial cells for drug permeability and absorption studies.",
    "aoiDrugEffect": "The drug of study, dexamethasone, was loaded into ethylcellulose nanocapsules and subjected to freeze-drying. The study observed that the freeze-dried formulation exhibited a more sustained drug release and slower permeation across Caco-2 cells compared to the liquid suspension. However, the drug did not induce any adverse medical events or significant effects on cell viability, as cell viability remained high (>80%). Therefore, \"No Drug Effect.\"",
    "approvedIndication": "The drug of study, dexamethasone, is conventionally used as a corticosteroid to treat inflammatory conditions, autoimmune diseases, and certain types of cancer. It is typically administered orally, intravenously, or via injection. In this study, dexamethasone was incorporated into ethylcellulose nanocapsules and tested in vitro using Caco-2 cells to evaluate its release and intestinal permeation. The study aimed to assess the impact of freeze-drying on the drug's delivery and performance, rather than treating a specific illness.",
    "aoiClassification": "No",
    "justification": "The study does not link the drug of study to any negative or adverse effects, as cell viability remained high (>80%) and no adverse events were reported.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUjrCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjrCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-5935880501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999290
  },
  {
    "id": "c32f62af-2659-4296-8efc-2f122d3b2bb5",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41391365",
    "title": "Vitexin ameliorates PM2.5-triggered pulmonary toxicity through dual modulation of endoplasmic reticulum stress and ferroptosis pathways.",
    "authors": [
      "Wei X",
      "Zhu T",
      "Gao R",
      "Zhang Y",
      "Zhang Z",
      "Wang H",
      "Jiang T",
      "Zhang L",
      "Yu C",
      "Guo J"
    ],
    "journal": "Ecotoxicol Environ Saf",
    "publicationDate": "2025-12-15",
    "abstract": "The study investigates the protective effects of Vitexin (VI), a natural flavonoid, against PM2.5-induced pulmonary toxicity through dual modulation of endoplasmic reticulum stress (ERS) and ferroptosis pathways. The research combines in vivo and in vitro approaches. In the in vivo study, PM2.5-exposed mice were treated with Vitexin (15-60 mg/kg) or dexamethasone (0.125 mg/kg) via oral gavage for 8 weeks, followed by biospecimen collection post-euthanasia. The in vitro study involved BEAS-2B cells pretreated with Vitexin and exposed to PM2.5 supernatant, with cellular responses assessed. Molecular simulations revealed Vitexin's high-affinity binding to GPX4, stabilizing it and reducing ferroptotic cell death. Vitexin activates the NRF2/HO-1/NQO1 pathway to enhance antioxidant capacity and suppresses ERS via the PERK/eIF2α/ATF4/CHOP axis, collectively reducing lipid peroxidation and ferroptosis. While the study mentions dexamethasone as a comparative treatment, no specific adverse events or human subjects are discussed. The findings highlight Vitexin's potential as a protective agent against air pollution-related lung injury.",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:02:31.813Z",
    "updatedAt": "2025-12-17T19:21:29.839Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41391365",
      "DOI": "https://doi.org/10.1016/j.ecoenv.2025.119558",
      "special_case": "No",
      "Country_of_first_author": "China",
      "Country_of_occurrence": "China",
      "Patient_details": "No human subject",
      "Key_events": "Key events: not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The study investigates the protective effects of Vitexin (VI), a natural flavonoid, against PM2.5-induced pulmonary toxicity through dual modulation of endoplasmic reticulum stress (ERS) and ferroptosis pathways. The research combines in vivo and in vitro approaches. In the in vivo study, PM2.5-exposed mice were treated with Vitexin (15-60 mg/kg) or dexamethasone (0.125 mg/kg) via oral gavage for 8 weeks, followed by biospecimen collection post-euthanasia. The in vitro study involved BEAS-2B cells pretreated with Vitexin and exposed to PM2.5 supernatant, with cellular responses assessed. Molecular simulations revealed Vitexin's high-affinity binding to GPX4, stabilizing it and reducing ferroptotic cell death. Vitexin activates the NRF2/HO-1/NQO1 pathway to enhance antioxidant capacity and suppresses ERS via the PERK/eIF2α/ATF4/CHOP axis, collectively reducing lipid peroxidation and ferroptosis. While the study mentions dexamethasone as a comparative treatment, no specific adverse events or human subjects are discussed. The findings highlight Vitexin's potential as a protective agent against air pollution-related lung injury.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article comments positively on Vitexin's protective effects against PM2.5-induced pulmonary toxicity, emphasizing its dual modulation of ERS and ferroptosis pathways.",
      "Adverse_event": "No AE",
      "Abstract": "Fine particulate matter (PM2.5) primarily damages the respiratory system, leading to lung injury with limited therapeutic options. Recent studies suggest that ferroptosis and endoplasmic reticulum stress (ERS) play pivotal roles in PM2.5-induced pulmonary injury. This integrated study, combining in vivo and in vitro approaches, evaluated the protective potential of Vitexin (VI), a natural flavonoid, against PM2.5-mediated lung injury, focusing on its mechanisms involving ERS and ferroptosis. For the in vivo arm, PM2.5-exposed mice received VI (15-60 mg/kg) or dexamethasone (0.125 mg/kg) via oral gavage over 8 weeks, with systemic biospecimen collection (serum/BALF/lung) post-euthanasia at endpoint. Concurrently, in vitro, BEAS-2B cells were pretreated with 30 μM VI and then exposed to PM2.5 supernatant (400 μg/mL) for 24 h, with cellular responses evaluated after standardized culture and viability assessment via CCK-8 assay. Meanwhile, we employed molecular simulations, which predicted a high-affinity binding between VI and GPX4, suggesting direct stabilization. Experimental investigations elucidated that VI alleviates PM2.5-triggered ferroptosis through a dual-pathway synergy: it activates the NRF2/HO-1/NQO1 pathway to enhance antioxidant capacity, while suppressing endoplasmic reticulum stress via the PERK/eIF2α/ATF4/CHOP axis. The attenuation of ERS, in turn, upregulates system Xc<sup>－</sup> activity and GPX4 expression. These integrated actions collectively reduce lipid peroxidation and attenuate ferroptotic cell death. In summary, VI significantly exerted a protective effect against PM2.5-induced lung injury by inhibiting ERS-mediated ferroptosis, highlighting its promise as a protective agent against air pollution-related pulmonary damage.",
      "Title": "Vitexin ameliorates PM2.5-triggered pulmonary toxicity through dual modulation of endoplasmic reticulum stress and ferroptosis pathways.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-16 05:31:22",
      "Vancouver_citation": "Wei X, Zhu T, Gao R, Zhang Y, Zhang Z, Wang H, Jiang T, Zhang L, Yu C, Guo J. Vitexin ameliorates PM2.5-triggered pulmonary toxicity through dual modulation of endoplasmic reticulum stress and ferroptosis pathways. Ecotoxicol Environ Saf. 2025;309119558",
      "pubdate": "2025-12-15",
      "Lead_author": "Wei X",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study include mice exposed to PM2.5 and treated with Vitexin or the drug of study (Dexamethasone) via oral gavage. Additionally, BEAS-2B cells were used in vitro, pretreated with Vitexin and exposed to PM2.5 supernatant. Both test subjects were utilized to evaluate the protective effects against PM2.5-induced pulmonary injury.",
      "AOI_drug_effect": "The drug of study (Dexamethasone) was administered to PM2.5-exposed mice as part of the in vivo study. However, the abstract does not specify any direct effect or event induced by Dexamethasone in the test subjects. The focus of the study was primarily on Vitexin's protective mechanisms. No Drug Effect.",
      "Approved_indication": "The drug of study, Dexamethasone, is conventionally used as a corticosteroid to treat inflammatory conditions, autoimmune diseases, and allergic reactions. It is typically administered orally, intravenously, or via injection. In this study, Dexamethasone was administered orally to PM2.5-exposed mice at a dose of 0.125 mg/kg over 8 weeks. It was intended to treat PM2.5-induced pulmonary injury.",
      "AOI_classification": "No",
      "Justification": "The study does not link Dexamethasone to any negative or adverse effects within the test subjects. The focus was on evaluating Vitexin's protective effects, and no adverse effects of Dexamethasone were mentioned.",
      "Client_name": "Demo",
      "Drugname": "DEXAMETHASONE"
    },
    "doi": "https://doi.org/10.1016/j.ecoenv.2025.119558",
    "specialCase": "No",
    "countryOfFirstAuthor": "China",
    "countryOfOccurrence": "China",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "The study investigates the protective effects of Vitexin (VI), a natural flavonoid, against PM2.5-induced pulmonary toxicity through dual modulation of endoplasmic reticulum stress (ERS) and ferroptosis pathways. The research combines in vivo and in vitro approaches. In the in vivo study, PM2.5-exposed mice were treated with Vitexin (15-60 mg/kg) or dexamethasone (0.125 mg/kg) via oral gavage for 8 weeks, followed by biospecimen collection post-euthanasia. The in vitro study involved BEAS-2B cells pretreated with Vitexin and exposed to PM2.5 supernatant, with cellular responses assessed. Molecular simulations revealed Vitexin's high-affinity binding to GPX4, stabilizing it and reducing ferroptotic cell death. Vitexin activates the NRF2/HO-1/NQO1 pathway to enhance antioxidant capacity and suppresses ERS via the PERK/eIF2α/ATF4/CHOP axis, collectively reducing lipid peroxidation and ferroptosis. While the study mentions dexamethasone as a comparative treatment, no specific adverse events or human subjects are discussed. The findings highlight Vitexin's potential as a protective agent against air pollution-related lung injury.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article comments positively on Vitexin's protective effects against PM2.5-induced pulmonary toxicity, emphasizing its dual modulation of ERS and ferroptosis pathways.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Wei X, Zhu T, Gao R, Zhang Y, Zhang Z, Wang H, Jiang T, Zhang L, Yu C, Guo J. Vitexin ameliorates PM2.5-triggered pulmonary toxicity through dual modulation of endoplasmic reticulum stress and ferroptosis pathways. Ecotoxicol Environ Saf. 2025;309119558",
    "leadAuthor": "Wei X",
    "serious": "No",
    "testSubject": "The test subjects involved in this study include mice exposed to PM2.5 and treated with Vitexin or the drug of study (Dexamethasone) via oral gavage. Additionally, BEAS-2B cells were used in vitro, pretreated with Vitexin and exposed to PM2.5 supernatant. Both test subjects were utilized to evaluate the protective effects against PM2.5-induced pulmonary injury.",
    "aoiDrugEffect": "The drug of study (Dexamethasone) was administered to PM2.5-exposed mice as part of the in vivo study. However, the abstract does not specify any direct effect or event induced by Dexamethasone in the test subjects. The focus of the study was primarily on Vitexin's protective mechanisms. No Drug Effect.",
    "approvedIndication": "The drug of study, Dexamethasone, is conventionally used as a corticosteroid to treat inflammatory conditions, autoimmune diseases, and allergic reactions. It is typically administered orally, intravenously, or via injection. In this study, Dexamethasone was administered orally to PM2.5-exposed mice at a dose of 0.125 mg/kg over 8 weeks. It was intended to treat PM2.5-induced pulmonary injury.",
    "aoiClassification": "No",
    "justification": "The study does not link Dexamethasone to any negative or adverse effects within the test subjects. The focus was on evaluating Vitexin's protective effects, and no adverse effects of Dexamethasone were mentioned.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUjsCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjsCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-58b1b80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999289
  },
  {
    "id": "f354c52d-9f0e-4f71-9553-867d9ef1c25e",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41390084",
    "title": "Disease remission and surgical outcomes of endoscopic transsphenoidal surgery for Cushing's Disease: a single centre experience.",
    "authors": [
      "Shapey J",
      "Lee KS",
      "Karunakaran V",
      "Okasha M",
      "Dey P",
      "Pate S",
      "Grzeda MT",
      "Gilbert J",
      "Carrol PV",
      "Whitelaw B",
      "Barkas K",
      "Maratos E",
      "Barazi S",
      "Aylwin S",
      "Thomas NWM"
    ],
    "journal": "World Neurosurg",
    "publicationDate": "2025-12-14",
    "abstract": "Article requires manual review",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:03:52.177Z",
    "updatedAt": "2025-12-17T19:21:29.796Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41390084",
      "DOI": "https://doi.org10.1016/j.wneu.2025.124700",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-16 05:33:50",
      "Drugname": "DEXAMETHASONE",
      "Vancouver_citation": "Shapey J, Lee KS, Karunakaran V, Okasha M, Dey P, Pate S, Grzeda MT, Gilbert J, Carrol PV, Whitelaw B, Barkas K, Maratos E, Barazi S, Aylwin S, Thomas NWM. Disease remission and surgical outcomes of endoscopic transsphenoidal surgery for Cushing's Disease: a single centre experience. World Neurosurg. 2025;124700",
      "pubdate": "2025-12-14",
      "Lead_author": "Shapey J",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.wneu.2025.124700",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Shapey J, Lee KS, Karunakaran V, Okasha M, Dey P, Pate S, Grzeda MT, Gilbert J, Carrol PV, Whitelaw B, Barkas K, Maratos E, Barazi S, Aylwin S, Thomas NWM. Disease remission and surgical outcomes of endoscopic transsphenoidal surgery for Cushing's Disease: a single centre experience. World Neurosurg. 2025;124700",
    "leadAuthor": "Shapey J",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUjtCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjtCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-58ab140501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999289
  },
  {
    "id": "29a555d8-da05-4361-82c7-bd11b953555a",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41389887",
    "title": "Inhibition of Joint Inflammation in Rheumatoid Arthritis by Wuwei Ganlu Medicinal Bath Granules via Blocking Toll-like Receptor 4/Nuclear Factor-kappa B and NOD-like Receptor Pyrin Domain-containing 3 Signaling.",
    "authors": [
      "Wang T",
      "Fang N",
      "Tang B",
      "Fu X",
      "Kang X",
      "Guanque C",
      "Yu J",
      "Zeng Y",
      "Su J",
      "Zhang Y"
    ],
    "journal": "J Ethnopharmacol",
    "publicationDate": "2025-12-14",
    "abstract": "The study investigates the anti-inflammatory effects of Wuwei Ganlu Medicinal Bath Granules (WGMG) in collagen-induced arthritis (CIA) in rats, focusing on its pharmacological mechanisms through the TLR4/NF-κB and NLRP3 signaling pathways. WGMG, derived from Tibetan medicine, consists of five medicinal plants and was administered to CIA rats via medicinal bath treatment at varying doses for 28 days. The study identified 89 compounds in WGMG, with 18 common compounds found in both serum and synovial fluid, including kaempferol and trans-ferulic acid. The findings revealed that WGMG significantly reduced arthritis scores, paw swelling, and spleen index in CIA rats, alleviating symptoms of arthritis. Histopathological analysis showed reduced synovial hyperplasia, inflammatory cell infiltration, and cartilage erosion. WGMG also inhibited serum levels of NF-κB, TNF-α, IL-1β, and IL-18 while enhancing IL-4 levels. Mechanistically, WGMG downregulated the protein and mRNA expression of TLR4, NF-κB, NLRP3, ASC, and caspase-1, with high-dose WGMG demonstrating therapeutic efficacy comparable to dexamethasone. The study highlights the potent anti-inflammatory activity of WGMG, attributed to its bioactive components kaempferol and trans-ferulic acid, and suggests its potential as a treatment for rheumatoid arthritis. No human subjects were involved in this study, and no adverse events were reported.",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:03:52.214Z",
    "updatedAt": "2025-12-17T19:21:29.906Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41389887",
      "DOI": "https://doi.org/10.1016/j.jep.2025.121034",
      "special_case": "No",
      "Country_of_first_author": "China",
      "Country_of_occurrence": "China",
      "Patient_details": "No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: Not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The study investigates the anti-inflammatory effects of Wuwei Ganlu Medicinal Bath Granules (WGMG) in collagen-induced arthritis (CIA) in rats, focusing on its pharmacological mechanisms through the TLR4/NF-κB and NLRP3 signaling pathways. WGMG, derived from Tibetan medicine, consists of five medicinal plants and was administered to CIA rats via medicinal bath treatment at varying doses for 28 days. The study identified 89 compounds in WGMG, with 18 common compounds found in both serum and synovial fluid, including kaempferol and trans-ferulic acid. The findings revealed that WGMG significantly reduced arthritis scores, paw swelling, and spleen index in CIA rats, alleviating symptoms of arthritis. Histopathological analysis showed reduced synovial hyperplasia, inflammatory cell infiltration, and cartilage erosion. WGMG also inhibited serum levels of NF-κB, TNF-α, IL-1β, and IL-18 while enhancing IL-4 levels. Mechanistically, WGMG downregulated the protein and mRNA expression of TLR4, NF-κB, NLRP3, ASC, and caspase-1, with high-dose WGMG demonstrating therapeutic efficacy comparable to dexamethasone. The study highlights the potent anti-inflammatory activity of WGMG, attributed to its bioactive components kaempferol and trans-ferulic acid, and suggests its potential as a treatment for rheumatoid arthritis. No human subjects were involved in this study, and no adverse events were reported.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article comments positively on the anti-inflammatory effects of WGMG in CIA rats, highlighting its therapeutic efficacy comparable to dexamethasone and its potential as a treatment for rheumatoid arthritis.",
      "Adverse_event": "No AE",
      "Abstract": "Lum medicinal bathing is a usage of external therapy in the Tibetan medicine system, Sowa Rigpa, specifically the application of herbal decoction to derive the bioactive compounds through skin absorption. Wuwei Ganlu (Five-Flavored Nectar) is one of the formulations used in treatment which is especially useful for the symptoms of rheumatoid arthritis (RA). The Four-Tantras (rGyud-bzhi), 8th-12th centuries, is the source of the preparation and clinical use of Wuwei Ganlu decoctions. In today's society, a standardized Tibetan herbal preparation called the Wuwei Ganlu Medicinal Bath Granules (WGMG) has been developed that maintains the core therapeutic characteristics of the traditional decoction while enhancing clinical applicability and standardization. It is composed of five kinds of Tibetan medicinal plants in equal proportions, the formula includes Juniperus formosana Hayata (Branch and Leaf), Rhododendron anthopogonoides Maxim. (Flower), Myricaria germanica (L.) Desv. (Stem and Leaf), Ephedra saxatilis Royle ex Florin (Stem), and Artemisia sieversiana Ehrhart ex Willd. (Whole Plant).\n\nThis study aimed to identify the active constituents of WGMG as well as understand the pharmacological mechanisms of WGMG in the treatment of collagen-induced arthritis (CIA) in rats. Furthermore, WGMG was screened for its core anti-inflammatory effects via the TLR4/NF-κB and NLRP3 signaling pathways.\n\nUPLC-Q-TOF/MS was used to characterize chemical components of WGMG in rat serum and synovial fluid. Potential targets and the associated pathways were predicted using network pharmacology. CIA rats in vivo, were treated with WGMG via medicinal bath treatment at doses of 2.95, 5.90, and 11.8 g/L for 28 days. The effectiveness of the treatment was determined by looking at the arthritis scores, swelling measurements of the paws, and the serum cytokines that were measured by ELISA. Hematoxylin and eosin (H&E) and Safranin O-fast green staining were used to examine histopathological alterations. The Western blot, immunohistochemistry, and RT-PCR analyzes were used to uncover the underlying molecular mechanisms targeting on TLR4/NF-κB and NLRP3 inflammasome-related signaling molecules.\n\nThe findings of the study revealed identification of a total of 89 compounds from WGMG, which were mainly composed of alkaloids, flavonoids, phenylpropanoids, phenolic acids and fatty acids. In addition, total of 28 and 21 compounds were respectively identified from serum and synovial fluid. Both serum and synovial fluid had eighteen common compounds such as kaempferol and trans-ferulic acid. The network pharmacology research indicates that 68 overlapping targets between WGMG components and RA were revealed. Moreover, TLR4/NF-κB was found to mediate the inflammation by regulating the signaling pathway. In CIA rats, WGMG-H group significantly decreased arthritis scores, paw swelling, and spleen index, indicating relievers of symptoms of arthritis. According to histopathological examination, WGMG-H reduced synovial hyperplasia, inflammatory cell infiltration, and cartilage erosion. Moreover, WGMG-H inhibited the serum levels of NF-κB, TNF-α, IL-1β, IL-18 while enhanced IL-4 levels. Mechanistically, the protein and mRNA expression of TLR4, NF-κB, NLRP3, ASC, and caspase-1 were downregulated by WGMG, with high-dose WGMG having therapeutic efficacy similar to dexamethasone.\n\nWGMG shows potent anti-inflammatory activity via inhibitory effect on NLRP3 inflammasome activation, which due to inhibition of TLR4/NF-κB signaling pathway. This pharmacological mechanism is likely attributed to the bioactive components kaempferol and trans-ferulic acid. This research shows how WGMG may work in the body. The authors hope their findings might lead to new treatments for rheumatoid arthritis.",
      "Title": "Inhibition of Joint Inflammation in Rheumatoid Arthritis by Wuwei Ganlu Medicinal Bath Granules via Blocking Toll-like Receptor 4/Nuclear Factor-kappa B and NOD-like Receptor Pyrin Domain-containing 3 Signaling.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-16 05:33:13",
      "Vancouver_citation": "Wang T, Fang N, Tang B, Fu X, Kang X, Guanque C, Yu J, Zeng Y, Su J, Zhang Y. Inhibition of Joint Inflammation in Rheumatoid Arthritis by Wuwei Ganlu Medicinal Bath Granules via Blocking Toll-like Receptor 4/Nuclear Factor-kappa B and NOD-like Receptor Pyrin Domain-containing 3 Signaling. J Ethnopharmacol. 2025;121034",
      "pubdate": "2025-12-14",
      "Lead_author": "Wang T",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study were rats with collagen-induced arthritis (CIA). These rats were treated with Wuwei Ganlu Medicinal Bath Granules (WGMG) via medicinal bath treatment at varying doses for 28 days.",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Dexamethasone, is conventionally used as a corticosteroid to treat inflammatory conditions, autoimmune diseases, and allergies. It is typically administered orally, intravenously, or as an injection, depending on the condition being treated. In this study, Dexamethasone was mentioned as a comparative agent to evaluate the therapeutic efficacy of WGMG. It was not directly administered to the test subjects, and its conventional use was not the focus of the study.",
      "AOI_classification": "No",
      "Justification": "The study does not link Dexamethasone to any negative or adverse effects within the test subjects, as it was only mentioned for comparison purposes and not actively used in the study.",
      "Client_name": "Demo",
      "Drugname": "DEXAMETHASONE"
    },
    "doi": "https://doi.org/10.1016/j.jep.2025.121034",
    "specialCase": "No",
    "countryOfFirstAuthor": "China",
    "countryOfOccurrence": "China",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: Not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "The study investigates the anti-inflammatory effects of Wuwei Ganlu Medicinal Bath Granules (WGMG) in collagen-induced arthritis (CIA) in rats, focusing on its pharmacological mechanisms through the TLR4/NF-κB and NLRP3 signaling pathways. WGMG, derived from Tibetan medicine, consists of five medicinal plants and was administered to CIA rats via medicinal bath treatment at varying doses for 28 days. The study identified 89 compounds in WGMG, with 18 common compounds found in both serum and synovial fluid, including kaempferol and trans-ferulic acid. The findings revealed that WGMG significantly reduced arthritis scores, paw swelling, and spleen index in CIA rats, alleviating symptoms of arthritis. Histopathological analysis showed reduced synovial hyperplasia, inflammatory cell infiltration, and cartilage erosion. WGMG also inhibited serum levels of NF-κB, TNF-α, IL-1β, and IL-18 while enhancing IL-4 levels. Mechanistically, WGMG downregulated the protein and mRNA expression of TLR4, NF-κB, NLRP3, ASC, and caspase-1, with high-dose WGMG demonstrating therapeutic efficacy comparable to dexamethasone. The study highlights the potent anti-inflammatory activity of WGMG, attributed to its bioactive components kaempferol and trans-ferulic acid, and suggests its potential as a treatment for rheumatoid arthritis. No human subjects were involved in this study, and no adverse events were reported.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article comments positively on the anti-inflammatory effects of WGMG in CIA rats, highlighting its therapeutic efficacy comparable to dexamethasone and its potential as a treatment for rheumatoid arthritis.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Wang T, Fang N, Tang B, Fu X, Kang X, Guanque C, Yu J, Zeng Y, Su J, Zhang Y. Inhibition of Joint Inflammation in Rheumatoid Arthritis by Wuwei Ganlu Medicinal Bath Granules via Blocking Toll-like Receptor 4/Nuclear Factor-kappa B and NOD-like Receptor Pyrin Domain-containing 3 Signaling. J Ethnopharmacol. 2025;121034",
    "leadAuthor": "Wang T",
    "serious": "No",
    "testSubject": "The test subjects involved in this study were rats with collagen-induced arthritis (CIA). These rats were treated with Wuwei Ganlu Medicinal Bath Granules (WGMG) via medicinal bath treatment at varying doses for 28 days.",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Dexamethasone, is conventionally used as a corticosteroid to treat inflammatory conditions, autoimmune diseases, and allergies. It is typically administered orally, intravenously, or as an injection, depending on the condition being treated. In this study, Dexamethasone was mentioned as a comparative agent to evaluate the therapeutic efficacy of WGMG. It was not directly administered to the test subjects, and its conventional use was not the focus of the study.",
    "aoiClassification": "No",
    "justification": "The study does not link Dexamethasone to any negative or adverse effects within the test subjects, as it was only mentioned for comparison purposes and not actively used in the study.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUjuCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjuCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-58bc140501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999289
  },
  {
    "id": "665cb328-5413-478e-b7d8-86fde88cab06",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41388560",
    "title": "A tissue-penetrably engineered deoxyribonuclease 1 to prevent nasal polyp formation in chronic rhinosinusitis.",
    "authors": [
      "Kwak SB",
      "Khalmuratova R",
      "Kim SJ",
      "Shin HW",
      "Park JW"
    ],
    "journal": "BMC Pharmacol Toxicol",
    "publicationDate": "2025-12-13",
    "abstract": "The study focuses on neutrophilic chronic rhinosinusitis (CRS), a condition characterized by persistent inflammation and resistance to corticosteroid therapy. The research highlights the role of neutrophil extracellular traps (NETs) in mucosal damage and polyp formation. A genetically engineered deoxyribonuclease 1, AR-CR8 Dnase1, was evaluated for its therapeutic potential in a mouse model of neutrophilic CRS. The study involved isolating human neutrophils and inducing NET formation using LPS, followed by the development of an animal model for CRS and polyps through intranasal administration of LPS and Staphylococcal toxin. AR-CR8 Dnase1 demonstrated efficacy in degrading NET-like structures in LPS-stimulated human neutrophils and significantly reduced nasal polyps in the mouse CRS model. Intranasal administration of AR-CR8 Dnase1 was as effective as dexamethasone injections in reducing polyp numbers and NET accumulation. The findings suggest that AR-CR8 Dnase1 could serve as an alternative therapeutic for CRS patients who are unsuitable for steroid therapy. However, further studies are required to assess dosing, durability, and safety before clinical application. The study does not involve human subjects, and no adverse events or specific drug effects are reported.",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:03:52.238Z",
    "updatedAt": "2025-12-17T19:21:30.270Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41388560",
      "DOI": "https://doi.org/10.1186/s40360-025-01066-z",
      "special_case": "No",
      "Country_of_first_author": "Korea",
      "Country_of_occurrence": "Korea",
      "Patient_details": "No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: Not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The study focuses on neutrophilic chronic rhinosinusitis (CRS), a condition characterized by persistent inflammation and resistance to corticosteroid therapy. The research highlights the role of neutrophil extracellular traps (NETs) in mucosal damage and polyp formation. A genetically engineered deoxyribonuclease 1, AR-CR8 Dnase1, was evaluated for its therapeutic potential in a mouse model of neutrophilic CRS. The study involved isolating human neutrophils and inducing NET formation using LPS, followed by the development of an animal model for CRS and polyps through intranasal administration of LPS and Staphylococcal toxin. AR-CR8 Dnase1 demonstrated efficacy in degrading NET-like structures in LPS-stimulated human neutrophils and significantly reduced nasal polyps in the mouse CRS model. Intranasal administration of AR-CR8 Dnase1 was as effective as dexamethasone injections in reducing polyp numbers and NET accumulation. The findings suggest that AR-CR8 Dnase1 could serve as an alternative therapeutic for CRS patients who are unsuitable for steroid therapy. However, further studies are required to assess dosing, durability, and safety before clinical application. The study does not involve human subjects, and no adverse events or specific drug effects are reported.",
      "Identifiable_human_subject": "No",
      "Text_type": "Animal Study",
      "Author_perspective": "The article suggests that AR-CR8 Dnase1 could be a promising alternative therapeutic for CRS patients resistant to steroid therapy, emphasizing its effectiveness in reducing polyp formation and NET accumulation in the mouse model. Further studies are recommended to evaluate its clinical applicability.",
      "Adverse_event": "No AE",
      "Abstract": "Neutrophilic chronic rhinosinusitis (CRS) is characterized by persistent inflammation and often responds poorly to corticosteroid therapy. In this disease, neutrophil extracellular traps (NETs) are increasingly recognized as key mediators of mucosal damage and polypogenesis. The removal of NETs by deoxyribonuclease 1 could be a potential therapeutic approach to overcome steroid resistance in neutrophilic CRS. In this study, we established a mouse model of neutrophilic CRS and evaluated the effect of a genetically engineered deoxyribonuclease 1 'AR-CR8 Dnase1' on NETs and polyp formation in the mice.\n\nHuman neutrophils were isolated and treated with LPS to induce NET formation. An animal model for neutrophilic CRS and polyps was developed by intranasal administration of LPS and Staphylococcal toxin. H&E staining and immunofluorescence were performed to identify polyps, NETs, and immune cells in nasal cavities.\n\nAR-CR8 Dnase1 effectively degraded NET-like structures in LPS-stimulated human neutrophils. In the mouse CRS model, the intranasal administration of AR-CR8 Dnase1 noticeably reduced the burden of nasal polyps. The intranasal treatment of Dnase1 was effective as much as an injection of dexamethasone in reducing polyp number and NET accumulation in this model.\n\nThese results suggest that an engineered deoxyribonuclease 1 like AR-CR8 Dnase1 be an emerging bio-drug to inhibit inflammatory reaction and polyp formation in patients with neutrophilic CRS. AR-CR8 Dnase1 may be an alternative therapeutic for patients with CRS who are not suitable for steroid therapy, and further studies comparing dosing, durability, and safety are needed before considering clinical use.\n\nNot applicable.",
      "Title": "A tissue-penetrably engineered deoxyribonuclease 1 to prevent nasal polyp formation in chronic rhinosinusitis.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-16 05:33:30",
      "Vancouver_citation": "Kwak SB, Khalmuratova R, Kim SJ, Shin HW, Park JW. A tissue-penetrably engineered deoxyribonuclease 1 to prevent nasal polyp formation in chronic rhinosinusitis. BMC Pharmacol Toxicol. 2025;",
      "pubdate": "2025-12-13",
      "Lead_author": "Kwak SB",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study include human neutrophils treated with LPS to induce NET formation and mice used to establish a model of neutrophilic chronic rhinosinusitis (CRS) and nasal polyps. These test subjects were exposed to AR-CR8 Dnase1 and dexamethasone (the drug of study) for comparative evaluation.",
      "AOI_drug_effect": "  \n2. The drug of study, dexamethasone, was used in the mouse CRS model to reduce polyp formation and NET accumulation. It was found to be as effective as the engineered deoxyribonuclease 1 (AR-CR8 Dnase1) in reducing the burden of nasal polyps and NET-like structures. However, the study does not specify any adverse events or other medical significance induced by dexamethasone.",
      "Approved_indication": "  \n3. Dexamethasone is conventionally used as a corticosteroid to treat inflammatory and autoimmune conditions, including chronic rhinosinusitis. It is typically administered via oral, intravenous, or intranasal routes depending on the condition being treated. In this study, dexamethasone was administered via injection to mice with neutrophilic CRS to evaluate its effectiveness in reducing nasal polyps and NET accumulation.",
      "AOI_classification": "No",
      "Justification": "  \n5. The study does not link dexamethasone to any negative or adverse effects within the test subjects. It only evaluates its effectiveness in reducing nasal polyps and NET accumulation.",
      "Client_name": "Demo",
      "Drugname": "DEXAMETHASONE"
    },
    "doi": "https://doi.org/10.1186/s40360-025-01066-z",
    "specialCase": "No",
    "countryOfFirstAuthor": "Korea",
    "countryOfOccurrence": "Korea",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: Not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "The study focuses on neutrophilic chronic rhinosinusitis (CRS), a condition characterized by persistent inflammation and resistance to corticosteroid therapy. The research highlights the role of neutrophil extracellular traps (NETs) in mucosal damage and polyp formation. A genetically engineered deoxyribonuclease 1, AR-CR8 Dnase1, was evaluated for its therapeutic potential in a mouse model of neutrophilic CRS. The study involved isolating human neutrophils and inducing NET formation using LPS, followed by the development of an animal model for CRS and polyps through intranasal administration of LPS and Staphylococcal toxin. AR-CR8 Dnase1 demonstrated efficacy in degrading NET-like structures in LPS-stimulated human neutrophils and significantly reduced nasal polyps in the mouse CRS model. Intranasal administration of AR-CR8 Dnase1 was as effective as dexamethasone injections in reducing polyp numbers and NET accumulation. The findings suggest that AR-CR8 Dnase1 could serve as an alternative therapeutic for CRS patients who are unsuitable for steroid therapy. However, further studies are required to assess dosing, durability, and safety before clinical application. The study does not involve human subjects, and no adverse events or specific drug effects are reported.",
    "identifiableHumanSubject": "No",
    "textType": "Animal Study",
    "authorPerspective": "The article suggests that AR-CR8 Dnase1 could be a promising alternative therapeutic for CRS patients resistant to steroid therapy, emphasizing its effectiveness in reducing polyp formation and NET accumulation in the mouse model. Further studies are recommended to evaluate its clinical applicability.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Kwak SB, Khalmuratova R, Kim SJ, Shin HW, Park JW. A tissue-penetrably engineered deoxyribonuclease 1 to prevent nasal polyp formation in chronic rhinosinusitis. BMC Pharmacol Toxicol. 2025;",
    "leadAuthor": "Kwak SB",
    "serious": "No",
    "testSubject": "The test subjects involved in this study include human neutrophils treated with LPS to induce NET formation and mice used to establish a model of neutrophilic chronic rhinosinusitis (CRS) and nasal polyps. These test subjects were exposed to AR-CR8 Dnase1 and dexamethasone (the drug of study) for comparative evaluation.",
    "aoiDrugEffect": "  \n2. The drug of study, dexamethasone, was used in the mouse CRS model to reduce polyp formation and NET accumulation. It was found to be as effective as the engineered deoxyribonuclease 1 (AR-CR8 Dnase1) in reducing the burden of nasal polyps and NET-like structures. However, the study does not specify any adverse events or other medical significance induced by dexamethasone.",
    "approvedIndication": "  \n3. Dexamethasone is conventionally used as a corticosteroid to treat inflammatory and autoimmune conditions, including chronic rhinosinusitis. It is typically administered via oral, intravenous, or intranasal routes depending on the condition being treated. In this study, dexamethasone was administered via injection to mice with neutrophilic CRS to evaluate its effectiveness in reducing nasal polyps and NET accumulation.",
    "aoiClassification": "No",
    "justification": "  \n5. The study does not link dexamethasone to any negative or adverse effects within the test subjects. It only evaluates its effectiveness in reducing nasal polyps and NET accumulation.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUjvCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjvCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-58f3100501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999290
  },
  {
    "id": "8133ea61-d602-438b-bec0-f6c3cd845e9c",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41387654",
    "title": "Endometrial Cell Senescence and Recurrent Spontaneous Abortion: Biomarker Potential of UCP2 and GSR.",
    "authors": [
      "Chen Z",
      "Fang F",
      "Zhang Y",
      "Huang X",
      "Huang J"
    ],
    "journal": "Reprod Sci",
    "publicationDate": "2025-12-13",
    "abstract": "The study explores the molecular mechanisms behind recurrent spontaneous abortion, focusing on endometrial cell senescence and its role in the pathology. It identifies uncoupling protein 2 (UCP2) and glutathione reductase (GSR) as significantly upregulated genes associated with cellular senescence. Increased activity of natural killer and T cells in affected tissues suggests an immune component in the condition. Drug prediction analysis highlights dexamethasone and menadione as potential treatments, indicating their therapeutic potential in improving endometrial health and reducing miscarriage risk. However, the study does not provide specific data on the administration of dexamethasone or its effects on human subjects. Further clinical studies are recommended to validate these findings and explore therapeutic applications. The study emphasizes the importance of oxidative stress-induced senescence in recurrent spontaneous abortion and identifies UCP2 and GSR as promising biomarkers and therapeutic targets.",
    "drugName": "DEXAMETHASONE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:03:52.278Z",
    "updatedAt": "2025-12-17T19:21:29.749Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41387654",
      "DOI": "https://doi.org/10.1007/s43032-025-02023-1",
      "special_case": "Pregnancy Exposure",
      "Country_of_first_author": "China",
      "Country_of_occurrence": "China",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: The study investigates recurrent spontaneous abortion, focusing on endometrial cell senescence and its molecular mechanisms. It identifies UCP2 and GSR as biomarkers and potential therapeutic targets. Increased activity of natural killer and T cells in affected tissues was observed, suggesting an immune component. Drug prediction analysis highlighted dexamethasone and menadione as potential treatments.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: dexamethasone, menadione",
      "Attributability": "Attributability: The study suggests oxidative stress-induced senescence as a critical factor in recurrent spontaneous abortion. Increased activity of natural killer and T cells was observed in affected tissues, indicating an immune component. Dexamethasone and menadione were identified as potential treatments, but no specific adverse events or complications were attributed to these drugs.",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The study explores the molecular mechanisms behind recurrent spontaneous abortion, focusing on endometrial cell senescence and its role in the pathology. It identifies uncoupling protein 2 (UCP2) and glutathione reductase (GSR) as significantly upregulated genes associated with cellular senescence. Increased activity of natural killer and T cells in affected tissues suggests an immune component in the condition. Drug prediction analysis highlights dexamethasone and menadione as potential treatments, indicating their therapeutic potential in improving endometrial health and reducing miscarriage risk. However, the study does not provide specific data on the administration of dexamethasone or its effects on human subjects. Further clinical studies are recommended to validate these findings and explore therapeutic applications. The study emphasizes the importance of oxidative stress-induced senescence in recurrent spontaneous abortion and identifies UCP2 and GSR as promising biomarkers and therapeutic targets.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article comments on the potential therapeutic effects of dexamethasone and menadione in improving endometrial health and reducing miscarriage risk. It suggests that oxidative stress-induced senescence plays a critical role in recurrent spontaneous abortion and highlights UCP2 and GSR as promising biomarkers and therapeutic targets. Further clinical studies are recommended to validate these findings.",
      "Adverse_event": "No AE",
      "Abstract": "This study explores the molecular mechanisms driving recurrent spontaneous abortion, a condition affecting 1-5% of women of reproductive age, with 40-50% of cases unexplained. Focusing on endometrial cell senescence, a process linked to irreversible cell cycle arrest, the research identifies uncoupling protein 2 (UCP2) and glutathione reductase (GSR) as key contributors to this pathology. By analyzing transcriptome data from the Gene Expression Omnibus database, 21 genes associated with cellular senescence were found to be differentially expressed, with UCP2 and GSR significantly upregulated. These findings were validated using a hydrogen peroxide-induced senescence model in human endometrial stromal cells. Diagnostic potential was confirmed through receiver operating characteristic curve analysis, showing promising results for both UCP2 and GSR. The study also observed increased activity of natural killer and T cells in affected tissues, pointing to an immune component in recurrent spontaneous abortion. Drug prediction analysis highlighted dexamethasone and menadione as potential treatments. These insights suggest that oxidative stress-induced senescence plays a critical role in recurrent spontaneous abortion, with UCP2 and GSR as promising biomarkers and therapeutic targets to improve endometrial health and reduce miscarriage risk. Further clinical studies are needed to validate these findings and explore their therapeutic applications.",
      "Title": "Endometrial Cell Senescence and Recurrent Spontaneous Abortion: Biomarker Potential of UCP2 and GSR.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "DEXAMETHASONE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-16 05:32:53",
      "Vancouver_citation": "Chen Z, Fang F, Zhang Y, Huang X, Huang J. Endometrial Cell Senescence and Recurrent Spontaneous Abortion: Biomarker Potential of UCP2 and GSR. Reprod Sci. 2025;",
      "pubdate": "2025-12-13",
      "Lead_author": "Chen Z",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Dexamethasone, is conventionally used for conditions such as cerebral oedema, severe acute asthma attacks, autoimmune diseases, severe infectious diseases, palliative oncology treatments, and prevention/treatment of postoperative vomiting. In this study, Dexamethasone was highlighted as a potential treatment for recurrent spontaneous abortion, which is not listed among its conventional uses. This qualifies as off-label use.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study suggests Dexamethasone as a potential treatment for recurrent spontaneous abortion, which is an off-label use.",
      "Client_name": "Demo",
      "Drugname": "DEXAMETHASONE"
    },
    "doi": "https://doi.org/10.1007/s43032-025-02023-1",
    "specialCase": "Pregnancy Exposure",
    "countryOfFirstAuthor": "China",
    "countryOfOccurrence": "China",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: The study investigates recurrent spontaneous abortion, focusing on endometrial cell senescence and its molecular mechanisms. It identifies UCP2 and GSR as biomarkers and potential therapeutic targets. Increased activity of natural killer and T cells in affected tissues was observed, suggesting an immune component. Drug prediction analysis highlighted dexamethasone and menadione as potential treatments.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: dexamethasone",
      "menadione"
    ],
    "attributability": "Attributability: The study suggests oxidative stress-induced senescence as a critical factor in recurrent spontaneous abortion. Increased activity of natural killer and T cells was observed in affected tissues, indicating an immune component. Dexamethasone and menadione were identified as potential treatments, but no specific adverse events or complications were attributed to these drugs.",
    "drugEffect": "Drug effect: no data",
    "summary": "The study explores the molecular mechanisms behind recurrent spontaneous abortion, focusing on endometrial cell senescence and its role in the pathology. It identifies uncoupling protein 2 (UCP2) and glutathione reductase (GSR) as significantly upregulated genes associated with cellular senescence. Increased activity of natural killer and T cells in affected tissues suggests an immune component in the condition. Drug prediction analysis highlights dexamethasone and menadione as potential treatments, indicating their therapeutic potential in improving endometrial health and reducing miscarriage risk. However, the study does not provide specific data on the administration of dexamethasone or its effects on human subjects. Further clinical studies are recommended to validate these findings and explore therapeutic applications. The study emphasizes the importance of oxidative stress-induced senescence in recurrent spontaneous abortion and identifies UCP2 and GSR as promising biomarkers and therapeutic targets.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article comments on the potential therapeutic effects of dexamethasone and menadione in improving endometrial health and reducing miscarriage risk. It suggests that oxidative stress-induced senescence plays a critical role in recurrent spontaneous abortion and highlights UCP2 and GSR as promising biomarkers and therapeutic targets. Further clinical studies are recommended to validate these findings.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "DEXAMETHASONE",
    "vancouverCitation": "Chen Z, Fang F, Zhang Y, Huang X, Huang J. Endometrial Cell Senescence and Recurrent Spontaneous Abortion: Biomarker Potential of UCP2 and GSR. Reprod Sci. 2025;",
    "leadAuthor": "Chen Z",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Dexamethasone, is conventionally used for conditions such as cerebral oedema, severe acute asthma attacks, autoimmune diseases, severe infectious diseases, palliative oncology treatments, and prevention/treatment of postoperative vomiting. In this study, Dexamethasone was highlighted as a potential treatment for recurrent spontaneous abortion, which is not listed among its conventional uses. This qualifies as off-label use.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The study suggests Dexamethasone as a potential treatment for recurrent spontaneous abortion, which is an off-label use.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUjwCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjwCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-58a3880501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999289
  },
  {
    "id": "1efccb74-0e85-40d2-8408-e59cc91d1163",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41394666",
    "title": "Therapy-induced PSMA2 Sensitizes Prostate Cancer Cells to Residual Androgen and Promotes Neuroendocrine Lineage Transformation.",
    "authors": [
      "Patterson N",
      "Badoi A",
      "Vadla GP",
      "Hasani M",
      "Moyer J",
      "De la Nuez Ramirez C",
      "Chabu YC"
    ],
    "journal": "bioRxiv",
    "publicationDate": "2025-12-15",
    "abstract": "The study investigates the role of PSMA2 in prostate cancer cells under androgen receptor (AR) blockade therapy, specifically focusing on the effects of Enzalutamide. It highlights that while Enzalutamide is initially effective in treating prostate cancer, it induces PSMA2 expression, which accelerates HSP90 turnover and hypersensitizes AR to residual androgen. This leads to AR nuclear activity even under androgen-poor conditions and confers resistance to Enzalutamide. Furthermore, PSMA2 promotes lineage plasticity, enhancing transcriptional and phenotypic conversion toward treatment-emergent neuroendocrine prostate cancer (tNEPC). The study identifies PSMA2 as a stress-induced node that maintains AR-dependent survival under androgen deprivation therapy (ADT) and drives the neuroendocrine transition. The findings suggest that PSMA2 is a therapeutically actionable driver of tNEPC evolution, presenting an opportunity for rational interception of the lethal ADT-CRPC-tNEPC trajectory. However, specific details about human subjects, adverse events, or direct clinical outcomes are not provided due to the lack of access to the full article.",
    "drugName": "ENZALUTAMIDE",
    "adverseEvent": "Adverse events: The study mentions Enzalutamide resistance and neuroendocrine lineage transformation as adverse outcomes associated with PSMA2 induction.",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:05:16.612Z",
    "updatedAt": "2025-12-17T19:21:30.637Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41394666",
      "DOI": "https://doi.org/10.1101/2025.11.25.690552",
      "special_case": "Lack of Efficacy",
      "Country_of_first_author": "Country of first author: Not mentioned",
      "Country_of_occurrence": "Relevant country of occurrence: Not mentioned",
      "Patient_details": "Patient details: Human involved, no specific data",
      "Key_events": "Key events: Human involved, no specific data",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Enzalutamide",
      "Attributability": "Attributability: The study suggests that Enzalutamide induces PSMA2 expression in AR-expressing prostate cancer cells, which accelerates HSP90 turnover, hypersensitizes AR to residual androgen, drives AR nuclear activity under androgen-poor conditions, and confers resistance to Enzalutamide. PSMA2 also promotes lineage plasticity and enhances transcriptional and phenotypic conversion toward treatment-emergent neuroendocrine prostate cancer (tNEPC).",
      "Drug_effect": "Drug effect: Enzalutamide initially effective but leads to resistance and promotes neuroendocrine lineage transformation through PSMA2 induction.",
      "Summary": "The study investigates the role of PSMA2 in prostate cancer cells under androgen receptor (AR) blockade therapy, specifically focusing on the effects of Enzalutamide. It highlights that while Enzalutamide is initially effective in treating prostate cancer, it induces PSMA2 expression, which accelerates HSP90 turnover and hypersensitizes AR to residual androgen. This leads to AR nuclear activity even under androgen-poor conditions and confers resistance to Enzalutamide. Furthermore, PSMA2 promotes lineage plasticity, enhancing transcriptional and phenotypic conversion toward treatment-emergent neuroendocrine prostate cancer (tNEPC). The study identifies PSMA2 as a stress-induced node that maintains AR-dependent survival under androgen deprivation therapy (ADT) and drives the neuroendocrine transition. The findings suggest that PSMA2 is a therapeutically actionable driver of tNEPC evolution, presenting an opportunity for rational interception of the lethal ADT-CRPC-tNEPC trajectory. However, specific details about human subjects, adverse events, or direct clinical outcomes are not provided due to the lack of access to the full article.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article comments on the effect of Enzalutamide, stating that while it is initially effective, it induces PSMA2 expression, leading to resistance and promoting neuroendocrine lineage transformation. It suggests that targeting PSMA2 could be a therapeutic strategy to intercept the progression of prostate cancer.",
      "Adverse_event": "Adverse events: The study mentions Enzalutamide resistance and neuroendocrine lineage transformation as adverse outcomes associated with PSMA2 induction.",
      "Abstract": "Aberrant activation of the androgen receptor (AR) pathway drives prostate cancer (PCa). Androgen deprivation therapy (ADT) and next-generation AR blockade (e.g., enzalutamide) are initially effective, but virtually all patients develop castration-resistant prostate cancer (CRPC), which frequently transitions to treatment-emergent neuroendocrine PCa (tNEPC) following AR suppression. The molecular logic that links AR blockade to lineage plasticity remains incompletely understood. Here, we identify PSMA2 (Proteasome Subunit Alpha 2) as a treatment-induced effector that mechanistically connects AR blockade to tNEPC evolution. Enzalutamide induces PSMA2 expression in AR-expressing PCa cells. Enforced PSMA2 expression accelerates HSP90 turnover, hypersensitizes AR to residual post-castration androgen, drives AR nuclear activity under androgen-poor conditions, and confers enzalutamide resistance. Conversely, PSMA2 silencing stabilizes HSP90, desensitizes CRPC to androgen, and re-sensitizes resistant cells to enzalutamide-induced cell death. Importantly, PSMA2 also promotes lineage plasticity: treatment-induced PSMA2 enhances transcriptional and phenotypic conversion toward tNEPC. Thus, we uncover a single stress-induced node (PSMA2) that both maintains AR-dependent survival under ADT and fuels the neuroendocrine transition. PSMA2 marks an AR-hypersensitized transitional state and is itself a therapeutically actionable driver of tNEPC evolution, revealing an opportunity for rational interception of the lethal ADT-CRPC-tNEPC trajectory.",
      "Title": "Therapy-induced PSMA2 Sensitizes Prostate Cancer Cells to Residual Androgen and Promotes Neuroendocrine Lineage Transformation.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "ENZALUTAMIDE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-16 05:34:15",
      "Vancouver_citation": "Patterson N, Badoi A, Vadla GP, Hasani M, Moyer J, De la Nuez Ramirez C, Chabu YC. Therapy-induced PSMA2 Sensitizes Prostate Cancer Cells to Residual Androgen and Promotes Neuroendocrine Lineage Transformation. bioRxiv. 2025;",
      "pubdate": "2025-12-15",
      "Lead_author": "Patterson N",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Enzalutamide, is conventionally used for treating high-risk biochemical recurrent non-metastatic hormone-sensitive prostate cancer (nmHSPC), metastatic hormone-sensitive prostate cancer (mHSPC), high-risk non-metastatic castration-resistant prostate cancer (CRPC), and metastatic CRPC under specific conditions. In this study, Enzalutamide was used to investigate its effects on prostate cancer cells, particularly its role in inducing PSMA2 expression and promoting neuroendocrine lineage transformation. This qualifies as off-label use since the study focuses on molecular mechanisms and lineage plasticity rather than the conventional therapeutic applications listed.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study links Enzalutamide to the induction of PSMA2 expression, which promotes neuroendocrine lineage transformation and enzalutamide resistance in prostate cancer cells.",
      "Client_name": "Demo",
      "Drugname": "ENZALUTAMIDE"
    },
    "doi": "https://doi.org/10.1101/2025.11.25.690552",
    "specialCase": "Lack of Efficacy",
    "countryOfFirstAuthor": "Country of first author: Not mentioned",
    "countryOfOccurrence": "Relevant country of occurrence: Not mentioned",
    "patientDetails": "Patient details: Human involved, no specific data",
    "keyEvents": "Key events: Human involved, no specific data",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Enzalutamide"
    ],
    "attributability": "Attributability: The study suggests that Enzalutamide induces PSMA2 expression in AR-expressing prostate cancer cells, which accelerates HSP90 turnover, hypersensitizes AR to residual androgen, drives AR nuclear activity under androgen-poor conditions, and confers resistance to Enzalutamide. PSMA2 also promotes lineage plasticity and enhances transcriptional and phenotypic conversion toward treatment-emergent neuroendocrine prostate cancer (tNEPC).",
    "drugEffect": "Drug effect: Enzalutamide initially effective but leads to resistance and promotes neuroendocrine lineage transformation through PSMA2 induction.",
    "summary": "The study investigates the role of PSMA2 in prostate cancer cells under androgen receptor (AR) blockade therapy, specifically focusing on the effects of Enzalutamide. It highlights that while Enzalutamide is initially effective in treating prostate cancer, it induces PSMA2 expression, which accelerates HSP90 turnover and hypersensitizes AR to residual androgen. This leads to AR nuclear activity even under androgen-poor conditions and confers resistance to Enzalutamide. Furthermore, PSMA2 promotes lineage plasticity, enhancing transcriptional and phenotypic conversion toward treatment-emergent neuroendocrine prostate cancer (tNEPC). The study identifies PSMA2 as a stress-induced node that maintains AR-dependent survival under androgen deprivation therapy (ADT) and drives the neuroendocrine transition. The findings suggest that PSMA2 is a therapeutically actionable driver of tNEPC evolution, presenting an opportunity for rational interception of the lethal ADT-CRPC-tNEPC trajectory. However, specific details about human subjects, adverse events, or direct clinical outcomes are not provided due to the lack of access to the full article.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article comments on the effect of Enzalutamide, stating that while it is initially effective, it induces PSMA2 expression, leading to resistance and promoting neuroendocrine lineage transformation. It suggests that targeting PSMA2 could be a therapeutic strategy to intercept the progression of prostate cancer.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "ENZALUTAMIDE",
    "vancouverCitation": "Patterson N, Badoi A, Vadla GP, Hasani M, Moyer J, De la Nuez Ramirez C, Chabu YC. Therapy-induced PSMA2 Sensitizes Prostate Cancer Cells to Residual Androgen and Promotes Neuroendocrine Lineage Transformation. bioRxiv. 2025;",
    "leadAuthor": "Patterson N",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Enzalutamide, is conventionally used for treating high-risk biochemical recurrent non-metastatic hormone-sensitive prostate cancer (nmHSPC), metastatic hormone-sensitive prostate cancer (mHSPC), high-risk non-metastatic castration-resistant prostate cancer (CRPC), and metastatic CRPC under specific conditions. In this study, Enzalutamide was used to investigate its effects on prostate cancer cells, particularly its role in inducing PSMA2 expression and promoting neuroendocrine lineage transformation. This qualifies as off-label use since the study focuses on molecular mechanisms and lineage plasticity rather than the conventional therapeutic applications listed.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The study links Enzalutamide to the induction of PSMA2 expression, which promotes neuroendocrine lineage transformation and enzalutamide resistance in prostate cancer cells.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUjxCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjxCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-592b480501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999290
  },
  {
    "id": "bb87c260-404b-43d5-9420-e6a64178e838",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41394651",
    "title": "Graded Notch Signaling Functions as a Rheostat of Lineage Plasticity and Therapy Resistance in Prostate Cancer.",
    "authors": [
      "Jiang Y",
      "Cheng S",
      "Zhang CY",
      "Jin X",
      "Li L",
      "Fraidenburg M",
      "Wang C",
      "Kim IY",
      "Mu P"
    ],
    "journal": "bioRxiv",
    "publicationDate": "2025-12-15",
    "abstract": "The study investigates the molecular mechanisms underlying resistance to androgen receptor-targeted therapies, specifically enzalutamide, in castration-resistant prostate cancer (CRPC). It identifies Notch signaling as a graded rheostat that governs cell fate transitions and lineage plasticity, which are critical factors in therapy resistance. The research highlights that intermediate Notch activity maintains a stem-like progenitor state, while reduced or elevated signaling drives differentiation toward luminal or neuroendocrine lineages. During CRPC progression and enzalutamide resistance, Notch signaling becomes dynamically rewired, peaking in progenitor-like populations that sustain plasticity and survival. The study utilized CRISPR-mediated knockout and pharmacologic inhibition of Notch signaling, which depleted these progenitor cells and restored enzalutamide sensitivity. This suggests that the level of Notch signaling, rather than its binary presence, dictates lineage directionality and therapeutic response in CRPC. The findings establish Notch signaling as a tunable and actionable driver of resistance, offering potential therapeutic strategies to overcome enzalutamide resistance in prostate cancer.",
    "drugName": "ENZALUTAMIDE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:05:16.689Z",
    "updatedAt": "2025-12-17T19:21:30.174Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41394651",
      "DOI": "https://doi.org/10.1101/2025.11.23.690056",
      "special_case": "Lack of Efficacy",
      "Country_of_first_author": "United States",
      "Country_of_occurrence": "United States",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: Human subjects were involved in a study focusing on castration-resistant prostate cancer (CRPC) progression and resistance to enzalutamide therapy. The study explored the role of Notch signaling in lineage plasticity and therapy resistance. CRISPR-mediated knockout and pharmacologic inhibition of Notch signaling were used to investigate its effects on progenitor-like populations and enzalutamide sensitivity.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Enzalutamide",
      "Attributability": "Attributability: The study attributes therapy resistance in CRPC to dynamic rewiring of Notch signaling, which peaks in progenitor-like populations. Pharmacologic inhibition of Notch signaling restored sensitivity to enzalutamide, suggesting a direct link between Notch activity and therapeutic response.",
      "Drug_effect": "Drug effect: summary. Enzalutamide resistance was observed in CRPC due to lineage plasticity governed by Notch signaling. Pharmacologic inhibition of Notch signaling restored sensitivity to enzalutamide, indicating its potential as a therapeutic target.",
      "Summary": "The study investigates the molecular mechanisms underlying resistance to androgen receptor-targeted therapies, specifically enzalutamide, in castration-resistant prostate cancer (CRPC). It identifies Notch signaling as a graded rheostat that governs cell fate transitions and lineage plasticity, which are critical factors in therapy resistance. The research highlights that intermediate Notch activity maintains a stem-like progenitor state, while reduced or elevated signaling drives differentiation toward luminal or neuroendocrine lineages. During CRPC progression and enzalutamide resistance, Notch signaling becomes dynamically rewired, peaking in progenitor-like populations that sustain plasticity and survival. The study utilized CRISPR-mediated knockout and pharmacologic inhibition of Notch signaling, which depleted these progenitor cells and restored enzalutamide sensitivity. This suggests that the level of Notch signaling, rather than its binary presence, dictates lineage directionality and therapeutic response in CRPC. The findings establish Notch signaling as a tunable and actionable driver of resistance, offering potential therapeutic strategies to overcome enzalutamide resistance in prostate cancer.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article comments on the effect of Notch signaling on enzalutamide resistance in CRPC. It suggests that pharmacologic inhibition of Notch signaling can restore sensitivity to enzalutamide, highlighting its potential as a therapeutic target.",
      "Adverse_event": "No AE",
      "Abstract": "Resistance to androgen receptor (AR)-targeted therapies such as enzalutamide in castration-resistant prostate cancer (CRPC) often arises through lineage plasticity, yet the molecular mechanisms that define this process remain incompletely understood. While previous studies reported that Notch1 and Notch2 exert distinct and sometimes opposing effects in prostate cancer differentiation, the integrated role of Notch pathway activity has not been systematically explored. Here, we identify Notch signaling as a graded Rheostat that governs prostate cancer cell fate transitions. Integrative transcriptomic and functional analyses revealed that intermediate Notch activity maintains a stem-like progenitor state, whereas reduced or elevated signaling drives divergent differentiation trajectories toward luminal or neuroendocrine lineages, respectively. During CRPC progression and enzalutamide resistance, Notch signaling becomes dynamically rewired, peaking in progenitor-like populations that sustain plasticity and survival. Both CRISPR-mediated knockout and pharmacologic inhibition of Notch signaling depleted these progenitor cells and restored enzalutamide sensitivity. These findings demonstrate that the level, rather than the binary presence, of Notch signaling dictates lineage directionality and therapeutic response in CRPC, establishing it as a tunable and actionable driver of resistance.",
      "Title": "Graded Notch Signaling Functions as a Rheostat of Lineage Plasticity and Therapy Resistance in Prostate Cancer.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "ENZALUTAMIDE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-16 05:34:58",
      "Vancouver_citation": "Jiang Y, Cheng S, Zhang CY, Jin X, Li L, Fraidenburg M, Wang C, Kim IY, Mu P. Graded Notch Signaling Functions as a Rheostat of Lineage Plasticity and Therapy Resistance in Prostate Cancer. bioRxiv. 2025;",
      "pubdate": "2025-12-15",
      "Lead_author": "Jiang Y",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Enzalutamide, is conventionally used to treat various forms of prostate cancer, including metastatic CRPC, non-metastatic CRPC, and hormone-sensitive prostate cancer, either as monotherapy or in combination with androgen deprivation therapy. In this study, Enzalutamide was mentioned in the context of resistance during CRPC progression, but there is no indication that it was administered to any test subject or used in a non-conventional way.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study does not provide evidence of adverse effects or negative outcomes directly linked to the drug of study.",
      "Client_name": "Demo",
      "Drugname": "ENZALUTAMIDE"
    },
    "doi": "https://doi.org/10.1101/2025.11.23.690056",
    "specialCase": "Lack of Efficacy",
    "countryOfFirstAuthor": "United States",
    "countryOfOccurrence": "United States",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: Human subjects were involved in a study focusing on castration-resistant prostate cancer (CRPC) progression and resistance to enzalutamide therapy. The study explored the role of Notch signaling in lineage plasticity and therapy resistance. CRISPR-mediated knockout and pharmacologic inhibition of Notch signaling were used to investigate its effects on progenitor-like populations and enzalutamide sensitivity.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Enzalutamide"
    ],
    "attributability": "Attributability: The study attributes therapy resistance in CRPC to dynamic rewiring of Notch signaling, which peaks in progenitor-like populations. Pharmacologic inhibition of Notch signaling restored sensitivity to enzalutamide, suggesting a direct link between Notch activity and therapeutic response.",
    "drugEffect": "Drug effect: summary. Enzalutamide resistance was observed in CRPC due to lineage plasticity governed by Notch signaling. Pharmacologic inhibition of Notch signaling restored sensitivity to enzalutamide, indicating its potential as a therapeutic target.",
    "summary": "The study investigates the molecular mechanisms underlying resistance to androgen receptor-targeted therapies, specifically enzalutamide, in castration-resistant prostate cancer (CRPC). It identifies Notch signaling as a graded rheostat that governs cell fate transitions and lineage plasticity, which are critical factors in therapy resistance. The research highlights that intermediate Notch activity maintains a stem-like progenitor state, while reduced or elevated signaling drives differentiation toward luminal or neuroendocrine lineages. During CRPC progression and enzalutamide resistance, Notch signaling becomes dynamically rewired, peaking in progenitor-like populations that sustain plasticity and survival. The study utilized CRISPR-mediated knockout and pharmacologic inhibition of Notch signaling, which depleted these progenitor cells and restored enzalutamide sensitivity. This suggests that the level of Notch signaling, rather than its binary presence, dictates lineage directionality and therapeutic response in CRPC. The findings establish Notch signaling as a tunable and actionable driver of resistance, offering potential therapeutic strategies to overcome enzalutamide resistance in prostate cancer.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article comments on the effect of Notch signaling on enzalutamide resistance in CRPC. It suggests that pharmacologic inhibition of Notch signaling can restore sensitivity to enzalutamide, highlighting its potential as a therapeutic target.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "ENZALUTAMIDE",
    "vancouverCitation": "Jiang Y, Cheng S, Zhang CY, Jin X, Li L, Fraidenburg M, Wang C, Kim IY, Mu P. Graded Notch Signaling Functions as a Rheostat of Lineage Plasticity and Therapy Resistance in Prostate Cancer. bioRxiv. 2025;",
    "leadAuthor": "Jiang Y",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Enzalutamide, is conventionally used to treat various forms of prostate cancer, including metastatic CRPC, non-metastatic CRPC, and hormone-sensitive prostate cancer, either as monotherapy or in combination with androgen deprivation therapy. In this study, Enzalutamide was mentioned in the context of resistance during CRPC progression, but there is no indication that it was administered to any test subject or used in a non-conventional way.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The study does not provide evidence of adverse effects or negative outcomes directly linked to the drug of study.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUjyCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjyCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-58e4680501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999290
  },
  {
    "id": "7de99f3a-483d-4a54-a53c-fadd32787ac3",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41394150",
    "title": "Cost-effectiveness analysis of eight first-line treatments for metastatic hormone-sensitive prostate cancer in China.",
    "authors": [
      "Han Z",
      "Xi Y",
      "Hu J",
      "Wang Y",
      "Ni H"
    ],
    "journal": "Front Pharmacol",
    "publicationDate": "2025-12-15",
    "abstract": "The article focuses on a cost-effectiveness analysis of eight first-line treatments for metastatic hormone-sensitive prostate cancer (mHSPC) in China, including enzalutamide plus androgen deprivation therapy (ADT). The study utilized a partitioned survival model to evaluate the clinical effectiveness and economic impact of these treatments over a 10-year horizon. Enzalutamide plus ADT yielded the highest quality-adjusted life years (QALYs) at 4.55, indicating its clinical effectiveness. However, abiraterone plus ADT emerged as the most cost-effective strategy with an incremental cost-effectiveness ratio (ICER) of US$17,437.16 per QALY, which is substantially below the willingness-to-pay (WTP) threshold set at three times China's GDP per capita. The study highlights the economic and clinical considerations for selecting first-line treatments for mHSPC but does not provide specific details on adverse events or patient outcomes related to enzalutamide or other drugs.",
    "drugName": "ENZALUTAMIDE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:05:16.724Z",
    "updatedAt": "2025-12-17T19:21:30.443Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41394150",
      "DOI": "https://doi.org/10.3389/fphar.2025.1684966",
      "special_case": "No",
      "Country_of_first_author": "China",
      "Country_of_occurrence": "China",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: Human subjects were involved in a study analyzing the cost-effectiveness of eight first-line treatments for metastatic hormone-sensitive prostate cancer (mHSPC) in China. The study evaluated the clinical effectiveness and economic impact of these treatments over a 10-year horizon.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: docetaxel, abiraterone, apalutamide, enzalutamide, rezvilutamide, darolutamide, androgen deprivation therapy (ADT). Duration of administration is not specified.",
      "Attributability": "Attributability: The study does not provide specific details on adverse events or medical complications attributable to the drugs administered.",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The article focuses on a cost-effectiveness analysis of eight first-line treatments for metastatic hormone-sensitive prostate cancer (mHSPC) in China, including enzalutamide plus androgen deprivation therapy (ADT). The study utilized a partitioned survival model to evaluate the clinical effectiveness and economic impact of these treatments over a 10-year horizon. Enzalutamide plus ADT yielded the highest quality-adjusted life years (QALYs) at 4.55, indicating its clinical effectiveness. However, abiraterone plus ADT emerged as the most cost-effective strategy with an incremental cost-effectiveness ratio (ICER) of US$17,437.16 per QALY, which is substantially below the willingness-to-pay (WTP) threshold set at three times China's GDP per capita. The study highlights the economic and clinical considerations for selecting first-line treatments for mHSPC but does not provide specific details on adverse events or patient outcomes related to enzalutamide or other drugs.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article comments on the cost-effectiveness and clinical effectiveness of enzalutamide plus ADT, noting that it yielded the highest QALYs among the eight treatment regimens analyzed. However, abiraterone plus ADT was identified as the most cost-effective strategy.",
      "Adverse_event": "No AE",
      "Abstract": "The treatment of metastatic hormone-sensitive prostate cancer (mHSPC) has shifted from androgen deprivation therapy (ADT) alone to doublet or triplet regimens building on ADT. However, the cost-effectiveness analysis of first-line treatments for mHSPC in China is uncertain. This study aims to perform a 10-year horizon health economic evaluation to comparatively analyze the cost-effectiveness of eight treatment regimens for mHSPC from the perspective of China's healthcare system, including (1) ADT alone and ADT plus one of the following: (2) docetaxel, (3) abiraterone, (4) apalutamide, (5) enzalutamide, (6) rezvilutamide, (7) darolutamide and docetaxel, (8) abiraterone and docetaxel.\n\nPartitioned survival model was developed to evaluate the cost-effectiveness of eight first-line treatment regimens for mHSPC. Drug costs were primarily extracted from pharmaceutical databases. The key outcomes were quality adjusted life years (QALYs), costs and the incremental cost-effectiveness ratio (ICER). Willingness-to-pay (WTP) threshold was set as three-time China's gross domestic product (GDP) <i>per capita</i> (US$38,024) per QALY.\n\nFor costs, the 10-year cost estimates ranged from US$120,844 for ADT alone to US$216,294 for darolutamide plus ADT with docetaxel. For clinical effectiveness, enzalutamide plus ADT yielded the highest QALYs (4.55), while ADT alone gained lowest QALYs (3.01). For cost-effectiveness, the three treatment regimens of ADT alone, abiraterone plus ADT and enzalutamide plus ADT constituted the cost-effectiveness frontier. Abiraterone plus ADT emerged as the most cost-effective strategy, indicative of an ICER of US$17437.16 per QALY, substantially below WTP threshold.\n\nAbiraterone plus ADT was likely to be cost-effective for mHSPC treatment at a WTP threshold of three-time <i>per capita</i> GDP per QALY.",
      "Title": "Cost-effectiveness analysis of eight first-line treatments for metastatic hormone-sensitive prostate cancer in China.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "ENZALUTAMIDE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-16 05:35:14",
      "Vancouver_citation": "Han Z, Xi Y, Hu J, Wang Y, Ni H. Cost-effectiveness analysis of eight first-line treatments for metastatic hormone-sensitive prostate cancer in China. Front Pharmacol. 2025;161684966",
      "pubdate": "2025-12-15",
      "Lead_author": "Han Z",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Enzalutamide, is conventionally used for metastatic hormone-sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy (ADT), which aligns with its use in this study. Therefore, the drug was not used in a non-conventional way or off-label.",
      "AOI_classification": "No",
      "Justification": "The study does not link the drug of study to any negative or adverse effects. It focuses on cost-effectiveness analysis rather than clinical outcomes or adverse events.",
      "Client_name": "Demo",
      "Drugname": "ENZALUTAMIDE"
    },
    "doi": "https://doi.org/10.3389/fphar.2025.1684966",
    "specialCase": "No",
    "countryOfFirstAuthor": "China",
    "countryOfOccurrence": "China",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: Human subjects were involved in a study analyzing the cost-effectiveness of eight first-line treatments for metastatic hormone-sensitive prostate cancer (mHSPC) in China. The study evaluated the clinical effectiveness and economic impact of these treatments over a 10-year horizon.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: docetaxel",
      "abiraterone",
      "apalutamide",
      "enzalutamide",
      "rezvilutamide",
      "darolutamide",
      "androgen deprivation therapy (ADT). Duration of administration is not specified."
    ],
    "attributability": "Attributability: The study does not provide specific details on adverse events or medical complications attributable to the drugs administered.",
    "drugEffect": "Drug effect: no data",
    "summary": "The article focuses on a cost-effectiveness analysis of eight first-line treatments for metastatic hormone-sensitive prostate cancer (mHSPC) in China, including enzalutamide plus androgen deprivation therapy (ADT). The study utilized a partitioned survival model to evaluate the clinical effectiveness and economic impact of these treatments over a 10-year horizon. Enzalutamide plus ADT yielded the highest quality-adjusted life years (QALYs) at 4.55, indicating its clinical effectiveness. However, abiraterone plus ADT emerged as the most cost-effective strategy with an incremental cost-effectiveness ratio (ICER) of US$17,437.16 per QALY, which is substantially below the willingness-to-pay (WTP) threshold set at three times China's GDP per capita. The study highlights the economic and clinical considerations for selecting first-line treatments for mHSPC but does not provide specific details on adverse events or patient outcomes related to enzalutamide or other drugs.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article comments on the cost-effectiveness and clinical effectiveness of enzalutamide plus ADT, noting that it yielded the highest QALYs among the eight treatment regimens analyzed. However, abiraterone plus ADT was identified as the most cost-effective strategy.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "ENZALUTAMIDE",
    "vancouverCitation": "Han Z, Xi Y, Hu J, Wang Y, Ni H. Cost-effectiveness analysis of eight first-line treatments for metastatic hormone-sensitive prostate cancer in China. Front Pharmacol. 2025;161684966",
    "leadAuthor": "Han Z",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Enzalutamide, is conventionally used for metastatic hormone-sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy (ADT), which aligns with its use in this study. Therefore, the drug was not used in a non-conventional way or off-label.",
    "aoiClassification": "No",
    "justification": "The study does not link the drug of study to any negative or adverse effects. It focuses on cost-effectiveness analysis rather than clinical outcomes or adverse events.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUjzCAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUjzCAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-590de00501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999290
  },
  {
    "id": "164d7a5c-c467-4f43-a4a1-862a9b757daa",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41387022",
    "title": "Impact of Metastatic Hormone-sensitive Prostate Cancer Treatments on Health-related Quality of Life: A Systematic Review and Network Meta-analysis.",
    "authors": [
      "van Elst T",
      "Lopez P",
      "Buffart LM",
      "Custers JAE",
      "Wever L",
      "de Bie JC",
      "Mulders PFA",
      "Bloemendal HJ",
      "van Basten JA",
      "Mehra N"
    ],
    "journal": "Eur Urol Focus",
    "publicationDate": "2025-12-13",
    "abstract": "The study systematically reviewed and analyzed the impact of various treatment strategies on health-related quality of life (HRQoL) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). It compared androgen deprivation therapy (ADT) alone or combined with placebo, radiotherapy, abiraterone, apalutamide, enzalutamide, and/or docetaxel. The network meta-analysis evaluated 12-month treatment effects using standardized mean differences (SMDs) with 95% confidence intervals (CIs). ADT combined with abiraterone demonstrated significantly less pain, less fatigue, and better physical functioning compared to ADT combined with enzalutamide, apalutamide, or placebo. However, ADT combined with abiraterone was associated with worse general health perception compared to ADT alone, ADT combined with docetaxel, and ADT combined with radiotherapy. The study highlighted that HRQoL outcomes differ across treatment strategies, with ADT combined with abiraterone yielding the most favorable HRQoL profile at 12 months. The study also noted limitations, including heterogeneity and few eligible trials. While enzalutamide was mentioned, the study primarily emphasized the comparative benefits and drawbacks of abiraterone in HRQoL outcomes.",
    "drugName": "ENZALUTAMIDE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:05:16.753Z",
    "updatedAt": "2025-12-17T19:21:30.129Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41387022",
      "DOI": "https://doi.org/10.1016/j.euf.2025.12.001",
      "special_case": "No",
      "Country_of_first_author": "Netherlands",
      "Country_of_occurrence": "Netherlands",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: The study analyzed the impact of various treatment strategies on health-related quality of life (HRQoL) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). It compared androgen deprivation therapy (ADT) alone or combined with placebo, radiotherapy, abiraterone, apalutamide, enzalutamide, and/or docetaxel. The study focused on patient-reported outcome measures (PROMs) and harmonized HRQoL domains using the Wilson and Cleary model. The network meta-analysis evaluated 12-month treatment effects.",
      "Relevant_dates": "Relevant dates: Databases were searched in April 2022 and April 2024.",
      "Administered_drugs": "Administered drugs: Abiraterone, apalutamide, enzalutamide, docetaxel, radiotherapy, placebo, androgen deprivation therapy (ADT). Duration of administration: 12 months.",
      "Attributability": "Attributability: The study reported that ADT combined with abiraterone resulted in significantly less pain, less fatigue, and better physical functioning compared to ADT combined with enzalutamide, apalutamide, or placebo. However, ADT combined with abiraterone was associated with worse general health perception compared to ADT alone, ADT combined with docetaxel, and ADT combined with radiotherapy.",
      "Drug_effect": "Drug effect: ADT combined with abiraterone showed the most favorable HRQoL profile at 12 months, including less pain, less fatigue, and better physical functioning compared to other combinations. However, it was associated with worse general health perception compared to some other treatments.",
      "Summary": "The study systematically reviewed and analyzed the impact of various treatment strategies on health-related quality of life (HRQoL) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). It compared androgen deprivation therapy (ADT) alone or combined with placebo, radiotherapy, abiraterone, apalutamide, enzalutamide, and/or docetaxel. The network meta-analysis evaluated 12-month treatment effects using standardized mean differences (SMDs) with 95% confidence intervals (CIs). ADT combined with abiraterone demonstrated significantly less pain, less fatigue, and better physical functioning compared to ADT combined with enzalutamide, apalutamide, or placebo. However, ADT combined with abiraterone was associated with worse general health perception compared to ADT alone, ADT combined with docetaxel, and ADT combined with radiotherapy. The study highlighted that HRQoL outcomes differ across treatment strategies, with ADT combined with abiraterone yielding the most favorable HRQoL profile at 12 months. The study also noted limitations, including heterogeneity and few eligible trials. While enzalutamide was mentioned, the study primarily emphasized the comparative benefits and drawbacks of abiraterone in HRQoL outcomes.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Meta-analysis",
      "Author_perspective": "The article comments that ADT combined with abiraterone yielded the most favorable HRQoL profile at 12 months, including less pain, less fatigue, and better physical functioning compared to other combinations. However, it also noted worse general health perception compared to some other treatments.",
      "Adverse_event": "No AE",
      "Abstract": "In metastatic hormone-sensitive prostate cancer (mHSPC), health-related quality of life (HRQoL) is key for personalised treatment decisions. We compared the impact of different mHSPC treatment strategies on HRQoL, tackling a previously unaddressed challenge in comparing the outcomes across different patient-reported outcome measures (PROMs).\n\nA systematic review was conducted of prospective studies reporting HRQoL outcomes of androgen deprivation therapy (ADT) alone or with placebo, radiotherapy, abiraterone, apalutamide, enzalutamide, and/or docetaxel in mHSPC (CRD42021227902). Databases were searched in April 2022 and April 2024. HRQoL domains across different PROMs were harmonised using the Wilson and Cleary model. A frequentist network meta-analysis (NMA) compared 12-mo treatment effects using standardised mean differences (SMDs) with 95% confidence intervals (CIs). Statistical significance was defined as p < 0.05.\n\nOf the 24 articles included, nine were analysed in the NMA (eight trials, n = 6248). ADT + abiraterone resulted in significantly less pain than ADT + placebo (SMD: -0.22, 95% CI [-0.33; -0.10], p < 0.001), ADT + apalutamide (SMD: -0.17, 95% CI [-0.31; -0.02], p = 0.022), and ADT + enzalutamide (SMD: -0.23, 95% CI [-0.37; -0.09], p = 0.001). Less fatigue was observed with ADT + abiraterone versus ADT + enzalutamide (SMD: -0.45, 95% CI [-0.88; -0.02], p = 0.041). ADT + abiraterone showed significantly better physical functioning than ADT + enzalutamide (p = 0.015) and ADT + placebo (p = 0.032). Both were also associated with significantly worse general health perception than ADT alone, ADT + docetaxel, and ADT + radiotherapy. General health perception and overall quality of life were significantly better with ADT + abiraterone than with ADT + enzalutamide, ADT + apalutamide, and ADT + placebo (p < 0.001). The limitations include heterogeneity (0-76%) and few eligible trials.\n\nHRQoL outcomes differ across treatment strategies for mHSPC. At 12 mo, ADT + abiraterone yielded the most favourable HRQoL profile.",
      "Title": "Impact of Metastatic Hormone-sensitive Prostate Cancer Treatments on Health-related Quality of Life: A Systematic Review and Network Meta-analysis.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "ENZALUTAMIDE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-16 05:34:39",
      "Vancouver_citation": "van Elst T, Lopez P, Buffart LM, Custers JAE, Wever L, de Bie JC, Mulders PFA, Bloemendal HJ, van Basten JA, Mehra N. Impact of Metastatic Hormone-sensitive Prostate Cancer Treatments on Health-related Quality of Life: A Systematic Review and Network Meta-analysis. Eur Urol Focus. 2025;",
      "pubdate": "2025-12-13",
      "Lead_author": "van Elst T",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study are human patients diagnosed with metastatic hormone-sensitive prostate cancer (mHSPC). The study analyzed data from eight trials with a total of 6248 participants.",
      "AOI_drug_effect": "The drug of study, enzalutamide, was part of the treatment strategies analyzed in combination with androgen deprivation therapy (ADT). The study reported that ADT combined with enzalutamide resulted in worse outcomes in terms of pain, fatigue, physical functioning, general health perception, and overall quality of life compared to ADT combined with abiraterone.",
      "Approved_indication": "The drug of study, enzalutamide, is conventionally used for metastatic hormone-sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy (ADT), which aligns with its use in this study. Therefore, the drug was not used in a non-conventional or off-label manner.",
      "AOI_classification": "Yes",
      "Justification": "The study links the drug of study, enzalutamide, to negative effects such as increased pain, fatigue, worse physical functioning, and poorer general health perception and overall quality of life compared to other treatment strategies.",
      "Client_name": "Demo",
      "Drugname": "ENZALUTAMIDE"
    },
    "doi": "https://doi.org/10.1016/j.euf.2025.12.001",
    "specialCase": "No",
    "countryOfFirstAuthor": "Netherlands",
    "countryOfOccurrence": "Netherlands",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: The study analyzed the impact of various treatment strategies on health-related quality of life (HRQoL) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). It compared androgen deprivation therapy (ADT) alone or combined with placebo, radiotherapy, abiraterone, apalutamide, enzalutamide, and/or docetaxel. The study focused on patient-reported outcome measures (PROMs) and harmonized HRQoL domains using the Wilson and Cleary model. The network meta-analysis evaluated 12-month treatment effects.",
    "relevantDates": "Relevant dates: Databases were searched in April 2022 and April 2024.",
    "administeredDrugs": [
      "Administered drugs: Abiraterone",
      "apalutamide",
      "enzalutamide",
      "docetaxel",
      "radiotherapy",
      "placebo",
      "androgen deprivation therapy (ADT). Duration of administration: 12 months."
    ],
    "attributability": "Attributability: The study reported that ADT combined with abiraterone resulted in significantly less pain, less fatigue, and better physical functioning compared to ADT combined with enzalutamide, apalutamide, or placebo. However, ADT combined with abiraterone was associated with worse general health perception compared to ADT alone, ADT combined with docetaxel, and ADT combined with radiotherapy.",
    "drugEffect": "Drug effect: ADT combined with abiraterone showed the most favorable HRQoL profile at 12 months, including less pain, less fatigue, and better physical functioning compared to other combinations. However, it was associated with worse general health perception compared to some other treatments.",
    "summary": "The study systematically reviewed and analyzed the impact of various treatment strategies on health-related quality of life (HRQoL) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). It compared androgen deprivation therapy (ADT) alone or combined with placebo, radiotherapy, abiraterone, apalutamide, enzalutamide, and/or docetaxel. The network meta-analysis evaluated 12-month treatment effects using standardized mean differences (SMDs) with 95% confidence intervals (CIs). ADT combined with abiraterone demonstrated significantly less pain, less fatigue, and better physical functioning compared to ADT combined with enzalutamide, apalutamide, or placebo. However, ADT combined with abiraterone was associated with worse general health perception compared to ADT alone, ADT combined with docetaxel, and ADT combined with radiotherapy. The study highlighted that HRQoL outcomes differ across treatment strategies, with ADT combined with abiraterone yielding the most favorable HRQoL profile at 12 months. The study also noted limitations, including heterogeneity and few eligible trials. While enzalutamide was mentioned, the study primarily emphasized the comparative benefits and drawbacks of abiraterone in HRQoL outcomes.",
    "identifiableHumanSubject": "Yes",
    "textType": "Meta-analysis",
    "authorPerspective": "The article comments that ADT combined with abiraterone yielded the most favorable HRQoL profile at 12 months, including less pain, less fatigue, and better physical functioning compared to other combinations. However, it also noted worse general health perception compared to some other treatments.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "ENZALUTAMIDE",
    "vancouverCitation": "van Elst T, Lopez P, Buffart LM, Custers JAE, Wever L, de Bie JC, Mulders PFA, Bloemendal HJ, van Basten JA, Mehra N. Impact of Metastatic Hormone-sensitive Prostate Cancer Treatments on Health-related Quality of Life: A Systematic Review and Network Meta-analysis. Eur Urol Focus. 2025;",
    "leadAuthor": "van Elst T",
    "serious": "No",
    "testSubject": "The test subjects involved in this study are human patients diagnosed with metastatic hormone-sensitive prostate cancer (mHSPC). The study analyzed data from eight trials with a total of 6248 participants.",
    "aoiDrugEffect": "The drug of study, enzalutamide, was part of the treatment strategies analyzed in combination with androgen deprivation therapy (ADT). The study reported that ADT combined with enzalutamide resulted in worse outcomes in terms of pain, fatigue, physical functioning, general health perception, and overall quality of life compared to ADT combined with abiraterone.",
    "approvedIndication": "The drug of study, enzalutamide, is conventionally used for metastatic hormone-sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy (ADT), which aligns with its use in this study. Therefore, the drug was not used in a non-conventional or off-label manner.",
    "aoiClassification": "Yes",
    "justification": "The study links the drug of study, enzalutamide, to negative effects such as increased pain, fatigue, worse physical functioning, and poorer general health perception and overall quality of life compared to other treatment strategies.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUj0CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj0CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-58dd9c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999290
  },
  {
    "id": "eb94d594-a6c3-42af-9de1-1214293870bd",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41388589",
    "title": "3D Bioprinted Human Synovium-Cartilage Models Mimic Rheumatoid Arthritis Microenvironment and Recapitulate In Vivo Therapeutic Responses.",
    "authors": [
      "Zhou H",
      "Zhang Z",
      "Mu Y",
      "Ma L",
      "Hu X",
      "Liu B",
      "Wang DA"
    ],
    "journal": "Adv Mater",
    "publicationDate": "2025-12-13",
    "abstract": "The article discusses the development of a 3D bioprinted human synovium-cartilage model designed to mimic the microenvironment of rheumatoid arthritis (RA) and replicate in vivo therapeutic responses. This in vitro model incorporates chondrocytes recellularized type II collagen scaffold and a bi-layered Gelatin-Matrigel hydrogel containing fibroblast-like synoviocytes (FLS), proinflammatory macrophages, and protective barrier macrophages. The model successfully recapitulates key inflammatory processes associated with RA, such as the production of proinflammatory mediators, degradative enzymes, reactive oxygen species generation, FLS invasion into cartilage, macrophage phenotypic alterations, and depletion of extracellular matrix components. The study validates the model's effectiveness in screening anti-arthritis drugs, specifically celecoxib and tofacitinib, and demonstrates its accuracy in replicating in vivo pathological conditions through transcriptomic and proteomic analysis. The model's response to drugs is compared to a rat model of RA, highlighting its potential as a reliable tool for preclinical drug screening in RA therapeutics. However, no specific data on human subjects or adverse events is provided, and the full article is not available for further details.",
    "drugName": "CELECOXIB",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:05:50.303Z",
    "updatedAt": "2025-12-17T19:21:29.979Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41388589",
      "DOI": "https://doi.org/10.1002/adma.202513952",
      "special_case": "No",
      "Country_of_first_author": "China",
      "Country_of_occurrence": "China",
      "Patient_details": "No human subject",
      "Key_events": "Key events: Not applicable",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Celecoxib, Tofacitinib",
      "Attributability": "Attributability: Not applicable",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The article discusses the development of a 3D bioprinted human synovium-cartilage model designed to mimic the microenvironment of rheumatoid arthritis (RA) and replicate in vivo therapeutic responses. This in vitro model incorporates chondrocytes recellularized type II collagen scaffold and a bi-layered Gelatin-Matrigel hydrogel containing fibroblast-like synoviocytes (FLS), proinflammatory macrophages, and protective barrier macrophages. The model successfully recapitulates key inflammatory processes associated with RA, such as the production of proinflammatory mediators, degradative enzymes, reactive oxygen species generation, FLS invasion into cartilage, macrophage phenotypic alterations, and depletion of extracellular matrix components. The study validates the model's effectiveness in screening anti-arthritis drugs, specifically celecoxib and tofacitinib, and demonstrates its accuracy in replicating in vivo pathological conditions through transcriptomic and proteomic analysis. The model's response to drugs is compared to a rat model of RA, highlighting its potential as a reliable tool for preclinical drug screening in RA therapeutics. However, no specific data on human subjects or adverse events is provided, and the full article is not available for further details.",
      "Identifiable_human_subject": "No",
      "Text_type": "In Vitro Study",
      "Author_perspective": "The article comments positively on the drug screening capabilities of the developed in vitro model, emphasizing its accuracy in replicating in vivo pathological conditions and its potential for preclinical RA therapeutic research.",
      "Adverse_event": "No AE",
      "Abstract": "Rheumatoid arthritis (RA) models play crucial roles in therapeutic discovery and fundamental research. However, current models have limited success at accurately simulating in vivo microenvironment and lacking intricate cellular cross-talk. Here, this work presents a human in vitro RA model that faithfully captures functional and compositional properties of cartilage and synovial lining in vivo, established with chondrocytes recellularized type II collagen scaffold and 3D-bioprinted bi-layered Gelatin-Matrigel hydrogel incorporating fibroblast-like synoviocytes (FLS) and proinflammatory macrophages in the top layer and protective barrier macrophages in the bottom layer. This synovium-cartilage system recapitulates key inflammatory processes akin to RA, including enhanced production of proinflammatory mediators and degradative enzymes, as well as reactive oxygen species generation, invasion of FLS into cartilage, phenotypic alterations of macrophages and the depletion of cartilaginous extracellular matrix components. The established model enables effective screening of anti-arthritis drugs, which is validated by leveraging celecoxib and tofacitinib. Furthermore, the transcriptomic and proteomic landscape of this model demonstrates accuracy in replicating in vivo pathological conditions. Notably, this in vitro model reflects the response of the disease to the drug compared to the rat model of RA. Overall, this study provides reliable in vitro human synovium-cartilage models for screening preclinical drugs in RA therapeutics.",
      "Title": "3D Bioprinted Human Synovium-Cartilage Models Mimic Rheumatoid Arthritis Microenvironment and Recapitulate In Vivo Therapeutic Responses.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "CELECOXIB",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-16 05:35:40",
      "Vancouver_citation": "Zhou H, Zhang Z, Mu Y, Ma L, Hu X, Liu B, Wang DA. 3D Bioprinted Human Synovium-Cartilage Models Mimic Rheumatoid Arthritis Microenvironment and Recapitulate In Vivo Therapeutic Responses. Adv Mater. 2025;e13952",
      "pubdate": "2025-12-13",
      "Lead_author": "Zhou H",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study are human-derived cells, specifically chondrocytes, fibroblast-like synoviocytes (FLS), and macrophages, which were incorporated into a 3D bioprinted synovium-cartilage model. These cells were used to simulate the microenvironment of rheumatoid arthritis (RA) in vitro.",
      "AOI_drug_effect": "The drug of study, Celecoxib, was used in this research to validate the effectiveness of the in vitro RA model for screening anti-arthritis drugs. The study demonstrated that the model accurately reflected the therapeutic response of RA to Celecoxib, as well as to another drug, Tofacitinib. However, there is no mention of Celecoxib inducing any specific medical event or adverse event in the test subjects.",
      "Approved_indication": "Celecoxib is conventionally used as a nonsteroidal anti-inflammatory drug (NSAID) to treat pain and inflammation associated with conditions such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. It is typically administered orally. In this study, Celecoxib was used as part of the drug screening process to evaluate its therapeutic response in the 3D bioprinted human synovium-cartilage model, which mimics the RA microenvironment.",
      "AOI_classification": "No",
      "Justification": "The study does not link Celecoxib to any negative or adverse effects within the test subjects. It focuses on validating the therapeutic response of the drug in the RA model without mentioning any side effects or adverse events.",
      "Client_name": "Demo",
      "Drugname": "CELECOXIB"
    },
    "doi": "https://doi.org/10.1002/adma.202513952",
    "specialCase": "No",
    "countryOfFirstAuthor": "China",
    "countryOfOccurrence": "China",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: Not applicable",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Celecoxib",
      "Tofacitinib"
    ],
    "attributability": "Attributability: Not applicable",
    "drugEffect": "Drug effect: no data",
    "summary": "The article discusses the development of a 3D bioprinted human synovium-cartilage model designed to mimic the microenvironment of rheumatoid arthritis (RA) and replicate in vivo therapeutic responses. This in vitro model incorporates chondrocytes recellularized type II collagen scaffold and a bi-layered Gelatin-Matrigel hydrogel containing fibroblast-like synoviocytes (FLS), proinflammatory macrophages, and protective barrier macrophages. The model successfully recapitulates key inflammatory processes associated with RA, such as the production of proinflammatory mediators, degradative enzymes, reactive oxygen species generation, FLS invasion into cartilage, macrophage phenotypic alterations, and depletion of extracellular matrix components. The study validates the model's effectiveness in screening anti-arthritis drugs, specifically celecoxib and tofacitinib, and demonstrates its accuracy in replicating in vivo pathological conditions through transcriptomic and proteomic analysis. The model's response to drugs is compared to a rat model of RA, highlighting its potential as a reliable tool for preclinical drug screening in RA therapeutics. However, no specific data on human subjects or adverse events is provided, and the full article is not available for further details.",
    "identifiableHumanSubject": "No",
    "textType": "In Vitro Study",
    "authorPerspective": "The article comments positively on the drug screening capabilities of the developed in vitro model, emphasizing its accuracy in replicating in vivo pathological conditions and its potential for preclinical RA therapeutic research.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "CELECOXIB",
    "vancouverCitation": "Zhou H, Zhang Z, Mu Y, Ma L, Hu X, Liu B, Wang DA. 3D Bioprinted Human Synovium-Cartilage Models Mimic Rheumatoid Arthritis Microenvironment and Recapitulate In Vivo Therapeutic Responses. Adv Mater. 2025;e13952",
    "leadAuthor": "Zhou H",
    "serious": "No",
    "testSubject": "The test subjects involved in this study are human-derived cells, specifically chondrocytes, fibroblast-like synoviocytes (FLS), and macrophages, which were incorporated into a 3D bioprinted synovium-cartilage model. These cells were used to simulate the microenvironment of rheumatoid arthritis (RA) in vitro.",
    "aoiDrugEffect": "The drug of study, Celecoxib, was used in this research to validate the effectiveness of the in vitro RA model for screening anti-arthritis drugs. The study demonstrated that the model accurately reflected the therapeutic response of RA to Celecoxib, as well as to another drug, Tofacitinib. However, there is no mention of Celecoxib inducing any specific medical event or adverse event in the test subjects.",
    "approvedIndication": "Celecoxib is conventionally used as a nonsteroidal anti-inflammatory drug (NSAID) to treat pain and inflammation associated with conditions such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. It is typically administered orally. In this study, Celecoxib was used as part of the drug screening process to evaluate its therapeutic response in the 3D bioprinted human synovium-cartilage model, which mimics the RA microenvironment.",
    "aoiClassification": "No",
    "justification": "The study does not link Celecoxib to any negative or adverse effects within the test subjects. It focuses on validating the therapeutic response of the drug in the RA model without mentioning any side effects or adverse events.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUj1CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj1CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-58c7380501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999289
  },
  {
    "id": "92679a14-1fc0-4287-92de-44d1d41929e4",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41384858",
    "title": "Innovation Versus Consolidation: Critical Reflections on Suzetrigine and the Tramadol-Celecoxib Co-Crystal.",
    "authors": [
      "Alcántara Montero A"
    ],
    "journal": "J Pain Palliat Care Pharmacother",
    "publicationDate": "2025-12-12",
    "abstract": "Article requires manual review",
    "drugName": "CELECOXIB",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:05:50.348Z",
    "updatedAt": "2025-12-17T19:21:30.336Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41384858",
      "DOI": "https://doi.org10.1080/15360288.2025.2600077",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CELECOXIB",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-16 05:35:48",
      "Drugname": "CELECOXIB",
      "Vancouver_citation": "Alcántara Montero A. Innovation Versus Consolidation: Critical Reflections on Suzetrigine and the Tramadol-Celecoxib Co-Crystal. J Pain Palliat Care Pharmacother. 2025;1-3",
      "pubdate": "2025-12-12",
      "Lead_author": "Alcántara Montero A",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1080/15360288.2025.2600077",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CELECOXIB",
    "vancouverCitation": "Alcántara Montero A. Innovation Versus Consolidation: Critical Reflections on Suzetrigine and the Tramadol-Celecoxib Co-Crystal. J Pain Palliat Care Pharmacother. 2025;1-3",
    "leadAuthor": "Alcántara Montero A",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUj2CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj2CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-58fd5c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999290
  },
  {
    "id": "83f5773b-ece8-45f7-9910-74d41d60ab22",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41391767",
    "title": "The divergent roles of tryptophans W354 and W217 in OCT1 transport: similar localization, distinct functions.",
    "authors": [
      "Römer S",
      "Ebel L",
      "Neumann A",
      "Rönnpagel V",
      "Schulig L",
      "Meyer-Tönnies MJ",
      "Tzvetkov MV"
    ],
    "journal": "J Biol Chem",
    "publicationDate": "2025-12-15",
    "abstract": "The article investigates the roles of specific amino acids in the hepatic organic cation transporter 1 (OCT1), which is responsible for transporting various structurally diverse substrates, including drugs such as morphine, metformin, sumatriptan, and fenoterol. The study utilized cryo-EM data and functional analyses to explore the effects of mutations in amino acids W217, W354, and I446 on OCT1 transport in HEK293 cells. The W354A mutation resulted in a complete loss of function for all tested substrates, while the W354Y mutation retained partial OCT1 activity. Molecular dynamics simulations revealed that W354 stabilizes OCT1 in its outward open conformation by forming a hydrogen bond with N453. On the other hand, W217A showed substrate-dependent effects, with smaller and less lipophilic substrates being more strongly affected. The study also identified a compensatory mechanism between W217 and F244, as the double mutant W217A/F244A significantly reduced uptake of all tested substrates. I446 mutations had only marginal effects on OCT1 transport. The findings highlight the distinct roles of W354 and W217 in OCT1 function and substrate specificity, with W354 being crucial for conformational changes and W217 contributing to substrate interaction. While morphine is mentioned as one of the substrates transported by OCT1, the study does not provide specific data on its transport or adverse effects related to morphine.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "aoi_assessment",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "267126ca-46be-4407-ae4e-1efc394744c8",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"AOI\". Moving to QC Triage.",
        "timestamp": "2025-12-17T20:20:55.922Z",
        "type": "system"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-16T00:07:07.855Z",
    "updatedAt": "2025-12-17T20:21:04.166Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41391767",
      "DOI": "https://doi.org/10.1016/j.jbc.2025.111051",
      "special_case": "No",
      "Country_of_first_author": "Germany",
      "Country_of_occurrence": "Germany",
      "Patient_details": "No human subject",
      "Key_events": "Key events: No human subject",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: No human subject",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The article investigates the roles of specific amino acids in the hepatic organic cation transporter 1 (OCT1), which is responsible for transporting various structurally diverse substrates, including drugs such as morphine, metformin, sumatriptan, and fenoterol. The study utilized cryo-EM data and functional analyses to explore the effects of mutations in amino acids W217, W354, and I446 on OCT1 transport in HEK293 cells. The W354A mutation resulted in a complete loss of function for all tested substrates, while the W354Y mutation retained partial OCT1 activity. Molecular dynamics simulations revealed that W354 stabilizes OCT1 in its outward open conformation by forming a hydrogen bond with N453. On the other hand, W217A showed substrate-dependent effects, with smaller and less lipophilic substrates being more strongly affected. The study also identified a compensatory mechanism between W217 and F244, as the double mutant W217A/F244A significantly reduced uptake of all tested substrates. I446 mutations had only marginal effects on OCT1 transport. The findings highlight the distinct roles of W354 and W217 in OCT1 function and substrate specificity, with W354 being crucial for conformational changes and W217 contributing to substrate interaction. While morphine is mentioned as one of the substrates transported by OCT1, the study does not provide specific data on its transport or adverse effects related to morphine.",
      "Identifiable_human_subject": "No",
      "Text_type": "In Vitro Study",
      "Author_perspective": "The article comments on the distinct roles of amino acids W354 and W217 in OCT1 transport and substrate specificity, emphasizing their importance in the function and interaction of OCT1 with various substrates. However, it does not provide specific opinions on the effect of morphine or other drugs on human subjects.",
      "Adverse_event": "No AE",
      "Abstract": "Hepatic organic cation transporter 1 (OCT1, SLC22A1) has a broad spectrum of structurally diverse substrates, including drugs like morphine, metformin, sumatriptan, and fenoterol. Here, we leveraged existing cryo-EM data to identify amino acids that constrain the binding pocket toward the intracellular lumen and performed functional analyses to determine their roles in OCT1 transport, in general, and in substrate specificity, in particular. We mutated W217, W354, and I446 and analyzed their effects on the transport of 27 structurally highly diverse substrates in HEK293 cells. The W354A mutant resulted in a complete loss of function for all tested substrates, whereas only the W354Y mutant partially retained OCT1 activity. Molecular dynamics simulations and functional analyses suggest that W354 affects OCT1 transport by forming a hydrogen bond with N453 in transmembrane helix 10, thereby stabilizing OCT1 in its outward open conformation. W217A showed strongly substrate-dependent effects, with the aromatic ring of tryptophan being the key property affecting transport. Smaller, less lipophilic substrates were more strongly affected. The substrate-specific effects of the W217A mutant correlated significantly with those of the F244A mutant. The double mutant W217A/F244A strongly reduced uptake of all tested substrates, indicating a compensatory mechanism between these two amino acids. I446 showed only marginal effects on OCT1 transport. Our data suggest that W354 is crucial for OCT1 function by mediating the switch from an inward- occluded to inward-open conformation but is not directly involved in substrate interaction. In contrast, W217, along with the previously known F244, contributes to the substrate specificity of OCT1.",
      "Title": "The divergent roles of tryptophans W354 and W217 in OCT1 transport: similar localization, distinct functions.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-16 05:37:05",
      "Vancouver_citation": "Römer S, Ebel L, Neumann A, Rönnpagel V, Schulig L, Meyer-Tönnies MJ, Tzvetkov MV. The divergent roles of tryptophans W354 and W217 in OCT1 transport: similar localization, distinct functions. J Biol Chem. 2025;111051",
      "pubdate": "2025-12-15",
      "Lead_author": "Römer S",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study are HEK293 cells, which are human embryonic kidney cells. These cells were used to analyze the transport of various substrates, including the drug of study, morphine, through the OCT1 transporter.",
      "AOI_drug_effect": "No Drug Effect. The study does not investigate any medical event or adverse event caused by the drug of study. Instead, it focuses on the transport mechanism and substrate specificity of OCT1, which includes morphine as one of the substrates.",
      "Approved_indication": "The drug of study, morphine, is conventionally used as an opioid analgesic for the treatment of moderate to severe pain. It is typically administered orally, intravenously, or via other routes depending on the clinical scenario. In this study, morphine was not administered to patients but was used as a substrate in functional analyses involving HEK293 cells to study OCT1 transport mechanisms.",
      "AOI_classification": "No",
      "Justification": "The study does not link the drug of study to any negative or adverse effects. It focuses on the transport properties of OCT1 and the role of specific amino acids in substrate specificity, including morphine.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.1016/j.jbc.2025.111051",
    "specialCase": "No",
    "countryOfFirstAuthor": "Germany",
    "countryOfOccurrence": "Germany",
    "patientDetails": "No human subject",
    "keyEvents": "Key events: No human subject",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: No human subject",
    "drugEffect": "Drug effect: no data",
    "summary": "The article investigates the roles of specific amino acids in the hepatic organic cation transporter 1 (OCT1), which is responsible for transporting various structurally diverse substrates, including drugs such as morphine, metformin, sumatriptan, and fenoterol. The study utilized cryo-EM data and functional analyses to explore the effects of mutations in amino acids W217, W354, and I446 on OCT1 transport in HEK293 cells. The W354A mutation resulted in a complete loss of function for all tested substrates, while the W354Y mutation retained partial OCT1 activity. Molecular dynamics simulations revealed that W354 stabilizes OCT1 in its outward open conformation by forming a hydrogen bond with N453. On the other hand, W217A showed substrate-dependent effects, with smaller and less lipophilic substrates being more strongly affected. The study also identified a compensatory mechanism between W217 and F244, as the double mutant W217A/F244A significantly reduced uptake of all tested substrates. I446 mutations had only marginal effects on OCT1 transport. The findings highlight the distinct roles of W354 and W217 in OCT1 function and substrate specificity, with W354 being crucial for conformational changes and W217 contributing to substrate interaction. While morphine is mentioned as one of the substrates transported by OCT1, the study does not provide specific data on its transport or adverse effects related to morphine.",
    "identifiableHumanSubject": "No",
    "textType": "In Vitro Study",
    "authorPerspective": "The article comments on the distinct roles of amino acids W354 and W217 in OCT1 transport and substrate specificity, emphasizing their importance in the function and interaction of OCT1 with various substrates. However, it does not provide specific opinions on the effect of morphine or other drugs on human subjects.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Römer S, Ebel L, Neumann A, Rönnpagel V, Schulig L, Meyer-Tönnies MJ, Tzvetkov MV. The divergent roles of tryptophans W354 and W217 in OCT1 transport: similar localization, distinct functions. J Biol Chem. 2025;111051",
    "leadAuthor": "Römer S",
    "serious": "No",
    "testSubject": "The test subjects involved in this study are HEK293 cells, which are human embryonic kidney cells. These cells were used to analyze the transport of various substrates, including the drug of study, morphine, through the OCT1 transporter.",
    "aoiDrugEffect": "No Drug Effect. The study does not investigate any medical event or adverse event caused by the drug of study. Instead, it focuses on the transport mechanism and substrate specificity of OCT1, which includes morphine as one of the substrates.",
    "approvedIndication": "The drug of study, morphine, is conventionally used as an opioid analgesic for the treatment of moderate to severe pain. It is typically administered orally, intravenously, or via other routes depending on the clinical scenario. In this study, morphine was not administered to patients but was used as a substrate in functional analyses involving HEK293 cells to study OCT1 transport mechanisms.",
    "aoiClassification": "No",
    "justification": "Special Situations",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "AOI",
    "effectiveClassification": "AOI",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-17T20:21:04.157Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Auto approved QC",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUj3CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj3CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f92-ab287c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1766002864
  },
  {
    "id": "bc02bb51-2f8f-4549-8f43-17975e625329",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41391529",
    "title": "Primates as animal models for CPP research.",
    "authors": [
      "Correia MBM",
      "Monferrari-Martins B",
      "Barros M",
      "Maior RS"
    ],
    "journal": "Neurosci Biobehav Rev",
    "publicationDate": "2025-12-15",
    "abstract": "The article discusses the use of nonhuman primates (NHPs) as models for conditioned place preference (CPP) research, a method used to evaluate the rewarding effects of drug and non-drug stimuli. The review highlights the neurophysiological differences between rodents and humans, emphasizing the limitations of rodent models and the ethical challenges of human research. Over the past 25 years, CPP protocols have been applied to NHPs, specifically macaques and marmosets, with 14 studies meeting the inclusion criteria. The findings demonstrate that CPP effects were consistently observed with cocaine, methylphenidate, and palatable food in marmosets, and with morphine and methamphetamine in macaques. The article suggests that NHPs offer greater translational validity compared to rodent models due to their closer neurobiological and behavioral similarities to humans. However, the article does not provide specific details about human subjects, drug administration, or adverse events, as the focus is on animal models.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:07:07.902Z",
    "updatedAt": "2025-12-17T19:21:30.792Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41391529",
      "DOI": "https://doi.org/10.1016/j.neubiorev.2025.106522",
      "special_case": "No",
      "Country_of_first_author": "Brazil",
      "Country_of_occurrence": "Brazil",
      "Patient_details": "No human subject",
      "Key_events": "No human subject",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: no human subject",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The article discusses the use of nonhuman primates (NHPs) as models for conditioned place preference (CPP) research, a method used to evaluate the rewarding effects of drug and non-drug stimuli. The review highlights the neurophysiological differences between rodents and humans, emphasizing the limitations of rodent models and the ethical challenges of human research. Over the past 25 years, CPP protocols have been applied to NHPs, specifically macaques and marmosets, with 14 studies meeting the inclusion criteria. The findings demonstrate that CPP effects were consistently observed with cocaine, methylphenidate, and palatable food in marmosets, and with morphine and methamphetamine in macaques. The article suggests that NHPs offer greater translational validity compared to rodent models due to their closer neurobiological and behavioral similarities to humans. However, the article does not provide specific details about human subjects, drug administration, or adverse events, as the focus is on animal models.",
      "Identifiable_human_subject": "No",
      "Text_type": "Review Article",
      "Author_perspective": "The article comments positively on the use of nonhuman primates as viable and versatile models for CPP research, emphasizing their greater translational validity compared to rodent models due to their neurobiological and behavioral similarities to humans.",
      "Adverse_event": "No AE",
      "Abstract": "Conditioned place preference (CPP) is a widely used method to assess the rewarding effects of drug and non-drug stimuli. This paradigm has been successfully demonstrated across several species, although rats seem to be the most prevalent model. Given the significant neurophysiological discrepancies between rodents and humans, as well as the technical and ethical limitations of research involving the latter, CPP protocols employing nonhuman primates (NHPs) have been reported in the past 25 years. In this review, we examined the literature on CPP studies using NHPs, including a variety of unconditioned stimuli. A total of 14 studies, involving macaques or marmosets, met the inclusion criteria. Overall, findings indicate that CPP effects were consistently achieved using cocaine, methylphenidate (MPH), and highly palatable food in marmosets, as well as with morphine and methamphetamine (METH) in macaques. Despite the relatively low number of reports, the available evidence suggests that NHP species represent viable and versatile alternatives for CPP research, offering greater translational validity compared to rodent models due to their closer neurobiological, cognitive, and behavioral similarities to humans.",
      "Title": "Primates as animal models for CPP research.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-16 05:36:50",
      "Vancouver_citation": "Correia MBM, Monferrari-Martins B, Barros M, Maior RS. Primates as animal models for CPP research. Neurosci Biobehav Rev. 2025;106522",
      "pubdate": "2025-12-15",
      "Lead_author": "Correia MBM",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, the drug of study was used to assess its rewarding effects in nonhuman primates, which qualifies as off-label use.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The drug of study was used in a non-conventional way to assess its rewarding effects in nonhuman primates.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.1016/j.neubiorev.2025.106522",
    "specialCase": "No",
    "countryOfFirstAuthor": "Brazil",
    "countryOfOccurrence": "Brazil",
    "patientDetails": "No human subject",
    "keyEvents": "No human subject",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: no human subject",
    "drugEffect": "Drug effect: no data",
    "summary": "The article discusses the use of nonhuman primates (NHPs) as models for conditioned place preference (CPP) research, a method used to evaluate the rewarding effects of drug and non-drug stimuli. The review highlights the neurophysiological differences between rodents and humans, emphasizing the limitations of rodent models and the ethical challenges of human research. Over the past 25 years, CPP protocols have been applied to NHPs, specifically macaques and marmosets, with 14 studies meeting the inclusion criteria. The findings demonstrate that CPP effects were consistently observed with cocaine, methylphenidate, and palatable food in marmosets, and with morphine and methamphetamine in macaques. The article suggests that NHPs offer greater translational validity compared to rodent models due to their closer neurobiological and behavioral similarities to humans. However, the article does not provide specific details about human subjects, drug administration, or adverse events, as the focus is on animal models.",
    "identifiableHumanSubject": "No",
    "textType": "Review Article",
    "authorPerspective": "The article comments positively on the use of nonhuman primates as viable and versatile models for CPP research, emphasizing their greater translational validity compared to rodent models due to their neurobiological and behavioral similarities to humans.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Correia MBM, Monferrari-Martins B, Barros M, Maior RS. Primates as animal models for CPP research. Neurosci Biobehav Rev. 2025;106522",
    "leadAuthor": "Correia MBM",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, the drug of study was used to assess its rewarding effects in nonhuman primates, which qualifies as off-label use.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The drug of study was used in a non-conventional way to assess its rewarding effects in nonhuman primates.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUj4CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj4CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-5942e80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999290
  },
  {
    "id": "48e0a17e-4fd3-49d6-8b1e-10888a764e68",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41387636",
    "title": "Efficacy of Ultrasound-Guided PENG Block for Acute Pain Relief in Adult Hip Fracture Patients: A Double-Blind Randomized Trial.",
    "authors": [
      "Vijayan B",
      "Ayyan SM",
      "Palaniappan P",
      "Pudhiyasamy PR",
      "Ramesh S",
      "Muthanikkatt AM"
    ],
    "journal": "Acad Emerg Med",
    "publicationDate": "2025-12-13",
    "abstract": "The study evaluated the efficacy and safety of ultrasound-guided pericapsular nerve group (PENG) block for pain management in adult patients with hip fractures in an emergency department setting. Patients were randomized to receive either the PENG block with bupivacaine or a sham procedure, alongside standard intravenous analgesia. Pain scores were significantly lower in the PENG block group at multiple time intervals, and the requirement for rescue analgesia in morphine equivalents was also reduced. No significant adverse events were reported, including hematoma, quadriceps weakness, local anesthetic systemic toxicity (LAST), or opioid-related adverse events. The study concluded that the PENG block is an effective and opioid-sparing analgesic strategy for acute hip fractures in the emergency department. Morphine was used as rescue analgesia, but no adverse effects were attributed to its use. The study highlights the potential of the PENG block to reduce opioid dependency and improve pain management outcomes in hip fracture patients.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:07:07.943Z",
    "updatedAt": "2025-12-17T19:21:30.223Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41387636",
      "DOI": "https://doi.org/10.1111/acem.70206",
      "special_case": "No",
      "Country_of_first_author": "India",
      "Country_of_occurrence": "India",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: Adult patients with traumatic hip fractures and pain scores >4 on the Numerical Rating Scale were randomized to receive either ultrasound-guided PENG block with bupivacaine or a sham procedure. Both groups were administered standard intravenous analgesia. The study aimed to evaluate pain relief over 3 hours and the need for rescue analgesia. No significant adverse events were reported during the study.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: bupivacaine, morphine",
      "Attributability": "Attributability: No adverse events were attributed to the PENG block or morphine administration. The study reported no significant adverse events such as hematoma, quadriceps weakness, local anesthetic systemic toxicity (LAST), or opioid-related adverse events.",
      "Drug_effect": "Drug effect: summary: The PENG block significantly reduced pain scores and opioid requirements compared to the sham procedure. Pain relief was observed at 30 minutes, 60 minutes, and 120 minutes post-procedure. No adverse events were reported.",
      "Summary": "The study evaluated the efficacy and safety of ultrasound-guided pericapsular nerve group (PENG) block for pain management in adult patients with hip fractures in an emergency department setting. Patients were randomized to receive either the PENG block with bupivacaine or a sham procedure, alongside standard intravenous analgesia. Pain scores were significantly lower in the PENG block group at multiple time intervals, and the requirement for rescue analgesia in morphine equivalents was also reduced. No significant adverse events were reported, including hematoma, quadriceps weakness, local anesthetic systemic toxicity (LAST), or opioid-related adverse events. The study concluded that the PENG block is an effective and opioid-sparing analgesic strategy for acute hip fractures in the emergency department. Morphine was used as rescue analgesia, but no adverse effects were attributed to its use. The study highlights the potential of the PENG block to reduce opioid dependency and improve pain management outcomes in hip fracture patients.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article comments positively on the efficacy of the PENG block in reducing pain scores and opioid requirements in hip fracture patients. It highlights the absence of significant adverse events and suggests that the PENG block is an effective, opioid-sparing analgesic strategy for acute pain management in the emergency department.",
      "Adverse_event": "No AE",
      "Abstract": "We evaluated the efficacy and safety of ultrasound-guided pericapsular nerve group (PENG) block for initial pain management in adult emergency department (ED) patients with hip fractures.\n\nThis prospective, randomized, double-blinded, controlled trial was conducted at a tertiary care academic ED. Adult patients (≥ 18 years) with traumatic hip fractures and Numerical Rating Scale (NRS) pain scores > 4 were randomized to ultrasound-guided PENG block with bupivacaine or sham procedure. Both groups received standard intravenous analgesia. The primary outcome was the difference in NRS scores over 3 h. Secondary outcomes included total rescue analgesia (morphine equivalents) and adverse events.\n\nOf 167 screened, 80 patients were enrolled (40 per group). Pain scores were significantly lower in the PENG block group at 30 min (mean difference [MD] -3.2; 95% confidence interval [CI]-4.2 to -2.2), 60 min (MD -3.1; 95% CI -4.1 to -2.1), and 120 min (MD -2.0; 95% CI -2.6, -1.4), compared with sham. Total rescue analgesia was significantly lower in the PENG block group (MD -4.6 mg morphine equivalents; 95% CI -6.2 to -3.1). No significant adverse events were reported, such as hematoma, quadriceps weakness, signs of local anesthetic systemic toxicity (LAST), or significant opioid-related adverse events.\n\nIn adult ED patients with hip fractures, ultrasound-guided PENG block significantly reduced pain scores and opioid requirements compared with sham, with no significant adverse events reported. PENG block may be an effective, opioid-sparing analgesic strategy for acute hip fractures in the ED.\n\nClinical Trial Registry-India: CTRI/2023/08/056595.",
      "Title": "Efficacy of Ultrasound-Guided PENG Block for Acute Pain Relief in Adult Hip Fracture Patients: A Double-Blind Randomized Trial.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-16 05:36:34",
      "Vancouver_citation": "Vijayan B, Ayyan SM, Palaniappan P, Pudhiyasamy PR, Ramesh S, Muthanikkatt AM. Efficacy of Ultrasound-Guided PENG Block for Acute Pain Relief in Adult Hip Fracture Patients: A Double-Blind Randomized Trial. Acad Emerg Med. 2025;",
      "pubdate": "2025-12-13",
      "Lead_author": "Vijayan B",
      "Serious": "No",
      "Test_subject": "The test subjects in this study were adult patients (≥18 years) with traumatic hip fractures and Numerical Rating Scale (NRS) pain scores >4. A total of 80 patients were enrolled in the study.",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Morphine, is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, Morphine was administered as part of standard intravenous analgesia and as rescue analgesia in the form of morphine equivalents. It was used to manage pain in adult patients with hip fractures, which aligns with its conventional use for severe pain. Therefore, this does not qualify as off-label use.",
      "AOI_classification": "No",
      "Justification": "The study does not link Morphine to any adverse effects or negative outcomes. It mentions no significant opioid-related adverse events.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.1111/acem.70206",
    "specialCase": "No",
    "countryOfFirstAuthor": "India",
    "countryOfOccurrence": "India",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: Adult patients with traumatic hip fractures and pain scores >4 on the Numerical Rating Scale were randomized to receive either ultrasound-guided PENG block with bupivacaine or a sham procedure. Both groups were administered standard intravenous analgesia. The study aimed to evaluate pain relief over 3 hours and the need for rescue analgesia. No significant adverse events were reported during the study.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: bupivacaine",
      "morphine"
    ],
    "attributability": "Attributability: No adverse events were attributed to the PENG block or morphine administration. The study reported no significant adverse events such as hematoma, quadriceps weakness, local anesthetic systemic toxicity (LAST), or opioid-related adverse events.",
    "drugEffect": "Drug effect: summary: The PENG block significantly reduced pain scores and opioid requirements compared to the sham procedure. Pain relief was observed at 30 minutes, 60 minutes, and 120 minutes post-procedure. No adverse events were reported.",
    "summary": "The study evaluated the efficacy and safety of ultrasound-guided pericapsular nerve group (PENG) block for pain management in adult patients with hip fractures in an emergency department setting. Patients were randomized to receive either the PENG block with bupivacaine or a sham procedure, alongside standard intravenous analgesia. Pain scores were significantly lower in the PENG block group at multiple time intervals, and the requirement for rescue analgesia in morphine equivalents was also reduced. No significant adverse events were reported, including hematoma, quadriceps weakness, local anesthetic systemic toxicity (LAST), or opioid-related adverse events. The study concluded that the PENG block is an effective and opioid-sparing analgesic strategy for acute hip fractures in the emergency department. Morphine was used as rescue analgesia, but no adverse effects were attributed to its use. The study highlights the potential of the PENG block to reduce opioid dependency and improve pain management outcomes in hip fracture patients.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article comments positively on the efficacy of the PENG block in reducing pain scores and opioid requirements in hip fracture patients. It highlights the absence of significant adverse events and suggests that the PENG block is an effective, opioid-sparing analgesic strategy for acute pain management in the emergency department.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Vijayan B, Ayyan SM, Palaniappan P, Pudhiyasamy PR, Ramesh S, Muthanikkatt AM. Efficacy of Ultrasound-Guided PENG Block for Acute Pain Relief in Adult Hip Fracture Patients: A Double-Blind Randomized Trial. Acad Emerg Med. 2025;",
    "leadAuthor": "Vijayan B",
    "serious": "No",
    "testSubject": "The test subjects in this study were adult patients (≥18 years) with traumatic hip fractures and Numerical Rating Scale (NRS) pain scores >4. A total of 80 patients were enrolled in the study.",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Morphine, is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, Morphine was administered as part of standard intravenous analgesia and as rescue analgesia in the form of morphine equivalents. It was used to manage pain in adult patients with hip fractures, which aligns with its conventional use for severe pain. Therefore, this does not qualify as off-label use.",
    "aoiClassification": "No",
    "justification": "The study does not link Morphine to any adverse effects or negative outcomes. It mentions no significant opioid-related adverse events.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUj5CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj5CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-58ec740501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999290
  },
  {
    "id": "fb8d6e32-0110-4b76-99c2-d37c437bca17",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41385742",
    "title": "Trace determination of morphine and codeine in whole blood samples using pH-switchable hydrophobic deep eutectic solvents based liquid phase microextraction followed by HPLC-UV.",
    "authors": [
      "Ameen F"
    ],
    "journal": "J Sep Sci",
    "publicationDate": "2025-12-12",
    "abstract": "The study focused on the development of an environmentally friendly and efficient method for the extraction and analysis of morphine and codeine in whole blood samples. Using pH-switchable hydrophobic deep eutectic solvents combined with HPLC-UV detection, the researchers synthesized seven solvents and investigated their pH-switchability. The method demonstrated high precision and accuracy, with relative standard deviation values for intra-day and inter-day measurements ranging from 3.7-4.3% and 5.4-6.2%, respectively. Calibration graphs were linear within the range of 1.5-300 μg L<sup>-1</sup>, and the limit of detection for both morphine and codeine was 0.5 μg L<sup>-1</sup>. The enrichment factor and extraction recovery for morphine and codeine were 152-166 and 76-83%, respectively. Morphine and codeine were successfully detected in the blood sample of an addicted person, and relative recoveries of spiked blood samples ranged from 91.8-107.0%. While the study highlights the effectiveness of the method in detecting these drugs, no specific adverse events, medical complications, or therapeutic effects related to morphine were discussed. The study does not provide detailed information about the human subject or any adverse effects associated with the drugs.",
    "drugName": "MORPHINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:07:07.973Z",
    "updatedAt": "2025-12-17T19:21:30.838Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41385742",
      "DOI": "https://doi.org/10.1002/jssc.202300336",
      "special_case": "No",
      "Country_of_first_author": "Saudi Arabia",
      "Country_of_occurrence": "Saudi Arabia",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: The study involved the detection of morphine and codeine in whole blood samples using a novel pH-switchable hydrophobic deep eutectic solvent-based liquid phase microextraction method combined with HPLC-UV detection. The blood sample of an addicted person was analyzed, and morphine and codeine were detected. No further specific details about the patient or event are provided.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: no data",
      "Attributability": "Attributability: The study detected morphine and codeine in the blood sample of an addicted person, but no specific adverse events or medical complications were attributed to these drugs.",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The study focused on the development of an environmentally friendly and efficient method for the extraction and analysis of morphine and codeine in whole blood samples. Using pH-switchable hydrophobic deep eutectic solvents combined with HPLC-UV detection, the researchers synthesized seven solvents and investigated their pH-switchability. The method demonstrated high precision and accuracy, with relative standard deviation values for intra-day and inter-day measurements ranging from 3.7-4.3% and 5.4-6.2%, respectively. Calibration graphs were linear within the range of 1.5-300 μg L<sup>-1</sup>, and the limit of detection for both morphine and codeine was 0.5 μg L<sup>-1</sup>. The enrichment factor and extraction recovery for morphine and codeine were 152-166 and 76-83%, respectively. Morphine and codeine were successfully detected in the blood sample of an addicted person, and relative recoveries of spiked blood samples ranged from 91.8-107.0%. While the study highlights the effectiveness of the method in detecting these drugs, no specific adverse events, medical complications, or therapeutic effects related to morphine were discussed. The study does not provide detailed information about the human subject or any adverse effects associated with the drugs.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article does not provide any specific opinion on the effect of morphine or codeine on the subjects of the study. It focuses on the methodology and results of the detection process rather than commenting on the drug's effects.",
      "Adverse_event": "No AE",
      "Abstract": "An environmental friendly, fast, easy and inexpensive pH-switchable hydrophobic deep eutectic solvent-based liquid phase microextraction procedure was developed and combined with HPLC-UV detection for the extraction and analysis of morphine and codeine in whole blood samples. In this method, seven deep eutectic solvents were synthesized and then their switchability with pH was investigated. Deep eutectic solvents that could be switched with pH were used as extractant. Under the optimum conditions, relative standard deviation values for intra-day and inter-day of the method based on seven replicate measurements of 50 μg L<sup>-1</sup> of morphine and codeine in blood samples were in the range of 3.7-4.3% and 5.4-6.2%, respectively. The calibration graphs were linear in the range of 1.5-300 μg L<sup>-1</sup> and limit of detection for both analytes was 0.5 μg L<sup>-1</sup>. The enrichment factor and the extraction recovery of morphine and codeine were in the ranges of 152-166, and 76-83%, respectively. The results showed that both morphine and codeine were detected in the blood sample of the addicted person. The relative recoveries of real blood samples which have been spiked with different levels of morphine and codeine were 91.8-107.0%. This article is protected by copyright. All rights reserved.",
      "Title": "Trace determination of morphine and codeine in whole blood samples using pH-switchable hydrophobic deep eutectic solvents based liquid phase microextraction followed by HPLC-UV.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "MORPHINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-16 05:36:17",
      "Vancouver_citation": "Ameen F. Trace determination of morphine and codeine in whole blood samples using pH-switchable hydrophobic deep eutectic solvents based liquid phase microextraction followed by HPLC-UV. J Sep Sci. 2025;e2300336",
      "pubdate": "2025-12-12",
      "Lead_author": "Ameen F",
      "Serious": "No",
      "Test_subject": "The test subject involved in this study is a blood sample obtained from an addicted person. The study focuses on the detection and analysis of morphine and codeine in this blood sample.",
      "AOI_drug_effect": "The drug of study, morphine, was detected in the blood sample of the addicted person. However, the study does not investigate any medical event or adverse effect induced by the drug. The focus is on the analytical method for detection rather than the drug's impact. No Drug Effect.",
      "Approved_indication": "Morphine is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, morphine was not administered to treat any illness but was detected in the blood sample of an addicted person. This qualifies as off-label use since the drug was not used within its accepted scope of treatment.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study involves the detection of morphine in the blood sample of an addicted person, which qualifies as non-conventional use.",
      "Client_name": "Demo",
      "Drugname": "MORPHINE"
    },
    "doi": "https://doi.org/10.1002/jssc.202300336",
    "specialCase": "No",
    "countryOfFirstAuthor": "Saudi Arabia",
    "countryOfOccurrence": "Saudi Arabia",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: The study involved the detection of morphine and codeine in whole blood samples using a novel pH-switchable hydrophobic deep eutectic solvent-based liquid phase microextraction method combined with HPLC-UV detection. The blood sample of an addicted person was analyzed, and morphine and codeine were detected. No further specific details about the patient or event are provided.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: no data"
    ],
    "attributability": "Attributability: The study detected morphine and codeine in the blood sample of an addicted person, but no specific adverse events or medical complications were attributed to these drugs.",
    "drugEffect": "Drug effect: no data",
    "summary": "The study focused on the development of an environmentally friendly and efficient method for the extraction and analysis of morphine and codeine in whole blood samples. Using pH-switchable hydrophobic deep eutectic solvents combined with HPLC-UV detection, the researchers synthesized seven solvents and investigated their pH-switchability. The method demonstrated high precision and accuracy, with relative standard deviation values for intra-day and inter-day measurements ranging from 3.7-4.3% and 5.4-6.2%, respectively. Calibration graphs were linear within the range of 1.5-300 μg L<sup>-1</sup>, and the limit of detection for both morphine and codeine was 0.5 μg L<sup>-1</sup>. The enrichment factor and extraction recovery for morphine and codeine were 152-166 and 76-83%, respectively. Morphine and codeine were successfully detected in the blood sample of an addicted person, and relative recoveries of spiked blood samples ranged from 91.8-107.0%. While the study highlights the effectiveness of the method in detecting these drugs, no specific adverse events, medical complications, or therapeutic effects related to morphine were discussed. The study does not provide detailed information about the human subject or any adverse effects associated with the drugs.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article does not provide any specific opinion on the effect of morphine or codeine on the subjects of the study. It focuses on the methodology and results of the detection process rather than commenting on the drug's effects.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "MORPHINE",
    "vancouverCitation": "Ameen F. Trace determination of morphine and codeine in whole blood samples using pH-switchable hydrophobic deep eutectic solvents based liquid phase microextraction followed by HPLC-UV. J Sep Sci. 2025;e2300336",
    "leadAuthor": "Ameen F",
    "serious": "No",
    "testSubject": "The test subject involved in this study is a blood sample obtained from an addicted person. The study focuses on the detection and analysis of morphine and codeine in this blood sample.",
    "aoiDrugEffect": "The drug of study, morphine, was detected in the blood sample of the addicted person. However, the study does not investigate any medical event or adverse effect induced by the drug. The focus is on the analytical method for detection rather than the drug's impact. No Drug Effect.",
    "approvedIndication": "Morphine is conventionally used for the treatment of severe pain, pain associated with myocardial infarction, and insomnia produced by intense pain. In this study, morphine was not administered to treat any illness but was detected in the blood sample of an addicted person. This qualifies as off-label use since the drug was not used within its accepted scope of treatment.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The study involves the detection of morphine in the blood sample of an addicted person, which qualifies as non-conventional use.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": "user_98c52d20-9492-478b-838b-42902ee87dc2",
    "lockedAt": "2025-12-17T17:24:10.728Z",
    "_rid": "Vf9WAOX6zUj6CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj6CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-5949fc0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999290
  },
  {
    "id": "6a949941-eacf-499a-b898-3c2880ba5cb1",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39846496",
    "title": "Effect of antipsychotics on the focal adhesion pathway.",
    "authors": [
      "Panizzutti B",
      "Bortolasci CC",
      "Spolding B",
      "Kidnapillai S",
      "Connor T",
      "Truong TT",
      "Liu ZS",
      "Hernández D",
      "Gray L",
      "Kim JH",
      "Dean OM",
      "Berk M",
      "Walder K"
    ],
    "journal": "World J Biol Psychiatry",
    "publicationDate": "2025-01-23",
    "abstract": "This study investigated the impact of antipsychotic drugs, including clozapine, on the focal adhesion pathway using NT2-N neuron-like cells. The research aimed to address the interaction between pharmacological treatments for bipolar disorder and schizophrenia and the expression of genes involved in the focal adhesion pathway. The study exposed NT2-N cells to amisulpride, aripiprazole, chlorpromazine, clozapine, haloperidol, olanzapine, quetiapine, risperidone, or a vehicle for 24 hours. Genome-wide mRNA expression analysis revealed that seven out of eight drugs, including clozapine, downregulated the expression of genes associated with the focal adhesion pathway. Focal adhesion was identified as the pathway with the most negative normalized enrichment score across all treatments. The findings suggest that focal adhesion pathways may play a role in the pathophysiology of bipolar disorder and schizophrenia. Furthermore, the study highlights the importance of distinguishing medication effects from disease mechanisms in psychiatric research, particularly given the medicated state of most study participants. While the study provides valuable insights into the molecular effects of antipsychotic drugs, it does not involve human subjects or report adverse events.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:07:58.243Z",
    "updatedAt": "2025-12-17T19:21:30.948Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39846496",
      "DOI": "https://doi.org/10.1080/15622975.2025.2453181",
      "special_case": "No",
      "Country_of_first_author": "Australia",
      "Country_of_occurrence": "Australia",
      "Patient_details": "No human subject",
      "Key_events": "No human subject",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: amisulpride, aripiprazole, chlorpromazine, clozapine, haloperidol, olanzapine, quetiapine, risperidone",
      "Attributability": "Attributability: No human subject involved, no events attributable to specific medication or therapy",
      "Drug_effect": "Drug effect: summary: Seven out of eight drugs downregulated the expression of genes associated with the focal adhesion pathway.",
      "Summary": "This study investigated the impact of antipsychotic drugs, including clozapine, on the focal adhesion pathway using NT2-N neuron-like cells. The research aimed to address the interaction between pharmacological treatments for bipolar disorder and schizophrenia and the expression of genes involved in the focal adhesion pathway. The study exposed NT2-N cells to amisulpride, aripiprazole, chlorpromazine, clozapine, haloperidol, olanzapine, quetiapine, risperidone, or a vehicle for 24 hours. Genome-wide mRNA expression analysis revealed that seven out of eight drugs, including clozapine, downregulated the expression of genes associated with the focal adhesion pathway. Focal adhesion was identified as the pathway with the most negative normalized enrichment score across all treatments. The findings suggest that focal adhesion pathways may play a role in the pathophysiology of bipolar disorder and schizophrenia. Furthermore, the study highlights the importance of distinguishing medication effects from disease mechanisms in psychiatric research, particularly given the medicated state of most study participants. While the study provides valuable insights into the molecular effects of antipsychotic drugs, it does not involve human subjects or report adverse events.",
      "Identifiable_human_subject": "No",
      "Text_type": "In Vitro Study",
      "Author_perspective": "The article comments on the effect of antipsychotic drugs, including clozapine, on the focal adhesion pathway, noting that seven out of eight drugs downregulated gene expression associated with this pathway. It emphasizes the importance of differentiating medication effects from disease mechanisms in psychiatric research.",
      "Adverse_event": "No AE",
      "Abstract": "Focal adhesions and their dynamic nature are essential for various physiological processes, including the formation of neurites, synaptic function and plasticity. Alterations in these processes have been associated with schizophrenia and bipolar disorder.\n\nThis study aimed to explore the impact of pharmacological treatments used for bipolar disorder and schizophrenia on the expression of genes involved in the focal adhesion pathway, addressing a gap in understanding the interaction between medication effects and disease pathophysiology.\n\nNT2-N (neuron-like) cells were exposed to treatment with amisulpride, aripiprazole, chlorpromazine, clozapine, haloperidol, olanzapine, quetiapine, risperidone, or vehicle for 24 h. Genome-wide mRNA expression was analysed using gene set enrichment analysis.\n\nThe analysis revealed that seven out of the eight drugs widely prescribed for bipolar disorder and schizophrenia downregulate the expression of genes associated with the focal adhesions pathway. Focal adhesion was the pathway with the most negative normalised enrichment score across all treatments.\n\nOur results support the hypothesis that focal adhesion pathways may play a role in the pathophysiology of bipolar disorder and schizophrenia. Moreover, the data underscore the importance of differentiating medication effects from disease mechanisms in psychiatric research, a challenge compounded by the medicated state of most study participants.",
      "Title": "Effect of antipsychotics on the focal adhesion pathway.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-16 05:37:26",
      "Vancouver_citation": "Panizzutti B, Bortolasci CC, Spolding B, Kidnapillai S, Connor T, Truong TT, Liu ZS, Hernández D, Gray L, Kim JH, Dean OM, Berk M, Walder K. Effect of antipsychotics on the focal adhesion pathway. World J Biol Psychiatry. 2025;26(3):146-52",
      "pubdate": "2025-01-23",
      "Lead_author": "Panizzutti B",
      "Serious": "No",
      "Test_subject": "NT2-N (neuron-like) cells were used as the test subject in this study. These cells were exposed to various antipsychotic drugs, including the drug of study, Clozapine, for 24 hours.",
      "AOI_drug_effect": "The drug of study, Clozapine, along with other antipsychotics, was found to downregulate the expression of genes associated with the focal adhesion pathway in NT2-N cells. This indicates that the drug had an effect on the test subject, specifically altering gene expression related to focal adhesions.",
      "Approved_indication": "The drug of study, Clozapine, is conventionally used as an antipsychotic medication primarily for treatment-resistant schizophrenia. It is typically administered orally to patients with severe schizophrenia or schizoaffective disorder. In this study, Clozapine was administered to NT2-N cells in vitro to investigate its impact on gene expression related to the focal adhesion pathway, rather than to treat an illness.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study links the drug of study, Clozapine, to a negative effect on gene expression in the focal adhesion pathway, which may have implications for understanding its impact on disease mechanisms in schizophrenia and bipolar disorder.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1080/15622975.2025.2453181",
    "specialCase": "No",
    "countryOfFirstAuthor": "Australia",
    "countryOfOccurrence": "Australia",
    "patientDetails": "No human subject",
    "keyEvents": "No human subject",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: amisulpride",
      "aripiprazole",
      "chlorpromazine",
      "clozapine",
      "haloperidol",
      "olanzapine",
      "quetiapine",
      "risperidone"
    ],
    "attributability": "Attributability: No human subject involved, no events attributable to specific medication or therapy",
    "drugEffect": "Drug effect: summary: Seven out of eight drugs downregulated the expression of genes associated with the focal adhesion pathway.",
    "summary": "This study investigated the impact of antipsychotic drugs, including clozapine, on the focal adhesion pathway using NT2-N neuron-like cells. The research aimed to address the interaction between pharmacological treatments for bipolar disorder and schizophrenia and the expression of genes involved in the focal adhesion pathway. The study exposed NT2-N cells to amisulpride, aripiprazole, chlorpromazine, clozapine, haloperidol, olanzapine, quetiapine, risperidone, or a vehicle for 24 hours. Genome-wide mRNA expression analysis revealed that seven out of eight drugs, including clozapine, downregulated the expression of genes associated with the focal adhesion pathway. Focal adhesion was identified as the pathway with the most negative normalized enrichment score across all treatments. The findings suggest that focal adhesion pathways may play a role in the pathophysiology of bipolar disorder and schizophrenia. Furthermore, the study highlights the importance of distinguishing medication effects from disease mechanisms in psychiatric research, particularly given the medicated state of most study participants. While the study provides valuable insights into the molecular effects of antipsychotic drugs, it does not involve human subjects or report adverse events.",
    "identifiableHumanSubject": "No",
    "textType": "In Vitro Study",
    "authorPerspective": "The article comments on the effect of antipsychotic drugs, including clozapine, on the focal adhesion pathway, noting that seven out of eight drugs downregulated gene expression associated with this pathway. It emphasizes the importance of differentiating medication effects from disease mechanisms in psychiatric research.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Panizzutti B, Bortolasci CC, Spolding B, Kidnapillai S, Connor T, Truong TT, Liu ZS, Hernández D, Gray L, Kim JH, Dean OM, Berk M, Walder K. Effect of antipsychotics on the focal adhesion pathway. World J Biol Psychiatry. 2025;26(3):146-52",
    "leadAuthor": "Panizzutti B",
    "serious": "No",
    "testSubject": "NT2-N (neuron-like) cells were used as the test subject in this study. These cells were exposed to various antipsychotic drugs, including the drug of study, Clozapine, for 24 hours.",
    "aoiDrugEffect": "The drug of study, Clozapine, along with other antipsychotics, was found to downregulate the expression of genes associated with the focal adhesion pathway in NT2-N cells. This indicates that the drug had an effect on the test subject, specifically altering gene expression related to focal adhesions.",
    "approvedIndication": "The drug of study, Clozapine, is conventionally used as an antipsychotic medication primarily for treatment-resistant schizophrenia. It is typically administered orally to patients with severe schizophrenia or schizoaffective disorder. In this study, Clozapine was administered to NT2-N cells in vitro to investigate its impact on gene expression related to the focal adhesion pathway, rather than to treat an illness.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "The study links the drug of study, Clozapine, to a negative effect on gene expression in the focal adhesion pathway, which may have implications for understanding its impact on disease mechanisms in schizophrenia and bipolar disorder.",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUj7CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj7CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-595aa80501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999290
  },
  {
    "id": "c608bba3-d80c-438d-a775-e5244c5c92e3",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39837260",
    "title": "Letter to the editor concerning: Risk of agranulocytosis and neutropenia in patients with Parkinson's disease psychosis receiving clozapine treatment: A systematic review and meta-analysis. Limveeraprajak N, Makkapavee W, Likhitsathian S, Srisurapanont M. Possibly a greater risk?",
    "authors": [
      "Friedman JH"
    ],
    "journal": "Possibly a greater risk? Gen Hosp Psychiatry",
    "publicationDate": "2025-01-22",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "50c7705a-071d-4740-b7c8-a888eb916230",
        "userId": "user_bf28651c-0b97-4303-a5b5-250ec8bd1d28",
        "userName": "Test_Admin 01",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-17T17:23:11.377Z",
        "type": "system"
      },
      {
        "id": "953dda7c-134f-4e55-9541-40fa746cef80",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-17T17:52:50.105Z",
        "type": "QC_approval"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-16T00:07:58.284Z",
    "updatedAt": "2025-12-17T17:52:50.115Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39837260",
      "DOI": "https://doi.org10.1016/j.genhosppsych.2025.01.010",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-16 05:37:34",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Friedman JH. Letter to the editor concerning: Risk of agranulocytosis and neutropenia in patients with Parkinson's disease psychosis receiving clozapine treatment: A systematic review and meta-analysis. Limveeraprajak N, Makkapavee W, Likhitsathian S, Srisurapanont M. Possibly a greater risk? Gen Hosp Psychiatry. 2025;9380-1",
      "pubdate": "2025-01-22",
      "Lead_author": "Friedman JH",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1016/j.genhosppsych.2025.01.010",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Friedman JH. Letter to the editor concerning: Risk of agranulocytosis and neutropenia in patients with Parkinson's disease psychosis receiving clozapine treatment: A systematic review and meta-analysis. Limveeraprajak N, Makkapavee W, Likhitsathian S, Srisurapanont M. Possibly a greater risk? Gen Hosp Psychiatry. 2025;9380-1",
    "leadAuthor": "Friedman JH",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-17T17:52:50.104Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": "Listed",
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUj8CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj8CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f7d-f5e43c0501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765993970
  },
  {
    "id": "f0717615-3f88-4382-bdc5-3c93cdfe15e1",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "39547704",
    "title": "Early Treatment-Resistance in First Episode Psychosis.",
    "authors": [
      "Fernando P",
      "Strauss J",
      "Wagner E",
      "Löhrs L",
      "Campana M",
      "Falkai P",
      "Hasan A",
      "Papazova I"
    ],
    "journal": "Pharmacopsychiatry",
    "publicationDate": "2024-11-16",
    "abstract": "Article requires manual review",
    "drugName": "CLOZAPINE",
    "adverseEvent": "Article requires manual review",
    "status": "Under Triage Review",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [],
    "attachments": [],
    "createdAt": "2025-12-16T00:07:58.311Z",
    "updatedAt": "2025-12-17T19:21:30.903Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "39547704",
      "DOI": "https://doi.org10.1055/a-2421-2411",
      "Country_of_first_author": "Article requires manual review",
      "Client_name": "Demo",
      "Country_of_occurrence": "Article requires manual review",
      "Patient_details": "Article requires manual review",
      "Key_events": "Article requires manual review",
      "Relevant_dates": "Article requires manual review",
      "Administered_drugs": "Article requires manual review",
      "Attributability": "Article requires manual review",
      "Drug_effect": "Article requires manual review",
      "Summary": "Article requires manual review",
      "Identifiable_human_subject": "Article requires manual review",
      "Text_type": "Article requires manual review",
      "Author_perspective": "Article requires manual review",
      "Adverse_event": "Article requires manual review",
      "ICSR_classification": "Article requires manual review",
      "Test_subject": "Article requires manual review",
      "Approved_indication": "Article requires manual review",
      "Justification": "Article requires manual review",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "Article requires manual review",
      "Date_and_time": "2025-12-16 05:37:56",
      "Drugname": "CLOZAPINE",
      "Vancouver_citation": "Fernando P, Strauss J, Wagner E, Löhrs L, Campana M, Falkai P, Hasan A, Papazova I. Early Treatment-Resistance in First Episode Psychosis. Pharmacopsychiatry. 2025;58(2):63-70",
      "pubdate": "2024-11-16",
      "Lead_author": "Fernando P",
      "Confirmed_potential_ICSR": "P",
      "Serious": "Article requires manual review",
      "AOI_drug_effect": "Article requires manual review",
      "AOI_classification": "Article requires manual review"
    },
    "doi": "https://doi.org10.1055/a-2421-2411",
    "specialCase": null,
    "countryOfFirstAuthor": "Article requires manual review",
    "countryOfOccurrence": "Article requires manual review",
    "patientDetails": "Article requires manual review",
    "keyEvents": "Article requires manual review",
    "relevantDates": "Article requires manual review",
    "administeredDrugs": [
      "Article requires manual review"
    ],
    "attributability": "Article requires manual review",
    "drugEffect": "Article requires manual review",
    "summary": "Article requires manual review",
    "identifiableHumanSubject": "Article requires manual review",
    "textType": "Article requires manual review",
    "authorPerspective": "Article requires manual review",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Article requires manual review",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Fernando P, Strauss J, Wagner E, Löhrs L, Campana M, Falkai P, Hasan A, Papazova I. Early Treatment-Resistance in First Episode Psychosis. Pharmacopsychiatry. 2025;58(2):63-70",
    "leadAuthor": "Fernando P",
    "serious": "Article requires manual review",
    "testSubject": "Article requires manual review",
    "aoiDrugEffect": "Article requires manual review",
    "approvedIndication": "Article requires manual review",
    "aoiClassification": "Article requires manual review",
    "justification": "Article requires manual review",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": null,
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "manual_qc",
    "qaApprovedBy": null,
    "qaApprovedAt": null,
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "Selected for QC Triage",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUj9CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj9CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-5954180501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999290
  },
  {
    "id": "e21b3921-cff8-4b08-b3d1-0ab32e0f44d1",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41401723",
    "title": "Sodium benzoate treatment linked to increased glutathione levels and improved positive and negative symptoms, global function, and quality of life in patients with clozapine-resistant schizophrenia: secondary analysis of a randomized clinical trial.",
    "authors": [
      "Lin CH",
      "Lane HY"
    ],
    "journal": "Eur Neuropsychopharmacol",
    "publicationDate": "2025-12-17",
    "abstract": "This study focused on the effects of sodium benzoate as an adjunctive treatment for patients with clozapine-resistant schizophrenia (CRS). The secondary analysis utilized data from a double-blind trial involving 60 patients randomized to receive either sodium benzoate (n=40) or placebo (n=20) for six weeks. Plasma levels of glutathione (GSH), a crucial antioxidant often reduced in schizophrenia, were measured at baseline and endpoint. The findings revealed that sodium benzoate treatment was associated with increased GSH levels compared to placebo. Furthermore, among the 40 patients receiving sodium benzoate, changes in GSH levels were correlated with improvements in positive and negative symptoms, quality of life, and global function. In contrast, no such correlations were observed among placebo recipients. The study highlights the potential of sodium benzoate to enhance GSH levels and improve clinical and functional outcomes in CRS patients. While clozapine was mentioned as part of the patient profile, the study primarily focused on the adjunctive effects of sodium benzoate. No adverse events or complications were reported in relation to the treatment, and the study calls for longer-term research in other populations to further validate these findings.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "b4696717-ce9b-46fb-ac14-607861870fd9",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-17T20:20:47.264Z",
        "type": "system"
      },
      {
        "id": "b03e7554-255a-4849-947e-42b01b0d582f",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-17T20:21:14.875Z",
        "type": "QC_approval"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-17T18:12:50.158Z",
    "updatedAt": "2025-12-17T20:21:14.885Z",
    "createdBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41401723",
      "DOI": "https://doi.org/10.1016/j.euroneuro.2025.11.010",
      "special_case": "No",
      "Country_of_first_author": "Taiwan",
      "Country_of_occurrence": "Taiwan",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: The study involved 60 patients with clozapine-resistant schizophrenia (CRS) who were randomized to receive either sodium benzoate (n=40) or placebo (n=20) for six weeks. Clinical and functional assessments were conducted bi-weekly, and plasma levels of glutathione (GSH) were measured at baseline and endpoint.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Sodium benzoate, Clozapine",
      "Attributability": "Attributability: The study suggests that sodium benzoate treatment was associated with increased GSH levels and improvements in positive and negative symptoms, quality of life, and global function in patients with clozapine-resistant schizophrenia. No specific adverse events or complications were attributed to the treatment.",
      "Drug_effect": "Drug effect: summary: Sodium benzoate treatment was linked to increased GSH levels and correlated with improvements in positive and negative symptoms, quality of life, and global function in patients with clozapine-resistant schizophrenia.",
      "Summary": "This study focused on the effects of sodium benzoate as an adjunctive treatment for patients with clozapine-resistant schizophrenia (CRS). The secondary analysis utilized data from a double-blind trial involving 60 patients randomized to receive either sodium benzoate (n=40) or placebo (n=20) for six weeks. Plasma levels of glutathione (GSH), a crucial antioxidant often reduced in schizophrenia, were measured at baseline and endpoint. The findings revealed that sodium benzoate treatment was associated with increased GSH levels compared to placebo. Furthermore, among the 40 patients receiving sodium benzoate, changes in GSH levels were correlated with improvements in positive and negative symptoms, quality of life, and global function. In contrast, no such correlations were observed among placebo recipients. The study highlights the potential of sodium benzoate to enhance GSH levels and improve clinical and functional outcomes in CRS patients. While clozapine was mentioned as part of the patient profile, the study primarily focused on the adjunctive effects of sodium benzoate. No adverse events or complications were reported in relation to the treatment, and the study calls for longer-term research in other populations to further validate these findings.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Clinical Trial",
      "Author_perspective": "The article comments positively on the effect of sodium benzoate on subjects, noting its association with increased GSH levels and improvements in clinical and functional outcomes for patients with clozapine-resistant schizophrenia. It suggests the potential therapeutic efficacy of sodium benzoate and calls for further studies to confirm these findings.",
      "Adverse_event": "No AE",
      "Abstract": "Oxidative stress is implicated in schizophrenia. Glutathione (GSH), a crucial endogenous antioxidant, is usually reduced in individuals with schizophrenia. GSH and its precursor, N-acetyl cysteine, have demonstrated potential as adjunctive treatment for schizophrenia; however, their effectiveness appears inconsistent, possibly because of their limited ability to penetrate the blood-brain barrier (BBB). Administration of sodium benzoate, capable of crossing BBB, enhanced GSH capacity and antipsychotic-like activity in animals. Further, adjunctive benzoate therapy improved clinical and functional outcomes in patients with schizophrenia, including clozapine-resistant schizophrenia (CRS). Whether sodium benzoate can also boost GSH to exert its therapeutic efficacy for schizophrenia deserves elucidation. This secondary analysis used data from a double-blind trial, in which 60 patients with CRS were randomized to receive addon treatment of sodium benzoate (n = 40) or placebo (n = 20) for 6 weeks. Clinical and functional assessments were conducted bi-weekly. Plasma levels of GSH were assayed at baseline and endpoint. As a result, six-week treatment of sodium benzoate was linked to increased GSH levels than placebo. Among the 40 benzoate receivers, the changes in GSH levels were correlated with the improvements in positive symptoms, negative symptoms, quality of life, and global function. In comparison, among placebo recipients, GSH changes were not associated with any changes in clinical or functional variables. The findings suggest that benzoate treatment may be related with elevation in GSH levels in CRS patients and improvement in functional outcomes as well as positive and negative symptoms. Longer-term studies in other populations are necessary in the future.",
      "Title": "Sodium benzoate treatment linked to increased glutathione levels and improved positive and negative symptoms, global function, and quality of life in patients with clozapine-resistant schizophrenia: secondary analysis of a randomized clinical trial.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "No Case",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-17 23:39:14",
      "Vancouver_citation": "Lin CH, Lane HY. Sodium benzoate treatment linked to increased glutathione levels and improved positive and negative symptoms, global function, and quality of life in patients with clozapine-resistant schizophrenia: secondary analysis of a randomized clinical trial. Eur Neuropsychopharmacol. 2025;103112733",
      "pubdate": "2025-12-17",
      "Lead_author": "Lin CH",
      "Serious": "No",
      "Test_subject": "The test subjects involved in this study were 60 patients diagnosed with clozapine-resistant schizophrenia (CRS). These patients were randomized into two groups: one group received sodium benzoate as an addon treatment (n=40), and the other group received a placebo (n=20).",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, clozapine was administered to patients with clozapine-resistant schizophrenia (CRS), which aligns with its conventional use. There is no indication of off-label use or non-conventional administration of clozapine in this study.",
      "AOI_classification": "No",
      "Justification": "The study does not link clozapine to any adverse effects or negative outcomes within the subjects. It focuses on the effects of sodium benzoate as an addon treatment rather than clozapine itself.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1016/j.euroneuro.2025.11.010",
    "specialCase": "No",
    "countryOfFirstAuthor": "Taiwan",
    "countryOfOccurrence": "Taiwan",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: The study involved 60 patients with clozapine-resistant schizophrenia (CRS) who were randomized to receive either sodium benzoate (n=40) or placebo (n=20) for six weeks. Clinical and functional assessments were conducted bi-weekly, and plasma levels of glutathione (GSH) were measured at baseline and endpoint.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Sodium benzoate",
      "Clozapine"
    ],
    "attributability": "Attributability: The study suggests that sodium benzoate treatment was associated with increased GSH levels and improvements in positive and negative symptoms, quality of life, and global function in patients with clozapine-resistant schizophrenia. No specific adverse events or complications were attributed to the treatment.",
    "drugEffect": "Drug effect: summary: Sodium benzoate treatment was linked to increased GSH levels and correlated with improvements in positive and negative symptoms, quality of life, and global function in patients with clozapine-resistant schizophrenia.",
    "summary": "This study focused on the effects of sodium benzoate as an adjunctive treatment for patients with clozapine-resistant schizophrenia (CRS). The secondary analysis utilized data from a double-blind trial involving 60 patients randomized to receive either sodium benzoate (n=40) or placebo (n=20) for six weeks. Plasma levels of glutathione (GSH), a crucial antioxidant often reduced in schizophrenia, were measured at baseline and endpoint. The findings revealed that sodium benzoate treatment was associated with increased GSH levels compared to placebo. Furthermore, among the 40 patients receiving sodium benzoate, changes in GSH levels were correlated with improvements in positive and negative symptoms, quality of life, and global function. In contrast, no such correlations were observed among placebo recipients. The study highlights the potential of sodium benzoate to enhance GSH levels and improve clinical and functional outcomes in CRS patients. While clozapine was mentioned as part of the patient profile, the study primarily focused on the adjunctive effects of sodium benzoate. No adverse events or complications were reported in relation to the treatment, and the study calls for longer-term research in other populations to further validate these findings.",
    "identifiableHumanSubject": "Yes",
    "textType": "Clinical Trial",
    "authorPerspective": "The article comments positively on the effect of sodium benzoate on subjects, noting its association with increased GSH levels and improvements in clinical and functional outcomes for patients with clozapine-resistant schizophrenia. It suggests the potential therapeutic efficacy of sodium benzoate and calls for further studies to confirm these findings.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "No Case",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "Lin CH, Lane HY. Sodium benzoate treatment linked to increased glutathione levels and improved positive and negative symptoms, global function, and quality of life in patients with clozapine-resistant schizophrenia: secondary analysis of a randomized clinical trial. Eur Neuropsychopharmacol. 2025;103112733",
    "leadAuthor": "Lin CH",
    "serious": "No",
    "testSubject": "The test subjects involved in this study were 60 patients diagnosed with clozapine-resistant schizophrenia (CRS). These patients were randomized into two groups: one group received sodium benzoate as an addon treatment (n=40), and the other group received a placebo (n=20).",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, clozapine was administered to patients with clozapine-resistant schizophrenia (CRS), which aligns with its conventional use. There is no indication of off-label use or non-conventional administration of clozapine in this study.",
    "aoiClassification": "No",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-17T20:21:14.875Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUj+CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj+CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f92-b18c380501dc\"",
    "_attachments": "attachments/",
    "_ts": 1766002874
  },
  {
    "id": "5200ac3b-4985-4b7b-92ee-b78dbf841923",
    "organizationId": "94b7e106-1e86-4805-9725-5bdec4a4375f",
    "pmid": "41192073",
    "title": "Complete genome and comparative genomic analysis of cefpodoxime resistant Pantoea septica strain GABEPS69 isolated from saliva of a patient diagnosed with treatment resistant schizophrenia.",
    "authors": [
      "McDonagh F",
      "Kovarova A",
      "Tumeo A",
      "O'Connor A",
      "McEvoy N",
      "Lonappan AM",
      "Venkateswaran K",
      "Murray EK",
      "Hallahan B",
      "Miliotis G"
    ],
    "journal": "Int J Med Microbiol",
    "publicationDate": "2025-11-6",
    "abstract": "The study focuses on the complete genome sequencing and comparative genomic analysis of Pantoea septica strain GABEPS69, which was isolated from the saliva of a patient diagnosed with treatment-resistant schizophrenia. The patient was prescribed clozapine, an antipsychotic medication, which led to a dysbiotic oral microbiome. The strain exhibited resistance to cefpodoxime, a third-generation cephalosporin, and harbored various virulence factors and antimicrobial resistance genes. The study highlights the presence of a conserved chromosomal class-A β-lactamase homologue and a plasmid containing an aerobactin pathogenicity island homologue, which is associated with enhanced virulence. Additionally, bioactive thiopeptide biosynthetic gene clusters were universally present in P. septica genomes, suggesting a role in microbiome modulation. The findings emphasize the clinical relevance of P. septica and the need for surveillance of transient oral microbiota in vulnerable populations, including patients receiving clozapine. However, specific details regarding the patient's clinical outcomes, adverse events, or drug effects were not provided in the abstract.",
    "drugName": "CLOZAPINE",
    "adverseEvent": "No AE",
    "status": "qc_triage",
    "reviewDetails": {
      "severity": "",
      "causality": "",
      "expectedness": "",
      "outcomes": [],
      "recommendations": ""
    },
    "comments": [
      {
        "id": "bd1cb60e-ca38-4880-a1f3-1e3578f4b9e5",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Manual classification updated to \"ICSR\". Moving to QC Triage.",
        "timestamp": "2025-12-17T19:21:23.383Z",
        "type": "system"
      },
      {
        "id": "debd3998-9810-4be3-aa27-db0395f8f3c0",
        "userId": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
        "userName": "Arnab Nath",
        "comment": "Classification \"ICSR\" approved by QC",
        "timestamp": "2025-12-17T19:21:41.273Z",
        "type": "QC_approval"
      }
    ],
    "attachments": [],
    "createdAt": "2025-12-17T18:17:45.726Z",
    "updatedAt": "2025-12-17T19:21:41.282Z",
    "createdBy": "user_bf28651c-0b97-4303-a5b5-250ec8bd1d28",
    "reviewedBy": null,
    "approvedBy": null,
    "approvedAt": null,
    "type": "study",
    "aiInferenceData": {
      "PMID": "41192073",
      "DOI": "https://doi.org/10.1016/j.ijmm.2025.151681",
      "special_case": "No",
      "Country_of_first_author": "Ireland",
      "Country_of_occurrence": "Ireland",
      "Patient_details": "Human involved, no specific data",
      "Key_events": "Key events: The study involved the isolation of Pantoea septica strain GABEPS69 from the saliva of a patient diagnosed with treatment-resistant schizophrenia. The patient was prescribed clozapine, which led to a dysbiotic oral microbiome. The study focused on genomic analysis and resistance profiling of the isolated strain.",
      "Relevant_dates": "Relevant dates: not mentioned",
      "Administered_drugs": "Administered drugs: Clozapine",
      "Attributability": "Attributability: The dysbiotic oral microbiome and the opportunistic colonization by Pantoea septica strain GABEPS69 were attributed to the administration of clozapine.",
      "Drug_effect": "Drug effect: no data",
      "Summary": "The study focuses on the complete genome sequencing and comparative genomic analysis of Pantoea septica strain GABEPS69, which was isolated from the saliva of a patient diagnosed with treatment-resistant schizophrenia. The patient was prescribed clozapine, an antipsychotic medication, which led to a dysbiotic oral microbiome. The strain exhibited resistance to cefpodoxime, a third-generation cephalosporin, and harbored various virulence factors and antimicrobial resistance genes. The study highlights the presence of a conserved chromosomal class-A β-lactamase homologue and a plasmid containing an aerobactin pathogenicity island homologue, which is associated with enhanced virulence. Additionally, bioactive thiopeptide biosynthetic gene clusters were universally present in P. septica genomes, suggesting a role in microbiome modulation. The findings emphasize the clinical relevance of P. septica and the need for surveillance of transient oral microbiota in vulnerable populations, including patients receiving clozapine. However, specific details regarding the patient's clinical outcomes, adverse events, or drug effects were not provided in the abstract.",
      "Identifiable_human_subject": "Yes",
      "Text_type": "Case Report",
      "Author_perspective": "The article comments on the potential microbiome-modulating capacity of Pantoea septica and its clinical relevance, particularly in patients receiving clozapine. It highlights the strain's resistance to cefpodoxime and its virulence potential, suggesting the need for surveillance in at-risk populations.",
      "Adverse_event": "No AE",
      "Abstract": "This study aims to generate the first complete genome of Pantoea septica and provide a thorough genomic characterisation of this under-documented species. The study seeks to enhance understanding of P. septica, clarifying features relevant to opportunistic infection in vulnerable cohorts.\n\nP. septica GABEPS69 was an opportunistic coloniser isolated from the saliva of a patient prescribed the antipsychotic clozapine, leading to a dysbiotic oral microbiome. A hybrid sequencing approach yielded a closed genome comprising a 4.1 Mb chromosome and six plasmids. Phenotypic susceptibility was determined by disk-diffusion and minimum inhibitory concentration (MIC) assays. Its chromosomal and plasmidic content was bioinformatically analysed alongside all canonical GenBank available P. septica genomes and the type strains of taxonomic neighbours Pantoea piersonii and \"Pantoea latae\", with focus on virulence-factors (VFs), antimicrobial-resistance-genes (ARGs), metal-resistance-genes (MRGs) and biosynthetic gene clusters.\n\nGABEPS69 exhibited a narrow resistance spectrum, displaying resistance to the third-generation cephalosporin cefpodoxime. Plasmid pGABEPS69_1 harboured an aerobactin pathogenicity island homologue; a locus implicated in enhanced virulence, that was also identified across most other P. septica genomes and in the closely related human-pathogen Pantoea piersonii. A conserved chromosomal class-A β-lactamase homologue was also identified. Additionally, a universal presence of bioactive thiopeptide biosynthetic-gene-clusters was observed in P. septica genomes, suggesting a potential role in microbiome modulation.\n\nThis study presents a first complete genome of P. septica, revealing its genomic architecture, resistance, and virulence potential. Detailed plasmid analysis and comparative genomics enhance our understanding of the species clinical relevance and microbiome-modulating capacity. These findings motivate surveillance of transient oral microbiota in at-risk populations, including patients receiving clozapine.",
      "Title": "Complete genome and comparative genomic analysis of cefpodoxime resistant Pantoea septica strain GABEPS69 isolated from saliva of a patient diagnosed with treatment resistant schizophrenia.",
      "Confirmed_potential_ICSR": "P",
      "ICSR_classification": "Probable ICSR/AOI",
      "Substance_group": "CLOZAPINE",
      "Reference_database": "PUBMED",
      "Date_and_time": "2025-12-17 23:44:25",
      "Vancouver_citation": "McDonagh F, Kovarova A, Tumeo A, O'Connor A, McEvoy N, Lonappan AM, Venkateswaran K, Murray EK, Hallahan B, Miliotis G. Complete genome and comparative genomic analysis of cefpodoxime resistant Pantoea septica strain GABEPS69 isolated from saliva of a patient diagnosed with treatment resistant schizophrenia. Int J Med Microbiol. 2025;321151681",
      "pubdate": "2025-11-6",
      "Lead_author": "McDonagh F",
      "Serious": "No",
      "Test_subject": "No Test Subject",
      "AOI_drug_effect": "No Drug Effect",
      "Approved_indication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, the drug was prescribed to a patient diagnosed with treatment-resistant schizophrenia, which aligns with its conventional use. There is no indication of off-label use or non-conventional administration.",
      "AOI_classification": "Yes (ICSR)",
      "Justification": "The study mentions that the patient prescribed the drug of study experienced a dysbiotic oral microbiome, which led to the colonization of Pantoea septica. This suggests a link between the drug and a negative effect, even though the specific adverse event is not detailed.",
      "Client_name": "Demo",
      "Drugname": "CLOZAPINE"
    },
    "doi": "https://doi.org/10.1016/j.ijmm.2025.151681",
    "specialCase": "No",
    "countryOfFirstAuthor": "Ireland",
    "countryOfOccurrence": "Ireland",
    "patientDetails": "Human involved, no specific data",
    "keyEvents": "Key events: The study involved the isolation of Pantoea septica strain GABEPS69 from the saliva of a patient diagnosed with treatment-resistant schizophrenia. The patient was prescribed clozapine, which led to a dysbiotic oral microbiome. The study focused on genomic analysis and resistance profiling of the isolated strain.",
    "relevantDates": "Relevant dates: not mentioned",
    "administeredDrugs": [
      "Administered drugs: Clozapine"
    ],
    "attributability": "Attributability: The dysbiotic oral microbiome and the opportunistic colonization by Pantoea septica strain GABEPS69 were attributed to the administration of clozapine.",
    "drugEffect": "Drug effect: no data",
    "summary": "The study focuses on the complete genome sequencing and comparative genomic analysis of Pantoea septica strain GABEPS69, which was isolated from the saliva of a patient diagnosed with treatment-resistant schizophrenia. The patient was prescribed clozapine, an antipsychotic medication, which led to a dysbiotic oral microbiome. The strain exhibited resistance to cefpodoxime, a third-generation cephalosporin, and harbored various virulence factors and antimicrobial resistance genes. The study highlights the presence of a conserved chromosomal class-A β-lactamase homologue and a plasmid containing an aerobactin pathogenicity island homologue, which is associated with enhanced virulence. Additionally, bioactive thiopeptide biosynthetic gene clusters were universally present in P. septica genomes, suggesting a role in microbiome modulation. The findings emphasize the clinical relevance of P. septica and the need for surveillance of transient oral microbiota in vulnerable populations, including patients receiving clozapine. However, specific details regarding the patient's clinical outcomes, adverse events, or drug effects were not provided in the abstract.",
    "identifiableHumanSubject": "Yes",
    "textType": "Case Report",
    "authorPerspective": "The article comments on the potential microbiome-modulating capacity of Pantoea septica and its clinical relevance, particularly in patients receiving clozapine. It highlights the strain's resistance to cefpodoxime and its virulence potential, suggesting the need for surveillance in at-risk populations.",
    "confirmedPotentialICSR": "P",
    "icsrClassification": "Probable ICSR/AOI",
    "substanceGroup": "CLOZAPINE",
    "vancouverCitation": "McDonagh F, Kovarova A, Tumeo A, O'Connor A, McEvoy N, Lonappan AM, Venkateswaran K, Murray EK, Hallahan B, Miliotis G. Complete genome and comparative genomic analysis of cefpodoxime resistant Pantoea septica strain GABEPS69 isolated from saliva of a patient diagnosed with treatment resistant schizophrenia. Int J Med Microbiol. 2025;321151681",
    "leadAuthor": "McDonagh F",
    "serious": "No",
    "testSubject": "No Test Subject",
    "aoiDrugEffect": "No Drug Effect",
    "approvedIndication": "The drug of study, Clozapine, is conventionally used for treatment-resistant schizophrenia and psychotic disorders during Parkinson's disease when standard treatments fail. In this study, the drug was prescribed to a patient diagnosed with treatment-resistant schizophrenia, which aligns with its conventional use. There is no indication of off-label use or non-conventional administration.",
    "aoiClassification": "Yes (ICSR)",
    "justification": "Valid Case",
    "clientName": "Demo",
    "sponsor": "Demo",
    "userTag": "ICSR",
    "effectiveClassification": "ICSR",
    "qaApprovalStatus": "approved",
    "qaApprovedBy": "8ecfefd9-2cbe-4ffd-8040-64bf6c875e84",
    "qaApprovedAt": "2025-12-17T19:21:41.273Z",
    "qaRejectedBy": null,
    "qaRejectedAt": null,
    "qaComments": "",
    "r3FormData": null,
    "r3FormStatus": "not_started",
    "r3FormCompletedBy": null,
    "r3FormCompletedAt": null,
    "qcR3Status": "not_applicable",
    "qcR3ApprovedBy": null,
    "qcR3ApprovedAt": null,
    "qcR3RejectedBy": null,
    "qcR3RejectedAt": null,
    "qcR3Comments": null,
    "listedness": null,
    "seriousness": null,
    "aoiAssessedBy": null,
    "aoiAssessedAt": null,
    "medicalReviewStatus": "not_started",
    "medicalReviewedBy": null,
    "medicalReviewedAt": null,
    "fieldComments": [],
    "revokedBy": null,
    "revokedAt": null,
    "revocationReason": null,
    "assignedTo": null,
    "lockedAt": null,
    "_rid": "Vf9WAOX6zUj-CAAAAAAAAA==",
    "_self": "dbs/Vf9WAA==/colls/Vf9WAOX6zUg=/docs/Vf9WAOX6zUj-CAAAAAAAAA==/",
    "_etag": "\"00000000-0000-0000-6f8a-5f83840501dc\"",
    "_attachments": "attachments/",
    "_ts": 1765999301
  }
]